<SEC-DOCUMENT>0000885725-23-000026.txt : 20230504
<SEC-HEADER>0000885725-23-000026.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504160719
ACCESSION NUMBER:		0000885725-23-000026
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		75
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		23888676

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bsx-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:9cbc6555-e4c7-43a3-bb56-c8c16faaf364,g:530e6bfc-c5ff-4de2-ac46-2fa9fa8fd4fc,d:43fadb9987444221929c0db0dedbaf58--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:bsx="http://www.bostonscientific.com/20230331" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt="http://fasb.org/srt/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl8zLTEtMS0xLTE5MDkwMA_90f54358-ecb9-47be-a7fb-9fd571c35636">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl80LTEtMS0xLTE5MDkwMA_d6452de4-11a3-4e5f-b321-c2aadd21610f">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl81LTEtMS0xLTE5MDkwMA_426111ba-9d3e-41c0-80da-5bc968ad9bef">2023</ix:nonNumeric><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl82LTEtMS0xLTE5MDkwMA_6d302b1a-d2a5-4c8e-bb12-d7a5028dcbb7">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl83LTEtMS0xLTE5MDkwMA_ca0614e2-7c36-45b5-aefd-e9cfa38aa208">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ibc1ec8ea8b374d0f9b1e9578a88e69eb_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i988810e1696c4da3b18cc0a7b19cf868_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i084ee228a45f4b7bb61fef97408d319a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idadc520412e74e82b77efd62c7563138_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d208a9bfbca47429c91e10ed844e600_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83010d83b2be4843a9ea73d6857ee43b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcda9e1071cc41d1b93c4164824d0842_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6363b1347143b687c646c7bb59890c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4beb43815f44c8b975c46b4b7dcd066_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96e1149027c4441c86624768b5319f84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52087d690e344eaf99a1374ee56c5df4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79e80c25d9ef462985f4e0f891a5b5cd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e47b7f759564f6592973c4f4e05220f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe43718923134537b554888041f98acb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78ee2c8696148b78cf12753cd58c0d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bbe8629ec3a41feb7b1b3879baf9550_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fec5a384762417b96db579ad6bd03ad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3892319bf8004a208cbf25a606b4a2ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b064580a3054b7d8d6931e0234eef25_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8922db963039472f89f06b87d8657844_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd4b8ebe7cc34378889bcc457b5e983e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18021923822a43228b64f5223b7421f5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife464a07c09f41ecacbbec13eb93f31d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d52170be4f743378a4992e23d45569a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519498f0b57b477a94d127c9d99d8c5c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8039f48a66e437e86506c950f222249_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i550af412f2a94281896257850ac5c3cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10379de39e614c0bb89ed6c005f3c30d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f36ed1cf1547ba8293d1a829a2537e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7482b0cc18cc4cb5b95be5e301a03847_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6a51d9fab43472e9dba2c8acb6cbee6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec344c42ac640aaa2b967fe3886e028_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657a9b55825b423f8043e4c0876ac4e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2475a56a63d43499ecd47cd83f768cf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic86f00778306481a9e2dc5461c401ba6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2e1f4c4ff1e4eb6af4ba1ad9104b9e9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31ddba351344e03b261775eff8755cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff97cdf22f9541feb9bbf358623cd961_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf26ed1cd4b4ca5b515533656d047c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide43a5e742264d82bcb232842cf9058d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i479f625a10cb442d893bd1055659f74b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b5bcfa88dc4695b6f53f461176ea44_I20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ApolloMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibc8125bb5d9343a4aa4a0b3bea2a48af_D20230404-20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ApolloMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-04</xbrli:startDate><xbrli:endDate>2023-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bb00ce3cc2f43ed83cc43d46d7f4ece_I20230220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1076c0e73c48b8b0c16cb99f3fffa9_D20230220-20230220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-20</xbrli:startDate><xbrli:endDate>2023-02-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="krw"><xbrli:measure>iso4217:KRW</xbrli:measure></xbrli:unit><xbrli:context id="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i098c221da06c4b958585f779d2867c19_I20230220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93085ad25bc42338a5eab7de3e2cc41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99682e6da7ba40fab6c56eea230eec3f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6514d87e72ac4153a2523faf7d9b4ca6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21630f12b7d5477cbc3cbb55360587fb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c05ab454f604b7e938efdb8a3a9bedf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aeee52d764f4a80911bef9fddad1874_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d69f63508e4a52a7d288bbf2fa5e41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86dca2ec31934d279f4e60c2ac7559cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3e100c180dc4202883a3c603581fbc8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0216d912a174028acfdb839676e95d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b304742c4c54945b75a66597634648a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i586764f8498244c29e88444e4724fcbf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad160e4bd8e4bcaae224e370af0b112_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1330d5e86f34de7b8796fe68b26f65f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81d6dae3feb405fb58015de09433300_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e856d6687ec4e31a4d71bf973d3f28a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50cbf9066de44563ae1182748610f8cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86458492bffb48499c122917fa84b6b6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0700cfd128447b2b2157afb226d4c49_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfd41fe9b8c14589a6244f96d5d3a3a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="if0bcfb39920f4c2784fb6593b98b240a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c92289dc0046e1b8af6587d9138ebb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied91f3fdd793487f8fafa2ef73d957a5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75960dbfc53b4af29aeaf34569b6fa73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7064ffd3368f4eb3a7afa617f099937f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a460c2d84a40f2ab75d16a46ca5cf6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9902b3acea745368d2e51c9c3ed82a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44c957fd74e4baeb93c089d85303850_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6eb7f283e54256a9c5b643698ee72a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c98bbaa94e4fb39183b5fc22e895a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c826c5e16734ec89717f304d8a0b98b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7783d7ba4b7469eb8012fe17848bea5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f826c50348c4250a015338b19792179_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i713c9dc3fe0f4edbb6508415483a74d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a25af27795f4ad8995a221fef790ba3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i933e991579d346d98f5c6e3aef002501_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437328dd08c04fb38d5a0b1b7015575b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide57541620ac4f40b0aae359edea5b51_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife05e78966de43f7831ac0435f16576a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="idf9290bf261f4bbc88ca0dbf2972f8f8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i163d6247ba884128b6b3970a5d92963d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative_instrument"><xbrli:measure>bsx:derivative_instrument</xbrli:measure></xbrli:unit><xbrli:context id="i4daa711fa7aa43a598a5f35231e982df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b1a0b34b25746219cf0093a08066c29_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i916d03913e7d49e3a4641da09851e47e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e34a5fda334589af3a7f69f399f02e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb8afe4953c841d8aa1dc82c3cacc365_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i260db5b023b64acb974aa51c8180c68b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab5e7cbf2c543baa4c3f372a5dae6d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id43b656f9a51461296e0ba67c8f28cbc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa626542bcf4ab68ce0b85324fa5af0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88522e1e6ca14c4791fddea4df68cca6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="units"><xbrli:measure>bsx:units</xbrli:measure></xbrli:unit><xbrli:context id="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4353264371b04e91b16a346daea2114e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i783e008233514aabb69842649a72e8e1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b13667e719d448990cfdf861dda79e9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5662554837084169851758271c9ea643_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfe2b43cff154363a0fbd139022c61e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i988b6f2675a842b0bf177b07312667ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533dcba4722d4149a322054e6c21ee4e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic842743075f046118858ebcc610ace3b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a67240557664530a64b7331a50a1002_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c9733ef28a84cab80420249d9e34d87_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3156378bfa9448c8b52d41d89ee9ce34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia66d194331bf40009415048dd898504b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0625121c73b44dba2d3eade5207ea87_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07d1fca83b854131a110d8eddc52fb99_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i945f22e98cb74c1c921b309349665d17_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ac0fa25ca3e402287e10a15580bdd69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dbe63612beb45b3af51e535c5506a1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ce906fb637148c7bbedc7b9646ab929_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic29f210b79834812843eecfdcd89818f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38524f4cd7624584aff36aaaa318766a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i898b0c24ec0d4089ac323f8880881ab3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173913dc9a954a229c38034702d71dc5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dc55f108fce475dbd810515e835da38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a5c614a81345d596f132ed31bd8119_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64284d2d674f41c599406b01b23425de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b970c3c44be41b196e66ac05259c26d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bd7be06f3824d1989da8148901d8857_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2485d2d4fc42b2b4036a2cad3a8e72_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9892c74d12a64698ac3adb3291ee7fff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifae34dead96b45bcaba914062e411b97_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d6aed0afb24247bf0a0818471c3a5f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i238dacb96f504855af458d65d8c5cce3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i227be4a1b97846078107b1f776038d7a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03bea69ff7e4976a0b0e30e39be825e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i568fb51f289d40f6ba75256d02005ddf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62061beaf669413399ee8f50383a8892_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd06220f00384ae1a2d2a575490aaa1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2338d944a80349399e24d2d75f5c59bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2e5cf0d439f46b3b717276488fa7f9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c4a58684af4de9a487717ee618db7c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6c809593e643f1a097ae6dde04b29b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib14a9ce7ffb8424bafe5c3db543bd32a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i088272e4bb994960b019011fb46c0bcd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329ce681993e4c38be14123408b7f068_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc024eaf21d42bc86c27732930f65b6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i312f5201ec3c474d9b5a19c25fa7259b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c3009e88a024e31b2102e6f4b8d5acb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i756598df01014441b201792edc1fde81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a479cf5286f46b28b355c4f1a206db6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0554d11e01874a65b0a89d983fc7a7a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d7028932f6e425aab12bf8635b89b38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc2b17f7d56a4b5aa6d7e274b8e3927b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791d7b45dd054f389d7c0019d2f8803c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c3d756333b4be29340b18df8cd60c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i466b11229a244bf095c3c6d222c59179_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67d72460629d49a5bfd6e1d207d392c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8331296051435fb2a207702eabbbd7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ed1700e1b14f63b822bf214bf1ce6e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7750de1d7104c23afc566121d84f163_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fae5b08170b41889f5b3dedb667c496_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i960943048d6b4bd9ba267c6e877a0a08_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0b0dd532a74f04a579435e6746d19e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fc300f5c54f4bb08de690a8b948588e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb6225368867454f86259df1ee8ed4f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a33141a69104417b94015557d906a3c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e31ad2072de41b69ce29a3a8a2beccb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77928e50ff7a48e385018d59595b61eb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b7c20939ab4f34a1fa7424a5d6d03f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib94a53ec039740fa8792e11ae883a02c_I20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31562662eb6547fe95ffff0dfca2001c_D20210510-20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-10</xbrli:startDate><xbrli:endDate>2021-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie74fb9edc1e54a079f786a420c2ee7ef_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib16e6c7d489f4c34bf5a29a3c06aa219_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c5d438e1c44a81b2540ede941cd82f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id82f0c35a27940c9ae9176b5aeb5e9d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d9caf21868444e99250f18158da8bab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac1e88fabb7b45c9855c38e764079bc7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8202332b83334006af73c7c6ce87639e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e5721798f64931ab7f86adf91517af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1db4cf9dde84158b7c54dd06393c41d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c5612e005724c8d8c4db7a76f3396e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fd64d7c247c409fa4207f722c6c224c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c8a81e01b64601bd86cd95599e9025_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b1a47c2971475a887f95d6f09d61f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingAggregatePrincipalAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i093f5b3abdd745f1a8241d0453842764_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561fec84ddc04b59a8105f1d9d8ac489_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i703997e880b841bf912c19d2455d4f77_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e8b97cc2e8d4eb88ae1bdfe5cc6884c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib453388f5f184e4a82c28c4a8350b8bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d7c0732e164ffa8188acb478deb5c8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice1cde59638b4723b05549750c61c718_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99eaf8749fec4bd4bef896df3b9fd8c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40a0ea6834ac41f1b607a21df3a62801_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia218bd3302d5488a916178d33c82b82b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801c5c1c6a2442c086808723bb7fc47b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6c9ebfb99fa4dfeb3304751f22498b5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924e9479e6bf4f81906b0781426a7ba1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i524c7cd3f2f6432d98a7ae708c5f5aca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d88790c2af246f9a293243672a14f79_D20230131-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-31</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c8184b4c8c243b8af7637900054690c_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7f86060f0074e3fa81c9253f3234640_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ef2210d01348d08fdd30f6ff1570b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21deea3483f54e3b81ef33228bfe3f5f_D20230424-20230424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-24</xbrli:startDate><xbrli:endDate>2023-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i729502d0e5784f61982c93b93148e4fb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25a90bd0f1c4959a574e6b17d6a6895_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb4decd76ac944aba2576f8d09ebafe2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia920d3162ecd41e8890b68584ba18ffd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84eb384121c84b858baf58516ec1fe4a_I20201214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reportablesegments"><xbrli:measure>bsx:reportablesegments</xbrli:measure></xbrli:unit><xbrli:context id="ia353d52644074339b237aca193b8b1e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892e1507c0f84e27b277daf33bcc248a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabd1740aa87b4096a3a080290bcc5749_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i720152cb93a648a2bb7df641008979ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1209edcbb30e47fa9c4fb81d208f7e6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1262f85d5444afeb2e8bf8a337371ed_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ae924fcb6454d58b1beb6db9683dbdd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3179b68ff7d44c6494abf26a8009b478_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2beece93d3c417d868a8435ec76e880_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="business"><xbrli:measure>bsx:business</xbrli:measure></xbrli:unit><xbrli:context id="i3c68fb8458984a4f8ea9ffdd46d5ea2c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e2cf8c97fd4c64965a5f6aa819f9e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id347fa0ecf034855bd36b1bc5861689f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dc12ab5d66c4eb2b1365bc49a5014fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie71b6743f2b6457e8bf78a9b44e1408a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b43f39a384c40b3a17cb49b4126801d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20046af1ade34a1bb48b675de0ca23e5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9d8827599584437aad144dac6477fee_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc3815af2cc4d4a9f6872e38a324d73_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ddbe086cb5145cd83bb64b7179f7739_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b5346710804266aa4d620df4bb34fc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e204df240ac4042a4b13bf6f20f5c4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i096721fee95e47b791ea57339f0c6c6e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f00f6a7bb3544d58920179cebba0281_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie96d08ce6f50458ab49816d256c5879f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0790d1be80ae447488c9e5a9fc97437c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a866861cad402094fd324c25ba0ee9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cdc59667be948b992bcf7274af8504f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff459ba706d649ddbd4ec72d239941dd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3e41fa3eab7468c8b4e91101c3d9016_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib57c51fa109d491fbf453b46c2cf46ca_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idefdec8766de4485b6cdc952038f1024_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f524aabbb214853af93224fac9bf26a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c333bda857d4e739b41fed616fa6e68_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18982ae6885f4b8198ee1ce626bc22fd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01b2243c2754130a4e2ed20fe142983_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e952a467484badaea6d0b16ca1fa44_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife24678eb6c34b28945046363ea2e300_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic784b1fc58dc49f699ae6044fe608256_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93ae74b5a9e41fdbaa62e517659928e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08294063f673491c88ed513f79e9696f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i943d4120b79b4e69b07762eaf7b26e21_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6096985306aa4386b7ea6027c25d855c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3410600120b47b5bfe3ab5c48f59e1c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if02e957943204cfb9fb85d6b73a32689_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie616f026675d4c09a0ac3e6282f05cf8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38f221dbc7b741d79383b223f9e27c7b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26380f708b9e4841930b61b187def315_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee563d35506f470b9f10eb39f4283205_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8d8f220044d42889463ea08e1cf165b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0c54cf535041beb749a2a1df797e45_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5556344fb56743dbae6d822773174a4a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28b59b162ea849ca9be28f0f9fa67f2d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078220c195b64332b042b94c0d76ab95_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd1c2ac83d1f46a6be7dd082708aa903_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c352b4948b8481485df395a9cc353c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10971b0415014c579cc2dbb8f66240e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7961173213db4f5d91d6d2e7211fd02c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f0050baa10746afa4706c455030ba41_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i829d668e2b3c49fc845a7c3a6cdd828c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3889e23d356499d9f44ad951bed2120_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb44bd7e5a5c407ebc133a722c9a1308_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03e6d0e45f264ed697fcf267f645c2fc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4503a934cd0405d9071461ef9d0b03c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad755ea2c6d3473d8e3a08e615f25c1b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3068a1c629b847b3b49438fc4cb80ef1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b5eca007cb54f15afd6e2c739116757_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9688a45fc2049beb9a82a633381002e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5422ebead84c4ded81dca3fef4d9458f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844a962b3a3d4374b6d7ab653485bcbd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73f4b2c0cdd4b4d86b93f555d5f2835_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a6956ee87544c1ad636a7500e3ef26_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb98bc5824349e0a016e837ad7726b5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic937499f758443ae828dea9b24a41dba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i510c5d8a3423489a9deb5ae4f8f2de17_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fc93a4a42604befa962d6c0f4e94d6e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica31a05afc6142cdb6e3553ebec68348_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89df95595aa24a1c9855a94a80a41df0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f896077c40e4dbabd217e2aa1f4c9a5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bba908d72404714bf08fea400279688_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f4f8c9dec7f4aec8d00394ff1f2c185_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieffcfd57b85847f5b9ac168b84a7fb47_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d805dfd29434cc483bf10e47f598abd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975a78bf3f974f3d82fb89c8f671b311_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dc7a3a9179c4bee8cc766a1114c8a59_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6264f6b9421a4ec4a9454dbc24c596cc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i43fadb9987444221929c0db0dedbaf58_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA1_58c3106e-5487-4e22-8fa6-9abf532771e2">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6YWU4YzExYjgzZTE0NDhkYzkwYTc3MWIyZGRhZDUyODkvdGFibGVyYW5nZTphZThjMTFiODNlMTQ0OGRjOTBhNzcxYjJkZGFkNTI4OV8wLTAtMS0xLTE5MDkwMA_4297bc37-a7e4-4e9d-bdd7-c89f42e81d1c">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8xMjA_09ca490d-fa99-4803-a981-d69ba4bd0fa4">March&#160;31, 2023</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6OTY0NTE0MDU4NTdmNDNhZTg4ZjllODBlNmM1ZGNiZmUvdGFibGVyYW5nZTo5NjQ1MTQwNTg1N2Y0M2FlODhmOWU4MGU2YzVkY2JmZV8wLTAtMS0xLTE5MDkwMA_275e632f-f555-4933-bbda-186ed5fdffa8">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEw_26439fe7-7691-4d96-851e-54fbed352bdd">1-11083</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEx_74fdedff-be60-42c3-abf8-7fd833e6c578">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6Njc4NjUxZjhjZDQ5NDllMmI5OTUwMWNmMGQ4MzRhM2YvdGFibGVyYW5nZTo2Nzg2NTFmOGNkNDk0OWUyYjk5NTAxY2YwZDgzNGEzZl8wLTAtMS0xLTE5MDkwMA_9ca6deeb-dd06-4f8b-a512-c0f64e9ebe64">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6Njc4NjUxZjhjZDQ5NDllMmI5OTUwMWNmMGQ4MzRhM2YvdGFibGVyYW5nZTo2Nzg2NTFmOGNkNDk0OWUyYjk5NTAxY2YwZDgzNGEzZl8wLTItMS0xLTE5MDkwMA_c2a647e4-6d44-4f0c-b96f-5cfceedbaad0">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA2_89575c21-083c-4136-8eb7-2054a3a922c8">300 Boston Scientific Way</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA3_ebadd50e-b810-47b3-90d4-5c9d76e52473">Marlborough</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEy_15e62344-8782-4677-b1c1-67cdb6a9f026">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDAx_0d4c3d30-8ef1-4b41-8585-c5fd623d7dc5">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA4_aad7cf8a-4ce3-4f6d-b0bc-7a7c54b807b7">508</ix:nonNumeric> <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEz_2123a617-8e29-4b6f-9152-a415530fe99d">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8xLTAtMS0xLTE5MDkwMA_a5e35047-fee6-4649-b90a-311ed4513247">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8xLTItMS0xLTE5MDkwMA_e62245ad-ae3e-4be0-a7b3-cdb5f8f2685a">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8xLTQtMS0xLTE5MDkwMA_eb95bbcd-4aa0-4af1-8721-c0a1e3c36dc6">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8yLTAtMS0xLTE5MDkwMA_e42e08ce-2f85-488f-98a1-f58523a67a76">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8yLTItMS0xLTE5MDkwMA_8c6119c8-b373-4642-94bc-fbb174d859a2">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8yLTQtMS0xLTE5MDkwMA_e04aef53-b5a0-4abe-8551-cd406a7151f2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8zLTAtMS0xLTE5MDkwMA_bccf9afb-ba54-4e5f-af4b-263367f72544">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8zLTItMS0xLTE5MDkwMA_baa76ba9-ac8a-4103-bcad-3db3454571b4">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8zLTQtMS0xLTE5MDkwMA_8fdc917e-62f0-4872-a152-1fa74203a3d6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA0_39eea763-84eb-4181-9d9a-0f74baaa7d6a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDAy_edc10973-5ca0-4c26-994a-8fd966cbe15b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDM0ZTk2OGUxZmU2NGU1MThkOTgzYmIyZWMzMmFmMTQvdGFibGVyYW5nZTpkMzRlOTY4ZTFmZTY0ZTUxOGQ5ODNiYjJlYzMyYWYxNF8wLTAtMS0xLTE5MDkwMA_f65a95ba-38e9-49b8-a148-3b346d232233">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDM0ZTk2OGUxZmU2NGU1MThkOTgzYmIyZWMzMmFmMTQvdGFibGVyYW5nZTpkMzRlOTY4ZTFmZTY0ZTUxOGQ5ODNiYjJlYzMyYWYxNF8xLTMtMS0xLTE5MDkwMA_5e4e4c3b-0fc2-40f0-9394-d042a7fd301f">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDM0ZTk2OGUxZmU2NGU1MThkOTgzYmIyZWMzMmFmMTQvdGFibGVyYW5nZTpkMzRlOTY4ZTFmZTY0ZTUxOGQ5ODNiYjJlYzMyYWYxNF8yLTMtMS0xLTE5MDkwMA_ab5e586f-d15c-427b-9e28-328f904626ad">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDAz_4fdd04be-96a1-4c6e-a312-301409e9b774">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of Common Stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="2" name="dei:EntityListingParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8xOTYy_1213641e-c4cc-49bf-8ee8-92e1f304eb3f">0.01</ix:nonFraction> par value per share, as of April&#160;28, 2023 was <ix:nonFraction unitRef="shares" contextRef="ibc1ec8ea8b374d0f9b1e9578a88e69eb_I20230428" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8xOTk5_c31e140b-b819-4539-a99e-e71b71fea8ba">1,437,698,101</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_16">Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_19">Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_22">Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_22">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_25">Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_25">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_28">Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_31">Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_34">Notes to the Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_34">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_130">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_130">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_130">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_157">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_157">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_157">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_160">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_160">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_160">51</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_163">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_163">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_163">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_166">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_166">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_166">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_169">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_169">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_169">52</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_175">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_175">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_175">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_178">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_178">54</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMy0xLTEtMS0xOTA5MDA_a1b7245a-68c0-4aa6-9702-5d9c69514baa">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMy0zLTEtMS0xOTA5MDA_48df2a06-27d8-42ac-b8b8-8f2e135c377f">3,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNC0xLTEtMS0xOTA5MDA_fe07021c-af01-4747-ab07-b0d2741a4301">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNC0zLTEtMS0xOTA5MDA_250919c6-14aa-42be-bf15-555f53ab0adc">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNS0xLTEtMS0xOTA5MDA_b7416a25-c404-4dc5-93be-3bfd7dc9922a">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNS0zLTEtMS0xOTA5MDA_411af54a-4429-426c-ba0d-02dcf472df2a">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOC0xLTEtMS0xOTA5MDA_43cd86ee-ae56-4be7-ae9f-aef7d70780df">1,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOC0zLTEtMS0xOTA5MDA_c52d1d5c-fb33-42c5-8b81-efc67e873c2e">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOS0xLTEtMS0xOTA5MDA_51769dd9-29b5-4b29-b0a6-a6ad7fa31753">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOS0zLTEtMS0xOTA5MDA_e54ac776-ae80-4d25-a5d2-16b12eaafe71">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTAtMS0xLTEtMTkwOTAw_193b4c43-c4d6-468e-9d01-d9d912df9caa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTAtMy0xLTEtMTkwOTAw_f25a4c59-0047-4757-a14c-69489f9c6c5c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTEtMS0xLTEtMTkwOTAw_329bc664-19b3-4471-bafc-f5376467f6aa">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTEtMy0xLTEtMTkwOTAw_a194df8f-8ce3-4ed7-b7c9-50bc9cc178a7">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTQtMS0xLTEtMTkwOTAw_42bbf697-c5b2-4444-84a9-d11b8ea3e76b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTQtMy0xLTEtMTkwOTAw_7657d510-02cb-4202-a40b-8d4bd709e834">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTUtMS0xLTEtMTkwOTAw_83573916-dbd1-425b-9c9b-08099677ea2d">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTUtMy0xLTEtMTkwOTAw_7acb73fb-df4e-4924-82d6-839a73910a6a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTgtMS0xLTEtMTkwOTAw_43bc5d7b-8796-424b-abbb-c99179c0ce12">1,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTgtMy0xLTEtMTkwOTAw_27776946-6545-4a4e-b29e-1f685d367c1a">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTktMS0xLTEtMTkwOTAw_dcb620b8-6fe7-4fb4-9c22-22952ecafd68">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTktMy0xLTEtMTkwOTAw_15aea8b8-667c-4ed6-b937-9177c8d0f78c">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjItMS0xLTEtMTkwOTAw_9a76d258-db44-4f31-881a-69088d07036c">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjItMy0xLTEtMTkwOTAw_354c7682-951b-440f-ba55-4bb482a0f1f7">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjMtMS0xLTEtMTkwOTAw_f16d8eac-cc2e-4272-8105-424a2f5a01ca">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjMtMy0xLTEtMTkwOTAw_c3704d91-b57a-45db-9dc4-2406ff7f84e7">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjQtMS0xLTEtMTkwOTAw_644f3d8f-fd6b-4ef8-bcf6-2d364451c8ed">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjQtMy0xLTEtMTkwOTAw_cde1a182-d2ee-4615-85d6-56fdf6f6baf2">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjUtMS0xLTEtMTkwOTAw_e23d01e1-2d1a-42d2-9baf-bd3050c3f733">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjUtMy0xLTEtMTkwOTAw_f11fe47b-5ba8-4ae1-acb5-b1abc3853ecb">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjYtMS0xLTEtMTkwOTAw_f1787460-5268-4352-a0ae-c09b45ec0105">314</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjYtMy0xLTEtMTkwOTAw_ceaf1812-609a-4f4d-888c-fe47738c5cfd">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjctMS0xLTEtMTkwOTAw_b326dba5-8ab4-479c-8c35-7c45bc4cda42">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjctMy0xLTEtMTkwOTAw_9987c680-3f21-4ce5-b81f-5a10f6ea3f00">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjktMS0xLTEtMjEzODcz_bff3f0d2-165b-4609-a3ae-d4bbe7935c56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjktMy0xLTEtMjEzODcz_80aa467e-7263-4042-98c8-d6200a5cdb35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to Boston Scientific common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:NetIncomeLossAttributableToBostonScientificCommonStockholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjgtMS0xLTEtMTkwOTAw_355f9ad3-bacb-4020-bc07-99f0a443cddd">300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="bsx:NetIncomeLossAttributableToBostonScientificCommonStockholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjgtMy0xLTEtMTkwOTAw_65f7d587-1c0b-4f7e-b5ce-f5ddda048057">97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzAtMS0xLTEtMTkwOTAw_09869312-1242-40bc-8e66-8a8d25d710e5">0.21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzAtMy0xLTEtMTkwOTAw_e7c102ea-e010-47cc-a206-d566046fbd8c">0.07</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzEtMS0xLTEtMTkwOTAw_d2c7a8e2-3674-4a94-b67f-03fb55a87973">0.21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzEtMy0xLTEtMTkwOTAw_17c13657-aede-4ee3-a23f-3514486f07f7">0.07</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzQtMS0xLTEtMTkwOTAw_e341ed4a-e7cf-4720-95ad-bff58593a76d">1,435.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzQtMy0xLTEtMTkwOTAw_2057ff1d-9b03-401d-9381-4d0efa14bde3">1,427.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzUtMS0xLTEtMTkwOTAw_c5fb5842-a199-4545-8dc7-3e4ea347b41d">1,446.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzUtMy0xLTEtMTkwOTAw_1a3f809e-585e-46da-a693-0bcb0cd626bc">1,438.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMi0xLTEtMS0xOTA5MDA_f1787460-5268-4352-a0ae-c09b45ec0105">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMi0zLTEtMS0xOTA5MDA_ceaf1812-609a-4f4d-888c-fe47738c5cfd">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNC0xLTEtMS0xOTA5MDA_dd7b95ba-1fee-4a98-8eff-fc69cfb34c06">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNC0zLTEtMS0xOTA5MDA_1ff23a7f-12bb-4e49-8921-e98a11494dae">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNS0xLTEtMS0xOTA5MDA_362014a3-c54b-4b53-babd-01728298a5b4">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNS0zLTEtMS0xOTA5MDA_d9e3b17b-1c97-4209-b215-f6f97e7e0427">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNy0xLTEtMS0xOTA5MDA_7aa92dfd-4bed-4a79-ad49-8fbb098f3852">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNy0zLTEtMS0xOTA5MDA_acf35cc8-67c2-43a1-9003-ebd9ba16662a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOC0xLTEtMS0xOTA5MDA_ac12faec-3dfe-4e21-b8b1-a6847086f91c">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOC0zLTEtMS0xOTA5MDA_f39f491e-2b8e-4006-bb24-b3b40cd9c71e">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOS0xLTEtMS0xOTA5MDA_12243445-414e-401e-8781-49b0daea3e3d">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOS0zLTEtMS0xOTA5MDA_13a0db0e-09e8-4dba-9112-8ca11e3b59a3">69</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTAtMS0xLTEtMjA0Mjc2_aa26840f-145f-45d1-a14e-e6419efb51cf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTAtMy0xLTEtMjA0Mjg0_5cd1d855-9999-4abd-b26e-5e0e8520ef33">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Boston Scientific common stockholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTEtMS0xLTEtMjA0Mjc2_3bb0a7e4-9d76-47d9-866d-b27117be2971">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTEtMy0xLTEtMjA0Mjg0_39045199-d018-4893-b496-4659f06e9acb">69</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNC0xLTEtMS0xOTA5MDA_a3f851be-acd1-4cc9-8d1d-aee7ae265019">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNC0zLTEtMS0xOTA5MDA_9e25bd26-f147-4006-93bf-772a1d72d370">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNS0xLTEtMS0xOTA5MDA_172a1097-7156-4551-be0c-0294cb17d671">2,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNS0zLTEtMS0xOTA5MDA_187ce7cd-9d5c-4cea-8c06-f90d1a8c7019">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNi0xLTEtMS0xOTA5MDA_e83d32de-efb3-4610-a692-1c3dcc5bb2e2">2,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNi0zLTEtMS0xOTA5MDA_205fa99f-f4dd-4987-bbdd-40fc8d2746f6">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNy0xLTEtMS0xOTA5MDA_80d8249d-5785-4c8f-b652-26a48e8f384d">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNy0zLTEtMS0xOTA5MDA_4d963b7f-8774-4e96-b6c9-8e8737f6ac8f">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfOS0xLTEtMS0xOTA5MDA_656cb860-6275-4542-8fd5-490b79fc86cf">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfOS0zLTEtMS0xOTA5MDA_5a200384-2e0d-445c-8007-0a7f1ed058be">731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTAtMS0xLTEtMTkwOTAw_cad188ee-1be7-4870-bb97-f5521c324866">5,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTAtMy0xLTEtMTkwOTAw_97c70ce9-d36d-4bba-a665-02f13bfc5a3a">5,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTEtMS0xLTEtMTkwOTAw_70459911-14a1-4569-9f25-36803ae14adc">2,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTEtMy0xLTEtMTkwOTAw_49149d3d-f5b6-4761-a100-4ef9885d44f1">2,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTItMS0xLTEtMTkwOTAw_2b32bcc5-8f5b-4240-a9ec-8009e259f4fa">13,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTItMy0xLTEtMTkwOTAw_35bc769e-f733-48cb-8f0e-8d07bc2ae168">12,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTMtMS0xLTEtMTkwOTAw_93da46b3-01ae-4580-a92e-126d31874737">6,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTMtMy0xLTEtMTkwOTAw_9c78c2f3-a622-4b3a-b245-0dd192c68aa1">5,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTQtMS0xLTEtMTkwOTAw_e0cb44b0-bd73-486b-af6f-5e7bd923e22b">3,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTQtMy0xLTEtMTkwOTAw_617685c5-18f0-4877-99a1-1976f031d3c6">3,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTUtMS0xLTEtMTkwOTAw_4c573ded-30cb-46b1-91ee-d6daeda42cbf">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTUtMy0xLTEtMTkwOTAw_7b05d348-e3c8-44c9-8f64-be5ff3d369d9">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTYtMS0xLTEtMTkwOTAw_7ce19842-93e1-49e9-b1f0-51d43a28ad09">32,892</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTYtMy0xLTEtMTkwOTAw_eef1f5de-d33f-497a-be5f-4020fabd1145">32,469</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjAtMS0xLTEtMTkwOTAw_6dbe0254-45d2-4909-ab77-a3be641affb6">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjAtMy0xLTEtMTkwOTAw_f4d9e20f-80f5-442c-a0a2-8d51ecf3f9e0">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjEtMS0xLTEtMTkwOTAw_294b5328-c280-40f2-91a1-b0e215282e58">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjEtMy0xLTEtMTkwOTAw_974be403-a615-4a59-a387-d2520ebd10e3">862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjItMS0xLTEtMTkwOTAw_fcceb9c9-e876-4658-9cad-f5bc8c52cf94">1,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjItMy0xLTEtMTkwOTAw_e34dd29b-a130-466a-9d83-dd90e39ef525">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjMtMS0xLTEtMTkwOTAw_e286facd-8f41-4cf6-ad2c-831dfffdaa98">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjMtMy0xLTEtMTkwOTAw_88eb6f54-3046-4fe3-84b4-1010eb8508ac">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjQtMS0xLTEtMTkwOTAw_c9b4058e-b736-4189-ae60-1e347879845d">4,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjQtMy0xLTEtMTkwOTAw_2cf34e8e-236d-42da-93ce-144287ee7906">3,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjUtMS0xLTEtMTkwOTAw_a446cb3d-79e4-44f7-add8-6adf648891ca">8,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjUtMy0xLTEtMTkwOTAw_4e5074ad-65b2-48c1-928b-09ca691ea003">8,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjYtMS0xLTEtMTkwOTAw_1baa34c0-8ea7-476e-b4bc-ede9e940883e">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjYtMy0xLTEtMTkwOTAw_32b92c68-2e2b-4d41-9b2f-d97ff8c75b3f">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjctMS0xLTEtMTkwOTAw_4336c5be-7cd6-4086-acb2-059dd314ba2a">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjctMy0xLTEtMTkwOTAw_fc2989ce-d1b2-4491-a24f-20bff54d83f0">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjktMS0xLTEtMTkwOTAw_8e1eae3a-8e7e-4333-9ca4-e0b1ab6add46"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjktMy0xLTEtMTkwOTAw_b8d454d7-a743-4a34-b61d-b09a2a571ffe"></ix:nonFraction></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfMjE_04069b73-0ba7-4f1e-9341-cb6b43539ee2"><ix:nonFraction unitRef="usdPerShare" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfMjE_acaeeb5e-9b25-49eb-925d-7ec6d0363bd6">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNDc_930cdab0-d6d5-4357-9c40-ab02fedaae60"><ix:nonFraction unitRef="shares" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNDc_dd91a30d-c7eb-4f75-9650-021687e74649">50,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNjY_15a7b00a-b5f3-479d-958f-e5e447b432cb"><ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNjY_38f33198-585e-4f0f-8d98-621bc3d10100">10,062,500</ix:nonFraction></ix:nonFraction> shares as of March&#160;31, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMS0xLTEtMTkwOTAw_d09820ae-9edc-48b9-947a-b8338c242739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMy0xLTEtMTkwOTAw_cebd71db-7f1c-47b9-aa63-d5d8343e8296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfMTg_426048c0-9485-4a48-9e5b-ebdd8de1bb9c"><ix:nonFraction unitRef="usdPerShare" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfMTg_e3f37f63-a634-4a87-aac1-0ebc5339db2f">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfNDQ_1981ac40-f733-4895-ad07-adb5838b9b7a"><ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfNDQ_f99949aa-f6f3-40bb-9f92-d0e9b6e4e84c">2,000,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfNTQ5NzU1ODE0MDQ0_3d4ce748-11fe-4985-bd35-82719f8317eb">1,700,828,873</ix:nonFraction> shares as of March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfMTAy_934d7d64-7451-4092-ae28-aa7c2ed65fe6">1,696,633,993</ix:nonFraction> shares as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMS0xLTEtMTkwOTAw_5782d451-dbb1-4d5f-a190-afb3f515aab5">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMy0xLTEtMTkwOTAw_1aea7773-49b8-4151-8a5b-0f0d245885b1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="0" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246YzVmZTI0YTJkOTA5NDMzOTgyNDczZDhjNDM0Njg4NjhfMzA_97a6d4de-340c-483c-adb3-ba5666fd5a73"><ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="0" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246YzVmZTI0YTJkOTA5NDMzOTgyNDczZDhjNDM0Njg4NjhfMzA_d668475a-218b-436f-a581-e75c12e231a5">263,289,848</ix:nonFraction></ix:nonFraction> shares as of March&#160;31, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMS0xLTEtMTkwOTAw_3036e4d2-e7ef-41e7-98f9-31f824540892">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMy0xLTEtMTkwOTAw_5fb89591-d2a8-46f4-8663-760d63b61160">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzUtMS0xLTEtMTkwOTAw_76aa1949-1c9b-476f-a9c8-49ac452b5fbb">20,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzUtMy0xLTEtMTkwOTAw_f996aa4b-57a7-41a4-a8c9-5df63b62212e">20,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzYtMS0xLTEtMTkwOTAw_9b4bf53d-9356-49db-9c4a-c7bc3d723627">450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzYtMy0xLTEtMTkwOTAw_0cc41653-6c97-404d-a644-4ff714dafd9f">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzctMS0xLTEtMTkwOTAw_3f657852-bb5d-497f-bed9-55a95d131f97">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzctMy0xLTEtMTkwOTAw_cfd2ea7f-0108-45c0-b3d3-932e919dfe44">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzgtMS0xLTEtMTkwOTAw_db0dbb8c-a468-4737-8145-0ffaf538ab58">17,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzgtMy0xLTEtMTkwOTAw_ca67fe7e-2d39-4fdc-a84f-589bc445b1a8">17,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMS0xLTEtMTkyMjg5_e1aea8b5-82ae-4404-9d0f-21ac17512a3e">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMy0xLTEtMTkyMjk3_8ad91a68-4ccd-4ba0-bd16-b2b3b90133d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNDAtMS0xLTEtMTkzMDQ3_c9f87448-98b6-4754-ac72-d69cd4d659a0">18,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNDAtMy0xLTEtMTkzMDM3_6f46721f-38c7-46dc-8de9-a33214fb2995">17,573</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMS0xLTEtMTkwOTAw_a6e7c76c-08fe-4bb6-a5d8-e6d1de87052f">32,892</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMy0xLTEtMTkwOTAw_51d4e01e-607d-4d60-bcd3-2332d550f91d">32,469</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred stock shares issued</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084ee228a45f4b7bb61fef97408d319a_I20221231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMy0xLTEtMS0xOTA5MDA_a4d03878-30a5-473c-abe1-130aff4589bd">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idadc520412e74e82b77efd62c7563138_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMy0zLTEtMS0xOTA5MDA_29f00b4a-b1bd-4e16-96ec-f0d5cecc7358">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d208a9bfbca47429c91e10ed844e600_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNC0xLTEtMS0xOTA5MDA_c3ebf336-b1a1-4bac-8901-adad8dcb80bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83010d83b2be4843a9ea73d6857ee43b_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNC0zLTEtMS0xOTA5MDA_ee77214d-0092-4f88-80cf-bccac9ad6b3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifcda9e1071cc41d1b93c4164824d0842_I20230331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNS0xLTEtMS0xOTA5MDA_14f47a0e-d256-4730-b8a1-3ef18868c88e">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica6363b1347143b687c646c7bb59890c_I20220331" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNS0zLTEtMS0xOTA5MDA_1eff8d89-defb-43e7-9546-ef32b3e70170">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock shares issued</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4beb43815f44c8b975c46b4b7dcd066_I20221231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNy0xLTEtMS0xOTA5MDA_2f992e0f-8175-4a04-a588-7ab2b34c7dc6">1,696,633,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96e1149027c4441c86624768b5319f84_I20211231" decimals="0" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNy0zLTEtMS0xOTA5MDA_b62ff99a-95ee-482c-9039-cd8230c98067">1,688,810,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOC0xLTEtMS0xOTA5MDA_3fb25a5d-c873-4119-96be-f92d7fd0facb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOC0zLTEtMS0xOTA5MDA_7a5cc832-2549-4c7e-930f-e33564ad7c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOS0xLTEtMS0xOTA5MDA_2ca25875-e90e-40c9-8fac-2f7b6d5cbc24">4,194,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOS0zLTEtMS0xOTA5MDA_47347554-7ddc-431d-a358-a698fc3d49d3">4,018,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTAtMS0xLTEtMTkwOTAw_1683620d-cbcb-4f4e-b843-33e47a79d538">1,700,828,873</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTAtMy0xLTEtMTkwOTAw_3c305ea6-36e8-4d89-a285-ec87ff041dde">1,692,828,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084ee228a45f4b7bb61fef97408d319a_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTMtMS0xLTEtMTkwOTAw_b7676f56-2983-4643-90d0-5af61a8e9b42">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadc520412e74e82b77efd62c7563138_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTMtMy0xLTEtMTkwOTAw_9d3f84da-0e59-47b0-bf15-2348028ee381">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d208a9bfbca47429c91e10ed844e600_D20230101-20230331" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTQtMS0xLTEtMTkwOTAw_0467c718-b1b7-45e3-ae24-201a297fa754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83010d83b2be4843a9ea73d6857ee43b_D20220101-20220331" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTQtMy0xLTEtMTkwOTAw_8049b0e1-df6d-4f60-997f-c87d267a6d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcda9e1071cc41d1b93c4164824d0842_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTUtMS0xLTEtMTkwOTAw_ab13c31e-dbad-48af-88d0-656cdd3a34f3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6363b1347143b687c646c7bb59890c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTUtMy0xLTEtMTkwOTAw_f7721c9c-35f1-4eb4-a3eb-ba35925ecf63">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4beb43815f44c8b975c46b4b7dcd066_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTctMS0xLTEtMTkwOTAw_dc7eb818-a280-465b-af7c-37f0fb3aca28">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e1149027c4441c86624768b5319f84_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTctMy0xLTEtMTkwOTAw_24ccb4d5-dac7-4f2e-a4de-bbd9cd846f89">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTgtMS0xLTEtMTkwOTAw_8907d047-afd8-4607-87ed-d6667d1ec7f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331" decimals="-6" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTgtMy0xLTEtMTkwOTAw_5d525fb7-ebcf-433b-a276-f00f002dcfc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTktMS0xLTEtMTkwOTAw_888cdc71-b6cb-4407-b6ba-09cb86c199a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTktMy0xLTEtMTkwOTAw_51c4f8fa-bc62-45c9-af6c-3a7ce82ffcf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79e80c25d9ef462985f4e0f891a5b5cd_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjAtMS0xLTEtMTkwOTAw_14aed425-78fa-4831-a101-f83ee1238337">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e47b7f759564f6592973c4f4e05220f_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjAtMy0xLTEtMTkwOTAw_08fadb1c-0053-4c32-9d32-515460ebf625">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe43718923134537b554888041f98acb_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjItMS0xLTEtMTkwOTAw_d2b52b92-185e-4883-a5b9-4ad678940539">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib78ee2c8696148b78cf12753cd58c0d8_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjItMy0xLTEtMTkwOTAw_21a663f5-b4cb-425f-99d4-008387762cf6">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbe8629ec3a41feb7b1b3879baf9550_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjMtMS0xLTEtMTkwOTAw_d893d329-043b-4d63-a538-074e8758e9f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fec5a384762417b96db579ad6bd03ad_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjMtMy0xLTEtMTkwOTAw_78b62f45-934e-4dba-9ed0-cb9a2d13e0e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3892319bf8004a208cbf25a606b4a2ab_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjQtMS0xLTEtMTkwOTAw_0ab35f81-9410-45a6-9826-d9210f7f4ca3">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b064580a3054b7d8d6931e0234eef25_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjQtMy0xLTEtMTkwOTAw_c97490d4-9fd5-4dfd-a517-ee19d0c6418b">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8922db963039472f89f06b87d8657844_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjYtMS0xLTEtMTkwOTAw_79ea34a8-aa8b-463b-b862-4dbf98a9b0dc">20,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4b8ebe7cc34378889bcc457b5e983e_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjYtMy0xLTEtMTkwOTAw_c80930c6-0fdb-48b4-b04c-941d3338faa1">19,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18021923822a43228b64f5223b7421f5_D20230101-20230331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjktMS0xLTEtMTkwOTAw_d9fcb140-273c-4bb0-b6c4-5b7f288c8168">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife464a07c09f41ecacbbec13eb93f31d_D20220101-20220331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjktMy0xLTEtMTkwOTAw_e1cff3b0-d7a0-4dc0-95f2-2c12ae978af3">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d52170be4f743378a4992e23d45569a_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzAtMS0xLTEtMTkwOTAw_d8abd47e-6581-4b24-b459-d498a9f3a63a">20,356</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519498f0b57b477a94d127c9d99d8c5c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzAtMy0xLTEtMTkwOTAw_64a22d50-28b1-413c-85ed-eba75d469962">20,043</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8039f48a66e437e86506c950f222249_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzItMS0xLTEtMTkwOTAw_f2e4759b-0e4b-4d3a-be1e-ba32358c63fb">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i550af412f2a94281896257850ac5c3cd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzItMy0xLTEtMTkwOTAw_a9d5a03e-ae7f-4f14-99de-b2e307b812d6">1,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10379de39e614c0bb89ed6c005f3c30d_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzMtMS0xLTEtMTkwOTAw_fe5a86eb-22fa-4181-a251-8fe425fd41b8">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f36ed1cf1547ba8293d1a829a2537e_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzMtMy0xLTEtMTkwOTAw_50a8b326-0603-4c5a-afd8-9e8d2e0a3856">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10379de39e614c0bb89ed6c005f3c30d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzQtMS0xLTEtMTkwOTAw_70a821bf-2c1f-41f4-b882-8f591f83966f">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0f36ed1cf1547ba8293d1a829a2537e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzQtMy0xLTEtMTkwOTAw_987d9a46-b143-4ff1-bc2b-be33ed816a45">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7482b0cc18cc4cb5b95be5e301a03847_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzUtMS0xLTEtMTkwOTAw_0724e536-4b40-4bd5-8707-50f274ecd3f7">450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6a51d9fab43472e9dba2c8acb6cbee6_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzUtMy0xLTEtMTkwOTAw_66e7782d-082a-47cc-a48f-96dc7467d04d">1,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss), Net of Tax </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec344c42ac640aaa2b967fe3886e028_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzctMS0xLTEtMTkwOTAw_1df53416-4532-484f-ad3d-d5bdf6205516">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657a9b55825b423f8043e4c0876ac4e1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzctMy0xLTEtMTkwOTAw_69a14372-664c-459d-ac6d-f7aacad1a8e0">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2475a56a63d43499ecd47cd83f768cf_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzgtMS0xLTEtMTkwOTAw_4ef4cc38-6f8b-46b6-b070-591903b06817">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic86f00778306481a9e2dc5461c401ba6_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzgtMy0xLTEtMTkwOTAw_9c5525c2-3554-49de-b146-c8ff63218cab">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2e1f4c4ff1e4eb6af4ba1ad9104b9e9_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzktMS0xLTEtMTkwOTAw_ff00ee60-909d-4973-83ef-6e20d59c2572">178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31ddba351344e03b261775eff8755cf_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzktMy0xLTEtMTkwOTAw_66e1ecb9-9b24-42e4-bc08-6f667b69bc87">222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDAtMS0xLTEtMTkwOTAw_987ad8f4-99c6-4e66-b2dc-61c927c3e7be">17,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDAtMy0xLTEtMTkwOTAw_e3ccf39f-bba8-4afa-a691-2fbb799e7900">16,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff97cdf22f9541feb9bbf358623cd961_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDMtMS0xLTEtMjE2NDM5_2ead4d0c-f9b3-4af6-9de5-ee2b04229959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf26ed1cd4b4ca5b515533656d047c3_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDMtMy0xLTEtMjE3NzQ4_f2ba58f5-255d-4b93-b5cf-8282533e6b22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDQtMS0xLTEtMjE2NDM5_84ed8a1b-6ae8-4074-b1cf-a6dc92ac948f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDQtMy0xLTEtMjE3NzQ4_ab30bd27-2c6a-4fd6-8244-9d341b27af88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDUtMS0xLTEtMjE3NzM2_c4bcde9d-ded2-4a65-a1c8-e9c6c1826dbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDUtMy0xLTEtMjE3NzQ4_d9615e9b-03ad-4139-ad24-a8b7cb16c7f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes to noncontrolling ownership interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDYtMS0xLTEtMjE3NzE0_d15fc27c-9311-4240-90d0-1fe2588f9947">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDYtMy0xLTEtMjE3NzQ4_64f94272-6f1b-4af7-88da-6945a47d9bbf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide43a5e742264d82bcb232842cf9058d_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDYtMS0xLTEtMjE2NDUx_4e7ebc31-2f39-49c4-a7de-4cf4878fca8d">259</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i479f625a10cb442d893bd1055659f74b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDctMy0xLTEtMjE3NzQ4_6a263480-f65a-4bdf-a1ca-8f03a96841a9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total equity</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDgtMS0xLTEtMjE2NDE3_879dfe7b-5c16-4928-a87f-8b821913466f">18,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDgtMy0xLTEtMjE2NDI3_db05423b-2c9e-480d-b34b-779fb03d8cc1">16,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMi0xLTEtMS0xOTA5MDA_6f4697be-3697-4b1f-9122-4ef7c1665d67">314</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMi0zLTEtMS0xOTA5MDA_213ccc73-6489-4209-bef6-9e4061bd4525">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNS0xLTEtMS0xOTA5MDA_fd21f7a5-4619-4734-acf4-de4bb1c598bf">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNS0zLTEtMS0xOTA5MDA_e5d8f7a9-dea5-46f5-b949-d2de2df40349">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred and prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNi0xLTEtMS0xOTA5MDA_adbbb724-8913-4721-97d5-c5be55f15fdb">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNi0zLTEtMS0xOTA5MDA_1bf4ddf4-eb49-4831-91b2-1dfbfe185372">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNy0xLTEtMS0xOTA5MDA_a8fef64b-7760-4a5c-ab1f-cb46023a0359">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNy0zLTEtMS0xOTA5MDA_3c98db47-c092-4d12-b890-09b881713352">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss (gain) on investments and notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfOS0xLTEtMS0xOTA5MDA_54b81fe9-e947-4abd-ae49-c70c8e5d8e3a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfOS0zLTEtMS0xOTA5MDA_61c738e9-6355-496a-82c5-f72d84b5806f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTAtMS0xLTEtMTkwOTAw_e4c31059-c723-42c9-8711-07eafbd76969">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTAtMy0xLTEtMTkwOTAw_dd70530d-a13e-465c-9db3-2902c4fe2254">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:InventoryStepUpAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTEtMS0xLTEtMTkwOTAw_f3c8ae38-3cec-4546-bc61-0f873b36cfde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTEtMy0xLTEtMTkwOTAw_6781d158-3a25-4d00-af1c-c9e66a889a45">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTMtMS0xLTEtMTkwOTAw_343f7953-ea1d-4281-b589-a6923fb40299">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTMtMy0xLTEtMTkwOTAw_4b77eaa5-1c6f-4873-8eab-4501b37848cd">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTQtMS0xLTEtMTkwOTAw_e18e3ad1-30f6-467f-9027-2ea23ee5f96e">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTQtMy0xLTEtMTkwOTAw_9402e80f-54c4-4073-9f24-46c935997caf">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTYtMS0xLTEtMTkwOTAw_a69c15e9-341e-42e6-87ac-8750ea10b7d4">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTYtMy0xLTEtMTkwOTAw_00891407-84c7-4154-a804-cd018895b8e6">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTctMS0xLTEtMTkwOTAw_13492677-0c01-4c2b-b2f6-bfc387d62530">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTctMy0xLTEtMTkwOTAw_33e7277e-6d4d-4b8b-9e18-12fb129babdb">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTgtMS0xLTEtMTkwOTAw_8df93ea8-9550-4fe2-8a34-ea7fc769b59e">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTgtMy0xLTEtMTkwOTAw_8956ade8-e8b0-4eb7-a0a6-6e762fdb38b0">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTktMS0xLTEtMTkwOTAw_73f02d37-126c-4855-8390-0fe2239cd71f">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTktMy0xLTEtMTkwOTAw_60b13a67-3e89-4bb6-adee-6795ed2f3e0d">368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjEtMS0xLTEtMTkwOTAw_618ef1bb-6dfa-4e41-a1b8-993b1c87dec1">190</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjEtMy0xLTEtMTkwOTAw_7252984e-a678-4f9b-b743-e443cf77cf4c">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment and internal use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjQtMS0xLTEtMTkwOTAw_c2d9142c-3538-431e-abd0-58786bc8d04a">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjQtMy0xLTEtMTkwOTAw_233dba4c-01d3-4171-acae-1bb6cbc4707c">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjUtMS0xLTEtMTkwOTAw_01add138-ad43-4ce0-bee2-43bbfe5ba0a2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjUtMy0xLTEtMTkwOTAw_97766767-58c8-4287-a28d-5b25cebef20c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjYtMS0xLTEtMTkwOTAw_11b5846e-36d1-4332-837a-fd26a78492e9">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjYtMy0xLTEtMTkwOTAw_221def01-a481-4ad2-b3d0-384fedcb7cae">1,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from (payments for) investments and acquisitions of certain technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjctMS0xLTEtMTkwOTAw_0e8cb054-ff2b-40a5-93a8-d69961a23012">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjctMy0xLTEtMTkwOTAw_8f443b47-9148-4dfe-b3cd-b17c1213e618">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjktMS0xLTEtMTkwOTAw_347c92af-a711-424f-a7be-f61cf158374b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjktMy0xLTEtMTkwOTAw_dc2747f0-e23e-4975-8325-629ea872bfe8">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzEtMS0xLTEtMTkwOTAw_1ea5e0fb-3513-49e7-af67-35d684f8d9c5">484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzEtMy0xLTEtMTkwOTAw_7a6ec952-c594-481e-89a9-fba92d4a897f">1,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration previously established in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzQtMS0xLTEtMTkwOTAw_c465b6d6-2aa4-4b68-b983-af01a6eda53c">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzQtMy0xLTEtMTkwOTAw_107bc4d2-6647-4875-9316-1477637fdbbb">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzUtMS0xLTEtMTkwOTAw_d691ba4c-1d66-4cd9-9529-33e936bb72b8">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzUtMy0xLTEtMTkwOTAw_787269c9-75f9-4370-b525-9d94696202e1">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzYtMS0xLTEtMTkwOTAw_fbc3adcc-0c3f-48ca-9e9e-07767ddf7d97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzYtMy0xLTEtMTkwOTAw_462f6b96-6dfb-402e-93a1-521c1e7dc634">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzgtMS0xLTEtMTkwOTAw_e02b3452-742a-4675-a13b-0a86ef960736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzgtMy0xLTEtMTkwOTAw_422c4e15-318f-4e6e-9639-28814c707dc9">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on long-term borrowings and debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDEtMS0xLTEtMTkwOTAw_afb74c6d-43df-4010-b0b5-4bc37ad47309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDEtMy0xLTEtMTkwOTAw_623bd7bb-7b0d-4463-abc4-afacd8e383bb">3,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDItMS0xLTEtMTkwOTAw_7b6efbbf-ca25-4883-b331-7a47e49e6a2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDItMy0xLTEtMTkwOTAw_4ac2f287-1612-4ef3-b9be-23cebab00e44">3,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDMtMS0xLTEtMTkwOTAw_ae2aefcc-a53b-4b73-a6e2-7748174357b7">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDMtMy0xLTEtMTkwOTAw_d09fad32-5302-4135-911d-bd90bede03a5">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash used to net share settle employee equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDYtMS0xLTEtMTkwOTAw_521bdb71-1329-4dca-bc48-94bd56d44cea">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDYtMy0xLTEtMTkwOTAw_cc28e152-2769-42c8-979f-10271c051c90">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDctMS0xLTEtMTkwOTAw_202e6c16-d8b1-4c6d-a3ec-a95177d159e4">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDctMy0xLTEtMTkwOTAw_72dcdbc1-bddc-4623-b635-18fc648ad709">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDgtMS0xLTEtMTkwOTAw_bcbdd978-b986-405f-84a6-847bfb95587a">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDgtMy0xLTEtMTkwOTAw_622cc74b-0846-47c7-aeb9-038093d28873">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTAtMS0xLTEtMTkwOTAw_0b891057-ea26-4090-a971-89e7bea48c1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTAtMy0xLTEtMTkwOTAw_71f0fdf5-a892-4da5-a05d-b565eeb04fe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTItMS0xLTEtMTkwOTAw_18486ba1-68d3-4018-b041-c51bad99600a">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTItMy0xLTEtMTkwOTAw_ad727bcc-9776-4b23-aeb5-375435dbdce5">1,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTMtMS0xLTEtMTkwOTAw_96ba7a76-33a2-4320-9410-aea4f1fe8357">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTMtMy0xLTEtMTkwOTAw_62decddd-2eba-4bfd-965d-63836fc4a24c">2,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTQtMS0xLTEtMTkwOTAw_52104f42-616c-4b8d-9215-213dc8cbe0f3">763</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTQtMy0xLTEtMTkwOTAw_fcad2cad-71a8-41d4-ad62-971fe2cf13cf">529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(SUPPLEMENTAL INFORMATION)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfMy0xLTEtMS0xOTA5MDA_d1c2b6f4-9acd-4ed9-afe8-5c99d2c223b8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfMy0zLTEtMS0xOTA5MDA_fb38efbf-d976-4cd9-bc5c-707b3e1b7e04">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfNS0xLTEtMS0xOTA5MDA_50197c63-05a9-499b-a0f7-84f96abde0ac">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfNS0zLTEtMS0xOTA5MDA_4e68f25e-2c6f-4674-bb6d-00596ebe3a10">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Reconciliation to amounts within the unaudited consolidated balance sheets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMi0xLTEtMS0xOTA5MDA_a3f851be-acd1-4cc9-8d1d-aee7ae265019">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMi0zLTEtMS0xOTA5MDA_ac8e8d21-7119-40f3-83f8-f13e75be871b">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMy0xLTEtMS0xOTA5MDA_44990b9d-e93b-4893-a830-2fe7aa90379c">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMy0zLTEtMS0xOTA5MDA_c6af4bc8-bb90-447f-bb97-d012ef28ea12">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNC0xLTEtMS0xOTA5MDA_5cd487b8-c1a8-4032-963b-2d527ef397eb">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNC0zLTEtMS0xOTA5MDA_f518e1ef-4872-43b5-b3fa-6be7203ba32d">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNS0xLTEtMS0xOTA5MDA_7d65ee37-9843-4739-a9f9-b0f7ee4c8ac6"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNS0xLTEtMS0xOTA5MDA_f8bce413-3461-4074-bede-8075b5083fb2">763</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNS0zLTEtMS0xOTA5MDA_ae8ab1aa-d5c9-4bbc-b277-f461037f00d9">529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_37"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zNy9mcmFnOjA5Mjg0ODFiYjc0YTRmYjZiNzZiNjZhYmYzNDUyNjJlL3RleHRyZWdpb246MDkyODQ4MWJiNzRhNGZiNmI3NmI2NmFiZjM0NTI2MmVfMTkzMw_c874fd3e-ee77-4337-b0dc-edf978f1d1ed" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements include the accounts of the Company's wholly owned- subsidiaries and entities for which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2023, we acquired a majority stake investment in Acotec Scientific Holdings Limited (Acotec) and have elected to consolidate their financial statements on a one quarter lag. Accordingly, their results of operations for the period following the closing of the transaction on February 20, 2023 are omitted from the Company&#8217;s unaudited consolidated statements of operations for the quarter ended March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zNy9mcmFnOjA5Mjg0ODFiYjc0YTRmYjZiNzZiNjZhYmYzNDUyNjJlL3RleHRyZWdpb246MDkyODQ4MWJiNzRhNGZiNmI3NmI2NmFiZjM0NTI2MmVfMTk0Mw_aa7bc990-8882-4e73-8cac-555383e66ebb" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note B &#8211; Acquisitions, Divestitures and Strategic Investments, Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_43"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NTU_9b38e7be-dd5d-4130-9ffd-d461d499f9a2" continuedAt="ib085b1e6e98d46dfafe6a295234861c9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2023, we completed our acquisition of <ix:nonFraction unitRef="number" contextRef="i50b5bcfa88dc4695b6f53f461176ea44_I20230404" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjM3Ng_36c09289-d177-4615-b369-0ec7ecaa8af7">100</ix:nonFraction> percent of the outstanding equity of Apollo Endosurgery, Inc. (Apollo), a public company which offers a portfolio of devices used during endoluminal procedures to close gastrointestinal defects, manage gastrointestinal complications and aid in weight loss for patients suffering from obesity. The agreement consisted of an upfront cash payment of $<ix:nonFraction unitRef="usdPerShare" contextRef="i50b5bcfa88dc4695b6f53f461176ea44_I20230404" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjM4Ng_ce3d1764-bdda-4ceb-9c2f-4d96f010f0d2">10.00</ix:nonFraction> per share, or approximately $<ix:nonFraction unitRef="usd" contextRef="ibc8125bb5d9343a4aa4a0b3bea2a48af_D20230404-20230404" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQyNQ_ab8077a9-44e1-44af-a9dc-85b1385e3b30">615</ix:nonFraction> million. The Apollo business is being integrated into our Endoscopy division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 20, 2023, we completed the acquisition of a majority stake investment in Acotec, a publicly traded Chinese manufacturer of drug-coated balloons used in the treatment of vascular and other diseases. We acquired approximately <ix:nonFraction unitRef="number" contextRef="i3bb00ce3cc2f43ed83cc43d46d7f4ece_I20230220" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQ4MQ_cb21fe9b-4a24-4a85-8d24-6238aa83e474">65</ix:nonFraction> percent of the outstanding shares of Acotec, for an upfront cash payment of HK$<ix:nonFraction unitRef="krw" contextRef="i0f1076c0e73c48b8b0c16cb99f3fffa9_D20230220-20230220" decimals="0" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQ1Ng_e03f8889-0af5-46f6-82a0-30f6480ebf35">20.00</ix:nonFraction> per share, or $<ix:nonFraction unitRef="usd" contextRef="i0f1076c0e73c48b8b0c16cb99f3fffa9_D20230220-20230220" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQ0Mw_c6111197-eb07-4b61-81bb-20ff99974588">519</ix:nonFraction> million at foreign currency exchange rates at closing. The Acotec portfolio complements our existing Peripheral Interventions portfolio.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ib085b1e6e98d46dfafe6a295234861c9" continuedAt="i5c1241672d5e4f63886b6dc4cd39187a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We accounted for the Acotec transaction as a business combination in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(FASB ASC Topic 805). The preliminary purchase price was comprised of the amount presented below: </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfNTQ5NzU1ODQ0NDcy_b8bb75fd-a772-4965-84c2-0cd124558a34" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.082%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for majority interest acquisition, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY5NWQxZTU4MjIyODQ0NWE5M2NlNTc5MTM0MmI4MTliL3RhYmxlcmFuZ2U6Zjk1ZDFlNTgyMjI4NDQ1YTkzY2U1NzkxMzQyYjgxOWJfMS0xLTEtMS0yMTY4Mzk_b9cbdbec-763c-46de-950c-35630022514d">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY5NWQxZTU4MjIyODQ0NWE5M2NlNTc5MTM0MmI4MTliL3RhYmxlcmFuZ2U6Zjk1ZDFlNTgyMjI4NDQ1YTkzY2U1NzkxMzQyYjgxOWJfMi0xLTEtMS0yMTY4NTA_4517ef1f-286e-4302-826d-b5066e786291">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excludes approximately $<ix:nonFraction unitRef="usd" contextRef="i3bb00ce3cc2f43ed83cc43d46d7f4ece_I20230220" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY1NTEzNw_8cb416d1-4f19-45bb-8600-adf65d60bcb5">140</ix:nonFraction> million of cash on hand at the closing of the transaction.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded the assets acquired, liabilities assumed and the noncontrolling interest at their respective fair values as of the closing of the transaction. <ix:nonNumeric contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfNTQ5NzU1ODQ0NDcz_c3998293-4797-46aa-83ca-6fc839d8318f" continuedAt="i0d9fdfa4e23c42459fb4ac99a0623072" escape="true">The preliminary purchase price allocation was comprised of the following components and the final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with FASB ASC Topic 805: </ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i0d9fdfa4e23c42459fb4ac99a0623072"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfMS0xLTEtMS0yMTY4NTg_c6f4f813-45fd-415e-8ac6-a187c255bf63">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfMi0xLTEtMS0yMTY4NTg_45113075-7e78-4411-8ad9-017c995ffd61">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNC0xLTEtMS0yMTY4NjY_d270d58f-0b8e-4913-b7e0-f07ec01a1b82">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNS0xLTEtMS0yMTY4NzQ_6721414c-5480-4064-b5ac-ed73b302bb56">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNi0xLTEtMS0yMTY4NzQ_f6cc8005-cbe4-448b-aa48-023dff8a4193">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of noncontrolling interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNy0xLTEtMS0yMTkyNjU_45e90ab8-eab6-4bed-896d-d1b8736ca098">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNy0xLTEtMS0yMTY4NzQ_6c754631-c091-4f23-b3e8-e18bce1778e8">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the noncontrolling interest was based on the publicly traded market value of the remaining <ix:nonFraction unitRef="number" contextRef="i098c221da06c4b958585f779d2867c19_I20230220" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY1ODM4Mg_56fe5516-065d-4f63-af91-1f7eb3409ef6">35</ix:nonFraction> percent of the outstanding shares we did not acquire as of the transaction date and is presented within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Stockholders' equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Goodwill was primarily established due to opportunities for collaboration in research and development, manufacturing and commercial strategies, and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfNTQ5NzU1ODQ0NDc0_f7a01f64-33c8-4019-ab2e-3fba8c36d804" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93085ad25bc42338a5eab7de3e2cc41_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfMy0xLTEtMS0yMTc0MzE_4d656921-95a1-48ac-a2c6-1c10ac94c1c7">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i99682e6da7ba40fab6c56eea230eec3f_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfMy0zLTEtMS0yMTc0MzE_7d75b654-76a3-4d09-90ca-995a5d1c571a">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6514d87e72ac4153a2523faf7d9b4ca6_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfMy01LTEtMS0yMTc0MzE_375f5709-9e20-426c-a6ac-93b7e3276927">14</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21630f12b7d5477cbc3cbb55360587fb_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNC0xLTEtMS0yMTc0MzE_5c14d478-db16-4bba-8b06-b0d3a4e91b00">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c05ab454f604b7e938efdb8a3a9bedf_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNC0zLTEtMS0yMTc0MzE_6460a2ba-d824-4946-bcb7-43e28c507faa">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3aeee52d764f4a80911bef9fddad1874_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNC01LTEtMS0yMTc0MzE_70ad9df0-f894-4e31-ad94-cff738b21e0e">14</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d69f63508e4a52a7d288bbf2fa5e41_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNS0xLTEtMS0yMTc0MzE_90c93878-5e79-4eef-a42f-768f93c169f0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i86dca2ec31934d279f4e60c2ac7559cc_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNS0zLTEtMS0yMTc0MzE_4a9735b1-32ab-4c4d-8efe-9421aeb47caa">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3e100c180dc4202883a3c603581fbc8_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNS01LTEtMS0yMTc0MzE_94c8a923-7df0-42b9-ae47-34f63a166e58">14</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfOC0xLTEtMS0yMTc0MzE_45113075-7e78-4411-8ad9-017c995ffd61">334</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which developed the radiofrequency (RF) NRG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and VersaCross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which expanded our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTY2NA_3d63c648-cff8-4120-807e-6f3db1ae54e7">1.463</ix:nonFraction> billion, net of cash acquired, subject to closing adjustments. We are integrating the Baylis Medical business into our Cardiology division.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i5c1241672d5e4f63886b6dc4cd39187a" continuedAt="i70b8b0718fc349e48e1693edf1b5313c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of Baylis Medical as a business combination in accordance with FASB ASC Topic 805, Business Combinations. The final purchase price was comprised of the amount presented below: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NDg_ca764d8e-57f2-48e5-961f-ce3ef9151e96" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjNkZjI2NGMwODk2ZTQ3MGY4OGUxODNjNGY5OTQ2NWQzL3RhYmxlcmFuZ2U6M2RmMjY0YzA4OTZlNDcwZjg4ZTE4M2M0Zjk5NDY1ZDNfMS0xLTEtMS0xOTA5MDA_3d63c648-cff8-4120-807e-6f3db1ae54e7">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjNkZjI2NGMwODk2ZTQ3MGY4OGUxODNjNGY5OTQ2NWQzL3RhYmxlcmFuZ2U6M2RmMjY0YzA4OTZlNDcwZjg4ZTE4M2M0Zjk5NDY1ZDNfNC0xLTEtMS0xOTA5MDA_7d497ad6-7494-4b3e-ac67-d6f3ba9b92b1">1,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. <ix:nonNumeric contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NDk_c654895f-0aa3-4f2b-bde7-6f41a6544093" continuedAt="ie065f55451e1455caec832a5eee72f46" escape="true">The final purchase price allocation was comprised of the following components:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ie065f55451e1455caec832a5eee72f46"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfMS0xLTEtMS0xOTA5MDA_ff964a07-df69-4753-b74e-530a4d292684">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfMi0xLTEtMS0xOTA5MDA_2c69ed59-537b-4500-b8e1-29a59e0f0caa">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfNC0xLTEtMS0xOTA5MDA_048fb420-83ce-46af-9c8b-2b39c14ce9a6">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfNi0xLTEtMS0xOTA5MDA_7cb12e17-e2a4-4bf6-98c6-246956b353af">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfNy0xLTEtMS0xOTA5MDA_8909cabc-9026-4b7b-b0e4-3f35bc1c04e9">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfOC0xLTEtMS0xOTA5MDA_52a42427-0615-4ad3-a41b-7de09f63d097">1,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and is deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NDA_7806b9be-b9c1-4435-b33c-0be629d48aec" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b304742c4c54945b75a66597634648a_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfMy0xLTEtMS0xOTA5MDA_4a6982b8-aa0f-4ac6-8fb1-436013030a1a">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i586764f8498244c29e88444e4724fcbf_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfMy0zLTEtMS0xOTA5MDA_46fcf1f1-3be8-4a98-aba5-356184e5c90b">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ad160e4bd8e4bcaae224e370af0b112_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfMy01LTEtMS0xOTA5MDA_f5805eeb-f715-49bf-9d44-cfc36115aa30">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0216d912a174028acfdb839676e95d6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfOC0xLTEtMS0xOTA5MDA_8cec826f-f2b2-405f-9e50-a89bf76ef12a">657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our acquisitions that closed during the first quarters of 2023 or 2022 contained contingent consideration arrangements. <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2MjU_afeef178-55df-49b9-85e7-54be47165f17" continuedAt="ieb140b94d3904a5e9e13b014f0cc8903" escape="true">Changes in the fair value of our contingent consideration liability during the first quarter of 2023 associated with prior period acquisitions were as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:continuation id="ieb140b94d3904a5e9e13b014f0cc8903"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfMS0xLTEtMS0xOTA5MDA_14a5528d-aeec-4686-95f6-e017c3791d4d">149</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfNC0xLTEtMS0xOTA5MDA_6b22568d-a926-4221-9cfb-85393af9df2e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfNS0xLTEtMS0xOTA5MDA_2a93ece4-fef1-4032-8953-3fe220b7c69c">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfNi0xLTEtMS0xOTA5MDA_bb7660e0-f281-427a-9e09-bfa9def2c666">93</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payments made during the first quarter of 2023 were primarily related to our 2021 acquisition of Farapulse, Inc. As of March&#160;31, 2023, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was approximately $<ix:nonFraction unitRef="usd" contextRef="ia1330d5e86f34de7b8796fe68b26f65f_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfODUyMw_12dbd7a3-77a3-4a9b-878a-9041a8faad92">359</ix:nonFraction> million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i70b8b0718fc349e48e1693edf1b5313c" continuedAt="i92b7b12af3ed49368e44849bca015c11"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2MjA_dcfad165-65e2-4834-8f6b-e885548644e8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic81d6dae3feb405fb58015de09433300_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS0xLTEtMS0xOTA5MDA_9c4a6c14-67c3-448e-9880-e5f6d92ef8f8">13</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e856d6687ec4e31a4d71bf973d3f28a_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS00LTEtMS0xOTA5MDA_70d16b5c-636e-455a-a1a9-c1ca2c0dab2e">1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50cbf9066de44563ae1182748610f8cc_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS02LTEtMS0xOTA5MDA_6772970d-c89c-46f6-b806-91a17fb7ad80">2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86458492bffb48499c122917fa84b6b6_I20230331" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS03LTEtMS0xOTA5MDA_17e9416d-483a-45b6-8273-34479ce46ce0">2</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e856d6687ec4e31a4d71bf973d3f28a_I20230331" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMi00LTEtMS0xOTA5MDA_d218cc18-7da0-479d-8543-de58a99690c8">10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50cbf9066de44563ae1182748610f8cc_I20230331" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMi02LTEtMS0xOTA5MDA_40cb952e-631d-4f1d-a985-d9c67ecdeb5a">25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86458492bffb48499c122917fa84b6b6_I20230331" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMi03LTEtMS0xOTA5MDA_b70ac1fc-5095-4f5d-a928-caae8e06a247">22</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie0700cfd128447b2b2157afb226d4c49_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC0xLTEtMS0xOTA5MDA_bde221a4-0704-4b79-87ed-43526e908617">80</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="icfd41fe9b8c14589a6244f96d5d3a3a7_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC00LTEtMS0xOTA5MDA_4c6a51c5-4218-4f06-9160-59c9dd39ad1e">6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0bcfb39920f4c2784fb6593b98b240a_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC02LTEtMS0xOTA5MDA_3785f66b-e9a7-4447-a9ed-f12425abc172">14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i94c92289dc0046e1b8af6587d9138ebb_I20230331" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC03LTEtMS0xOTA5MDA_c8e79f0f-6f99-4cee-bd6c-03d69de5e691">7</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0700cfd128447b2b2157afb226d4c49_I20230331" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNS00LTEtMS0xOTA5MDA_07afc07d-965e-41d8-a16d-ad4ea9c95eb0">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94c92289dc0046e1b8af6587d9138ebb_I20230331" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNS03LTEtMS0xOTA5MDA_d9d86145-3973-4598-9556-d132e32dfe2b">100</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to research and development (R&amp;D), regulatory and commercialization-based milestones and revenue-based payments are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of March&#160;31, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NTI_2f1e6715-6590-4ab2-8263-1e134aab7813" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMi0xLTEtMS0xOTA5MDA_4be4e5cf-9d66-4858-93fb-6d0907c1d35a">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMi0zLTEtMS0xOTA5MDA_3805e258-3485-4f45-b9c8-7f28a532ab61">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1, 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMy0xLTEtMS0xOTA5MDA_1b9a524a-1c5c-4889-8d0c-c0c9a8277d88">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMy0zLTEtMS0xOTA5MDA_cb5fb182-56b0-4c8e-8fb2-014b1f6c5a03">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfNi0xLTEtMS0xOTA5MDA_39c6b3f7-88fa-4af8-9f13-866f0249aaa5">385</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfNi0zLTEtMS0xOTA5MDA_3b550d31-c4d3-40fa-9797-b2261d0ea367">407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Includes publicly-held securities measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i92b7b12af3ed49368e44849bca015c11">As of March&#160;31, 2023, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA0NzU_7032fbf3-606d-457d-b0f5-edd0c03d2969">209</ix:nonFraction> million, which represents amortizable intangible assets, in-process research and development (IPR&amp;D), goodwill and deferred tax liabilities.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RleHRyZWdpb246MWEyYjc5NzE2MDVkNDU3Njg4NWU1ZmFiOWIzZjk4M2FfNTQ5NA_048fa059-ad85-4b7e-962f-4a1954514261" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RleHRyZWdpb246MWEyYjc5NzE2MDVkNDU3Njg4NWU1ZmFiOWIzZjk4M2FfNTQ3Nw_09bf01cc-1ae0-4406-9de6-da64f1e06e9f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied91f3fdd793487f8fafa2ef73d957a5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi0xLTEtMS0xOTA5MDA_fc09b878-07a0-48c8-80c3-0070f3cd0302">12,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied91f3fdd793487f8fafa2ef73d957a5_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi0zLTEtMS0xOTA5MDA_f1182640-ec7a-45c5-86b6-2e4f3df334ed">7,553</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75960dbfc53b4af29aeaf34569b6fa73_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi01LTEtMS0xOTA5MDA_9b08941a-8123-4594-b6df-2980f9654e82">12,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75960dbfc53b4af29aeaf34569b6fa73_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi03LTEtMS0xOTA5MDA_2e39216c-5b2e-4fc8-8114-0946b8e37a77">7,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7064ffd3368f4eb3a7afa617f099937f_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy0xLTEtMS0xOTA5MDA_d4487ead-23ef-4b73-b38f-e3836dfc8a77">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7064ffd3368f4eb3a7afa617f099937f_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy0zLTEtMS0xOTA5MDA_3ec21d3d-e667-4999-8596-3c7ad62e6e7b">381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a460c2d84a40f2ab75d16a46ca5cf6_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy01LTEtMS0xOTA5MDA_8bcbc3e7-48c9-474e-8bb7-81f07080e3a4">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4a460c2d84a40f2ab75d16a46ca5cf6_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy03LTEtMS0xOTA5MDA_a2540abb-27aa-43e1-8251-a994a6fe7102">394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9902b3acea745368d2e51c9c3ed82a7_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC0xLTEtMS0xOTA5MDA_7d6cb7eb-cd65-4a61-8562-9288d0449747">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9902b3acea745368d2e51c9c3ed82a7_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC0zLTEtMS0xOTA5MDA_1019c8c3-8e19-46ff-bc9f-969196735f2a">1,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44c957fd74e4baeb93c089d85303850_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC01LTEtMS0xOTA5MDA_ab0fd33e-37b2-42db-ae9a-fe62e45c9a39">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44c957fd74e4baeb93c089d85303850_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC03LTEtMS0xOTA5MDA_80f0d3aa-4536-4480-aac4-76acb3a6e7e1">1,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS0xLTEtMS0xOTA5MDA_168003b5-78e6-466e-8baf-49d3a24603be">15,185</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS0zLTEtMS0xOTA5MDA_ca758393-4d9d-478d-98f2-ba037350547a">9,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS01LTEtMS0xOTA5MDA_59e18d80-7e45-4fda-a5b6-22e8e70fffb9">14,843</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS03LTEtMS0xOTA5MDA_b6078225-af34-4871-875b-4db25a0411f6">9,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6eb7f283e54256a9c5b643698ee72a_I20230331" decimals="-6" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy0xLTEtMS0xOTA5MDA_49879ad5-d08c-4657-901e-03dac805223a">23,169</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice6eb7f283e54256a9c5b643698ee72a_I20230331" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy0zLTEtMS0xOTA5MDA_b8286c25-1507-4470-b2b4-4ca4246e4930">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c98bbaa94e4fb39183b5fc22e895a5_I20221231" decimals="-6" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy01LTEtMS0xOTA5MDA_c2d8f235-c885-4a15-8e58-a2992c3ea6a1">22,820</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72c98bbaa94e4fb39183b5fc22e895a5_I20221231" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy03LTEtMS0xOTA5MDA_f02361b2-cd04-4968-9276-8e672443db17">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c826c5e16734ec89717f304d8a0b98b_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfOS0xLTEtMS0xOTA5MDA_25df7151-a549-4925-a400-0c9b001291b6">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7783d7ba4b7469eb8012fe17848bea5_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfOS01LTEtMS0xOTA5MDA_de52a677-3893-47ce-a9d2-d00dad6b32dc">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f826c50348c4250a015338b19792179_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTAtMS0xLTEtMTkwOTAw_9137673b-9870-4c57-acb4-15d848738578">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713c9dc3fe0f4edbb6508415483a74d7_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTAtNS0xLTEtMTkwOTAw_44a51614-a7fe-4041-9278-a14f0353c925">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTEtMS0xLTEtMTkwOTAw_b777554e-a5a1-427b-8da5-d79f446014bc">232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTEtNS0xLTEtMTkwOTAw_32164d70-6b76-4621-a2a8-30bfc9ffd827">232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in our balance of goodwill and amortizable intangible assets is related primarily to our acquisition of a majority stake investment in Acotec completed in the first quarter of 2023. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RleHRyZWdpb246MWEyYjc5NzE2MDVkNDU3Njg4NWU1ZmFiOWIzZjk4M2FfNTQ3MQ_6ec562e4-2d6e-4b8c-95dd-454dd2b3d6d4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following represents a roll-forward of our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a25af27795f4ad8995a221fef790ba3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfMS0xLTEtMS0xOTA5MDA_4fb7ace5-242d-481f-9b2c-e0933e6802d1">4,237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i933e991579d346d98f5c6e3aef002501_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfMS0zLTEtMS0xOTA5MDA_d7abc2fd-ddf0-4459-aa61-d0634b192b95">8,684</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfMS03LTEtMS0xOTA5MDA_e282f9f3-190c-43ee-acb3-d97628d8039c">12,920</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC0xLTEtMS0xOTA5MDA_b69679c6-8e5f-416e-8228-7d05577d97e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC0zLTEtMS0xOTA5MDA_21ead877-6d7d-4419-a063-57abc8106f25"><ix:nonFraction unitRef="usd" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC0zLTEtMS0xOTA5MDA_536050c6-d176-4a2e-8e65-4cadc2a3a0eb">336</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC03LTEtMS0xOTA5MDA_a2664bcf-3249-41d4-9891-9d136c1995dd">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and purchase price adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNS0xLTEtMS0xOTA5MDA_19a742ed-d44b-470f-bd42-b6062878ec0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNS0zLTEtMS0xOTA5MDA_977c9d12-641d-4bf8-bfa1-5452c7ba68c2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNS03LTEtMS0xOTA5MDA_bf17473b-1c96-4712-a105-ccb58e26eb87">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437328dd08c04fb38d5a0b1b7015575b_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNi0xLTEtMS0xOTA5MDA_d36a2f93-76c4-426f-9798-5c85e80f8ba0">4,237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide57541620ac4f40b0aae359edea5b51_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNi0zLTEtMS0xOTA5MDA_d4aa68b4-6836-44e6-bb75-c6e88733c968">9,032</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNi03LTEtMS0xOTA5MDA_7785e0cf-76eb-42da-b49b-83de58f8efc4">13,269</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Asset Impairments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the first quarters 2023 or 2022. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_55"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNTU_6bd84cd7-bc33-4b17-bd04-4091814acadf" continuedAt="ibb4f3621ef694e178f4e73890e1fb728" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and actively monitoring counterparty credit ratings. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ibb4f3621ef694e178f4e73890e1fb728" continuedAt="id027f8151d23407da38f67f1cb721805"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, British pound sterling, Swiss franc, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815, Derivatives and Hedging (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our unaudited consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our unaudited consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time. The cash flows related to the derivative instruments designated as cash flow hedges are reported as operating activities in our consolidated statements of cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of March&#160;31, 2023 and December&#160;31, 2022, we designated as a net investment hedge our &#8364;<ix:nonFraction unitRef="eur" contextRef="ife05e78966de43f7831ac0435f16576a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMzQyOQ_fcb0fa53-b33c-47a1-8db9-271deea5dd26">900</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ife05e78966de43f7831ac0435f16576a_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMzQ2NQ_7199218e-0561-49ea-9936-76cefbb9da2e">0.625</ix:nonFraction>% euro-denominated senior notes issued in November 2019 and due in 2027 (2027 Notes). For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Cumulative Translation Adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ther Comprehensive Income (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than <ix:nonNumeric contextRef="idf9290bf261f4bbc88ca0dbf2972f8f8_D20230101-20230331" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNDQyMg_a87b23d9-f68a-4717-bae0-b73d595e5d37">one year</ix:nonNumeric>, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="derivative_instrument" contextRef="i163d6247ba884128b6b3970a5d92963d_I20230331" decimals="0" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNTE3Mw_addfe1f4-e070-431b-850c-56bbd3b63965"><ix:nonFraction unitRef="derivative_instrument" contextRef="i4daa711fa7aa43a598a5f35231e982df_I20221231" decimals="0" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNTE3Mw_fbc44c2b-6335-48b3-ac27-a6790ff99cee">no</ix:nonFraction></ix:nonFraction> interest rate derivative instruments designated as cash flow hedges outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id027f8151d23407da38f67f1cb721805" continuedAt="if59fcd294919426f863dd4107266c515"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNjQ_f567a446-9a79-44d0-8784-d47111f43c19" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.430%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1a0b34b25746219cf0093a08066c29_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMi00LTEtMS0xOTA5MDA_f8d484e6-143d-4c15-8eb9-a29c44bf875c">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i916d03913e7d49e3a4641da09851e47e_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMi02LTEtMS0xOTA5MDA_8ab6989a-8ed0-42e7-ae58-acd5eedc0d2f">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e34a5fda334589af3a7f69f399f02e_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMy00LTEtMS0xOTA5MDA_b542d239-4de0-43b2-8029-3767743a24e7">365</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8afe4953c841d8aa1dc82c3cacc365_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMy02LTEtMS0xOTA5MDA_e7967d34-b1b4-4048-a8cd-fe4bba5fcac2">365</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i260db5b023b64acb974aa51c8180c68b_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNC00LTEtMS0xOTA5MDA_2bcaba32-7ff9-4806-9267-8138b8ed8adc">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab5e7cbf2c543baa4c3f372a5dae6d6_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNC02LTEtMS0xOTA5MDA_b78a5622-9a2a-4538-acd0-291a638bc171">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id43b656f9a51461296e0ba67c8f28cbc_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNS00LTEtMS0xOTA5MDA_17551758-6cad-41d2-b4ee-292074e09913">3,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aa626542bcf4ab68ce0b85324fa5af0_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNS02LTEtMS0xOTA5MDA_adfee72e-1dbd-4274-a719-29e7bae90f95">4,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNy00LTEtMS0xOTA5MDA_dec75e76-dc7e-4cfb-9f1e-9759a9808237">7,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNy02LTEtMS0xOTA5MDA_4a940370-9d07-4d1e-9960-09917f908607">8,321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#8364;<ix:nonFraction unitRef="eur" contextRef="ife05e78966de43f7831ac0435f16576a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNjI4Ng_fcb0fa53-b33c-47a1-8db9-271deea5dd26">900</ix:nonFraction> million debt principal associated with our 2027 Notes designated as a net investment hedge.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the remaining time to maturity is within <ix:nonFraction unitRef="units" contextRef="i88522e1e6ca14c4791fddea4df68cca6_I20230331" decimals="INF" name="bsx:ForwardCurrencyContractsTimetoMaturity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNjQyNQ_ad92e96b-d898-4102-9e5c-3b9b461e0014">36</ix:nonFraction>&#160;months for all forward currency contracts designated as cash flow hedges and generally less than <ix:nonNumeric contextRef="idf9290bf261f4bbc88ca0dbf2972f8f8_D20230101-20230331" name="us-gaap:DerivativeRemainingMaturity1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNjUyNQ_11fe4527-c346-4ad8-92b0-ec4a843d1ace">one year</ix:nonNumeric> for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature between one and three years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="if59fcd294919426f863dd4107266c515" continuedAt="i6e277579e6204522a9efef5c8acffca2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNjg_f5f6e97b-3579-43ef-ac53-b6edd41102b8" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0xLTEtMS0xOTA5MDA_83bf1d9f-d852-4fd3-ba28-f74049dbf776">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0yLTEtMS0xOTA5MDA_f55f663f-3306-4132-9b29-6743d1263239">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0zLTEtMS0xOTA5MDA_c6af3df1-9319-4088-a5a7-a192ed33ea53">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS02LTEtMS0xOTA5MDA_57a1cb01-1118-428e-a3b8-293216b78f2a">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS04LTEtMS0xOTA5MDA_61dc5c2b-e2c1-4fc7-9819-c35cfc2b3e11">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS05LTEtMS0xOTA5MDA_07212487-9850-4cf4-80ba-a4378db623d7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0xMC0xLTEtMTkwOTAw_147615d7-b636-44e2-80a3-80b1c24fb0f1">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0xLTEtMS0xOTA5MDA_e7302308-daaf-443a-aec2-e2b12a33c58f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0yLTEtMS0xOTA5MDA_e0a08402-d28b-4b0e-9435-31ad84b6bfd3">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0zLTEtMS0xOTA5MDA_bedf6048-3904-4ab1-8564-61001ca45d95">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi02LTEtMS0xOTA5MDA_435718f0-acbc-4dc7-924d-fa738da41b1f">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi04LTEtMS0xOTA5MDA_e208bff1-7740-4d63-b18b-31d41d3e71cb">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi05LTEtMS0xOTA5MDA_dde6b2d8-d2fc-4099-8ca5-fc3a8c530e3b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0xMC0xLTEtMTkwOTAw_572c687c-581b-4e38-b49e-a28495ea0636">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0xLTEtMS0xOTA5MDA_532cb633-dd50-47b9-a4b7-5991e5d2c739">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0yLTEtMS0xOTA5MDA_4d6d7ea9-ed5a-438a-aae5-2e93eba06ece">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0zLTEtMS0xOTA5MDA_a7680845-8242-4ba9-a0c8-0b7c493173bf">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC02LTEtMS0xOTA5MDA_a1456219-077d-4036-b254-e9328652f2c9">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC04LTEtMS0xOTA5MDA_cfb15e2f-f5af-4ac6-9efe-21b3fc302568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC05LTEtMS0xOTA5MDA_c55201a7-d0de-47f7-a135-d7bee0a018af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0xMC0xLTEtMTkwOTAw_22d9633a-e335-4546-9184-eabe03045b1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMS0xLTEtMTkwOTAw_6048a163-50f7-4855-a363-1a5f6cb4f1e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMi0xLTEtMTkwOTAw_25a0bcce-56c6-4692-b097-59c8486f00bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMy0xLTEtMTkwOTAw_1eff7cab-2003-4f69-ab29-fb872e5da0ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtNi0xLTEtMTkwOTAw_435718f0-acbc-4dc7-924d-fa738da41b1f">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtOC0xLTEtMTkwOTAw_51bbaf8b-3b71-415a-b713-75283f88d1ad">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtOS0xLTEtMTkwOTAw_62588d5d-a2c4-4e3c-af03-65ea7106fa02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMTAtMS0xLTE5MDkwMA_7a290d73-e06c-4721-bd5f-a9103b3ebd50">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0xLTEtMS0xOTA5MDA_e3f0cb63-cfff-477c-9285-673b3cd4c67a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0yLTEtMS0xOTA5MDA_a7cb5715-94cf-4fd7-b38a-18b4301f9be0">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0zLTEtMS0xOTA5MDA_dd9c2ca6-c1dc-4117-9505-77a34c51f610">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS02LTEtMS0xOTA5MDA_7c7f4ad1-3f51-4351-ba7e-3b6a052b4bdc">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS04LTEtMS0xOTA5MDA_00f516b3-253a-49b8-bf9e-60969397ac7e">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS05LTEtMS0xOTA5MDA_4a2e87a2-34d3-4a85-9d63-bebc2052c06b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0xMC0xLTEtMTkwOTAw_dda97b59-2f85-4fca-be3c-ed07b7ffae19">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0xLTEtMS0xOTA5MDA_c4bb1d01-76da-4e1f-908e-5ac7c6da1e12">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0yLTEtMS0xOTA5MDA_8661090d-966f-46d9-a726-115d7aa5084e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0zLTEtMS0xOTA5MDA_8bfbfbfc-98c8-4c4e-8ade-53d2dfb7f805">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi02LTEtMS0xOTA5MDA_fc71126f-21b7-4079-b775-140217ccb6ff">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi04LTEtMS0xOTA5MDA_42a67fd2-a8b9-4791-adfd-bc841264a806">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi05LTEtMS0xOTA5MDA_d5ec38e4-676e-4862-8ca0-99d280d96bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0xMC0xLTEtMTkwOTAw_65e93823-eb67-4fdb-a9e4-e96143ab5677">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0xLTEtMS0xOTA5MDA_6ec960ce-9f0c-45e3-8ca7-5a1217d97fd8">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0yLTEtMS0xOTA5MDA_eea9085a-5194-4955-81e1-03833f184da5">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0zLTEtMS0xOTA5MDA_1ce41d2c-58ec-4ce8-978b-30cc47bc3282">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC02LTEtMS0xOTA5MDA_d187d415-ec34-4eeb-a1ea-fd2bc0cc9194">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC04LTEtMS0xOTA5MDA_11a86315-33ae-47bd-9fbd-46492cc215cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC05LTEtMS0xOTA5MDA_3b9778fa-80c4-4b77-801f-33446fb766ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0xMC0xLTEtMTkwOTAw_9317c160-b1de-4ca3-af8b-9474c29619b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMS0xLTEtMTkwOTAw_195649ae-ae9b-4c93-8c1d-9c753163ef5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMi0xLTEtMTkwOTAw_b1b1ef5b-aab1-4e69-9b32-f149e999ea09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMy0xLTEtMTkwOTAw_2f26b51a-c5c0-4c8e-8dbe-cfd8b0608749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtNi0xLTEtMTkwOTAw_fc71126f-21b7-4079-b775-140217ccb6ff">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtOC0xLTEtMTkwOTAw_53167074-ede9-46e9-9cd7-4b4e08c15423">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtOS0xLTEtMTkwOTAw_270e2b6d-fd63-4f95-a732-e6803d84b249">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMTAtMS0xLTE5MDkwMA_ede68a8e-7765-4cd4-aa5e-cf3631372bf3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. <ix:nonFraction unitRef="usd" contextRef="i9b13667e719d448990cfdf861dda79e9_D20230101-20230331" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_29689ede-1f5b-442a-b35e-06700a51d862"><ix:nonFraction unitRef="usd" contextRef="i9b13667e719d448990cfdf861dda79e9_D20230101-20230331" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_b46dbc61-95c8-4f44-8649-c52eb480d31f"><ix:nonFraction unitRef="usd" contextRef="i5662554837084169851758271c9ea643_D20220101-20220331" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_c9850542-259a-4068-a8df-f7f87e3cc40f"><ix:nonFraction unitRef="usd" contextRef="i5662554837084169851758271c9ea643_D20220101-20220331" decimals="0" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_fd29fda2-bd91-4f33-a4e7-e6dff3153536">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6e277579e6204522a9efef5c8acffca2" continuedAt="i775b27f3acd349618c68470053676e16"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNjA_bdf3f4e1-45d1-4a9d-bff2-f197256052cc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.663%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfe2b43cff154363a0fbd139022c61e4_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjEzYzI5Y2RjNzdiODQzZDFiM2UwZWI3MmZmOGVkODZiL3RhYmxlcmFuZ2U6MTNjMjljZGM3N2I4NDNkMWIzZTBlYjcyZmY4ZWQ4NmJfMi02LTEtMS0xOTA5MDA_b6594121-6312-49a4-8693-d3f08b81cba2">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b6f2675a842b0bf177b07312667ed_I20230331" decimals="-6" name="bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjEzYzI5Y2RjNzdiODQzZDFiM2UwZWI3MmZmOGVkODZiL3RhYmxlcmFuZ2U6MTNjMjljZGM3N2I4NDNkMWIzZTBlYjcyZmY4ZWQ4NmJfMy02LTEtMS0xOTA5MDA_7ae20cd4-068f-43dc-a89a-deb971c5cdc3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i533dcba4722d4149a322054e6c21ee4e_I20230331" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjEzYzI5Y2RjNzdiODQzZDFiM2UwZWI3MmZmOGVkODZiL3RhYmxlcmFuZ2U6MTNjMjljZGM3N2I4NDNkMWIzZTBlYjcyZmY4ZWQ4NmJfNC02LTEtMS0xOTA5MDA_3a024e7e-7d13-4e57-8f45-03113d2ad764">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxOTg_dbd00209-786e-4a37-938c-f9182a510ec0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.114%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic842743075f046118858ebcc610ace3b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMi00LTEtMS0xOTA5MDA_4e4ad668-55ba-4ddc-9ca0-94b1393939dd">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMi02LTEtMS0xOTA5MDA_9fa3fddd-6eca-461d-a7df-5ddf07fe212f">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic842743075f046118858ebcc610ace3b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMy00LTEtMS0xOTA5MDA_9a353da9-fdc4-452a-9017-3f85ca7fe954">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMy02LTEtMS0xOTA5MDA_bfe3f286-aa5d-42b9-86eb-98436bd83252">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic842743075f046118858ebcc610ace3b_D20230101-20230331" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfNC00LTEtMS0xOTA5MDA_0442aa93-0fa1-4371-8bcd-376e6a79ea37">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfNC02LTEtMS0xOTA5MDA_2917b02a-60bb-4509-87a7-062591ef7b46">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxOTA_1eb0cf5c-4dd8-4d49-8acb-4bc5cfdc4bf3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i775b27f3acd349618c68470053676e16" continuedAt="if8e04741e4d741f085c3cf52509e2511"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNzU_4c246301-612a-4068-89bd-0c1c4dd6ae10" continuedAt="i780eea9181534eed8f15c5f6ffadffb9" escape="true">The following are the balances of our derivative and nonderivative assets and liabilities:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i780eea9181534eed8f15c5f6ffadffb9"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.911%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a67240557664530a64b7331a50a1002_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNC00LTEtMS0xOTA5MDA_c8288b8a-847b-4d1f-9940-39b7b9bb0bed">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c9733ef28a84cab80420249d9e34d87_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNC02LTEtMS0xOTA5MDA_2775a26a-fd36-4c7d-8171-61a15e6cfdcf">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3156378bfa9448c8b52d41d89ee9ce34_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNS00LTEtMS0xOTA5MDA_ef46caea-8b42-4553-a443-4a4f987e623a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66d194331bf40009415048dd898504b_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNS02LTEtMS0xOTA5MDA_98291def-fa46-40b9-99a3-496038472acd">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0625121c73b44dba2d3eade5207ea87_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNi00LTEtMS0xOTA5MDA_90ddbbe3-6957-4d30-b1c5-bc4b7de06351">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d1fca83b854131a110d8eddc52fb99_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNi02LTEtMS0xOTA5MDA_3086c4b0-cb1d-47c5-8bd7-cf3ba4be1467">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i945f22e98cb74c1c921b309349665d17_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfOC00LTEtMS0xOTA5MDA_0239ebce-fe30-43ae-803d-5aaf63936df3">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac0fa25ca3e402287e10a15580bdd69_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfOC02LTEtMS0xOTA5MDA_fb30e9d2-5410-48cc-90f4-3c551ce828a1">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTAtNC0xLTEtMTkwOTAw_7737a891-3fc4-4c44-b52b-6def7eec03c0">319</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTAtNi0xLTEtMTkwOTAw_923857f4-4999-476c-9234-be19d1ccefe8">381</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dbe63612beb45b3af51e535c5506a1e_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTUtNC0xLTEtMTkwOTAw_9396b3c8-928f-4e13-aa51-484a435f826b">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce906fb637148c7bbedc7b9646ab929_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTUtNi0xLTEtMTkwOTAw_7ba3ebc2-9b7e-4a38-a13b-841f48738d93">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic29f210b79834812843eecfdcd89818f_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTYtNC0xLTEtMTkwOTAw_1c4a1e0b-b70f-4a9f-b87a-dbe0a68eb113">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38524f4cd7624584aff36aaaa318766a_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTYtNi0xLTEtMTkwOTAw_0f5c1a0e-c039-48d3-8dd2-bcbd224d2b41">952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0625121c73b44dba2d3eade5207ea87_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTgtNC0xLTEtMTkwOTAw_f663ec30-1955-46e1-96c8-189c5e707461">972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d1fca83b854131a110d8eddc52fb99_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTgtNi0xLTEtMTkwOTAw_7489c034-92c0-40f7-a1e7-24dc7444e269">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i898b0c24ec0d4089ac323f8880881ab3_I20230331" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjAtNC0xLTEtMTkwOTAw_40d065fd-f851-4f06-a8d4-95afc12ef296">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173913dc9a954a229c38034702d71dc5_I20221231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjAtNi0xLTEtMTkwOTAw_82b491b3-6b15-4329-aa49-79ab5b3f4397">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjEtNC0xLTEtMTkwOTAw_2ad0cac3-2699-4337-844b-a3a4b7f8235c">1,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjEtNi0xLTEtMTkwOTAw_711aa731-ab1b-4a67-be16-626f339408b6">1,005</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#8364;<ix:nonFraction unitRef="eur" contextRef="ife05e78966de43f7831ac0435f16576a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfOTkxMg_fcb0fa53-b33c-47a1-8db9-271deea5dd26">900</ix:nonFraction> million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="if8e04741e4d741f085c3cf52509e2511" continuedAt="iaf36012257994275ade01ef36bca18cd"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNzE_b6444e9d-9607-46cd-866c-b17f55a5eef8" continuedAt="i68b2b4db77e74ee2b45328a31f3a153d" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xLTEtMS0xOTA5MDA_314ab883-a11c-441f-b505-7914c7b0a8ae">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0zLTEtMS0xOTA5MDA_ca53fefd-1bed-4108-b04a-a23477fa1e49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC01LTEtMS0xOTA5MDA_80c00944-86bc-4827-8338-14933428a311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC03LTEtMS0xOTA5MDA_e50c1239-a71b-4a85-a595-b0de65e6eae7">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC05LTEtMS0xOTA5MDA_2e395b67-8d8e-4117-a5c9-3550c7d0c171">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xMS0xLTEtMTkwOTAw_fab77f84-dfc7-4c10-863f-9c79d260338e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xMy0xLTEtMTkwOTAw_84dca408-4427-4eaa-813c-adcf96fdd0b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xNS0xLTEtMTkwOTAw_f0dd1175-cf26-4d03-9826-57492726e05f">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xLTEtMS0xOTA5MDA_e542af8c-4b0c-400b-a1ad-fb85c3b15427">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0zLTEtMS0xOTA5MDA_9723d3db-9b2c-47ea-a70a-6d4e27fa932f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS01LTEtMS0xOTA5MDA_62722c64-b46b-4ee1-a821-298784cf7f84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS03LTEtMS0xOTA5MDA_386a4f6b-354b-4446-80ac-7b6748fdb70a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS05LTEtMS0xOTA5MDA_f693ea15-f840-4a9b-9d6c-a3db994e4fa9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xMS0xLTEtMTkwOTAw_6a3e4e42-bd53-4fb7-b644-f52d478a8b6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xMy0xLTEtMTkwOTAw_eb81e857-d71a-4636-9e61-109630ae41db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xNS0xLTEtMTkwOTAw_e1a35aab-c742-408b-98b4-a929009dab3a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xLTEtMS0xOTA5MDA_9ecbab1e-a6be-4c7e-a0af-ff3781d1a41f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0zLTEtMS0xOTA5MDA_f34b37b1-3c55-429e-827e-d751181da376">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi01LTEtMS0xOTA5MDA_ff8c41ee-08bd-4a9f-85e6-ea61fb2fd09e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi03LTEtMS0xOTA5MDA_c211a95b-8673-40f5-9aa3-92106dc613b6">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi05LTEtMS0xOTA5MDA_862efa8e-f15d-47ac-9be1-97827272962e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xMS0xLTEtMTkwOTAw_bfe50c05-4a66-429a-845e-0028b778e7ea">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xMy0xLTEtMTkwOTAw_a3c06e9b-0ec1-4dd3-818d-6612d1377d7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xNS0xLTEtMTkwOTAw_8f58f001-a124-46b0-aec4-7ec22fc87fb2">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xLTEtMS0xOTA5MDA_360a4805-2731-4c18-acc5-7d1ae78d7b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0zLTEtMS0xOTA5MDA_a8b47554-9977-4d00-b576-3d406d88e418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy01LTEtMS0xOTA5MDA_2f19bb55-7b5e-4d8b-a2f8-0052532af7cf">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy03LTEtMS0xOTA5MDA_c72f9b63-9886-4083-90ca-c6eb58b74e86">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy05LTEtMS0xOTA5MDA_9ffbf972-b545-4937-923a-4c33b1bd14df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="bsx:Licensingarrangementsasset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xMS0xLTEtMTkwOTAw_39ed1404-c65a-4c99-9bb2-f7b31d9175b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xMy0xLTEtMTkwOTAw_80632c42-ee09-45e3-ae5d-1bffe6f1f755">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xNS0xLTEtMTkwOTAw_350f1422-0715-480c-8723-4d2daa9783a4">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xLTEtMS0xOTA5MDA_6bed7698-73de-410f-9fb8-0023ce3ffc56">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0zLTEtMS0xOTA5MDA_d7ee5a5d-d387-4c27-bfe1-4ef3e29958f2">319</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC01LTEtMS0xOTA5MDA_41383734-b543-4edb-b42b-5f1685b04db3">113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC03LTEtMS0xOTA5MDA_c97fde6a-b2f0-40ff-a9b9-be0b3d2a3fa7">604</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC05LTEtMS0xOTA5MDA_2e782927-511f-4b8c-b701-5ead155068de">674</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xMS0xLTEtMTkwOTAw_cbefff54-6d5d-44ee-83a0-bad05b67288f">381</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xMy0xLTEtMTkwOTAw_3788a87c-1efe-42c3-8356-48425cf91874">127</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xNS0xLTEtMTkwOTAw_e1e752d0-eeff-45ec-982d-68703227db31">1,182</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMS0xLTEtMTkwOTAw_fd181395-ebac-4589-a844-b62e1d68ac72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMy0xLTEtMTkwOTAw_28a3cd05-50bc-47df-92a0-7376d17b8186">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtNS0xLTEtMTkwOTAw_42133548-0107-4009-9c3c-701013db2147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtNy0xLTEtMTkwOTAw_a8b02708-fcdd-4a65-904a-17d705732edb">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtOS0xLTEtMTkwOTAw_539daa5f-b78f-4985-b483-3b3cf3dacafa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMTEtMS0xLTE5MDkwMA_f8a67ab3-891b-423f-b766-cf891e5cae96">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMTMtMS0xLTE5MDkwMA_a0dbccad-de5e-4cec-9959-6534c60f581e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMTUtMS0xLTE5MDkwMA_c3ff4c70-b0bb-48a8-a15c-dd86aed8fa2a">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMS0xLTEtMTkwOTAw_7e32d864-25ac-4a36-8f25-637edbb8d3cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMy0xLTEtMTkwOTAw_6cd3c0fd-e93d-4ffd-8149-68ba860704af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtNS0xLTEtMTkwOTAw_2bc47a1c-bfb1-4859-a09f-e8de423a63a5">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtNy0xLTEtMTkwOTAw_04e3cad7-2b2f-44b0-aaa4-627e4a92a2b5">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtOS0xLTEtMTkwOTAw_24feb00e-e404-41dd-863e-cf8d43185d25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMTEtMS0xLTE5MDkwMA_58176d24-4c50-413c-bd12-7eccd74d85e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMTMtMS0xLTE5MDkwMA_637bb6a8-190d-462e-a258-b3f303dd21b6">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMTUtMS0xLTE5MDkwMA_117cc8ea-6481-477e-9907-eb4e186df299">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMS0xLTEtMTkwOTAw_a8b2ec5c-4eb2-4a59-9b78-4e16094e9abf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMy0xLTEtMTkwOTAw_cf2e81b0-5e87-43fd-a252-cb4259785ad9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItNS0xLTEtMTkwOTAw_85c64eba-02a0-48b1-9350-afd01fc54759">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItNy0xLTEtMTkwOTAw_710ff144-4aed-4d13-ac17-12b50d2b8a26">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItOS0xLTEtMTkwOTAw_23666e66-dcc5-439f-8930-ae53c1b06f65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="bsx:Licensingarrangementsliability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMTEtMS0xLTE5MDkwMA_af55ee11-f3d9-4c93-a482-0608c3d22095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMTMtMS0xLTE5MDkwMA_42ec3dde-8a34-4ca7-86ca-cb8029c3b811">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMTUtMS0xLTE5MDkwMA_87bf7d2b-630b-405f-857f-71b99d697372">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMS0xLTEtMTkwOTAw_2fc7ec00-f23a-4146-9ceb-ed251170b891">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc55f108fce475dbd810515e835da38_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMy0xLTEtMTkwOTAw_569b1e1e-9563-4c60-93fa-1daeed5ec520">1,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtNS0xLTEtMTkwOTAw_2c5f3656-6277-4df4-b62a-78219280d46b">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtNy0xLTEtMTkwOTAw_10ad80b8-6d74-4c5e-9ce9-9401f312ba9c">1,222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtOS0xLTEtMTkwOTAw_0e0880d4-94fb-438c-a8b0-0d2bc6005f22">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64284d2d674f41c599406b01b23425de_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMTEtMS0xLTE5MDkwMA_b341ee8c-918f-4328-80e5-ae24a078c97b">1,005</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMTMtMS0xLTE5MDkwMA_47ac1156-2f33-47bc-b1f7-63707bd4318b">308</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMTUtMS0xLTE5MDkwMA_92878604-aaa1-4134-b70a-1e85a9ef7e96">1,313</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $<ix:nonFraction unitRef="usd" contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTE2MTM_314ab883-a11c-441f-b505-7914c7b0a8ae">170</ix:nonFraction> million invested in money market funds and time deposits as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTE2Nzg_2e395b67-8d8e-4117-a5c9-3550c7d0c171">673</ix:nonFraction> million as of December&#160;31, 2022, we held $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTE2OTk_b7bd2586-5555-4e8c-9ee3-96ad5c5577a7">400</ix:nonFraction> million in interest-bearing and non-interest-bearing bank accounts as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTA5OTUxMTY0MzAwNQ_86fed00e-ed7d-4d78-8e72-094d4b7e4c56">256</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We maintain a financial asset and associated liability for our licensing arrangements measured at fair value in our accompanying unaudited consolidated balance sheets in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We elected the fair value option to measure the financial asset and associated liability as it provides for consistency and comparability of these financial instruments with others. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i68b2b4db77e74ee2b45328a31f3a153d" continuedAt="i35fef4078df74fa79134d2100c37261d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of March&#160;31, 2023 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ied2485d2d4fc42b2b4036a2cad3a8e72_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfMS0xLTEtMS0xOTA5MDA_1e6f99a9-4604-4e69-985b-4bea16b6190f">113</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9892c74d12a64698ac3adb3291ee7fff_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfMS00LTEtMS0xOTA5MDA_d80cde16-f716-4c28-8537-f71859272eb4">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifae34dead96b45bcaba914062e411b97_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfMS03LTEtMS0xOTA5MDA_43deb376-eae2-48a6-b3b8-eeb840acc200">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ied2485d2d4fc42b2b4036a2cad3a8e72_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC0xLTEtMS0xOTA5MDA_6a289c10-1fc0-49c4-b40e-97fcfde06973">120</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64d6aed0afb24247bf0a0818471c3a5f_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC00LTEtMS0xOTA5MDA_9fe30e75-e527-48e9-94a2-2b6e43f956a4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i238dacb96f504855af458d65d8c5cce3_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC02LTEtMS0xOTA5MDA_a5724c60-1827-4a6a-993c-d6bee00ef7b6">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i227be4a1b97846078107b1f776038d7a_I20230331" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC03LTEtMS0xOTA5MDA_94ae2689-e4db-4469-96b8-d2ae63b46ed2">13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="iaf36012257994275ade01ef36bca18cd"><ix:continuation id="i35fef4078df74fa79134d2100c37261d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfMS0xLTEtMS0xOTA5MDA_9dffbdfe-9af2-4f6f-a04a-1c8e2f30e189">127</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if03bea69ff7e4976a0b0e30e39be825e_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfMi0xLTEtMS0xOTA5MDA_2db7ee43-d9a7-4aa7-a398-9ad1c443c57f">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if03bea69ff7e4976a0b0e30e39be825e_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfMy0xLTEtMS0xOTA5MDA_6b0617ae-b455-4348-ba58-dd0e855ffd80">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfNC0xLTEtMS0xOTA5MDA_4c8f4018-1dfa-4839-9fc9-21092abbf8ee">113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfMS0xLTEtMS0xOTA5MDA_c5f00acf-00d1-45bc-8fb0-fabfcd2f2d37">159</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i568fb51f289d40f6ba75256d02005ddf_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfMi0xLTEtMS0xOTA5MDA_264c1ad0-d5b2-4e57-9f37-306a2d80a634">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i568fb51f289d40f6ba75256d02005ddf_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfMy0xLTEtMS0xOTA5MDA_49c9c889-d7e8-40f0-b226-c33042aaaefd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfNC0xLTEtMS0xOTA5MDA_37a326d5-7905-426f-b82e-469198ccfa77">120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTM4MDg_c04d5b1b-9662-4eef-92e9-218b9326ca90">8.467</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTM4MjQ_fc5b76f2-d26b-4e1f-ad35-63243e83b79c">8.203</ix:nonFraction> billion as of December&#160;31, 2022. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkzNw_e9e80d0c-d7e1-4d7f-9621-79c90067180f" continuedAt="iebaf31ccd59e49c599c87e8ae52158e6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzk_a8c45f24-5a6b-4e3f-9eb2-b74a5aa47735">9.005</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfOTU_4808aa9c-5c3f-4751-946b-de11c39b5524">8.935</ix:nonFraction> billion as of December&#160;31, 2022, with current obligations of $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTM2_d0c99085-efdc-45f5-9a55-66bc523b35dc">510</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTUy_1d248772-ca78-401c-91fb-3a804d2ea6a0">20</ix:nonFraction> million as of December&#160;31, 2022. <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkyMg_29b25e48-0ff6-4c01-b0b7-cb8c015e30df" continuedAt="i237ccf107dfa4b2c821b186bf1b2e2e2" escape="true">The debt maturity schedule for our long-term debt obligations is presented below: </ix:nonNumeric></span></div><ix:continuation id="i237ccf107dfa4b2c821b186bf1b2e2e2" continuedAt="ie5f13d09df1a4e8a93682cce9d5ed4ad"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62061beaf669413399ee8f50383a8892_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNC02LTEtMS0xOTA5MDA_26f9d7bd-2efd-47b1-a28f-4a989b452f87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd06220f00384ae1a2d2a575490aaa1f_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNC04LTEtMS0xOTA5MDA_0aaa1230-a59f-4132-b2fb-4b069b2a1895">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62061beaf669413399ee8f50383a8892_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNC0xMC0xLTEtMTkwOTAw_3ab279a8-d20e-4dce-ade3-c5b30d75c1d2">3.450</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNS02LTEtMS0xOTA5MDA_6b5a789b-9fb9-4b2a-a45c-f5c4de189446">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e5cf0d439f46b3b717276488fa7f9d_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNS04LTEtMS0xOTA5MDA_dc2b67c4-01ff-4530-9e74-395847e46292">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNS0xMC0xLTEtMTkwOTAw_be91e41e-e93f-46ff-a36f-70ec62a6b27c">0.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c4a58684af4de9a487717ee618db7c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNy02LTEtMS0xOTA5MDA_22a0032a-08b5-4910-a751-595f6e8a3c15">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6c809593e643f1a097ae6dde04b29b_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNy04LTEtMS0xOTA5MDA_cd98618e-2731-48d2-b26f-12c824c7acbe">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15c4a58684af4de9a487717ee618db7c_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNy0xMC0xLTEtMTkwOTAw_a65e3151-e09d-4418-b56f-e92fbf22a54d">1.900</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib14a9ce7ffb8424bafe5c3db543bd32a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOC02LTEtMS0xOTA5MDA_ae0eda16-0f97-4c0e-a4ff-23c81ba9e909">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088272e4bb994960b019011fb46c0bcd_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOC04LTEtMS0xOTA5MDA_34b1d457-7374-445e-acad-889a2f43c9cb">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib14a9ce7ffb8424bafe5c3db543bd32a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOC0xMC0xLTEtMTkwOTAw_da0b9780-2585-4609-a862-887b00c121b2">3.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife05e78966de43f7831ac0435f16576a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOS02LTEtMS0xOTA5MDA_0a60bb9f-8815-4d0e-b755-735865b6747d">979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329ce681993e4c38be14123408b7f068_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOS04LTEtMS0xOTA5MDA_f64ec8e1-5594-4a6d-8081-4bbf68e69765">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife05e78966de43f7831ac0435f16576a_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOS0xMC0xLTEtMTkwOTAw_016ed6dd-b6c3-43e8-b689-29f1a27c9afa">0.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTAtNi0xLTEtMTkwOTAw_771b011a-dc10-4758-bc59-f8156922e231">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312f5201ec3c474d9b5a19c25fa7259b_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTAtOC0xLTEtMTkwOTAw_8513c8d1-be57-490a-9eeb-130428513686">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTAtMTAtMS0xLTE5MDkwMA_955f3563-03e0-4835-b944-f0eda2b99c9f">1.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3009e88a024e31b2102e6f4b8d5acb_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTEtNi0xLTEtMTkwOTAw_152b53cd-251e-4cdf-ba13-bbc5af62a06f">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i756598df01014441b201792edc1fde81_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTEtOC0xLTEtMTkwOTAw_a9958174-a26f-47eb-a0f2-71a2acc44b80">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c3009e88a024e31b2102e6f4b8d5acb_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTEtMTAtMS0xLTE5MDkwMA_1940fc08-95ff-400e-aae0-0d8880f1adf0">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a479cf5286f46b28b355c4f1a206db6_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTItNi0xLTEtMTkwOTAw_625a0556-6852-4b2b-8a87-cf0676d7cdcb">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0554d11e01874a65b0a89d983fc7a7a6_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTItOC0xLTEtMTkwOTAw_224f4245-a982-4315-8f56-7a4d22aaa7f2">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a479cf5286f46b28b355c4f1a206db6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTItMTAtMS0xLTE5MDkwMA_a5001517-62f7-42fc-b097-15cedb8e1ae0">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d7028932f6e425aab12bf8635b89b38_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTMtNi0xLTEtMTkwOTAw_8fdecbd7-ace0-4877-b2af-9915d93b17bc">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2b17f7d56a4b5aa6d7e274b8e3927b_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTMtOC0xLTEtMTkwOTAw_90a746ab-fdb4-43fe-9c0f-2fdfba3ab8a4">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d7028932f6e425aab12bf8635b89b38_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTMtMTAtMS0xLTE5MDkwMA_43083b20-809b-49c1-9b96-d747695d5b26">2.650</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTQtNi0xLTEtMTkwOTAw_700e83a7-aa55-4dfc-a8ac-e9659ff226e8">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c3d756333b4be29340b18df8cd60c3_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTQtOC0xLTEtMTkwOTAw_1a5ef0a2-5a63-44a8-b2b9-4fdc86e39866">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTQtMTAtMS0xLTE5MDkwMA_d8541632-1e3d-427e-811e-3cef5c11cce2">1.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i466b11229a244bf095c3c6d222c59179_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTUtNi0xLTEtMTkwOTAw_2df4ef09-e50f-49f0-bc26-884d566bf574">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d72460629d49a5bfd6e1d207d392c8_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTUtOC0xLTEtMTkwOTAw_85635932-d066-49ba-b67e-4e5d8218835e">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i466b11229a244bf095c3c6d222c59179_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTUtMTAtMS0xLTE5MDkwMA_5a0736b6-166a-4176-a9de-66db7fbe1d7a">1.875</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8331296051435fb2a207702eabbbd7_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTYtNi0xLTEtMTkwOTAw_ba290da7-0a97-4f28-838f-a1bb1feedbda">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ed1700e1b14f63b822bf214bf1ce6e_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTYtOC0xLTEtMTkwOTAw_0891c2c3-9248-4d84-b9a7-c4584b069b91">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf8331296051435fb2a207702eabbbd7_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTYtMTAtMS0xLTE5MDkwMA_dba312da-3f26-48eb-af97-28e36d9ef332">6.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7750de1d7104c23afc566121d84f163_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTctNi0xLTEtMTkwOTAw_679c672d-ce6d-4c7f-ae26-1da41b57e19e">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fae5b08170b41889f5b3dedb667c496_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTctOC0xLTEtMTkwOTAw_c5dab5b7-e435-4faa-96ec-cfa166edcd8e">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7750de1d7104c23afc566121d84f163_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTctMTAtMS0xLTE5MDkwMA_c7a2ff21-0876-48e9-a5b9-067ad02f170b">4.550</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960943048d6b4bd9ba267c6e877a0a08_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTgtNi0xLTEtMTkwOTAw_fe6d0483-4d24-46c9-9e52-7289ceb0bd18">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0b0dd532a74f04a579435e6746d19e_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTgtOC0xLTEtMTkwOTAw_19b645fe-6921-4997-abad-976a320d7405">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i960943048d6b4bd9ba267c6e877a0a08_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTgtMTAtMS0xLTE5MDkwMA_93bc0cc3-b21a-4e51-8606-1b10df6410cb">7.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc300f5c54f4bb08de690a8b948588e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTktNi0xLTEtMTkwOTAw_35461b61-4db8-450d-b865-dccf46a589ea">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6225368867454f86259df1ee8ed4f0_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTktOC0xLTEtMTkwOTAw_eb58db8e-3c5c-40bd-81fa-083e5c5e8f01">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fc300f5c54f4bb08de690a8b948588e_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTktMTAtMS0xLTE5MDkwMA_484b62be-4d75-4947-8a0a-f17a34c6532c">4.700</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a33141a69104417b94015557d906a3c_I20230331" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjAtNi0xLTEtMTkwOTAw_f57c79fc-4d8e-4d72-b196-c425baada9e7">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e31ad2072de41b69ce29a3a8a2beccb_I20221231" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjAtOC0xLTEtMTkwOTAw_819d9dac-1bac-4a93-8b9c-f90b7f9cc7b6">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77928e50ff7a48e385018d59595b61eb_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjItNi0xLTEtMTkwOTAw_afc593f5-6075-4a21-b168-74d54c5a7655">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b7c20939ab4f34a1fa7424a5d6d03f_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjItOC0xLTEtMTkwOTAw_9cc4a6bb-7dab-4d86-914e-cd44e156f4e7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjMtNi0xLTEtMTkwOTAw_c751bac8-a3ed-4661-9032-1569d2e77ba4">8,495</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjMtOC0xLTEtMTkwOTAw_aa6daa83-0145-46d2-8d5f-c61f438a64eb">8,915</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective May 2023, the interest rate payable will decrease by 0.25 percent and begin accruing at a rate of 6.50 percent following recent upgrades to our credit ratings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"><ix:continuation id="ie5f13d09df1a4e8a93682cce9d5ed4ad" continuedAt="if715b41c73944ec2b0e51cba3613fefd">(4)&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="if715b41c73944ec2b0e51cba3613fefd">Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021, we entered into a new $<ix:nonFraction unitRef="usd" contextRef="ib94a53ec039740fa8792e11ae883a02c_I20210510" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTQ0Nw_d60c0371-153e-474f-8745-55e75783ca4c">2.750</ix:nonFraction> billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks scheduled to mature on May 10, 2026, with <ix:nonNumeric contextRef="i31562662eb6547fe95ffff0dfca2001c_D20210510-20210510" name="bsx:DebtInstrumentExtensionOptionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkzOA_928531c0-465e-4671-917e-492986221b62">one-year</ix:nonNumeric> extension options, subject to certain conditions. On March 1, 2023, we entered into an amendment of the 2021 Revolving Credit Facility credit agreement, which provided for an extension of the scheduled maturity date to May 10, 2027 and replaced the London Interbank Offered Rate (LIBOR) with the Secured Overnight Financing Rate (SOFR) as the Eurocurrency Rate for Dollars, including applicable credit spread adjustments and relevant SOFR benchmark provisions, among other things described under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were <ix:nonFraction unitRef="usd" contextRef="ie74fb9edc1e54a079f786a420c2ee7ef_I20230331" decimals="0" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTg5MA_395350f7-532a-42b4-a559-5e424e469487"><ix:nonFraction unitRef="usd" contextRef="ib16e6c7d489f4c34bf5a29a3c06aa219_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTg5MA_c86d4532-dfe5-4edd-9958-c9f8304e0746">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the 2021 Revolving Credit Facility as of March&#160;31, 2023 or December&#160;31, 2022.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="iebaf31ccd59e49c599c87e8ae52158e6" continuedAt="i4b764b50758b4dadb84fc2df75e71dd8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkyNQ_c993f6fe-2d74-473d-a1f5-5de2541f6083" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility, as amended.</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:32.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1c5d438e1c44a81b2540ede941cd82f_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmU1YTIzYzk5MTc0OTRiZGVhMTNmYzUzN2RhYzgzZGY3L3RhYmxlcmFuZ2U6ZTVhMjNjOTkxNzQ5NGJkZWExM2ZjNTM3ZGFjODNkZjdfMi0yLTEtMS0xOTA5MDA_b197b32f-0768-49bf-9a08-000626fd5571">3.75</ix:nonFraction> times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id82f0c35a27940c9ae9176b5aeb5e9d3_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmU1YTIzYzk5MTc0OTRiZGVhMTNmYzUzN2RhYzgzZGY3L3RhYmxlcmFuZ2U6ZTVhMjNjOTkxNzQ5NGJkZWExM2ZjNTM3ZGFjODNkZjdfMi00LTEtMS0xOTA5MDA_81b8234e-b024-4fcf-a7ea-64f01a92b701">2.52</ix:nonFraction> times</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of <ix:nonFraction unitRef="number" contextRef="i7d9caf21868444e99250f18158da8bab_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjQyNw_d3d289bd-cdd1-43e2-893b-c9d01a9b997a">3.75</ix:nonFraction> times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:QualifiedAcquisitionConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjYwNw_2c3c7893-cd75-4e78-8d52-afb56d3e509b">1.000</ix:nonFraction> billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is <ix:nonFraction unitRef="number" contextRef="iac1e88fabb7b45c9855c38e764079bc7_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjc5OQ_ec275608-810f-4cf5-9952-0fc3aa56c9f1">4.75</ix:nonFraction> times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to <ix:nonFraction unitRef="number" contextRef="i8202332b83334006af73c7c6ce87639e_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjg5OA_6cbf27ed-a2fc-4383-ba65-4d682ac0ea09">4.50</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="ie8e5721798f64931ab7f86adf91517af_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjkwMg_8dcaccc3-e65b-4ed7-8618-063e04de8e44">4.25</ix:nonFraction> times and <ix:nonFraction unitRef="number" contextRef="ic1db4cf9dde84158b7c54dd06393c41d_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjkwOQ_936f25ef-dda6-420b-93c7-3d09d0c58bba">4.00</ix:nonFraction> times, respectively. Thereafter, a maximum leverage ratio of <ix:nonFraction unitRef="number" contextRef="i2c5612e005724c8d8c4db7a76f3396e6_I20230331" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjk2Nw_e0c9f03e-601d-40a4-914f-51965383bd5d">3.75</ix:nonFraction> times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for any qualified acquisitions due to our funding of these acquisitions using cash on hand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement, as amended on March 1, 2023, provides for an exclusion from the calculation of consolidated EBITDA, as defined by the credit agreement, through maturity, of certain charges and expenses. The credit agreement amendment reset the starting date for purposes of calculating such permitted exclusions in each case from March 31, 2021 to December 31, 2022. Permitted exclusions include any non-cash charges and up to $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:ExclusionFromEbitdaForRestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzQxNg_445b8cbe-6c03-4f65-b157-1112dad7ad2e">500</ix:nonFraction> million in restructuring charges and restructuring-related expenses associated with our current or future restructuring plans. As of March&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzU1MA_fd516dff-8461-4016-9e6f-185b72eb33ad">457</ix:nonFraction> million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:LitigationPaymentExclusionFromEBITDA" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzg4MA_f85bfaba-0d67-4a8d-a2e9-e168bcf3ea2e">1.000</ix:nonFraction> billion plus all accrued legal liabilities as of December&#160;31, 2022 for a total of $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:LitigationAndDebtExclusionFromEbitda" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTQ5NzU1ODE1MjcxOQ_59195504-ee34-44f0-a836-d20a68bc70d6">1.443</ix:nonFraction> billion. As of March&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzkxOA_979d4840-881c-4542-964a-b3b65423c46f">1.424</ix:nonFraction> billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility. <ix:nonNumeric contextRef="i6fd64d7c247c409fa4207f722c6c224c_D20230101-20230331" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkwMw_9725760b-bb5e-4b85-abce-1258aa17a21b" escape="true">We had <ix:nonFraction unitRef="usd" contextRef="ie74fb9edc1e54a079f786a420c2ee7ef_I20230331" decimals="0" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDc4MQ_395350f7-532a-42b4-a559-5e424e469487"><ix:nonFraction unitRef="usd" contextRef="ib16e6c7d489f4c34bf5a29a3c06aa219_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDc4MQ_c86d4532-dfe5-4edd-9958-c9f8304e0746">no</ix:nonFraction></ix:nonFraction> commercial paper outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In April 2023, we issued commercial paper to partially fund our acquisition of Apollo. As of the date of this Quarterly Report on Form 10-Q, we had approximately $<ix:nonFraction unitRef="usd" contextRef="id5c8a81e01b64601bd86cd95599e9025_I20230331" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTQ5NzU1ODE1MjQxOA_38371083-969a-44f4-847b-6fab663c72ca">400</ix:nonFraction> million of commercial paper outstanding, which directly reduces our borrowing capacity under the 2021 Revolving Credit Facility.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $<ix:nonFraction unitRef="usd" contextRef="i6a33141a69104417b94015557d906a3c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDg4MQ_921286bb-1d6f-4eef-8010-bc0a42dacbe2">9.067</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i9e31ad2072de41b69ce29a3a8a2beccb_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDg5Nw_e4545d30-1246-4aa7-a406-1e6011f672a8">8.986</ix:nonFraction> billion as of December&#160;31, 2022. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, American Medical Systems Europe B.V. (AMS Europe), an indirect, wholly owned subsidiary of Boston Scientific, completed a registered public offering (the Offering) of &#8364;<ix:nonFraction unitRef="eur" contextRef="i33b1a47c2971475a887f95d6f09d61f6_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTQyOA_c47bb229-d9c3-4b0a-ade9-5fccd0ba9489">3.000</ix:nonFraction> billion in aggregate principal amount of euro-dominated senior notes comprised of &#8364;<ix:nonFraction unitRef="eur" contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTUwNQ_1aa3d264-ee69-4f0b-a992-c0891080e843">1.000</ix:nonFraction> billion of <ix:nonFraction unitRef="rate" contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTUxMQ_9196adce-2f7d-4b87-b879-d9350c1d83d5">0.750</ix:nonFraction>% Senior Notes due 2025, &#8364;<ix:nonFraction unitRef="eur" contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTUzNw_85ee19d7-e481-412d-b897-a97fe2967af3">750</ix:nonFraction> million of <ix:nonFraction unitRef="rate" contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTU0Mw_2d8c2ddb-42e6-4fee-8f29-450dcce9ffb3">1.375</ix:nonFraction>% Senior Notes due 2028, &#8364;<ix:nonFraction unitRef="eur" contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTU2OQ_209d00ca-7ad1-4091-8a6e-37e605bbc6bb">750</ix:nonFraction> million of <ix:nonFraction unitRef="rate" contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTU3NQ_1cf14a9f-efc4-48a9-9be4-6ea2bf09b7d7">1.625</ix:nonFraction>% Senior Notes due 2031 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i466b11229a244bf095c3c6d222c59179_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTYwNA_81b90762-1f55-442b-bda3-fef8c798b5ce">500</ix:nonFraction> million of <ix:nonFraction unitRef="rate" contextRef="i466b11229a244bf095c3c6d222c59179_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTYxMA_f1e0a402-119d-4e90-9059-29098479fe7c">1.875</ix:nonFraction>% Senior Notes due 2034 (collectively, the Eurobonds). Boston Scientific has fully and unconditionally guaranteed all of AMS Europe's obligations under the Eurobonds, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i4b764b50758b4dadb84fc2df75e71dd8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and no other subsidiary of Boston Scientific will guarantee these obligations. AMS Europe is a &#8220;finance subsidiary&#8221; as defined in Rule 13-01(a)(4)(vi) of Regulation S-X. The financial condition, results of operations and cash flows of AMS Europe are consolidated in the financial statements of Boston Scientific. The Offering resulted in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i093f5b3abdd745f1a8241d0453842764_D20220101-20221231" decimals="-6" name="bsx:CashProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNjEzMw_33c35350-2ffe-4413-b938-c9ebef25f143">3.270</ix:nonFraction> billion, net of investor discounts and issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i561fec84ddc04b59a8105f1d9d8ac489_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNjMxNQ_b920b9c9-e0c2-494e-8b65-2ef09db1ed9b">3.275</ix:nonFraction>&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. We recorded associated debt extinguishment charges of $<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNjQ4OA_36ae2218-04b3-4bd5-8988-2084676d7043">194</ix:nonFraction> million during the first quarter of 2022 presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkwNw_13c68774-e493-42c1-ba09-2e6f70228d96" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.912%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i703997e880b841bf912c19d2455d4f77_I20230331" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi0xLTEtMS0xOTA5MDA_3fac6dc4-520d-4000-b58b-b8393c573a9e">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e8b97cc2e8d4eb88ae1bdfe5cc6884c_D20230101-20230331" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi0zLTEtMS0xOTA5MDA_b9931753-ed29-4c20-b317-1a5167e7fa6f">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib453388f5f184e4a82c28c4a8350b8bc_I20221231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi01LTEtMS0xOTA5MDA_6c5a836d-ec6a-41ae-8609-0a0ac03d3f6a">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1d7c0732e164ffa8188acb478deb5c8_D20220101-20221231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi03LTEtMS0xOTA5MDA_b49a8446-8528-4553-bd2d-97843136048c">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice1cde59638b4723b05549750c61c718_I20230331" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy0xLTEtMS0xOTA5MDA_245fca9c-9731-4674-9c7a-b373ef8aeafa">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99eaf8749fec4bd4bef896df3b9fd8c3_D20230101-20230331" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy0zLTEtMS0xOTA5MDA_f70fe0f5-c644-4bdb-b98e-0ce277117929">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a0ea6834ac41f1b607a21df3a62801_I20221231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy01LTEtMS0xOTA5MDA_f7251323-216a-4316-bb57-05f12b81d151">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia218bd3302d5488a916178d33c82b82b_D20220101-20221231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy03LTEtMS0xOTA5MDA_352e37fe-7f1f-43a3-b09a-a3aa9731920b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801c5c1c6a2442c086808723bb7fc47b_I20230331" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC0xLTEtMS0xOTA5MDA_d3c0930e-6488-40d9-a117-ab723a87edb4">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6c9ebfb99fa4dfeb3304751f22498b5_D20230101-20230331" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC0zLTEtMS0xOTA5MDA_5101dc3b-54f5-4fb2-bbc6-870a71e8b6c2">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924e9479e6bf4f81906b0781426a7ba1_I20221231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC01LTEtMS0xOTA5MDA_e274d07a-bbb6-48c7-9c3e-0ce414c2cff1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i524c7cd3f2f6432d98a7ae708c5f5aca_D20220101-20221231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC03LTEtMS0xOTA5MDA_3e2757bc-6ce9-4acc-8451-30e19841535c">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzM5NQ_1113ee2f-13a1-4d99-a3db-3a87fd893d08">143</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzQxMQ_a12e48d9-0188-4aab-8aa4-ce724bdeb83b">135</ix:nonFraction> million as of December&#160;31, 2022, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of March&#160;31, 2023 and December&#160;31, 2022 we had not recognized a related liability for any outstanding letters of credit within our accompanying unaudited consolidated balance sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a supplier financing program offered primarily in the U.S. where our suppliers can opt to receive early payment at a nominal discount, while allowing us to lengthen our payment terms and optimize working capital. Our standard payment term in the U.S. is 90 days. All outstanding payables related to the supplier finance program are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited consolidated balance sheets and were $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:SupplierFinanceProgramObligationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTA5OTUxMTYzOTkwMA_a8ee6a44-bdf9-4d44-8346-be52b993cf13">128</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:SupplierFinanceProgramObligationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTA5OTUxMTYzOTg4NQ_6ab30a5f-83b7-4fc9-a727-6622d8178c03">129</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_76"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc2NA_fa62b81a-c949-4e9b-b8a7-92fc5a83f6b7" continuedAt="ifec0cc4afafb41329d1daae043ace08a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc1MA_8c5ff44a-7457-4912-8dd4-7c56fb75b110" continuedAt="i36703bd300be499ca78ad84d203e8eb2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMi0xLTEtMS0xOTA5MDA_27e9d991-4f56-4747-9feb-5ae4c812733c">2,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMi0zLTEtMS0xOTA5MDA_29c40b35-6200-4845-97fa-1228942dd75e">2,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMy0xLTEtMS0xOTA5MDA_23b77a4d-dae7-40e1-96d0-200c9df09624">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMy0zLTEtMS0xOTA5MDA_a623d9af-2c84-47b6-95e7-820e1a8c4748">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfNC0xLTEtMS0xOTA5MDA_1078254b-ca18-4238-9307-388348334641">2,076</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfNC0zLTEtMS0xOTA5MDA_4819fbf0-d460-4177-9265-c18a27ae1f20">1,970</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifec0cc4afafb41329d1daae043ace08a" continuedAt="idda7d47b174e4e279d62893abe0fefad"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:continuation id="i36703bd300be499ca78ad84d203e8eb2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMi0xLTEtMS0xOTA5MDA_e8b687d7-83f5-4106-b478-8713db3d2d2f">109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMi0zLTEtMS0xOTA5MDA_085f60d7-a3e1-4f06-96f0-ad8eb97fc6b8">108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMy0xLTEtMS0xOTA5MDA_18e49edf-fa6b-40fa-9cf2-17277d712ae4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMy0zLTEtMS0xOTA5MDA_70edde59-a11a-4030-bb7b-96a45bcea62e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNC0xLTEtMS0xOTA5MDA_0ef383f7-91d2-4889-ba1d-7da0032b6a9a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNC0zLTEtMS0xOTA5MDA_f2399c7e-0999-4b6f-9531-af9ffc19b825">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNS0xLTEtMS0xOTA5MDA_a5ccb4e8-d057-40a6-9f1a-76a77c744feb">118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNS0zLTEtMS0xOTA5MDA_6be7bb7d-e632-4276-a0d4-1afbfe078ae0">113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 326), we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach, applying country or region-specific factors, to determine the reserve to record at accounts receivable commencement for certain customers. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. In addition, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc2MQ_897916e3-89b5-4b4d-a3ea-c55b4d24d920" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMi0xLTEtMS0xOTA5MDA_89cecba6-bdbb-470d-9a54-7a49e41b0b75">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMi0zLTEtMS0xOTA5MDA_97c8bdae-1014-40fb-a8a1-794b185640ea">1,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMy0xLTEtMS0xOTA5MDA_0d594695-3cdf-4b06-83aa-c8286b55a659">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMy0zLTEtMS0xOTA5MDA_b78aa2df-3813-4da1-ad02-790984910897">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNC0xLTEtMS0xOTA5MDA_962b65d8-a36e-4fcd-8cf7-ea3fd61b2bc7">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNC0zLTEtMS0xOTA5MDA_835fdd39-c44b-4214-94dd-fb914e9f618a">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNS0xLTEtMS0xOTA5MDA_b6a39518-d805-4171-aa66-630099f7012f">2,050</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNS0zLTEtMS0xOTA5MDA_d75cc5a0-da69-4d88-a563-4e15decb6e9d">1,867</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:1pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:1pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjczNg_6c04bf30-1f18-418c-abb4-f1129967231d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMi0xLTEtMS0xOTA5MDA_77534565-27c2-485b-ae85-e8417cd0c59d">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMi0zLTEtMS0xOTA5MDA_1aa96047-9242-4ed6-8146-3e5e58db69e4">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMy0xLTEtMS0xOTA5MDA_c35d173a-c7eb-42b4-af91-61ceb770617c">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMy0zLTEtMS0xOTA5MDA_ec666ab9-07ba-4254-9b31-5fc9f50514f3">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNC0xLTEtMS0xOTA5MDA_6f80d074-26b0-4b38-a4e2-df24cec98f31">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNC0zLTEtMS0xOTA5MDA_09231015-c827-4552-a4bf-0b008b800384">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNS0xLTEtMS0xOTA5MDA_0c407898-e0ca-40a9-993f-46b0357db80f">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNS0zLTEtMS0xOTA5MDA_5cff76a2-401f-47ff-ade4-b17d57a24c35">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNi0xLTEtMS0xOTA5MDA_dea787a1-eb3e-46b6-beac-5ac40700e597">711</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNi0zLTEtMS0xOTA5MDA_266d7eda-bd40-4e36-89ba-899533dc3a4f">731</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="idda7d47b174e4e279d62893abe0fefad" continuedAt="if63641e8a1b640aeb9a2c02ba5aa5294"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjcyNA_e976c90a-b6a8-4f25-8986-b2065399e060" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMi0xLTEtMS0xOTA5MDA_0ddd3a94-84e1-449b-abe9-8dad90e84415">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMi0zLTEtMS0xOTA5MDA_d37ff7d1-13c2-4d26-963d-39c20c940985">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMy0xLTEtMS0xOTA5MDA_8dae29f1-8c2e-4c13-883f-ff877427506a">1,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMy0zLTEtMS0xOTA5MDA_6019fe7a-c04f-4636-89a7-404ca64b99d8">1,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:EquipmentFurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNC0xLTEtMS0xOTA5MDA_ac129a15-d792-402e-bc82-6c230631e981">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:EquipmentFurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNC0zLTEtMS0xOTA5MDA_bded6c73-9977-4782-9c9b-15d66c138404">3,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNS0xLTEtMS0xOTA5MDA_5f83147e-f270-4e0a-9388-7474a4d208f4">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNS0zLTEtMS0xOTA5MDA_b8792792-8986-411d-890e-4ba2b52a3078">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNi0xLTEtMS0xOTA5MDA_3ad7082b-8503-4bff-b104-6c40aaebea69">5,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNi0zLTEtMS0xOTA5MDA_9ddfe742-1a9f-4354-88a8-543aa4f3350f">5,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNy0xLTEtMS0xOTA5MDA_62fe37a4-a026-4d80-8559-d97c05f0e79e">3,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNy0zLTEtMS0xOTA5MDA_551fb855-278d-42fb-95e1-7a32078c7188">3,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfOC0xLTEtMS0xOTA5MDA_e91be736-b417-462c-b12a-23f949b0e60b">2,478</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfOC0zLTEtMS0xOTA5MDA_0d913c3f-bc39-414f-a58e-eba3c027857d">2,446</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMTA5OTUxMTYzMDU5Mg_e8cfcbba-dddd-4420-9754-1fcd3f08a152">82</ix:nonFraction> million for the first quarter of 2023 and $<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjAwMw_ec27ee1c-e211-4a30-a3ec-5a7f68efe0f2">76</ix:nonFraction> million for the first quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc0NQ_0348905a-ce66-488b-a7c3-e9089ac3a10e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMi0xLTEtMS0xOTA5MDA_10b323fc-8269-4d9f-ba45-36507f3f507f">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMi0zLTEtMS0xOTA5MDA_342a5155-2a65-43a5-a340-1edb2b133f6e">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMy0xLTEtMS0xOTA5MDA_1268d436-9999-493f-bf8b-160c896d604b">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMy0zLTEtMS0xOTA5MDA_debfe007-1b37-4a94-9a48-4d63f65c4d66">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNC0xLTEtMS0xOTA5MDA_9dd71232-6273-4b6d-aa54-be5a7a03a878">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNC0zLTEtMS0xOTA5MDA_8f9efbaa-96d6-4137-bf75-1fc965ab3a44">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNS0xLTEtMS0xOTA5MDA_d5091d85-eca3-42ae-b6ec-3279160e78fa">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNS0zLTEtMS0xOTA5MDA_4e8238ce-467a-4349-b9ca-08fd60ca7973">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNi0xLTEtMS0xOTA5MDA_0cafe917-0fa7-4b89-9162-fc469e5d94d7">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNi0zLTEtMS0xOTA5MDA_e7f120fd-34ee-474c-856c-1e457404f0e9">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:IndemnificationAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNy0xLTEtMS0xOTA5MDA_95558f1f-a0c6-42e2-bd50-4201b6c45074">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:IndemnificationAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNy0zLTEtMS0xOTA5MDA_eae72371-9339-473d-a266-6d827be9ebe8">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOC0xLTEtMS0xOTA5MDA_f8ecdda4-1857-463a-8df2-434940649555">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOC0zLTEtMS0xOTA5MDA_0890a05b-6805-42d0-808e-e848cd0af03d">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOS0xLTEtMS0xOTA5MDA_6f790e6c-5715-4baf-bc1e-70ef7a08eb2e">1,482</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOS0zLTEtMS0xOTA5MDA_80921a0a-30be-4750-84ee-63e37f7194ab">1,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc3MA_337d2a2c-cc06-4fbb-9645-7bbbef796f91" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMi0xLTEtMS0xOTA5MDA_23ec3014-baf4-4441-aff1-f10d663ad2e7">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMi0zLTEtMS0xOTA5MDA_660997f1-1f08-4b22-b1d3-9f1dcc88bf3a">231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMy0xLTEtMS0xOTA5MDA_0e285e38-aeb1-482a-b04a-54ef07fd9cf3">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMy0zLTEtMS0xOTA5MDA_7c9f7615-e870-454d-b871-59215931fd9c">830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNC0xLTEtMS0xOTA5MDA_adf38cda-19e6-4a65-90e9-9523c220be6e">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNC0zLTEtMS0xOTA5MDA_d269e1c5-2f11-4bc3-9a9b-0f472174eee9">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNS0xLTEtMS0xOTA5MDA_e43ca630-97c8-4fd5-ae20-3e56686dce02">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNS0zLTEtMS0xOTA5MDA_a6ba9bfe-2db9-4b2b-b6de-05a7dd28d853">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNi0xLTEtMS0xOTA5MDA_2bcb9cec-4749-48d1-9abb-6e8c67bd8507">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNi0zLTEtMS0xOTA5MDA_cfaf165d-42ad-45df-a26c-d448c20fa2ae">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNy0xLTEtMS0xOTA5MDA_f69cd9c2-f456-4c75-bff4-d31143c2c1d1">1,918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNy0zLTEtMS0xOTA5MDA_7978a241-6b7f-404b-99b6-204d05908969">2,160</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc3MQ_8346e1dc-fc9e-4324-80f7-4e1399ad238a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMi0xLTEtMS0xOTA5MDA_75c269fb-5c94-445b-99b8-81d3249109f5">231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMi0zLTEtMS0xOTA5MDA_c2e19fb9-b9e0-4a88-9298-10a9d7a5ab64">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMy0xLTEtMS0xOTA5MDA_0f927afc-b99b-4bf0-aea3-badd445f057b">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMy0zLTEtMS0xOTA5MDA_74125b7b-ae1d-48d4-843b-f010c6d9cc21">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNC0xLTEtMS0xOTA5MDA_ce9a422b-2a25-4c4b-b1b6-0830969eefcd">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNC0zLTEtMS0xOTA5MDA_a7a70a26-bea6-44ba-a301-fb617a0fba11">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNi0xLTEtMS0xOTA5MDA_4e21adfc-1830-45a6-921d-da13f04db274">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNi0zLTEtMS0xOTA5MDA_1d92d3a8-f49f-4eb8-ae1b-aa8dfaceb2c7">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNy0xLTEtMS0xOTA5MDA_454fbf8e-5ed7-40ba-b992-277dd54f80f9">787</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNy0zLTEtMS0xOTA5MDA_c56a248a-7dfd-44d2-9b91-80225ace812a">761</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if63641e8a1b640aeb9a2c02ba5aa5294"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc1OA_dd67451c-13c3-45ad-a4a5-725c16600779" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMi0xLTEtMS0xOTA5MDA_f21df74a-022f-4167-80cc-358fe9941791">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMi0zLTEtMS0xOTA5MDA_961ee9f4-0cf6-4c28-8256-3501e558637b">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMy0xLTEtMS0xOTA5MDA_50eff50b-68e8-49da-91f1-cc0cc68b387e">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMy0zLTEtMS0xOTA5MDA_e9b9201b-9e36-4b3d-9858-120782840105">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNC0xLTEtMS0xOTA5MDA_84d6bda5-0422-41c9-9cd5-54ad5e4fadfe">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNC0zLTEtMS0xOTA5MDA_cb196a5f-9c5c-458e-bfa8-e9e05e193326">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNS0xLTEtMS0xOTA5MDA_9fd22c8f-472d-44e8-8311-8eb669996dd4">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNS0zLTEtMS0xOTA5MDA_e45ce938-44d0-411e-873a-6e9b1d0dc941">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNi0xLTEtMS0xOTA5MDA_27eb5e28-eca4-473b-b1fc-343dfc1d7da8">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNi0zLTEtMS0xOTA5MDA_0ac9d45a-22c0-432c-88c5-65425682c0a8">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNy0xLTEtMS0xOTA5MDA_af229ef5-68f2-48d5-98e4-54949fe470ab">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNy0zLTEtMS0xOTA5MDA_2c0d3ac9-55ad-4465-b994-f024b1ee5805">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOC0xLTEtMS0xOTA5MDA_0ff111a0-6bc0-4706-a191-6c3f267f2937">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOC0zLTEtMS0xOTA5MDA_edcb33e2-e109-4eb5-8540-8c59d7caa977">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOS0xLTEtMS0xOTA5MDA_21d0ed2b-c357-48a7-ad7c-115acdedf594">1,995</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOS0zLTEtMS0xOTA5MDA_379c39b2-6aa9-4bf8-b446-3b0b3d4010e1">2,035</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_85"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfMTMwMg_13b5b851-a1d9-4a47-a101-035d37fc2ff8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfMTMwNA_fbcbdf74-222a-4d4f-8ce2-47743f916bb1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.851%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RhYmxlOjIyZTA2YTEzYWY1MjRiOTg5OGNhNTBhM2EwZDFhNDE5L3RhYmxlcmFuZ2U6MjJlMDZhMTNhZjUyNGI5ODk4Y2E1MGEzYTBkMWE0MTlfMi0xLTEtMS0xOTA5MDA_aa8ec6d3-6480-4163-a6c3-d4a9b1c6f27e">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RhYmxlOjIyZTA2YTEzYWY1MjRiOTg5OGNhNTBhM2EwZDFhNDE5L3RhYmxlcmFuZ2U6MjJlMDZhMTNhZjUyNGI5ODk4Y2E1MGEzYTBkMWE0MTlfMi0zLTEtMS0xOTA5MDA_936205d0-1bc3-4d9f-acc3-939f1d7681a2">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our reported tax rates for the first quarter of 2023, as compared to the same period in 2022, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include debt extinguishment charges recorded in the first quarter of 2022, as well as certain discrete tax items primarily related to provision-to-return adjustments recorded in the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfNjYw_846111b3-cd71-47c4-930e-262289314e98">501</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfNzE0_92041702-4dd6-4456-a562-886309ec93e3">415</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfNzg3_874767a3-a982-47c8-9778-9a3b3ff2824d">492</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfODQx_97089ec6-aa51-4789-ae78-36d1fafd45cc">410</ix:nonFraction> million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfMTI4Nw_96451dd2-4c42-4b11-becb-d1ad425691b0">77</ix:nonFraction> million.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_91"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMTMxMjY_c54d0fc9-bed3-42fb-b1d5-e885fac37384" continuedAt="i66460a18479b4df090fadea1172808ef" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i66460a18479b4df090fadea1172808ef" continuedAt="i619be7d49a304dd2855d649e334df999"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, product liability, securities and commercial claims have been asserted against us and similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity. For additional information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMTMxMzE_bd7685b7-fc00-4899-a752-1e59e2cf6e7b" continuedAt="ia148bb46975842cf9783f79f81f1745c" escape="true">FASB ASC Topic 450, </ix:nonNumeric></span><ix:continuation id="ia148bb46975842cf9783f79f81f1745c" continuedAt="i31237795d76642eba1c16ad10ae1568d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i31237795d76642eba1c16ad10ae1568d">within our accompanying unaudited consolidated statements of operations.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjU0NQ_cc5befef-75e9-4f71-93e4-2359ebec1d62">416</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjU2MQ_c854ff8b-dc5c-41b9-a0e6-9cfd53ce246f">443</ix:nonFraction> million as of December&#160;31, 2022 and includes certain estimated costs of settlement, damages and defense primarily related to product liability cases or claims related to our transvaginal surgical mesh products. A portion of this accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjkzNw_44990b9d-e93b-4893-a830-2fe7aa90379c">135</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjk1Mw_4eb20e28-0e6a-4293-8f8c-27dcd4f4c4b6">149</ix:nonFraction> million as of December&#160;31, 2022. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We did not record any litigation-related net charges during the first quarter of 2023 or 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against four then-asserted patents, which resulted in the court staying the case until 2020. All IPRs concluded and confirmed the validity of certain claims of each challenged patent. In </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i619be7d49a304dd2855d649e334df999" continuedAt="ib365c1bd87964bf3b3a90bf4991a2c4a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2023, the District Court issued summary judgment rulings dismissing certain claims and defenses. Trial on the remaining two asserted patents is scheduled for May 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2017, The Board of Regents, University of Texas System and TissueGen. Inc. (collectively, UT), served a lawsuit against us in the Western District of Texas. The complaint against the Company alleges patent infringement of two U.S. patents owned by UT, relating to &#8220;Drug Releasing Biodegradable Fiber Implant&#8221; and &#8220;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#8221; and affects the manufacture, use and sale of our Synergy&#8482; Stent System. UT primarily seeks a reasonable royalty. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the UT&#8217;s Petition for Certiorari. UT proceeded with its case against us in Delaware. In January 2023, a jury trial was held on the issue of whether the one UT patent still asserted in the case was valid and whether it was infringed by the Company. On January 31, 2023, a jury concluded that UT&#8217;s patent was valid and willfully infringed by the Company, and awarded UT $<ix:nonFraction unitRef="usd" contextRef="i4d88790c2af246f9a293243672a14f79_D20230131-20230131" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfNTQ5NzU1ODQzMzAy_331cca7c-db1c-4cd2-a6d4-920df5439cf7">42</ix:nonFraction> million in damages. Following the trial, UT has filed a motion seeking prejudgment interest and enhanced damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has filed a motion seeking judgment as a matter of law in its favor or alternatively a new trial.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Multiple product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us, predominantly in the United States, Canada, the United Kingdom, Scotland, Ireland, and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. We have entered into individual and master settlement agreements in principle or are in the final stages of entering agreements with certain plaintiffs' counsel, to resolve the majority of these cases and claims. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. In addition, in April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records related to mesh settlements. The Company has notified our insurer and retained counsel to respond to the demand. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for remaining claims asserted against us associated with our transvaginal surgical mesh products and the costs of defense thereof. We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest these cases and claims. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and <ix:nonFraction unitRef="units" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="INF" name="bsx:BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfNTQ5NzU1ODI4MTc4_e9b55f5f-cff0-4be1-bafc-ebb88733d9b4">29</ix:nonFraction> individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#8217;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. Subsequently, on March 30, 2022, the Federal Prosecutor&#8217;s office issued a non-binding recommendation that is contrary to the Attorney General&#8217;s recommendation. The full Commission is considering both of these recommendations but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#8217;s decision.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ib365c1bd87964bf3b3a90bf4991a2c4a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam. The Company has received related subpoenas for documents from the Office of the U.S. Attorney for the District of Massachusetts and the Securities and Exchange Commission. The Company is cooperating with government agencies while investigating these allegations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2023, the Company received a subpoena from the U.S. Department of Justice (DOJ) that seeks documents and information relating to its ambulatory electrocardiography monitoring (AECG) business. The Company is cooperating with the DOJ in responding to this subpoena.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020, Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all others similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. The plaintiffs filed an Amended Complaint in June 2021 that seeks unspecified compensatory damages in favor of the alleged class as well as unspecified equitable relief. The Company filed a Motion to Dismiss in July 2021, which, in December 2022, the Court granted in part and denied in part. The Company intends to vigorously defend itself against the surviving allegations. On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#8217;s decision to retire the LOTUS System and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company cooperated fully with the requests, and on January 3, 2022, the SEC informed us that it was concluding its investigation and that it did not intend to recommend an enforcement action. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above. The Company received letters on behalf of the Union Excavators Local 731 Pension Fund, Diane Nachbaur, and Frank Tripson, three stockholders of the Company, on July 26, 2021, July 29, 2021, and February 13, 2023, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items. On February 7, 2023, Diane Nachbaur filed a shareholder derivative complaint in the United States District Court for the District of Massachusetts against the Company, Michael F. Mahoney, Nelda J. Connors, Charles J. Dockendorff, Yoshiaki Fujimori, Donna A. James, Edward J. Ludwig, David Roux, John E. Sununu, Ellen M. Zane, Joseph M. Fitzgerald, Daniel J. Brennan, Shawn McCarthy, Ian Meredith, Kevin Ballinger, and Susan Vissers Lisa.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_97"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfMTcxNA_a9cf6137-758e-4c1e-95ac-99be98de2f82" continuedAt="i1ccc310e6b6541a5bc5c5eca2d618545" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNTI_b6b0481e-cdfd-450c-8c5f-a76653cc2b0b">50</ix:nonFraction> million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="i5c8184b4c8c243b8af7637900054690c_I20200527" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNDY4_3d8e9522-4762-48e8-ad28-b4558169c4ce">10,062,500</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="ib7f86060f0074e3fa81c9253f3234640_D20200527-20200527" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNDgx_1ea9d662-1c2b-4222-b816-95c9d5c69f67">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5c8184b4c8c243b8af7637900054690c_I20200527" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNTky_13a78b1c-cb45-4f57-aff6-5c08553fce8b">100</ix:nonFraction> per share. The net proceeds from the MCPS offering were approximately $<ix:nonFraction unitRef="usd" contextRef="ib7f86060f0074e3fa81c9253f3234640_D20200527-20200527" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNjYz_a91a8aec-2d13-460e-9e51-0ba8bc9f087c">975</ix:nonFraction>&#160;million after deducting underwriting discounts and commissions and offering expenses. As of March&#160;31, 2023, our MCPS had an aggregate liquidation preference of $<ix:nonFraction unitRef="usd" contextRef="i95ef2210d01348d08fdd30f6ff1570b1_I20230331" decimals="-6" name="us-gaap:PreferredStockLiquidationPreferenceValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfODA0_36fc31c9-a711-4167-91b9-7ff2e39476e4">1.006</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared, and we paid, a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfMTAyMA_3491d997-fc6e-407a-ba18-e203de08b64b">1.375</ix:nonFraction> per MCPS share to holders of our MCPS as of February 15, 2023, representing a dividend period from December 2022 through February 2023. On April 24, 2023 the Committee declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i21deea3483f54e3b81ef33228bfe3f5f_D20230424-20230424" decimals="4" name="us-gaap:PreferredStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfMTIxMQ_77d9b023-e08c-4c81-a9a7-2fb8583a8bbc">1.375</ix:nonFraction> per MCPS share to holders of our MCPS as of May 15, 2023, </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i1ccc310e6b6541a5bc5c5eca2d618545"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">representing a dividend period from March through May 2023. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheet as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.</span></div></ix:continuation><div id="i43fadb9987444221929c0db0dedbaf58_100"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzIwOTg_ef27ad79-520f-4072-8962-5074e6b1f0fa" escape="true"><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzIxMDA_35eaa3e2-7a5f-49f1-8c01-00c3a19ff64f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzItMS0xLTEtMTkwOTAw_e341ed4a-e7cf-4720-95ad-bff58593a76d">1,435.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzItMy0xLTEtMTkwOTAw_2057ff1d-9b03-401d-9381-4d0efa14bde3">1,427.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzMtMS0xLTEtMTkwOTAw_5240b6fe-fe7a-44d5-8578-ae958fe9f8e5">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzMtMy0xLTEtMTkwOTAw_6c42ea76-3b55-4335-be03-29005fa94179">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzQtMS0xLTEtMTkwOTAw_c5fb5842-a199-4545-8dc7-3e4ea347b41d">1,446.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzQtMy0xLTEtMTkwOTAw_1a3f809e-585e-46da-a693-0bcb0cd626bc">1,438.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzIxMDc_1523d865-93d7-4743-94a1-67a1c2e73f68" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of diluted weighted average shares outstanding because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i729502d0e5784f61982c93b93148e4fb_D20230101-20230331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzItMS0xLTEtMTkwOTAw_c342ff22-f63a-4e89-9bc7-02f28f9dbbb3">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib25a90bd0f1c4959a574e6b17d6a6895_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzItMy0xLTEtMTkwOTAw_aeb0d7d2-424d-40fb-a950-8d666fa68d9b">3</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb4decd76ac944aba2576f8d09ebafe2_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzMtMS0xLTEtMTkwOTAw_a583c5db-b4fd-4a42-96d5-b2a039d851c6">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia920d3162ecd41e8890b68584ba18ffd_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzMtMy0xLTEtMTkwOTAw_b5114e94-b5e0-49e4-b364-5a26ea30392f">24</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the first quarter of 2023 and 2022, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented within our accompanying unaudited consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to Boston Scientific common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We issued approximately <ix:nonFraction unitRef="shares" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzU0OTc1NTgxNjM0MA_5dd041c8-9fe6-4014-8336-3d7dd64ff663"><ix:nonFraction unitRef="shares" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzU0OTc1NTgxNjM0MA_f0cabbfc-9212-40f0-a9ad-6b0e2d719ebe">four million</ix:nonFraction></ix:nonFraction> shares of our common stock in the first quarter of 2023 and 2022 following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first quarter of 2023 or 2022. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i84eb384121c84b858baf58516ec1fe4a_I20201214" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzE5OTY_86ff54bb-b0c0-4a07-92ca-04ac832801ff">1.000</ix:nonFraction> billion of our common stock. As of March&#160;31, 2023, we had the full amount remaining available under the authorization.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90ZXh0cmVnaW9uOmQyNWNhYjA1NzBlMjRjZmFiODNmY2M2ZmY0ODAyNzdmXzE4ODU_e52df917-370e-4165-a5dc-43e45e682473" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aggregate our core businesses into <ix:nonFraction unitRef="reportablesegments" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90ZXh0cmVnaW9uOmQyNWNhYjA1NzBlMjRjZmFiODNmY2M2ZmY0ODAyNzdmXzI5Mg_8500daf6-f47f-496d-baa3-bfea303dc951">two</ix:nonFraction> reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. In accordance with FASB ASC Topic 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we identified our reportable segments based on the nature of our products, production processes, type of customer, selling and distribution methods and regulatory environment, as well as the economic characteristics of each of our operating segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and evaluate our reportable segments based on their respective net sales, operating income, excluding intersegment profits, and operating income as a percentage of net sales, all excluding the impact of foreign currency. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations and are included in the reconciliation below. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for net sales by reportable segment presented in accordance with U.S. GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90ZXh0cmVnaW9uOmQyNWNhYjA1NzBlMjRjZmFiODNmY2M2ZmY0ODAyNzdmXzE4ODQ_f5a3aa51-67fe-46b6-943f-d485610935e4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzUtMS0xLTEtMTkwOTAw_262f9622-7805-42ec-935f-f838906e6cc1">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzUtMy0xLTEtMTkwOTAw_29d62156-ceff-4f41-99ef-c04e6009cb82">1,164</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzktMS0xLTEtMTkwOTAw_7a37b9d7-dcad-427d-a7e5-07a5f5afd221">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzktMy0xLTEtMTkwOTAw_980c1bff-2912-4d59-a5da-c0ab407566b5">1,902</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892e1507c0f84e27b277daf33bcc248a_D20230101-20230331" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEwLTEtMS0xLTE5MDkwMA_3872cbde-5311-4197-b4e1-95354a480179">3,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd1740aa87b4096a3a080290bcc5749_D20220101-20220331" decimals="-6" name="bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEwLTMtMS0xLTE5MDkwMA_f2e18d07-e719-4e19-bb3b-363e4863ff05">3,066</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEzLTEtMS0xLTE5MDkwMA_d634245d-c0fc-4620-a9ff-7d0a962e5af1">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEzLTMtMS0xLTE5MDkwMA_013dc147-dfed-4afe-af9e-1a0d554aedc3">40</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzE0LTEtMS0xLTE5MDkwMA_099de6e2-446d-4802-b419-eeede2414cef">3,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzE0LTMtMS0xLTE5MDkwMA_d91165a1-de3e-4070-9479-17897ecab1c3">3,026</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzItMS0xLTEtMTkwOTAw_3a7aa5d3-b87f-4730-8165-7594a1152e59">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzItMy0xLTEtMTkwOTAw_0ff98262-85b2-4d68-bde9-69271028a8d4">371</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzMtMS0xLTEtMTkwOTAw_ebd3be58-b535-4001-8d0f-9eaec0c5213e">541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzMtMy0xLTEtMTkwOTAw_4f03b04e-e5bf-47a9-a2f4-4a2c710ae122">477</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720152cb93a648a2bb7df641008979ab_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzQtMS0xLTEtMTkwOTAw_114b8cae-2ac4-446f-8205-e3916a4f7522">940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1209edcbb30e47fa9c4fb81d208f7e6d_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzQtMy0xLTEtMTkwOTAw_22bee932-e2bb-4985-916d-64a23fd74750">847</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1262f85d5444afeb2e8bf8a337371ed_D20230101-20230331" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzctMS0xLTEtMTkwOTAw_8098dede-2bec-40ff-aff4-d699bbe31ee0">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ae924fcb6454d58b1beb6db9683dbdd_D20220101-20220331" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzctMy0xLTEtMTkwOTAw_c831ceb9-afca-4b78-ba06-3b8116622b95">66</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3179b68ff7d44c6494abf26a8009b478_D20230101-20230331" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzgtMS0xLTEtMTkwOTAw_6657c27c-2918-40c0-8fea-73af7f320c21">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2beece93d3c417d868a8435ec76e880_D20220101-20220331" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzgtMy0xLTEtMTkwOTAw_08605f6a-f820-424e-bad3-3bfcabfa86cf">117</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzktMS0xLTEtMTkwOTAw_4572f071-d59f-40ba-ad87-20f7defcfe4d">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzktMy0xLTEtMTkwOTAw_71fd532d-7bd4-4bd9-9e51-83de81f460d4">198</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEwLTEtMS0xLTE5MDkwMA_6b9467a5-6afc-47cd-9db7-d7263b5ff7c9">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEwLTMtMS0xLTE5MDkwMA_4d9442f8-0f49-47e3-bd3d-c00d25ff8de3">466</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzExLTEtMS0xLTE5MDkwMA_84da4c2d-316d-495b-b5aa-2d427a3b2de7">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzExLTMtMS0xLTE5MDkwMA_1d8c50dc-1344-4cf7-be26-b591c24d30e8">310</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEyLTEtMS0xLTE5MDkwMA_00e568ec-9f65-4f39-b14f-eceb4a2b72eb">444</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEyLTMtMS0xLTE5MDkwMA_a5511e4e-bff0-4d2d-8109-ae15396ced22">156</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzItMS0xLTEtMTkwOTAw_b7e9ec11-0aa9-4cfe-b49f-020e0a6f77f2">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzItMy0xLTEtMTkwOTAw_4ef737dc-8bca-43a7-985c-ae946eb569b0">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzMtMS0xLTEtMTkwOTAw_37a7afc2-47cd-4365-82bc-05a775d64ef2">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzMtMy0xLTEtMTkwOTAw_2ee172d5-9eb9-4f8b-b7da-caaf0c34c1cf">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzI2NDE_203bf293-c1a5-4be6-9bcd-37e189d7373e" continuedAt="ib4a75ad25dc943bca3b7634ff1188cab" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes within our accompanying unaudited consolidated statements of operations. Our business structure is organized into <ix:nonFraction unitRef="business" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="0" name="bsx:NumberOfBusinesses" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzIyMw_9df7a0a7-6b95-4032-a56b-c1aa0929e682">five</ix:nonFraction> operating segments. <ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzI2NDQ_950b726f-2ae1-4b89-a46c-4b6db286dbe3" continuedAt="ic851462c599b4d768fb92035db46e35e" escape="true">The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ic851462c599b4d768fb92035db46e35e" continuedAt="ic1374fb329d9444c99263d5e18658165"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c68fb8458984a4f8ea9ffdd46d5ea2c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtMS0xLTEtMTkwOTAw_70703c9a-64b1-4ebf-842f-76fb373d5082">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e2cf8c97fd4c64965a5f6aa819f9e4_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtMy0xLTEtMTkwOTAw_fc3fafd6-dca1-41f0-91d1-aee770207b49">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id347fa0ecf034855bd36b1bc5861689f_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtNS0xLTEtMTkwOTAw_08959919-d622-49cc-81c8-6e1b1f23bfc7">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc12ab5d66c4eb2b1365bc49a5014fe_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtNy0xLTEtMTkwOTAw_0fdef2ce-42a7-4bb8-8ccd-e8c9fd6794c6">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71b6743f2b6457e8bf78a9b44e1408a_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtOS0xLTEtMTkwOTAw_4d76dcc3-6842-4712-a465-cba936f338b5">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b43f39a384c40b3a17cb49b4126801d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtMTEtMS0xLTE5MDkwMA_1780efe6-db49-4f9c-8e1e-590b298b7dbd">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20046af1ade34a1bb48b675de0ca23e5_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtMS0xLTEtMTkwOTAw_962835af-684a-4f8d-a632-1b3047c286ca">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9d8827599584437aad144dac6477fee_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtMy0xLTEtMTkwOTAw_1a3acf4d-4bfd-44d3-89e3-489baffa9fe9">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc3815af2cc4d4a9f6872e38a324d73_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtNS0xLTEtMTkwOTAw_135ed890-32e8-438f-8c08-7b9d397eebab">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ddbe086cb5145cd83bb64b7179f7739_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtNy0xLTEtMTkwOTAw_b12a2993-b54a-4292-9a48-5ae12007fd47">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5346710804266aa4d620df4bb34fc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtOS0xLTEtMTkwOTAw_e35c5432-3169-4b52-8f43-baac96d27913">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e204df240ac4042a4b13bf6f20f5c4b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtMTEtMS0xLTE5MDkwMA_7144e824-2874-48c2-b176-dce437cda8a7">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i096721fee95e47b791ea57339f0c6c6e_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtMS0xLTEtMTkwOTAw_5a64879d-37a7-44d7-86d7-fed9b788dea8">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f00f6a7bb3544d58920179cebba0281_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtMy0xLTEtMTkwOTAw_ccd2e363-a9be-487b-9102-1700eac0cd01">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie96d08ce6f50458ab49816d256c5879f_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtNS0xLTEtMTkwOTAw_686f1ea2-2936-4482-99e0-cc92cabb9bf1">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0790d1be80ae447488c9e5a9fc97437c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtNy0xLTEtMTkwOTAw_6225a460-74dd-465f-900e-296e4ab10c15">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a866861cad402094fd324c25ba0ee9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtOS0xLTEtMTkwOTAw_f54f22a3-7dc8-4386-9e53-0590a49c7137">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cdc59667be948b992bcf7274af8504f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtMTEtMS0xLTE5MDkwMA_44b9de20-2064-4c63-8370-6aa0958a8e69">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff459ba706d649ddbd4ec72d239941dd_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtMS0xLTEtMTkwOTAw_04df89cc-aa21-441c-b6d7-8d6b660e0e74">850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e41fa3eab7468c8b4e91101c3d9016_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtMy0xLTEtMTkwOTAw_475b482f-abfb-4307-bf0e-d5aa194437cc">430</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtNS0xLTEtMTkwOTAw_fbcabe9d-889b-42b3-943b-afc5926db36d">1,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57c51fa109d491fbf453b46c2cf46ca_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtNy0xLTEtMTkwOTAw_2421d7cb-a7a1-43a4-b965-def13597b5f1">758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefdec8766de4485b6cdc952038f1024_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtOS0xLTEtMTkwOTAw_3ee0fc5d-0420-424a-aa48-30d322363026">395</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtMTEtMS0xLTE5MDkwMA_919ddaa1-8271-486a-a99a-bf6cacb2c97e">1,153</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f524aabbb214853af93224fac9bf26a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctMS0xLTEtMTkwOTAw_e2907425-4570-4743-8fd5-677bee711599">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c333bda857d4e739b41fed616fa6e68_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctMy0xLTEtMTkwOTAw_aeb244bf-7504-4b50-b6d3-b5bbb2d5881b">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18982ae6885f4b8198ee1ce626bc22fd_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctNS0xLTEtMTkwOTAw_47204d98-07b2-4c0b-9feb-e23671760fac">591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01b2243c2754130a4e2ed20fe142983_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctNy0xLTEtMTkwOTAw_6254ef07-63e5-43ea-88f1-5dad155d01c1">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e952a467484badaea6d0b16ca1fa44_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctOS0xLTEtMTkwOTAw_9e71d1bc-4d96-4bd0-96ca-1588fc04c004">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife24678eb6c34b28945046363ea2e300_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctMTEtMS0xLTE5MDkwMA_212aa759-24c0-4ded-9f6d-1243709cff1f">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic784b1fc58dc49f699ae6044fe608256_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtMS0xLTEtMTkwOTAw_6c193b86-9694-462e-bdb0-7823eddf22ac">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93ae74b5a9e41fdbaa62e517659928e_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtMy0xLTEtMTkwOTAw_ccf304ac-e2cc-4a84-9f0a-a0714abf8af1">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08294063f673491c88ed513f79e9696f_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtNS0xLTEtMTkwOTAw_f19c53c7-f939-4689-9efa-839c98b03134">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943d4120b79b4e69b07762eaf7b26e21_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtNy0xLTEtMTkwOTAw_3db3e5c6-a577-40ca-b860-c74728c8256d">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6096985306aa4386b7ea6027c25d855c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtOS0xLTEtMTkwOTAw_95476f91-8d7b-4a6c-915e-f230aa6e6981">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3410600120b47b5bfe3ab5c48f59e1c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtMTEtMS0xLTE5MDkwMA_d6f80e5b-5334-42b7-b4a9-283b18002e51">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if02e957943204cfb9fb85d6b73a32689_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktMS0xLTEtMTkwOTAw_6f8dc5ff-6b9c-4f73-9ff9-65c1cef2702b">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie616f026675d4c09a0ac3e6282f05cf8_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktMy0xLTEtMTkwOTAw_4a5702f9-727e-4b96-bf25-7444d82202c9">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f221dbc7b741d79383b223f9e27c7b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktNS0xLTEtMTkwOTAw_0782a681-8ef1-4320-908f-540766918f11">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26380f708b9e4841930b61b187def315_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktNy0xLTEtMTkwOTAw_d4d4c80c-9b29-4ede-90f5-6d1033b452fe">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee563d35506f470b9f10eb39f4283205_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktOS0xLTEtMTkwOTAw_31fdfcd1-7cb9-4102-af16-38352e824e4c">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d8f220044d42889463ea08e1cf165b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktMTEtMS0xLTE5MDkwMA_36489aa7-82ce-4f55-a23d-dc9b2d5b605a">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0c54cf535041beb749a2a1df797e45_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTEtMS0xLTE5MDkwMA_64eb456b-78db-4bb0-95dd-13fe7a3b1811">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5556344fb56743dbae6d822773174a4a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTMtMS0xLTE5MDkwMA_9a3ae9ab-509c-4440-a0ae-f0cb1b493ebb">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28b59b162ea849ca9be28f0f9fa67f2d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTUtMS0xLTE5MDkwMA_45682eed-2280-4ff5-8196-01171cf4bb5c">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078220c195b64332b042b94c0d76ab95_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTctMS0xLTE5MDkwMA_258f6949-17f1-47e9-ab58-fdd6622f4ef7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1c2ac83d1f46a6be7dd082708aa903_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTktMS0xLTE5MDkwMA_23e3fffc-c727-49f4-bad9-50c31ca79bd3">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c352b4948b8481485df395a9cc353c5_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTExLTEtMS0xOTA5MDA_6bfc674b-ff57-47d2-bbb7-d7e686f0e08d">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10971b0415014c579cc2dbb8f66240e4_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTEtMS0xLTE5MDkwMA_ef1904a5-8e54-4d6e-918b-c8a218a21811">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7961173213db4f5d91d6d2e7211fd02c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTMtMS0xLTE5MDkwMA_65a1c5f7-2fab-4a1a-9080-5b6f89759063">727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0050baa10746afa4706c455030ba41_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTUtMS0xLTE5MDkwMA_ed877d49-5a7e-4f99-b951-f49d5743bda9">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i829d668e2b3c49fc845a7c3a6cdd828c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTctMS0xLTE5MDkwMA_03c9f31c-b8f6-405e-8638-7e446d11acb2">764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3889e23d356499d9f44ad951bed2120_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTktMS0xLTE5MDkwMA_775a5c5c-c8f5-4d7c-a611-d655f968d7ea">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb44bd7e5a5c407ebc133a722c9a1308_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTExLTEtMS0xOTA5MDA_b39446b3-9070-4e33-80c2-897c6affc3a6">1,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e6d0e45f264ed697fcf267f645c2fc_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTEtMS0xLTE5MDkwMA_77bb0971-0390-4e1c-a55c-af7d930feba6">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4503a934cd0405d9071461ef9d0b03c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTMtMS0xLTE5MDkwMA_33a33d3b-d30e-4859-b254-bd8999979901">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad755ea2c6d3473d8e3a08e615f25c1b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTUtMS0xLTE5MDkwMA_e62a8c52-fabf-4541-b6b1-8ded971cf702">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3068a1c629b847b3b49438fc4cb80ef1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTctMS0xLTE5MDkwMA_0d134990-ea39-41da-8078-9ecabb7415b2">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5eca007cb54f15afd6e2c739116757_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTktMS0xLTE5MDkwMA_7cbbad33-c673-46d9-9155-093383f647ec">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9688a45fc2049beb9a82a633381002e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTExLTEtMS0xOTA5MDA_64e4ada0-9fe5-49a0-b290-e81c3d4b9c12">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5422ebead84c4ded81dca3fef4d9458f_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTEtMS0xLTE5MDkwMA_bec07abb-611c-4b04-a1cc-fa31b25ed6f2">1,154</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844a962b3a3d4374b6d7ab653485bcbd_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTMtMS0xLTE5MDkwMA_32f30353-c740-4656-972f-3957de8af0ed">956</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTUtMS0xLTE5MDkwMA_05d42b5a-039f-4373-810e-a3e5e7b52ba6">2,110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73f4b2c0cdd4b4d86b93f555d5f2835_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTctMS0xLTE5MDkwMA_1b6afaa8-f7f3-4e72-a7a3-993a96a03be6">1,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a6956ee87544c1ad636a7500e3ef26_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTktMS0xLTE5MDkwMA_c3083d01-e30c-44c4-9e10-21f0e6a8cdf8">853</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTExLTEtMS0xOTA5MDA_8efce28e-1622-42d7-b26b-c3d6869d5421">1,873</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb98bc5824349e0a016e837ad7726b5_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTEtMS0xLTE5MDkwMA_a889054f-3079-43b8-bb0f-aa13e4d43658">2,003</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic937499f758443ae828dea9b24a41dba_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTMtMS0xLTE5MDkwMA_c04612d4-fdb2-41c0-a814-5490631a0b44">1,386</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTUtMS0xLTE5MDkwMA_5ecff000-f056-441b-a287-b2ffb9c100e3">3,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510c5d8a3423489a9deb5ae4f8f2de17_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTctMS0xLTE5MDkwMA_e8e7724f-53f3-4305-af29-af52415e0c3b">1,778</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc93a4a42604befa962d6c0f4e94d6e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTktMS0xLTE5MDkwMA_a1eb89da-9c3b-4ec0-b7f1-c518ed859b8f">1,248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTExLTEtMS0xOTA5MDA_1d7ce86b-d601-4d55-b6ec-4ca8bcd3e2dc">3,026</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note K- Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information on our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica31a05afc6142cdb6e3553ebec68348_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzItMS0xLTEtMTkwOTAw_f5086eb8-82e4-4537-9e31-fa24e9d3b4bc">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89df95595aa24a1c9855a94a80a41df0_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzItMy0xLTEtMTkwOTAw_18e639e0-fae8-4362-a36d-587c307b2771">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f896077c40e4dbabd217e2aa1f4c9a5_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzMtMS0xLTEtMTkwOTAw_f5dadb22-2a7c-4974-83d8-8e3dfd94c332">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bba908d72404714bf08fea400279688_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzMtMy0xLTEtMTkwOTAw_c0f60d61-0828-4568-9d54-0f1653b4c805">624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4f8c9dec7f4aec8d00394ff1f2c185_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzQtMS0xLTEtMTkwOTAw_e8cc8615-3b45-4f90-aadb-f40ff01e6d72">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieffcfd57b85847f5b9ac168b84a7fb47_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzQtMy0xLTEtMTkwOTAw_b7515618-538c-4d53-b9b6-2c44e31d322c">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d805dfd29434cc483bf10e47f598abd_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzUtMS0xLTEtMTkwOTAw_fcd4fae3-5328-4805-8039-5ce35065de00">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975a78bf3f974f3d82fb89c8f671b311_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzUtMy0xLTEtMTkwOTAw_1a7acd05-f042-4710-b399-99003ebf7099">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEwLTEtMS0xLTE5MDkwMA_5ecff000-f056-441b-a287-b2ffb9c100e3">3,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEwLTMtMS0xLTE5MDkwMA_5a126123-72cc-4556-9277-0fcc5d65a77f">3,026</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc7a3a9179c4bee8cc766a1114c8a59_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEyLTEtMS0xLTE5MDkwMA_abdb2a59-3ef0-41b7-b5e7-efbdf077a414">529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6264f6b9421a4ec4a9454dbc24c596cc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEyLTMtMS0xLTE5MDkwMA_47be3d05-8228-4c3f-bd2a-6490103ecd0d">440</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"><ix:continuation id="ic1374fb329d9444c99263d5e18658165" continuedAt="i65267ff5551f4eb7b3f4ca4d3d3bf5c7">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i65267ff5551f4eb7b3f4ca4d3d3bf5c7">Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzE0NDE_a17daa72-be0b-468e-b636-502cfc8e6e83">521</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzE0NTc_5562dd5f-b974-46fe-961f-27348e374eb0">509</ix:nonFraction> million as of December&#160;31, 2022. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiology business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our Cardiology business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzIwMTI_83627fe3-3194-4275-b47a-54db7f0ba14c">42</ix:nonFraction> million in the first quarter that was included in the above contract liability balance as of December&#160;31, 2022. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><ix:continuation id="ib4a75ad25dc943bca3b7634ff1188cab" continuedAt="i293ef699a4b14fc997471b53fbe6370b">Variable Consideration</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i293ef699a4b14fc997471b53fbe6370b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on variable consideration, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_118"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90ZXh0cmVnaW9uOjdjZjQ3MWVkYmI3YTRlNDhiMWVjMmZkZWExMDQ4Y2Q5XzMzMg_34de7b2c-334e-4fd4-9038-791a71479d88" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90ZXh0cmVnaW9uOjdjZjQ3MWVkYmI3YTRlNDhiMWVjMmZkZWExMDQ4Y2Q5XzMzNg_f9415a6a-afe3-46f2-858d-b38b89081524" continuedAt="i24849e2d326340958b1952916e508b55" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtMS0xLTEtMTkwOTAw_7a5a19b3-d1e2-4b11-8c0c-f0c414079575">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtMy0xLTEtMTkwOTAw_5e3a29e0-50e4-4fa3-8dd2-1b7679381d25">269</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtNy0xLTEtMTkwOTAw_539ea107-1271-4b6b-bbf6-789e017b2a00">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtOS0xLTEtMTkwOTAw_971886e8-eaef-453f-8fd5-471cca5038ef">269</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItMS0xLTEtMTkwOTAw_549f4525-92d5-42f5-b5cf-187c35f26973">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItMy0xLTEtMTkwOTAw_bcbc45ad-3569-4af9-a5ee-079d499190af">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItNy0xLTEtMTkwOTAw_b5dc3fa1-f4e2-462b-a3f4-144f442c8661">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItOS0xLTEtMTkwOTAw_ee038d57-295f-491c-a3a3-a31e255f2285">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtMS0xLTEtMTkwOTAw_e391fa68-e344-4578-964f-a35c332f6d35">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtMy0xLTEtMTkwOTAw_44770456-0eb8-47ec-9abe-ef9997da1249">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtNy0xLTEtMTkwOTAw_f3dc82f3-f4de-4f1e-a876-41fee761f1c6">0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtOS0xLTEtMTkwOTAw_1eefcff9-d1b7-48c3-af12-3317771ec153">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtMS0xLTEtMTkwOTAw_8d4521ea-e00d-46f2-8046-c26c9bf3f9bc">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtMy0xLTEtMTkwOTAw_7afec61c-e7b1-4182-ba11-60e5b86f2e55">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtNy0xLTEtMTkwOTAw_c414d577-c05f-4b27-ab91-d06a978de754">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtOS0xLTEtMTkwOTAw_83f9e1b3-dd06-470d-8b5e-5f3a16884818">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtMS0xLTEtMTkwOTAw_8dbd4908-44d2-4685-9eef-91d8431122bb">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtMy0xLTEtMTkwOTAw_b219a86a-5f0a-4ca8-bef6-9c5bccacc474">225</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtNy0xLTEtMTkwOTAw_e28d1736-bde4-41d0-8a8f-5e30001619f9">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtOS0xLTEtMTkwOTAw_9351c2bd-fe5a-4488-b2c8-5e875306dfa8">178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtMS0xLTEtMTkwOTAw_9d5193b5-5d53-4070-b01a-7f6db835e111">93</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtMy0xLTEtMTkwOTAw_a8aa3f30-213c-4bd6-8a43-b4fe229b54e1">206</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtNy0xLTEtMTkwOTAw_7977f47d-7774-4d84-a1f5-3f0b8f7abe99">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtOS0xLTEtMTkwOTAw_158998e1-b2f6-4a19-934f-d06a94daf38e">263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItMS0xLTEtMTkwOTAw_0c84435f-0426-43bb-b6ce-a5b1230f4b61">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItMy0xLTEtMTkwOTAw_e075e1f1-f867-4d2e-9264-e23b7d6056fd">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItNy0xLTEtMTkwOTAw_18128200-9486-4fce-8625-059a01267070">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItOS0xLTEtMTkwOTAw_e9ef5748-5e10-40e3-9719-f299c2dc2ae0">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtMS0xLTEtMTkwOTAw_85f0a9a0-8256-4f71-bfe4-0cd057fc850c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtMy0xLTEtMTkwOTAw_fa4f94eb-ce5c-493e-a559-d4e670f7fcda">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtNy0xLTEtMTkwOTAw_c390a30f-ac45-4771-96df-c592aad7b4df">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtOS0xLTEtMTkwOTAw_70a4c2f9-ce8b-479d-931a-ed085ad96962">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtMS0xLTEtMTkwOTAw_b9abe2dc-09c7-4fd0-a69b-f158d92a5e7d">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtMy0xLTEtMTkwOTAw_7fc604c5-1cf4-436c-be8f-c8a50c369793">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtNy0xLTEtMTkwOTAw_87c5ff5c-689b-4a0f-887d-3e3f7b271d09">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtOS0xLTEtMTkwOTAw_e579f13c-3e08-4b40-bb45-b473f3029d5f">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtMS0xLTEtMTkwOTAw_05b85ad6-1d9a-4c7b-90b4-1ef0413a7188">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtMy0xLTEtMTkwOTAw_1322f267-e20a-4a95-b00b-5459267372b2">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtNy0xLTEtMTkwOTAw_7b5319e8-d358-48b4-b73a-5a6f4ee6da02">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtOS0xLTEtMTkwOTAw_a4598470-b4f0-4d06-9afe-d174d9c7f081">222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i24849e2d326340958b1952916e508b55">R</ix:continuation>efer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_124"></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:NewAccountingPronouncementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0Mjc_c348c7c0-eabc-4dde-a1b6-89b459ece7ab" continuedAt="i93ae48e60b7449f691169df6906576fe" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first quarter of 2023, we implemented the following standards on a prospective basis, none of which had a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0OTc1NTgzMjY4NA_a9aa5957-45de-40c6-a978-f562a7a05eb5" continuedAt="ibe3ea1d59950459888c2474ff68b94a2" escape="true">ASC Update No. 2022-01</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ibe3ea1d59950459888c2474ff68b94a2" continuedAt="if6c98472ad234aaa99fb87129ab49cc7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if6c98472ad234aaa99fb87129ab49cc7">Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0OTc1NTgzMjY4Mw_aa96cb22-a2b3-430f-bc14-e6beb2734314" continuedAt="i021334eebbae4e03b29580f2211ede54" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2022-02</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments- Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i93ae48e60b7449f691169df6906576fe"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i021334eebbae4e03b29580f2211ede54">amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0OTc1NTgzMjY4Mg_9820ac5a-bf61-4e67-bc20-98e4b4420b94" continuedAt="i7e959f74106d4adfba5c87a3bf57e61a" escape="true">ASC Update No. 2022-04</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i7e959f74106d4adfba5c87a3bf57e61a" continuedAt="i914253c959954b2fb5b9439ba0277fc8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities&#8212; Supplier Finance Programs (Subtopic 405-50) </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i914253c959954b2fb5b9439ba0277fc8">enhances the transparency of supplier finance programs by requiring that a buyer in a supplier finance program disclose sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331" name="bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0MDg_a4068733-d62f-4efe-8f1c-daca7250aa60" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASC Update No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:49.5pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.36pt">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 40 years, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients&#8217; quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. We advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2023</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the first quarter of 2023 were $3.389 billion, as compared to $3.026 billion for the first quarter of 2022. This increase of $363 million, or 12.0 percent, included operational</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net sales growth of 14.9 percent and the negative impact of 290 basis points from foreign currency fluctuations. Operational net sales growth included organic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net sales growth of 14.0 percent and the positive impact of 90 basis points from our acquisition of Baylis Medical Company, Inc. (Baylis Medical) during the first quarter of 2022 for which there is less than a full period of comparable sales. The increase in our net sales was primarily driven by recent acquisitions as well as the strength and diversity of our product portfolio coupled with growth in the underlying markets in which we compete and strong commercial execution. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our net sales by global business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income attributable to Boston Scientific common stockholders for the first quarter of 2023 was $300 million, or $0.21 per diluted share. Our reported results for the first quarter of 2023 included certain charges and/or credits totaling $373 million (after-tax), or $0.26 per diluted share. Excluding these items, adjusted net income available to Boston Scientific common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $673 million, or $0.47 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the first quarter of 2022 was $97 million, or $0.07 per diluted share. Our reported results for the first quarter of 2022 included certain charges and/or credits totaling $465 million (after-tax), or $0.32 per diluted share. Excluding these items, adjusted net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $562 million, or $0.39 per diluted share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational net sales growth excludes the impact of foreign currency fluctuations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted measures, including operational and organic net sales growth, exclude certain items required by generally accepted accounting principles in the United States (U.S. GAAP), are not prepared in accordance with U.S. GAAP and should not be considered in isolation from, or as a replacement for, the most directly comparable GAAP measure. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for a discussion of management&#8217;s use of these non-GAAP financial measures. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.506%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Boston Scientific Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">314</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">300</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">787</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">673</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Tax Expense (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Loss) Attributable to Boston Scientific Common Stockholders</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.07</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">575</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">562</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> For the first quarter of 2023 and 2022, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">and Adjusted net loss were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss attributable to Boston Scientific common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_133"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Results and Business Overview </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section describes our net sales and results of operations by reportable segment and business unit. For additional information on our businesses and product offerings, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,873</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.7%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less-invasive technologies. Net sales of Endoscopy products of $577 million for the first quarter of 2023 represented 17 percent of our consolidated net sales. Endoscopy net sales increased $46 million, or 8.6 percent, during the first quarter of 2023, compared to the prior year period. During the first quarter of 2023, this increase included operational net sales growth of 11.5 percent and a negative impact of 290 basis points from foreign currency fluctuations, compared to the prior year period. This growth was primarily driven by our biliary franchise led by our AXIOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.96pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stent and Delivery System, and our hemostasis, infection prevention and single use imaging franchises. Within our single use imaging franchise, during the first quarter of 2023 we launched our third generation EXALT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.96pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> D Single-use Duodenoscope featuring several design updates based on physician feedback that are intended to improve the overall user experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies. Net sales of Urology products of $469 million for the first quarter of 2023 represented 14 percent of our consolidated net sales. Urology net sales increased $56 million, or 13.5 percent, during the first quarter of 2023, compared to the prior year period. During the first quarter of 2023, this increase included operational net sales growth of 15.6 percent and a negative impact of 210 basis points from foreign currency fluctuations, compared to the prior year period. This growth was driven by our stone management franchise led by our LithoVue&#8482; Single-Use Digital Flexible Ureteroscope System, our prosthetic urology franchise led by our AMS 700&#8482; Inflatable Penile Prosthesis Device and our prostate health franchise led by our Rezum&#8482; Water Vapor Therapy System.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Net sales of Neuromodulation products of $234 million for the first quarter of 2023 represented 7 percent of our consolidated net sales. Neuromodulation net sales increased $25 million, or 11.9 percent, during the first quarter of 2023 compared to the prior year period. During the first quarter of 2023, operational net sales growth of 13.7 percent was offset by a negative impact of 180 basis points from foreign currency fluctuations, compared to the prior year period. Operational net sales growth for the first quarter of 2023 was primarily due to strong procedural volume growth within our spinal cord stimulation (SCS) franchise driven by our WaveWriter Alpha&#8482; SCS System, as well as growth within our Brain franchise primarily driven by the recent U.S. launch of the Guide&#8482; XT software.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiology business develops and manufactures devices and medical technologies for diagnosing and treating a variety of diseases and abnormalities of the heart. Net sales of Cardiology products of $1.606 billion for the first quarter of 2023 represented 47 percent of our consolidated net sales. Cardiology net sales increased $199 million, or 14.1 percent, during the first quarter of 2023 compared to the prior year period. During the first quarter of 2023, this increase included operational net sales growth of 17.3 percent and a negative impact of 310 basis points from foreign currency fluctuations, compared to the prior year period. Operational net sales growth included organic net sales growth of 15.4 percent in the first quarter of 2023 and the positive impact of 190 basis points from our acquisition of Baylis Medical in the first quarter of 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organic net sales growth was primarily driven by continued market expansion of Left Atrial Appendage Closure (LAAC) procedures with our WATCHMAN&#8482; FLX LAAC Device, as well as growth of our percutaneous coronary intervention guidance, diagnostics, access solutions and structural heart valve franchises and our Farapulse&#8482; Ablation System.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. Net sales of Peripheral Interventions products of $503 million for the first quarter of 2023 represented 15 percent of our consolidated net sales. Peripheral Interventions net sales increased $38 million, or 8.2 percent, during the first quarter of 2023 compared to the prior year period. During the first quarter of 2023, this increase included operational net sales growth of 11.5 percent and a negative impact of 340 basis points from foreign currency fluctuations, compared to the prior year period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organic net sales growth was primarily driven by our Ranger&#8482; Drug-Coated Balloon and Eluvia&#8482; Drug-Eluting Stent System, as well as our interventional oncology franchise led by our Therasphere&#8482; Y-90 Radioactive Glass Microspheres and our EMBOLD&#8482; Fibered Coil. In the first quarter of 2023, we acquired a majority stake investment in Acotec Scientific Holdings Limited (Acotec) and have elected to consolidate their results of operations on a one quarter lag. Accordingly, their net sales for the period following the closing of the transaction on February 20, 2023 are omitted from our unaudited consolidated statements of operations for the quarter ended March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic imperative to drive global expansion, we are seeking to grow net sales and market share by expanding our global presence, including in Emerging Markets. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation. Our Emerging Markets net sales represented 16 percent and 15 percent of our consolidated net sales during the first quarter of 2023 and 2022, respectively. During the first quarter of 2023, our Emerging Markets net sales grew 20.2 percent on a reported basis, which included operational net sales growth of 26.3 percent and a negative impact of 600 basis points from foreign currency fluctuations, compared to the prior year period. Operational growth was driven primarily by growth in China with previously delayed procedures driving increased demand. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic Trends</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has been impacted by global supply chain disruptions. In particular, we have experienced increases in cost and limited availability of raw materials, components, and other inputs necessary to manufacture and distribute our products due to constraints and inflation within the global supply chain, as well as increases in wage costs and the cost and time to distribute our products. Uncertainty around inflationary pressures, rising interest rates, monetary policy and changes in tax laws could potentially cause new, or exacerbate existing, economic challenges that we may face, including the impact of foreign currency fluctuations on our results of operations. These conditions could worsen, or others could arise, if the U.S. and global economies were to enter recessionary periods, triggered or exacerbated by monetary policy designed to curb inflation. Existing and future potential geopolitical dynamics, including matters related to the Russia/Ukraine war, as well as the tension between China/Taiwan, may create economic, supply chain, energy, and other challenges, which impact, and may in the future negatively impact our business. In particular, international conflicts may result in sanctions, tariffs, and other measures that restrict international trade and negatively affect our business operations and results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $2.349 billion for the first quarter of 2023 and $2.071 billion for the first quarter of 2022. As a percentage of net sales, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased to 69.3 percent during the first quarter of 2023, as compared to 68.4 percent in the first quarter of 2022. The following is a reconciliation of our gross profit margin and a description of the drivers of the changes from period to period:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.269%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.4%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing, volume and mix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and supply costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69.3%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in our gross profit margin resulted primarily from favorable sales mix and increased sales of higher margin products, as well as improvements in manufacturing and supply costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While global supply chain challenges persist, we experienced improvement in the first quarter as recovery continues. These impacts were partially offset by the unfavorable impact of foreign currency and period expenses. We expect our gross profit margin for the first half of 2023 to be higher than the second half primarily due to timing of foreign currency movements in the prior year period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our operating expenses:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.652%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A Expenses)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $155 million, or 15 percent, as compared to the prior year period and were 90 basis points higher as a percentage of net sales. The increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were primarily due to higher selling costs driven by higher global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D Expenses)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to advancing medical technologies and investing in meaningful R&amp;D projects across our businesses. During the first quarter of 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $17 million, or 5 percent, as compared to the prior year period and were 60 basis points lower as a percentage of net sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased as a result of investments across our businesses in order to maintain a pipeline of new products that we believe will contribute to profitable sales growth.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Operating Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary of certain of our other operating expenses, which are excluded by management for purposes of evaluating operating performance; refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further description.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $5 million, or 2 percent, compared to the prior year period. The increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was driven by the addition of amortizable intangible assets associated with our recent acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Net Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To recognize changes in the fair value of our contingent consideration liability, we recorded net charges of $12 million in the first quarter of 2023 and 2022, respectively. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q for additional details related to our contingent consideration arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2023, our Board of Directors approved, and we committed to, a new global restructuring program (the 2023 Restructuring Plan). The 2023 Restructuring Plan is intended to meet evolving global market demands and conditions by ensuring that we are structured and resourced to support our strategic imperatives and deliver sustainable value. For more information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Restructuring Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contained in Item&#160;7 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to this program, we recorded restructuring charges in accordance with to FASB ASC Topic 420,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$20 million in the first quarter of 2023. In addition, we recorded restructuring-related charges of $24 million in the first quarter of 2023 primarily within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the first quarter of 2022, we recorded restructuring charges of $4&#160;million and restructuring-related charges of $25&#160;million associated with our 2019 Restructuring Plan, which was substantially completed as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and average borrowing rate:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.274%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average borrowing rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our average borrowing rate decreased during the first quarter of 2023 compared to the prior year period, due to $194&#160;million of charges associated with the early extinguishment of $3.275 billion of certain of our senior notes, including payment of tender premiums and the acceleration of unamortized debt issuance costs, as well as the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the issuance of euro-denominated bonds, which carry lower interest rates, during the first quarter of 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For the first quarter of 2022, the weighted average borrowing rate associated with our outstanding senior notes was 3.7 percent. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q for information regarding our debt obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rate</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.253%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our reported tax rates for the first quarter of 2023, as compared to the same period in 2022, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include debt extinguishment charges recorded in the first quarter of 2022, as well as certain discrete tax items primarily related to provision-to-return adjustments recorded in the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results are affected by the selection and application of accounting policies and methods. During the first quarter of 2023, there were no material changes to the application of critical accounting policies previously disclosed in our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current business plan, we believe our existing balance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, future cash generated from operations, access to capital markets and existing credit facilities will be sufficient to fund our operations, invest in our infrastructure, pay our legal-related liabilities, pay taxes due, service and repay our existing debt and fund possible acquisitions for the next 12 months and for the foreseeable future. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $570 million of unrestricted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on hand, including approximately $140 million held by Acotec, a less than wholly owned entity of which we acquired a majority stake investment during the first quarter of 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance is comprised of $170 million invested in money market funds and time deposits and $400 million in interest bearing and non-interest-bearing bank accounts. We invest excess cash on hand in short-term financial instruments that earn at market interest rates while mitigating principal risk through instrument and counterparty diversification, as well as what we believe to be prudent instrument selection. We limit our direct exposure to securities in any one industry or issuer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks scheduled to mature on May 10, 2026, with one-year extension options, subject to certain conditions. On March 1, 2023, we entered into an amendment of the 2021 Revolving Credit Facility credit agreement, which provided for an extension of the scheduled maturity date to May 10, 2027 and replaced the London Interbank Offered Rate (LIBOR) with the Secured Overnight Financing Rate (SOFR) as the Eurocurrency Rate for Dollars, including applicable credit spread adjustments and relevant SOFR benchmark provisions, as well as modification to the calculation of consolidated EBITDA, described under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. As of&#160;March&#160;31, 2023, we had no commercial paper debt outstanding, resulting in the full $2.750 billion of available liquidity under the 2021 Revolving Credit Facility. In April 2023, we issued commercial paper to partially fund our acquisition of Apollo. As of the date of this Quarterly Report on Form 10-Q, we had approximately $400 million of commercial paper outstanding, which directly reduces our borrowing capacity under the 2021 Revolving Credit Facility. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details related to our debt obligations, including our financial covenant requirement, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary and description of our net cash inflows (outflows):</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, cash provided by (used for) operating activities increased $248 million as compared to the prior year period primarily due to comparatively higher net sales and operating income as well as lower acquisition-related and restructuring-related payments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, cash provided by (used for) investing activities included cash payments of $375 million, net of cash acquired, for the acquisition of a majority stake in Acotec, as well as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">purchases of property, plant and equipment and internal use software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $111 million. During the first quarter of 2022, cash used for investing activities included a net cash payment of $1.471 billion for the acquisition of Baylis Medical. For more information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q. In addition, we made </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">purchases of property, plant and equipment and internal use software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $121 million during the first quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by (used for) financing activities in the first quarter of 2023 included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cash used to net share settle employee equity awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $50 million and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $63 million. In the first quarter of 2022, we completed a public offering (the Offering) of &#8364;3.000 billion in aggregate principal amount of euro-dominated senior notes. The Offering resulted in cash proceeds of $3.270&#160;billion, net of investor discounts and issuance costs. We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $3.275&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. For more information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item 1 of Part I of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility, as amended, as described below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of 3.75 times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for any qualified acquisitions due to the funding of these acquisitions using cash on hand. We believe that we have the ability to comply with the financial covenant for the next 12 months. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement, as amended on March 1, 2023, provides for an exclusion from the calculation of consolidated EBITDA, as defined by the credit agreement, through maturity, of certain charges and expenses. The credit agreement amendment reset the starting date for purposes of calculating such permitted exclusions in each case from March 31, 2021 to December 31, 2022. Permitted exclusions include any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses associated with our current or future restructuring plans. As of March&#160;31, 2023, we had $457 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $1.000 billion plus all accrued legal liabilities as of December&#160;31, 2022 for a total of $1.443 billion. As of March&#160;31, 2023, we had $1.424 billion of the litigation exclusion remaining.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our acquisitions involve the payment of contingent consideration. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q for further details regarding the estimated potential amount of future contingent consideration we could be required to pay associated with our acquisitions. There have been no other material changes to our contractual obligations and commitments as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received $63 million during the first quarter of 2023 and $52 million during the first quarter of 2022 in proceeds from stock issuances related to our stock option and employee stock purchase plans. Proceeds from the exercise of employee stock options and employee stock purchases vary from period to period based upon, among other factors, fluctuations in the trading price of our common stock and in the exercise and stock purchase patterns of our employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during the first quarter of 2023 or 2022. On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of March&#160;31, 2023, we had the full amount remaining available under the authorization. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our material legal proceedings refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements implemented since December&#160;31, 2022 and relevant accounting pronouncements to be implemented in the future are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note N &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item 1 of Part I of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Responsibility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sustainable environmental, social and governance practices underpin all aspects of our global business. Our approach is aligned with the United Nations Sustainable Development Goals and our material topics and practices are informed by a broad range of internal and external stakeholders &#8211; locally, nationally and globally. Our employees around the world work with suppliers and other organizations that share our commitment to these practices that help address issues related to health inequity, economic disparity, climate change and environmental protection. These efforts are supported by our cross-functional Corporate Social Responsibility Steering Committee, our Corporate Social Responsibility Council, our Environmental Health and Safety teams and policies, our Global Council for Inclusion, as well as our local, regional and national employee and community engagement programs. In addition, since 2021, our annual bonus plan has included performance measured against certain environmental, social and governance goals. For additional information on our sustainability efforts, as well as our Diversity, Equity and Inclusion (DE&amp;I) initiatives, refer to our most recent Annual Report on Form 10-K. For additional information on our annual bonus plan, refer to our Proxy Statement for the 2023 Annual Meeting of Shareholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures to escalate enterprise level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Under our framework, cybersecurity issues are analyzed by subject matter experts and a crisis committee for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact. Matters determined to present potential material impacts to the Company&#8217;s financial results, operations, and/or reputation are immediately reported by management to the Board of Directors, or individual members or committees thereof, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made or updated, as appropriate.&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International conflicts, including, but not limited to the Russia/Ukraine war and tension between China/Taiwan, have heightened cybersecurity risks on a global basis. While there is significant uncertainty around implications of cybersecurity attacks resulting from the conflict, we have taken steps to better understand our readiness, including the resilience of our critical business functions, with the goal of reducing the impact if such an event were to occur.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Trading Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers are subject to our Stock Trading Policy, which is designed to facilitate compliance with insider trading laws and governs transactions in our common stock and related derivative securities. Our policy designates certain regular periods, dictated by release of financial results, in which trading is restricted for individuals in information-sensitive positions, including directors and executive officers. In addition, additional periods of trading restriction may be imposed as determined by the President and Chief Executive Officer, General Counsel, or Chief Financial Officer in light of material pending developments. Further, during permitted windows, certain individuals in information-sensitive positions are required to seek pre-clearance for trades from the General Counsel, who assesses whether there are any important pending developments which need to be made public before the individual may participate in the market.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, certain of our executive officers adopt written stock trading plans in accordance with Rule 10b5-1 under the Exchange Act and our own Stock Trading Policy. A Rule 10b5-1 Trading Plan is a written document that pre-establishes the amount, prices and dates (or formulas for determining the amounts, prices and dates) of future purchases or sales of our stock, including shares issued upon exercise of stock options or vesting of deferred stock units. These plans are entered into at a time when the person is not in possession of material non-public information about the Company. We disclose details regarding individual Rule 10b5-1 Trading Plans on the Investor Relations section of our website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share (EPS) that exclude certain charges (credits); operational net sales, which exclude the impact of foreign currency fluctuations; and organic net sales, which exclude the impact of foreign currency fluctuations as well as the impact of acquisitions and divestitures with less than a full period of comparable net sales. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income and GAAP net income attributable to Boston Scientific common stockholders, which include amortization expense, goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), investment portfolio gains and losses, restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), EU MDR implementation costs, debt extinguishment charges, deferred tax expenses (benefits) and discrete tax items. Amounts are presented after-tax using our effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 740-270-30, "General Methodology and Use of Estimated Annual Effective Tax Rate." Please refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission for an explanation of each of these adjustments and the reasons for excluding each item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) attributable to Boston Scientific common stockholders and GAAP net income (loss) per common share - diluted, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. To calculate organic net sales growth rates, we also remove the impact of acquisitions and divestitures with less than a full period of comparable net sales. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales on a GAAP basis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the relevant sections of this Quarterly Report.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders, adjusted net income (loss) per share, operational net sales and organic net sales growth rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe Harbor for Forward-Looking Statements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we may make from time to time, including statements contained in this Quarterly Report on Form 10-Q and information incorporated by reference herein, constitute &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; "goal," "target," "continue," "hope," "may" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Quarterly Report on Form 10-Q are based on certain risks and uncertainties, including the risk factors described in Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K and the specific risk factors discussed herein and in connection with forward-looking statements throughout this Quarterly Report on Form 10-Q, which could cause actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this Quarterly Report on Form 10-Q.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: the impact of foreign currency fluctuations, future U.S. and global economic, political, competitive, reimbursement and regulatory conditions; manufacturing, distribution and supply chain disruptions and cost increases; disruptions caused by cybersecurity events; the impact of the COVID-19 pandemic on our operations and financial results; disruptions caused by extreme weather or other climate change-related events; labor shortages and increases in labor costs; new product introductions and the market acceptance of those products; markets for our products; expected pricing environment; expected procedural volumes; the closing and integration of acquisitions; clinical trial results; demographic trends; intellectual property rights; litigation; financial market conditions; the execution and effect of our restructuring program; the execution and effect of our business strategy, including our cost-savings and growth initiatives; our ability to achieve environmental, social and governance goals and commitments; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or may increase in significance or likelihood as a result of the COVID-19 pandemic. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, refer to Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in subsequent Quarterly Reports on Form 10-Q that we will file hereafter.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span id="ieee55914fd2248b1a52a1595849539fc_60213"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the important risk factors that could cause our actual results to differ materially from our expectations in any forward-looking statements. For further discussion of these and other risk factors, refer to Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Businesses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Labor shortages and the impact of inflation on the cost of raw materials and direct labor,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Risks associated with challenging or uncertain domestic and international economic conditions, including those related to rising interest rates, inflation, adverse developments and volatility in the banking industry, currency devaluations or economies entering into periods of recession,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of the COVID-19 pandemic and economic conditions created in part by the pandemic on worldwide economies, financial markets, manufacturing and distribution systems, including disruption in the manufacture or supply of certain components, materials or products, and business operations,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of natural disasters, climate change, additional future public health crises and other catastrophic events on our ability to manufacture, distribute and sell our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of competitive offerings, value-based procurement practices, government-imposed payback provisions and changes in reimbursement practices and policies on average selling prices for our products,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing impact on our business of physician alignment to hospitals, governmental investigations and audits of hospitals and other market and economic conditions on the overall number of procedures performed,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The performance of, and physician and patient confidence in, our products and technologies or those of our competitors,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact and outcome of ongoing and future clinical trials and market studies undertaken by us, our competitors or other third parties or perceived product performance of our or our competitors' products,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variations in clinical results, reliability or product performance of our and our competitors' products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to acquire or develop, launch and supply new or next-generation products and technologies worldwide and in line with our commercialization strategies in a timely and successful manner and with respect to our recent acquisitions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of consolidation and competition in the markets in which we do business or plan to do business,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as some of our products are more profitable than others,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to attract and retain talent, including key personnel associated with recent acquisitions, and to maintain our robust corporate culture,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain and maintain regulatory approval in the U.S. and around the world, including EU MDR and the associated timing and cost of product approval, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased pressure on the availability and rate of third-party reimbursement for our products and procedures in the U.S. and around the world, including with respect to the timing and costs of creating and expanding markets for new products and technologies, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of potential goodwill and intangible asset impairment charges on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Compliance, Litigation and Data Protection</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of healthcare policy changes and legislative or regulatory efforts in the U.S., the EU and around the world to modify product approval or reimbursement processes, including a trend toward demonstrating clinical outcomes, comparative effectiveness and cost efficiency, as well as the impact of other healthcare reform legislation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with our regulatory compliance and quality systems and activities in the U.S., the EU and around the world, including meeting regulatory standards applicable to manufacturing and quality processes,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of global legal, regulatory or market responses to climate change, including increased compliance burdens and costs to meet regulatory obligations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to minimize or avoid future field actions or FDA warning letters relating to our products and processes and the ongoing inherent risk of potential physician advisories related to our or our competitors' products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased scrutiny of and heightened global regulatory enforcement facing the medical device industry arising from political and regulatory changes, economic pressures or otherwise, including under U.S. Anti-Kickback Statute, U.S. False Claims Act and similar laws in other jurisdictions, U.S. Foreign Corrupt Practices Act (FCPA) and similar laws in other jurisdictions, and U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with current and future asserted litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of our litigation and risk management practices, including self-insurance and compliance activities on our loss contingencies, legal provisions and cash flows,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of, diversion of management attention as a result of, and costs to cooperate with, litigate and/or resolve governmental investigations and our class action, product liability, contract and other legal proceedings,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of failure to protect our intellectual property rights and the outcome of patent litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate properly our information systems that support our business operations and protect our data integrity and products from a cyber-attack or other breach that has a material adverse effect on our business, reputation or results of operations including increased risks as an indirect result of the ongoing Russia/ Ukraine war, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovation and Certain Growth Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing, size and nature of our strategic growth initiatives and market opportunities, including with respect to our internal research and development platforms and externally available research and development platforms and technologies and the ultimate cost and success of those initiatives and opportunities,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to complete planned clinical trials successfully, obtain regulatory approvals and launch new and next generation products in a timely manner consistent with cost estimates, including the successful completion of projects from in-process research and development,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to identify and prioritize our internal research and development project portfolio and our external investment portfolio on profitable net sales growth opportunities as well as to maintain the estimated timing and costs of such projects and expected revenue levels for the resulting products and technologies,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute appropriate decisions to discontinue, write-down or reduce the funding of any of our research and development projects, including projects from in-process research and development from our acquisitions, in our growth adjacencies or otherwise,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on acquisitions, alliances or investments to introduce new products or technologies and to enter new or adjacent growth markets and our ability to fund them or to fund contingent payments with respect to those acquisitions, alliances and investments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential failure to complete, successfully integrate and/or realize the expected benefits, including cost synergies, from the strategic acquisitions, alliances and investments we have consummated or may consummate in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependency on international net sales to achieve growth, and our ability to maintain or expand our worldwide market positions in the various markets in which we compete or seek to compete, including through investments in Emerging Markets such as Brazil, India and China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing and collectability of customer payments, as well as our ability to continue factoring customer receivables where we have factoring arrangements, or to enter new factoring arrangements with favorable terms, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The impact on pricing due to national and regional tenders, including value-based procurement practices and government-imposed payback provisions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">The impact of the Russia/Ukraine war and tension between China/Taiwan, and related, downstream effects thereof, including the impact of sanctions on U.S. manufacturers doing business in these regions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protection of our intellectual property, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, EU MDR and similar laws in other jurisdictions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of significant developments or uncertainties stemming from changes in the U.S. government following congressional elections, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, particularly China, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, operating expenses and resulting profit margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to generate sufficient cash flow to fund operations, capital expenditures, global expansion initiatives, any litigation settlements and judgments, share repurchases and strategic investments and acquisitions as well as maintaining our investment grade ratings and managing our debt levels and financial covenant compliance,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access the public and private capital markets when desired and to issue debt or equity securities on terms reasonably acceptable to us,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open tax matters, exposure to additional tax liabilities and the impact of changes in U.S. and international tax laws,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open litigation matters, exposure to additional loss contingencies and legal provisions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of examinations and assessments by domestic and international taxing authorities on our tax provisions, financial condition or results of operations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of counterparty default on our derivative financial instruments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to collect outstanding and future receivables and/or sell receivables under our factoring programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Reduction and Optimization Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with changes made or expected to be made to our organizational and operational structure, pursuant to our restructuring plans as well as any further restructuring or optimization plans we may undertake in the future and our ability to recognize benefits and cost reductions from such programs, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business disruption and employee distraction as we execute our global compliance program, restructuring and optimization plans and divestitures of assets or businesses and implement our other strategic and cost reduction initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell medical devices globally and our earnings and cash flows are exposed to market risk from changes in currency exchange rates and interest rates. We address these risks through a risk management program that includes the use of derivative financial instruments. We operate the program pursuant to documented corporate risk management policies. We do not enter derivative transactions for speculative purposes. Gains and losses on derivative financial instruments substantially offset losses and gains on underlying hedged exposures. Furthermore, we manage our exposure to counterparty risk on derivative instruments by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our currency risk consists primarily of foreign currency denominated firm commitments, forecasted foreign currency denominated intercompany and third-party transactions and net investments in certain subsidiaries. We use both nonderivative (primarily European manufacturing operations) and derivative instruments to manage our earnings and cash flow exposure to changes in currency exchange rates. We had currency derivative instruments outstanding in the contract amount of $6.660 billion as of March&#160;31, 2023 and $7.324 billion as of December&#160;31, 2022. A ten percent appreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would increase the derivative instruments&#8217; fair value by $241 million as of March&#160;31, 2023 as compared to $208 million as of December&#160;31, 2022. A ten percent depreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would decrease the derivative instruments&#8217; fair value by $294 million as of March&#160;31, 2023 as compared to $254 million as of December&#160;31, 2022. Any increase or decrease in the fair value of our currency exchange rate sensitive derivative instruments would be substantially offset by a corresponding decrease or increase in the fair value of the hedged underlying asset, liability or forecasted transaction, resulting in minimal impacts on our unaudited consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We have historically used interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. We had no interest rate derivative instruments outstanding as of March&#160;31, 2023 and December&#160;31, 2022. As of March&#160;31, 2023, $9.067 billion in aggregate principal amount of our outstanding debt obligations was at fixed interest rates, representing approximately 100 percent of our total debt, on an amortized cost basis. As of March&#160;31, 2023, our outstanding debt obligations at fixed interest rates were comprised of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q for further information regarding our derivative financial instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (CEO) and our Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of March&#160;31, 2023 pursuant to Rule&#160;13a-15(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Disclosure controls and procedures are designed to ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, our CEO and CFO concluded that, as of March&#160;31, 2023, our disclosure controls and procedures were effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we began a multi-year implementation of a new global enterprise resource planning (ERP) system, which will replace our existing system. The implementation is expected to occur in phases over the next several years. The portion of the transition to the new ERP system which we have completed to date resulted in changes in our internal control over financial reporting in the first quarter of 2023. As future phases are implemented, we expect the changes to have a material impact on our internal controls over financial reporting and will evaluate quarterly whether these process changes necessitate further changes in the design of and testing for effectiveness of internal controls over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note G &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to other information contained elsewhere in this report, you should carefully consider the factors discussed in Part&#160;I, Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report filed on Form 10-K, which could materially affect our business, financial condition or future results.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i43fadb9987444221929c0db0dedbaf58_175"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (* documents filed or furnished with this report; # compensatory plans or arrangements)</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572523000010/exhibit101.htm">Second Amendment, dated as of March 1, 2023, to Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 1, 2023, File No. 1-11083).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102-2023grantxnqagreemen.htm">Form of 2023 Global Non-Qualified Stock Option Agreement under the Company&#8217;s Amended and Restated 2011 Long-Term Incentive Plan. #</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103-2023grantxrsuagreeme.htm">Form of 2023 Global Restricted Stock Unit Award Agreement under the Company&#8217;s Amended and Restated 2011 Long-Term Incentive Plan. #</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104-2023grantxtsrawardag.htm">Form of 2023 Performance Share Unit Award Agreement under the Company&#8217;s Amended and Restated 2011 Long-Term Incentive Plan (Total Shareholder Return). #</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex105-2023grantxonsgawarda.htm">Form of 2023 Performance Share Unit Award Agreement under the Company&#8217;s Amended and Restated 2011 Long-Term Incentive Plan (Organic Net Sales Growth). # </a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-subsidiaryissuer.htm">Subsidiary Issuer of Guaranteed Securities</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302q12023.htm">Certification of the Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302q12023.htm">Certification of the Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906q12023.htm">Certification of the Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906q12023.htm">Certification of the Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 73pt;text-align:left;text-indent:-72pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i43fadb9987444221929c0db0dedbaf58_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i43fadb9987444221929c0db0dedbaf58_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May&#160;4, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and<br/>Chief Financial Officer&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ex102-2023grantxnqagreemen.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib3f10e14ed3349609eceab43fc96da9b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Global Non-Qualified Stock Option Agreement</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Global Non-Qualified Stock Option Agreement (the &#8220;Agreement&#8221;), is between you and Boston Scientific Corporation, a Delaware corporation, (the &#8220;Company&#8221;) in connection with the Non-Qualified Stock Option Award granted to you by the Committee under the Boston Scientific Corporation Amended and Restated</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2011 Long-Term Incentive Plan (the &#8220;Plan&#8221;).  This Agreement sets forth the terms and conditions relating to your Stock Option pursuant to the Plan.  Capitalized terms used but not defined in this Agreement shall have the same meaning as assigned to them in the Plan.  The applicable terms and conditions of the Plan are incorporated into and made a part of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee hereby grants you a Stock Option to purchase that number of shares of Stock set forth in your Equity Award and Acceptance Summary (the &#8220;Option Shares&#8221;) at the price set forth herein (the &#8220;Grant Price&#8221;).  The Grant Price is equal to the Fair Market Value of the Company&#8217;s Stock on the Grant Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term and Vesting of Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided in Section 4 below, your Stock Option shall have a term of ten (10) years from date of grant until the &#8220;Expiration Date&#8221; and shall vest in accordance with the vesting schedule.  If the Expiration Date falls on a date on which the New York Stock Exchange is closed for trading, the Expiration Date shall be the trading day immediately prior to the Expiration Date.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise of Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  While this Stock Option remains exercisable, you may exercise any vested portion of the Option Shares by delivering to the Company or its designee, in the form and at the location specified by the Company, notice stating your intent to exercise a specified number of Option Shares and payment of the full Grant Price for the specified number of Option Shares.  Payment in full for the Option Shares being exercised may be paid in such manner as the Committee may specify from time to time, in its sole discretion, including, but not limited to the following&#58;  (a) in cash, (b) by certified check or bank draft payable in U.S. dollars (US$) to the order of the Company, (c) in whole or in part in shares of Stock owned by you, valued at Fair Market Value, or (d) if available to you, via cashless exercise, by which you deliver to your securities broker instructions to sell a sufficient number of shares of Stock to cover the Grant Price for the Option Shares, any applicable tax obligations and the brokerage fees and expenses associated therewith.  Notwithstanding the foregoing, if you reside in a country where the local laws and&#47;or regulations preclude the remittance of currency out of the country for purposes of paying the Grant Price for the Option Shares being exercised, require the Company, its Affiliates and&#47;or you to secure any legal or regulatory approvals or complete any legal or regulatory filings, or undertake any additional steps for remitting currency out of the country, the Company may restrict the method of exercise to a form of cashless exercise (either a cashless &#8220;sell all&#8221; exercise and&#47;or a cashless &#8220;sell to cover&#8221; exercise) as it shall determine in its sole discretion.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The exercise date applicable to your exercise of the specified number of Option Shares pursuant to this Section 3 will be deemed to be the date on which the Company receives your irrevocable commitment to exercise the Option Shares in writing, subject to your payment in full of the Option Shares to be exercised within 10 (ten) days of the notice of exercise of the Option Shares to be exercised.  The notice and payment in full of the Option Shares being exercised, must be received by the Company or its designee on or prior to the last day of the Stock Option term, as set forth in Section 2 above, except as provided in Section 4 below.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12.2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Upon the Company&#8217;s determination that there has been a valid exercise of the Option Shares, the Company shall issue certificates in accordance with the terms of this Agreement or cause the Company&#8217;s transfer agent to make the necessary book entries for the shares of Stock subject to the exercised Option Shares.  However, the Company shall not be liable to you, your personal representative or your successor(s)-in-interest for damages relating to any delays in issuing the certificates or in making book entries, any loss of the certificates, or any mistakes or errors in the issuance of the certificates or in making book entries, or in the certificates themselves.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a.&#160;&#160;&#160;&#160;In the event that your employment terminates due to death or Disability (as such term is defined in the Plan or determined under local law, as applicable), all remaining unexercised portion(s) of your Stock Option shall immediately vest and become exercisable by you or your appointed representative, as the case may be, until the expiration of the term of the Stock Option or such other term as the Committee may determine at or after grant, provided that such exercise period does not extend beyond the original term of the Stock Option.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;b.&#160;&#160;&#160;&#160;Provided that you have remained in continuous service with the Company or an Affiliate through the first anniversary of the Grant Date, in the event your employment terminates due to Retirement, all remaining unexercised portion(s) of your Stock Option shall immediately vest and become exercisable by you until the expiration of the term of the Stock Option or such other term as the Committee may determine at or after grant, provided that such exercise period does not extend beyond the original term of the Stock Option.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;c.&#160;&#160;&#160;&#160;In the event that your employment terminates due to Retirement prior to the first anniversary of the Grant Date, the Option Shares shall immediately be forfeited in their entirety.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;d.&#160;&#160;&#160;&#160;Upon termination of your employment for reasons other than for Cause, death, Disability or Retirement, you shall have the shorter of (i) one (1) year from the date of termination and (ii) the remaining term of the Stock Option to exercise all vested Option Shares.  Immediately upon termination of your employment for reasons other than for Cause, death, Disability or Retirement, all unvested Option Shares shall be forfeited&#59; provided, however, that the Committee, in its sole discretion, may extend the exercise period and&#47;or accelerate vesting of any unvested Option Shares (provided that such exercise period does not extend beyond the original term of the Stock Option).  Your termination date shall be the last day of your active service with the Company or an Affiliate (if applicable).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;e.&#160;&#160;&#160;&#160;Immediately upon notice of termination of your employment for Cause, all unexercised Option Shares, whether vested or unvested, shall be forfeited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;f.&#160;&#160;&#160;&#160;The Option Shares, to the extent unexercised on the date following the end of any period described above or the term of the Stock Option set forth above in Section 2, shall thereupon be forfeited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;g.&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in the Plan or the Agreement, and for purposes of clarity, any termination of employment shall be effective as of the date your active employment ceases and shall not be extended by any statutory or common law notice of termination period.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;h.&#160;&#160;&#160;&#160;Any one of your permitted transferee(s) (pursuant to Section 7 below) shall receive the rights herein granted subject to the terms and conditions of this Agreement and any applicable Addendum.  No transfer of this Stock Option shall be approved and effected by the Administrator unless (i) the Administrator shall have been timely furnished with written notice of such transfer and any copies of such notice as the Committee may deem, in its sole discretion, necessary to establish the validity of the transfer&#59; (ii) the transferee or transferees shall have agreed in writing to be bound by the terms and conditions of this Agreement and any applicable Addendum&#59; and (iii) such transfer complies with applicable laws and regulations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;i.&#160;&#160;&#160;&#160;If you are a resident or employed in a country that is a member of the European Union, the grant of the Stock Option and this Agreement are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;).  To the extent that a court or tribunal of competent jurisdiction determines that any provision of the Stock Option is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;j.&#160;&#160;&#160;&#160;If you reside or work in a country where the local foreign exchange rules and regulations require the repatriation of sale proceeds, the Company may require you to sell any Option Shares you acquire under the Plan immediately or within a specified period following your termination of employment (in which case, this Agreement shall give the Company the authority to issue sales instructions on your behalf).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent that you have not entered into a Change in Control Agreement with the Company and except as the Administrator (as defined in the Plan) may otherwise determine, immediately prior to a Change in Control (as defined in the Plan), any unvested portion of the Stock Option shall vest and become exercisable.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the Stock Option shall terminate immediately prior to the Change in Control unless the Stock Option is exercised coincident therewith or assumed in accordance with the immediately following sentence.  If there is a surviving or acquiring entity, the Administrator may provide for a substitution or assumption of the Stock Option by the acquiring or surviving entity or an affiliate thereof, on such terms as the Administrator determines.  If there is no surviving or acquiring entity, or if the Administrator does not provide for a substitution or assumption of the Stock Option, any unvested portion of the Stock Option shall vest and become exercisable on a basis that gives you a reasonable opportunity to participate as a stockholder in the Change in Control.  If you have entered into a Change in Control agreement with the Company, the Stock Option will vest according to the provisions of the Change in Control agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Current Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant to the Company&#8217;s recoupment policy and to the extent permitted by governing law, the Board, in its discretion, may seek Recovery of the Award granted to you if you are a Current Executive Officer or Former Executive Officer and you, in the judgment of the Board, commit misconduct or a gross dereliction of duty that results in a material violation of Company policy and causes significant harm to the Company while serving in your capacity as Executive Officer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms, when used in this Section 6, shall have the meaning set forth below&#58;</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;&#8220;Current Executive Officer&#8221; means any individual currently designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;&#8220;Executive Officer&#8221; means any Current Executive Officer or Former Executive Officer.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;&#8220;Former Executive Officer&#8221; means any individual previously (but not currently) designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange&#160;Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)&#160;&#160;&#160;&#160;&#8220;Recovery&#8221; means the forfeiture or cancellation of unexercised Stock Options, whether vested or unvested.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Provisions Required by Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company subsequently determines that it is required by law to apply a &#8220;clawback&#8221; or alternate recoupment provision to outstanding Awards, under the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise, then such clawback or recoupment provision also shall apply to this Award, as applicable, as if it had been included on the Grant Date and the Company shall notify you of such additional provision.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions on Shares&#59; Legend on Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Shares of Stock issued to you in certificate form or to your book entry account upon exercise of the Stock Option may be restricted from transfer or sale by the Company and evidenced by stop-transfer instructions upon your book entry account or restricted legend(s) affixed to certificates in the form as the Company or its counsel may require with respect to any applicable restrictions on sale or transfer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as required by law, you shall not sell, transfer, assign, pledge, gift, hypothecate or otherwise dispose of the Stock Option granted under this Agreement other than by will or the laws of descent and distribution or without payment of consideration to your Family Members or to trusts or other entities for the benefit of your Family Members.  During your lifetime, the Stock Option is exercisable only by you, subject to Section 4 above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Satisfaction of Tax Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Regardless of any action the Company or the Affiliate that employs you (the &#8220;Employer&#8221;) (if applicable) takes with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge and agree that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and&#47;or the Employer (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Stock Option, including the grant of the Stock Option, the vesting of the Stock Option, the exercise of the Stock Option, the subsequent sale of any shares of Stock acquired upon exercise of the Stock Option and the receipt of any dividends, and (b) do not commit to structure the terms of the grant or any aspect of the Stock Option to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Prior to the delivery of shares of Stock upon exercise of the Stock Option, if your country of residence (and&#47;or the country of employment, if different) requires withholding of Tax-Related Items, the Company may withhold a sufficient whole number of shares of Stock otherwise issuable upon exercise of the Stock Option that has an aggregate Fair Market Value sufficient to pay the Tax-Related Items required to be withheld with respect to the shares of </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stock, or to the extent it would not result in adverse accounting treatment, the Company may, in its sole discretion, withhold shares of Stock based on a rate of up to the maximum applicable withholding rate.  If the obligation for Tax-Related Items is satisfied by withholding shares of Stock to be issued upon exercise of the Stock Option, for tax purposes, you are deemed to have been issued the full number of shares of Stock subject to the Stock Option, notwithstanding that a number of shares of Stock are withheld solely for the purpose of paying the Tax-Related Items. You will have no further rights with respect to any shares of Stock that are retained by the Company pursuant to this provision.  By accepting the Stock Option, you expressly consent to the withholding of shares of Stock as provided for hereunder.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Alternatively, you hereby authorize the Company (on your behalf and at your direction pursuant to this authorization) to immediately sell a sufficient whole number of shares of Stock acquired upon exercise resulting in sale proceeds sufficient to pay the Tax-Related Items required to be withheld.  You agree to sign any agreements, forms and&#47;or consents that reasonably may be requested by the Company (or the Company&#8217;s designated brokerage firm) to effectuate the sale of the shares of Stock (including, without limitation, as to the transfer of the sale proceeds to the Company to satisfy the Tax-Related Items required to be withheld).  Further, the Company or the Employer may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from your salary or any other amounts payable to you, with no withholding of shares of Stock or sale of shares of Stock, or may require you to submit a cash payment equivalent to the Tax-Related Items required to be withheld with respect to the exercised Stock Option.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;All other Tax-Related Items related to the Stock Option and any shares of Stock delivered in payment thereof are your sole responsibility.  In no event, shall whole shares of Stock be withheld by or delivered to the Company in satisfaction of any Tax-Related Items in excess of the maximum statutory tax withholding required by law.  You agree to indemnify the Company and its Affiliates against any and all liabilities, damages, costs and expenses that the Company and its Affiliates may hereafter incur, suffer or be required to pay with respect to the payment or withholding of any Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Stock Option is intended to be exempt from the requirements of Section&#160;409A of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).  The Plan and this Agreement shall be administered and interpreted in a manner consistent with this intent.  If the Company determines that the Agreement is subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, in its sole discretion, and without your consent, amend this Agreement to cause it to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation and Legal&#47;Tax Compliance Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a resident or employed outside of the United States, you agree to repatriate all payments attributable to the shares of Stock and&#47;or cash acquired under the Plan (including, but not limited to, dividends and any proceeds derived from the sale of the shares of Stock acquired pursuant to the Stock Option) in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different).  In addition, you agree to take any and all actions, and consent to any and all actions taken by the Company and the Employer, as may be required to allow the Company and the Employer to comply with local laws, rules and regulations in your country of residence (and country of employment, if different).  Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other Stock Option grant materials by and among, as applicable, the Employer, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;You understand that the Company and the Employer may hold certain personal information about you, including (but not limited to) your name, home address, email address and telephone number, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any shares of Stock or directorships held in the Company, and details of all Stock Options awarded to you or any other entitlements to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor (&#8220;Data&#8221;) for the purpose of implementing, managing and administering the Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that Data may be transferred to any third parties assisting the Company with the implementation, administration and management of the Plan, including but not limited to E*TRADE Securities LLC (&#8220;E*TRADE&#8221;) or any successor or any other third party that the Company or E*TRADE (or its successor) may engage to assist with the administration of the Plan from time to time.  You understand the recipients of the Data may be located in your country, in the United States or elsewhere, and that the recipients&#8217; country may have different data privacy laws and protections than your country.  You understand that you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares of Stock acquired upon exercise of the Stock Option.  You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consent herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consent herein on a purely voluntary basis.  If you do not consent, or if you later revoke your consent, your employment status or service with the Employer will not be adversely affected&#59; the only consequence of refusing or withdrawing your consent is that the Company would not be able to grant you Stock Options or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.</font></div><div><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By participating in the Plan, you acknowledge, understand and agree that&#58; </font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.2pt">the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Administrator at any time, to the extent permitted by the Plan&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">the grant of the Stock Option is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants or benefits in lieu of Stock Options, even if Stock Options have been granted in the past&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.2pt">all decisions with respect to future grants of Stock Options, if any, will be at the sole discretion of the Administrator&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">the Stock Option grant and your participation in the Plan shall not create a right to employment or be interpreted as forming an employment or service contract with the Company, the Employer or Affiliate and shall not interfere with the ability of the Company, the Employer or any Affiliate, as applicable, to terminate your employment or service relationship (if any)&#59; </font></div><div style="padding-left:40.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.2pt">you are voluntarily participating in the Plan&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.53pt">the Stock Option is not intended to replace any pension rights or compensation&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">the Stock Option, the shares of Stock subject to the Stock Option, and the income and value of same are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar payments&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">the future value of the shares of Stock subject to the Stock Option is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.19pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Stock Option resulting from the termination of your employment or other service relationship (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.19pt">unless otherwise agreed with the Company in writing, the Stock Option, the shares of Stock subject to the Stock Option, and the income from and value of same are not granted as consideration for, or in connection with, any service you may provide as a director of an Affiliate&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">for purposes of the Stock Option, your employment or other service relationship will be considered terminated as of the date you are no longer actively providing services to the Company or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, the period (if any) during which you may exercise the Option will commence as of such date and will not be extended by any notice period mandated under employment laws in the jurisdiction where you are employed or the terms </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of your employment agreement, if any&#59; the Administrator shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of the Stock Option grant (including whether you may still be considered to be providing services while on an approved leave of absence)&#59; and</font></div><div style="padding-left:72pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.19pt">the following provisions apply only if you are providing services outside the United States&#58; (A) the Stock Option, the shares of Stock subject to the Stock Option, and the income from and value of same are not part of normal or expected compensation or salary for any purpose&#59; and (B) neither the Company, the Employer nor any Affiliate shall be liable for any foreign exchange rate fluctuation between your local currency and the U.S. dollar that may affect the value of the Stock Option or of any amount due to you pursuant to the exercise of the Stock Option or the subsequent sale of any shares of Stock acquired upon exercise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the acquisition of any shares of Stock pursuant to the exercise of the Stock Option, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Public Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the grant of the Stock Option under the Plan nor the issuance of the underlying shares of Stock upon exercise of the Stock Option is intended to be a public offering of securities in your country of residence (and country of employment, if different).  The Company has not submitted any registration statement, prospectus or other filings to the local securities authorities unless otherwise required under local law. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Advice Regarding Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No Employee of the Company is permitted to advise you regarding whether you should purchase shares of Stock under the Plan.  Investment in shares of Stock involves a degree of risk.  Before deciding to purchase shares of Stock pursuant to the Stock Option, you should carefully consider all risk factors relevant to the acquisition of shares of Stock under the Plan, and you should carefully review all of the materials related to the Stock Option and the Plan.  You are hereby advised to consult with your own personal tax, legal and financial advisors before taking any action related to the Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that, depending on your or your broker&#8217;s country of residence or where the shares of Stock are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of shares of Stock, rights to those shares of Stock (e.g., Stock Options) or rights linked to the value of shares of Stock (e.g., phantom awards, futures) during such times you are considered to have &#8220;inside information&#8221; regarding the Company, as defined in the laws or regulations in your country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed insider information.  Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Keep in mind that third parties include fellow employees.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to a personal advisor on this matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery of Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may, in its sole discretion, deliver any documents related to the Stock Option and participation in the Plan, or future grants of Stock Options that may be granted under the Plan, by electronic means unless otherwise </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">prohibited by local law.  You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party-designated by the Company.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are resident outside of the United States, you hereby acknowledge and agree that it is your express intent that this Agreement and any applicable Addendum, the Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Stock Option, be drawn up in English. You acknowledge that you are proficient in the English language and understand the terms of this Agreement or have had the ability to consult with an advisor who is sufficiently proficient in the English language. If you have received this Agreement and any applicable Addendum, the Plan or any other documents related to the Stock Option translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version will control.  </font></div><div style="padding-right:-12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision of this Agreement to the contrary, the Stock Option shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) as are forth in the applicable addendum to the Agreement (the &#8220;Addendum&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in the Addendum to this Agreement, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  Any applicable Addendum shall constitute part of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator reserves the right to impose other requirements on the Stock Option, any shares of Stock acquired pursuant to the Stock Option and your participation in the Plan to the extent the Administrator determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local laws or to facilitate the administration of the Plan.  Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any legal notice necessary under this Agreement shall be addressed to the Company in care of its Secretary at the principal executive office of the Company and to you at the address appearing in the personnel records of the Company for you or to either party at such other address as either party may designate in writing to the other.  Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Choice of Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The interpretation, performance and enforcement of this Agreement shall be governed by the laws of The Commonwealth of Massachusetts (without regard to the conflicts of laws principles) and applicable federal laws. For purposes of litigating any dispute under the Agreement, including the Addendum, the parties hereby submit to and consent to the exclusive jurisdiction of The Commonwealth of Massachusetts and agree that such litigation shall be conducted only in the courts of Boston or the federal courts for the United States for the District of Massachusetts, and no other courts where the grant of the Stock Option is made and&#47;or to be performed.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan&#59; Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;The Stock Option granted pursuant to this Agreement and any applicable Addendum is subject to the Plan.  The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference.  This </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreement contains terms and provisions established by the Committee specifically for the grant described herein.  Unless the Committee has exercised its authority under the Plan to establish specific terms of an Award, the terms of the Plan shall govern.  Subject to the limitations set forth in the Plan, the Committee retains the right to alter or modify the Stock Option granted under this Agreement as the Committee may determine are in the best interests of the Company.  You hereby accept the Stock Option subject to all the terms and provisions of the Plan and this Agreement and agree that all decisions under, and interpretations of, the Plan and this Agreement by the Administrator, Committee or the Board shall be final, binding and conclusive upon you and your heirs and legal representatives.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;24.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings contained in this Agreement are for convenience only and shall not affect the meaning or interpretation of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree that the provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You understand that the waiver by the Company with respect to your compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach of a provision of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;27.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the Company, by its duly authorized officer, and the Optionee have executed and delivered this Agreement effective as of the date and year first above written.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BOSTON SCIENTIFIC CORPORATION&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:330px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:75px;margin-bottom:5pt;vertical-align:text-bottom;width:329px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Michael F. Mahoney</font></div><div style="padding-left:144pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BOSTON SCIENTIFIC CORPORATION</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO THE AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO NON-QUALIFIED STOCK OPTIONS GRANTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE <br>AMENDED AND RESTATED 2011 LONG-TERM INCENTIVE PLAN</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the Plan and the Agreement, the Stock Option is subject to the following additional terms and conditions.  All defined terms contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement.  Pursuant to Section 19 of the Agreement, if you transfer your residence and&#47;or employment to another country reflected in an Addendum, the additional terms and conditions for such country (if any) will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EUROPEAN UNION (&#8220;EU&#8221;) &#47; EUROPEAN ECONOMIC AREA (&#8220;EEA&#8221;), UNITED KINGDOM AND SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision replaces Section 11 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Pursuant to applicable personal data protection laws, the Company and the Employer hereby notify you of the following in relation to your Personal Data (defined below) and the collection, processing and transfer in electronic or other form of such Personal Data in relation to the grant of the Stock Option and your participation in the Plan.  The collection, processing and transfer of your Personal Data is necessary for the legitimate purpose of the Company and the Employer&#8217;s administration of the Plan and your participation in the Plan, and your denial and&#47;or objection to the collection, processing and transfer of Personal Data may affect your participation in the Plan.  As such, by accepting the Award, you acknowledge the collection, use, processing and transfer of Personal Data as described herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that the Company and the Employer hold certain personally identifiable information about you, specifically, your name, home address and telephone number, date of birth, social security number or other employee identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all Stock Options or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of managing and administering the Plan (&#8220;Personal Data&#8221;).  The Personal Data may be provided by you to or collected, where lawful, from third parties.  The Company or the Employer each act as controllers of the Personal Data and will process the Personal Data in this context for the exclusive legitimate purpose of implementing, administering and managing your participation in the Plan and meeting related legal obligations associated with these actions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The processing will take place through electronic and non-electronic means according to logics and procedures correlated to the purposes for which the Personal Data was collected and with confidentiality and security provisions as set forth by applicable laws and regulations.  Personal Data will be accessible within the Company&#8217;s organization only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and other aspects of the employment relationship and for participation in the Plan.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company and the Employer will transfer Personal Data amongst themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan, and the Company and the Employer may each further transfer Personal Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan, including E*TRADE Securities LLC and its affiliates or any successor or other third party that the Company, the Employer or E*TRADE Securities LLC (or its successor) may engage to assist with the administration of the Plan from time to time.  These recipients may be located in the EU&#47;EEA, the United Kingdom, Switzerland or elsewhere throughout the world, such as the United States.  By participating in the Plan, you understand that these recipients may receive, possess, use, retain and transfer the Personal Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Personal Data as may be required for the administration of the Plan and&#47;or the subsequent holding of shares of Stock on your behalf to a broker or other third party with whom you may elect to deposit any shares of Stock acquired pursuant to the Plan.  You further understand that you may request a list with the names and addresses of any potential recipients of your Personal Data by contacting your local Human Resources manager or the Company&#8217;s Human Resources Department.  When transferring Personal Data to these potential recipients, the Company and the Employer provide appropriate safeguards in accordance with EU Standard Contractual Clauses or other legally binding and permissible arrangements.  You may request a copy of such safeguards from your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">To the extent provided by law, you may, at any time, have the right to request&#58; access to Personal Data, rectification of Personal Data, erasure of Personal Data, restriction of processing of Personal Data, and portability of Personal Data.  You may also have the right to object, on grounds related to a particular situation, to the processing of Personal Data, as well as opt-out of the Plan herein, in any case without cost, by contacting in writing your Human Resources manager.  Your provision of Personal Data is a contractual requirement.  You understand, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to grant the Stock Option to you, or grant other equity awards or administer or maintain such equity awards.  For more information on the consequences of your refusal to provide Personal Data, you understand that you may contact your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">When the Company and the Employer no longer need to use Personal Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Personal Data from their systems and&#47;or records containing the Personal Data and&#47;or take steps to properly anonymize it so that you can longer be identified from it.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Type of Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the grant of the Stock Option, nor the issuance of shares of Stock subject to the grant, constitutes a public offering. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you acquire shares of Stock under the Plan and offers such shares of Stock for sale to a person or entity resident in Australia, the offer may be subject to disclosure </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">requirements under Australian law. You are advised to obtain legal advice regarding your disclosure obligations prior to making any such offer. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limitations on Exercisability Following Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision in the Agreement or the Plan to the contrary, in the event your employment terminates for any reason, your vested Stock Option will no longer be exercisable after the earlier of&#58; (i)&#160;thirty (30) days from the date of termination of employment&#59; and (ii) the Expiration Date specified in Section&#160;2 of the Agreement.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Breach of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Agreement or the Plan, you will not be entitled to, and shall not claim any benefit (including without limitation a legal right) under the Plan if the provision of such benefit would give rise to a breach of Part 2D.2 of the Corporations Act 2001 (Cth), any other provision of that Act, or any other applicable statute, rule or regulation which limits or restricts the giving of such benefits.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acceptance of Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order for the Stock Option to be subject to taxation at the time of grant, you must affirmatively accept the Stock Option in writing within 60 days after the offer date by signing below and returning this original executed Addendum to&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific<br>Green Square<br>Lambroekstraat 5D<br>1831 Diegem<br>Belgium</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attn.&#58;  Nathalie Derue</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I hereby accept ________ (number) Option Shares underlying the Stock Option granted to me by the Company on the Grant Date. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"><br>The undersigned acknowledges that he&#47;she has been encouraged to discuss this matter with a financial and&#47;or tax advisor and that this decision is made in full knowledge. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Printed Name&#58;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date of Acceptance&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>If you fail to affirmatively accept the Stock Option in writing within 60 days after the offer date, the Stock Option will not be subject to taxation at the time of grant but instead will be subject to taxation on the date you exercise the Stock Option (or such other treatment as may apply under Belgian tax law at the time of exercise).</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Undertaking for Qualifying Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are accepting the Stock Option in writing within 60 days after the offer date and wish to have the Stock Option subject to a lower valuation for </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Belgium tax purposes pursuant to the article 43, &#167;6 of the Belgian law of 26 March 1999, you may agree and undertake to (a) not exercise the Stock Option before the end of the third calendar year following the calendar year in which the offer date falls, and (b) not transfer the Stock Option under any circumstances (except upon on rights your heir might have in the Stock Option upon your death).  If you wish to make this undertaking, you must sign below and return this executed Addendum to the address listed above. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Printed Name&#58;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Stock Option, you acknowledge that you agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the Stock Option, the receipt of any dividends, and the sale of shares of Stock acquired under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Policy and Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 12 of the Agreement&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Stock Option, you agree that (i) the benefits provided under the Agreement and the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Agreement and the Plan are not a part of the terms and conditions of your employment&#59; and (iii) the income from the Stock Option, if any, is not part of your remuneration from employment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Previously Owned Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision in Section 3 of the Agreement or the Plan to the contrary, if you are resident in Canada, you may not use previously-owned shares of Stock to pay the Grant Price or any Tax-Related Items in connection with the Stock Option.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 11 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby authorize the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  You further authorize the Company, any Affiliate and the Administrator to disclose and discuss the Plan with their advisors.  You further authorize the Company and any Affiliate to record such information and to keep such information in your employee file.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are permitted to sell shares of Stock acquired under the Plan through the designated broker appointed under the Plan, if any, provided that the sale of shares of Stock takes place outside Canada through the facilities of a stock exchange on which the shares of Stock are listed (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the New York Stock Exchange).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All or a portion of the shares of Stock subject to the Stock Option may be &#8220;non-qualified securities&#8221; within the meaning of the Income Tax Act (Canada).</font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The following provision supplements Section 12(k) of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of the Stock Options, your employment or service relationship will be considered terminated as of the earliest of&#58; (a) the date that your employment or service relationship with the Company or one of its Affiliates is terminated&#59; (b) the date that you receive a notice of termination of employment or service&#59; and (c) the date upon which you cease to actively provide services, regardless of any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law. You will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. The Administrator shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of the Stock Option grant (including whether you may still be considered to be providing services while on a leave of absence). Notwithstanding the foregoing, if applicable employment legislation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the Stock Options, if any, will terminate effective as of the last date of the minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">French Language Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision will apply if you are a resident of Quebec&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A French translation of this Agreement and certain other documents related to the Stock Option will be made available to you as soon as reasonably practicable. You understand that, from time to time, additional information related to the Stock Option may be provided in English and such information may not be immediately available in French. However, upon request, the Company will provide a translation of such information into French as soon as reasonably practicable.&#160; Notwithstanding anything to the contrary in the Agreement, and unless you indicate otherwise, the French translation of this Agreement and certain other documents related to the Stock Option will govern your participation in the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHILE</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The offer of the Stock Option constitutes a private offering of securities in Chile effective as of the Grant Date. This offer of the Stock Option is made subject to general ruling N&#176; 336 of the Commission for the Financial Market (Comisi&#243;n para el Mercado Financiero, &#8220;CMF&#8221;). The offer refers to securities not registered at the securities registry or at the foreign securities registry of the CMF, and, therefore, such securities are not subject to oversight of the CMF. Given that the Stock Option is not registered in Chile, the Company is not required to provide public information about the Stock Option or the shares of Stock in Chile. Unless the Stock Option and&#47;or the shares of Stock are registered with the CMF, a public offering of such securities cannot be made in Chile.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Esta oferta de opci&#243;n sobre acciones (&#8220;Opci&#243;n&#8221;) constituye una oferta privada de valores en Chile y se inicia en la Fecha de la Concesi&#243;n. Esta oferta de Opci&#243;n se acoge a las disposiciones de la Norma de Car&#225;cter General N&#186; 336 (&#8220;NCG 336&#8221;) de la Comisi&#243;n para el Mercado Financiero de Chile (&#8220;CMF&#8221;). Esta oferta versa sobre valores no inscritos en el Registro de Valores o en el Registro de Valores Extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta. Por tratarse los Opci&#243;nes de valores no registrados en Chile, no existe obligaci&#243;n por parte de la Compa&#241;&#237;a de entregar en Chile informaci&#243;n p&#250;blica </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">respecto de los Opci&#243;nes or sus Acciones. Estos valores no podr&#225;n ser objeto de oferta p&#250;blica en Chile mientras no sean inscritos en el Registro de Valores correspondiente.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHINA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The following provisions govern your participation in the Plan if you are a national of the People&#8217;s Republic of China (&#8220;China&#8221;) resident in mainland China, as determined by the Company in its sole discretion&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Cashless Sell-All Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As permitted under Section&#160;3 of the Agreement and unless and until the Committee determines otherwise, the method of exercise of the Stock Option shall be limited to mandatory cashless, sell-all exercise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limitations on Exercisability Following Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision in the Agreement or the Plan to the contrary, in the event your employment terminates for any reason, your Stock Option will no longer be exercisable after the earlier of&#58; (i)&#160;the period set forth in Section 4 of the Agreement&#59; (ii) the last day of the 90 day period beginning on the date of termination of employment (or such earlier date as may be required by China State Administration of Foreign Exchange (&#8220;SAFE&#8221;))&#59; and (iii) the Expiration Date specified in Section&#160;2 of the Agreement.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You understand and agree that, pursuant to local exchange control requirements, you will be required immediately to repatriate to China the proceeds from the sale of any shares of Stock acquired under the Plan.  You further understand that such repatriation of proceeds may need to be effected through a special bank account established by the Company or its Affiliate, and you hereby consent and agree that proceeds from the sale of shares of Stock acquired under the Plan may be transferred to such account by the Company on your behalf prior to being delivered to you and that no interest shall be paid with respect to funds held in such account.  The proceeds may be paid to you in U.S. dollars or local currency at the Company&#8217;s discretion.  If the proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds may be deposited into such account.  If the proceeds are paid to you in local currency, you acknowledge that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the proceeds to local currency due to exchange control restrictions.  You agree to bear any currency fluctuation risk between the time the shares of Stock are sold and the net proceeds are converted into local currency and distributed to you.  You further agree to comply with any other requirements that may be imposed by the Company and its Affiliates in the future in order to facilitate compliance with exchange control requirements in China.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not be liable for any costs, fees, lost interest or dividends or other losses you may incur or suffer resulting from the enforcement of the terms of this Addendum or otherwise from the Company&#8217;s operation and enforcement of the Plan, the Agreement and the Award in accordance with Chinese law including, without limitation, any applicable SAFE rules, regulations and requirements.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The above requirements will not apply to non-Chinese nationals, unless otherwise required by the Company or by SAFE.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BY ELECTRONICALLY ACCEPTING THIS AGREEMENT, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE TERMS AND CONDITIONS OF THE PLAN, THE AGREEMENT AND THIS ADDENDUM.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 12 of the Agreement&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose.  Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock are not and will not be registered with the Colombian registry of publicly held securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and, therefore, the shares of Stock may not be offered to the public in Colombia. Nothing in the Agreement should be construed as making a public offer of securities in Colombia.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CZECH REPUBLIC</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Stock Option Upon Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provisions in the Agreement to the contrary, the treatment of the Stock Option upon your termination of employment shall be governed by the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the &#8220;Stock Option Act&#8221;), as in effect at the time of your termination of employment (as determined by the Administrator, in its discretion, in consultation with legal counsel). You acknowledge having received an &#8220;Employer Information Statement&#8221; in Danish, which is being provided to comply with the Stock Option Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Stock Option is not granted under the French specific regime provided by Articles L. 225-177 and seq. or L. 22-10-59 and L. 22-10-60 of the French commercial code, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that it is your express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vous reconnaissez et consentez que c&#8217;est votre souhait expr&#232;s qui cet accord, de meme que tous documents, toutes notifications et tous proc&#233;d&#233;s l&#233;gaux est entr&#233; dans, donn&#233; ou institut&#233; conform&#233;ment ci-annex&#233; ou relatant directement ou indirectement ci-annex&#233;, est formul&#233; dans l&#8217;anglais.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GREECE</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, for any reason, shares of Stock are issued to you within six months after the Grant Date, you agree that you will not sell or otherwise dispose of any such shares of Stock prior to the six-month anniversary of the Grant Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">IMPORTANT NOTICE&#47;WARNING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The contents of this document have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of the documents, you should obtain independent professional advice. The Stock Option and shares of Stock issued upon exercise do not constitute a public offering of securities under Hong Kong law and are available only to employees of the Company or its Affiliates.  The Agreement, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a &#8220;prospectus&#8221; for a public offering of securities under the applicable securities legislation in Hong Kong. The Stock Option is intended only for the personal use of each eligible employee of the Employer, the Company or any Affiliate and may not be distributed to any other person.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Wages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Stock Option and shares of Stock subject to the Stock Option do not form part of your wages for the purposes of calculating any statutory or contractual payments under Hong Kong law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Scheme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that the Company specifically intends that the Plan will not be an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Cashless Sell-All Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As permitted under Section&#160;3 of the Agreement and unless and until the Committee determines otherwise, the method of exercise of the Stock Option shall be limited to mandatory cashless, sell-all exercise.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDONESIA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ISRAEL</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">102 Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Stock Option is granted to you pursuant to the Israeli Sub-Plan to the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Israeli Sub-Plan&#8221;), and is subject to the terms and conditions stated in the Israeli Sub-Plan, the Plan, and the Agreement, including this Addendum. By accepting the Stock Option you acknowledge and agree to be bound by the terms of the Israeli Sub-Plan and consent to the terms of the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> &#8220;Consent Letter - 102 Capital Gain Awards&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Consent Letter&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. If you do not affirmatively accept the Stock Option (and accordingly, the terms of the Israeli Sub-Plan, the Agreement and the Consent Letter) within ninety (90) days after the Grant Date, the Stock Option may not qualify under the capital gain tax treatment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Until further election by the Company, the Stock Option and any shares of Stock received upon exercise of the Stock Option are intended to qualify for the tax treatment available in Israel pursuant to the provisions of the &#8220;capital gain track&#8221; under Section 102 (&#8220;Section 102&#8221;) of the Israeli Income Tax Ordinance &#91;New Version&#93;, 1961 (the &#8220;ITO&#8221;), including the provisions of the Income Tax Rules (Tax Benefits in Shares Issuance to Employees), 2003 and any Tax Ruling. However, in the event the Stock Option does not meet the requirements of Section 102 of the ITO, such Stock Option and the underlying shares of Stock shall not qualify for the favorable tax treatment under the capital gain track. The Company makes no representations or guarantees that the Stock Option will qualify for favorable tax treatment and will not be liable or responsible if favorable tax treatment is not available under Section 102. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Stock Option is subject to the trust (the &#8220;Trust&#8221;) established by the trust and services agreement (the &#8220;Trust Agreement&#8221;) with ESOP Management and Trust Services Ltd. (the &#8220;Trustee&#8221;). To receive the tax treatment provided for in Sections 102(b)(2) and 102(b)(3) of the ITO, shares of Stock acquired by you upon exercise of the Stock Option will be issued directly to the Trustee or controlled by the Trustee under a supervisory trustee arrangement, and will be held by the Trustee on your behalf or controlled by the Trustee at least until the end of the Required Holding Period (as defined in the Israeli Sub-Plan), which is currently twenty-four (24) months from the Grant Date, or any other period determined under the ITO as now in effect or as hereafter amended or by the Israeli Income Tax Authority. Subject to the conclusion of the Required Holding Period and any further period included herein, shares of Stock acquired by you upon exercise of the Stock Option will be held or controlled by the Trustee until their sale, unless you request to release the shares of Stock to your direct holding, in which case the release will be subject to the receipt by the Trustee of an acknowledgment from the Israeli Income Tax Authority that you have paid all applicable taxes due pursuant to the ITO and Section 102, or the Trustee withholds any applicable tax due pursuant to the ITO and Section 102. Notwithstanding the foregoing, in the event you elect to sell or release any shares of Stock acquired upon exercise of the Stock Option prior to the conclusion of the Required Holding Period, the tax consequences under Section 102 shall apply to and shall be borne solely by you, as further set forth in the Israeli Sub-Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company may at its sole discretion replace the Trustee from time to time and instruct the transfer of all Stock Options and shares of Stock held and&#47;or administered by such Trustee at </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such time to its successor and the provisions of your Agreement shall apply to the new Trustee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any and all Tax-Related Items due in relation to the Stock Option and shares of Stock shall be borne solely by you and in the event of death, by your heirs. The Company, the Employer and&#47;or the Trustee shall withhold Tax-Related Items according to the requirements under the applicable laws, the rules, and regulations, including withholding Tax-Related Items at source. Furthermore, you hereby agree to indemnify the Company, the Employer and&#47;or the Trustee and hold them harmless against and from any and all liability for any such Tax-Related Items or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such Tax-Related Items from any payment made to you. The Company, the Employer and&#47;or the Trustee, to the extent permitted by law, shall have the right to deduct from any payment otherwise due to you, or from proceeds of the sale of any shares of Stock, an amount equal to any Tax-Related Items required by law to be withheld with respect to such shares of Stock. You will pay to the Company, the Employer or the Trustee any Tax-Related Items that the Company, the Employer or the Trustee may be required to withhold with respect to any shares of Stock that cannot be satisfied by the means previously described. The Company may refuse to deliver any shares of Stock if you fail to comply with your obligations in connection with the Tax-Related Items as described in this section. Any fees associated with any vesting, sale, transfer or any act in relation to the Stock Option and the shares of Stock, shall be borne by you. The Trustee, the Company and&#47;or the Employer shall be entitled to withhold or deduct such fees from payments otherwise due to&#47;from the Company, the Employer or the Trustee.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; The Company has obtained from the Israel Securities Authority an exemption from the requirement to file a prospectus in relation to the Plan. Copies of the Plan and the Form S-8 registration statement for the Plan filed with the U.S. Securities and Exchange Commission are available by contacting your local human resources manager.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Cashless Sell-All Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   As permitted under Section&#160;3 of the Agreement and unless and until the Committee determines otherwise, the method of exercise of the Stock Option shall be limited to mandatory cashless, sell-all exercise.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 12 of the Agreement&#58;  You further acknowledge that you have read and specifically and expressly approve the following sections of the Agreement&#58;  Grant of Stock Option, Exercise of Stock Option, Termination of Employment, Recoupment Policy, Satisfaction of Tax Obligations, Nature of Grant, and Choice of Law and Venue.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">KAZAKHSTAN</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This offer is addressed only to certain eligible employees of the Company and its Affiliates in the form of Shares to be issued by the Company, subject to the terms and conditions of the Agreement and the Plan. Neither the Plan nor the Agreement has been approved, nor do they need to be approved, by the National Bank of Kazakhstan. This offer </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">is intended only for the original recipient and is not for general circulation in the Republic of Kazakhstan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LEBANON</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Plan does not constitute the marketing or offering of securities in Lebanon pursuant to Law No. 161 (2011), the Capital Markets Law.  Offerings under the Plan are being made only to eligible employees of the Company and its Affiliates.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MALAYSIA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Conditioned upon Election to Pay Taxes Directly to the Malaysian Inland Revenue Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You understand and agree that your Award is conditioned upon your completing, signing and submitting a letter to your Employer, indicating your election to pay any income tax or other tax liability arising in connection with taxable income recognized under the Plan directly to the Malaysian Inland Revenue Board.  (You may contact your Employer to request a form letter for this purpose.)  You understand that if you fail to file such an election letter with your Employer, your Award will be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consent to Collection, Processing and Transfer of Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   This provision replaces Section&#160;11 of the Agreement in its entirety&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data, as described in this Addendum and any other grant materials by and among, as applicable, the Company and Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan. </font></div><div style="padding-right:2.75pt"><font><br></font></div><div style="padding-right:2.75pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that the Company and Affiliates may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all Stock Options or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  The Data is supplied by the Company and also by you through information collected in connection with the Agreement and the Plan.   </font></div><div style="padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:9pt;padding-right:2.75pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:126%">You understand that Data will be transferred to the current stock plan service providers or a stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country. You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +(65) 6418 8817.  You authorize the Company, the stock plan service provider and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any transfer of such Data as may be required to a broker, escrow agent or other third party with whom the shares of Stock received upon exercise of the Stock Option may be deposited.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, limit the processing of Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consent herein on a purely voluntary basis.  If you do not consent, or if you later seek to revoke your consent, your employment status or service and career with the Company will not be adversely affected&#59; the only adverse consequence of refusing or withdrawing your consent is that the Company may not be able to grant you Stock Options or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.</font></div><div style="margin-bottom:6pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please take note that by electronically accepting this Agreement, you have confirmed that you explicitly, voluntarily and unambiguously consent to the collection, use and transfer of your personal data in accordance with the terms in this notification. However, if for any reason you do not consent to the processing of your personal data, you have the right to reject such consent by contacting your local human resources representative&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6418</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8817.  </font></div></td><td colspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda dengan ini secara eksplisit dan tanpa sebarang keraguan mengizinkan pengumpulan, penggunaan dan pemindahan, dalam bentuk elektronik atau lain-lain, data peribadi anda seperti yang diterangkan dalam Lampiran ini dan apa-apa bahan pemberian Opsyen saham terhad yang lain oleh dan di antara, seperti yang berkenaan, Syarikat dan Ahli Gabungan untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan penyertaan anda di dalam Pelan. </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda memahami bahawa Syarikat Ahli Gabungan mungkin memegang maklumat peribadi tertentu tentang anda, termasuk, tetapi tidak terhad kepada, nama anda, alamat rumah dan nombor telefon, tarikh lahir, nombor insurans sosial atau nombor pengenalan lain, gaji, kewarganegaraan, jawatan, apa-apa syer saham Biasa atau jawatan pengarah yang dipegang dalam Syarikat, butir-butir semua Opsyen saham terhad, atau apa-apa hak lain atas syer Biasa saham yang dianugerahkan,  dibatalkan, dilaksanakan, terletak hak, tidak diletak hak ataupun yang belum dijelaskan bagi faedahanda, untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan Pelan tersebut (&#8220;Data&#8221;). Data tersebut dibekalkan oleh Syarikat dan juga oleh anda berkenaan dengan Perjanjian dan Pelan.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda memahami bahawa Data ini akan dipindahkan kepada pembekal perkhidmatan pelan saham semasa atau pembekal perkhidmatan pelan saham yang mungkin dipilih oleh Syarikat pada masa depan, yang membantu Syarikat dengan pelaksanaan, pentadbiran dan pengurusan Pelan. Anda memahami bahawa penerima-penerima Data mungkin berada di Amerika Syarikat atau mana-mana tempat lain, dan bahawa negara penerima-penerima (contohnya, Amerika Syarikat) mungkin mempunyai undang-undang privasi data dan perlindungan yang berbeza daripada negara anda. Anda memahami bahawa sekiranya anda menetap di luar Amerika Syarikat, anda boleh meminta satu senarai yang mengandungi nama-nama dan alamat-alamat penerima-penerima Data yang berpotensi dengan menghubungi wakil sumber manusia tempatan anda&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">6418</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">8817.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda memberi kuasa kepada Syarikat, pembekal perkhidmatan pelan saham dan mana-mana penerima-penerima kemungkinan lain yang mungkin akan membantu Syarikat (pada masa sekarang atau pada masa depan) dengan melaksanakan, mentadbir dan menguruskan Pelan untuk menerima, memiliki, menggunakan, mengekalkan dan memindahkan Data, dalam bentuk elektronik atau lain-lain, bagi tujuan melaksanakan, mentadbir dan menguruskan penyertaan anda  di dalam Pelan, termasuk segala pemindahan Data tersebut sebagaimana yang dikehendaki kepada broker, egen eskrow atau pihak ketiga  dengan siapa syer Biasa saham diterima semasa peletakhakan saham terhad Opsyen mungkin didepositkan.  Anda memahami bahawa Data hanya akan disimpan selagi ia adalah diperlukan untuk melaksanakan, mentadbir, dan menguruskan penyertaan anda dalam Pelan. Anda memahami bahawa sekiranya anda menetap di luar Amerika Syarikat, anda boleh, pada bila-bila masa, melihat Data, meminta maklumat tambahan mengenai penyimpanan dan pemprosesan Data, meminta bahawa pindaan-pindaan dilaksanakan ke atas Data, mengehadkan pemprosean Data atau menolak atau menarik balik persetujuan dalam ini, dalam mana-mana kes, tanpa kos, dengan menghubungi secara bertulis wakil sumber manusia tempatan.  Selanjutnya, anda memahami bahawa anda memberikan persetujuan di sini secara sukarela semata-mata. Sekiranya anda tidak bersetuju, atau sekiranya anda kemudian membatalkan persetujuan anda, status pekerjaan atau perkhidmatan dan kerjaya anda dengan Syarikat tidak akan terjejas&#59; satu-satunya akibat buruk sekiranya anda tidak bersetuju atau menarik balik persetujuan andaadalah bahawa Syarikat tidak akan dapat memberikan Opsyen saham terhad anda atau anugerah ekuiti lain atau mentadbir atau mengekalkan anugerah-anugerah tersebut. Oleh itu, anda memahami bahawa keengganan atau penarikan balik persetujuan anda boleh menjejaskan keupayaan anda untuk mengambil bahagian dalam Pelan. Untuk maklumat lebih lanjut mengenai akibat-akibat keengganan anda untuk memberikan keizinan atau penarikan balik keizinan, anda memahami bahawa anda boleh menghubungi wakil sumber manusia tempatan.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Sila ambil perhatian bahawa dengan menerima Perjanjian ini secara elektronik, anda mengesahkan bahawa anda secara eksplisit, sukarela, dan tanpa sebarang keraguan bersetuju dengan pengumpulan, penggunaan, dan pemindahan data peribadi anda mengikut terma-terma dalam notis ini. Walaubagaimanapun, jika atas apa-apa sebab-sebab tertentu anda tidak bersetuju dengan pemprosesan data peribadi anda, anda mempunyai hak untuk menolak persetujuan anda dengan menghubungi wakil sumber manusia tempatan anda&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">6418</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">8817.</font></div></td></tr></table></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You expressly recognize and acknowledge that the Company&#8217;s grant of the Stock Option and the underlying shares of Stock under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico.  In addition, the Plan, the Agreement and any other document relating to the Stock Option may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of the Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Stock Option, you acknowledge that have received a copy of the Plan and the Agreement, including this Addendum, which you have reviewed.  You further acknowledge that you accept all the provisions of the Plan and the Agreement, including this Addendum.  You also acknowledge that you have read and specifically and expressly approve the terms and conditions set forth in Section 12 of the Agreement, which clearly provide as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Your participation in the Plan does not constitute an acquired right&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;The Plan and your participation in it are offered by the Company on a wholly discretionary basis&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Your participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;The Company and its Affiliates are not responsible for any decrease in the value of any shares of Stock acquired at exercise of the Stock Option. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Reconocimiento del Contrato</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  Al aceptar la Opci&#243;n, Usted reconoce que ha recibido una copia del Plan y del contrato, incluyendo este Ap&#233;ndice, mismos que ha revisado.  Usted reconoce, adem&#225;s, que acepta todas las disposiciones del Plan, y del contrato, incluyendo este Ap&#233;ndice.  Tambi&#233;n reconoce que ha le&#237;do y aprueba de forma expresa los t&#233;rminos y condiciones establecidos en la secci&#243;n doce 12 del contrato que claramente dispone lo siguiente&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(1)&#160;&#160;&#160;&#160;Su participaci&#243;n en el Plan no constituye un derecho adquirido&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(2)&#160;&#160;&#160;&#160;El Plan su participaci&#243;n en el mismo son ofrecidos por la Compa&#241;&#237;a de forma totalmente discrecional&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(3)&#160;&#160;&#160;&#160;Su participaci&#243;n en el Plan es voluntaria&#59; y </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(4)&#160;&#160;&#160;&#160;La Compa&#241;&#237;a y sus afiliados no son responsables por cualquier disminuci&#243;n en el valor de las Acciones adquiridas al momento de tener derecho conforme a la Opci&#243;n.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Acknowledgement and Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Stock Option, you acknowledge that Boston Scientific Corporation, with registered offices at </font><font style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">300 Boston Scientific Way, Marlborough, Massachusetts 01752</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, United States of America, is solely responsible for the administration of the Plan.  You further acknowledge your participation in the Plan, the grant of the Stock Option and any acquisition of shares of Stock under the Plan do not constitute an employment relationship between you and Boston Scientific Corporation because you are participating in the Plan on a wholly commercial basis and your sole employer is a Mexican legal entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(&#8220;Boston Scientific-Mexico&#8221;).  Based on the foregoing, you expressly acknowledge that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your Employer, Boston Scientific-Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Boston Scientific-Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is the result of a unilateral and discretionary decision of Boston Scientific Corporation, therefore, Boston Scientific Corporation reserves the absolute right to amend and&#47;or discontinue your participation in the Plan at any time, without any liability to you.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve to yourself any action or right to bring any claim against Boston Scientific Corporation for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and that you therefore grant a full and broad release to Boston Scientific Corporation its Affiliates, branches, representation offices, shareholders, officers, agents and legal representatives, with respect to any claim that may arise. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Reconocimiento de Ley Laboral y Declaraci&#243;n de la Pol&#237;tica</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  Al aceptar el Otorgamiento de la Opci&#243;n, Usted reconoce que Boston Scientific Corporation, con oficinas registradas en </font><font style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">300 Boston Scientific Way, Marlborough, Massachusetts 01752</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, Estados Unidos de Am&#233;rica, es &#250;nicamente responsable de la administraci&#243;n del Plan.  Usted adem&#225;s reconoce que su participaci&#243;n en el Plan, la concesi&#243;n de Opci&#243;n y cualquier adquisici&#243;n de acciones de conformidad con el Plan no constituyen una relaci&#243;n de trabajo entre Usted y Boston Scientific Corporation, ya que Usted est&#225; participando en el Plan sobre una base totalmente comercial y su &#250;nico patr&#243;n es una sociedad mercantil Mexicana (&#8220;Boston Scientific-M&#233;xico&#8221;).  Derivado de lo anterior, Usted expresamente reconoce que el Plan y los beneficios que pueden derivarle de la participaci&#243;n en el Plan no establecen ning&#250;n derecho entre Usted y su Patr&#243;n, Boston Scientific-M&#233;xico, y no forman parte de las condiciones de trabajo y&#47;o prestaciones otorgadas por Boston Scientific-M&#233;xico, y cualquier modificaci&#243;n al Plan o su terminaci&#243;n no constituir&#225; un cambio o perjuicio de los t&#233;rminos y condiciones de su trabajo. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Usted adem&#225;s entiende que su participaci&#243;n en el Plan es resultado de una decisi&#243;n unilateral y discrecional de Boston Scientific Corporation, por lo tanto Boston Scientific Corporation se reserva el derecho absoluto de modificar el Plan y&#47;o discontinuar su participaci&#243;n en el Plan en cualquier momento, sin responsabilidad alguna para hacia Usted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Finalmente, Usted declara que no se reserva acci&#243;n o derecho alguno para presentar una reclamaci&#243;n o demanda en contra de Boston Scientific Corporation por cualquier compensaci&#243;n o da&#241;o o perjuicio en relaci&#243;n con cualquier disposici&#243;n del Plan o los beneficios derivados del Plan y, por lo tanto, otorga un amplio y total finiquito a Boston Scientific Corporation, sus afiliados, afiliadas, sucursales, oficinas de representaci&#243;n, </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">accionistas, directores, funcionarios, agentes y representantes con respecto a cualquier reclamaci&#243;n o demanda que pudiera surgir.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Stock Option, you hereby waive any and all rights to compensation or damages as a result of the termination of employment with Boston Scientific Corporation and the Employer for any reason whatsoever, insofar as those rights result or may result from (i) the loss or diminution in value of such rights or entitlements under the Plan, or (ii)&#160;your ceasing to have rights under, or ceasing to be entitled to any awards under the Plan as a result of such termination.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Warning</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is an offer of a Stock Option which, upon exercise and settlement in accordance with the terms of the Plan and the Agreement, will be converted into shares of Stock.  Shares of Stock give you a stake in the ownership of Boston Scientific Corporation. You may receive a return if dividends are paid.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If Boston Scientific Corporation runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference shares have been paid.  You may lose some or all of your investment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">New Zealand law normally requires people who offer financial products to give information to investors before they invest.  This information is designed to help investors to make an informed decision.  The usual rules do not apply to this offer because it is made under an employee share purchase scheme.  As a result, you may not be given all the information usually required.  You will also have fewer other legal protections for this investment. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ask questions, read all documents carefully, and seek independent financial advice before committing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to the exercise and settlement of the Stock Option, you will not have any rights of ownership (e.g., voting or dividend rights) with respect to the underlying shares of Stock. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No interest in any Stock Option may be transferred (legally or beneficially), assigned, mortgaged, charged or encumbered.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The shares of Stock are quoted on the New York Stock Exchange.  This means that if you acquire shares of Stock under the Plan, you may be able to sell them on the New York Stock Exchange if there are interested buyers.  You may get less than you invested.  The price will depend on the demand for the shares of Stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You also are hereby notified that the documents listed below are available for review on sites at the web addresses listed below&#58;</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation&#8217;s most recent Annual Report (Form 10-K)&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.sec.gov&#47;cgi-bin&#47;browse-edgar&#63;CIK&#61;bsx&#38;owner&#61;exclude&#38;action&#61;getcompany&#38;Find&#61;Search</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation&#8217;s most recent published financial statements (Form 10-Q or 10-K) and the auditor&#8217;s report on those financial statements&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.sec.gov&#47;cgi-bin&#47;browse-edgar&#63;CIK&#61;bsx&#38;owner&#61;exclude&#38;action&#61;getcompany&#38;Find&#61;Search</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">The Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan&#58;  This document can be accessed at https&#58;&#47;&#47;us.etrade.com&#47;home -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation Non-Qualified Stock Option Grant and Amended and Restated 2011 Long-Term Incentive Plan Q&#38;A Summary Sheet&#58; This document can be accessed at https&#58;&#47;&#47;us.etrade.com&#47;home -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt"> Boston Scientific Corporation Equity Award and Acceptance Summary&#58; This document can be accessed at https&#58;&#47;&#47;us.etrade.com&#47;home -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the above documents will be sent to you free of charge on written request being mailed to&#58;  Boston Scientific Corporation, Corporate Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 300 Boston Scientific Way, Marlborough, MA 01752, USA.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NORWAY</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERU</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The grant of the Stock Option is considered a private offering in Peru&#59; therefore, it is not subject to registration. For more information concerning the grant, you acknowledge that you should refer to the Plan, the Agreement, and any other materials made available by the Company.&#160;For more information regarding the Company, you acknowledge that you should refer to the Company's most recent annual report on Form&#160;10-K and quarterly report on Form 10-Q available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Acknowledgement of Nature of Plan and the Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the Stock Option, you understand, acknowledge and agree that the Stock Option is being granted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ex gratia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PHILIPPINES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Cashless Sell-All Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As permitted under Section&#160;3 of the Agreement and unless and until the Committee determines otherwise, the method of exercise of the Stock Option shall be limited to mandatory cashless, sell-all exercise.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and the Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Conhecimento da Lingua</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  Por meio do presente, eu declaro expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que li, compreendi e livremente aceitei e concordei com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the grant of the Stock Option, you acknowledge that you are proficient in reading and understanding English and fully understand the terms of the documents related to the grant (the Agreement and the Plan), which were provided in the English language.&#160;You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consimtamant cu Privire la Limba</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. Accept&#226;nd acordarea op&#539;iune de stoc, recunoa&#537;te&#539;i c&#259; sunte&#539;i competen&#539;i &#238;n citirea &#537;i &#238;n&#539;elegerea limbii engleze &#537;i &#238;n&#539;elege&#539;i pe deplin termenii documentelor legate de subven&#539;ie (Acordul de acordare &#537;i planul), care au fost furnizate &#238;n limba englez&#259;. Accepta&#539;i termenii acestor documente &#238;n consecin&#539;&#259;.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RUSSIA</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You understand that the Stock Option shall be valid and this Agreement shall be concluded and become effective only when the Agreement is received by the Company in the United States.  Upon exercise of the Stock Option, any shares of Stock to be issued to you shall be delivered to you through a bank or brokerage account in the United States.  In no event will shares of Stock be delivered to you in Russia&#59; instead, all shares of Stock acquired upon exercise of the Stock Option will be maintained on your behalf in the United States.  You are not permitted to sell shares of Stock acquired at vesting directly to a Russian legal entity or resident.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You acknowledge that the Stock Option, the Equity Award and Acceptance Summary, the Agreement, the Plan and all other materials that you may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia.  The shares of Stock acquired pursuant to the Plan have not and will not be registered in Russia and, therefore, neither the Stock Option nor the shares of Stock may be used for offering or public circulation in Russia.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cashless Exercise Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Agreement, depending on the development of local regulatory requirements, the Company reserves the right to restrict exercise of your Stock Option to a cashless exercise through a licensed securities broker acceptable to the Company, such that all shares of Stock subject to the exercised Stock Option will be sold immediately upon exercise and the proceeds of sale, less the Grant Price, any Tax-Related Items and broker&#8217;s fees or commissions, will be remitted to you in accordance with any applicable exchange control laws and regulations.</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree to promptly repatriate proceeds resulting from the sale of shares of Stock acquired under the Plan to a foreign currency account at an authorized bank in Russia if legally required at the time shares of Stock are sold and to comply with all applicable local foreign exchange rules and regulations.  Neither the Company nor any of its Affiliates shall be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The repatriation requirement may not apply with respect to cash amounts received in an account that is considered by the Central Bank of Russia to be a foreign brokerage account opened with a financial market institution other than a bank.  Statutory exceptions to the repatriation requirement also may apply.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of Stock of foreign companies such as the Company). Accordingly, you should inform the Company if you are covered by these laws because you should not hold shares of Stock acquired under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you continue to hold shares of Stock acquired upon exercise of the Stock Option after an involuntary termination of employment, you may not be eligible to receive unemployment benefits in Russia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting and Exercise of Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Depending on the development of local regulatory requirements, the Company reserves the right to postpone the vesting and&#47;or the ability to exercise the Stock Option, to restrict exercise of the Stock Option to a cashless sell-all exercise and&#47;or to pay any proceeds related to the Stock Option to you through local payroll, or to cancel the Stock Option for no consideration.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SAUDI ARABIA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the Stock Option is not subject to the regulations concerning public offers and private placements under the Law on Capital Markets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The grant of the Stock Option under the Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore and is not regulated by any financial supervisory authority pursuant to any legislation in Singapore. Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. You should note that the Stock Option is subject to section 257 of the SFA and you will not be able to make any subsequent sale of the shares of Stock in Singapore, or any offer of such subsequent sale of the shares of Stock subject to the Stock Option in Singapore, unless such sale or offer in is made (i) after six months from the Grant Date or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In compliance with South African securities law, the documents listed below are available for review on the Company&#8217;s external and internal sites at the web addresses listed below&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;Boston Scientific Corporation&#8217;s most recent Annual Report (Form 10-K)&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.sec.gov&#47;cgi-bin&#47;browse-edgar&#63;CIK&#61;bsx&#38;owner&#61;exclude&#38;action&#61;getcompany&#38;Find&#61;Search</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;The Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan&#58;  This document can be accessed at https&#58;&#47;&#47;us.etrade.com&#47;home -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;Boston Scientific Corporation Non-Qualified Stock Option Grant and Amended and Restated 2011 Long-Term Incentive Plan Q&#38;A Summary Sheet&#58;  This document can be accessed at https&#58;&#47;&#47;us.etrade.com&#47;home -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;Boston Scientific Corporation Equity Award and Acceptance Summary&#58; This</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">document can be accessed at https&#58;&#47;&#47;us.etrade.com&#47;home -&#62; My Stock Plan -&#62;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge that you may have copies of the above documents sent to you, at no charge, on written request being mailed to Boston Scientific Corporation, attn&#58; Corporate Compensation, 300 Boston Scientific Way, Marlborough, MA 01752, USA.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that you are advised to carefully read the materials provided before making a decision whether to participate in the Plan and to contact your tax advisor for specific information concerning your personal tax situation with regard to Plan participation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consent to Collection, Processing and Transfer of Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By electronically accepting this Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">You agree to the collection, use, processing and transfer of Data as described in Section&#160;11 of the Agreement&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">You agree to the processing of your unique identifying information (resident registration number) as described in Section 11 of the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of Discretionary Nature of the Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This provision supplements the terms of the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accepting the Stock Option grant, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that the Company has unilaterally, gratuitously and in its sole discretion granted Stock Options under the Plan to individuals who may be employees of the Company or its Affiliates throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Affiliates on an ongoing basis.  Consequently, you understand that the Stock Option is granted on the assumption and condition that the Stock Option and the shares of Stock acquired upon exercise of the Stock Option shall not become a part of any employment contract (either with the Company or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever.  In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above&#59; thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the Stock Option grant shall be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the Stock Option grant, your termination of employment for any reason (including the reasons listed below) will automatically result in the loss of the Stock Option to the extent the Stock Option has not vested as of date you cease active employment.  In particular, you understand and agree that any unvested Stock Option as of the date you cease active employment and any vested portion of the Stock Option not exercised within the post-termination exercise period set out in the Agreement will be forfeited without entitlement to the underlying shares of Stock or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, resignation or retirement prior to the first anniversary of the Grant Date, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause, individual or collective dismissal on objective grounds, whether adjudged or recognized to be with or without cause, material modification of the terms of employment under Article 41 of the Workers&#8217; Statute, relocation under Article&#160;40 of the Workers&#8217; Statute, Article 50 of the Workers&#8217; Statute, unilateral withdrawal by the Employer and under Article 10.3 of the Royal Decree 1382&#47;1985.  You acknowledge that you have read and specifically accept the conditions referred to in the Agreement regarding the impact of a termination of employment on your Stock Option.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BY ELECTRONICALLY ACCEPTING THIS AGREEMENT, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE TERMS AND CONDITIONS OF THE PLAN, THE AGREEMENT AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWEDEN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall supplement Section 9 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limiting the Company&#8217;s and the Employer&#8217;s authority to satisfy their withholding obligations for Tax-Related Items as set forth in the Section 9 of the Agreement, in accepting the grant of the Stock Option, you authorize the Company to sell shares of Stock otherwise deliverable to you upon exercise of the Stock Option to satisfy Tax-Related Items, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither this document nor any other materials relating to the Stock Option (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (ii) may be publicly distributed or otherwise made publicly </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">available in Switzerland to any person other than an employee of the Corporation or a Subsidiary or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority, FINMA.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award and the shares of Stock to be issued pursuant to the Plan are available only for Employees.  The Award is not a public offer of securities by a Taiwanese company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THAILAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Under Turkish law, you are not permitted to sell shares of Stock acquired under the Plan in Turkey. The shares of Stock are currently traded on the New York Stock Exchange, which is located outside Turkey and the shares of Stock may be sold through this exchange.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan is an employee equity incentive plan and is only being offered to select employees in the United Arab Emirates. The Plan and the Agreement are intended for distribution only to such employees and must not be delivered to, or relied on by, any other person. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic Development have approved the Plan or the Agreement nor taken steps to verify the information set out therein, and have no responsibility for such documents. You should conduct your own due diligence on the securities offered under the Plan. If you do not understand the contents of&#160;the&#160;Agreement or the Plan, you should consult an authorized financial advisor.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall supplement Section 9 of the Agreement&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation Section 9 of the Agreement, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, the Employer or by HM Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  You also agree to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay on your behalf to HMRC (or any other tax authority or any other relevant authority).</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, you understand that if you are a director or executive officer (within the meaning of Section 13(k) of the U.S. Securities Exchange Act of 1934, as amended), the terms of the immediately foregoing provision may not apply.  In the event that you are a director or executive officer and income tax due is not collected from or paid by you within 90 days after the UK tax year in which an event giving rise to the indemnification described above occurs, the amount of any uncollected tax may constitute a benefit on which additional income tax and national insurance contributions may be payable. You acknowledge that you ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer (as applicable) for the value of any employee national insurance contributions due on this additional benefit, which the Company and&#47;or the Employer may recover from you at any time thereafter by any of the means referred to in Section 9 of the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that you will have no entitlement to compensation or damages insofar as such entitlement arises or may arise from your ceasing to have rights under or to be entitled to the Award, whether or not as a result of your termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the Award.  Upon the grant of your Award, you shall be deemed irrevocably to have waived any such entitlement. </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">APPENDIX A</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSENT LETTER</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">102 CAPITAL GAIN AWARDS FOR PARTICIPANTS RESIDING IN ISRAEL</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dear Participant,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation (the &#8220;Company&#8221;) has elected to apply the capital gains route in accordance with the provisions of Section 102 of the Israeli Income Tax Ordinance (the &#8220;Ordinance&#8221;) on awards granted under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Incentive Plan&#8221;) to Israeli Participants (as defined in the Israeli sub-plan to the Incentive Plan (the &#8220;Israel Sub-Plan&#8221;), which was approved by the Executive Compensation and Human Resources Committee of the Company&#8217;s Board of Directors on November 14, 2022) and any future incentive plan implemented by the Company in Israel (&#8220;Awards&#8221; and &#8220;Capital Gains Route&#8221;), subject to the Company&#8217;s absolute discretion to change such election on future grants, with or without advance notice. Unless otherwise notified to you in writing by the Company, the Awards shall be granted to you under the Capital Gains Route, subject to compliance with the requirements of such tax route. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Capital Gains Route election will enable you to enjoy lower tax rates on a portion of the income received upon disposition of the shares of Company common stock (&#8220;Shares&#8221;) issued to you from or in connection to the Awards, provided however that all the requirements under Section 102 of the Ordinance and the Income Tax (Tax Abatement on the Grant of Shares to Employees) Regulations 2003 (the &#8220;Regulations&#8221;) are met.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below you will find a brief description of the Israeli income tax consequences of the Capital Gains Route. PLEASE NOTE THAT THE SUMMARY BELOW IS ONLY A BRIEF SUMMARY THAT DOES NOT COVER ALL THE PROVISIONS OF SECTION 102 OF THE ORDINANCE AND THE REGULATIONS AND IS NOT INTENDED TO PROVIDE ANY TAX ADVICE. IN ADDITION, THE TAX LAWS AND REGULATIONS DESCRIBED HEREIN ARE SUBJECT TO CHANGE. THEREFORE, IT IS RECOMMENDED THAT YOU CONSULT WITH A TAX ADVISER BEFORE ACCEPTING THE TERMS OF THIS CONSENT LETTER OR BEFORE ACCEPTING ANY AWARDS OR DISPOSING OF SHARES. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The main restrictions that are included under Section 102 of the Ordinance are as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1) Your Awards and the Shares issued under such Awards will be held in trust or controlled by a trustee for at least a period determined in Section 102 under the Capital Gains Route (&#8220;Required Holding Period&#8221;) (currently twenty-four months from the date in which the Awards were granted to you).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2) During the Required Holding Period you will not be able to sell, pledge, release from trust or otherwise perform any transaction in connection to the Awards or Shares granted to you. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Provided that all conditions set by the Ordinance under the Capital Gains Route are met, including the above conditions, you will, in general, be taxed as follows&#58;&#160; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">The lower of (1) the difference between the fair market value of the underlying Shares on the grant date and the exercise price (plus any transactional expenses incurred in </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">connection with the sale) and (2) the difference between the sale proceeds and the exercise price (plus any transactional expenses incurred in connection with the sale) will be treated as ordinary income subject to income tax and employee&#47;employer social insurance contributions (to the extent the applicable contribution ceiling has not been exceeded). For tax purposes, the fair market value of the Shares at grant is deemed to be the average price of the Shares over the 30 trading days preceding the grant.&#160; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">The remainder of the gain, if any, will be treated as a capital gain and will be taxed at the capital gains tax rate of 25%.&#160; No social insurance contributions will be due on this portion of the gain.&#160; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, a surtax may be imposed if your income is in excess of the applicable annual threshold.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you sell your Shares, or release the Shares from trust, before the end of the Holding Period, you will immediately be subject to income tax on the gain, at your marginal income tax rate, and will be also required to pay social security and health tax contributions on all your profit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In order to enable you to enjoy the benefits of the Capital Gains Route, please express your acceptance and confirmation of the following terms, by accepting the Award through the electronic acceptance procedures established by the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;I undertake to comply with all the terms and conditions set under Section 102 of the Ordinance with regard to the Capital Gains Route and the Regulations.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;I have had the opportunity to obtain the advice of counsel prior to accepting this Consent Letter. I am familiar with and understand the provisions of Section 102 of the Ordinance in general, and the tax arrangement under the Capital Gains Route in particular, and agree to comply with such provisions, as amended from time to time. </font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;I agree that Awards granted to me, and the Shares that may be derived from such Awards, will be held or controlled by a trustee for at least the duration of the Required Holding Period, as determined in Section 102 under the Capital Gains Route (currently twenty-four months from the date in which the Awards were granted). </font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;I agree to the trust deed signed between the Company, my employer and the trustee available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trust Deed RSU-Stock Option - Hebrew.pdf</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;I understand that any release of such Awards or Shares from trust, or any sale of the Shares prior to the termination of the Required Holding Period, will result in taxation at my marginal tax rate, in addition to deductions of appropriate social security and health tax contributions.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;I authorize the Company and&#47;or my employer to provide the trustee with any information required for administrating the grant of the Awards, including without limitation information about my Awards, income tax rates, salary bank account, contact details and identification number and any reasonable information required by the trustee.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7. &#160;&#160;&#160;&#160;I declare that I am a resident of the state of Israel for tax purposes and agree to notify the Company upon any change in the residence address and acknowledge that if I cease to be an Israeli resident or if my engagement with the Company or any affiliate is </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">terminated, the Awards and underlying Shares shall remain subject to Section 102, the trust agreement and the applicable equity plan and grant document.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;I understand and agree that until the Company will determine otherwise, my acceptance of the terms of this Consent Letter will be sufficient, to apply to all potential future grants of Awards. I hereby confirm that by accepting this Consent Letter, I will be deemed to have elected to accept the terms and conditions herein in respect of any such potential future grant of Awards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9. &#160;&#160;&#160;&#160;I acknowledge, understand and agree that the Awards are an extraordinary, one-time benefit granted to me, and do not create any contractual or other right to receive future grant of Awards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10. &#160;&#160;&#160;&#160;I understand that neither the Company nor any affiliates guarantee that any Awards granted to me will be eligible for tax benefits pursuant to the Capital Gains Route and I agree that I will not hold the Company and&#47;or any affiliate and&#47;or the trustee liable for any tax consequences relating to my Awards, including any penalties or other negative tax consequences I could receive or be subject to if my Awards do not obtain the Capital Gains Route tax treatment, regardless of the reason for the Capital Gains Route tax treatment not being available.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 12. 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>ex103-2023grantxrsuagreeme.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4ca9ee4c9ebc4e498971ab4d599c1e2a_1"></div><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Global Restricted Stock Unit Award Agreement</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Global Restricted Stock Unit Award Agreement (the &#8220;Agreement&#8221;) is between you and Boston Scientific Corporation, a Delaware corporation, (the &#8220;Company&#8221;) in connection with the award of Restricted Stock Units (the &#8220;Award&#8221;) by the Committee under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Plan&#8221;).  Capitalized terms used but not defined in this Agreement shall have the same meaning as assigned to them in the Plan.  The applicable terms and conditions of the Plan are incorporated into and made a part of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee hereby grants you that number of Restricted Stock Units as set forth in your Equity Award and Acceptance Summary (the &#8220;Units&#8221;).  Each Unit represents the Company&#8217;s commitment to issue to you one share of Stock subject to the conditions set forth in this Agreement.  This Award is granted pursuant to and is subject to the provisions of the Plan and the terms and conditions of this Agreement and any applicable Addendum.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Units shall vest and shares of Stock will be issued to you in accordance with the schedule provided in your Equity Award and Acceptance Summary.  Except as otherwise provided in Sections 4, 5, 6, 7 and 8 below, the Units will vest, subject to the conditions described in Section 7 below. Shares of Stock for Units that vest in accordance with this Section 2 will be delivered to you within fifteen (15) days after the applicable vesting date but in no event later than the last day of the calendar year that includes the applicable vesting date.  No shares of Stock shall otherwise be issued to you prior to the date on which the Units vest.  Notwithstanding anything in the Agreement to the contrary, the Company may, in its sole discretion, settle the Units in the form of a cash payment to the extent that settlement in shares of Stock is prohibited under local law or would require the Company and&#47;or any of its Affiliates to obtain the approval of or complete any legal or regulatory filing with any governmental and&#47;or regulatory body in your country of residence (or country of employment, if different).  Alternatively, the Company may, in its sole discretion, settle the Units in the form of shares of Stock but require you to sell such Stock immediately or within a specified time following your termination of employment (in which case, this Agreement shall give the Company the authority to issue sales instructions on your behalf).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant&#8217;s Rights in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock, if and when issued to you pursuant to this Agreement, shall be registered in your name and evidenced in a manner as determined by the Company, in its sole discretion.  Under no circumstance will you be deemed, by virtue of the granting of the Units, to be a holder of any shares of Stock underlying the Units or be entitled to the rights or privileges of a holder of such shares of Stock (including the right to receive dividends or vote the shares of Stock), unless and until the Units have vested with respect to such shares of Stock and the shares of Stock have been issued to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event you terminate employment by reason of death, any Units that have not vested prior to the date of your death shall immediately vest and shares of Stock shall be issued in accordance with your will or the laws of descent and distribution.  Shares of Stock for Units which vest under this Section 4 will be delivered within sixty (60) days after your employment termination date.  </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you terminate employment by reason of your Retirement, any Units that have not vested prior to the date of your Retirement shall immediately vest and shares of Stock shall be issued to you, provided you have remained in continuous service with the Company or an Affiliate through the first anniversary of the Grant Date.  In the event that your Retirement occurs prior to the first anniversary of the Grant Date, all unvested Units shall immediately terminate and be forfeited in their entirety.  Shares of Stock for Units which vest under this Section 5 will be delivered within thirty (30) days after your employment termination date.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;In this regard, if you are a local national of and employed in a country that is a member of the European Union, the grant of the Units and the terms and conditions governing the Units are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;).  To the extent that a court or tribunal of competent jurisdiction determines that any provision of the Units is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.  &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you terminate employment by reason of your Disability (as the term is defined in the Plan or determined under local law), any Units that have not vested prior to the date of your termination by reason of Disability shall immediately vest and shares of Stock shall be issued to you.  Shares of Stock for Units which vest under this Section 6 will be delivered within thirty (30) days after your employment termination date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Termination of Employment&#59; Certain Vesting Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your employment terminates for any reason other than death, Retirement or Disability, any Units that have not vested prior to the date of your termination shall terminate and be forfeited on the effective date of such termination, except if your employment terminates for Cause, in which case, all unvested Units shall be forfeited upon notice to you of your termination for Cause.  Subject to Sections 4, 5 and 6 of this Agreement, the issuance of shares of Stock is conditioned on your continuous employment with the Company or an Affiliate through and on the applicable anniversary of the Grant Date as set forth in Section 2 above.  For purposes of the vesting conditions set forth in this Agreement, the effective date of your termination shall be deemed to be the last day of your active service with the Company or an Affiliate (if applicable).  Notwithstanding anything to the contrary in the Plan or this Agreement, and for purposes of clarity, the date of your termination of employment shall not be extended by any statutory or common law notice of termination period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event you are employed by the Company or an Affiliate at the time of a Change in Control, any Units that have not vested prior to the Change in Control shall immediately vest and shares of Stock will be issued to you immediately prior to the Change in Control&#59; provided, however, that if you have entered into a Change in Control agreement with the Company, the Units will vest according to the provisions of the Change in Control agreement.  In the event you have terminated employment with the Company or an Affiliate prior to a Change in Control as a result of death, Disability, or Retirement occurring on or after the first anniversary of the Grant Date, and the Change in Control occurs following your termination of employment, shares of Stock for any Units that have vested under Section 4, 5 or 6 but which have not yet been issued will be issued immediately prior to the Change in Control.  Notwithstanding the foregoing and unless otherwise specifically provided in any agreement of the Company or any of its Affiliates with you pertaining to the effect of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Change in Control on outstanding Awards which is in effect as of the Change in Control, if this Award is subject to and not exempt from the application of Section 409A of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and provides for settlement or payment upon a Change in Control, the definition of Change in Control shall be limited to events which qualify as a change in the ownership of a corporation within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(v), or a change in the ownership of a substantial portion of the assets of a corporation within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(vii)&#59; provided, however, that this requirement shall not cause an event that would not otherwise be considered a Change in Control under the definition of a Change in Control under the Plan to be considered a Change in Control.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Current Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant to the Company&#8217;s recoupment policy and to the extent permitted by governing law, the Board, in its discretion, may seek Recovery of the Award granted to you if you are a Current Executive Officer or Former Executive Officer and you, in the judgment of the Board, commit misconduct or a gross dereliction of duty that results in a material violation of Company policy and causes significant harm to the Company while serving in your capacity as Executive Officer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms, when used in this Section 9, shall have the meaning set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;&#8220;Current Executive Officer&#8221; means any individual currently designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange&#160; Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;&#8220;Executive Officer&#8221; means any Current Executive Officer or Former Executive Officer.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;&#8220;Former Executive Officer&#8221; means any individual previously (but not currently) designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange&#160; Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)&#160;&#160;&#160;&#160;&#8220;Recovery&#8221; means the forfeiture or cancellation of unvested Units.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Provisions Required by Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company subsequently determines that it is required by law to apply a &#8220;clawback&#8221; or alternate recoupment provision to outstanding Awards, under the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise, then such clawback or recoupment provision also shall apply to this Award, as applicable, as if it had been included on the Grant Date and the Company shall notify you of such additional provision.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration for Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock subject to the Units are intended to be issued for no cash consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not be obligated to issue any shares of Stock until (a) all federal, state and local laws and regulations, as the Company may deem applicable, have been complied with&#59; (b) the shares have been listed or authorized for listing upon official notice to the New York Stock Exchange, Inc. or have otherwise been accorded trading privileges&#59; and (c) all other legal matters in connection </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with the issuance and delivery of the shares have been approved by the Company&#8217;s legal department.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transferability&#59; Restrictions on Shares&#59; Legend on Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Until the vesting conditions of this Award have been satisfied and shares of Stock have been issued in accordance with the terms of this Agreement and any applicable Addendum or by action of the Committee, the Units awarded under this Agreement are not transferable and you shall not sell, transfer, assign, pledge, gift, hypothecate or otherwise dispose of or encumber the Units awarded under this Agreement.  Transfers of shares of Stock by you are subject to the Company&#8217;s Stock Trading Policy and applicable securities laws.  Shares of Stock issued to you in certificate form or to your book entry account upon satisfaction of the vesting and other conditions of this Award may be restricted from transfer or sale by the Company and evidenced by stop-transfer instructions upon your book entry account or restricted legend(s) affixed to certificates in the form as the Company or its counsel may require with respect to any applicable restrictions on sale or transfer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Satisfaction of Tax Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Regardless of any action the Company or the Affiliate that employs you (the &#8220;Employer&#8221;) (if applicable) takes with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge and agree that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and&#47;or the Employer (a)&#160;make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Units or the shares of Stock issued upon vesting of the Units, and (b) do not commit to structure the terms of the Award (or any aspect of the Units) to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Upon the issuance of shares of Stock or the satisfaction of any vesting condition with respect to the shares of Stock to be issued hereunder, if your country of residence (and&#47;or the country of employment, if different) requires withholding of Tax-Related Items, the Company may hold back from the total number of shares of Stock to be delivered to you, and shall cause to be transferred to the Company, whole shares of Stock that have an aggregate Fair Market Value sufficient to pay the Tax-Related Items required to be withheld with respect to the shares of Stock, or to the extent it would not result in adverse accounting treatment, the Company may, in its sole discretion, hold back shares of Stock based on a rate of up to the maximum applicable withholding rate. If the obligation for Tax-Related Items is satisfied by holding back shares of Stock to be delivered upon settlement of the Units, for tax purposes, you are deemed to have been issued the full number of shares of Stock subject to the Units, notwithstanding that a number of shares of Stock are held back solely for the purpose of paying the Tax-Related Items. You will have no further rights with respect to any shares of Stock that are retained by the Company pursuant to this provision.  By accepting the grant of the Units, you expressly consent to the withholding of shares of Stock and&#47;or cash as provided for hereunder.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Alternatively, you hereby authorize the Company (on your behalf and at your direction pursuant to this authorization) to immediately sell a sufficient whole number of shares of Stock acquired upon vesting resulting in sale proceeds sufficient to pay the Tax-Related Items required to be withheld.  You agree to sign any agreements, forms and&#47;or consents that reasonably may be requested by the Company (or the Company&#8217;s designated brokerage firm) to effectuate the sale of the shares of Stock (including, without limitation, as to the transfer of the sale proceeds to the Company to satisfy the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tax-Related Items required to be withheld).  Further, the Company or the Employer may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from your salary or any other amounts payable to you, with no withholding of shares of Stock or sale of shares of Stock, or may require you to submit a cash payment equivalent to the Tax-Related Items required to be withheld with respect to the Units.  &#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;All other Tax-Related Items related to the grant of the Units and any shares of Stock delivered in settlement thereof are your sole responsibility.  In no event shall whole shares be withheld by or delivered to the Company in satisfaction of any Tax-Related Items in excess of the maximum statutory tax withholding required by law.  You agree to indemnify the Company and its Affiliates against any and all liabilities, damages, costs and expenses that the Company and its Affiliates may hereafter incur, suffer or be required to pay with respect to the payment or withholding of any Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Units are intended to comply with or be exempt from the requirements of Code Section 409A.  The Plan and this Agreement shall be administered and interpreted in a manner consistent with this intent.  If the Company determines that the Agreement is subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, in its sole discretion, and without your consent, amend this Agreement to cause it to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notwithstanding any provision of this Agreement to the contrary, in the event that any settlement or payment of this Award occurs as a result of your termination of employment and the Company determines that you are a &#8220;specified employee&#8221; (as that term is defined under Code Section 409A) subject to Code Section 409A at the time your termination of employment, and provided further that such payment or settlement does not otherwise qualify for an applicable exemption from Code Section 409A, then no such settlement or payment shall be paid to you until the date that is the earlier to occur of&#58; (i) your death, or (ii) six (6) months and one (1) day following your termination of employment.  Any portion of this Award delayed as a result of the preceding sentence, which is (i) in whole or in part, settled in cash and (ii) based on the value of Stock, shall be based on the value of the Stock at the time the Award would have otherwise been settled or paid without application of the delay described in the preceding sentence.  If this Award does not otherwise qualify for an applicable exemption from Code Section 409A, the terms &#8220;Retirement&#8221;, &#8220;terminate,&#8221; &#8220;termination,&#8221; &#8220;termination of employment,&#8221; and variations thereof as used in this agreement, are intended to mean a termination of employment that constitutes a &#8220;separation from service&#8221; as such term is defined under Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any action or inaction by the Administrator, you are exclusively responsible for any tax consequences under Code Section 409A resulting from this Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation and Legal&#47;Tax Compliance Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you are resident or employed outside of the United States, you agree to repatriate all payments attributable to the shares of Stock and&#47;or cash acquired under the Plan (including, but not limited to, dividends and any proceeds derived from the sale of the shares of Stock acquired pursuant to the Units) in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different).  In addition, you agree to take any and all actions, and consent to any and all actions taken by the Company and the Employer, as may be required to allow the Company and the Employer to comply with local laws, rules and regulations in your country of residence (and country of employment, if different).  Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.  You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your  personal data as described in this Agreement and any other grant materials by and among, as applicable, the Employer, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;You understand that the Company and the Employer may hold certain personal information about you, including (but not limited to) your name, home address, email address and telephone number, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any shares of Stock or directorships held in the Company, and details of all Units awarded to you or any other entitlements to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor (&#8220;Data&#8221;) for the purpose of implementing, managing and administering the Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that Data may be transferred to any third parties assisting the Company with the implementation, administration and management of the Plan, including but not limited to E*TRADE Securities LLC (&#8220;E*TRADE&#8221;) or any successor or any other third party that the Company or E*TRADE (or its successor) may engage to assist with the administration of the Plan from time to time.  You understand the recipients of the Data may be located in your country, in the United States or elsewhere, and that the recipients&#8217; country may have different data privacy laws and protections than your country.  You understand that  you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative.  </font></div><div style="text-align:justify;text-indent:35.3pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares of Stock acquired upon vesting of the Units.  You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consents herein on a purely voluntary basis.  If you do not consent, or if you later revoke your consent, your employment status or service with the Employer will not be adversely affected&#59; the only consequence of refusing or withdrawing your consent is that the Company would not be able to grant you Units or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By participating in the Plan, you acknowledge, understand and agree that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Administrator at any time, to the extent permitted by the Plan&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the grant of the Units is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants or benefits in lieu of Units, even if Units have been granted in the past&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">all decisions with respect to future grants of Units, if any, will be at the sole discretion of the Administrator&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the grant of the Units and your participation in the Plan shall not create a right to employment or be interpreted as forming an employment or service contract with the Company, the Employer or Affiliate and shall not interfere with the ability of the Company, the Employer or any Affiliate, as applicable, to terminate your employment or service relationship (if any)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">you are voluntarily participating in the Plan&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">the Units are not intended to replace any pension rights or compensation&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Units, the underlying Shares, and the income and value of same are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar payments&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the future value of the underlying shares of Stock is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Units resulting from the termination of your employment or other service relationship (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">unless otherwise agreed with the Company in writing, the Units, the underlying shares of Stock and the income from and value of same are not granted as consideration for, or in connection with, any service you may provide as a director of an Affiliate&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">for purposes of the Units, your employment or other service relationship will be considered terminated as of the date you are no longer actively providing services to the Company or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, your right to vest in the Units under this Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., your period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; the Administrator shall have the exclusive discretion to determine when you are no longer actively providing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">services for purposes of the Unit grant (including whether you may still be considered to be providing services while on an approved leave of absence)&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the following provisions apply only if you are providing services outside the United States&#58; (A) the Units, the underlying shares of Stock, and the income from and value of same are not part of normal or expected compensation or salary for any purpose&#59; and (B) neither the Company, the Employer nor any Affiliate shall be liable for any foreign exchange rate fluctuation between your local currency and the U.S. dollar that may affect the value of the Units or of any amount due to you pursuant to the settlement of the Units or the subsequent sale of any shares of Stock acquired upon settlement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Public Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The grant of the Units under the Plan is not intended to be a public offering of securities in your country of residence (and country of employment, if different).  The Company has not submitted any registration statement, prospectus or other filings to the local securities authorities unless otherwise required under local law, and the grant of the Units is not subject to the supervision of the local securities authorities.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Advice Regarding Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No Employee of the Company is permitted to advise you regarding your participation in the Plan or your acquisition or sale of the shares of Stock subject to the Units.  Investment in shares of Stock involves a degree of risk.  Before deciding whether to participate in the Plan, you should carefully consider all risk factors relevant to the acquisition of shares of Stock under the Plan, and you should carefully review all of the materials related to the Units and the Plan.  You are hereby advised to consult with your own personal tax, legal and financial advisors before taking any action related to the Plan.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Intent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that the acquisition of the shares of Stock to be issued hereunder is for investment purposes without a view to distribution thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that, depending on your or your broker&#8217;s country of residence or where the shares of Stock are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws that may affect your ability to accept, acquire, sell or otherwise dispose of shares of Stock, rights to those shares of Stock (e.g., Units) or rights linked to the value of shares (e.g., phantom awards, futures) during such times you are considered to have &#8220;inside information&#8221; regarding the Company, as defined in the laws or regulations in your country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed insider information.  Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Keep in mind that third parties include fellow employees.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery of Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may, in its sole discretion, deliver any documents related to the Units and participation in the Plan or future grants of Units that may be granted under the Plan, by electronic means unless otherwise prohibited by local law.  You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">system established and maintained by the Company or a third party-designated by the Company. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are resident outside of the United States, you hereby acknowledge and agree that it is your express intent that this Agreement and any applicable Addendum, the Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Units, be drawn up in English. You acknowledge that you are proficient in the English language and understand the terms of this Agreement or have had the ability to consult with an advisor who is sufficiently proficient in the English language. If you have received this Agreement and any applicable Addendum, the Plan or any other documents related to the Units translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version will control.  </font></div><div style="padding-right:-12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision of this Agreement to the contrary, the Units shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) as are forth in the applicable addendum to the Agreement (the &#8220;Addendum&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in the Addendum to this Agreement, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  Any applicable Addendum shall constitute part of this Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;24.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator reserves the right to impose other requirements on the Units, any shares of Stock acquired pursuant to the Units and your participation in the Plan to the extent the Administrator determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local laws or to facilitate the administration of the Plan.  Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any legal notice necessary under this Agreement shall be addressed to the Company in care of its General Counsel at the principle executive offices of the Company and to you at the address appearing in the personnel records of the Company for you or to either party at such other address as either party may designate in writing to the other.  Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;26.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to the Plan&#59; Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Units granted pursuant to this Agreement and any applicable Addendum is subject to the Plan.  The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference.  This Agreement contains terms and provisions established by the Committee specifically for the grant described herein.  Unless the Committee has exercised its authority under the Plan to establish specific terms of an Award, the terms of the Plan shall govern.  Subject to the limitations set forth in the Plan, the Committee retains the right to alter or modify the Units granted pursuant to this Agreement as the Committee may determine are in the best interests of the Company.  You hereby accept the Units subject to all the terms and provisions of the Plan and this Agreement and agree that all decisions under, and interpretations of, the Plan and this Agreement by the Administrator, Committee or the Board shall be final, binding and conclusive upon you and your heirs and legal representatives.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;27.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The interpretation, performance and enforcement of this Agreement shall be governed by the laws of The Commonwealth of Massachusetts (without regard to the conflict of laws principles thereof) and applicable federal laws.  For purposes of litigating any dispute under the Agreement, including the Addendum, the parties hereby submit to and consent to the exclusive jurisdiction of The Commonwealth of Massachusetts and agree that such litigation shall be conducted only in the courts of Boston, or the federal courts for the United States for the District of Massachusetts and no other courts where the grant of the Units is made and&#47;or to be performed.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;28.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings contained in this Agreement are for convenience only and shall not affect the meaning or interpretation of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;29.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree that the provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You understand that the waiver by the Company with respect to your compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach of a provision of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;31.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be the one and the same instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company, by its duly authorized officer, and the Participant have executed and delivered this Agreement as a sealed instrument as of the date and year first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:right"><img alt="image_0.jpg" src="image_0.jpg" style="height:75px;margin-bottom:5pt;vertical-align:text-bottom;width:330px"></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BOSTON SCIENTIFIC CORPORATION</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO THE AWARD AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO RESTRICTED STOCK UNITS GRANTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE <br>AMENDED AND RESTATED 2011 LONG-TERM INCENTIVE PLAN</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the Plan and the Agreement, the Units are subject to the following additional terms and conditions.  All defined terms contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement.  Pursuant to Section&#160;23 of the Agreement, if you transfer your residence and&#47;or employment to another country reflected in the Addendum, the additional terms and conditions for such country (if any) will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EUROPEAN UNION (&#8220;EU&#8221;) &#47; EUROPEAN ECONOMIC AREA (&#8220;EEA&#8221;), UNITED KINGDOM AND SWITZERLAND&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision replaces Section 15 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Pursuant to applicable personal data protection laws, the Company and the Employer hereby notify you of the following in relation to your Personal Data (defined below) and the collection, processing and transfer in electronic or other form of such Personal Data in relation to the grant of the Units and your participation in the Plan.  The collection, processing and transfer of your Personal Data is necessary for the legitimate purpose of the Company and the Employer&#8217;s administration of the Plan and your participation in the Plan, and your denial and&#47;or objection to the collection, processing and transfer of Personal Data may affect your participation in the Plan.  As such, by accepting the Award, you acknowledge the collection, use, processing and transfer of Personal Data as described herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that the Company and the Employer hold certain personally identifiable information about you, specifically, your name, home address and telephone number, date of birth, social security number or other employee identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all Units or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of managing and administering the Plan (&#8220;Personal Data&#8221;).  The Personal Data may be provided by you to or collected, where lawful, from third parties.  The Company or the Employer each act as controllers of the Personal Data and will process the Personal Data in this context for the exclusive legitimate purpose of implementing, administering and managing your participation in the Plan and meeting related legal obligations associated with these actions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The processing will take place through electronic and non-electronic means according to logics and procedures correlated to the purposes for which the Personal Data was collected and with confidentiality and security provisions as set forth by applicable laws and regulations.  Personal Data will be accessible within the Company&#8217;s organization only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and other aspects of the employment relationship and for participation in the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company and the Employer will transfer Personal Data amongst themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan, and the Company and the Employer may each further transfer Personal Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan, including E*TRADE Securities LLC and its affiliates or any successor or other third party that the Company, the Employer or E*TRADE Securities LLC (or its successor) may engage to assist with the administration of the Plan from time to time.  These recipients may be located in the EU&#47;EEA, the United Kingdom, Switzerland or elsewhere throughout the world, such as the United States.  By participating in the Plan, you understand that these recipients may receive, possess, use, retain and transfer the Personal Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Personal Data as may be required for the administration of the Plan and&#47;or the subsequent holding of shares of Stock on your behalf to a broker or other third party with whom you may elect to deposit any shares of Stock acquired pursuant to the Plan.  You further understand that you may request a list with the names and addresses of any potential recipients of your Personal Data by contacting your local Human Resources manager or the Company&#8217;s Human Resources Department. When transferring Personal Data to these potential recipients, the Company and the Employer provide appropriate safeguards in accordance with EU Standard Contractual Clauses or other legally binding and permissible arrangements.  You may request a copy of such safeguards from your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">To the extent provided by law, you may, at any time, have the right to request&#58; access to Personal Data, rectification of Personal Data, erasure of Personal Data, restriction of processing of Personal Data, and portability of Personal Data.  You may also have the right to object, on grounds related to a particular situation, to the processing of Personal Data, as well as opt-out of the Plan herein, in any case without cost, by contacting in writing your Human Resources manager.  Your provision of Personal Data is a contractual requirement.  You understand, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to grant the Units to you, or grant other equity awards or administer or maintain such equity awards.  For more information on the consequences of your refusal to provide Personal Data, you understand that you may contact your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">When the Company and the Employer no longer need to use Personal Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Personal Data from their systems and&#47;or records containing the Personal Data and&#47;or take steps to properly anonymize it so that you can longer be identified from it.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Type of Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the grant of the Units, nor the issuance of shares of Stock subject to the grant, constitutes a public offering.  </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This grant is being made under Division 1A, Part 7.12 of the Australia Corporations Act (Cth).  Please note that if you offer shares of Stock for sale to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law. You should obtain legal advice on the relevant disclosure obligations prior to making any such offer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Breach of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Agreement or the Plan, you will not be entitled to, and shall not claim any benefit (including without limitation a legal right) under the Plan if the provision of such benefit would give rise to a breach of Part 2D.2 of the Corporations Act 2001 (Cth), any other provision of that Act, or any other applicable statute, rule or regulation which limits or restricts the giving of such benefits.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Plan is a program to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the &#8220;Act&#8221;) applies (subject to the conditions in that Act).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Units, you acknowledge that you agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the Units, the receipt of any dividends, and the sale of shares of Stock acquired under the Plan.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Policy and Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 16 of the Agreement&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Units, you agree that (i) the benefits provided under the Agreement and the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Agreement and the Plan are not a part of the terms and conditions of your employment&#59; and (iii) the income from the Units, if any, is not part of your remuneration from employment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Agreement or the Plan, all Units shall be settled only in shares of Stock (and shall not be settled in cash).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 15 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby authorize the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  You further authorize the Company, any Affiliate and the Administrator to disclose and discuss the Plan with their advisors.  You further authorize the Company and any Affiliate to record such information and to keep such information in your employee file.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are permitted to sell shares of Stock acquired under the Plan through the designated broker appointed under the Plan, if any, provided that the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">sale of shares of Stock takes place outside Canada through the facilities of a stock exchange on which the shares are listed (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the New York Stock Exchange).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision supplements Section 16(k) of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of the Units, your employment or service relationship will be considered terminated as of the earliest of&#58;  (a) the date that your employment or service relationship with the Company or one of its Affiliates is terminated&#59; (b) the date that you receive a notice of termination of employment or service&#59; and (c)&#160;the date upon which you cease to actively provide services, regardless of any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under local law. You will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. The Administrator shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of the Unit grant (including whether you may still be considered to be providing services while on a leave of absence). Notwithstanding the foregoing, if applicable employment legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the Units, if any, will terminate effective as of the last date of the minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">French Language Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision will apply if you are a resident of Quebec&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A French translation of this Agreement and certain other documents related to the Units will be made available to you as soon as reasonably practicable. You understand that, from time to time, additional information related to the Units may be provided in English and such information may not be immediately available in French. However, upon request, the Company will provide a translation of such information into French as soon as reasonably practicable.&#160; Notwithstanding anything to the contrary in the Agreement, and unless you indicate otherwise, the French translation of this Agreement and certain other documents related to the Units will govern your participation in the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHILE</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The offer of the Units constitutes a private offering of securities in Chile effective as of the Grant Date. This offer of Units is made subject to general ruling N&#176; 336 of the Commission for the Financial Market (Comisi&#243;n para el Mercado Financiero, &#8220;CMF&#8221;). The offer refers to securities not registered at the securities registry or at the foreign securities registry of the CMF, and, therefore, such securities are not subject to oversight of the CMF. Given that the Units are not registered in Chile, the Company is not required to provide public information about the Units or the shares of Stock in Chile. Unless the Units and&#47;or the shares of Stock are registered with the CMF, a public offering of such securities cannot be made in Chile.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Esta oferta de Unidades de Acciones Restringidas (&#8220;Units&#8221;) constituye una oferta privada de valores en Chile y se inicia en la Fecha de la Concesi&#243;n. Esta oferta de Units se acoge a las disposiciones de la Norma de Car&#225;cter General N&#186; 336 (&#8220;NCG 336&#8221;) de la Comisi&#243;n para el Mercado Financiero de Chile (&#8220;CMF&#8221;). Esta oferta versa sobre valores no inscritos en el Registro de Valores o en el Registro de Valores Extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta. Por tratarse los Units de valores no registrados en Chile, no existe obligaci&#243;n por parte de la Compa&#241;&#237;a de entregar en Chile informaci&#243;n p&#250;blica respecto de los Units or sus Acciones. Estos valores no podr&#225;n ser objeto de oferta p&#250;blica en Chile mientras no sean inscritos en el Registro de Valores correspondiente.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHINA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The following provisions govern your participation in the Plan if you are a national of the People&#8217;s Republic of China (&#8220;China&#8221;) resident in mainland China, as determined by the Company in its sole discretion&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares of Stock Must Be Held with Designated Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All shares of Stock issued upon settlement of your Units will be deposited into a personal brokerage account established with the Company&#8217;s designated broker, E*TRADE (or any successor broker designated by the Company), on your behalf.  You understand that you may sell the shares of Stock at any time after they are deposited in such account, however, you may not transfer the shares of Stock out of the brokerage account. If the Company changes its designated broker, you acknowledge and agree that the Company may transfer any shares of Stock issued under the Plan to the new designated broker, if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer of shares of Stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Sale of Shares Following Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You are required to sell all shares of Stock acquired upon vesting of the Units no later than 90 days following your termination of employment with the Company and its Affiliates (or such earlier date as may be required by the China State Administration of Foreign Exchange (&#8220;SAFE&#8221;)), in which case, this Addendum shall give the Company the authority to issue sales instructions on your behalf).  If any shares remain outstanding on the 90th day following your employment termination date (or such earlier date as may be required by SAFE), you hereby direct, instruct and authorize the Company to issue sale instructions on your behalf.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You agree to sign any additional agreements, forms and&#47;or consents that reasonably may be requested by the Company (or the Company&#8217;s designated brokerage firm) to effectuate the sale of the shares of Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange control matters noted below) and shall otherwise cooperate with the Company with respect to such matters. You acknowledge that neither the Company nor the designated brokerage firm is under any obligation to arrange for such sale of shares of Stock at any particular price (it being understood that the sale will occur in the market) and that broker&#8217;s fees and similar expenses may be incurred in any such sale.  In any event, when the shares of Stock are sold, the sale proceeds, less any tax withholding, any broker&#8217;s fees or commissions, and any similar expenses of the sale will be remitted to you in accordance with applicable exchange control laws and regulations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You understand and agree that, pursuant to local exchange control requirements, you will be required immediately to repatriate to China the proceeds from the sale of any shares of Stock acquired under the Plan.  You further understand that such repatriation of proceeds may be effected through a special bank account established by the Company or its Affiliate, and you hereby consent and agree that proceeds from the sale of shares of Stock acquired under the Plan may be transferred to such account by the Company on your behalf prior to being delivered to you and that no interest shall be paid with respect to funds held in such account.  The proceeds may be paid to you in U.S. dollars or local currency at the Company&#8217;s discretion.  If the proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds may be deposited into such account.  If the proceeds are paid to you in local currency, you acknowledge that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the proceeds to local currency due to exchange control restrictions.  You agree to bear any currency fluctuation risk between </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the time the shares of Stock are sold and the net proceeds are converted into local currency and distributed to you.  You further agree to comply with any other requirements that may be imposed by the Company in the future in order to facilitate compliance with exchange control requirements in China.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not be liable for any costs, fees, lost interest or dividends or other losses you may incur or suffer resulting from the enforcement of the terms of this Addendum or otherwise from the Company&#8217;s operation and enforcement of the Plan, the Agreement and the Award in accordance with Chinese law including, without limitation, any applicable SAFE rules, regulations and requirements.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The above requirements will not apply to non-Chinese nationals, unless otherwise required by the Company or by SAFE.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BY ELECTRONICALLY ACCEPTING THIS AGREEMENT, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE TERMS AND CONDITIONS OF THE PLAN, THE AGREEMENT AND THIS ADDENDUM.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 16 of the Agreement&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose.  Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock are not and will not be registered with the Colombian registry of publicly held securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and, therefore, the shares of Stock may not be offered to the public in Colombia.  Nothing in the Agreement should be construed as making a public offer of securities in Colombia.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CZECH REPUBLIC</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Units upon Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provisions in the Agreement to the contrary, the treatment of the Units upon your termination of employment shall be governed by the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the &#8220;Stock Option Act&#8221;), as in effect at the time of your termination of employment (as determined by the Administrator, in its discretion, in consultation with legal counsel). You acknowledge having received an &#8220;Employer Information Statement&#8221; in Danish, which is provided to comply with the Stock Option Act.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Type of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Units are granted as French-Qualified Restricted Stock Units and are intended to qualify for the special tax and social security treatment applicable to shares of Stock granted for no consideration under Sections L. 225-197-1 to L. 225-197-5  and Sections L.&#160;22-10-59 to L. 22-10-60 of the French Commercial Code, as amended. The Award is granted subject to the terms and conditions of the Rules of the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan French Sub-Plan (the &#8220;French Sub-Plan&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms not defined herein, the Agreement or the Plan shall have the meanings ascribed to them in the French Sub-Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Certain events may affect the status of the Units as French-Qualified RSUs or the underlying shares of Stock, and the Award or the underlying shares of Stock may be disqualified in the future.  The Company does not make any undertaking or representation to maintain the qualified status of the French-Qualified RSUs or of the underlying shares of Stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Restrictions on Sale or Transfer of Shares of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Minimum Vesting&#47;Issuance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award will vest according to the vesting schedule set forth in the Equity Award and Acceptance Summary, provided, however, that under no circumstances will shares of Stock underlying the Award be issued and delivered to a French Participant prior to the expiration of such period as is required to comply with the minimum mandatory period applicable to the Award under Section L. 225-197-1 of the French Commercial Code, as amended, the relevant sections of the French Tax Code and&#47;or the relevant sections of the French Social Security Code, as amended, except in the case of your death. The minimum mandatory period is currently one (1) year from the Grant Date.  </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Minimum Mandatory Holding Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You may not sell or transfer the shares of Stock acquired upon vesting of the Award until such time as is required to comply with the minimum mandatory holding period applicable to the Award under Section L. 225-197-1 of the French Commercial Code, as amended, the relevant sections of the French Tax Code and&#47;or the relevant sections of the French Social Security Code, as amended, except in the case of your death or Disability (as defined in the French Sub-Plan). The minimum mandatory holding period is currently two (2) years from the Grant Date.  </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except in the case of your termination of employment due to death or Disability (as defined in the French Sub-Plan), the minimum mandatory holding period restriction will continue to apply even if you are no longer an Employee.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Closed Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You may not sell any Stock issued upon vesting of the Award during certain Closed Periods, to the extent applicable to the Stock underlying the Award granted by the Company, as described in the French Sub-Plan. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Termination of Service Due to Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of your death, your heirs may request the issuance of the Stock underlying any French-Qualified RSUs that have not vested prior to your death subject to the Award within six (6) months from the date of your death. If your heirs do not request the shares of Stock within six (6) months from the date of your death, the Award will be forfeited.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that it is your express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Utilisation de la langue anglaise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. Vous reconnaissez et acceptez qu&#8217;il est de votre volont&#233; que le pr&#233;sent accord, ainsi que tous documents, toutes notifications et toutes proc&#233;dures judiciaires conclues, re&#231;ues ou intent&#233;es en vertu des pr&#233;sentes ou s&#8217;y rapportant directement ou indirectement, soient r&#233;dig&#233;s en anglais.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GREECE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Agreement, Addendum or the Plan, the Units shall be settled only in shares of Stock (and may not be settled in cash).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, for any reason, shares of Stock are issued to you within six months after the Grant Date, you agree that you will not sell or otherwise dispose of any such shares of Stock prior to the six-month anniversary of the Grant Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">IMPORTANT NOTICE&#47;WARNING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The contents of this document have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of the documents, you should obtain independent professional advice. The Units and shares of Stock issued at vesting do not constitute a public offering of securities under Hong Kong law and are available only to employees of the Company or its Affiliates. The Agreement, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a &#8220;prospectus&#8221; for a public offering of securities under the applicable securities legislation in Hong Kong. The Units are intended only for the personal use of each eligible employee of the Employer, the Company or any Affiliate and may not be distributed to any other person.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Wages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Units and shares of Stock subject to the Units do not form part of your wages for the purposes of calculating any statutory or contractual payments under Hong Kong law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company specifically intends that the Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;).  To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the Units shall be null and void.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forced Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Due to regulatory requirements in India, the Company reserves the right to require that you sell all shares of Stock delivered to you, either immediately upon receipt of such shares of Stock or upon your termination of employment. In this regard, you agree that the Company is authorized to instruct E*TRADE or any successor or other third party that the Company may engage to assist with the administration of the Plan from time to time, to assist with any such mandatory sale of shares of Stock (on your behalf pursuant to this authorization), and you expressly authorize the designated broker to complete the sale of such shares of Stock.&#160;You also agree to sign any agreements, forms and&#47;or consents that may be reasonably requested by the Company (or the designated broker) to effectuate the sale of the shares of Stock and shall otherwise cooperate with the Company with respect to such matters, provided that you shall not be permitted to exercise any influence over how, when or whether the sales occur.&#160;You acknowledge that E*TRADE or subsequent designated broker is under no obligation to arrange for the sale of the shares of Stock at any particular price. Due to fluctuations in the Stock price and&#47;or applicable exchange rates between the date the shares of Stock are delivered to you and (if later) the date on which the shares of Stock are sold, the amount of proceeds ultimately distributed to you may be more or less than the market value of the shares of Stock on the relevant vesting date or the date on which the shares are delivered to you.&#160; Upon the sale of the shares of Stock, the cash proceeds from the sale of shares of Stock (less any applicable Tax-Related Items, brokerage fees or commissions) will be delivered to you in accordance with applicable laws and regulations, as determined by the Company in its sole discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Alternatively, depending on applicable regulatory requirements then in effect, the Company reserves the discretion to determine whether to settle any vested Units in cash.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDONESIA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Agreement or the Plan, all Units shall be settled only in shares of Stock (and shall not be settled in cash).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ISRAEL</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">102 Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Units are granted to you pursuant to the Israeli Sub-Plan to the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Israeli Sub-Plan&#8221;), and are subject to the terms and conditions stated in the Israeli Sub-Plan, the Plan, and the Agreement, including this Addendum. By accepting the Units, you acknowledge and agree to be bound by the terms of the Israeli Sub-Plan and consent to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the terms of the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> &#8220;Consent Letter - 102 Capital Gain Awards&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Consent Letter&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  If you do not affirmatively accept the Units (and accordingly, the terms of the Israeli Sub-Plan, the Agreement and the Consent Letter) within ninety (90) days after the Grant Date, the Units may not qualify under the capital gain tax treatment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Until further election by the Company, the Units and any shares of Stock received upon vesting of the Units are intended to qualify for the tax treatment available in Israel pursuant to the provisions of the &#8220;capital gain track&#8221; under Section 102 (&#8220;Section 102&#8221;) of the Israeli Income Tax Ordinance &#91;New Version&#93;, 1961 (the &#8220;ITO&#8221;), including the provisions of the Income Tax Rules (Tax Benefits in Shares Issuance to Employees), 2003 and any Tax Ruling. However, in the event the Units do not meet the requirements of Section 102 of the ITO, such Units and the underlying shares of Stock shall not qualify for the favorable tax treatment under the capital gain track. The Company makes no representations or guarantees that the Units will qualify for favorable tax treatment and will not be liable or responsible if favorable tax treatment is not available under Section 102.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Units are subject to the trust (the &#8220;Trust&#8221;) established by the trust and services agreement (the &#8220;Trust Agreement&#8221;) with ESOP Management and Trust Services Ltd. (the &#8220;Trustee&#8221;).  To receive the tax treatment provided for in Sections 102(b)(2) and 102(b)(3) of the ITO, shares of Stock acquired by you upon vesting of the Units will be issued directly to the Trustee or controlled by the Trustee under a supervisory trustee arrangement, and will be held by the Trustee on your behalf or controlled by the Trustee at least until the end of the Required Holding Period (as defined in the Israeli Sub-Plan), which is currently twenty-four (24) months from the Grant Date, or any other period determined under the ITO as now in effect or as hereafter amended or by the Israeli Income Tax Authority. Subject to the conclusion of the Required Holding Period and any further period included herein, shares of Stock acquired by you upon vesting of the Units will be held or controlled by the Trustee until their sale, unless you request to release the shares of Stock to your direct holding, in which case the release will be subject to the receipt by the Trustee of an acknowledgment from the Israeli Income Tax Authority that you have paid all applicable taxes due pursuant to the ITO and Section 102, or the Trustee withholds any applicable tax due pursuant to the ITO and Section 102. You will not be permitted to elect to sell or release any shares of Stock acquired upon vesting of the Units prior to the conclusion of the Required Holding Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company may at its sole discretion replace the Trustee from time to time and instruct the transfer of all Units and shares of Stock held and&#47;or administered by such Trustee at such time to its successor and the provisions of your Agreement shall apply to the new Trustee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any and all Tax-Related Items due in relation to the Units and shares of Stock shall be borne solely by you and in the event of death, by your heirs. The Company, the Employer and&#47;or the Trustee shall withhold Tax-Related Items according to the requirements under the applicable laws, the rules, and regulations, including withholding Tax-Related Items at source. Furthermore, you hereby agree to indemnify the Company, the Employer and&#47;or the Trustee and hold them harmless against and from any and all liability for any such Tax-Related Items or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such Tax-Related Items from any payment made to you. The Company, the Employer and&#47;or the Trustee, to the extent permitted by law, shall have the right to deduct from any payment otherwise due to you, or from proceeds of the sale of any shares of Stock, an amount equal to any Tax-Related Items required by law to be withheld with respect to such shares of Stock. You </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will pay to the Company, the Employer or the Trustee any Tax-Related Items that the Company, the Employer or the Trustee may be required to withhold with respect to any shares of Stock that cannot be satisfied by the means previously described. The Company may refuse to deliver any shares of Stock if you fail to comply with your obligations in connection with the Tax-Related Items as described in this section. Any fees associated with any vesting, sale, transfer or any act in relation to the Units and the shares of Stock, shall be borne by you. The Trustee, the Company and&#47;or the Employer shall be entitled to withhold or deduct such fees from payments otherwise due to&#47;from the Company, the Employer or the Trustee.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; The Company has obtained from the Israel Securities Authority an exemption from the requirement to file a prospectus in relation to the Plan. Copies of the Plan and the Form S-8 registration statement for the Plan filed with the U.S. Securities and Exchange Commission are available by contacting your local human resources manager.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision supplements Section 16 of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further acknowledge that you have read and specifically and expressly approve the following sections of the Agreement&#58;  Vesting, Other Termination of Employment, Certain Vesting Conditions, Recoupment Policy, Issuance of Stock, Satisfaction of Tax Obligations, Nature of Grant, and Choice of Law and Venue.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">KAZAKHSTAN</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This offer is addressed only to certain eligible employees of the Company and its Affiliates in the form of shares of Stock to be issued by the Company, subject to the terms and conditions of the Agreement and the Plan. Neither the Plan nor the Agreement has been approved, nor do they need to be approved, by the National Bank of Kazakhstan. This offer is intended only for the original recipient and is not for general circulation in the Republic of Kazakhstan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LEBANON</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Plan does not constitute the marketing or offering of securities in Lebanon pursuant to Law No. 161 (2011), the Capital Markets Law.  Offerings under the Plan are being made only to eligible employees of the Company and its Affiliates.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MALAYSIA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Conditioned upon Election to Pay Taxes Directly to the Malaysian Inland Revenue Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You understand and agree that your Award is conditioned upon your completing, signing and submitting a letter to your Employer, indicating your election to pay any income tax or other tax liability arising in connection with taxable income recognized under the Plan directly to the Malaysian Inland Revenue Board.  (You may contact your Employer to request a form letter for this purpose.)  You understand that if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">you fail to file such an election letter with your Employer, your Award will be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consent to Collection, Processing and Transfer of Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This provision replaces Section 15 of the Agreement in its entirety&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data, as described in this Addendum and any other grant materials by and among, as applicable, the Company and Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan. </font></div><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that the Company and Affiliates may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all Units or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  The Data is supplied by the Company and also by you through information collected in connection with the Agreement and the Plan.   </font></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:126%">You understand that Data will be transferred to the current stock plan service providers or a stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country. You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +(65) 6418 8817.  You authorize the Company, the stock plan service provider and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any transfer of such Data as may be required to a broker, escrow agent or other third party with whom the shares of Stock received upon vesting of the  Units may be deposited.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, limit the processing of Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consent herein on a purely voluntary basis.  If you do not consent, or if you later seek to revoke your consent, your employment status or service and career with the Company will not be adversely affected&#59; the only adverse consequence of refusing or withdrawing your consent is that the Company may not be able to grant you Units or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Please take note that by electronically accepting this Agreement, you have confirmed that you explicitly, voluntarily and unambiguously consent to the collection, use and transfer of your personal data in accordance with the terms in this notification. However, if for any reason you do not consent to the processing of your personal data, you have the right to reject such consent by contacting your local human resources representative&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6418</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8817.</font></div></td><td colspan="3" style="border-bottom:0.5pt dotted #000000;border-left:0.5pt dotted #000000;border-right:0.5pt dotted #000000;border-top:0.5pt dotted #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda dengan ini secara eksplisit dan tanpa sebarang keraguan mengizinkan pengumpulan, penggunaan dan pemindahan, dalam bentuk elektronik atau lain-lain, data peribadi anda seperti yang diterangkan dalam Lampiran ini dan apa-apa bahan pemberian unit saham terhad yang lain oleh dan di antara, seperti yang berkenaan, Syarikat dan Ahli Gabungan untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan penyertaan anda di dalam Pelan. </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda memahami bahawa Syarikat Ahli Gabungan mungkin memegang maklumat peribadi tertentu tentang anda, termasuk, tetapi tidak terhad kepada, nama anda, alamat rumah dan nombor telefon, tarikh lahir, nombor insurans sosial atau nombor pengenalan lain, gaji, kewarganegaraan, jawatan, apa-apa syer saham Biasa atau jawatan pengarah yang dipegang dalam Syarikat, butir-butir semua unit saham terhad, atau apa-apa hak lain atas syer Biasa saham yang dianugerahkan,  dibatalkan, dilaksanakan, terletak hak, tidak diletak hak ataupun yang belum dijelaskan bagi faedahanda, untuk tujuan eksklusif bagi melaksanakan, mentadbir dan menguruskan Pelan tersebut (&#8220;Data&#8221;). Data tersebut dibekalkan oleh Syarikat dan juga oleh anda berkenaan dengan Perjanjian dan Pelan.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Anda memahami bahawa Data ini akan dipindahkan kepada pembekal perkhidmatan pelan saham semasa atau pembekal perkhidmatan pelan saham yang mungkin dipilih oleh Syarikat pada masa depan, yang membantu Syarikat dengan pelaksanaan, pentadbiran dan pengurusan Pelan. Anda memahami bahawa penerima-penerima Data mungkin berada di Amerika Syarikat atau mana-mana tempat lain, dan bahawa negara penerima-penerima (contohnya, Amerika Syarikat) mungkin mempunyai undang-undang privasi data dan perlindungan yang berbeza daripada negara anda. Anda memahami bahawa sekiranya anda menetap di luar Amerika Syarikat, anda boleh meminta satu senarai yang mengandungi nama-nama dan alamat-alamat penerima-penerima Data yang berpotensi dengan menghubungi wakil sumber manusia tempatan anda&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">6418</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">8817. Anda memberi kuasa kepada Syarikat, pembekal perkhidmatan pelan saham dan mana-mana penerima-penerima kemungkinan lain yang mungkin akan membantu Syarikat (pada masa sekarang atau pada masa depan) dengan melaksanakan, mentadbir dan menguruskan Pelan untuk menerima, memiliki, menggunakan, mengekalkan dan memindahkan Data, dalam bentuk elektronik atau lain-lain, bagi tujuan melaksanakan, mentadbir dan menguruskan penyertaan anda  di dalam Pelan, termasuk segala pemindahan Data tersebut sebagaimana yang dikehendaki kepada broker, egen eskrow atau pihak ketiga  dengan siapa syer Biasa saham diterima semasa peletakhakan saham terhad unit mungkin didepositkan.  Anda memahami bahawa Data hanya akan disimpan selagi ia adalah diperlukan untuk melaksanakan, mentadbir, dan menguruskan penyertaan anda dalam Pelan. Anda memahami bahawa sekiranya anda menetap di luar Amerika Syarikat, anda boleh, pada bila-bila masa, melihat Data, meminta maklumat tambahan mengenai penyimpanan dan pemprosesan Data, meminta bahawa pindaan-pindaan dilaksanakan ke atas Data, mengehadkan pemprosean Data atau menolak atau menarik balik persetujuan dalam ini, dalam mana-mana kes, tanpa kos, dengan menghubungi secara bertulis wakil sumber manusia tempatan.  Selanjutnya, anda memahami bahawa anda memberikan persetujuan di sini secara sukarela semata-mata. Sekiranya anda tidak bersetuju, atau sekiranya anda kemudian membatalkan persetujuan anda, status pekerjaan atau perkhidmatan dan kerjaya anda dengan Syarikat tidak akan terjejas&#59; satu-satunya akibat buruk sekiranya anda tidak bersetuju atau menarik balik persetujuan andaadalah bahawa Syarikat tidak akan dapat memberikan unit saham terhad anda atau anugerah ekuiti lain atau mentadbir atau mengekalkan anugerah-anugerah tersebut. Oleh itu, anda memahami bahawa keengganan atau penarikan balik persetujuan anda boleh menjejaskan keupayaan anda untuk mengambil bahagian dalam Pelan. Untuk maklumat lebih lanjut mengenai akibat-akibat keengganan anda untuk memberikan keizinan atau penarikan balik keizinan, anda memahami bahawa anda boleh menghubungi wakil sumber manusia tempatan.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Sila ambil perhatian bahawa dengan menerima Perjanjian ini secara elektronik, anda mengesahkan bahawa anda secara eksplisit, sukarela, dan tanpa sebarang keraguan bersetuju dengan pengumpulan, penggunaan, dan pemindahan data peribadi anda mengikut terma-terma dalam notis ini. Walaubagaimanapun, jika atas apa-apa sebab-sebab tertentu anda tidak bersetuju dengan pemprosesan data peribadi anda, anda mempunyai hak untuk menolak persetujuan anda dengan menghubungi wakil sumber manusia tempatan anda&#58; Shu Li Lee, Boston Scientific Asia Pacific Pte Ltd, Suite 20-01, Metropolis Tower One, 9 North Buona Vista Drive, Singapore 138588&#59; +</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">6418</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">8817.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You expressly recognize and acknowledge that the Company&#8217;s grant of the Units and the underlying shares of Stock under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico.  In addition, the Plan, the Agreement and any other document relating to the Units may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of the Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Units, you acknowledge that you have received a copy of the Plan and the Agreement, including this Addendum, which you have reviewed.  You further acknowledge that you accept all the provisions of the Plan and the Agreement, including this Addendum.  You also acknowledge that you have read and specifically and expressly approve the terms and conditions set forth in the &#8220;Nature of Grant&#8221; section of the Agreement, which clearly provide as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Your participation in the Plan does not constitute an acquired right&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;The Plan and your participation in it are offered by the Company on a wholly discretionary basis&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Your participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;The Company and its Affiliates are not responsible for any decrease in the value of any shares of Stock acquired at vesting of the Units. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Reconocimiento del Contrato</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  Al aceptar los Unidades, usted reconoce que ha recibido una copia del Plan y del Contrato con inclusi&#243;n de este Ap&#233;ndice, que le ha examinado. Usted reconoce, adem&#225;s, que usted acepta todas las disposiciones del Plan y del Contrato.  Usted tambi&#233;n reconoce que ha le&#237;do y, concretamente, y aprobar de forma expresa los t&#233;rminos y condiciones establecidos en la &#8220;Naturaleza del Otorgamiento&#8221; que claramente dispone lo siguiente&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(1)&#160;&#160;&#160;&#160;Su participaci&#243;n en el Plan no constituye un derecho adquirido&#59;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(2)&#160;&#160;&#160;&#160;El Plan y su participaci&#243;n en el Plan se ofrecen por Boston Scientific Corporation en su totalidad sobre una base discrecional&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(3)&#160;&#160;&#160;&#160;Su participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(4)&#160;&#160;&#160;&#160;Boston Scientific Corporation y sus afiliadas no son responsables de ninguna disminuci&#243;n en el valor de las acciones adquiridas en la adquisici&#243;n de los Unidades.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Acknowledgement and Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Units, you acknowledge that Boston Scientific Corporation, with registered offices at </font><font style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">300 Boston Scientific Way, Marlborough, Massachusetts 01752</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, United States of America, is solely </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">responsible for the administration of the Plan.  You further acknowledge that your participation in the Plan, the grant of Units and any acquisition of shares of Stock under the Plan do not constitute an employment relationship between you and Boston Scientific Corporation because you are participating in the Plan on a wholly commercial basis and your sole employer is a Mexican legal entity (&#8220;Boston Scientific-Mexico&#8221;).  Based on the foregoing, you expressly acknowledge that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and the Employer, Boston Scientific-Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Boston Scientific-Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is the result of a unilateral and discretionary decision of Boston Scientific Corporation, therefore, Boston Scientific Corporation reserves the absolute right to amend and&#47;or discontinue your participation in the Plan at any time, without any liability to you.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve to you any action or right to bring any claim against Boston Scientific Corporation for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and that you therefore grant a full and broad release to Boston Scientific Corporation, its Affiliates, branches, representation offices, shareholders, officers, agents and legal representatives, with respect to any claim that may arise. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Reconocimiento de Ausencia de Relaci&#243;n Laboral y Declaraci&#243;n de la Pol&#237;tica</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  Al aceptar los Unidades, usted reconoce que Boston Scientific Corporation, con oficians registradas on </font><font style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">300 Boston Scientific Way, Marlborough, Massachusetts 01752</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">, Estados Unidos de Am&#233;rica, es el &#250;nico responsable de la administraci&#243;n del Plan.  Adem&#225;s, usted acepta que su participaci&#243;n en el Plan, la concesi&#243;n de los Unidades y cualquier adquisici&#243;n de acciones en el marco del Plan no constituyen una relaci&#243;n laboral entre usted y Boston Scientific Corporation porque usted est&#225; participando en el Plan en su totalidad sobre una base comercial y su &#250;nico empleador es una sociedad mercantil Mexicana (&#8220;Boston Scientific-Mexico&#8221;).  Derivado de lo anterior, usted expresamente reconoce que el Plan y los beneficios que pueden derivarse de la participaci&#243;n en el Plan no establece ning&#250;n derecho entre usted y su Empleador, Boston Scientific-Mexico, y que no forman parte de las condiciones de empleo y &#47; o prestaciones previstas por Boston Scientific-Mexico, y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de su contrato no constituir&#225; un cambio o deterioro de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Adem&#225;s, usted entiende que su participaci&#243;n en el Plan es causada por una decisi&#243;n discrecional y unilateral de Boston Scientific Corporation, por lo que Boston Scientific Corporation se reserva el derecho absoluto a modificar y&#47;o suspender su participaci&#243;n en el Plan en cualquier momento, sin responsabilidad alguna para con usted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Finalmente, usted manifiesta que no se reserva ninguna acci&#243;n o derecho que origine una demanda en contra de Boston Scientific Corporation, por cualquier compensaci&#243;n o da&#241;o en relaci&#243;n con cualquier disposici&#243;n del Plan o de los beneficios derivados del mismo, y en consecuencia usted otorga un amplio y total finiquito a Boston Scientific Corporation, sus afiliadas, sucursales, oficinas de representaci&#243;n, sus accionistas, directores, agentes y representantes legales con respecto a cualquier demanda que pudiera surgir.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Units, you hereby waive any and all rights to compensation or damages as a result of the termination of employment with the Company and the Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the Plan, or (b) your ceasing to have rights under, or ceasing to be entitled to any awards under the Plan as a result of such termination.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Warning</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is an offer of Units which, upon vesting and settlement in accordance with the terms of the Plan and the Agreement, will be converted into shares of Stock. Shares of Stock give you a stake in the ownership of Boston Scientific Corporation. You may receive a return if dividends are paid.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If Boston Scientific Corporation runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference shares have been paid.  You may lose some or all of your investment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">New Zealand law normally requires people who offer financial products to give information to investors before they invest.  This information is designed to help investors to make an informed decision.  The usual rules do not apply to this offer because it is made under an employee share purchase scheme.  As a result, you may not be given all the information usually required.  You will also have fewer other legal protections for this investment. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ask questions, read all documents carefully, and seek independent financial advice before committing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to the vesting and settlement of the Units, you will not have any rights of ownership (e.g., voting or dividend rights) with respect to the underlying shares of Stock. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No interest in any Units may be transferred (legally or beneficially), assigned, mortgaged, charged or encumbered.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The shares of Stock are quoted on the New York Stock Exchange.  This means that if you acquire shares of Stock under the Plan, you may be able to sell them on the New York Stock Exchange if there are interested buyers.  You may get less than you invested.  The price will depend on the demand for the shares of Stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You also are hereby notified that the documents listed below are available for review on sites at the web addresses listed below&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation&#8217;s most recent Annual Report (Form 10-K)&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.sec.gov&#47;cgi-bin&#47;browse-edgar&#63;CIK&#61;bsx&#38;owner&#61;exclude&#38;action&#61;getcompany&#38;Find&#61;Search.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation&#8217;s most recent published financial statements (Form 10-Q or 10-K) and the auditor&#8217;s report on those financial statements&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">www.sec.gov&#47;cgi-bin&#47;browse-edgar&#63;CIK&#61;bsx&#38;owner&#61;exclude&#38;action&#61;getcompany&#38;Find&#61;Search.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">The Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan&#58;  This document can be accessed at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;us.etrade.com&#47;home</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation Restricted Stock Unit Award Agreement and Amended and Restated 2011 Long-Term Incentive Plan Q&#38;A Summary Sheet&#58;  This document can be accessed at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;us.etrade.com&#47;home</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation Equity Award and Acceptance Summary&#58; This document can be accessed at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;us.etrade.com&#47;home</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the above documents will be sent to you free of charge on written request being mailed to&#58;  Boston Scientific Corporation, Corporate Compensation, 300 Boston Scientific Way, Marlborough, MA 01752, USA.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NORWAY</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERU</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The grant of Units is considered a private offering in Peru&#59; therefore, it is not subject to registration. For more information concerning the grant, you acknowledge that you should refer to the Plan, the Agreement, and any other materials made available by the Company.&#160;For more information regarding the Company, you acknowledge that you should refer to the Company&#8217;s most recent annual report on Form&#160;10-K and quarterly report on Form 10-Q available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Acknowledgement of Nature of Plan and the Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the Units, you understand, acknowledge and agree that the Units are being granted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ex gratia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> by the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PHILIPPINES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant Section 2 of the Agreement, the Company shall settle your Units in the form of a cash payment unless, at the time of vesting, share settlement does not trigger the need for any approval from and&#47;or filing with the Philippines Securities and Exchange Commission.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and the Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Conhecimento da Lingua</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  Por meio do presente, eu declaro expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que li, compreendi e livremente aceitei e concordei com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the grant of Units, you acknowledge that you are proficient in reading and understanding English and fully understand the terms of the documents related to the grant (the Agreement and the Plan), which were provided in the English language.&#160;You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consimtamant cu Privire la Limba</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. Accept&#226;nd acordarea unit&#259;&#539;ilor de Unit-uri, recunoa&#537;te&#539;i c&#259; sunte&#539;i competen&#539;i &#238;n citirea &#537;i &#238;n&#539;elegerea limbii engleze &#537;i &#238;n&#539;elege&#539;i pe deplin termenii documentelor legate de subven&#539;ie (Acordul de acordare &#537;i planul), care au fost furnizate &#238;n limba englez&#259;. Accepta&#539;i termenii acestor documente &#238;n consecin&#539;&#259;.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RUSSIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You understand that the Units shall be valid and this Agreement shall be concluded and become effective only when the Agreement is received by the Company in the United States.  Upon vesting of the Units, any shares of Stock to be issued to you shall be delivered to you through a bank or brokerage account in the United States.  In no event will shares of Stock be delivered to you in Russia&#59; instead, all shares of Stock acquired upon vesting of the Units will be maintained on your behalf in the United States.  You are not permitted to sell shares of Stock acquired at vesting directly to a Russian legal entity or resident.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You acknowledge that the Units, the Equity Award and Acceptance Summary, the Agreement, the Plan and all other materials that you may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia.  The shares of Stock acquired pursuant to the Plan have not and will not be registered in Russia and, therefore, neither the Units nor the shares of Stock may be used for offering or public circulation in Russia.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree to promptly repatriate proceeds resulting from the sale of shares of Stock acquired under the Plan to a foreign currency account at an authorized bank in Russia if legally required at the time shares of Stock are sold and to comply with all applicable local foreign exchange rules and regulations.  Neither the Company nor any of its Affiliates shall be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The repatriation requirement may not apply with respect to cash amounts received in an account that is considered by the Central Bank of Russia to be a foreign brokerage account opened with a financial market institution other than a bank.  Statutory exceptions to the repatriation requirement also may apply.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of Stock of foreign companies such as the Company). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Accordingly, you should inform the Company if you are covered by these laws because you should not hold shares of Stock acquired under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you continue to hold shares of Stock acquired upon settlement of the Units after an involuntary termination of employment, you may not be eligible to receive unemployment benefits in Russia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Depending on applicable restrictions then in effect, the Company has the sole discretion to postpone the vesting and&#47;or settlement of any Units, to determine whether to settle any vested Units in shares of Stock or in cash, or to cancel such Units for no consideration.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SAUDI ARABIA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the Units is not subject to the regulations concerning public offers and private placements under the Law on Capital Markets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The grant of the Units is being made pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore and is not regulated by any financial supervisory authority pursuant to any legislation in Singapore. Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. You should note that the Units are subject to section 257 of the SFA and you will not be able to make any subsequent sale of the shares of Stock in Singapore, or any offer of such subsequent sale of the shares of Stock subject to the grant in Singapore, unless such sale or offer is made (i) after six months from the Grant Date or (ii) pursuant to the exemptions under Part XIII Division 1 Subdivision (4) (other than section 280) of the SFA.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In compliance with South African securities law, the documents listed below are available for review on the Company&#8217;s external and internal sites at the web addresses listed below&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation&#8217;s most recent Annual Report (Form 10-K)&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.sec.gov&#47;cgi-bin&#47;browse-edgar&#63;CIK&#61;bsx&#38;owner&#61;exclude&#38;action&#61;getcompany&#38;Find&#61;Search.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">The Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan&#58;  This document can be accessed at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;us.etrade.com&#47;home</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation Restricted Stock Unit Award Agreement and Amended and Restated 2011 Long-Term Incentive Plan Q&#38;A Summary Sheet&#58;  This document can be accessed at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;us.etrade.com&#47;home</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Boston Scientific Corporation Equity Award and Acceptance Summary&#58; This document can be accessed at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;us.etrade.com&#47;home</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> -&#62; My Stock Plan -&#62; Holdings -&#62; click on a grant date and select &#8220;View Grant Documents&#8221;.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge that you may have copies of the above documents sent to you, at no charge, on written request being mailed to Boston Scientific Corporation, attn&#58; Corporate Compensation, 300 Boston Scientific Way, Marlborough, MA 01752, USA.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that you are advised to carefully read the materials provided before making a decision whether to participate in the Plan and to contact your tax advisor for specific information concerning your personal tax situation with regard to Plan participation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consent to Collection, Processing and Transfer of Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By electronically accepting this Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">You agree to the collection, use, processing and transfer of Data as described in Section 15 of the Agreement&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">You agree to the processing of your unique identifying information (resident registration number) as described in Section 15 of the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of Discretionary Nature of the Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This provision supplements the terms of the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accepting the grant of Units, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand that the Company has unilaterally, gratuitously and in its sole discretion granted Units under the Plan to individuals who may be employees of the Company or its Affiliates throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Affiliates on an ongoing basis.  Consequently, you understand that the Units are granted on the assumption and condition that the Units and the shares of Stock acquired upon vesting of the Units shall not become a part of any employment contract (either with the Company or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever.  In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above&#59; thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the grant of the Units shall be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the Units, your termination of employment for any reason (including the reasons listed below) will automatically result in the loss of the Units to the extent the Units have not vested as of date that you cease active employment.  In particular, you understand and agree that any unvested Units as of the date you cease active employment will be forfeited without entitlement to the underlying shares of Stock or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, resignation or retirement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">prior to the first anniversary of the Grant Date, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause, individual or collective dismissal on objective grounds, whether adjudged or recognized to be with or without cause, material modification of the terms of employment under Article 41 of the Workers&#8217; Statute, relocation under Article&#160;40 of the Workers&#8217; Statute, Article 50 of the Workers&#8217; Statute, unilateral withdrawal by the Employer and under Article 10.3 of the Royal Decree 1382&#47;1985.  You acknowledge that you have read and specifically accept the conditions referred to in the Agreement regarding the impact of a termination of employment on your Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BY ELECTRONICALLY ACCEPTING THIS AGREEMENT, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE TERMS AND CONDITIONS OF THE PLAN, THE AGREEMENT AND THIS ADDENDUM.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWEDEN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall supplement Section 13 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limiting the Company&#8217;s and the Employer&#8217;s authority to satisfy their withholding obligations for Tax-Related Items as set forth in the Section 13 of the Agreement, in accepting the grant of the Units, you authorize the Company to withhold shares of Stock or to sell shares of Stock otherwise deliverable to you upon settlement of the Units to satisfy Tax-Related Items, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither this document nor any other materials relating to the Units (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (ii) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Corporation or a Subsidiary or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority, FINMA.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award and the shares of Stock to be issued pursuant to the Plan are available only for Employees.  The Award is not a public offer of securities by a Taiwanese company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THAILAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country-specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Under Turkish law, you are not permitted to sell shares of Stock acquired under the Plan in Turkey. The shares of Stock are currently traded on the New York Stock Exchange, which is located outside Turkey and the shares of Stock may be sold through this exchange.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Plan is an employee equity incentive plan and is only being offered to select employees in the United Arab Emirates. The Plan and the Agreement are intended for distribution only to such employees and must not be delivered to, or relied on by, any other person. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic Development have approved the Plan or the Agreement nor taken steps to verify the information set out therein, and have no responsibility for such documents. You should conduct your own due diligence on the securities offered under the Plan. If you do not understand the contents of&#160;the&#160;Agreement or the Plan, you should consult an authorized financial advisor.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall supplement Section 13 of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation Section 13 of the Agreement, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, the Employer or by HM Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  You also agree to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay on your behalf to HMRC (or any other tax authority or any other relevant authority).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, you understand that if you are a director or executive officer (within the meaning of Section 13(k) of the U.S. Securities Exchange Act of 1934, as amended), the terms of the immediately foregoing provision may not apply. In the event that you are a director or executive officer and income tax due is not collected from or paid by you within 90 days after the UK tax year in which an event giving rise to the indemnification described above occurs, the amount of any uncollected tax may constitute a benefit on which additional income tax and national insurance contributions may be payable. You acknowledge that you ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer (as applicable) for the value of any employee national insurance contributions due on this additional benefit, which the Company and&#47;or the Employer may recover from you at any time thereafter by any of the means referred to in Section 13 of the Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that you will have no entitlement to compensation or damages insofar as such entitlement arises or may arise from your ceasing to have rights under or to be entitled to the Award, whether or not as a result of your termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the Award.  Upon the grant of your Award, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">APPENDIX A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSENT LETTER</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">102 CAPITAL GAIN AWARDS FOR PARTICIPANTS RESIDING IN ISRAEL</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dear Participant,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation (the &#8220;Company&#8221;) has elected to apply the capital gains route in accordance with the provisions of Section 102 of the Israeli Income Tax Ordinance (the &#8220;Ordinance&#8221;) on awards granted under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Incentive Plan&#8221;) to Israeli Participants (as defined in the Israeli sub-plan to the Incentive Plan (the &#8220;Israel Sub-Plan&#8221;), which was approved by the Executive Compensation and Human Resources Committee of the Company&#8217;s Board of Directors on November 14, 2022) and any future incentive plan implemented by the Company in Israel (&#8220;Awards&#8221; and &#8220;Capital Gains Route&#8221;), subject to the Company&#8217;s absolute discretion to change such election on future grants, with or without advance notice. Unless otherwise notified to you in writing by the Company, the Awards shall be granted to you under the Capital Gains Route, subject to compliance with the requirements of such tax route. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Capital Gains Route election will enable you to enjoy lower tax rates on a portion of the income received upon disposition of the shares of Company common stock (&#8220;Shares&#8221;) issued to you from or in connection to the Awards, provided however that all the requirements under Section 102 of the Ordinance and the Income Tax (Tax Abatement on the Grant of Shares to Employees) Regulations 2003 (the &#8220;Regulations&#8221;) are met.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below you will find a brief description of the Israeli income tax consequences of the Capital Gains Route. PLEASE NOTE THAT THE SUMMARY BELOW IS ONLY A BRIEF SUMMARY THAT DOES NOT COVER ALL THE PROVISIONS OF SECTION 102 OF THE ORDINANCE AND THE REGULATIONS AND IS NOT INTENDED TO PROVIDE ANY TAX ADVICE. IN ADDITION, THE TAX LAWS AND REGULATIONS DESCRIBED HEREIN ARE SUBJECT TO CHANGE. THEREFORE, IT IS RECOMMENDED THAT YOU CONSULT WITH A TAX ADVISER BEFORE ACCEPTING THE TERMS OF THIS CONSENT LETTER OR BEFORE ACCEPTING ANY AWARDS OR DISPOSING OF SHARES. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The main restrictions that are included under Section 102 of the Ordinance are as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1) Your Awards and the Shares issued under such Awards will be held in trust or controlled by a trustee for at least a period determined in Section 102 under the Capital Gains Route (&#8220;Required Holding Period&#8221;) (currently twenty-four months from the date in which the Awards were granted to you).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2) During the Required Holding Period you will not be able to sell, pledge, release from trust or otherwise perform any transaction in connection to the Awards or Shares granted to you. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Provided that all conditions set by the Ordinance under the Capital Gains Route are met, including the above conditions, you will, in general, be taxed as follows&#58;&#160; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">The fair market value of the underlying Shares at grant will be treated as ordinary income subject to income tax and employee&#47;employer social insurance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">contributions (to the extent the applicable contribution ceiling has not been exceeded). For tax purposes, the fair market value of the Shares at grant is deemed to be the average price of the Shares over the 30 trading days preceding the grant.&#160; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">The remainder of the gain, if any, will be treated as a capital gain and will be taxed at the capital gains tax rate of 25%.&#160; No social insurance contributions will be due on this portion of the gain.&#160; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, a surtax may be imposed if your income is in excess of the applicable annual threshold.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Company were to permit you to sell your Shares, or release the Shares from trust, before the end of the Holding Period, you will immediately be subject to income tax on the gain, at your marginal income tax rate, and will be also required to pay social security and health tax contributions on all your profit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In order to enable you to enjoy the benefits of the Capital Gains Route, please express your acceptance and confirmation of the following terms, by accepting the Award through the electronic acceptance procedures established by the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;I undertake to comply with all the terms and conditions set under Section 102 of the Ordinance with regard to the Capital Gains Route and the Regulations.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;I have had the opportunity to obtain the advice of counsel prior to accepting this Consent Letter. I am familiar with and understand the provisions of Section 102 of the Ordinance in general, and the tax arrangement under the Capital Gains Route in particular, and agree to comply with such provisions, as amended from time to time. </font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;I agree that Awards granted to me, and the Shares that may be derived from such Awards, will be held or controlled by a trustee for at least the duration of the Required Holding Period, as determined in Section 102 under the Capital Gains Route (currently twenty-four months from the date in which the Awards were granted). </font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;I agree to the trust deed signed between the Company, my employer and the trustee available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trust Deed RSU-Stock Option - Hebrew.pdf</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;I understand that any release of such Awards or Shares from trust, or any sale of the Shares prior to the termination of the Required Holding Period, will result in taxation at my marginal tax rate, in addition to deductions of appropriate social security and health tax contributions.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;I authorize the Company and&#47;or my employer to provide the trustee with any information required for administrating the grant of the Awards, including without limitation information about my Awards, income tax rates, salary bank account, contact details and identification number and any reasonable information required by the trustee.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7. &#160;&#160;&#160;&#160;I declare that I am a resident of the state of Israel for tax purposes and agree to notify the Company upon any change in the residence address and acknowledge that if I cease to be an Israeli resident or if my engagement with the Company or any affiliate is terminated, the Awards and underlying Shares shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">remain subject to Section 102, the trust agreement and the applicable equity plan and grant document.</font></div><div style="margin-bottom:12pt;padding-left:38.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;I understand and agree that until the Company will determine otherwise, my acceptance of the terms of this Consent Letter will be sufficient, to apply to all potential future grants of Awards. I hereby confirm that by accepting this Consent Letter, I will be deemed to have elected to accept the terms and conditions herein in respect of any such potential future grant of Awards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9. &#160;&#160;&#160;&#160;I acknowledge, understand and agree that the Awards are an extraordinary, one-time benefit granted to me, and do not create any contractual or other right to receive future grant of Awards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10. &#160;&#160;&#160;&#160;I understand that neither the Company nor any of its affiliates guarantee that any Awards granted to me will be eligible for tax benefits pursuant to the Capital Gains Route and I agree that I will not hold the Company and&#47;or any affiliate and&#47;or the trustee liable for any tax consequences relating to my Awards, including any penalties or other negative tax consequences I could receive or be subject to if my Awards do not obtain the Capital Gains Route tax treatment, regardless of the reason for the Capital Gains Route tax treatment not being available.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">&#8211;Rev 1.2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>ex104-2023grantxtsrawardag.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i079c4241685c4b41910722888acba34f_1"></div><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="padding-left:41.73pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.729%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant&#58;  %%FIRST_NAME%-% %%LAST_NAME%-%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee ID&#58;  %%EMPLOYEE_IDENTIFIER%-%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Award Type&#58; Performance Share Unit Award Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan Name&#58;  rTSR PERFORMANCE SHARE PROGRAM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> -</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Award Date&#58;  %%OPTION_DATE,'Month DD, YYYY'%-%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Total Granted&#58;  %%TOTAL_SHARES_GRANTED%-%</font></div></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">INTENT TO GRANT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PERFORMANCE SHARE UNIT AWARD AGREEMENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Agreement, dated as of the %%OPTION_DATE,'Month DD, YYYY'%-% (the &#8220;Grant Date&#8221;), is between you and Boston Scientific Corporation, a Delaware corporation (the &#8220;Company&#8221;), in connection with the Award of Performance Share Units by the Company under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Plan&#8221;).  Capitalized terms not otherwise defined herein shall have the meaning ascribed thereto in either the Plan or in the Relative Total Shareholder Return Performance Share Program (the &#8220;Program&#8221;) for the period beginning January 1, 2023 and ending on December 31, 2025 (the &#8220;Performance Period&#8221;).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant and Acceptance of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company hereby indicates its award to you that number of Performance Share Units (the &#8220;Units&#8221;) set forth herein this Agreement (the &#8220;Award&#8221;).  Each Unit represents the Company&#8217;s commitment to issue to you shares of the Company&#8217;s common stock, par value USD 0.01 per share (&#8220;Stock&#8221;), subject to certain eligibility, performance and other conditions set forth herein.  The Award is intended to be granted pursuant to and is subject to the terms and conditions of this Agreement and the provisions of the Plan and the Program.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligibility Conditions upon Award of the Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You hereby acknowledge the intent of the Company to award the Units subject to certain eligibility, performance and other conditions set forth herein.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Satisfaction of Performance-Based Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the eligibility conditions described in Section 7 of this Agreement, except as otherwise provided in Section 8 of this Agreement and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and the satisfaction of the performance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conditions set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement during the Performance Period, the Company intends to award shares of Stock hereunder to you at the end of the Performance Period.  Shares of Stock shall be issued during the period January 1 to March 15 of the calendar year following the end of the Performance Period based on actual performance as determined at the first Committee meeting following the Performance Period.  Except as set forth in Section 8 of this Agreement, no shares of Stock in settlement of the Units shall be issued to you prior to the end of the Performance Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant&#8217;s Rights in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock, if and when issued hereunder, shall be registered in your name and evidenced in the manner as the Company may determine.  During the period prior to the issuance of shares of Stock, you will have no rights of a stockholder of the Company with respect to the shares of Stock, including no right to receive dividends or vote the shares of Stock underlying each Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to death or Disability (as the term is defined in the Plan or determined under local law), prior to the end of the Performance Period, shares of Stock shall be issued during the period January 1 to March 15 of the calendar year following the end of the Performance Period based on actual performance as determined at the first Committee meeting following the Performance Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to Retirement after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued during the period January 1 to March 15 of the calendar year following the end of the Performance Period on a prorated basis based on actual performance as determined at the first Committee meeting following the Performance Period.  The number of shares of Stock to be issued under the prorated Award shall be determined by calculating (a)(i) the number of Units set forth herein multiplied by (ii) the quotient of the number of full and partial months that you worked during the Performance Period (rounded up to the nearest whole month) divided by 36, and then multiplying the product of (a)(i) and (a)(ii) by (b) the percentile performance amount, as calculated in accordance with the terms of the Program.  In the event that you terminate your employment due to Retirement prior to January 1, 2024, the Award shall be forfeited in its entirety.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Termination of Employment -- Eligibility Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your employment with the Company and its Affiliates or subsidiaries is terminated or you separate from the Company and its Affiliates or subsidiaries for any reason other than death, Retirement or Disability, any Units that remain subject to eligibility conditions shall be void and no shares of Stock shall be issued. Except as set forth in Sections 5, 6 and 8, eligibility to be issued shares of Stock is conditioned on your continuous employment with the Company or an Affiliate through and on the last day of the Performance Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms of any separate Change in Control or similar agreement to which you are bound, in the event you are employed by the Company or an Affiliate at the time of a Change in Control after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued immediately prior to the Change in Control on a prorated basis based on actual performance using the last day of the month preceding the date on which the Change in Control is consummated as the ending date of the Performance Period in lieu of December 31, 2025, as determined by the Committee immediately prior to the consummation of the Change in Control.  The number of shares of Stock to be issued </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;2&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">under the prorated Award shall be determined by calculating (a)(i) the number of Units set forth herein multiplied by (ii) the quotient of the number of full and partial months during the Performance Period (rounded up to the nearest whole month) prior to the consummation of the Change in Control divided by 36, and then multiplying the product of (a)(i) and (a)(ii) by (b) the percentile performance amount  as calculated in accordance with the terms of the Program.  In the event that a Change in Control occurs prior to January 1, 2024, the Award shall be forfeited in its entirety.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to death or Disability prior to a Change in Control and a Change in Control occurs after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued immediately prior to the Change in Control based on actual performance using the last day of the month preceding the date on which the Change in Control is consummated as the ending date of the Performance Period in lieu of December 31, 2025, as determined by the Committee immediately prior to the consummation of the Change in Control. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to Retirement prior to a Change in Control after December&#160;31,&#160;2023 and a Change in Control occurs after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued immediately prior to the Change in Control on a prorated basis as determined under Section 6 based on actual performance using the last day of the month preceding the date on which the Change in Control is consummated as the ending date of the Performance Period in lieu of December 31, 2025, as determined by the Committee immediately prior to the consummation of the Change in Control.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Current Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant to the Company&#8217;s recoupment policy and to the extent permitted by governing law, the Board, in its discretion, may seek Recovery of the Award granted to you if you are a Current Executive Officer or Former Executive Officer and if, in the judgment of the Board, you commit misconduct or a gross dereliction of duty that results in a material violation of Company policy and causes significant harm to the Company while serving in your capacity as Executive Officer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms, when used in this Section 9, shall have the meaning set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;&#8220;Current Executive Officer&#8221; means any individual currently designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange&#160; Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;&#8220;Executive Officer&#8221; means any Current Executive Officer or Former Executive Officer.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;&#8220;Former Executive Officer&#8221; means any individual previously (but not currently) designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange&#160; Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)&#160;&#160;&#160;&#160;&#8220;Recovery&#8221; means the forfeiture or cancellation of unvested Units.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;3&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Provisions Required by Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company subsequently determines that it is required by law to apply a &#8220;clawback&#8221; or alternate recoupment provision to outstanding Awards, under the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise, then such clawback or recoupment provision also shall apply to this Award, as applicable, as if it had been included on the Grant Date and the Company shall notify you of such additional provision.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration for Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock are intended to be issued for no cash consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not be obligated to issue any shares of Stock until (i) all United States (&#8220;U.S.&#8221;) federal, state, local and non-U.S. laws and regulations as the Company may deem applicable have been complied with&#59; (ii)&#160;the shares of Stock have been listed or authorized for listing upon official notice to the New York Stock Exchange, Inc. or have otherwise been accorded trading privileges&#59; and (iii)&#160;all other legal matters in connection with the issuance and delivery of the shares of Stock have been approved by the Company&#8217;s legal department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Satisfaction of Tax Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Regardless of any action the Company or the Affiliate that employs you (the &#8220;Employer&#8221;) (if applicable) takes with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge and agree that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and&#47;or the Employer (a)&#160;make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Units or the shares of Stock issued upon vesting of the Units, and (b) do not commit to structure the terms of the Award (or any aspect of the Units) to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Upon the issuance of shares of Stock or the satisfaction of any vesting condition with respect to the shares of Stock to be issued hereunder, if your country of residence (and&#47;or the country of employment, if different) requires withholding of Tax-Related Items, the Company may hold back from the total number of shares of Stock to be delivered to you, and shall cause to be transferred to the Company, whole shares of Stock that have an aggregate Fair Market Value sufficient to pay the Tax-Related Items required to be withheld with respect to the shares of Stock, or to the extent it would not result in adverse accounting treatment, the Company may, in its sole discretion, hold back shares of Stock based on a rate of up to the maximum applicable withholding rate. If the obligation for Tax-Related Items is satisfied by holding back shares of Stock to be delivered upon settlement of the Units, for tax purposes, you are deemed to have been issued the full number of shares of Stock subject to the Units, notwithstanding that a number of shares of Stock are held back solely for the purpose of paying the Tax-Related Items. You will have no further rights with respect to any shares of Stock that are retained by the Company pursuant to this provision.   By accepting the grant of the Units, you expressly consent to the withholding of shares of Stock and&#47;or cash as provided for hereunder.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Alternatively, you hereby authorize the Company (on your behalf and at your direction pursuant to this authorization) to immediately sell a sufficient whole number of shares of Stock acquired upon vesting resulting in sale proceeds sufficient to pay the Tax-Related Items required to be withheld.  You agree to sign any agreements, forms and&#47;or consents that reasonably may be requested by the Company (or the Company&#8217;s designated brokerage firm) to effectuate the sale of the shares of Stock (including, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;4&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">without limitation, as to the transfer of the sale proceeds to the Company to satisfy the Tax-Related Items required to be withheld).  Further, the Company or the Employer may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from your salary or any other amounts payable to you, with no withholding of shares of Stock or sale of shares of Stock, or may require you to submit a cash payment equivalent to the Tax-Related Items required to be withheld with respect to the Units.  &#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;All other Tax-Related Items related to the grant of the Units and any shares of Stock delivered in settlement thereof are your sole responsibility.  In no event shall whole shares of Stock be withheld by or delivered to the Company in satisfaction of any Tax-Related Items in excess of the maximum statutory tax withholding required by law.  You agree to indemnify the Company and its Affiliates against any and all liabilities, damages, costs and expenses that the Company and its Affiliates may hereafter incur, suffer or be required to pay with respect to the payment or withholding of any Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Units are intended to comply with or be exempt from the requirements of Section&#160;409A of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).  The Plan and this Agreement shall be administered and interpreted in a manner consistent with this intent.  If the Company determines that the Agreement is subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, in its sole discretion, and without your consent, amend this Agreement to cause it to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provision of this Agreement to the contrary, in the event that any settlement or payment of this Award occurs as a result of your termination of employment and the Company determines that you are a &#8220;specified employee&#8221; (as that term is defined under Code Section 409A) subject to Code Section 409A at the time your termination of employment, and provided further that such payment or settlement does not otherwise qualify for an applicable exemption from Code Section 409A, then no such settlement or payment shall be paid to you until the date that is the earlier to occur of&#58; (i)&#160;your death, or (ii) six (6) months and one (1) day following your termination of employment.  Any portion of this Award delayed as a result of the preceding sentence, which is (i) in whole or in part, settled in cash and (ii) based on the value of shares of Stock, shall be based on the value of the shares of Stock at the time the Award would have otherwise been settled or paid without application of the delay described in the preceding sentence.  If this Award does not otherwise qualify for an applicable exemption from Code Section 409A, the terms &#8220;Retirement&#8221;, &#8220;terminate,&#8221; &#8220;termination,&#8221; &#8220;termination of employment,&#8221; and variations thereof as used in this agreement, are intended to mean a termination of employment that constitutes a &#8220;separation from service&#8221; as such term is defined under Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any action or inaction by the Administrator, you are exclusively responsible for any tax consequences under Code Section 409A resulting from this Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Intent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that the acquisition of the shares of Stock to be issued hereunder is for investment purposes without a view to distribution thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limits on Transferability&#59; Restrictions on Shares&#59; Legend on Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Until the eligibility conditions of this Award have been satisfied and shares of Stock have been issued in accordance with the terms of this Agreement or by action of the Committee, the Units awarded hereunder are not transferable and shall not be sold, transferred, assigned, pledged, gifted, hypothecated or otherwise disposed of or encumbered by you.  Transfers of shares of Stock by you are subject to the Company&#8217;s Stock Trading Policy and applicable securities laws.  Shares of Stock issued to you in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;5&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">certificate form or to your book entry account upon satisfaction of the vesting and other conditions of this Award may be restricted from transfer or sale by the Company and evidenced by stop-transfer instructions upon your book entry account or restricted legend(s) affixed to certificates in the form as the Company or its counsel may require with respect to any applicable restrictions on sale or transfer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to the Plan and the Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award to be made pursuant to this Agreement is made subject to the Plan and the Program.  The terms and provisions of the Plan and the Program, as each may be amended from time to time are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan or the Program, the applicable terms and conditions of the Plan or Program will govern and prevail.  However, no amendment of the Program after the grant date may materially and adversely impair a participant's rights under awards made pursuant to the Program without the participant's consent unless the amendment is necessary or desirable to facilitate compliance with applicable law, as determined in the sole discretion of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights to Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company&#8217;s intent to issue the shares of Stock hereunder shall not confer upon you any right to continued employment or other association with the Company or any of its Affiliates or subsidiaries&#59; and this Agreement shall not be construed in any way to limit the right of the Company or any of its subsidiaries or Affiliates to terminate your employment or other association with the Company or to change the terms of such employment or association at any time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any legal notice necessary under this Agreement shall be addressed to the Company in care of its General Counsel at the principle executive offices of the Company and to you at the address appearing in the personnel records of the Company for you or to either party at such other address as either party may designate in writing to the other.  Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision of this Agreement to the contrary, the Units shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) as are forth in the applicable appendix to the Agreement (the &#8220;Appendix&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in the Appendices to these Agreements, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  Any applicable Appendix shall constitute part of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The interpretation, performance and enforcement of this Agreement shall be governed by the laws of The Commonwealth of Massachusetts (without regard to the conflict of laws principles thereof) and applicable federal laws.  For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">evidenced</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> by this Agreement, the parties hereby submit and consent to the exclusive jurisdiction of the Commonwealth of Massachusetts and agree that such litigation shall be conducted only in the Commonwealth of Massachusetts, or the federal courts for the United States for the District of Massachusetts, and no other courts, where this Award is made and&#47;or to be performed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;6&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings contained in this Agreement are for convenience only and shall not affect the meaning or interpretation of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree that the provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You understand that the waiver by the Company with respect to your compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach of a provision of this Agreement.&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to the one and the same instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#91;remainder of  page intentionally left blank&#93;</font></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;7&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><div id="i079c4241685c4b41910722888acba34f_4"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-21pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">APPENDIX A</font></div><div style="padding-right:-21pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PLAN&#58; AMENDED AND RESTATED 2011 LONG-TERM INCENTIVE PLAN</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Performance Share Units will pay out in shares of Stock in a range of 0% to 200% of the number of Performance Share Units as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:95.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.215%"><tr><td style="width:1.0%"></td><td style="width:48.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">rTSR* Performance</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Percentile Rank</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1.18pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance Share Units<br>as a Percent of Target</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">75th Percentile or above</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">200%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">55th Percentile</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25th Percentile</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Percentile</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td></tr></table></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*Relative Total Shareholder Return</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 1.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><div id="i079c4241685c4b41910722888acba34f_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">APPENDIX B</font></div><div style="padding-right:-18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix B contains supplemental terms and conditions for awards of Units granted under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Plan&#8221;) to Participants who reside outside the United States or who are otherwise subject to the laws of a country other than the United States.  Capitalized terms used but not defined herein shall have the same meanings ascribed to them in the Agreement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section I of this Appendix B contains special terms and conditions that govern the Units outside of the United States.  Section II of this Appendix B includes special terms and conditions in the specific countries listed therein. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix B may also include information regarding exchange controls, taxation of awards and certain other issues of which you should be aware with respect to participation in the Plan.  The information is based on the securities, exchange control, tax and other laws concerning the Units in effect as of December 2022.  Such laws are often complex and change frequently&#59; the information may be out of date at the time you vest in the Units or sell shares of Stock acquired under the Plan. As a result, the Company strongly recommends that you not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, this Appendix B is general in nature, does not discuss all of the various laws, rules and regulations which may apply to your particular situation and the Company does not assure you of any particular result.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Accordingly, you should seek appropriate professional advice as to how the relevant laws in your country apply to your specific situation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Finally, if you are a citizen or resident of a country other than the one in which you are currently working, transferred employment after the Award was granted or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to you in the same manner.  In addition, the Company shall, in its sole discretion, determine to what extent the terms and conditions contained herein will apply under these circumstances (or the Company may establish alternative terms and conditions as may be necessary or advisable).  </font></div><div><font><br></font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section I. &#160;&#160;&#160;&#160;All Countries Outside the United States</font></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In accepting the grant, you acknowledge that&#58;</font></div><div style="padding-right:-18pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Administrator at any time, to the extent permitted by the Plan&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the grant of the Units is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants or benefits in lieu of Units, even if Units have been granted in the past&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">all decisions with respect to future grants of Units, if any, will be at the sole discretion of the Administrator&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the grant of the Units  and your participation in the Plan shall not create a right to employment or be interpreted as forming an employment or service contract with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company, the Employer or Affiliate and shall not interfere with the ability of the Company, the Employer or any Affiliate, as applicable, to terminate your employment or service relationship (if any)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">you are voluntarily participating in the Plan&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">the Units are not intended to replace any pension rights or compensation&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Units, the underlying shares of Stock, and the income and value of same are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar payments&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the future value of the underlying shares of Stock is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Units resulting from the termination of your employment or other service relationship (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">unless otherwise agreed with the Company in writing, the Units, the underlying shares of Stock and the income from and value of same are not granted as consideration for, or in connection with, any service you may provide as a director of an Affiliate&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">for purposes of the Units, your employment or other service relationship will be considered terminated as of the date you are no longer actively providing services to the Company or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, your right to vest in the Units under this Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., your period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; the Committee shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of the Unit grant (including whether you may still be considered to be providing services while on an approved leave of absence)&#59; and</font></div><div style="padding-right:-18pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the following provisions apply only if you are providing services outside the United States&#58; (A) the Units, the underlying shares of Stock, and the income from and value of same are not part of normal or expected compensation or salary for any purpose&#59; and (B) neither the Company, the Employer nor any Affiliate shall be liable for any foreign exchange rate fluctuation between your local currency and the U.S. dollar that may affect the value of the Units or of any amount due to you pursuant to the settlement of the Units or the subsequent sale of any shares of Stock acquired upon settlement.</font></div><div style="padding-left:18pt;padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery of Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may, in its sole discretion, decide to deliver any documents related to the Units granted under and participation in the Plan or future Units that may be granted under the Plan by electronic means or to request your </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">consent to participate in the Plan by electronic means.  You hereby consent to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. </font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You hereby acknowledge and agree that it is your express intent that this Agreement and any applicable Appendix, the Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Units, be drawn up in English. You acknowledge that you are proficient in the English language and understand the terms of this Agreement or have had the ability to consult with an advisor who is sufficiently proficient in the English language. If you have received this Agreement and any applicable Appendix, the Plan or any other documents related to the Units translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge that, depending on your or your broker&#8217;s country of residence or where the shares of Stock are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws that may affect your ability to accept, acquire,  sell or otherwise dispose of shares of Stock, rights to those shares of Stock (e.g., Units) or rights linked to the value of shares (e.g., phantom awards, futures) during such times you are considered to have &#8220;inside information&#8221; regarding the Company, as defined in the laws or regulations in your country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed insider information.  Furthermore, you could be prohibited from (i)&#160;disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Keep in mind that third parties include fellow employees.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section II.&#160;&#160;&#160;&#160; Country-Specific Terms and Conditions</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COUNTRIES OUTSIDE THE EUROPEAN UNION (&#8220;EU&#8221;) &#47; EUROPEAN ECONOMIC AREA (&#8220;EEA&#8221;), UNITED KINGDOM AND SWITZERLAND</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  If you do not reside and&#47;or are not employed in the EU &#47; EEA, the United Kingdom or Switzerland, the following provision applies&#58;</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your  personal data as described in this Agreement and any other Unit grant materials by and among, as applicable, the Employer, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that the Company and the Employer may hold certain personal information about you, including (but not limited to) your name, home address, email address and telephone number, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any shares of Stock or directorships held in the Company, and details of all Units awarded to you or any other entitlements to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor (&#8220;Data&#8221;) for the purpose of implementing, managing and administering the Plan.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that Data may be transferred to any third parties assisting the Company with the implementation, administration and management of the Plan, including but not limited to E*TRADE Securities LLC (&#8220;E*TRADE&#8221;) or any successor or any other third party that the Company or E*TRADE (or its successor) may engage to assist with the administration of the Plan from time to time.  You understand the recipients of the Data may be located in your country, in the United States or elsewhere, and that the recipients&#8217; country may have different data privacy laws and protections than your country.  You understand that you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative.  </font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares of Stock acquired upon vesting of the Units.  You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consents herein on a purely voluntary basis.  If you do not consent, or if you later revoke your consent, your employment status or service with the Employer will not be adversely affected&#59; the only consequence of refusing or withdrawing your consent is that the Company would not be able to grant you Units or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COUNTRIES WITHIN THE EU &#47; EEA, UNITED KINGDOM AND SWITZERLAND </font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  If you reside and&#47;or are employed in the EU &#47; EEA, the United Kingdom or Switzerland, the following provision applies&#58;</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Pursuant to applicable personal data protection laws, the Company and the Employer hereby notify you of the following in relation to your Personal Data (defined below) and the collection, processing and transfer in electronic or other form of such Personal Data in relation to the grant of the Units and your participation in the Plan.  The collection, processing and transfer of your Personal Data is necessary for the legitimate purpose of the Company and the Employer&#8217;s administration of the Plan and your participation in the Plan, and your denial and&#47;or objection to the collection, processing and transfer of Personal Data may affect your participation in the Plan.  As such, by accepting the Award, you acknowledge the collection, use, processing and transfer of Personal Data as described herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that the Company and the Employer hold certain personally identifiable information about you, specifically, your name, home address and telephone number, date of birth, social security number or other employee </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all Units or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of managing and administering the Plan (&#8220;Personal Data&#8221;). The Personal Data may be provided by you to or collected, where lawful, from third parties.  The Company or the Employer each act as controllers of the Personal Data and will process the Personal Data in this context for the exclusive legitimate purpose of implementing, administering and managing your participation in the Plan and meeting related legal obligations associated with these actions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The processing will take place through electronic and non-electronic means according to logics and procedures correlated to the purposes for which the Personal Data was collected and with confidentiality and security provisions as set forth by applicable laws and regulations.  Personal Data will be accessible within the Company&#8217;s organization only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and other aspects of the employment relationship and for participation in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company and the Employer will transfer Personal Data amongst themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan, and the Company and the Employer may each further transfer Personal Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan, including E*TRADE Securities LLC and its affiliates or any successor or other third party that the Company, the Employer or E*TRADE Securities LLC (or its successor) may engage to assist with the administration of the Plan from time to time.  These recipients may be located in the EU, EEA, the United Kingdom, Switzerland or elsewhere throughout the world, such as the United States.  By participating in the Plan, you understand that these recipients may receive, possess, use, retain and transfer the Personal Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Personal Data as may be required for the administration of the Plan and&#47;or the subsequent holding of shares of Stock on your behalf to a broker or other third party with whom you may elect to deposit any shares of Stock acquired pursuant to the Plan.  You further understand that you may request a list with the names and addresses of any potential recipients of your Personal Data by contacting your local Human Resources manager or the Company&#8217;s Human Resources Department.  When transferring Personal Data to these potential recipients, the Company and the Employer provide appropriate safeguards in accordance with EU Standard Contractual Clauses or other legally binding and permissible arrangements.  You may request a copy of such safeguards from your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">To the extent provided by law, you may, at any time, have the right to request&#58; access to Personal Data, rectification of Personal Data, erasure of Personal Data, restriction of processing of Personal Data, and portability of Personal Data.  You may also have the right to object, on grounds related to a particular situation, to the processing of Personal Data, as well as opt-out of the Plan herein, in any case without cost, by contacting in writing your Human Resources manager.  Your provision of Personal Data is a contractual requirement.  You understand, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to grant the Units to you, or grant other equity awards or administer or maintain such equity awards.  For more information on the consequences of your refusal to provide </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Personal Data, you understand that you may contact your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">When the Company and the Employer no longer need to use Personal Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Personal Data from their systems and&#47;or records containing the Personal Data and&#47;or take steps to properly anonymize it so that you can longer be identified from it.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Units are not granted under the French specific regime provided by Articles L225-197-1 and seq. or L. 22-10-59 and L. 22-10-60 of the French commercial code, as amended.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that it is your express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vous reconnaissez et consentez que c&#8217;est votre souhait expr&#232;s qui cet accord, de meme que tous documents, toutes notifications et tous proc&#233;d&#233;s l&#233;gaux est entr&#233; dans, donn&#233; ou institut&#233; conform&#233;ment ci-annex&#233; ou relatant directement ou indirectement ci-annex&#233;, est formul&#233; dans l&#8217;anglais.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406635481-v5&#92;NA_DMS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-Rev. 12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;rTSR Program</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>5
<FILENAME>ex105-2023grantxonsgawarda.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i678ea0c6101b45129641a911d96ae1c1_1"></div><div style="min-height:78.48pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="padding-left:41.73pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.729%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant&#58;  %%FIRST_NAME%-% %%LAST_NAME%-%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee ID&#58;  %%EMPLOYEE_IDENTIFIER%-%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Award Type&#58; Performance Share Unit Award Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan Name&#58;  ONSG PERFORMANCE SHARE PROGRAM</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Award Date&#58;  %%OPTION_DATE,'Month DD, YYYY'%-%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Total Granted&#58;  %%TOTAL_SHARES_GRANTED%-%</font></div></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">INTENT TO GRANT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PERFORMANCE SHARE UNIT AWARD AGREEMENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Agreement, dated as of the %%OPTION_DATE,'Month DD, YYYY'%-% (the &#8220;Grant Date&#8221;), is between you and Boston Scientific Corporation, a Delaware corporation (the &#8220;Company&#8221;), in connection with the Award of Performance Share Units by the Company under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Plan&#8221;).  Capitalized terms not otherwise defined herein shall have the meaning ascribed thereto in either the Plan or in the Organic Net Sales Growth Performance Share Program (the &#8220;Program&#8221;) for the period beginning January 1, 2023 and ending on December 31, 2025 (the &#8220;Performance Period&#8221;).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant and Acceptance of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company hereby indicates its award to you that number of Performance Share Units (the &#8220;Units&#8221;) set forth herein this Agreement (the &#8220;Award&#8221;).  Each Unit represents the Company&#8217;s commitment to issue to you shares of the Company&#8217;s common stock, par value USD 0.01 per share (&#8220;Stock&#8221;), subject to certain eligibility, performance and other conditions set forth herein.  The Award is intended to be granted pursuant to and is subject to the terms and conditions of this Agreement and the provisions of the Plan and the Program.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligibility Conditions upon Award of the Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You hereby acknowledge the intent of the Company to award the Units subject to certain eligibility, performance and other conditions set forth herein.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Satisfaction of Performance-Based Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the eligibility conditions described in Section 7 of this Agreement, except as otherwise provided in Section 8 of this Agreement and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and the satisfaction of the performance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:78.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conditions set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement during the Performance Period, the Company intends to award shares of Stock hereunder to you at the end of the Performance Period.  Shares of Stock shall be issued during the period January 1 to March 15 of the calendar year following the end of the Performance Period based on actual performance as determined at the first Committee meeting following the Performance Period.  Except as set forth in Section 8 of this Agreement, no shares of Stock in settlement of the Units shall be issued to you prior to the end of the Performance Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant&#8217;s Rights in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock, if and when issued hereunder, shall be registered in your name and evidenced in the manner as the Company may determine.  During the period prior to the issuance of shares of Stock, you will have no rights of a stockholder of the Company with respect to the shares of Stock, including no right to receive dividends or vote the shares of Stock underlying each Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to death or Disability (as the term is defined in the Plan or determined under local law), prior to the end of the Performance Period, shares of Stock shall be issued during the period January 1 to March 15 of the calendar year following the end of the Performance Period based on actual performance as determined at the first Committee meeting following the Performance Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to Retirement after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued during the period January 1 to March 15 of the calendar year following the end of the Performance Period on a prorated basis based on actual performance as determined at the first Committee meeting following the Performance Period.  The number of shares of Stock to be issued under the prorated Award shall be determined by calculating (a)(i) the number of Units set forth herein multiplied by (ii) the quotient of the number of full and partial months that you worked during the Performance Period (rounded up to the nearest whole month) divided by 36, and then multiplying the product of (a)(i) and (a)(ii) by (b) the percentile performance amount, as calculated in accordance with the terms of the Program.  In the event that you terminate your employment due to Retirement prior to January 1, 2024, the Award shall be forfeited in its entirety.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Termination of Employment -- Eligibility Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your employment with the Company and its Affiliates or subsidiaries is terminated or you separate from the Company and its Affiliates or subsidiaries for any reason other than death, Retirement or Disability, any Units that remain subject to eligibility conditions shall be void and no shares of Stock shall be issued. Except as set forth in Sections 5, 6 and 8, eligibility to be issued shares of Stock is conditioned on your continuous employment with the Company or an Affiliate through and on the last day of the Performance Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms of any separate Change in Control or similar agreement to which you are bound, in the event you are employed by the Company or an Affiliate at the time of a Change in Control after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued immediately prior to the Change in Control on a prorated basis based on actual performance using the last day of the month preceding the date on which the Change in Control is consummated as the ending date of the Performance Period in lieu of December 31, 2025, as determined by the Committee immediately prior to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;2&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:78.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">consummation of the Change in Control.  The number of shares of Stock to be issued under the prorated Award shall be determined by calculating (a)(i) the number of Units set forth herein multiplied by (ii) the quotient of the number of full and partial months during the Performance Period (rounded up to the nearest whole month) prior to the consummation of the Change in Control divided by 36, and then multiplying the product of (a)(i) and (a)(ii) by (b) the percentile performance amount as calculated in accordance with the terms of the Program.  In the event that a Change in Control occurs prior to January 1, 2024, the Award shall be forfeited in its entirety.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to death or Disability prior to a Change in Control and a Change in Control occurs after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued immediately prior to the Change in Control based on actual performance using the last day of the month preceding the date on which the Change in Control is consummated as the ending date of the Performance Period in lieu of December 31, 2025, as determined by the Committee immediately prior to the consummation of the Change in Control. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;In the event that your employment with the Company or its subsidiaries or Affiliates is terminated due to Retirement prior to a Change in Control after December&#160;31,&#160;2023 and a Change in Control occurs after December 31, 2023, but prior to the end of the Performance Period, shares of Stock shall be issued immediately prior to the Change in Control on a prorated basis as determined under Section 6 based on actual performance using the last day of the month preceding the date on which the Change in Control is consummated as the ending date of the Performance Period in lieu of December 31, 2025, as determined by the Committee immediately prior to the consummation of the Change in Control.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Current Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Pursuant to the Company&#8217;s recoupment policy and to the extent permitted by governing law, the Board, in its discretion, may seek Recovery of the Award granted to you if you are a Current Executive Officer or Former Executive Officer and if, in the judgment of the Board, you commit misconduct or a gross dereliction of duty that results in a material violation of Company policy and causes significant harm to the Company while serving in your capacity as Executive Officer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms, when used in this Section 9, shall have the meaning set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;&#8220;Current Executive Officer&#8221; means any individual currently designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;&#8220;Executive Officer&#8221; means any Current Executive Officer or Former Executive Officer.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-108pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;&#8220;Former Executive Officer&#8221; means any individual previously (but not currently) designated as an &#8220;executive officer&#8221; by the Board under Rule 3b-7 under the Securities Exchange&#160;Act of 1934, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;3&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:78.48pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)&#160;&#160;&#160;&#160;&#8220;Recovery&#8221; means the forfeiture or cancellation of unvested Units.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Provisions Required by Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company subsequently determines that it is required by law to apply a &#8220;clawback&#8221; or alternate recoupment provision to outstanding Awards, under the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise, then such clawback or recoupment provision also shall apply to this Award, as applicable, as if it had been included on the Grant Date and the Company shall notify you of such additional provision.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration for Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The shares of Stock are intended to be issued for no cash consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall not be obligated to issue any shares of Stock until (i) all United States (&#8220;U.S.&#8221;) federal, state, local and non-U.S. laws and regulations as the Company may deem applicable have been complied with&#59; (ii)&#160;the shares of Stock have been listed or authorized for listing upon official notice to the New York Stock Exchange, Inc. or have otherwise been accorded trading privileges&#59; and (iii)&#160;all other legal matters in connection with the issuance and delivery of the shares of Stock have been approved by the Company&#8217;s legal department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Satisfaction of Tax Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Regardless of any action the Company or the Affiliate that employs you (the &#8220;Employer&#8221;) (if applicable) takes with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge and agree that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and&#47;or the Employer (a)&#160;make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Units or the shares of Stock issued upon vesting of the Units, and (b) do not commit to structure the terms of the Award (or any aspect of the Units) to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Upon the issuance of shares of Stock or the satisfaction of any vesting condition with respect to the shares of Stock to be issued hereunder, if your country of residence (and&#47;or the country of employment, if different) requires withholding of Tax-Related Items, the Company may hold back from the total number of shares of Stock to be delivered to you, and shall cause to be transferred to the Company, whole shares of Stock that have an aggregate Fair Market Value sufficient to pay the Tax-Related Items required to be withheld with respect to the shares of Stock, or to the extent it would not result in adverse accounting treatment, the Company may, in its sole discretion, hold back shares of Stock based on a rate of up to the maximum applicable withholding rate. If the obligation for Tax-Related Items is satisfied by holding back shares of Stock to be delivered upon settlement of the Units, for tax purposes, you are deemed to have been issued the full number of shares of Stock subject to the Units, notwithstanding that a number of shares of Stock are held back solely for the purpose of paying the Tax-Related Items. You will have no further rights with respect to any shares of Stock that are retained by the Company pursuant to this provision.  By accepting the grant of the Units, you expressly consent to the withholding of shares of Stock and&#47;or cash as provided for hereunder.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Alternatively, you hereby authorize the Company (on your behalf and at your direction pursuant to this authorization) to immediately sell a sufficient whole number of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;4&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:78.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shares of Stock acquired upon vesting resulting in sale proceeds sufficient to pay the Tax-Related Items required to be withheld.  You agree to sign any agreements, forms and&#47;or consents that reasonably may be requested by the Company (or the Company&#8217;s designated brokerage firm) to effectuate the sale of the shares of Stock (including, without limitation, as to the transfer of the sale proceeds to the Company to satisfy the Tax-Related Items required to be withheld).  Further, the Company or the Employer may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from your salary or any other amounts payable to you, with no withholding of shares of Stock or sale of shares of Stock, or may require you to submit a cash payment equivalent to the Tax-Related Items required to be withheld with respect to the Units.  &#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;All other Tax-Related Items related to the grant of the Units and any shares of Stock delivered in settlement thereof are your sole responsibility.  In no event shall whole shares of Stock be withheld by or delivered to the Company in satisfaction of any Tax-Related Items in excess of the maximum statutory tax withholding required by law.  You agree to indemnify the Company and its Affiliates against any and all liabilities, damages, costs and expenses that the Company and its Affiliates may hereafter incur, suffer or be required to pay with respect to the payment or withholding of any Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Units are intended to comply with or be exempt from the requirements of Section&#160;409A of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).  The Plan and this Agreement shall be administered and interpreted in a manner consistent with this intent.  If the Company determines that the Agreement is subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, in its sole discretion, and without your consent, amend this Agreement to cause it to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provision of this Agreement to the contrary, in the event that any settlement or payment of this Award occurs as a result of your termination of employment and the Company determines that you are a &#8220;specified employee&#8221; (as that term is defined under Code Section 409A) subject to Code Section 409A at the time your termination of employment, and provided further that such payment or settlement does not otherwise qualify for an applicable exemption from Code Section 409A, then no such settlement or payment shall be paid to you until the date that is the earlier to occur of&#58; (i)&#160;your death, or (ii) six (6) months and one (1) day following your termination of employment.  Any portion of this Award delayed as a result of the preceding sentence, which is (i) in whole or in part, settled in cash and (ii) based on the value of shares of Stock, shall be based on the value of the shares of Stock at the time the Award would have otherwise been settled or paid without application of the delay described in the preceding sentence.  If this Award does not otherwise qualify for an applicable exemption from Code Section 409A, the terms &#8220;Retirement&#8221;, &#8220;terminate,&#8221; &#8220;termination,&#8221; &#8220;termination of employment,&#8221; and variations thereof as used in this agreement, are intended to mean a termination of employment that constitutes a &#8220;separation from service&#8221; as such term is defined under Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any action or inaction by the Administrator, you are exclusively responsible for any tax consequences under Code Section 409A resulting from this Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Intent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that the acquisition of the shares of Stock to be issued hereunder is for investment purposes without a view to distribution thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limits on Transferability&#59; Restrictions on Shares&#59; Legend on Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Until the eligibility conditions of this Award have been satisfied and shares of Stock have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;5&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:78.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">been issued in accordance with the terms of this Agreement or by action of the Committee, the Units awarded hereunder are not transferable and shall not be sold, transferred, assigned, pledged, gifted, hypothecated or otherwise disposed of or encumbered by you.  Transfers of shares of Stock by you are subject to the Company&#8217;s Stock Trading Policy and applicable securities laws.  Shares of Stock issued to you in certificate form or to your book entry account upon satisfaction of the vesting and other conditions of this Award may be restricted from transfer or sale by the Company and evidenced by stop-transfer instructions upon your book entry account or restricted legend(s) affixed to certificates in the form as the Company or its counsel may require with respect to any applicable restrictions on sale or transfer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to the Plan and the Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award to be made pursuant to this Agreement is made subject to the Plan and the Program.  The terms and provisions of the Plan and the Program, as each may be amended from time to time are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan or the Program, the applicable terms and conditions of the Plan or Program will govern and prevail.  However, no amendment of the Program after the grant date may materially and adversely impair a participant's rights under awards made pursuant to the Program without the participant's consent unless the amendment is necessary or desirable to facilitate compliance with applicable law, as determined in the sole discretion of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights to Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company&#8217;s intent to issue the shares of Stock hereunder shall not confer upon you any right to continued employment or other association with the Company or any of its Affiliates or subsidiaries&#59; and this Agreement shall not be construed in any way to limit the right of the Company or any of its subsidiaries or Affiliates to terminate your employment or other association with the Company or to change the terms of such employment or association at any time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any legal notice necessary under this Agreement shall be addressed to the Company in care of its General Counsel at the principle executive offices of the Company and to you at the address appearing in the personnel records of the Company for you or to either party at such other address as either party may designate in writing to the other.  Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision of this Agreement to the contrary, the Units shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) as are forth in the applicable appendix to the Agreement (the &#8220;Appendix&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in the Appendices to these Agreements, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law or to facilitate the administration of the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  Any applicable Appendix shall constitute part of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The interpretation, performance and enforcement of this Agreement shall be governed by the laws of The Commonwealth of Massachusetts (without regard to the conflict of laws principles thereof) and applicable federal laws.  For purposes of litigating any dispute that arises directly or indirectly from </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;6&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:78.48pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the relationship of the parties </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">evidenced</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> by this Agreement, the parties hereby submit and consent to the exclusive jurisdiction of the Commonwealth of Massachusetts and agree that such litigation shall be conducted only in the Commonwealth of Massachusetts, or the federal courts for the United States for the District of Massachusetts, and no other courts, where this Award is made and&#47;or to be performed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings contained in this Agreement are for convenience only and shall not affect the meaning or interpretation of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree that the provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You understand that the waiver by the Company with respect to your compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach of a provision of this Agreement.&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to the one and the same instrument.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#91;remainder of page intentionally left blank&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;7&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><div id="i678ea0c6101b45129641a911d96ae1c1_4"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-21pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">APPENDIX A</font></div><div style="padding-right:-21pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PLAN&#58; AMENDED AND RESTATED 2011 LONG-TERM INCENTIVE PLAN</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Performance Share Units will pay out in shares of Stock in a range of 0% to 200% of the number of Performance Share Units as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:95.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.215%"><tr><td style="width:1.0%"></td><td style="width:48.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ONSG* Performance</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">To Plan</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1.18pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance Share Units<br>as a Percent of Target</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">138.5%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">200%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61.5%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#60;61.5%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Linear interpolation between points</font></td></tr></table></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*Organic Net Sales Growth</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><div id="i678ea0c6101b45129641a911d96ae1c1_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">APPENDIX B</font></div><div style="padding-right:-18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix B contains supplemental terms and conditions for awards of Units granted under the Boston Scientific Corporation Amended and Restated 2011 Long-Term Incentive Plan (the &#8220;Plan&#8221;) to Participants who reside outside the United States or who are otherwise subject to the laws of a country other than the United States.  Capitalized terms used but not defined herein shall have the same meanings ascribed to them in the Agreement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section I of this Appendix B contains special terms and conditions that govern the Units outside of the United States.  Section II of this Appendix B includes special terms and conditions in the specific countries listed therein. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix B may also include information regarding exchange controls, taxation of awards and certain other issues of which you should be aware with respect to participation in the Plan.  The information is based on the securities, exchange control, tax and other laws concerning the Units in effect as of December 2022.  Such laws are often complex and change frequently&#59; the information may be out of date at the time you vest in the Units or sell shares of Stock acquired under the Plan. As a result, the Company strongly recommends that you not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, this Appendix B is general in nature, does not discuss all of the various laws, rules and regulations which may apply to your particular situation and the Company does not assure you of any particular result.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Accordingly, you should seek appropriate professional advice as to how the relevant laws in your country apply to your specific situation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Finally, if you are a citizen or resident of a country other than the one in which you are currently working, transferred employment after the Award was granted or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to you in the same manner.  In addition, the Company shall, in its sole discretion, determine to what extent the terms and conditions contained herein will apply under these circumstances (or the Company may establish alternative terms and conditions as may be necessary or advisable).  </font></div><div><font><br></font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section I. &#160;&#160;&#160;&#160;All Countries Outside the United States</font></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In accepting the grant, you acknowledge that&#58;</font></div><div style="padding-right:-18pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Administrator at any time, to the extent permitted by the Plan&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the grant of the Units is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants or benefits in lieu of Units, even if Units have been granted in the past&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">all decisions with respect to future grants of Units, if any, will be at the sole discretion of the Administrator&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the grant of the Units and your participation in the Plan shall not create a right to employment or be interpreted as forming an employment or service contract with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company, the Employer or Affiliate and shall not interfere with the ability of the Company, the Employer or any Affiliate, as applicable, to terminate your employment or service relationship (if any)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">you are voluntarily participating in the Plan&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">the Units are not intended to replace any pension rights or compensation&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Units, the underlying shares of Stock, and the income and value of same are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar payments&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the future value of the underlying shares of Stock is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Units resulting from the termination of your employment or other service relationship (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">unless otherwise agreed with the Company in writing, the Units, the underlying shares of Stock and the income from and value of same are not granted as consideration for, or in connection with, any service you may provide as a director of an Affiliate&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">for purposes of the Units, your employment or other service relationship will be considered terminated as of the date you are no longer actively providing services to the Company or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, your right to vest in the Units under this Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., your period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any)&#59; the Committee shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of the Unit grant (including whether you may still be considered to be providing services while on an approved leave of absence)&#59; and</font></div><div style="padding-right:-18pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the following provisions apply only if you are providing services outside the United States&#58; (A) the Units, the underlying shares of Stock, and the income from and value of same are not part of normal or expected compensation or salary for any purpose&#59; and (B) neither the Company, the Employer nor any Affiliate shall be liable for any foreign exchange rate fluctuation between your local currency and the U.S. dollar that may affect the value of the Units or of any amount due to you pursuant to the settlement of the Units or the subsequent sale of any shares of Stock acquired upon settlement.</font></div><div style="padding-left:18pt;padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery of Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may, in its sole discretion, decide to deliver any documents related to the Units granted under and participation in the Plan or future Units that may be granted under the Plan by electronic means or to request your </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">consent to participate in the Plan by electronic means.  You hereby consent to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. </font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You hereby acknowledge and agree that it is your express intent that this Agreement and any applicable Appendix, the Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Units, be drawn up in English. You acknowledge that you are proficient in the English language and understand the terms of this Agreement or have had the ability to consult with an advisor who is sufficiently proficient in the English language. If you have received this Agreement and any applicable Appendix, the Plan or any other documents related to the Units translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge that, depending on your or your broker&#8217;s country of residence or where the shares of Stock are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws that may affect your ability to accept, acquire, sell or otherwise dispose of shares of Stock, rights to those shares of Stock (e.g., Units) or rights linked to the value of shares (e.g., phantom awards, futures) during such times you are considered to have &#8220;inside information&#8221; regarding the Company, as defined in the laws or regulations in your country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed insider information.  Furthermore, you could be prohibited from (i)&#160;disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Keep in mind that third parties include fellow employees.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section II.&#160;&#160;&#160;&#160; Country-Specific Terms and Conditions</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COUNTRIES OUTSIDE THE EUROPEAN UNION (&#8220;EU&#8221;) &#47; EUROPEAN ECONOMIC AREA (&#8220;EEA&#8221;), UNITED KINGDOM AND SWITZERLAND</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  If you do not reside and&#47;or are not employed in the EU &#47; EEA, the United Kingdom or Switzerland, the following provision applies&#58;</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other Unit grant materials by and among, as applicable, the Employer, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that the Company and the Employer may hold certain personal information about you, including (but not limited to) your name, home address, email address and telephone number, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any shares of Stock or directorships held in the Company, and details of all Units awarded to you or any other entitlements to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor (&#8220;Data&#8221;) for the purpose of implementing, managing and administering the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that Data may be transferred to any third parties assisting the Company with the implementation, administration and management of the Plan, including but not limited to E*TRADE Securities LLC (&#8220;E*TRADE&#8221;) or any successor or any other third party that the Company or E*TRADE (or its successor) may engage to assist with the administration of the Plan from time to time.  You understand the recipients of the Data may be located in your country, in the United States or elsewhere, and that the recipients&#8217; country may have different data privacy laws and protections than your country.  You understand that you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative.  </font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares of Stock acquired upon vesting of the Units.  You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consents herein on a purely voluntary basis.  If you do not consent, or if you later revoke your consent, your employment status or service with the Employer will not be adversely affected&#59; the only consequence of refusing or withdrawing your consent is that the Company would not be able to grant you Units or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COUNTRIES WITHIN THE EU &#47; EEA, UNITED KINGDOM AND SWITZERLAND </font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  If you reside and&#47;or are employed in the EU &#47; EEA, the United Kingdom or Switzerland, the following provision applies&#58;</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Pursuant to applicable personal data protection laws, the Company and the Employer hereby notify you of the following in relation to your Personal Data (defined below) and the collection, processing and transfer in electronic or other form of such Personal Data in relation to the grant of the Units and your participation in the Plan.  The collection, processing and transfer of your Personal Data is necessary for the legitimate purpose of the Company and the Employer&#8217;s administration of the Plan and your participation in the Plan, and your denial and&#47;or objection to the collection, processing and transfer of Personal Data may affect your participation in the Plan.  As such, by accepting the Award, you acknowledge the collection, use, processing and transfer of Personal Data as described herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You understand that the Company and the Employer hold certain personally identifiable information about you, specifically, your name, home address and telephone number, date of birth, social security number or other employee </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all Units or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of managing and administering the Plan (&#8220;Personal Data&#8221;). The Personal Data may be provided by you to or collected, where lawful, from third parties.  The Company or the Employer each act as controllers of the Personal Data and will process the Personal Data in this context for the exclusive legitimate purpose of implementing, administering and managing your participation in the Plan and meeting related legal obligations associated with these actions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The processing will take place through electronic and non-electronic means according to logics and procedures correlated to the purposes for which the Personal Data was collected and with confidentiality and security provisions as set forth by applicable laws and regulations.  Personal Data will be accessible within the Company&#8217;s organization only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and other aspects of the employment relationship and for participation in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Company and the Employer will transfer Personal Data amongst themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan, and the Company and the Employer may each further transfer Personal Data to third parties assisting the Company or the Employer in the implementation, administration and management of the Plan, including E*TRADE Securities LLC and its affiliates or any successor or other third party that the Company, the Employer or E*TRADE Securities LLC (or its successor) may engage to assist with the administration of the Plan from time to time.  These recipients may be located in the EU, EEA, the United Kingdom, Switzerland or elsewhere throughout the world, such as the United States.  By participating in the Plan, you understand that these recipients may receive, possess, use, retain and transfer the Personal Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Personal Data as may be required for the administration of the Plan and&#47;or the subsequent holding of shares of Stock on your behalf to a broker or other third party with whom you may elect to deposit any shares of Stock acquired pursuant to the Plan.  You further understand that you may request a list with the names and addresses of any potential recipients of your Personal Data by contacting your local Human Resources manager or the Company&#8217;s Human Resources Department.  When transferring Personal Data to these potential recipients, the Company and the Employer provide appropriate safeguards in accordance with EU Standard Contractual Clauses or other legally binding and permissible arrangements.  You may request a copy of such safeguards from your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">To the extent provided by law, you may, at any time, have the right to request&#58; access to Personal Data, rectification of Personal Data, erasure of Personal Data, restriction of processing of Personal Data, and portability of Personal Data.  You may also have the right to object, on grounds related to a particular situation, to the processing of Personal Data, as well as opt-out of the Plan herein, in any case without cost, by contacting in writing your Human Resources manager.  Your provision of Personal Data is a contractual requirement.  You understand, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to grant the Units to you, or grant other equity awards or administer or maintain such equity awards.  For more information on the consequences of your refusal to provide </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Personal Data, you understand that you may contact your local human resources manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">When the Company and the Employer no longer need to use Personal Data for the purposes above or do not need to retain it for compliance with any legal or regulatory purpose, each will take reasonable steps to remove Personal Data from their systems and&#47;or records containing the Personal Data and&#47;or take steps to properly anonymize it so that you can longer be identified from it.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Units are not granted under the French specific regime provided by Articles L225-197-1 and seq. or L. 22-10-59 and L. 22-10-60 of the French commercial code, as amended.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that it is your express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vous reconnaissez et consentez que c&#8217;est votre souhait expr&#232;s qui cet accord, de meme que tous documents, toutes notifications et tous proc&#233;d&#233;s l&#233;gaux est entr&#233; dans, donn&#233; ou institut&#233; conform&#233;ment ci-annex&#233; ou relatant directement ou indirectement ci-annex&#233;, est formul&#233; dans l&#8217;anglais.</font></div><div style="padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div><div style="padding-right:-18pt"><font><br></font></div><div style="padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406684311-v4&#92;NA_DMS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12.2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ONSG Program</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>6
<FILENAME>exhibit22-subsidiaryissuer.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i821bd862b691481691e2a54eb37d9201_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 22</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiary Issuer of Guaranteed Securities</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Boston Scientific (the &#8220;Registrant&#8221;) is the guarantor of the senior unsecured registered notes listed below issued by American Medical Systems Europe B.V., a wholly-owned finance subsidiary of the Registrant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">American Medical Systems Europe B.V.&#58; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0.750% Senior Notes due 2025</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.375% Senior Notes due 2028</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.625% Senior Notes due 2031</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> 1.875% Senior Notes due 2034&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>exhibit311-ceo302q12023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib784135441c64de4a3639a16ad451ff6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael F. Mahoney, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>exhibit312-cfo302q12023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8f9bcdfd46cb4d659110725f895819d9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel J. Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>exhibit321-ceo906q12023.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i39df8dca87144a1da3e39f90eb247770_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>exhibit322-cfo906q12023.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifc5e4e9fd31d4fe9855bb7a5aaccdae9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2023</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>bsx-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9cbc6555-e4c7-43a3-bb56-c8c16faaf364,g:530e6bfc-c5ff-4de2-ac46-2fa9fa8fd4fc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0000001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited">
        <link:definition>0000002 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsSupplementalDisclosure" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.bostonscientific.com/role/BasisofPresentation">
        <link:definition>0000009 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandStrategicInvestments" roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments">
        <link:definition>0000010 - Disclosure - Acquisitions, Divestitures and Strategic Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000011 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurements" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements">
        <link:definition>0000012 - Disclosure - Hedging Activities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitments" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments">
        <link:definition>0000013 - Disclosure - Contractual Obligations and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation">
        <link:definition>0000014 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bostonscientific.com/role/IncomeTaxes">
        <link:definition>0000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.bostonscientific.com/role/StockholdersEquity">
        <link:definition>0000017 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstanding" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding">
        <link:definition>0000018 - Disclosure - Weighted Average Shares Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.bostonscientific.com/role/SegmentReporting">
        <link:definition>0000019 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bostonscientific.com/role/Revenue">
        <link:definition>0000020 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncome" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome">
        <link:definition>0000021 - Disclosure - Changes in Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements">
        <link:definition>0000022 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationBasisofPresentationPolicies" roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies">
        <link:definition>0000023 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies">
        <link:definition>0000024 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesCommitmentsandContingenciesPolicies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies">
        <link:definition>0000025 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies">
        <link:definition>0000026 - Disclosure - Changes in Other Comprehensive Income Changes in Other Comprehensive Income (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>0000027 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandStrategicInvestmentsTables" roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables">
        <link:definition>0000028 - Disclosure - Acquisitions, Divestitures and Strategic Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillTables" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables">
        <link:definition>0000029 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsTables" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables">
        <link:definition>0000030 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsTables" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables">
        <link:definition>0000031 - Disclosure - Contractual Obligations and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>0000032 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables">
        <link:definition>0000033 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingTables" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables">
        <link:definition>0000034 - Disclosure - Weighted Average Shares Outstanding (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.bostonscientific.com/role/SegmentReportingTables">
        <link:definition>0000035 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bostonscientific.com/role/RevenueTables">
        <link:definition>0000036 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeTables" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables">
        <link:definition>0000037 - Disclosure - Changes in Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetails" roleURI="http://www.bostonscientific.com/role/BasisofPresentationDetails">
        <link:definition>0000038 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresDetails" roleURI="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails">
        <link:definition>0000039 - Disclosure - Acquisitions and Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationDetails" roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails">
        <link:definition>0000040 - Disclosure - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails">
        <link:definition>0000041 - Disclosure - Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails">
        <link:definition>0000042 - Disclosure - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsDetails" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails">
        <link:definition>0000043 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsDetails" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails">
        <link:definition>0000044 - Disclosure - Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationDetails" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails">
        <link:definition>0000045 - Disclosure - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails">
        <link:definition>0000046 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000047 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails">
        <link:definition>0000048 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingDetails" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails">
        <link:definition>0000049 - Disclosure - Weighted Average Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails">
        <link:definition>0000050 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.bostonscientific.com/role/RevenueDetails">
        <link:definition>0000051 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeDetails" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails">
        <link:definition>0000052 - Disclosure - Changes in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_GlobalNeuromodulationNmReportingUnitMember" abstract="true" name="GlobalNeuromodulationNmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" abstract="false" name="ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_CorporateExpensesincludinghedgingactivitiesMember" abstract="true" name="CorporateExpensesincludinghedgingactivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Netcurrencyexchangegainloss" abstract="false" name="Netcurrencyexchangegainloss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2024NotesMember" abstract="true" name="March2024NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_BaylisMedicalMember" abstract="true" name="BaylisMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalEndoscopyEndoReportingUnitMember" abstract="true" name="GlobalEndoscopyEndoReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" abstract="false" name="NetIncomeLossAttributableToBostonScientificCommonStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationTextualsAbstract" abstract="true" name="SupplementalBalanceSheetInformationTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_The2018FacilityDomain" abstract="true" name="The2018FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CardiacRhythmManagementMember" abstract="true" name="CardiacRhythmManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_IndemnificationAsset" abstract="false" name="IndemnificationAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OperatingIncomeAllocatedToReportableSegments" abstract="false" name="OperatingIncomeAllocatedToReportableSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" abstract="false" name="ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" abstract="false" name="DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2026NotesMember" abstract="true" name="March2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_QualifiedAcquisitionConsideration" abstract="false" name="QualifiedAcquisitionConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ApolloMember" abstract="true" name="ApolloMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_AccruedRebatesCurrent" abstract="false" name="AccruedRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" abstract="false" name="ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" abstract="true" name="CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_March2029NotesMember" abstract="true" name="March2029NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2025NotesMember" abstract="true" name="March2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationLiabilityProbabilityOfPayment" abstract="false" name="ContingentConsiderationLiabilityProbabilityOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_LitigationAndDebtExclusionFromEbitda" abstract="false" name="LitigationAndDebtExclusionFromEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RevolvingCreditFacility2021Member" abstract="true" name="RevolvingCreditFacility2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ForeigncurrencydenominatedindebtMember" abstract="true" name="ForeigncurrencydenominatedindebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2028NotesMember" abstract="true" name="March2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalCardiologyReportingUnitMember" abstract="true" name="GlobalCardiologyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_YenDenominatedFactoringArrangementsMember" abstract="true" name="YenDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ActualCovenantMember" abstract="true" name="ActualCovenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CovenantAxis" abstract="true" name="CovenantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RenminbiDenominatedFactoringArrangementsMember" abstract="true" name="RenminbiDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2049NotesMember" abstract="true" name="March2049NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_EquipmentFurnitureAndFixturesGross" abstract="false" name="EquipmentFurnitureAndFixturesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" abstract="false" name="ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_TheOfferingAggregatePrincipalAmountMember" abstract="true" name="TheOfferingAggregatePrincipalAmountMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OtherOtherLongtermAssets" abstract="false" name="OtherOtherLongtermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CurrentRequirementMember" abstract="true" name="CurrentRequirementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" abstract="false" name="ImpactOfForeignCurrencyFluctuationsOnNetSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_IntangibleAssetsandGoodwillLineItems" abstract="true" name="IntangibleAssetsandGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EuroDenominatedFactoringArrangementsMember" abstract="true" name="EuroDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" abstract="false" name="ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" abstract="true" name="TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" abstract="false" name="CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationTable" abstract="true" name="ScheduleofIncomeTaxRateReconciliationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" abstract="true" name="CondensedConsolidatedBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_MaximumLeverageRatio" abstract="false" name="MaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_WatchmanMember" abstract="true" name="WatchmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Paymenttonetsharesettleemployeeequityawards" abstract="false" name="Paymenttonetsharesettleemployeeequityawards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_InventoryStepUpAmortization" abstract="false" name="InventoryStepUpAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementAxis" abstract="true" name="StatementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_OperatingIncomeUnallocatedToSegment" abstract="false" name="OperatingIncomeUnallocatedToSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementDomain" abstract="true" name="StatementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" abstract="true" name="CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EntityAbstract" abstract="true" name="EntityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_GlobalPeripheralInterventionsPiReportingUnitMember" abstract="true" name="GlobalPeripheralInterventionsPiReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2031NotesMember" abstract="true" name="March2031NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LitigationPaymentExclusionFromEBITDA" abstract="false" name="LitigationPaymentExclusionFromEBITDA" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" abstract="false" name="ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationLineItems" abstract="true" name="ScheduleofIncomeTaxRateReconciliationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_AcotecMember" abstract="true" name="AcotecMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LatinAmericaandCanadaMember" abstract="true" name="LatinAmericaandCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Licensingarrangementsliability" abstract="false" name="Licensingarrangementsliability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Segmentoperatingincomeaspercentageofnetsales" abstract="false" name="Segmentoperatingincomeaspercentageofnetsales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_Noncashimpactoftransferredroyaltyrights" abstract="false" name="Noncashimpactoftransferredroyaltyrights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CovenantDomain" abstract="true" name="CovenantDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2034NotesMember" abstract="true" name="March2034NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_BSXReportableSegmentsMember" abstract="true" name="BSXReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_LicensingarrangementassetsMember" abstract="true" name="LicensingarrangementassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_Licensingarrangementsasset" abstract="false" name="Licensingarrangementsasset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Licensingarrangements" abstract="false" name="Licensingarrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_NewAccountingPronouncementsPolicyTextBlock" abstract="false" name="NewAccountingPronouncementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_LicensingarrangementliabilitiesMember" abstract="true" name="LicensingarrangementliabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSixthQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_December2027NotesMember" abstract="true" name="December2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ElectrophysiologyEPMember" abstract="true" name="ElectrophysiologyEPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_PaymentsForRoyaltyRights" abstract="false" name="PaymentsForRoyaltyRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_MedsurgMember" abstract="true" name="MedsurgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SupplierFinanceProgramObligationCurrent" abstract="false" name="SupplierFinanceProgramObligationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_InterventionalCardiologyTherapiesMember" abstract="true" name="InterventionalCardiologyTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_June2030NotesMember" abstract="true" name="June2030NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2028SeniorNotesMember" abstract="true" name="March2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" abstract="false" name="RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RDRegulatoryandCommercializationbasedMilestoneMember" abstract="true" name="RDRegulatoryandCommercializationbasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_November2035NotesMember" abstract="true" name="November2035NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_ExclusionFromEbitdaForRestructuringCharges" abstract="false" name="ExclusionFromEbitdaForRestructuringCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SpecialChargesMember" abstract="true" name="SpecialChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_March2039NotesMember" abstract="true" name="March2039NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" abstract="false" name="SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_DebtInstrumentExtensionOptionTerm" abstract="false" name="DebtInstrumentExtensionOptionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_NumberOfBusinesses" abstract="false" name="NumberOfBusinesses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_OtherNet" abstract="false" name="OtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" abstract="false" name="DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" abstract="false" name="CashProceedsFromIssuanceOfSeniorLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_January2040NotesMember" abstract="true" name="January2040NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_AllBusinessAcquisitionsMember" abstract="true" name="AllBusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_GlobalUrologyandPelvicHealthReportingUnitMember" abstract="true" name="GlobalUrologyandPelvicHealthReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" abstract="false" name="BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DiscountRateFairValueInput" abstract="false" name="DiscountRateFairValueInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bsx_ForwardCurrencyContractsTimetoMaturity" abstract="false" name="ForwardCurrencyContractsTimetoMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_TotalAllocatedToReportableSegmentsMember" abstract="true" name="TotalAllocatedToReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfifthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>bsx-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9cbc6555-e4c7-43a3-bb56-c8c16faaf364,g:530e6bfc-c5ff-4de2-ac46-2fa9fa8fd4fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8d899f11-99a5-4fa1-a0d0-936a211fcbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1d87cc79-8b45-4402-93bf-2c94d74d113b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8d899f11-99a5-4fa1-a0d0-936a211fcbe7" xlink:to="loc_us-gaap_OperatingIncomeLoss_1d87cc79-8b45-4402-93bf-2c94d74d113b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8c31e753-bca2-40d6-b67a-76bb5b27a689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8d899f11-99a5-4fa1-a0d0-936a211fcbe7" xlink:to="loc_us-gaap_InterestExpense_8c31e753-bca2-40d6-b67a-76bb5b27a689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0533c6f4-229f-4b1b-9be5-502431637456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8d899f11-99a5-4fa1-a0d0-936a211fcbe7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0533c6f4-229f-4b1b-9be5-502431637456" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c6a39c64-1fec-4bb9-a77f-be0b8cbd453b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c6fd3038-dad7-4f08-8274-fdedc092df2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c6a39c64-1fec-4bb9-a77f-be0b8cbd453b" xlink:to="loc_us-gaap_GrossProfit_c6fd3038-dad7-4f08-8274-fdedc092df2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_af1daf2b-5854-46fa-b291-443aa41b2b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c6a39c64-1fec-4bb9-a77f-be0b8cbd453b" xlink:to="loc_us-gaap_OperatingExpenses_af1daf2b-5854-46fa-b291-443aa41b2b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_58ba60bc-3cb3-41f9-ac6e-186af5b9602f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6ee0dcef-da93-42ac-9bce-2910a754b16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_58ba60bc-3cb3-41f9-ac6e-186af5b9602f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6ee0dcef-da93-42ac-9bce-2910a754b16d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_835a804c-233b-4e7b-b1fc-2ac300729254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_58ba60bc-3cb3-41f9-ac6e-186af5b9602f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_835a804c-233b-4e7b-b1fc-2ac300729254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dc298bd3-d6b9-458e-9f4c-ce2e711a61e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c0e0b67c-795f-4f08-b7d2-602f1ff4d027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dc298bd3-d6b9-458e-9f4c-ce2e711a61e0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c0e0b67c-795f-4f08-b7d2-602f1ff4d027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_deb69a62-7171-4dc9-9e0b-44d5b641d5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dc298bd3-d6b9-458e-9f4c-ce2e711a61e0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_deb69a62-7171-4dc9-9e0b-44d5b641d5cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ca400bf5-65a5-49ec-84d8-f10e49a96cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ca400bf5-65a5-49ec-84d8-f10e49a96cf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f580a7e9-210d-4a7e-a75d-b7d932a5b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f580a7e9-210d-4a7e-a75d-b7d932a5b5ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_24a54a11-9cca-4203-a0d9-6ea4bb5b9667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:to="loc_us-gaap_RoyaltyExpense_24a54a11-9cca-4203-a0d9-6ea4bb5b9667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3686af09-f3f7-4813-b7d6-17cd492bf57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3686af09-f3f7-4813-b7d6-17cd492bf57a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aea1ae3c-724b-49ef-8f85-0665a2501867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aea1ae3c-724b-49ef-8f85-0665a2501867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6caf5402-72b6-4eb7-88e8-9671af6de862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3e963800-de88-48ea-bc35-0640a230b232" xlink:to="loc_us-gaap_RestructuringCharges_6caf5402-72b6-4eb7-88e8-9671af6de862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_926bfa83-cd68-47d4-ab0b-779b3b564f7c" xlink:href="bsx-20230331.xsd#bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d5034895-cd87-4703-8719-808a658b7032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_926bfa83-cd68-47d4-ab0b-779b3b564f7c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d5034895-cd87-4703-8719-808a658b7032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_654c3657-ab9f-4a6a-af17-a224d74d7973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_926bfa83-cd68-47d4-ab0b-779b3b564f7c" xlink:to="loc_us-gaap_ProfitLoss_654c3657-ab9f-4a6a-af17-a224d74d7973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_508509ee-060f-4a2e-86e1-b6a581d22c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_926bfa83-cd68-47d4-ab0b-779b3b564f7c" xlink:to="loc_us-gaap_DividendsPreferredStockStock_508509ee-060f-4a2e-86e1-b6a581d22c1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df0a2700-c844-4896-ac2e-82ad212204b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e5775f43-067f-46f9-b382-e26b2f00f62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df0a2700-c844-4896-ac2e-82ad212204b6" xlink:to="loc_us-gaap_ProfitLoss_e5775f43-067f-46f9-b382-e26b2f00f62e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8be9968-f8b8-4f73-8392-26ba31be2d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df0a2700-c844-4896-ac2e-82ad212204b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8be9968-f8b8-4f73-8392-26ba31be2d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8c07377c-d460-404d-b598-70b5bcb6fe3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_685689e2-40b1-4948-a7b9-2dee849f2515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8c07377c-d460-404d-b598-70b5bcb6fe3b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_685689e2-40b1-4948-a7b9-2dee849f2515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_4376f10c-1cfb-4d78-b659-92431c72833d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8c07377c-d460-404d-b598-70b5bcb6fe3b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_4376f10c-1cfb-4d78-b659-92431c72833d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23ea6f31-8584-4cd2-b69f-7a99f7e5c83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_881adb90-47d4-433b-9a7d-10e134c69baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23ea6f31-8584-4cd2-b69f-7a99f7e5c83e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_881adb90-47d4-433b-9a7d-10e134c69baa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f2f93825-1f5b-432d-99a2-a34049caa508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23ea6f31-8584-4cd2-b69f-7a99f7e5c83e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f2f93825-1f5b-432d-99a2-a34049caa508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_bf63dbdc-b021-409f-98e5-482de4c93cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_23ea6f31-8584-4cd2-b69f-7a99f7e5c83e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_bf63dbdc-b021-409f-98e5-482de4c93cc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6b7165ba-f409-4611-94f1-4714e0fde67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:to="loc_us-gaap_AssetsCurrent_6b7165ba-f409-4611-94f1-4714e0fde67a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9e2527bf-ea19-4084-91e3-ff4e13ca1705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9e2527bf-ea19-4084-91e3-ff4e13ca1705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6c346f15-86c0-4aa9-8250-01307f6a28fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:to="loc_us-gaap_Goodwill_6c346f15-86c0-4aa9-8250-01307f6a28fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8e6b2d7-6ee0-4785-bc64-a3ffb127c057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8e6b2d7-6ee0-4785-bc64-a3ffb127c057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6283055b-c876-4a60-b810-18f630bcfb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6283055b-c876-4a60-b810-18f630bcfb2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_434a8a49-965b-4145-a403-a66dca89c7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d45be5-ca9a-4aeb-8d87-57d5bfe09828" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_434a8a49-965b-4145-a403-a66dca89c7ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3b31c69c-9a78-48fe-931c-2499e4a7a6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_032cf3b2-e90d-4478-9af7-5055c64489a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b31c69c-9a78-48fe-931c-2499e4a7a6f1" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_032cf3b2-e90d-4478-9af7-5055c64489a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a04efbd-ed92-465f-9e94-e67ac195cb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b31c69c-9a78-48fe-931c-2499e4a7a6f1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a04efbd-ed92-465f-9e94-e67ac195cb87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_938c5b3b-f665-44a2-91ad-814dfa4e0bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b31c69c-9a78-48fe-931c-2499e4a7a6f1" xlink:to="loc_us-gaap_PrepaidTaxes_938c5b3b-f665-44a2-91ad-814dfa4e0bc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2b036164-921d-4984-9217-55a930fc9d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b31c69c-9a78-48fe-931c-2499e4a7a6f1" xlink:to="loc_us-gaap_InventoryNet_2b036164-921d-4984-9217-55a930fc9d42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db9b5520-5597-48e8-ac17-46960040e871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b31c69c-9a78-48fe-931c-2499e4a7a6f1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db9b5520-5597-48e8-ac17-46960040e871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a3e7518e-dd41-4018-9d87-3d49fcbe1b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_321a8231-67e7-414b-b950-5756776a84c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a3e7518e-dd41-4018-9d87-3d49fcbe1b18" xlink:to="loc_us-gaap_DebtCurrent_321a8231-67e7-414b-b950-5756776a84c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2d750aa5-762f-451b-ba31-502eb65d8d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a3e7518e-dd41-4018-9d87-3d49fcbe1b18" xlink:to="loc_us-gaap_AccountsPayableCurrent_2d750aa5-762f-451b-ba31-502eb65d8d6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ec2542d1-c73a-40f2-9980-73059f6602c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a3e7518e-dd41-4018-9d87-3d49fcbe1b18" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ec2542d1-c73a-40f2-9980-73059f6602c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f60be78d-50b3-413e-af7b-85e2df8fe47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a3e7518e-dd41-4018-9d87-3d49fcbe1b18" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f60be78d-50b3-413e-af7b-85e2df8fe47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_950255dd-01bb-4343-96fe-464b75926d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_PreferredStockValue_950255dd-01bb-4343-96fe-464b75926d4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_42999aa9-b602-494e-aa4f-57b5e06174ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_CommonStockValue_42999aa9-b602-494e-aa4f-57b5e06174ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_89a96fca-713e-47bd-9951-d90aa4da49c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_TreasuryStockValue_89a96fca-713e-47bd-9951-d90aa4da49c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fb1b2a91-791a-45e1-8321-d8e533085d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fb1b2a91-791a-45e1-8321-d8e533085d02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2cc8646e-832f-4449-b0c7-8b3e70c366e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2cc8646e-832f-4449-b0c7-8b3e70c366e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bcf3c96d-3d7d-48ec-97aa-021fd7f1ac90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bcf3c96d-3d7d-48ec-97aa-021fd7f1ac90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_91864296-9738-4726-a80b-c859fa3742e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3946a8da-053b-4e4c-92ef-724d5b209bf6" xlink:to="loc_us-gaap_MinorityInterest_91864296-9738-4726-a80b-c859fa3742e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_836ca540-1117-48a6-80a8-fd44137e3a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:to="loc_us-gaap_LiabilitiesCurrent_836ca540-1117-48a6-80a8-fd44137e3a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_56ec76a5-ed48-443e-98ff-a40956cc417d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_56ec76a5-ed48-443e-98ff-a40956cc417d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_17d9d68c-8f7e-4709-9765-08389f7d649d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_17d9d68c-8f7e-4709-9765-08389f7d649d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_396209f4-132c-4d2f-8a9d-91ad0eb0e9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_396209f4-132c-4d2f-8a9d-91ad0eb0e9e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8eca08f1-e9aa-4684-8feb-dc09b4d17031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8eca08f1-e9aa-4684-8feb-dc09b4d17031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f37f4397-2639-4c67-ae8c-fd37438482a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_288207fd-e0ae-44bf-8e37-5a04f9a3b8ae" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f37f4397-2639-4c67-ae8c-fd37438482a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_db7a9f5a-30a7-4248-b5f2-713d546bc857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:to="loc_us-gaap_PreferredStockValue_db7a9f5a-30a7-4248-b5f2-713d546bc857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_05d6d52c-3939-42fd-ae00-5e3d1685c4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:to="loc_us-gaap_CommonStockValue_05d6d52c-3939-42fd-ae00-5e3d1685c4cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d1d1bff1-2eaa-472e-b16d-df64a2a08991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:to="loc_us-gaap_TreasuryStockValue_d1d1bff1-2eaa-472e-b16d-df64a2a08991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_be13236d-bd86-4237-bd27-0c6da066b237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_be13236d-bd86-4237-bd27-0c6da066b237" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_882bd77b-81da-4040-98c2-7da2fd887f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_882bd77b-81da-4040-98c2-7da2fd887f65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_08a0b255-5293-4edc-8dcb-ececddc888f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb5ba432-51bf-466c-9715-41ec1bc60b5a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_08a0b255-5293-4edc-8dcb-ececddc888f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_33038645-edc1-4386-801c-b6272482b362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_33038645-edc1-4386-801c-b6272482b362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_189d19cb-f7b6-46d3-a9bc-e7e4235da8d0" xlink:href="bsx-20230331.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_bsx_PaymentsForRoyaltyRights_189d19cb-f7b6-46d3-a9bc-e7e4235da8d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_773e1d84-acf3-423e-b07d-3aa7608d4769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_773e1d84-acf3-423e-b07d-3aa7608d4769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_3c450324-b509-45e5-ab66-7229b44ec457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_3c450324-b509-45e5-ab66-7229b44ec457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_cdf350dc-e4f5-44bb-b0a2-6b811e04cd18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_cdf350dc-e4f5-44bb-b0a2-6b811e04cd18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_534af97a-82e6-4dd5-aa1c-dabd4771c506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_534af97a-82e6-4dd5-aa1c-dabd4771c506" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_0accbb56-e2bc-4354-a61b-b6a3de34d81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_PaymentsOfDividends_0accbb56-e2bc-4354-a61b-b6a3de34d81a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_f267da12-db0b-428e-87eb-d5c59f005b76" xlink:href="bsx-20230331.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_f267da12-db0b-428e-87eb-d5c59f005b76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_3b05543f-b0cd-4fe7-842e-1c89e4afae0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95974a9e-0c6d-4814-b41f-7cbfae9d2e6d" xlink:to="loc_us-gaap_ProceedsFromStockPlans_3b05543f-b0cd-4fe7-842e-1c89e4afae0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1559dd77-1cfc-456a-8b72-d277901e84b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1559dd77-1cfc-456a-8b72-d277901e84b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_85b899e7-65e8-42fb-bd28-1d06614bd1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_85b899e7-65e8-42fb-bd28-1d06614bd1f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6cfab6d3-fc5e-45e6-8d0c-11b44ed8bc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_GainLossOnInvestments_6cfab6d3-fc5e-45e6-8d0c-11b44ed8bc90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b699049c-9051-4bea-8ca8-7cf027dd8c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_ShareBasedCompensation_b699049c-9051-4bea-8ca8-7cf027dd8c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d1ca2a9f-4c00-400d-85e4-5260aa906175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d1ca2a9f-4c00-400d-85e4-5260aa906175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_10c995ac-1d29-413b-88fb-cc71739c1013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_10c995ac-1d29-413b-88fb-cc71739c1013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_8fe72c1a-4124-4896-8b95-a7f3bb4e785f" xlink:href="bsx-20230331.xsd#bsx_InventoryStepUpAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_bsx_InventoryStepUpAmortization_8fe72c1a-4124-4896-8b95-a7f3bb4e785f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_2d103b3d-511a-47d7-a5e0-167a85e84f71" xlink:href="bsx-20230331.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_2d103b3d-511a-47d7-a5e0-167a85e84f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_03a0bfce-44fe-4444-aead-061a0e1178ad" xlink:href="bsx-20230331.xsd#bsx_OtherNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_bsx_OtherNet_03a0bfce-44fe-4444-aead-061a0e1178ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_36aab06f-54e0-488f-96ee-f17ad294a737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_ProfitLoss_36aab06f-54e0-488f-96ee-f17ad294a737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5de4970b-59bb-44ff-9d5f-92792cf60b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5de4970b-59bb-44ff-9d5f-92792cf60b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d007bd22-59bb-4567-8934-7bb21ce0e9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d007bd22-59bb-4567-8934-7bb21ce0e9b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_61db413a-92de-4996-bf6b-7cd218a06a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a7f59b47-8acf-404d-bbfe-9e00771234b1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_61db413a-92de-4996-bf6b-7cd218a06a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dad7fe4-bb97-443a-858f-c0c9678ec757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_f8f8ed93-abd0-4a3b-87d3-3adbb8585683" xlink:href="bsx-20230331.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dad7fe4-bb97-443a-858f-c0c9678ec757" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_f8f8ed93-abd0-4a3b-87d3-3adbb8585683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_721bc31f-ae37-40c5-9489-27934b583b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dad7fe4-bb97-443a-858f-c0c9678ec757" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_721bc31f-ae37-40c5-9489-27934b583b3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b8317fcc-1ad5-4697-8457-188fde0f98a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dad7fe4-bb97-443a-858f-c0c9678ec757" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b8317fcc-1ad5-4697-8457-188fde0f98a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_0892355f-1b37-4c10-be2f-bd116a4bf5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dad7fe4-bb97-443a-858f-c0c9678ec757" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_0892355f-1b37-4c10-be2f-bd116a4bf5c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d55d15ef-aeca-41a5-bd6a-34c5c2e14ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dad7fe4-bb97-443a-858f-c0c9678ec757" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d55d15ef-aeca-41a5-bd6a-34c5c2e14ff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f3d78fb-717d-47a7-84f9-cc57ac74cf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6d513ab-2f20-4044-86ed-80613d319a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f3d78fb-717d-47a7-84f9-cc57ac74cf6f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6d513ab-2f20-4044-86ed-80613d319a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e65c81a7-2871-492e-b407-50e6b8c0ae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f3d78fb-717d-47a7-84f9-cc57ac74cf6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e65c81a7-2871-492e-b407-50e6b8c0ae8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86381e9f-4b10-4894-9ff1-2a776f50849e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f3d78fb-717d-47a7-84f9-cc57ac74cf6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86381e9f-4b10-4894-9ff1-2a776f50849e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c0cd3f82-6945-40ef-b7e8-9eb61f50df07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0f3d78fb-717d-47a7-84f9-cc57ac74cf6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c0cd3f82-6945-40ef-b7e8-9eb61f50df07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7672d113-44fa-4ce2-babf-118dacdeeab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_23fd0ba5-670a-4b13-8b5b-ac41f5f05e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_7672d113-44fa-4ce2-babf-118dacdeeab8" xlink:to="loc_us-gaap_TaxesPayableCurrent_23fd0ba5-670a-4b13-8b5b-ac41f5f05e62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_e43a08cd-e11e-48ee-af6d-80eca36643cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_7672d113-44fa-4ce2-babf-118dacdeeab8" xlink:to="loc_us-gaap_DeferredRevenueCurrent_e43a08cd-e11e-48ee-af6d-80eca36643cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_a579b5c2-1fd4-4235-8216-f49ed4d08bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_7672d113-44fa-4ce2-babf-118dacdeeab8" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_a579b5c2-1fd4-4235-8216-f49ed4d08bfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_a54f80bd-aa42-4322-a3ce-8e5fac70fc82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_7672d113-44fa-4ce2-babf-118dacdeeab8" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_a54f80bd-aa42-4322-a3ce-8e5fac70fc82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_934b16ab-1529-4cfc-9844-1f27f5a5b12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_28e8808b-5abc-492e-acd7-5a5090f536b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_934b16ab-1529-4cfc-9844-1f27f5a5b12f" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_28e8808b-5abc-492e-acd7-5a5090f536b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_59d83be5-d3b3-4440-857b-b6f420d182dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_934b16ab-1529-4cfc-9844-1f27f5a5b12f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_59d83be5-d3b3-4440-857b-b6f420d182dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_8f6822ee-0d5f-47a2-80de-d1805a03eaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_95d65c2a-13fa-4ac4-9330-8bc61e5da4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8f6822ee-0d5f-47a2-80de-d1805a03eaf1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_95d65c2a-13fa-4ac4-9330-8bc61e5da4ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_806b1fff-6c7e-41e8-9f1d-8c895b50123f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8f6822ee-0d5f-47a2-80de-d1805a03eaf1" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_806b1fff-6c7e-41e8-9f1d-8c895b50123f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_0904e6ec-f10f-4b99-acab-f5ba953e3d94" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8f6822ee-0d5f-47a2-80de-d1805a03eaf1" xlink:to="loc_bsx_Licensingarrangements_0904e6ec-f10f-4b99-acab-f5ba953e3d94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_1aeb02f5-f555-4e33-aebe-464a930e18d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8f6822ee-0d5f-47a2-80de-d1805a03eaf1" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_1aeb02f5-f555-4e33-aebe-464a930e18d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_c3cf2afe-201e-457b-ba01-0c4c79cfd5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_c3cf2afe-201e-457b-ba01-0c4c79cfd5c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_17c31350-74b6-4adf-8fab-09706afcc136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_17c31350-74b6-4adf-8fab-09706afcc136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_494dd17d-54ce-4e7d-b010-3bb410d0042c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_494dd17d-54ce-4e7d-b010-3bb410d0042c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_a48ca8a3-6560-44d6-9fab-30709f274a81" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsliability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_bsx_Licensingarrangementsliability_a48ca8a3-6560-44d6-9fab-30709f274a81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da74fcf1-598c-402b-a7c1-da03f1e8c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da74fcf1-598c-402b-a7c1-da03f1e8c9ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_d1952757-8f45-4425-a30d-12907b362ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_us-gaap_DeferredRevenue_d1952757-8f45-4425-a30d-12907b362ffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_b1ea75ee-531b-44c0-85e7-9e596a45da05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_034e5544-4a3f-43c6-9c85-dbc514acf6e4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_b1ea75ee-531b-44c0-85e7-9e596a45da05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e68eb653-b9b1-42b1-a43e-fedd1ed159d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_59fe1890-4e5e-41ed-8ca6-e37ce2d5f641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e68eb653-b9b1-42b1-a43e-fedd1ed159d6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_59fe1890-4e5e-41ed-8ca6-e37ce2d5f641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f255796c-da15-44a5-8914-3b2ae91d2ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e68eb653-b9b1-42b1-a43e-fedd1ed159d6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f255796c-da15-44a5-8914-3b2ae91d2ae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1ddd9edf-061c-4490-9f41-ce81fd127879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e68eb653-b9b1-42b1-a43e-fedd1ed159d6" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1ddd9edf-061c-4490-9f41-ce81fd127879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b967d2b3-3c3a-422b-9d5d-e91c2c6aae28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_20359640-1fa5-4c67-90b1-b92d0dede861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b967d2b3-3c3a-422b-9d5d-e91c2c6aae28" xlink:to="loc_us-gaap_LitigationReserveCurrent_20359640-1fa5-4c67-90b1-b92d0dede861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c972c2f3-d93c-4915-b66d-1ba026dbc58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b967d2b3-3c3a-422b-9d5d-e91c2c6aae28" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c972c2f3-d93c-4915-b66d-1ba026dbc58e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_927017cb-937b-47e5-864e-96444b3efc06" xlink:href="bsx-20230331.xsd#bsx_AccruedRebatesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b967d2b3-3c3a-422b-9d5d-e91c2c6aae28" xlink:to="loc_bsx_AccruedRebatesCurrent_927017cb-937b-47e5-864e-96444b3efc06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_97eeb329-d7d6-45d5-9614-76d571a9606f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b967d2b3-3c3a-422b-9d5d-e91c2c6aae28" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_97eeb329-d7d6-45d5-9614-76d571a9606f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_498529be-c647-468d-a280-589681c3acf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b967d2b3-3c3a-422b-9d5d-e91c2c6aae28" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_498529be-c647-468d-a280-589681c3acf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_e8c22d36-9f20-4ca9-8e66-6966872479a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_e8c22d36-9f20-4ca9-8e66-6966872479a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9f040594-6ca2-40fe-865f-cbb4612cea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9f040594-6ca2-40fe-865f-cbb4612cea99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c7c6cb3a-a74f-4479-9584-2fcdc30ff41c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_us-gaap_DerivativeAssets_c7c6cb3a-a74f-4479-9584-2fcdc30ff41c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_af4a955c-f638-4edb-b9e0-b8d18f542a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_us-gaap_Investments_af4a955c-f638-4edb-b9e0-b8d18f542a6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_40fee273-fd1f-40cd-8457-61c5aa2327da" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsasset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_bsx_Licensingarrangementsasset_40fee273-fd1f-40cd-8457-61c5aa2327da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IndemnificationAsset_7216765e-fec0-4bf0-84e0-e4b6b9154ea7" xlink:href="bsx-20230331.xsd#bsx_IndemnificationAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_bsx_IndemnificationAsset_7216765e-fec0-4bf0-84e0-e4b6b9154ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_f1e25468-ed17-4af2-bef6-8cf6ab9c1434" xlink:href="bsx-20230331.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_4a71b49d-cd32-46d4-b387-ba519273853d" xlink:to="loc_bsx_OtherOtherLongtermAssets_f1e25468-ed17-4af2-bef6-8cf6ab9c1434" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cc187c4b-5e5c-479a-a0b0-f6be00d28238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d2f765f9-b4a7-418d-ba95-67b2b1355df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cc187c4b-5e5c-479a-a0b0-f6be00d28238" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d2f765f9-b4a7-418d-ba95-67b2b1355df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_563d5927-fcb7-4547-9f72-c0242f7a6bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cc187c4b-5e5c-479a-a0b0-f6be00d28238" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_563d5927-fcb7-4547-9f72-c0242f7a6bc4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a845ed3f-ff17-4663-b7d4-d90bc353201d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25442990-ac69-4f34-b204-d8575b8437ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a845ed3f-ff17-4663-b7d4-d90bc353201d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25442990-ac69-4f34-b204-d8575b8437ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ab0882c5-d588-47ce-99e5-e34dc0750f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a845ed3f-ff17-4663-b7d4-d90bc353201d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ab0882c5-d588-47ce-99e5-e34dc0750f14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc073d1-eef7-4b36-b5ba-0b375bfb73da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_05e868fe-40fb-4fce-92f6-ec074e22fbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc073d1-eef7-4b36-b5ba-0b375bfb73da" xlink:to="loc_us-gaap_OperatingIncomeLoss_05e868fe-40fb-4fce-92f6-ec074e22fbb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_96a9c620-0f5c-43ea-a608-af59ef551b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc073d1-eef7-4b36-b5ba-0b375bfb73da" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_96a9c620-0f5c-43ea-a608-af59ef551b15" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ae9ed596-d881-44f1-b594-24c09d636478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_751f523b-6f99-4e28-a698-ca710bc2e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ae9ed596-d881-44f1-b594-24c09d636478" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_751f523b-6f99-4e28-a698-ca710bc2e509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_e4a40955-adb0-4a72-aef6-b4177b7534dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ae9ed596-d881-44f1-b594-24c09d636478" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_e4a40955-adb0-4a72-aef6-b4177b7534dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_502aaa76-ba0c-465d-8baf-b131159a8f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c88be47f-52d9-4afd-a9a9-3cbbf2dec441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_502aaa76-ba0c-465d-8baf-b131159a8f6b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c88be47f-52d9-4afd-a9a9-3cbbf2dec441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_386d9fed-714c-4276-94f3-b2e5e3141f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_502aaa76-ba0c-465d-8baf-b131159a8f6b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_386d9fed-714c-4276-94f3-b2e5e3141f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9c52b9b1-08dd-4cde-b8ab-0c1ccf46a221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_920ac2f4-1337-4856-b9d5-1f93cae48451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9c52b9b1-08dd-4cde-b8ab-0c1ccf46a221" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_920ac2f4-1337-4856-b9d5-1f93cae48451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_09b45d8d-29aa-4cb8-892f-218543cbf5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9c52b9b1-08dd-4cde-b8ab-0c1ccf46a221" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_09b45d8d-29aa-4cb8-892f-218543cbf5d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fd59292c-d964-4c62-9f09-7ef3c7023b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1b029e8d-9276-4f4f-a614-71f2b067d207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fd59292c-d964-4c62-9f09-7ef3c7023b82" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1b029e8d-9276-4f4f-a614-71f2b067d207" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e6d76d12-d990-4522-a0e6-e8e9ddface47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fd59292c-d964-4c62-9f09-7ef3c7023b82" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e6d76d12-d990-4522-a0e6-e8e9ddface47" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>bsx-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9cbc6555-e4c7-43a3-bb56-c8c16faaf364,g:530e6bfc-c5ff-4de2-ac46-2fa9fa8fd4fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20230331.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i78eb54bfed994e9fb40ef5c696ec5700_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_040b481f-20e4-4af6-862a-9adea5861788" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentType_040b481f-20e4-4af6-862a-9adea5861788" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_cf286d54-f003-4c96-8f9e-651e6fac755a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentQuarterlyReport_cf286d54-f003-4c96-8f9e-651e6fac755a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9275f959-a6a4-4ead-a687-8410f6697854" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentPeriodEndDate_9275f959-a6a4-4ead-a687-8410f6697854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_dbc2c999-5098-4ccb-8c77-c1cabbe82edf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentTransitionReport_dbc2c999-5098-4ccb-8c77-c1cabbe82edf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_cd67bf20-9b64-48cf-b24d-6adabe27603b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityFileNumber_cd67bf20-9b64-48cf-b24d-6adabe27603b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e7c83e41-4473-46cd-b497-cd8c7ebdbdb7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityRegistrantName_e7c83e41-4473-46cd-b497-cd8c7ebdbdb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0752d43b-1b64-4570-859f-a74b17dd8b1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0752d43b-1b64-4570-859f-a74b17dd8b1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4bfa1d5e-9606-4bb1-aab2-6009ad79cb62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityTaxIdentificationNumber_4bfa1d5e-9606-4bb1-aab2-6009ad79cb62" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_22954b0e-24e6-4954-a834-f21c699cc962" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressAddressLine1_22954b0e-24e6-4954-a834-f21c699cc962" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_48f140b8-bb16-45ff-9654-616667db663c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressCityOrTown_48f140b8-bb16-45ff-9654-616667db663c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7afe4a31-c7d5-412f-b7e7-db0b62e5bf3c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressStateOrProvince_7afe4a31-c7d5-412f-b7e7-db0b62e5bf3c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e0bbc2a8-4301-4044-ab89-6785ebd0b10e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressPostalZipCode_e0bbc2a8-4301-4044-ab89-6785ebd0b10e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_34cc935c-9248-49f8-8acd-f934f2ccf7f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_CityAreaCode_34cc935c-9248-49f8-8acd-f934f2ccf7f0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b8f41319-edf0-4259-b59f-b239230d9ba9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_LocalPhoneNumber_b8f41319-edf0-4259-b59f-b239230d9ba9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a24d8d9e-cefd-42c1-be77-9537deff4bc4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_Security12bTitle_a24d8d9e-cefd-42c1-be77-9537deff4bc4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f535203e-9fbb-4c79-aaad-9f1471cd7cac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_TradingSymbol_f535203e-9fbb-4c79-aaad-9f1471cd7cac" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c5e0f858-2267-4a25-b9fd-2714f0bc8858" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_SecurityExchangeName_c5e0f858-2267-4a25-b9fd-2714f0bc8858" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_70824263-04e4-430d-92b3-71137b54ab45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityCurrentReportingStatus_70824263-04e4-430d-92b3-71137b54ab45" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_68e56036-d71b-45c8-bf97-7dd901ad1f4f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityInteractiveDataCurrent_68e56036-d71b-45c8-bf97-7dd901ad1f4f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_bccde279-dd03-4721-94af-bcc8fcc29042" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityFilerCategory_bccde279-dd03-4721-94af-bcc8fcc29042" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_cf96b446-3f3e-4761-8499-1830b8fd0027" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntitySmallBusiness_cf96b446-3f3e-4761-8499-1830b8fd0027" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9948745d-07c9-4e9d-a38c-52fcb7362ba9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityEmergingGrowthCompany_9948745d-07c9-4e9d-a38c-52fcb7362ba9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d2fb423b-e54c-4171-9b4c-acfed5bf679d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityShellCompany_d2fb423b-e54c-4171-9b4c-acfed5bf679d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_a1ec8cd2-3f86-4e57-adec-bb3e5e3e4fa2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityListingParValuePerShare_a1ec8cd2-3f86-4e57-adec-bb3e5e3e4fa2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_19c6b20c-6106-4bad-a44b-458ea4ebc404" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_19c6b20c-6106-4bad-a44b-458ea4ebc404" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_56b2ee3a-3045-4541-b130-c6ce6d6446ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityCentralIndexKey_56b2ee3a-3045-4541-b130-c6ce6d6446ec" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_143e83f3-deff-4533-b10b-2316cc96f266" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_CurrentFiscalYearEndDate_143e83f3-deff-4533-b10b-2316cc96f266" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_8632a8fb-39c7-45fe-b854-841312ccb23b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentFiscalYearFocus_8632a8fb-39c7-45fe-b854-841312ccb23b" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c926c515-7307-472e-b9c9-9484a2fea131" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c926c515-7307-472e-b9c9-9484a2fea131" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7e53e15b-69fd-487a-af4f-28d25bbe5f9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_AmendmentFlag_7e53e15b-69fd-487a-af4f-28d25bbe5f9b" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:to="loc_us-gaap_ClassOfStockDomain_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:to="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b4bd062a-4f23-42e2-be60-f4465522ce00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:to="loc_us-gaap_CommonStockMember_b4bd062a-4f23-42e2-be60-f4465522ce00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_4831b0fd-a217-4008-8b25-c2669fd30cf9" xlink:href="bsx-20230331.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:to="loc_bsx_SeniorNotedue2027Member_4831b0fd-a217-4008-8b25-c2669fd30cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_e6c0721c-573e-4d5b-812d-c3548b6b11c1" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:to="loc_bsx_A550MCPSSeriesAMember_e6c0721c-573e-4d5b-812d-c3548b6b11c1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i63041a05da3548ee9a6339798eff9038_ConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c9db4d3-d211-4d46-99f8-36eb05a30f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c9db4d3-d211-4d46-99f8-36eb05a30f82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_104a7e10-a9d6-45c3-9335-2db8dc5b4bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_104a7e10-a9d6-45c3-9335-2db8dc5b4bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9fdb98fd-33c8-4303-bc0b-71339a8a9232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_GrossProfit_9fdb98fd-33c8-4303-bc0b-71339a8a9232" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f5102f3-0f48-4cc9-8176-68df5ef05acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f5102f3-0f48-4cc9-8176-68df5ef05acb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f69a7ec0-c9ee-4eeb-8f87-f193a8540789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f69a7ec0-c9ee-4eeb-8f87-f193a8540789" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_21f3fea9-5132-43ba-a3f0-9a1b311c7ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_RoyaltyExpense_21f3fea9-5132-43ba-a3f0-9a1b311c7ec5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2634f06d-9eda-4397-91d4-d0e8e7027cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2634f06d-9eda-4397-91d4-d0e8e7027cb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf867b6c-37f1-44e6-9e15-19ca93279866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf867b6c-37f1-44e6-9e15-19ca93279866" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2c3ab73a-af90-4ded-a680-994f4c3e2c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_RestructuringCharges_2c3ab73a-af90-4ded-a680-994f4c3e2c1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6c12618c-805a-451d-90c4-42c54e904438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_OperatingExpenses_6c12618c-805a-451d-90c4-42c54e904438" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e8dc02ed-e61d-4e86-b6e1-3105903a7fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_OperatingIncomeLoss_e8dc02ed-e61d-4e86-b6e1-3105903a7fdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0f22cc31-1523-41f4-8ba9-83fc063abee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:to="loc_us-gaap_InterestExpense_0f22cc31-1523-41f4-8ba9-83fc063abee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e30d4af1-17ea-4e37-84b4-eed313af4dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e30d4af1-17ea-4e37-84b4-eed313af4dcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34bbd1c7-5ad7-4bc1-b9bf-3fc3957c1ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34bbd1c7-5ad7-4bc1-b9bf-3fc3957c1ecf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9f9eee69-f1a0-45d2-8e4e-91b8da9cfd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9f9eee69-f1a0-45d2-8e4e-91b8da9cfd22" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_67120829-76b6-4ab8-bbf3-dedc747440b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_ProfitLoss_67120829-76b6-4ab8-bbf3-dedc747440b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_71c6ab5d-efd3-433b-bef8-8b57b9cabd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_DividendsPreferredStockStock_71c6ab5d-efd3-433b-bef8-8b57b9cabd8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5682c868-a922-4d22-9c0b-6b9f2ad491ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5682c868-a922-4d22-9c0b-6b9f2ad491ee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_c0ea578e-b331-44d7-adc1-3d90c0b916be" xlink:href="bsx-20230331.xsd#bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_c0ea578e-b331-44d7-adc1-3d90c0b916be" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6c8db84f-9861-4abb-bb69-c31bf1189e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_EarningsPerShareBasic_6c8db84f-9861-4abb-bb69-c31bf1189e3e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4696d586-b22a-4deb-998b-f8e349d93fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4696d586-b22a-4deb-998b-f8e349d93fd1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_456cc22a-cacb-4a0b-840e-9502a120ac56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_456cc22a-cacb-4a0b-840e-9502a120ac56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea3df3b8-0c0a-4ec7-ba8b-9c21522ca2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea3df3b8-0c0a-4ec7-ba8b-9c21522ca2e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:to="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7401afc3-fc47-4902-ae9b-d46825ecb8eb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7401afc3-fc47-4902-ae9b-d46825ecb8eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_837aeccc-e370-4e4f-975e-0fc0602fb123" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_837aeccc-e370-4e4f-975e-0fc0602fb123" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="ia56550fbcd8147aeb371f359a43d5ded_ConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3a54fdcb-22c8-4633-acc6-769e8f69c0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_ProfitLoss_3a54fdcb-22c8-4633-acc6-769e8f69c0be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_75731e7f-68cc-48d2-ba90-dcdde9b5dc85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_75731e7f-68cc-48d2-ba90-dcdde9b5dc85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bc6c8591-ae8e-4303-87e1-2225896aeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bc6c8591-ae8e-4303-87e1-2225896aeaba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_473076e6-9dfb-4fa1-8e3e-55ed60afe4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_473076e6-9dfb-4fa1-8e3e-55ed60afe4fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f234ad34-0b23-44cc-92cf-facce8744f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f234ad34-0b23-44cc-92cf-facce8744f32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ba81b25-cd4a-43d0-87db-337a5becfb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ba81b25-cd4a-43d0-87db-337a5becfb34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_ddf38dff-1be0-4e1b-922d-453f7b767039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_ddf38dff-1be0-4e1b-922d-453f7b767039" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_34743f20-a922-4a3b-9bea-7c3368eaaba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_34743f20-a922-4a3b-9bea-7c3368eaaba8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:to="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ff518265-4c1c-42ab-9473-f013fb36f107_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ff518265-4c1c-42ab-9473-f013fb36f107_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e90ffa5f-33e0-4824-9acf-adc64a2fd29e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e90ffa5f-33e0-4824-9acf-adc64a2fd29e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="ifb65a0574db24e4ba069b79d799ebaa6_ConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:to="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_feea5e34-c414-4f24-b828-3936d230f5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_feea5e34-c414-4f24-b828-3936d230f5ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ceae8136-3e06-46d9-ad78-e84e0b350623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ceae8136-3e06-46d9-ad78-e84e0b350623" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_63e70a7f-1a85-46b8-8089-015f448cfac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_InventoryNet_63e70a7f-1a85-46b8-8089-015f448cfac7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_d6ddb452-f05e-4140-87b6-6de244ca823f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_PrepaidTaxes_d6ddb452-f05e-4140-87b6-6de244ca823f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11f76cb4-9cb2-486d-b9bb-fde4eb798adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11f76cb4-9cb2-486d-b9bb-fde4eb798adb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_41061ff7-44e4-4d18-93e3-c19d96daa354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_AssetsCurrent_41061ff7-44e4-4d18-93e3-c19d96daa354" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_01ac58e8-080b-4aa8-9473-c3e4c49d36c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_01ac58e8-080b-4aa8-9473-c3e4c49d36c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4fb60bec-d50b-484e-8105-45566d11cbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_Goodwill_4fb60bec-d50b-484e-8105-45566d11cbf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f8f18c91-3294-4900-8399-7e3e19d981de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f8f18c91-3294-4900-8399-7e3e19d981de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f7dbbc90-8d21-4da7-ae86-53b1c461c966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f7dbbc90-8d21-4da7-ae86-53b1c461c966" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2be35f5b-93e1-4a6f-8576-953749c5e071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2be35f5b-93e1-4a6f-8576-953749c5e071" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_71b89fe5-af10-4af8-a7dc-16bd13c52f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_Assets_71b89fe5-af10-4af8-a7dc-16bd13c52f7c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_801f11fd-8360-4728-9e6c-451e310e2b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_DebtCurrent_801f11fd-8360-4728-9e6c-451e310e2b24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e967d97a-61cc-42f3-98c9-980b64ece17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_AccountsPayableCurrent_e967d97a-61cc-42f3-98c9-980b64ece17c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6cd488ff-524d-45b3-b484-2532b8dd6513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6cd488ff-524d-45b3-b484-2532b8dd6513" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a6f2d32d-fd07-4fab-992b-05994a0dbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a6f2d32d-fd07-4fab-992b-05994a0dbaad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7779d2b9-c6d4-4ece-b0b0-ec54cdc0225a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_LiabilitiesCurrent_7779d2b9-c6d4-4ece-b0b0-ec54cdc0225a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_26d0c4b0-61fc-49a1-b4c2-60e2f1ece7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_26d0c4b0-61fc-49a1-b4c2-60e2f1ece7b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e267ac6a-0992-412e-90bd-1218c67bf77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e267ac6a-0992-412e-90bd-1218c67bf77a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f87b6895-0664-4053-9c0a-2ae8623a98a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f87b6895-0664-4053-9c0a-2ae8623a98a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d025f6f1-7506-4344-8637-c6b3eb86f2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d025f6f1-7506-4344-8637-c6b3eb86f2ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3af54c9e-c7b9-4903-b983-8e08b1959752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_PreferredStockValue_3af54c9e-c7b9-4903-b983-8e08b1959752" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2c3fff88-333b-414d-81b4-6144c99d6356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_CommonStockValue_2c3fff88-333b-414d-81b4-6144c99d6356" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0b0972b8-ed7b-446f-b6f3-e4790bd9dd96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_TreasuryStockValue_0b0972b8-ed7b-446f-b6f3-e4790bd9dd96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_89028c81-9b0f-43a6-b4b4-b9c4a918a5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_89028c81-9b0f-43a6-b4b4-b9c4a918a5a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4bb0f996-d5da-4989-b7b6-47930e57b65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4bb0f996-d5da-4989-b7b6-47930e57b65b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_54283459-9cf7-4ff1-a070-1e95fbd5b9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_54283459-9cf7-4ff1-a070-1e95fbd5b9dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_178a432f-b760-428f-83f2-5b12a1de4ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_StockholdersEquity_178a432f-b760-428f-83f2-5b12a1de4ac2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a8e5dfd9-f84a-4e97-a8c7-f73feb8e2c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_MinorityInterest_a8e5dfd9-f84a-4e97-a8c7-f73feb8e2c7d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1cc29358-6c80-4e48-a4a5-01a49d0226dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1cc29358-6c80-4e48-a4a5-01a49d0226dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_af3f51c2-3e05-4a36-be9c-eb3de10aa336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_af3f51c2-3e05-4a36-be9c-eb3de10aa336" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:to="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:to="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_209f766b-901e-4b93-b0be-3a8116da3bd3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_209f766b-901e-4b93-b0be-3a8116da3bd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ea68d6bb-30d0-4e86-8555-b577e2591395" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ea68d6bb-30d0-4e86-8555-b577e2591395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f777be41-9ad9-4edf-8c83-90aa242c522e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:to="loc_us-gaap_ClassOfStockDomain_f777be41-9ad9-4edf-8c83-90aa242c522e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_73220fe5-dbde-49a1-88d1-3a5362892fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:to="loc_us-gaap_ClassOfStockDomain_73220fe5-dbde-49a1-88d1-3a5362892fe8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i182001772c9244d296d45cf14d14cfff_ConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_99b1a185-303e-4005-8e37-2482cc4db495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_SharesIssued_99b1a185-303e-4005-8e37-2482cc4db495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b8007b74-bf43-4163-a566-08b7b5fdc965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b8007b74-bf43-4163-a566-08b7b5fdc965" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a43f108-f1ee-4bcc-8840-ee743e610f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a43f108-f1ee-4bcc-8840-ee743e610f7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b437db26-c59b-4ab2-8ee8-c5a2496acecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockholdersEquity_b437db26-c59b-4ab2-8ee8-c5a2496acecc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_df29d49a-af5e-4fd1-9b4d-2f38fc9fbf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_df29d49a-af5e-4fd1-9b4d-2f38fc9fbf7a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_eff07eee-1f0a-4338-ade8-d7b7ad2965cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_eff07eee-1f0a-4338-ade8-d7b7ad2965cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_33a7f5b4-1968-49ed-82b1-ea994d90363e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_33a7f5b4-1968-49ed-82b1-ea994d90363e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9e305b6c-140c-4c5a-b127-9088e5b2b120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9e305b6c-140c-4c5a-b127-9088e5b2b120" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a47c59e4-0b62-4fb4-9b5f-c18e044b6b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_CommonStockSharesIssued_a47c59e4-0b62-4fb4-9b5f-c18e044b6b23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_a9378814-00fa-48d1-b319-b3ab5fdee05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_a9378814-00fa-48d1-b319-b3ab5fdee05b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_72484dc6-1e03-4bb5-a2c0-2043ae4a72cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cad97d63-7d5f-4c09-9889-e87b2fa07e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cad97d63-7d5f-4c09-9889-e87b2fa07e67" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0647fc3-cb6d-4402-8a6b-04badc0d760a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df4920b3-6c21-4d37-92c7-6f0a6daaa723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_ProfitLoss_df4920b3-6c21-4d37-92c7-6f0a6daaa723" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_918f8492-2152-42cd-8090-e6fb600fdabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_DividendsPreferredStockCash_918f8492-2152-42cd-8090-e6fb600fdabc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93b75b18-b517-4b14-bb61-ac254b57d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93b75b18-b517-4b14-bb61-ac254b57d7f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_712f9de3-b210-4f8d-8d48-93b1a7d335b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:to="loc_us-gaap_EquityComponentDomain_712f9de3-b210-4f8d-8d48-93b1a7d335b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:to="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_04f28bac-4d7f-4520-a3e0-666fbf0cffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_PreferredStockMember_04f28bac-4d7f-4520-a3e0-666fbf0cffd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d9882fed-2948-43ca-bd1f-bbbb922db60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_CommonStockMember_d9882fed-2948-43ca-bd1f-bbbb922db60a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_30174558-ddaf-403f-8364-1666dc71941a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_30174558-ddaf-403f-8364-1666dc71941a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b6c5d671-e45d-4b20-9da9-1ca4778ee065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_RetainedEarningsMember_b6c5d671-e45d-4b20-9da9-1ca4778ee065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_94f47c89-a59e-449a-a3c6-e70299a0d947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_94f47c89-a59e-449a-a3c6-e70299a0d947" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_01370484-b08a-43b9-ac1b-b705847524dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_01370484-b08a-43b9-ac1b-b705847524dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_624e1ad2-2824-4893-b20b-232a552fd544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_TreasuryStockCommonMember_624e1ad2-2824-4893-b20b-232a552fd544" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i3c94e6ba7b2c4d50adbfea1e3ba81929_ConsolidatedStatementsofCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_395ed7d8-6e16-49d5-b2af-d57ea427f058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_ProfitLoss_395ed7d8-6e16-49d5-b2af-d57ea427f058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c6394bb0-8860-4d04-8807-2f3e4a256c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c6394bb0-8860-4d04-8807-2f3e4a256c22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_f8009e02-7b88-4f3e-beb9-aac0af658492" xlink:href="bsx-20230331.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_f8009e02-7b88-4f3e-beb9-aac0af658492" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bcce778f-5518-4935-9dd4-6f01ee5141be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_ShareBasedCompensation_bcce778f-5518-4935-9dd4-6f01ee5141be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_a6ef1bf6-ba55-4b49-bfa3-a739c689243c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_GainLossOnInvestments_a6ef1bf6-ba55-4b49-bfa3-a739c689243c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5eee6a50-ba45-4039-b1d4-e1bbb9b07772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5eee6a50-ba45-4039-b1d4-e1bbb9b07772" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_56d33c4f-61da-4693-87ca-e6c178d42c25" xlink:href="bsx-20230331.xsd#bsx_InventoryStepUpAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_bsx_InventoryStepUpAmortization_56d33c4f-61da-4693-87ca-e6c178d42c25" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_60435d71-9fcf-47c2-bd23-60d2ef41e968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_60435d71-9fcf-47c2-bd23-60d2ef41e968" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_76385bd7-1371-442e-9efe-6cdf6624cce2" xlink:href="bsx-20230331.xsd#bsx_OtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_bsx_OtherNet_76385bd7-1371-442e-9efe-6cdf6624cce2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9f679ef5-a908-4cb3-8da8-af4a020e4040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9f679ef5-a908-4cb3-8da8-af4a020e4040" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_55bce636-80e8-48d4-9a3f-a65f526fde6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_55bce636-80e8-48d4-9a3f-a65f526fde6b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9e510e3e-ee0f-4a32-9358-b26b10d92ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9e510e3e-ee0f-4a32-9358-b26b10d92ff2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_89cac4e4-02f5-4188-9649-c9a73e295206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_89cac4e4-02f5-4188-9649-c9a73e295206" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30c533b8-3ee7-48a4-a502-eb3732e1f655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30c533b8-3ee7-48a4-a502-eb3732e1f655" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e75846e-6c65-4b61-9727-de48b720edad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e75846e-6c65-4b61-9727-de48b720edad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d9b6043c-8d35-409d-a30d-dafb9f1a45db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d9b6043c-8d35-409d-a30d-dafb9f1a45db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_615c29d5-53cb-4d67-a12e-56f304f60336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_615c29d5-53cb-4d67-a12e-56f304f60336" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8dba98fa-da1e-4550-bdfe-eee51a36ffcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8dba98fa-da1e-4550-bdfe-eee51a36ffcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_73181be5-1d8b-4f2a-99c1-b932091bb926" xlink:href="bsx-20230331.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_73181be5-1d8b-4f2a-99c1-b932091bb926" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ff5094-499e-4c40-bbbc-92ad6a2e5b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ff5094-499e-4c40-bbbc-92ad6a2e5b27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4fe53d6b-9a81-4940-89df-fd5d794295d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4fe53d6b-9a81-4940-89df-fd5d794295d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_03b0af40-691c-4885-8c1b-90fd8c78b475" xlink:href="bsx-20230331.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_bsx_PaymentsForRoyaltyRights_03b0af40-691c-4885-8c1b-90fd8c78b475" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c9c763e2-57c6-4aaa-aab2-95a0d9f69e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c9c763e2-57c6-4aaa-aab2-95a0d9f69e1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_b9339c3a-729b-45aa-af22-c3a84e659e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_b9339c3a-729b-45aa-af22-c3a84e659e29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_138591a3-ae7e-4b87-a5c6-23b1f0c91649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_138591a3-ae7e-4b87-a5c6-23b1f0c91649" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_25c7e172-7f59-45ab-88fe-a1343193cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_25c7e172-7f59-45ab-88fe-a1343193cb5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e4917056-8802-4d69-9f99-1623904157ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_PaymentsOfDividends_e4917056-8802-4d69-9f99-1623904157ea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_973d2607-a677-4e64-ab38-b084977f9acb" xlink:href="bsx-20230331.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_973d2607-a677-4e64-ab38-b084977f9acb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_f7b2efff-fda1-442d-9190-0f8895934c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_ProceedsFromStockPlans_f7b2efff-fda1-442d-9190-0f8895934c61" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_631e6227-31be-49a9-ac71-857511542bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_631e6227-31be-49a9-ac71-857511542bd3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc47483d-a1f2-4ae5-8141-714e83fb576e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc47483d-a1f2-4ae5-8141-714e83fb576e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d87fb9-3af7-4ff7-b566-71f2e513b771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d87fb9-3af7-4ff7-b566-71f2e513b771" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7051cae-cfc0-4f57-a697-15bead05d23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7051cae-cfc0-4f57-a697-15bead05d23a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_966fd017-5262-48cf-b8d8-e68cd1f35642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b99ecbb2-d1bf-444c-94b4-8b9442528edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_62c89d4c-56b6-4286-b826-309421b99ac4" xlink:href="bsx-20230331.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_62c89d4c-56b6-4286-b826-309421b99ac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:to="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f6b86730-156b-4ddc-af9d-26fb5af28b7f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f6b86730-156b-4ddc-af9d-26fb5af28b7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_abe5be52-4b32-4a82-aa28-407d8f44d280" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_abe5be52-4b32-4a82-aa28-407d8f44d280" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofCashFlowsSupplementalDisclosure"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="extended" id="if156294721f04bd8a459d98c28e7a354_ConsolidatedStatementsofCashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_652359ee-432a-4c06-8c32-f6df498881c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_652359ee-432a-4c06-8c32-f6df498881c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f866b1ab-7556-4937-a714-236bb0a55173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f866b1ab-7556-4937-a714-236bb0a55173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_da38fc41-85ca-4bb7-b45f-8fc43503b916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_da38fc41-85ca-4bb7-b45f-8fc43503b916" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25254e9f-569c-4c7a-87b8-80db03ba8b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25254e9f-569c-4c7a-87b8-80db03ba8b52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:href="bsx-20230331.xsd#bsx_StatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:to="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_4037bbd3-b1f8-4233-b08c-0d81561b07d4_default" xlink:href="bsx-20230331.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:to="loc_bsx_StatementDomain_4037bbd3-b1f8-4233-b08c-0d81561b07d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_0b2cb0ee-7154-42b4-a6e9-75860db11d7d" xlink:href="bsx-20230331.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:to="loc_bsx_StatementDomain_0b2cb0ee-7154-42b4-a6e9-75860db11d7d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#AcquisitionsDivestituresandStrategicInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="extended" id="iad1c3bb8812f41a9be8aff891114509a_AcquisitionsDivestituresandStrategicInvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_70469e5e-4951-4058-8d6f-f9568c706a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_70469e5e-4951-4058-8d6f-f9568c706a75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7efc3eea-0673-4490-a14d-f045cb6951bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7efc3eea-0673-4490-a14d-f045cb6951bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a3bdbd5d-ca28-4073-8345-f4828812812c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a3bdbd5d-ca28-4073-8345-f4828812812c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4fb7446a-bea9-40bf-b568-23e6848b0eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4fb7446a-bea9-40bf-b568-23e6848b0eb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_4e0e5ac2-5834-44d8-b6ee-16393ec3544a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_4e0e5ac2-5834-44d8-b6ee-16393ec3544a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_e7775521-2297-473a-8b19-841bca821a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_e7775521-2297-473a-8b19-841bca821a4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f2030936-ddff-4d5b-9b25-589005193415_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f2030936-ddff-4d5b-9b25-589005193415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember_e6e51944-929e-483a-b6ca-b6ec9ddeaa00" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:to="loc_bsx_AcotecMember_e6e51944-929e-483a-b6ca-b6ec9ddeaa00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_ca74cd98-7f4c-40df-a1a1-d7db51036bd5" xlink:href="bsx-20230331.xsd#bsx_BaylisMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:to="loc_bsx_BaylisMedicalMember_ca74cd98-7f4c-40df-a1a1-d7db51036bd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe9a813b-fae5-4840-b750-01ffe50ea2c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe9a813b-fae5-4840-b750-01ffe50ea2c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d7f0c93-3e68-44f0-a449-e0d238720062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d7f0c93-3e68-44f0-a449-e0d238720062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_0ba3c021-4e84-446f-8ace-769589f813c8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:to="loc_srt_OwnershipDomain_0ba3c021-4e84-446f-8ace-769589f813c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_396d5513-cd05-432d-b9be-735b82f0667d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:to="loc_srt_OwnershipDomain_396d5513-cd05-432d-b9be-735b82f0667d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_dba5fabf-c224-469f-af3b-4b0e5e64eef7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:to="loc_us-gaap_ClassOfStockDomain_dba5fabf-c224-469f-af3b-4b0e5e64eef7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0de3d1d7-3cd8-4165-a0c1-676cc0170ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:to="loc_us-gaap_ClassOfStockDomain_0de3d1d7-3cd8-4165-a0c1-676cc0170ef5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended" id="i8bac1c27c2af4228acb7cdeb18860ba2_HedgingActivitiesandFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_c9f2c0c1-afa0-4cc8-a568-ca35db64b572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_c9f2c0c1-afa0-4cc8-a568-ca35db64b572" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2df1a210-07b4-427b-bdf4-9b5de30d2f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2df1a210-07b4-427b-bdf4-9b5de30d2f8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_e6c77896-17f2-4be1-97de-334a2db5a990" xlink:href="bsx-20230331.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_e6c77896-17f2-4be1-97de-334a2db5a990" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b92d59bb-e1d4-482b-b5f1-bf7ce3808def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b92d59bb-e1d4-482b-b5f1-bf7ce3808def" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_802bea24-d27b-49c6-8385-56d660424fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_802bea24-d27b-49c6-8385-56d660424fdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_050b6f33-e674-4ce8-9a70-d639a04c723c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_050b6f33-e674-4ce8-9a70-d639a04c723c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_763e9931-e6df-4623-b62a-32e5d66d94ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_763e9931-e6df-4623-b62a-32e5d66d94ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_da4f552f-0dd8-4954-b686-f67c5574c8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5b3bd3ed-ead1-43e4-8b1d-d82da6040c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_da4f552f-0dd8-4954-b686-f67c5574c8ea" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5b3bd3ed-ead1-43e4-8b1d-d82da6040c01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_da4f552f-0dd8-4954-b686-f67c5574c8ea" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5b157f23-6627-478c-ba6c-724e57c7300e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5b157f23-6627-478c-ba6c-724e57c7300e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_85d1bfe2-e4b1-421e-a474-1052a4447219_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_85d1bfe2-e4b1-421e-a474-1052a4447219_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d49fad92-daa6-4b3f-8e14-ab96693e9a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d49fad92-daa6-4b3f-8e14-ab96693e9a50" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended" id="ia187b42b25504706b8ff70981baaf151_ContractualObligationsandCommitmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_1f7d5a10-1637-4f33-9adf-50a73633f056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_41e02499-d458-42f3-842d-d570164577ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_1f7d5a10-1637-4f33-9adf-50a73633f056" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_41e02499-d458-42f3-842d-d570164577ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_1f7d5a10-1637-4f33-9adf-50a73633f056" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_b3d13030-a08f-473d-8c48-a950d97e2fde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_b3d13030-a08f-473d-8c48-a950d97e2fde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4887f332-9ec9-4796-a086-5706f2dbec15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4887f332-9ec9-4796-a086-5706f2dbec15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_faa71c48-9210-457c-9a20-7d2ea85c5795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4887f332-9ec9-4796-a086-5706f2dbec15" xlink:to="loc_us-gaap_CommercialPaperMember_faa71c48-9210-457c-9a20-7d2ea85c5795" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:to="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1378021b-9293-4def-be0c-5ffcbfe4dfae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1378021b-9293-4def-be0c-5ffcbfe4dfae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6cef02d3-0785-45a2-8e12-4fb2c3c17de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6cef02d3-0785-45a2-8e12-4fb2c3c17de9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended" id="i0fc44184dccf4bb0a3fef2e8dfcac176_IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_03c2ceb5-6cde-4797-a80d-4346d93f7f22" xlink:href="bsx-20230331.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:href="bsx-20230331.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_03c2ceb5-6cde-4797-a80d-4346d93f7f22" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:to="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_73c90a80-3901-434d-89e0-82ae41edb538_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:to="loc_us-gaap_VariableRateDomain_73c90a80-3901-434d-89e0-82ae41edb538_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cb18947f-7b62-401b-b5a6-628908b4f6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:to="loc_us-gaap_VariableRateDomain_cb18947f-7b62-401b-b5a6-628908b4f6ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#AcquisitionsandDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="extended" id="ie0b5b283322240c0b8eb10512a231e6e_AcquisitionsandDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f52fec6b-2c8a-4388-ba6e-6cc61036632b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f52fec6b-2c8a-4388-ba6e-6cc61036632b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e63e06c8-d2c6-4c08-bee3-28bf81d802ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e63e06c8-d2c6-4c08-bee3-28bf81d802ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd68a196-4c8a-4574-a1de-594929263213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd68a196-4c8a-4574-a1de-594929263213" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_01254ba3-3579-406e-9f79-efd8c6d891da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_01254ba3-3579-406e-9f79-efd8c6d891da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f9c1080-bd6d-4960-bdde-13a3d5a86e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f9c1080-bd6d-4960-bdde-13a3d5a86e52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa41de7c-3b14-4529-93f7-53d93b9164db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_Goodwill_aa41de7c-3b14-4529-93f7-53d93b9164db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46ab2f52-ddf3-4575-bfed-8166c4b2a197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46ab2f52-ddf3-4575-bfed-8166c4b2a197" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6eb90ee6-e0b3-4b3e-ab3e-677d5879bfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6eb90ee6-e0b3-4b3e-ab3e-677d5879bfb2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9b74d62-17a9-48c8-83c1-ba7270ac4d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9b74d62-17a9-48c8-83c1-ba7270ac4d47" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7f0924c1-cc4f-4e5e-8037-b679cb04a1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7f0924c1-cc4f-4e5e-8037-b679cb04a1df" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_de8c43ef-8201-4a7c-8ecb-62e8b3545ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_de8c43ef-8201-4a7c-8ecb-62e8b3545ecc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_571ec333-7325-4c80-adcf-2257d28cf020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_571ec333-7325-4c80-adcf-2257d28cf020" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_474c60ed-bd03-4c1b-a7e6-3b3e2bc6e022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_474c60ed-bd03-4c1b-a7e6-3b3e2bc6e022" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_7c1ffe3a-cb7a-472d-9e6c-53fd687ec2ed" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_bsx_DiscountRateFairValueInput_7c1ffe3a-cb7a-472d-9e6c-53fd687ec2ed" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65cbc1b9-f381-47a5-badb-fad3165a9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65cbc1b9-f381-47a5-badb-fad3165a9582" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fc8b321a-4520-45fa-9251-d20b23fb5274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fc8b321a-4520-45fa-9251-d20b23fb5274" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_f79f472c-b871-46ac-ac8f-c5aca8134982" xlink:href="bsx-20230331.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_bsx_PaymentOfContingentConsideration_f79f472c-b871-46ac-ac8f-c5aca8134982" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_9afaf56f-8030-4389-bd3c-37d2c2cf1caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_9afaf56f-8030-4389-bd3c-37d2c2cf1caa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_858194f4-0f8f-4892-a562-c602561dad8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_Cash_858194f4-0f8f-4892-a562-c602561dad8b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b0c6add1-5972-4d30-afe7-2d9f2469c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b0c6add1-5972-4d30-afe7-2d9f2469c65d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d170710e-a87c-4084-9641-e0ca8aeed1d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d170710e-a87c-4084-9641-e0ca8aeed1d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ApolloMember_0e18f355-de8c-4959-a8b1-ce48c867170e" xlink:href="bsx-20230331.xsd#bsx_ApolloMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:to="loc_bsx_ApolloMember_0e18f355-de8c-4959-a8b1-ce48c867170e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_d4bf583f-ec55-4141-bc4f-673618b07874" xlink:href="bsx-20230331.xsd#bsx_BaylisMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:to="loc_bsx_BaylisMedicalMember_d4bf583f-ec55-4141-bc4f-673618b07874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember_a5335df5-6e84-46e0-a116-28b9cc773abf" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:to="loc_bsx_AcotecMember_a5335df5-6e84-46e0-a116-28b9cc773abf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:to="loc_srt_RangeMember_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:to="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5f258ab5-90ba-4d52-9748-125654025a99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:to="loc_srt_MinimumMember_5f258ab5-90ba-4d52-9748-125654025a99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_60079893-69b2-4a96-911f-a0f74933c3df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:to="loc_srt_MaximumMember_60079893-69b2-4a96-911f-a0f74933c3df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_4aa18974-cb25-4cfa-8c95-dcd63009dedc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:to="loc_srt_WeightedAverageMember_4aa18974-cb25-4cfa-8c95-dcd63009dedc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2203084a-d854-4015-8469-171bc2c34245_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2203084a-d854-4015-8469-171bc2c34245_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cb2bb66a-e13d-4cca-bd2f-1dc058964a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cb2bb66a-e13d-4cca-bd2f-1dc058964a0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ca1ac614-0eb8-40ff-b007-41a706aa1a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ca1ac614-0eb8-40ff-b007-41a706aa1a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8c81b63e-d9a0-457c-93f8-74d37290e99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8c81b63e-d9a0-457c-93f8-74d37290e99f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4044ec98-5a3d-4430-bd4d-627390765c55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4044ec98-5a3d-4430-bd4d-627390765c55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6c95f137-0252-47ae-8c17-e289c42bfe87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6c95f137-0252-47ae-8c17-e289c42bfe87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_3e79be15-e1f8-4e74-8010-7941a89620df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_3e79be15-e1f8-4e74-8010-7941a89620df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab6140a7-de5e-4aa0-80bf-761686a4f705_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:to="loc_us-gaap_SegmentDomain_ab6140a7-de5e-4aa0-80bf-761686a4f705_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_376363d6-7840-42b4-83db-7fd2d67e9329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:to="loc_us-gaap_SegmentDomain_376363d6-7840-42b4-83db-7fd2d67e9329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_012dffaf-b0f2-473e-ac86-6aea87dc1d92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_012dffaf-b0f2-473e-ac86-6aea87dc1d92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b63a39f3-2898-4f09-922b-5f3788412bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b63a39f3-2898-4f09-922b-5f3788412bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f363bba-288f-407f-a798-414b7a5d10bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f363bba-288f-407f-a798-414b7a5d10bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d94ce9c-4c6e-4d7f-a5ae-dd5c2ebd4d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d94ce9c-4c6e-4d7f-a5ae-dd5c2ebd4d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f3202e43-39f3-4771-8119-bfddd0caf237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f3202e43-39f3-4771-8119-bfddd0caf237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_60136275-6268-44fa-8dbe-3eaa1b999260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_60136275-6268-44fa-8dbe-3eaa1b999260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6cc66ae3-f24d-42d1-8bc8-f86ac10ff347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_60136275-6268-44fa-8dbe-3eaa1b999260" xlink:to="loc_us-gaap_SubsequentEventMember_6cc66ae3-f24d-42d1-8bc8-f86ac10ff347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_12c8792d-e736-450e-bb50-49f49d401281_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:to="loc_srt_OwnershipDomain_12c8792d-e736-450e-bb50-49f49d401281_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2a624246-9250-46c0-a0fd-64e4b1d5760c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:to="loc_srt_OwnershipDomain_2a624246-9250-46c0-a0fd-64e4b1d5760c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember_dfbd0e6e-d74b-435d-9041-1e4425aa708c" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_2a624246-9250-46c0-a0fd-64e4b1d5760c" xlink:to="loc_bsx_AcotecMember_dfbd0e6e-d74b-435d-9041-1e4425aa708c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended" id="ifcfbba0e28dc44cf9820c2db3624514c_ContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d4a81ea9-2e43-4c43-b5d9-62455dae024e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d4a81ea9-2e43-4c43-b5d9-62455dae024e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8cbca641-a3bb-4233-9ee8-915b1a4b5193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8cbca641-a3bb-4233-9ee8-915b1a4b5193" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_e3ebe7c4-453f-4055-85a6-503b2107a4a7" xlink:href="bsx-20230331.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_bsx_PaymentOfContingentConsideration_e3ebe7c4-453f-4055-85a6-503b2107a4a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f9329242-976d-4e94-83c8-586e1d3867a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50047745-3b52-4fc4-8c34-f72da7d97d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50047745-3b52-4fc4-8c34-f72da7d97d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9071b0c6-f29d-4215-8b12-ac7c8e231016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_b0520a50-87fc-413f-a028-1433a54b24f7" xlink:href="bsx-20230331.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_b0520a50-87fc-413f-a028-1433a54b24f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_1604b897-aa3f-4754-b3b7-94eeb68de29f" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:to="loc_bsx_DiscountRateFairValueInput_1604b897-aa3f-4754-b3b7-94eeb68de29f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_22296dd6-9aea-4317-aeed-335e535f2a10_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:to="loc_srt_RangeMember_22296dd6-9aea-4317-aeed-335e535f2a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:to="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b342cc71-9353-4a44-b1fe-b8575e459850" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:to="loc_srt_MinimumMember_b342cc71-9353-4a44-b1fe-b8575e459850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d9e138c2-4677-4109-9d60-3583cded856d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:to="loc_srt_MaximumMember_d9e138c2-4677-4109-9d60-3583cded856d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_0e427954-9847-43cf-87c1-eb7ba5187521" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:to="loc_srt_WeightedAverageMember_0e427954-9847-43cf-87c1-eb7ba5187521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0363c38a-a9f5-4d9f-b703-63623335f4f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:to="loc_us-gaap_ValuationTechniqueDomain_0363c38a-a9f5-4d9f-b703-63623335f4f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_888a9f70-fa56-4073-9b5b-06b4f9c02ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:to="loc_us-gaap_ValuationTechniqueDomain_888a9f70-fa56-4073-9b5b-06b4f9c02ab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c3323181-36fa-4f25-96ee-14678df91e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_888a9f70-fa56-4073-9b5b-06b4f9c02ab6" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c3323181-36fa-4f25-96ee-14678df91e38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95d65818-729d-4d69-851d-e7f03a14dc2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95d65818-729d-4d69-851d-e7f03a14dc2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd97541-458b-4afd-adb4-0b4974e5b7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd97541-458b-4afd-adb4-0b4974e5b7d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllBusinessAcquisitionsMember_a6083079-187d-47e2-8fab-f5eafb03eef3" xlink:href="bsx-20230331.xsd#bsx_AllBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd97541-458b-4afd-adb4-0b4974e5b7d7" xlink:to="loc_bsx_AllBusinessAcquisitionsMember_a6083079-187d-47e2-8fab-f5eafb03eef3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_aab5ffd1-b801-4b13-bef7-40c27205631d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_aab5ffd1-b801-4b13-bef7-40c27205631d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_1a1fce8e-6417-4090-9815-06d34a82b496" xlink:href="bsx-20230331.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_1a1fce8e-6417-4090-9815-06d34a82b496" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_dbacc252-0a93-45bd-a271-716015f2750a" xlink:href="bsx-20230331.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:to="loc_bsx_RevenueBasedPaymentsMember_dbacc252-0a93-45bd-a271-716015f2750a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_604f488e-8de2-430f-a0b7-cd606b5517ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_604f488e-8de2-430f-a0b7-cd606b5517ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_45b2e89b-61d7-40d5-8a72-d144886109f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_45b2e89b-61d7-40d5-8a72-d144886109f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f6426809-d640-473f-9fd7-507ad21db336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_45b2e89b-61d7-40d5-8a72-d144886109f0" xlink:to="loc_us-gaap_SubsequentEventMember_f6426809-d640-473f-9fd7-507ad21db336" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#StrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended" id="i2339b77d2f2a4adbba394e0c45393187_StrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_39845a8e-e044-42f9-90c2-28447f87e7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_EquityMethodInvestments_39845a8e-e044-42f9-90c2-28447f87e7ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_05e9fbc9-1808-40d0-bd76-49ae2dd73727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_05e9fbc9-1808-40d0-bd76-49ae2dd73727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_5a34fc9d-e27b-4c67-b996-ff11113fcdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_Investments_5a34fc9d-e27b-4c67-b996-ff11113fcdc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_722d543e-e5a1-482a-9690-554d1e9e177a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_722d543e-e5a1-482a-9690-554d1e9e177a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f6381495-3937-4352-b7ba-e84fc6951228_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f6381495-3937-4352-b7ba-e84fc6951228_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_51919f53-2263-4560-ace1-058e88b5140b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_51919f53-2263-4560-ace1-058e88b5140b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b54e67ae-4ca5-4290-b39b-4293bc6a5e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_51919f53-2263-4560-ace1-058e88b5140b" xlink:to="loc_us-gaap_SubsequentEventMember_b54e67ae-4ca5-4290-b39b-4293bc6a5e78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c48cedfd-6398-48e2-b234-bc00b3763d30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c48cedfd-6398-48e2-b234-bc00b3763d30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4924747-a454-4c3f-afcf-3e8937b97b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4924747-a454-4c3f-afcf-3e8937b97b98" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="i8bb9bc986a9547388eaf9e0b93dd2aae_GoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:href="bsx-20230331.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_76993079-993c-46f1-92c8-e71cdec0f63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_76993079-993c-46f1-92c8-e71cdec0f63b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5b250bbf-4642-43f8-b82d-4a601c90ee05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5b250bbf-4642-43f8-b82d-4a601c90ee05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_e31a40c2-f753-4211-a35d-e3ae2762bba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_GoodwillGross_e31a40c2-f753-4211-a35d-e3ae2762bba4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5983104-3dc3-4ee8-996c-440f6bf872b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5983104-3dc3-4ee8-996c-440f6bf872b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dcc72f85-28a6-44d8-a9b9-6a707bf2b0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dcc72f85-28a6-44d8-a9b9-6a707bf2b0a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f97c0e5c-44aa-4de0-ac93-958d5757a368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_Goodwill_f97c0e5c-44aa-4de0-ac93-958d5757a368" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_47358a94-0c15-446d-9cdf-4b40dfe75baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_47358a94-0c15-446d-9cdf-4b40dfe75baa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_275873e9-2c96-42e2-9846-da2127252849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_275873e9-2c96-42e2-9846-da2127252849" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7f503050-61ae-4664-bad9-9c3743973633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bfe7f4bb-8fe9-48d3-89d9-453906a6f24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_NumberOfReportableSegments_bfe7f4bb-8fe9-48d3-89d9-453906a6f24e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3edaa9d-45af-496e-af16-2b8246207324_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3edaa9d-45af-496e-af16-2b8246207324_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7606ef62-b95c-49f3-99cf-8f285971e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7606ef62-b95c-49f3-99cf-8f285971e2ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_614d2e3e-bb57-4bfd-a911-8e4ae91619eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:to="loc_us-gaap_PatentsMember_614d2e3e-bb57-4bfd-a911-8e4ae91619eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a269abaf-bf78-45ae-a46c-54f13eacdd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a269abaf-bf78-45ae-a46c-54f13eacdd1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_57c938c0-4abc-4f1a-bbdd-81229bb1696b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_57c938c0-4abc-4f1a-bbdd-81229bb1696b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_645818b8-07f0-4721-b34d-23bdb25c23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:to="loc_us-gaap_GoodwillMember_645818b8-07f0-4721-b34d-23bdb25c23f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d8af9a69-eb67-4a0d-8930-46b5dd3448ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d8af9a69-eb67-4a0d-8930-46b5dd3448ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_577b2e41-069b-411a-956f-c6391a0abaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_577b2e41-069b-411a-956f-c6391a0abaa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:to="loc_us-gaap_SegmentDomain_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:to="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_f862414a-2e26-47dc-a3bd-aaf94117c71e" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:to="loc_bsx_MedsurgMember_f862414a-2e26-47dc-a3bd-aaf94117c71e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_f2fd4373-07b8-4437-befc-9d31f2c7f6d3" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:to="loc_bsx_CardiovascularMember_f2fd4373-07b8-4437-befc-9d31f2c7f6d3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended" id="i69f347ac8c8b4e39ab9ac21c6d905090_HedgingActivitiesandFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f37a0b10-5949-4944-a7dc-916766e1cb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_LongTermDebt_f37a0b10-5949-4944-a7dc-916766e1cb2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4e538087-23b6-4ffa-9a1c-b4a4200f9fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4e538087-23b6-4ffa-9a1c-b4a4200f9fd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_faaae123-6c34-49d7-a529-cee5b72239bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeTermOfContract_faaae123-6c34-49d7-a529-cee5b72239bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_a7901080-465a-4bae-bfd8-7f73317aaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_a7901080-465a-4bae-bfd8-7f73317aaa85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_b2c8a681-78c0-417e-b427-645035f07e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_b2c8a681-78c0-417e-b427-645035f07e2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8cfcc8fb-ba8d-4e70-9cea-bdf9c7f16b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8cfcc8fb-ba8d-4e70-9cea-bdf9c7f16b91" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_66bb0674-a9fb-4bc9-aebf-de71c061c7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_66bb0674-a9fb-4bc9-aebf-de71c061c7d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_ab6e02a9-b0d6-4e34-94ae-d4c7ac798b06" xlink:href="bsx-20230331.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_ab6e02a9-b0d6-4e34-94ae-d4c7ac798b06" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_a7b36140-4588-4c57-9237-21bfd421e0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_a7b36140-4588-4c57-9237-21bfd421e0f1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d072e343-0bd1-41a1-8d4e-afe487e3557b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d072e343-0bd1-41a1-8d4e-afe487e3557b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_50ef7ef9-38e7-43e4-9262-80bfafc55a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_50ef7ef9-38e7-43e4-9262-80bfafc55a79" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3b389402-6b0b-4980-acf4-2ed49f4bec4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3b389402-6b0b-4980-acf4-2ed49f4bec4c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e2780699-493e-4711-b2b9-ac452e27dcda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e2780699-493e-4711-b2b9-ac452e27dcda" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ad2adcf4-379b-41e0-8aa7-2baefbd9716b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ad2adcf4-379b-41e0-8aa7-2baefbd9716b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_d5edd886-1161-42d2-a4cb-c0d898a4e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_d5edd886-1161-42d2-a4cb-c0d898a4e78a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b3178381-e838-4e9f-aeb1-32291222d1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b3178381-e838-4e9f-aeb1-32291222d1b5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c07c11a2-1e15-4abb-ae36-fbdc7c282fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c07c11a2-1e15-4abb-ae36-fbdc7c282fd7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_6c357e13-dda4-4509-b4b2-71d9a250183d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_6c357e13-dda4-4509-b4b2-71d9a250183d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_515986bb-e0ea-4e70-8dee-180a4ee28da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_515986bb-e0ea-4e70-8dee-180a4ee28da0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c239f783-1f37-49c4-a2c1-ecab0389f007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_InterestExpense_c239f783-1f37-49c4-a2c1-ecab0389f007" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_fcbd22b2-7273-46f4-a2b4-d014e296be7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_fcbd22b2-7273-46f4-a2b4-d014e296be7a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_c87e8a96-8db1-4785-b615-6e03d5b839e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_c87e8a96-8db1-4785-b615-6e03d5b839e2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_4e7abb3f-097b-496d-adda-087ed9df5259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_4e7abb3f-097b-496d-adda-087ed9df5259" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f49c7c8b-fdf4-4218-b6c2-28d75993f385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f49c7c8b-fdf4-4218-b6c2-28d75993f385" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_862c42df-9003-42c2-89e6-e43f0ccbb5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_862c42df-9003-42c2-89e6-e43f0ccbb5b1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a558a962-33e9-4bab-898d-771e13cf33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a558a962-33e9-4bab-898d-771e13cf33a0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_d29f3538-6fc5-45cd-8150-79969bd08bb1" xlink:href="bsx-20230331.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_d29f3538-6fc5-45cd-8150-79969bd08bb1" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_d4d5c557-1cc6-4cd9-a996-4ad2fa18c86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_d4d5c557-1cc6-4cd9-a996-4ad2fa18c86a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e6cb9cb-c271-40b3-bfca-d6bf5efaec0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e6cb9cb-c271-40b3-bfca-d6bf5efaec0f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_ce244c07-9a80-422e-a0bb-6a3dbfa039f2" xlink:href="bsx-20230331.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_bsx_Netcurrencyexchangegainloss_ce244c07-9a80-422e-a0bb-6a3dbfa039f2" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_e98c8f91-816a-4928-917a-4c7ed4aa4813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_e98c8f91-816a-4928-917a-4c7ed4aa4813" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_b5040e41-e818-4a9a-9af3-37c51236c3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_b5040e41-e818-4a9a-9af3-37c51236c3e9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e02a82d2-b28c-42c8-a8a2-4f65e8ea43e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e02a82d2-b28c-42c8-a8a2-4f65e8ea43e2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_31b3b253-de06-49ca-b59b-8e27efd23f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_31b3b253-de06-49ca-b59b-8e27efd23f07" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_71fda03d-5b8c-4f4d-87f9-deeee6464661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_71fda03d-5b8c-4f4d-87f9-deeee6464661" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5a77cf6a-7404-481a-8858-db71b297fa97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5a77cf6a-7404-481a-8858-db71b297fa97" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ef391693-560b-4e16-a5b9-6da502384a77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ef391693-560b-4e16-a5b9-6da502384a77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:to="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_653a1742-bddf-4fcf-ba31-4da8fa6a3692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:to="loc_us-gaap_CashFlowHedgingMember_653a1742-bddf-4fcf-ba31-4da8fa6a3692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1f329dbe-596a-495a-9dcb-231236d0e44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1f329dbe-596a-495a-9dcb-231236d0e44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3fc50ede-d2a3-47fe-9648-68a13c2d09c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:to="loc_us-gaap_HedgingDesignationDomain_3fc50ede-d2a3-47fe-9648-68a13c2d09c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:to="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_624385ac-c65c-4a1f-a415-b275be6247cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_624385ac-c65c-4a1f-a415-b275be6247cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_faf31f12-d2c6-43bc-acd7-8024e52b5e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:to="loc_us-gaap_NondesignatedMember_faf31f12-d2c6-43bc-acd7-8024e52b5e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6eb7a25f-639e-488a-a895-d33c20c7b744_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6eb7a25f-639e-488a-a895-d33c20c7b744_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f706861c-6209-4912-8d38-0250cc423a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f706861c-6209-4912-8d38-0250cc423a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_815a8a23-d4de-47bd-952a-510e3c49dcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_ForeignExchangeContractMember_815a8a23-d4de-47bd-952a-510e3c49dcd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_b51240c1-85a3-4db8-950b-8babdd5bc344" xlink:href="bsx-20230331.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_b51240c1-85a3-4db8-950b-8babdd5bc344" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_8cc04df6-f5a9-488e-a74f-70e28df5c0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_InterestRateContractMember_8cc04df6-f5a9-488e-a74f-70e28df5c0f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_0f1224a2-7e3f-49bc-8673-b407c3f7883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_0f1224a2-7e3f-49bc-8673-b407c3f7883a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_99e00cdd-67d8-45b3-b5ff-3923b3308102_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_99e00cdd-67d8-45b3-b5ff-3923b3308102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_92a197e2-72ef-43de-8a93-e92946580824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_92a197e2-72ef-43de-8a93-e92946580824" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_13d4a74e-2605-4043-98d3-1602130f815b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_13d4a74e-2605-4043-98d3-1602130f815b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_af7f1200-bf13-48f0-8367-56747ad6a0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_af7f1200-bf13-48f0-8367-56747ad6a0ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_066ca0fa-7efd-4101-8cdc-654abb97c64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_066ca0fa-7efd-4101-8cdc-654abb97c64a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7e4466de-7605-428d-81eb-d97d078839d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7e4466de-7605-428d-81eb-d97d078839d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b1917f76-304f-4755-9a66-4a28615895b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:to="loc_us-gaap_CostOfSalesMember_b1917f76-304f-4755-9a66-4a28615895b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d607d9e4-33a3-418f-b23b-86a2a9e718e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:to="loc_us-gaap_InterestExpenseMember_d607d9e4-33a3-418f-b23b-86a2a9e718e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_247bc4f6-24fe-43e7-bf46-e62fe6868109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_247bc4f6-24fe-43e7-bf46-e62fe6868109" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5e49d94-7393-4c5d-827e-39b45d8f2e55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5e49d94-7393-4c5d-827e-39b45d8f2e55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86c992d8-b592-4a91-a2e0-e2a4d40fcbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86c992d8-b592-4a91-a2e0-e2a4d40fcbaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_f366f2d9-4c29-4d66-8f74-a102a4972ee6" xlink:href="bsx-20230331.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86c992d8-b592-4a91-a2e0-e2a4d40fcbaf" xlink:to="loc_bsx_December2027NotesMember_f366f2d9-4c29-4d66-8f74-a102a4972ee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:to="loc_us-gaap_EquityComponentDomain_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_762ddb8e-163c-4663-957f-cf170a2a5057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:to="loc_us-gaap_EquityComponentDomain_762ddb8e-163c-4663-957f-cf170a2a5057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dae79b2a-508b-46d5-88e0-cec1376fe830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_762ddb8e-163c-4663-957f-cf170a2a5057" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dae79b2a-508b-46d5-88e0-cec1376fe830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_ed2364b4-1b93-46e3-8f2b-ca77f24ddb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_ed2364b4-1b93-46e3-8f2b-ca77f24ddb82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_10ea0d7c-a145-4c04-9ac5-c2eda6e44aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_10ea0d7c-a145-4c04-9ac5-c2eda6e44aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_fe90b38b-e197-47ed-b3e0-99c961cba1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_DerivativeAssets_fe90b38b-e197-47ed-b3e0-99c961cba1bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_52c8f1c4-dd09-4d7e-94ca-91bff1cad42c" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsasset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_Licensingarrangementsasset_52c8f1c4-dd09-4d7e-94ca-91bff1cad42c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_15a92cb4-299b-4fab-8c2a-e71bc964d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_15a92cb4-299b-4fab-8c2a-e71bc964d24b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ef10d7b2-f183-4124-b9be-bb3acc7c5ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_DerivativeLiabilities_ef10d7b2-f183-4124-b9be-bb3acc7c5ead" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bee9b014-d283-48d0-9120-38c6d156fe32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bee9b014-d283-48d0-9120-38c6d156fe32" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_724e8856-8a53-4a32-92d2-1447ad2a3d6b" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsliability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_Licensingarrangementsliability_724e8856-8a53-4a32-92d2-1447ad2a3d6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_20a313d7-daab-406f-b1dc-fba8d490ac9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_PaymentsForRoyalties_20a313d7-daab-406f-b1dc-fba8d490ac9f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_77142788-bd3e-491f-8b05-f4887fe277a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_77142788-bd3e-491f-8b05-f4887fe277a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_7bf5bc2a-fce1-4bd1-8654-795c98a63fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_Cash_7bf5bc2a-fce1-4bd1-8654-795c98a63fa7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_b0e42dfd-40fe-4fca-be07-d55cce66c2a1" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_DiscountRateFairValueInput_b0e42dfd-40fe-4fca-be07-d55cce66c2a1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_42298032-7bfc-437d-9b43-de3e6c5f9ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_42298032-7bfc-437d-9b43-de3e6c5f9ca4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_c5996111-807f-4a4c-a4aa-6bfaf007f4f6" xlink:href="bsx-20230331.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_c5996111-807f-4a4c-a4aa-6bfaf007f4f6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_98864273-e045-4163-80b6-22be36803b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_98864273-e045-4163-80b6-22be36803b1f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_543f1623-e888-42bf-8e03-a0396a3dba63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_DebtInstrumentFairValue_543f1623-e888-42bf-8e03-a0396a3dba63" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b6e7e87-db7b-4c5e-ba9c-708b8280e053_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:to="loc_srt_RangeMember_9b6e7e87-db7b-4c5e-ba9c-708b8280e053_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:to="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_7e230637-5647-4281-81fb-95f26a741e1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:to="loc_srt_WeightedAverageMember_7e230637-5647-4281-81fb-95f26a741e1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c1bba7f9-0c83-4463-955a-715ef4742b7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:to="loc_srt_MinimumMember_c1bba7f9-0c83-4463-955a-715ef4742b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d235820-e0b2-4281-8c55-584ef75224e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:to="loc_srt_MaximumMember_2d235820-e0b2-4281-8c55-584ef75224e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_aa52279b-35a5-42f2-8e31-3a12f0b1d43c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_aa52279b-35a5-42f2-8e31-3a12f0b1d43c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_12abbdd4-f1f9-4ce6-bba6-73977f567546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_12abbdd4-f1f9-4ce6-bba6-73977f567546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_90935077-8703-4b79-bbfe-4a8d19350d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_12abbdd4-f1f9-4ce6-bba6-73977f567546" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_90935077-8703-4b79-bbfe-4a8d19350d04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0ec12466-6b4b-4f8b-8cb7-54026d038371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0ec12466-6b4b-4f8b-8cb7-54026d038371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ff13f901-6969-4351-8075-5822b1c5d9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ff13f901-6969-4351-8075-5822b1c5d9bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_359608c8-da40-47b6-ab4e-f4889a23d5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_359608c8-da40-47b6-ab4e-f4889a23d5fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de9fb9bd-17a9-496b-bbd0-a6443f74664b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de9fb9bd-17a9-496b-bbd0-a6443f74664b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_75001f5f-e203-4d59-8bf2-0dfac87cf325" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:to="loc_bsx_LicensingarrangementassetsMember_75001f5f-e203-4d59-8bf2-0dfac87cf325" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_55ce964e-5eac-4125-ae08-4a0ae1673843" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_55ce964e-5eac-4125-ae08-4a0ae1673843" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended" id="i328d447948d74fdc82da852fe06e8934_ContractualObligationsandCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_f94d3f0b-9860-41ee-8efa-105fc302c5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_f94d3f0b-9860-41ee-8efa-105fc302c5cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_267809e6-9979-4310-9fb7-10aab9d8fc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtCurrent_267809e6-9979-4310-9fb7-10aab9d8fc21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c4f0d8d0-bcb5-4df0-8efc-5eeda49216bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LongTermDebt_c4f0d8d0-bcb5-4df0-8efc-5eeda49216bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c336a9f0-a935-4570-82f3-03d25505b121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c336a9f0-a935-4570-82f3-03d25505b121" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4270736a-3265-4c32-adc3-fa990c596902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4270736a-3265-4c32-adc3-fa990c596902" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c6647d7c-0062-48e0-8986-1e7593ba3d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c6647d7c-0062-48e0-8986-1e7593ba3d9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f3872cac-a281-4078-9229-3d81d161f344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f3872cac-a281-4078-9229-3d81d161f344" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm_68bf51d6-b207-4fa4-ab9a-1d7e3a0e456c" xlink:href="bsx-20230331.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_DebtInstrumentExtensionOptionTerm_68bf51d6-b207-4fa4-ab9a-1d7e3a0e456c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b0a06abe-1913-4314-bf24-b43098d52dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b0a06abe-1913-4314-bf24-b43098d52dae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_e4b9b5e6-34c0-413b-a667-e42cc0b64a7c" xlink:href="bsx-20230331.xsd#bsx_MaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_MaximumLeverageRatio_e4b9b5e6-34c0-413b-a667-e42cc0b64a7c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_6ea774c7-7a72-4530-8bf5-7330f482f4cd" xlink:href="bsx-20230331.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_6ea774c7-7a72-4530-8bf5-7330f482f4cd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_dfdbb70a-b49e-4a4f-969d-b99094a18875" xlink:href="bsx-20230331.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_dfdbb70a-b49e-4a4f-969d-b99094a18875" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_c78bd823-0be1-481c-9b96-c02daa96721d" xlink:href="bsx-20230331.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_c78bd823-0be1-481c-9b96-c02daa96721d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_c35facb7-1601-46c6-b350-c405186d640c" xlink:href="bsx-20230331.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_c35facb7-1601-46c6-b350-c405186d640c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_e5a9a534-2a03-4971-ac49-9958b59da048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_e5a9a534-2a03-4971-ac49-9958b59da048" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_cf8cb42c-8f13-44a6-98de-5378d61d0365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_cf8cb42c-8f13-44a6-98de-5378d61d0365" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_89f56305-2b8e-45fb-97cd-2f9dcdb62e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_89f56305-2b8e-45fb-97cd-2f9dcdb62e06" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration_cb82dbd0-2d19-41c3-8948-fd2a65b7b145" xlink:href="bsx-20230331.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_QualifiedAcquisitionConsideration_cb82dbd0-2d19-41c3-8948-fd2a65b7b145" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_77aa4e41-7a79-46c9-a78e-aea35edfe6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_77aa4e41-7a79-46c9-a78e-aea35edfe6c0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_f7356421-a786-4887-a537-edcfb2a26548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_f7356421-a786-4887-a537-edcfb2a26548" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_70c722dc-7a50-445f-95a1-95948f0b49cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_PaymentsForRoyalties_70c722dc-7a50-445f-95a1-95948f0b49cc" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_41c764ed-0925-42f0-b20e-7912350cca86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_41c764ed-0925-42f0-b20e-7912350cca86" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_e944736c-277e-4d49-afe3-37eeb8765d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_CommercialPaper_e944736c-277e-4d49-afe3-37eeb8765d2d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplierFinanceProgramObligationCurrent_e74243f8-6f1e-408b-ac07-91bc10c73c00" xlink:href="bsx-20230331.xsd#bsx_SupplierFinanceProgramObligationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_SupplierFinanceProgramObligationCurrent_e74243f8-6f1e-408b-ac07-91bc10c73c00" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationPaymentExclusionFromEBITDA_d2b3ce58-4e88-4ade-ac9d-421cc467489a" xlink:href="bsx-20230331.xsd#bsx_LitigationPaymentExclusionFromEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_LitigationPaymentExclusionFromEBITDA_d2b3ce58-4e88-4ade-ac9d-421cc467489a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_fc0fa44b-aa26-4ae6-9a6f-d8d1f03092d4" xlink:href="bsx-20230331.xsd#bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_fc0fa44b-aa26-4ae6-9a6f-d8d1f03092d4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f9a3cfec-fffd-45b5-b555-630ad012ca1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f9a3cfec-fffd-45b5-b555-630ad012ca1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member_5ed59255-fc67-4b53-a897-f4fc981f3e85" xlink:href="bsx-20230331.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_RevolvingCreditFacility2021Member_5ed59255-fc67-4b53-a897-f4fc981f3e85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_8c33ad34-0796-4b13-bab4-14a75334c63f" xlink:href="bsx-20230331.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_8c33ad34-0796-4b13-bab4-14a75334c63f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_932c5020-8698-45b4-b774-da9b83e21b58" xlink:href="bsx-20230331.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_932c5020-8698-45b4-b774-da9b83e21b58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_0aa62300-80f9-4267-8a9b-32098d46d177" xlink:href="bsx-20230331.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_0aa62300-80f9-4267-8a9b-32098d46d177" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_c439aeec-352a-4748-a2e0-dafd4c10d07f" xlink:href="bsx-20230331.xsd#bsx_March2024NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2024NotesMember_c439aeec-352a-4748-a2e0-dafd4c10d07f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_19ef33c2-627c-4469-8491-61e41a6ec2d6" xlink:href="bsx-20230331.xsd#bsx_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_June2025NotesMember_19ef33c2-627c-4469-8491-61e41a6ec2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_bd249947-8421-4843-be5b-9f4e95486eb4" xlink:href="bsx-20230331.xsd#bsx_March2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2026NotesMember_bd249947-8421-4843-be5b-9f4e95486eb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_a81459a1-9212-4593-985c-8b6b229796f9" xlink:href="bsx-20230331.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_December2027NotesMember_a81459a1-9212-4593-985c-8b6b229796f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_1e22d211-573e-4a9b-9248-bdfa056bd6db" xlink:href="bsx-20230331.xsd#bsx_March2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2028NotesMember_1e22d211-573e-4a9b-9248-bdfa056bd6db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_1e4a511a-7e72-4c9f-993d-4de998b63459" xlink:href="bsx-20230331.xsd#bsx_March2029NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2029NotesMember_1e4a511a-7e72-4c9f-993d-4de998b63459" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_7030c1e1-05d2-4e13-b03c-2fc6b428f8d3" xlink:href="bsx-20230331.xsd#bsx_June2030NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_June2030NotesMember_7030c1e1-05d2-4e13-b03c-2fc6b428f8d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_1a08b96f-5147-4f66-83e0-b58315d617be" xlink:href="bsx-20230331.xsd#bsx_November2035NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_November2035NotesMember_1a08b96f-5147-4f66-83e0-b58315d617be" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_f07165c6-f437-4a51-ac3d-6a7f0a3db75b" xlink:href="bsx-20230331.xsd#bsx_March2039NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2039NotesMember_f07165c6-f437-4a51-ac3d-6a7f0a3db75b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_29d236f1-2368-4ce6-9d4b-18f3fdac1614" xlink:href="bsx-20230331.xsd#bsx_January2040NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_January2040NotesMember_29d236f1-2368-4ce6-9d4b-18f3fdac1614" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_92198b44-fa59-4d07-bcf5-253efc6f43d1" xlink:href="bsx-20230331.xsd#bsx_March2049NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2049NotesMember_92198b44-fa59-4d07-bcf5-253efc6f43d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ac156815-c98e-4b0a-a10b-2b4a3e2ba201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_us-gaap_SeniorNotesMember_ac156815-c98e-4b0a-a10b-2b4a3e2ba201" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_f436f5d3-cf01-4dc9-b692-02cf85f8b3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_f436f5d3-cf01-4dc9-b692-02cf85f8b3bc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f34588ce-9259-4a32-92a2-c34ae6c6bb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_us-gaap_LineOfCreditMember_f34588ce-9259-4a32-92a2-c34ae6c6bb13" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2025NotesMember_e86ea74d-a7bf-4b83-9aed-9d9260d4f0c4" xlink:href="bsx-20230331.xsd#bsx_March2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2025NotesMember_e86ea74d-a7bf-4b83-9aed-9d9260d4f0c4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028SeniorNotesMember_1917cfc3-8ac6-49a8-b112-c3393deeb2c2" xlink:href="bsx-20230331.xsd#bsx_March2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2028SeniorNotesMember_1917cfc3-8ac6-49a8-b112-c3393deeb2c2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2031NotesMember_932d9bbb-e3b6-4d28-9f69-af15c324c6fd" xlink:href="bsx-20230331.xsd#bsx_March2031NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2031NotesMember_932d9bbb-e3b6-4d28-9f69-af15c324c6fd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2034NotesMember_08863a98-a989-4962-866e-d31b1597a1ad" xlink:href="bsx-20230331.xsd#bsx_March2034NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2034NotesMember_08863a98-a989-4962-866e-d31b1597a1ad" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingAggregatePrincipalAmountMember_6d23833b-03a2-4204-a685-f4022d472d67" xlink:href="bsx-20230331.xsd#bsx_TheOfferingAggregatePrincipalAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_TheOfferingAggregatePrincipalAmountMember_6d23833b-03a2-4204-a685-f4022d472d67" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_11cd4556-2c58-4ac0-8b97-3782275477dd" xlink:href="bsx-20230331.xsd#bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_11cd4556-2c58-4ac0-8b97-3782275477dd" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_77d9a826-f9db-4da3-88dd-4b34912c07fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_77d9a826-f9db-4da3-88dd-4b34912c07fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4ce7ee3b-ef4d-4d90-a0ed-f932d58e5a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4ce7ee3b-ef4d-4d90-a0ed-f932d58e5a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_1c5c9ebc-4f06-4235-8348-94ccc05240f4" xlink:href="bsx-20230331.xsd#bsx_The2018FacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4ce7ee3b-ef4d-4d90-a0ed-f932d58e5a85" xlink:to="loc_bsx_The2018FacilityDomain_1c5c9ebc-4f06-4235-8348-94ccc05240f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e54afd23-78c2-4e18-b107-c1cbecc4d81f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:to="loc_us-gaap_CreditFacilityDomain_e54afd23-78c2-4e18-b107-c1cbecc4d81f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e942f691-015a-4dff-9f40-d8dedf5019cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:to="loc_us-gaap_CreditFacilityDomain_e942f691-015a-4dff-9f40-d8dedf5019cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2315517d-f4f8-4588-b166-9b01557450e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e942f691-015a-4dff-9f40-d8dedf5019cc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2315517d-f4f8-4588-b166-9b01557450e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:href="bsx-20230331.xsd#bsx_CovenantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_4739d6bc-a059-4ac7-bd64-9bb93f76e85c_default" xlink:href="bsx-20230331.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:to="loc_bsx_CovenantDomain_4739d6bc-a059-4ac7-bd64-9bb93f76e85c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:href="bsx-20230331.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:to="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_09665c5b-881f-4aea-87bd-901242269a9a" xlink:href="bsx-20230331.xsd#bsx_CurrentRequirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_CurrentRequirementMember_09665c5b-881f-4aea-87bd-901242269a9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_f6712453-2323-4883-b4d5-3967e21705b0" xlink:href="bsx-20230331.xsd#bsx_ActualCovenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_ActualCovenantMember_f6712453-2323-4883-b4d5-3967e21705b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_9078d242-557d-4d3d-b78d-07a79cb9d511" xlink:href="bsx-20230331.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_9078d242-557d-4d3d-b78d-07a79cb9d511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_75ee45fe-d8d3-4ce6-8f3a-07a0e9c6ffeb" xlink:href="bsx-20230331.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_75ee45fe-d8d3-4ce6-8f3a-07a0e9c6ffeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_a589448c-4341-41f7-9527-32144ce4fe22" xlink:href="bsx-20230331.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_a589448c-4341-41f7-9527-32144ce4fe22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_bb616f1a-24f9-402c-bc10-ecb829354772" xlink:href="bsx-20230331.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_bb616f1a-24f9-402c-bc10-ecb829354772" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_8da82bcb-50bf-42f3-9127-f4c1fd3457af" xlink:href="bsx-20230331.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_8da82bcb-50bf-42f3-9127-f4c1fd3457af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_cf7e2cea-9a6f-48e5-b462-3f8837711bac" xlink:href="bsx-20230331.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_cf7e2cea-9a6f-48e5-b462-3f8837711bac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e2f5fc29-ac61-41a6-b49d-5dc363ea2958_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e2f5fc29-ac61-41a6-b49d-5dc363ea2958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ee403d5b-6ac7-4563-aa8a-4cae55a2616d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ee403d5b-6ac7-4563-aa8a-4cae55a2616d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b113f6dc-2585-4a0a-9fcd-1e18cc6c4102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ee403d5b-6ac7-4563-aa8a-4cae55a2616d" xlink:to="loc_us-gaap_CommercialPaperMember_b113f6dc-2585-4a0a-9fcd-1e18cc6c4102" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_195d6d88-15bf-4e18-8a94-fb7d4823da18" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:to="loc_bsx_LicensingarrangementassetsMember_195d6d88-15bf-4e18-8a94-fb7d4823da18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_dd03fff0-17f0-4f0e-89af-45a9eee4f170" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_dd03fff0-17f0-4f0e-89af-45a9eee4f170" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i20fd1e61d4e9464e8d520416408e9acb_SupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:href="bsx-20230331.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82f4d914-c2e7-47ba-b036-a240e48153ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82f4d914-c2e7-47ba-b036-a240e48153ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_532b7800-bd5f-4abb-8986-c640c0cf068e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_532b7800-bd5f-4abb-8986-c640c0cf068e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_8eeef469-5569-4971-ae74-614e2cdda21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_8eeef469-5569-4971-ae74-614e2cdda21c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e99cb0c-d6bf-44b0-9bd1-31343027a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e99cb0c-d6bf-44b0-9bd1-31343027a0e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_21be9653-4fb9-4dba-9d4f-36e0163e3a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_Depreciation_21be9653-4fb9-4dba-9d4f-36e0163e3a38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d633db06-b689-4512-979a-f3d7dc6798f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d633db06-b689-4512-979a-f3d7dc6798f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_527ee53d-f891-4c90-bf47-5b940af8c9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_527ee53d-f891-4c90-bf47-5b940af8c9ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_376ae4e2-9703-4ce1-820c-b6577742555d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_376ae4e2-9703-4ce1-820c-b6577742555d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_174b23d2-b4ca-4642-b91c-69ef73f1ca72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_174b23d2-b4ca-4642-b91c-69ef73f1ca72" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="icead3fc73ceb4112afa51cfb183c56a7_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b3be5063-3634-404d-a2ef-ea005b04b999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b3be5063-3634-404d-a2ef-ea005b04b999" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_176511a9-bf63-470c-9e9a-9d2450744c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_176511a9-bf63-470c-9e9a-9d2450744c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_5d66cb4e-8391-4cdd-a60a-1a8a320cae32" xlink:href="bsx-20230331.xsd#bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_5d66cb4e-8391-4cdd-a60a-1a8a320cae32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6a9b3ccc-f6cd-4d32-8080-864ed99cb3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6a9b3ccc-f6cd-4d32-8080-864ed99cb3fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bea461d8-9550-4dde-9c27-29f5488c6e3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bea461d8-9550-4dde-9c27-29f5488c6e3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea35b6cc-5286-4f11-aace-5bd3124272f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea35b6cc-5286-4f11-aace-5bd3124272f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_dbda7627-e482-4149-8d01-b417a4a826b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:to="loc_us-gaap_LitigationStatusDomain_dbda7627-e482-4149-8d01-b417a4a826b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_eaa17436-5f13-46ed-ab66-e2c166bee175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:to="loc_us-gaap_LitigationStatusDomain_eaa17436-5f13-46ed-ab66-e2c166bee175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d5b7c131-e71e-4f2c-a78e-e885341a9ac9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:to="loc_srt_LitigationCaseTypeDomain_d5b7c131-e71e-4f2c-a78e-e885341a9ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ef62483b-7cef-42c2-a071-4f9bb4893d22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:to="loc_srt_LitigationCaseTypeDomain_ef62483b-7cef-42c2-a071-4f9bb4893d22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_321b71fe-d4b0-47a4-8637-cf6cb5afd97b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_321b71fe-d4b0-47a4-8637-cf6cb5afd97b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a1b12861-c58b-46b4-9cb6-d5dca4b3af18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a1b12861-c58b-46b4-9cb6-d5dca4b3af18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f7bf5220-9668-4c30-b1f9-954016d9a878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a1b12861-c58b-46b4-9cb6-d5dca4b3af18" xlink:to="loc_us-gaap_SubsequentEventMember_f7bf5220-9668-4c30-b1f9-954016d9a878" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended" id="i49c1416495054beb89e17312ac181010_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c7962a39-8133-46d6-a3e2-82e3ff9db029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c7962a39-8133-46d6-a3e2-82e3ff9db029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c9a98cdf-832f-4eed-a4fe-2e46c7a24188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c9a98cdf-832f-4eed-a4fe-2e46c7a24188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_da8b0b6c-44dc-42aa-ad8d-1d3b4ac6465d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_da8b0b6c-44dc-42aa-ad8d-1d3b4ac6465d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c113430d-3e67-467e-8380-3e87864a187e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c113430d-3e67-467e-8380-3e87864a187e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_2b194952-0792-4506-868d-7ceebdac33b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_2b194952-0792-4506-868d-7ceebdac33b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_d2a626b2-e77b-4afa-8557-55af4d4b09b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_d2a626b2-e77b-4afa-8557-55af4d4b09b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_c5cee5d3-6528-4f2e-a11c-6d39425ba0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_c5cee5d3-6528-4f2e-a11c-6d39425ba0e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_5bd2fc3e-22aa-494d-89be-475a1ca2e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_5bd2fc3e-22aa-494d-89be-475a1ca2e1c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c448a994-2890-4625-ad08-ee3352c67076_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:to="loc_us-gaap_ClassOfStockDomain_c448a994-2890-4625-ad08-ee3352c67076_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:to="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_8be2f687-5dea-4a96-bea1-2319e53b9c42" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:to="loc_bsx_A550MCPSSeriesAMember_8be2f687-5dea-4a96-bea1-2319e53b9c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_647c39f7-d2e1-41c7-8239-a08f4b6459fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:to="loc_us-gaap_CommonStockMember_647c39f7-d2e1-41c7-8239-a08f4b6459fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7f73b162-1b25-423d-951f-516481d48a68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7f73b162-1b25-423d-951f-516481d48a68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_db9698bf-9c9e-4fb1-bae3-a2a0e395cf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_db9698bf-9c9e-4fb1-bae3-a2a0e395cf7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a9dd6974-f518-434f-92ab-a9e73382d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_db9698bf-9c9e-4fb1-bae3-a2a0e395cf7e" xlink:to="loc_us-gaap_SubsequentEventMember_a9dd6974-f518-434f-92ab-a9e73382d32e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:to="loc_srt_RangeMember_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:to="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2e6f984d-f2c0-41f3-8557-7c777ff4972f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:to="loc_srt_MinimumMember_2e6f984d-f2c0-41f3-8557-7c777ff4972f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a81084d0-299f-4fb8-a1f8-5a29f1fb073e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:to="loc_srt_MaximumMember_a81084d0-299f-4fb8-a1f8-5a29f1fb073e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended" id="ie7109ec12ad84f7cba5b779fe3401b59_WeightedAverageSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d3134460-009b-417c-9aa8-efbca8322e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d3134460-009b-417c-9aa8-efbca8322e0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4ea9fcb-67f0-4555-b357-0f91163f8893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4ea9fcb-67f0-4555-b357-0f91163f8893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c80d7c94-9a82-47d9-acda-46ef60f5c043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c80d7c94-9a82-47d9-acda-46ef60f5c043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3348632-737f-41fa-ac89-c9a2381d2e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3348632-737f-41fa-ac89-c9a2381d2e87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62604e58-8547-41ab-822e-a88597c8eb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62604e58-8547-41ab-822e-a88597c8eb2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5257ed95-fc5d-4c44-8800-1fc31bd5b117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5257ed95-fc5d-4c44-8800-1fc31bd5b117" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_07a1bb70-faec-4e32-b089-e334b05982b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_07a1bb70-faec-4e32-b089-e334b05982b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_170a43e0-7420-41b5-b2ea-681255ae7425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_170a43e0-7420-41b5-b2ea-681255ae7425" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_f3bdceee-de21-492a-9565-35d871ad1e38" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:to="loc_bsx_A550MCPSSeriesAMember_f3bdceee-de21-492a-9565-35d871ad1e38" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended" id="i28140b4a348241d6b15b11a5d3c405b1_SegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_680aa4d5-52c1-4732-92d1-3a768cd2b2e6" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_680aa4d5-52c1-4732-92d1-3a768cd2b2e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_eaf1d929-21e9-45a6-8ce0-e5498fd5089e" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_2b0827f5-0f7d-4e92-9dcc-074c377130ac" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_2b0827f5-0f7d-4e92-9dcc-074c377130ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_db9e3a7e-a383-4e12-aeff-ebd6c8e889ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_db9e3a7e-a383-4e12-aeff-ebd6c8e889ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c0169bbb-53d4-48b3-b3dc-a335edbcf6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_OperatingIncomeLoss_c0169bbb-53d4-48b3-b3dc-a335edbcf6ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_566f33d7-f2bf-4f34-a05c-16d257a48807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_566f33d7-f2bf-4f34-a05c-16d257a48807" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bbc2aad-a084-448b-b671-851cb73e100c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bbc2aad-a084-448b-b671-851cb73e100c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_874a3979-dd7c-460e-a2d5-c6a5817f6162" xlink:href="bsx-20230331.xsd#bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_874a3979-dd7c-460e-a2d5-c6a5817f6162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_d3dd48e7-ab39-4e09-9a45-f5ab7d437d5c" xlink:href="bsx-20230331.xsd#bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_d3dd48e7-ab39-4e09-9a45-f5ab7d437d5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_cf01a725-43fa-4abd-a3a9-f13727ce6d8e" xlink:href="bsx-20230331.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_cf01a725-43fa-4abd-a3a9-f13727ce6d8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54528c67-4e09-4298-a8e9-511bb56cb366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54528c67-4e09-4298-a8e9-511bb56cb366" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:to="loc_us-gaap_SegmentDomain_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:to="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_2dcd3ab7-e10b-468b-9135-ac10f93ef9af" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_MedsurgMember_2dcd3ab7-e10b-468b-9135-ac10f93ef9af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_d41fd7cf-325a-4e11-a4f2-03239e00ad62" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_CardiovascularMember_d41fd7cf-325a-4e11-a4f2-03239e00ad62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_12924823-56ec-4aff-a52a-09bcb7c7d404" xlink:href="bsx-20230331.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_BSXReportableSegmentsMember_12924823-56ec-4aff-a52a-09bcb7c7d404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_5e53aaa2-890d-4bb4-bb6d-773be862c971" xlink:href="bsx-20230331.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_5e53aaa2-890d-4bb4-bb6d-773be862c971" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_538ac22f-2abe-4d03-84f2-98f42b63edcb" xlink:href="bsx-20230331.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_538ac22f-2abe-4d03-84f2-98f42b63edcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_999af10a-a6c6-4e3f-a39d-3846ec026a6b" xlink:href="bsx-20230331.xsd#bsx_SpecialChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_SpecialChargesMember_999af10a-a6c6-4e3f-a39d-3846ec026a6b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended" id="i8fe0ed2b1afb4e4cba1345526d04623f_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41519dad-3c8d-46e6-b9cf-8228f6f670a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41519dad-3c8d-46e6-b9cf-8228f6f670a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e99cfee-244b-4d37-ad72-0a34df3b1847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses_d8b3325e-14fd-4640-9f05-215f2a4d78c7" xlink:href="bsx-20230331.xsd#bsx_NumberOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:to="loc_bsx_NumberOfBusinesses_d8b3325e-14fd-4640-9f05-215f2a4d78c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d2d643d-b764-4c87-885d-abaaa160ec03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:to="loc_us-gaap_SegmentDomain_7d2d643d-b764-4c87-885d-abaaa160ec03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:to="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_7a3558c5-26bd-4503-8204-760204e1c861" xlink:href="bsx-20230331.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:to="loc_bsx_BSXReportableSegmentsMember_7a3558c5-26bd-4503-8204-760204e1c861" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_56d80609-95f2-47eb-a8b6-b8e4b433cf13" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:to="loc_bsx_MedsurgMember_56d80609-95f2-47eb-a8b6-b8e4b433cf13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_6610da0e-7c95-4d1b-aeac-93368be1dd98" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:to="loc_bsx_CardiovascularMember_6610da0e-7c95-4d1b-aeac-93368be1dd98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:to="loc_srt_ProductsAndServicesDomain_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:to="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_e8ffa499-4dc5-4b87-a1c1-0f09c8d977d0" xlink:href="bsx-20230331.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_e8ffa499-4dc5-4b87-a1c1-0f09c8d977d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_926097c2-9fc6-4a12-9446-935bf900f54d" xlink:href="bsx-20230331.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_926097c2-9fc6-4a12-9446-935bf900f54d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_e720a086-b06e-4f4b-8dcc-a879222f9a25" xlink:href="bsx-20230331.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_e720a086-b06e-4f4b-8dcc-a879222f9a25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember_97e2170f-d6e8-4f6c-86ad-448d539fd435" xlink:href="bsx-20230331.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_InterventionalCardiologyTherapiesMember_97e2170f-d6e8-4f6c-86ad-448d539fd435" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember_7d092bcb-9a99-498d-a1da-10beacd04302" xlink:href="bsx-20230331.xsd#bsx_WatchmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_WatchmanMember_7d092bcb-9a99-498d-a1da-10beacd04302" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember_69a8e239-a297-4f72-a50a-9fb5e55ba7c6" xlink:href="bsx-20230331.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_CardiacRhythmManagementMember_69a8e239-a297-4f72-a50a-9fb5e55ba7c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember_48d096ad-4f48-4ce7-bd72-2c2c31bf9761" xlink:href="bsx-20230331.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_ElectrophysiologyEPMember_48d096ad-4f48-4ce7-bd72-2c2c31bf9761" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember_e49bc74d-780d-47ab-8db3-c3093cdcd55b" xlink:href="bsx-20230331.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalCardiologyReportingUnitMember_e49bc74d-780d-47ab-8db3-c3093cdcd55b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fb26417f-857b-4e14-a7f9-049771ed2a55" xlink:href="bsx-20230331.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fb26417f-857b-4e14-a7f9-049771ed2a55" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fd6ba176-ed0e-4c30-a25e-2270e1704bb7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:to="loc_srt_SegmentGeographicalDomain_fd6ba176-ed0e-4c30-a25e-2270e1704bb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:to="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_374117ac-4f82-4e26-8b25-8728bfaa7142" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_country_US_374117ac-4f82-4e26-8b25-8728bfaa7142" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_f3f20dd8-2b1b-4ed9-b847-6a80f1877779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_us-gaap_NonUsMember_f3f20dd8-2b1b-4ed9-b847-6a80f1877779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_f6fe0f85-f84d-4dac-b14f-6d9bc2d81fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_us-gaap_EMEAMember_f6fe0f85-f84d-4dac-b14f-6d9bc2d81fcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_b1dda1e3-c954-476c-907f-47b83508f88f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_srt_AsiaPacificMember_b1dda1e3-c954-476c-907f-47b83508f88f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_dded7e3b-f816-4712-a960-5e42c1da1331" xlink:href="bsx-20230331.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_bsx_LatinAmericaandCanadaMember_dded7e3b-f816-4712-a960-5e42c1da1331" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_c8641bd6-fcd3-44de-a227-971e18678506" xlink:href="bsx-20230331.xsd#bsx_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_bsx_EmergingMarketsMember_c8641bd6-fcd3-44de-a227-971e18678506" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended" id="i515828f431d14e8daea6886b98bf49fa_ChangesinOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_20bdea81-bda6-46a1-8a94-84bf50a9286b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_20bdea81-bda6-46a1-8a94-84bf50a9286b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c31363ee-544f-4e53-be10-a246904f48fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c31363ee-544f-4e53-be10-a246904f48fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12107e0a-d65d-4ed6-850c-8edc97b326dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12107e0a-d65d-4ed6-850c-8edc97b326dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91da8a41-0c78-4428-b10b-7d2052532f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91da8a41-0c78-4428-b10b-7d2052532f89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b182e5a0-f324-4dcf-b45a-86b8dc525bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b182e5a0-f324-4dcf-b45a-86b8dc525bd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_40378624-7058-4f7d-9b6b-973057857836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_40378624-7058-4f7d-9b6b-973057857836" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d172199c-d55a-4301-84e1-8def14edd84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d172199c-d55a-4301-84e1-8def14edd84d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4e95c508-a459-4663-9720-acfd1315ed04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4e95c508-a459-4663-9720-acfd1315ed04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3fb2de1b-0330-4fe2-9d95-5deb2a070080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3fb2de1b-0330-4fe2-9d95-5deb2a070080" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7818fa27-ae7c-4667-82db-fb566f4a41d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7818fa27-ae7c-4667-82db-fb566f4a41d0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_51412abd-0477-486f-b2bd-e0123049791c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_51412abd-0477-486f-b2bd-e0123049791c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_3c3b8498-f32e-4083-bfd1-f03a4794abfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_3c3b8498-f32e-4083-bfd1-f03a4794abfc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_be1d6352-1d75-4655-8a52-0cebc27f303c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_be1d6352-1d75-4655-8a52-0cebc27f303c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_b70f43a6-ab1a-4fea-be97-7612804c84bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_b70f43a6-ab1a-4fea-be97-7612804c84bf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c54c0d71-a2a9-4f0f-9037-8c45948cb801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c54c0d71-a2a9-4f0f-9037-8c45948cb801" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_793abdf7-dce9-497c-a215-b788fc779ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_793abdf7-dce9-497c-a215-b788fc779ef4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_562e262b-f7ac-4485-b023-5a4e7bde224c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_562e262b-f7ac-4485-b023-5a4e7bde224c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5fb6e67b-b001-4a04-a08d-8b72643cbd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5fb6e67b-b001-4a04-a08d-8b72643cbd5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aab00d75-e066-4fe0-9b72-36aad024262b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aab00d75-e066-4fe0-9b72-36aad024262b" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>bsx-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9cbc6555-e4c7-43a3-bb56-c8c16faaf364,g:530e6bfc-c5ff-4de2-ac46-2fa9fa8fd4fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_02cc392f-d3a8-452b-887f-e252766a25b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5c3462a7-5bbb-45d2-bbb2-58c3781b12cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08404baf-a044-43c7-b9e8-612b432a6f66_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_70c2036d-1f76-4aca-a4c9-f592ce4f1304_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f0313a41-a91e-4f32-9ae6-83b1d0aa4e1f_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5ae79980-0695-4dd3-96fc-649f1fcf9b99_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock_6b2a71fe-9b05-430f-94d5-19ef22747380_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_db2ddfb6-957c-4906-ada2-cd1adf62f7c4_terseLabel_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20230331.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_11971e4a-e588-4ec2-b8a6-392d1d388c23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheOfferingAggregatePrincipalAmountMember_c46d2c55-8a23-463b-8258-f938627f448d_terseLabel_en-US" xlink:label="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering</link:label>
    <link:label id="lab_bsx_TheOfferingAggregatePrincipalAmountMember_label_en-US" xlink:label="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - aggregate principal amount [Member]</link:label>
    <link:label id="lab_bsx_TheOfferingAggregatePrincipalAmountMember_documentation_en-US" xlink:label="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - aggregate principal amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:href="bsx-20230331.xsd#bsx_TheOfferingAggregatePrincipalAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:to="lab_bsx_TheOfferingAggregatePrincipalAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_f1814d24-1534-4c02-85f6-8eebc32a946f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_5d171283-ebb0-4e51-ad2f-c3d3f25ed89a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) on investments and notes receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_67c175d3-393f-4f7d-80a3-d6ea8881d1d0_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8fda2ead-2f76-4813-94ca-357a29fc7d38_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_WatchmanMember_66b85377-4b60-4810-9d0a-bed2527ae1fb_terseLabel_en-US" xlink:label="lab_bsx_WatchmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watchman</link:label>
    <link:label id="lab_bsx_WatchmanMember_label_en-US" xlink:label="lab_bsx_WatchmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watchman [Member]</link:label>
    <link:label id="lab_bsx_WatchmanMember_documentation_en-US" xlink:label="lab_bsx_WatchmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watchman</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember" xlink:href="bsx-20230331.xsd#bsx_WatchmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_WatchmanMember" xlink:to="lab_bsx_WatchmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f3d8d008-d8f6-4f67-a588-105692410a0f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_f4df8b45-ca63-4c06-b036-2dd164061748_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e975294a-41af-4513-ab94-db1c65bed4e4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_a8a9b8e5-84a8-4b9c-a16d-6309e251be0d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_75c65c9a-092d-4ba4-81c8-dce92bc071b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_64c065a3-f22e-46f0-ba53-774ef142abc2_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_083e5a4e-a49b-4438-a7b5-ef7c6526ecdc_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_480cb53e-3ede-4d48-9d40-8940ca8b7db7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_694e5c9d-afd2-44c7-ba4b-3879de00748c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_af90abd4-fd30-47a7-a62b-f8cc34a7589e_verboseLabel_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_label_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_documentation_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:href="bsx-20230331.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:to="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76e0cc29-63cf-4208-a40a-ee74fd90cd9d_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_The2018FacilityDomain_46cbf036-f5d4-44f7-a7de-dfc9df61da1d_terseLabel_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Member]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_label_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_documentation_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain" xlink:href="bsx-20230331.xsd#bsx_The2018FacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_The2018FacilityDomain" xlink:to="lab_bsx_The2018FacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f48b843-f30b-4721-89f8-ed0126747be6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_2988e98e-89d4-4f3b-bc14-0a0d07885c94_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_79ed553b-141b-41a6-aa97-bb89bec70a64_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_edcadf59-6753-4525-9c3d-7e7a789c6bc9_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_48552a26-2bd1-4ad0-980b-0816fb57b55c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_620a7abe-9bac-46f1-861a-2aaa4a9aed37_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_637fbf15-f6ab-4904-86bb-723dcf3bf922_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_b15b7c1e-0a0e-4d88-ab57-99c1bb2126ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_a7823d92-0e2a-48fa-b413-87eef14d7923_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_873bc4aa-f415-4ef2-a687-8bf868142379_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_45a5e7c3-6a0d-449b-8395-a8078ecfca1b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_aca2b1d6-f822-4cf2-ad90-6a8fc7a8b9ff_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_edd258f8-41ee-4029-ae03-b749837c9ea3_terseLabel_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract" xlink:href="bsx-20230331.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCurrentAssetsAbstract" xlink:to="lab_bsx_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c293db86-eb54-4c41-b108-d0e3f5951cc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_0b559dde-4055-41c2-bf8d-e956138b51bc_terseLabel_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_label_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_documentation_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration" xlink:href="bsx-20230331.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_QualifiedAcquisitionConsideration" xlink:to="lab_bsx_QualifiedAcquisitionConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_719508b1-16de-41dc-9b90-e8e35c1eb027_terseLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_fd5ca5bf-8b56-4d16-bbf9-a4dd43b6d7af_negatedLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration" xlink:href="bsx-20230331.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentOfContingentConsideration" xlink:to="lab_bsx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_711cf17a-3657-4edb-b617-d262f0dbcf79_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ActualCovenantMember_551531dd-7ab8-42aa-9e82-06b1df7b94ad_terseLabel_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_label_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_documentation_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember" xlink:href="bsx-20230331.xsd#bsx_ActualCovenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ActualCovenantMember" xlink:to="lab_bsx_ActualCovenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_72f2d31f-098a-47e0-b0db-282b2e9c7fcb_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:href="bsx-20230331.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:to="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ade5eac6-d150-463d-8d22-cbdc90599e44_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_8176a94b-b8a2-4ac9-92b4-64e08f2a1a9d_terseLabel_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolving Credit Facility</link:label>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_label_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility 2021 [Member]</link:label>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_documentation_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member" xlink:href="bsx-20230331.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevolvingCreditFacility2021Member" xlink:to="lab_bsx_RevolvingCreditFacility2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MedsurgMember_2f49a4cd-6ae4-45e2-9618-9a10d8b7f1c0_terseLabel_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_label_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_documentation_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MedsurgMember" xlink:to="lab_bsx_MedsurgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_017e88a4-23a1-435e-8de2-7a9952eda900_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_0b542480-96dd-4a5f-8b2c-c97b5414be8a_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_02b11c1d-a821-4086-88a0-75ad2552b78b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_ca6bf0f4-3cbc-4be5-a3ed-452790f25fb3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_117cd4ca-1d21-4f68-a910-b2d6b84cc45c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_44e1011a-634e-4f6e-a8c7-802ce8dfe9aa_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_76e28048-7a75-4d81-8463-54d3bc55197c_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20230331.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_ccfd6641-af6f-4735-9bef-4b61d10255e8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_b21855d5-4040-45b6-be24-d0712baa7286_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_53abb250-6774-49ab-af39-d2e132225532_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4851e371-ff6b-4f0d-bdca-0b8a94f40c4d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_ea16c472-97d7-40d1-a3ef-08790f6f5949_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_b6e0303e-3dab-46b6-8c5a-88ca31aa6d58_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_ddcdebdd-2abf-494a-b2b7-1ed471c16363_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_a4cc461c-1d9e-4084-965c-1f1c29665f47_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_8725175f-4b65-4c50-813b-f7d904f21cb3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_cc2e7a55-10ea-4d18-a91f-b334c7147ccc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5893e891-9100-4189-931a-6bf05c2bc02d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_6c964f73-4370-4754-a623-99c9b25cde12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_3b3028b6-3dbb-4fb3-b221-1886058de4d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_d23dd929-4a82-4b31-b329-0eb794b1c3c3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangements_d746fcb5-3eed-419d-8962-fe342d53490c_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_label_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_documentation_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangements" xlink:to="lab_bsx_Licensingarrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4bdc7261-1d02-40e8-9197-70c142b5cee0_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c8eda4e5-bce1-4e6f-ac83-671ce75025eb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_8bd2ae20-74f0-49d2-b4c7-f34f975ad384_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligation</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiovascularMember_d5d57dbc-91f9-4078-a6d7-c2e705ae8f7c_terseLabel_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_label_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_documentation_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiovascularMember" xlink:to="lab_bsx_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_87d90ca6-ee7e-469e-9d27-e01ce4e74a7e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3f70b8a4-da22-406b-9bd9-265f9b91e06f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0a713b6a-89b3-4c41-8c49-3edced3947c6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_ab57fbe7-01e1-4b7a-8113-0278c8d23485_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_53404df3-3d82-4124-aa2a-32ee0c59bb70_terseLabel_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_label_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_documentation_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:href="bsx-20230331.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:to="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cd100cc1-4110-418d-a0f9-94d2204280e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_3bd3ea80-42d2-43e8-8015-1ada1402bdc2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2203f1e1-1042-41d4-bbc4-834f3bfed9ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_c170c459-e63c-4a2f-a4ef-e32de687d99a_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:href="bsx-20230331.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_01cd46d3-9411-4447-8809-1693fe44ce7e_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_6f3c3790-8c64-4e10-9016-42a8a1626109_terseLabel_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Urology [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:href="bsx-20230331.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:to="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0975b5c5-6ab0-456d-87ce-98789f254424_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_b3aa6e43-0aea-4ebe-895d-c2b36041355a_terseLabel_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peripheral Interventions [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:href="bsx-20230331.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:to="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_debb1279-c403-4706-a9d2-9cb5ba09b85b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_895d9d67-ab28-4448-b6cf-973e55aa236d_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_b82ed340-6bde-4321-88eb-795f86a78779_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fa2fd22a-772e-4e3c-98d9-8d16d7f380e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_9892d4f6-2d99-4f34-91ca-b693db0a896f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ApolloMember_9fe8c978-4f13-42a5-8001-7929ffb82180_terseLabel_en-US" xlink:label="lab_bsx_ApolloMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo</link:label>
    <link:label id="lab_bsx_ApolloMember_label_en-US" xlink:label="lab_bsx_ApolloMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo [Member]</link:label>
    <link:label id="lab_bsx_ApolloMember_documentation_en-US" xlink:label="lab_bsx_ApolloMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ApolloMember" xlink:href="bsx-20230331.xsd#bsx_ApolloMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ApolloMember" xlink:to="lab_bsx_ApolloMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_8d0ad95b-e1cf-4b6d-b981-a81516c2f647_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e40e7a17-a7e3-4c18-8543-076e15a5e781_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantAxis_ca8146fe-61fd-440c-af93-0dab065888d5_terseLabel_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_label_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_documentation_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis" xlink:href="bsx-20230331.xsd#bsx_CovenantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantAxis" xlink:to="lab_bsx_CovenantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1ccf9906-088c-4672-a8ed-32a096b26904_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_41c009a0-0056-4ef2-953e-b096461bbac5_verboseLabel_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses and currency exchange [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_label_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_documentation_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:href="bsx-20230331.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:to="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_8c0b4dff-60f7-4eb7-848a-f1f079c7b655_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4e7cbf90-d5ce-43f1-89fc-3130ab4ea2f9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_14a5f9cb-7704-4428-8294-9094af3b7703_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_f0ce46b1-15c7-42fb-add6-7cec1ac8e17b_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8e1b6ec4-c7b0-41bc-9f42-8cef542ad894_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_075f53c9-58c7-4766-a05a-365c8eea1525_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c88caf45-c62c-4709-a3a9-ec73db4a01d1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028NotesMember_207798f4-92f8-417a-990d-a104f5aab2b2_verboseLabel_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_label_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_documentation_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028NotesMember" xlink:to="lab_bsx_March2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_5922f3fa-2b32-4536-b8f0-3846d56c9f83_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockCash" xlink:to="lab_us-gaap_DividendsPreferredStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_3449fce1-041c-4995-9711-587ac969f9b5_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_4de57c68-c5a7-470f-8375-d6a82c1ba173_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InterventionalCardiologyTherapiesMember_1b6e55e1-c1bb-4d0f-b2a4-250eb9945069_terseLabel_en-US" xlink:label="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Cardiology Therapies</link:label>
    <link:label id="lab_bsx_InterventionalCardiologyTherapiesMember_label_en-US" xlink:label="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Cardiology Therapies [Member]</link:label>
    <link:label id="lab_bsx_InterventionalCardiologyTherapiesMember_documentation_en-US" xlink:label="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Cardiology Therapies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember" xlink:href="bsx-20230331.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InterventionalCardiologyTherapiesMember" xlink:to="lab_bsx_InterventionalCardiologyTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_3189a2c3-a794-4d18-b1bf-e0b3375421f4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_0c9b3f9f-1310-4b61-aef3-e1819b07c593_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_866b6a39-0e48-41d0-893f-701e46aa0a1d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8d8e02e2-23d1-408e-809b-325a044837dc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_bd3b7a31-fc04-4720-b4cd-d6699e2dc407_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_label_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeRemainingMaturity1" xlink:to="lab_us-gaap_DerivativeRemainingMaturity1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cba6e3c3-ff39-4d95-8c55-6caae9094878_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationPaymentExclusionFromEBITDA_e1296d8c-79d1-41b7-97ba-49de4e4a999e_terseLabel_en-US" xlink:label="lab_bsx_LitigationPaymentExclusionFromEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation payment exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationPaymentExclusionFromEBITDA_label_en-US" xlink:label="lab_bsx_LitigationPaymentExclusionFromEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation payment exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationPaymentExclusionFromEBITDA_documentation_en-US" xlink:label="lab_bsx_LitigationPaymentExclusionFromEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation payment exclusion from EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationPaymentExclusionFromEBITDA" xlink:href="bsx-20230331.xsd#bsx_LitigationPaymentExclusionFromEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationPaymentExclusionFromEBITDA" xlink:to="lab_bsx_LitigationPaymentExclusionFromEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6735bf99-31b4-41c2-97b3-54c9aa306c2f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_df9b1981-5338-41c5-875f-adfdc73125ea_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9d626d0c-36d8-4da1-9897-a6cf5b7e1484_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_25433cfc-4769-48ab-be2f-c41375d88792_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_3a3113ee-14b8-472f-80b1-2c54f174d133_terseLabel_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_label_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_documentation_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:href="bsx-20230331.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:to="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b24a594f-ed0e-423d-a6fb-5601e5038b00_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_f70b770d-9e8a-445d-a492-8f8006df11e2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NumberOfBusinesses_46d42a33-6b10-400a-aee4-5e2e9bb2eba1_terseLabel_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_bsx_NumberOfBusinesses_label_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_bsx_NumberOfBusinesses_documentation_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses" xlink:href="bsx-20230331.xsd#bsx_NumberOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NumberOfBusinesses" xlink:to="lab_bsx_NumberOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_edc5f029-4f68-4514-addd-a719c79e3c48_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementliabilitiesMember" xlink:to="lab_bsx_LicensingarrangementliabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_fe554985-943e-4139-8c43-cb003f7c61aa_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d8e2cc7d-a4de-43ab-8e90-cd7940c1729b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InventoryStepUpAmortization_3d6b470f-a63e-490c-8ce0-d7fc3a4007f6_terseLabel_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step-up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_label_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_documentation_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step up amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization" xlink:href="bsx-20230331.xsd#bsx_InventoryStepUpAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InventoryStepUpAmortization" xlink:to="lab_bsx_InventoryStepUpAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_e95e9976-8488-4537-a75d-84df4d7b6c6e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_6fadb9c3-f703-4dc2-a7d8-6b058a8882be_negatedTerseLabel_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_label_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_documentation_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:href="bsx-20230331.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:to="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3c84af1c-35d4-4872-9788-3a03200b1857_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_027e98ab-c8df-44fd-932a-5d061753a87e_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_label_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:href="bsx-20230331.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:to="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_6686c379-a8e9-4642-b6c1-0ed4c8769036_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_e8894cf4-85f5-4dca-9375-dd1eaa59dd30_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0cad995-b22d-478c-a633-a2fa82c641b3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_22de0ec6-7d18-4600-a04a-bbdc9a8f8e9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Other Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_2ff55b85-47ee-48cb-b213-c7d8cff22dd8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_0ecfa51f-bdd2-45ff-ada8-1a95c5a541b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dd8967fc-ffba-4599-badd-62a7354fecde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6aee9b80-34af-4d57-8331-adb64e933cad_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2f6a69fb-6091-4cb1-a82a-6ee2d3ff814b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IndemnificationAsset_576ade9b-f61a-48ce-9529-621959c6be22_terseLabel_en-US" xlink:label="lab_bsx_IndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification asset</link:label>
    <link:label id="lab_bsx_IndemnificationAsset_label_en-US" xlink:label="lab_bsx_IndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification asset</link:label>
    <link:label id="lab_bsx_IndemnificationAsset_documentation_en-US" xlink:label="lab_bsx_IndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IndemnificationAsset" xlink:href="bsx-20230331.xsd#bsx_IndemnificationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IndemnificationAsset" xlink:to="lab_bsx_IndemnificationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ba801023-9a0c-4c17-adaf-5fe6afc676bf_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_3c8b78b6-e0d3-47a6-8b58-242e0e349777_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_33d6dda9-6edf-47d0-8bfa-2ca05dbaa808_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:label id="lab_us-gaap_SharesIssued_489ae945-27f5-493f-a3a3-69e0a2b6dcb6_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_1ffca7fd-538a-49e0-b42f-ea8ce92b452d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ad02c419-fc49-4458-a433-a28d2d0859d0_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_413b537b-4f73-49a4-ba46-5e6e0d4dfedb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_c13a7547-5b2a-4e2d-8935-7ad8720f58c1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantDomain_012586fe-4b90-4f2e-bbe3-807bde12dbc7_terseLabel_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_label_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_documentation_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain" xlink:href="bsx-20230331.xsd#bsx_CovenantDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantDomain" xlink:to="lab_bsx_CovenantDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_082751cd-b9b0-44e7-bfff-6000b89c8577_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalCardiologyReportingUnitMember_50a27d44-6378-47ba-a814-69e937b0c3b6_terseLabel_en-US" xlink:label="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiology [Member]</link:label>
    <link:label id="lab_bsx_GlobalCardiologyReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Cardiology Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCardiologyReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Cardiology Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember" xlink:href="bsx-20230331.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalCardiologyReportingUnitMember" xlink:to="lab_bsx_GlobalCardiologyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8615db2e-8f21-4b1d-9c1a-3f4422502e77_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3643cc51-6602-4a35-846f-43db22149f67_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_5cd612d8-adc3-4108-bba5-21478ee9f85b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d740735e-b078-448c-a2b6-de1be97f4710_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_ce668b32-6b17-43dd-b0b3-216857a81279_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3cb5d493-a70e-4517-9feb-73baebecfc59_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb8c2d4c-b9f2-473d-b42c-ed42fea525af_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26c993b0-2df6-4d07-a357-abe55a8c929b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss)&#160;before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_c2dca9b9-75bd-4067-9793-d1eb30a790ef_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_1c024ab8-8d3a-4401-bcb0-c49b27dd847e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_d1113dc5-e90f-4ec7-9874-94ed71d3a08e_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_1bbcc1ce-e9cc-4a9d-be66-9427504c48f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_3c7f3f42-bc51-45b2-9991-825df63b31d3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Outstanding [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_776b3e2c-ace5-496e-bed6-22bb7f27bcec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_98a53ab2-7721-4427-84fa-5b08558066f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_af00f8c9-5ae5-456c-90bd-0d964b714856_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_d7f12c16-6d1b-4712-bea9-ef7ce7c9cd5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_190955e8-02a5-448e-be8c-0f6d0e14d50a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_e41bb6a4-5b93-4334-95ff-61b30a19ea6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_e760632b-c761-4f26-ba7d-f773b37a5722_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b33064bc-036d-462b-b915-0b358ecc3d68_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_19e5fb62-8e2a-4dbe-8839-347bcd6d05cd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_12ab506c-f5f1-45a9-b23b-2c2ad0769230_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_81b57c11-e9bd-4037-b051-5d294e654681_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_23c7e3e5-4469-4eff-a34c-321a403271d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_19681eb8-3b1f-4d1c-8933-6eb27a4844dd_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_18aadec8-7fdf-4d15-be4f-e15386ef506b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_47004ae1-4ca2-43a8-907a-296e56324338_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9033c462-55a7-42aa-b442-cddc1e2ad8f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_4ae4c3ee-7b6e-4fbc-b284-b523cc8ee8b9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_80e6c84d-e286-48df-b8ef-bb1975604652_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_5baa54f2-acab-47c0-b800-2fded4de7775_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_c3287ca4-7a4d-4f2e-819f-a017a7912036_terseLabel_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_label_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_documentation_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:href="bsx-20230331.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:to="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_26a83708-f890-4124-beb8-fb203993dcc2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_71d912b7-914e-4825-b5a7-dcacdb69d47d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_fb7e7232-abff-4d61-838c-3035eb867123_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_88af9a4c-738b-4d5e-8a67-621993ce4ec8_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_704b7990-6e9b-47a7-b0a2-123633b61c8a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_1bcaf640-36bf-4adf-8634-16bc34821ea7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_fee397e1-d194-4814-9a57-8770c9efddcb_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_f199b4fc-34f9-45ba-b17d-b50e98369ca5_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a7a33c40-3400-4d9e-9f78-a38f8c287a18_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_6f82efc6-ed55-460e-8142-dd3e4155e705_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_729da830-77c7-453a-9787-ba1b443e3670_terseLabel_en-US" xlink:label="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil CADE - # of individuals for alleged anti-competitive behavior</link:label>
    <link:label id="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_label_en-US" xlink:label="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil CADE - # of individuals for alleged anti-competitive behavior</link:label>
    <link:label id="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_documentation_en-US" xlink:label="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil CADE - # of individuals for alleged anti-competitive behavior</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" xlink:href="bsx-20230331.xsd#bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" xlink:to="lab_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_64b9dffb-c61b-407b-8d7a-a19db635344c_terseLabel_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_documentation_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:href="bsx-20230331.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:to="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_066b3e61-6b02-4efd-b8d1-932517b6f44a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2af5e594-1bc7-4542-89a9-f38d5545c7cb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_049f8ada-d518-4218-87fd-b8282c3994b7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f44f4684-e947-4876-91cf-9b78d2301dcd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2030NotesMember_51d09fbd-775d-4909-9eb8-765469c41faf_terseLabel_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_label_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_documentation_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember" xlink:href="bsx-20230331.xsd#bsx_June2030NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2030NotesMember" xlink:to="lab_bsx_June2030NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_df258def-1500-42fc-9355-10063e0c9178_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b20e93b4-4f86-4872-99d2-a40bca073c77_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_3943bb17-c2f2-4935-9902-2a6b1ef4f8f2_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9fd6a4b1-ac89-4777-a52d-74dfe5b41bf4_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and restricted cash equivalents included in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6258f4bd-8d89-4280-9020-4a43b9f5a6de_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_be86bbe5-04d1-403c-964a-ed84e0bbf849_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c395a297-04c1-4ca5-acb9-234fc3f57318_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_02ac8c0b-48d0-47e5-8cdf-5fd7147de751_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a1318e95-88b4-4aaa-b7ea-268d5b676448_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_9b39c2ec-6454-4001-a361-4fd8e4402309_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cf243616-ef2c-47ab-9f1d-03b5337f9108_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_be0bd438-b35d-400c-9904-c3d9f8d1b348_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_661bda18-033b-42e2-89b0-4b345d533ed1_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_label_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:href="bsx-20230331.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:to="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_79cb2add-1ee3-445e-8184-965c9a1355c7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_5223c171-2ecb-461b-95c8-d900d0acfcb5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_8a196bdd-43c5-457f-a7de-a460bf8713b7_terseLabel_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20230331.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_41958f98-7673-49ec-b498-c334d69b4f73_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9c77a76a-aa81-4225-95b4-c5af27e2cb94_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_592039ed-cc7f-4ecd-b44a-6d9d824b34bb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_8f8e652d-11b5-4bd3-9c41-50957ab96bd2_terseLabel_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_label_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_documentation_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets" xlink:href="bsx-20230331.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherOtherLongtermAssets" xlink:to="lab_bsx_OtherOtherLongtermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_5c26f32e-4aa1-408e-9bd3-8b4a03e2c700_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_41105cf9-7dce-42b6-8a29-7ef5707afd82_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4e09ef2f-f872-4461-928a-f888bbb45df4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_9214a06b-46c6-4d97-b52d-ebe6a59782f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_a8084cd5-f3da-4487-9a7e-2612bdd830e2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_e377cb21-e68f-40d5-8c79-ca136c8ce230_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_f84c5073-5f97-4229-86ab-afd662855d35_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_3da7e4c2-36ab-4116-8ace-9a33a243a8ec_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_616aafea-9ddd-43db-972c-876014a49125_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_fd287d35-2a04-4ba3-873e-8f5e5198f5c9_negatedTerseLabel_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_label_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights" xlink:href="bsx-20230331.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentsForRoyaltyRights" xlink:to="lab_bsx_PaymentsForRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b2abaf07-4b99-4b69-bcc2-93647de9c459_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND STRATEGIC INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_4b2051e6-d01f-41fd-a898-787c422b08e7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_68f66001-2b41-49d6-8ff0-6ddd379325a0_terseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:href="bsx-20230331.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:to="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e125f805-0cd9-409c-a96e-6c2d4cb7be0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8ad82400-8053-4b0c-8058-f765b095f533_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_663a1f3c-efa7-4182-8543-f64f8f8c4532_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_65608e67-cb6b-4b55-9d94-7e628a19c66e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_88416c32-3018-4483-842e-1ab83a98b64b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_56fe111b-4808-49f5-85c4-0ee1f892c7a1_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:href="bsx-20230331.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:to="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_cfe7a85d-158c-4e5f-8e91-1b0775ff9920_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_ad9cee70-f8b6-454b-9a1d-0d0d44dedc9a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_039197bd-5321-4109-8b32-624c283a0131_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_11eb128b-7242-4fce-b7bc-2451bf03f90e_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b9e94e8d-de5f-4de5-93d6-16f88dc55ffd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_77436e8c-4e01-4c28-acfb-3813fc13a9cc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_bb54b87d-e06d-4b2e-b9ca-a5e87149bc5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_8a3435a3-d2c9-4e96-9610-02afadce18c7_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_40e36831-ecb3-4c93-9df0-82fadfd241ed_terseLabel_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:href="bsx-20230331.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_e89fdf63-7715-47e3-956a-9b68402a3ba6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e604525-8bb7-46b9-bb8f-9f3851050a65_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_63c53112-fc76-4a05-84bd-116518d20d94_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_077af89f-40fe-4ec9-bee6-c8609b93ba06_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_06c312f9-0a71-4127-9bf6-1958e9525d40_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_030a8242-ed4c-4303-ad8b-5c8dc637cf11_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_fea089ee-9877-4ffe-9761-d0fdc0c571ca_terseLabel_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_label_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_documentation_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:href="bsx-20230331.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:to="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_3ca7209c-3b1f-4672-8394-ff844cb2eac4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_2015f403-a950-4330-807f-de5a722a2caf_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_03a6ccfc-a66f-4bbb-ab1c-63eda9b46d74_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_9f6bea8e-6770-4c75-ac81-beebebc6f497_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4517dbaf-bc96-478f-b38f-3aa684085bae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_e244c1bf-a6f9-4cd5-83df-b57f9d85928a_verboseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3d2c2f81-f9a3-497b-bb57-c3525bbe7b9c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6622536d-3c84-409c-a5d9-b95db2ceb8ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DiscountRateFairValueInput_d8fe0883-0196-4ff6-b154-99d9292beb74_terseLabel_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_label_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_documentation_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DiscountRateFairValueInput" xlink:to="lab_bsx_DiscountRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_7c934718-e27b-4090-8860-3d34133c93a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5d6bd94d-1ab3-447e-8e1e-a770984c33c6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_d3668f0e-30a5-44ed-b121-abcb71afafb5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_a8585386-d8ec-425a-8995-3dbf3d8fbc55_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_95b530fd-2d5e-42d1-b7be-3f99cbc7bff7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_e2050347-4daa-468f-96c9-95abbb1a0175_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_ad6555fa-88c3-4be9-a61b-5bd16ecd7fff_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_26368ae1-700f-4415-92d0-458b66715212_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7fee7ae8-472a-4722-878b-d51754c2b742_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_cb41b9d4-9b14-4d80-822f-9176a147950b_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Beginning Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_64d19ccb-8d67-4099-a6b3-ec25c25f3a36_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Ending Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f47dcb7e-efed-440d-a127-2f0e05f96002_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_86cbd45a-6503-43d9-9a3d-73fc69f1fa4e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EntityAbstract_efbf917a-5bd0-4385-b278-439bc9a02703_terseLabel_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_label_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_documentation_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract" xlink:href="bsx-20230331.xsd#bsx_EntityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EntityAbstract" xlink:to="lab_bsx_EntityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_64207694-f439-43e8-a9a0-591970cdb49c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_523a1fb0-9719-41e8-8a43-ad11a8d87581_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_12026cbb-704a-4188-b12d-ea37c85496de_terseLabel_en-US" xlink:label="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - early redemption of combined aggregate principal SN</link:label>
    <link:label id="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_label_en-US" xlink:label="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - early redemption of combined aggregate principal SN [Member]</link:label>
    <link:label id="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_documentation_en-US" xlink:label="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the Offering - early redemption of combined aggregate principal SN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:href="bsx-20230331.xsd#bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:to="lab_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_247d2b9d-a157-453e-9e3d-cb0a873e7e85_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_757f0612-7be1-4229-9cc0-6f8b124b56ec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_f824d253-b8e1-497e-9881-e5138c3e1a84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a19cf55c-7024-44d9-947a-5ad2dfbace0c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_7c80aecd-6d3d-4213-8dc0-7b02616e39c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration previously established in purchase accounting</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_ec5673f6-97ec-4048-bd1a-7e0166c5c31c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8e56c83f-6322-4f2c-9f8f-14973621819e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BaylisMedicalMember_ee385406-4b6e-42e9-8269-6af18902d484_terseLabel_en-US" xlink:label="lab_bsx_BaylisMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baylis Medical</link:label>
    <link:label id="lab_bsx_BaylisMedicalMember_label_en-US" xlink:label="lab_bsx_BaylisMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baylis Medical [Member]</link:label>
    <link:label id="lab_bsx_BaylisMedicalMember_documentation_en-US" xlink:label="lab_bsx_BaylisMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baylis Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember" xlink:href="bsx-20230331.xsd#bsx_BaylisMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BaylisMedicalMember" xlink:to="lab_bsx_BaylisMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1c096217-70d4-4011-875d-f94c02219084_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_36937e4d-3ba8-4dff-a603-cf8248cec1e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1a90f946-0b9e-4ea0-9a5e-d665823d790c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7e167971-ecd8-4bce-b7e4-bd2707040d17_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_cbe1c44a-25a9-439a-9cd6-d44e42dc70e5_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_3b22f122-b994-42f5-87b4-8c2f4ac39042_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_3b7874cd-dbe9-4f40-8464-c41f2603a0b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_d1e298db-47e9-4574-9051-ff4d87f80e87_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_39ca98e6-1f31-4f09-afe5-98c80a1ba32a_terseLabel_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_label_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_documentation_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:href="bsx-20230331.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:to="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_9738b4f7-7765-43b8-b036-0349e768dac5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d6040db2-dae8-40e6-901f-93176a759904_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_1984f847-1b15-47fe-8bdb-109194977c74_negatedTerseLabel_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_label_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_documentation_en-US" xlink:label="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (payments for) investments and acquisitions of certain technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:href="bsx-20230331.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:to="lab_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_da666f19-f82a-4702-9099-94b1209c0b32_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ac1288b8-4646-42f8-846a-b1f1b759d8df_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_f37f074c-8cdc-4d74-8ba9-09de46e5ab4a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_8a8ae759-2d84-4e76-957f-3165f6b2a552_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fa8dab36-c22c-498a-ad9a-b2228aa8f3fb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ab86b701-ee5b-4bd7-8021-c90be3b3fd90_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_cb83943f-6087-4cdb-a543-8cacedc1152f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_2a529d81-3adc-4ac3-95d1-8ca932338201_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_fd6777ef-1ffc-43c6-8535-9d7cfa11f4dd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_ca07e271-555c-4a78-84c0-8b4f84556395_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4e803ded-42db-4367-b06a-76681bdfbf88_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1ac1f9b1-0d5c-493b-92bb-017efe141b19_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_7ea3f7b5-3fb5-49b3-8630-ad2dc1426f47_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_58b51cd7-d344-4edb-841d-eaacb017960a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_20b8bc42-cfad-450d-9d4b-1db4755284d1_terseLabel_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20230331.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_a5f89a4f-d110-4467-a53e-d82ce8831f0d_terseLabel_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred and prepaid income taxes</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:href="bsx-20230331.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:to="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3f0673d9-6d29-4384-90c6-52446ffd0ff6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_95f5b9a6-fbd0-4d9c-8f2a-140562eb2a20_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_a33b1bf4-4c40-48cb-8358-b06daa9052a0_terseLabel_en-US" xlink:label="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Foreign Currency Fluctuations on Net Sales</link:label>
    <link:label id="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_label_en-US" xlink:label="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Foreign Currency Fluctuations on Net Sales</link:label>
    <link:label id="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_documentation_en-US" xlink:label="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Foreign Currency Fluctuations on Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:href="bsx-20230331.xsd#bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:to="lab_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c6ad4de0-fc6e-41b4-9e22-365ec36f6592_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bac81c94-cefe-4d74-8049-549264760fe6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_7c48eac8-23d9-4338-b0f2-297c924dba64_terseLabel_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember" xlink:href="bsx-20230331.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BSXReportableSegmentsMember" xlink:to="lab_bsx_BSXReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1cc4ec13-0b62-434a-ab57-01403451b8cb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a481a7b0-6418-49ad-b500-cfb75333afe9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_4219a81c-ce28-46f0-9ce3-4483ba9c646b_terseLabel_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_label_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_documentation_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm" xlink:href="bsx-20230331.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DebtInstrumentExtensionOptionTerm" xlink:to="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_de8befc0-fe79-452f-8ea1-9decf7d5b7cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_171b411d-bc19-484a-8278-34584df300b0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_9b716064-e505-4424-9834-897b16aa8dd4_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2035NotesMember_f2a145c2-2a50-4e20-a925-15d087b0bb73_terseLabel_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_label_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_documentation_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember" xlink:href="bsx-20230331.xsd#bsx_November2035NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2035NotesMember" xlink:to="lab_bsx_November2035NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_a75889fa-bc34-46cf-9dc7-6300974000c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative investments(1, 2)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_62e4216c-f6b4-4ac4-9212-e05c635221ad_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_5d917482-1074-4e98-a37c-3c32db58d3b9_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_9e0a3265-ecd3-4a98-bd10-6b6839ec436d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_9a4692d7-b886-4d5a-8b46-7e7f99595bef_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_09c556ff-c532-44c6-9642-9d8ce1a7233e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_de3733ce-7ea9-49fe-a9ea-e1c1d84b15f7_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_da1d93a7-b50a-4302-8cdf-6d5bb9c512e8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_88237323-7a54-4133-a557-52b04abbe7e8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8d5e1731-2dcd-49a9-9b7d-cee29461a0cd_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fbcf0f7f-0306-45c1-ae4f-07ad8cfc9d84_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingParValuePerShare_574ca4ec-a022-4622-bfaf-a05fbdea4f4d_terseLabel_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:label id="lab_dei_EntityListingParValuePerShare_label_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingParValuePerShare" xlink:to="lab_dei_EntityListingParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_85170ef3-d995-49ef-a25d-5e9b250d93b5_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5ba85a2c-95e3-48a8-bf66-c604b4ab6999_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2135c9f7-7be6-4328-bd65-56eedb8901fd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b67988ad-1946-4b25-b66c-b9c00f4f2846_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbda530d-32d3-4e23-80a9-8dccbc36bcad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_05bd5691-1d78-49de-8422-bfd34b3da492_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_99ab441b-12c1-4a1b-88f7-f7694ce16587_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AllBusinessAcquisitionsMember_add481ce-045e-4ef8-ac98-1f5b2228dc30_terseLabel_en-US" xlink:label="lab_bsx_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions</link:label>
    <link:label id="lab_bsx_AllBusinessAcquisitionsMember_label_en-US" xlink:label="lab_bsx_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_AllBusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_bsx_AllBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllBusinessAcquisitionsMember" xlink:href="bsx-20230331.xsd#bsx_AllBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AllBusinessAcquisitionsMember" xlink:to="lab_bsx_AllBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_bbc5e468-7b31-4be0-9581-cd94371b925b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f05e404c-8c05-4b28-ac8c-a4235b535751_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_d8249a77-d393-43a3-a6f1-a08e4a7f9c5d_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_010b1235-f1ad-4773-acbc-004a0a36630b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0cb67797-6f66-4bc2-9b78-3cc488be0093_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f0991e1e-e857-443d-a6e7-21ce4102f533_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_478aa34c-d5a3-4040-8c54-4d21f316bf13_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_901b43ea-2c73-44ab-9071-a32b0c4e084f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_934a1308-a706-42ad-9007-6fe439678663_terseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:href="bsx-20230331.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_f0e03ed9-674c-48b2-a93e-0a7a1a28a8e5_terseLabel_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20230331.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ea5399ec-1279-45bf-b50b-08b02bb84c62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_f2808c77-659d-4a53-8a65-2b3244d798f0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_850b09e5-d702-489d-bd92-918d8210ffd3_terseLabel_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:href="bsx-20230331.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_06ad7652-7a24-47d5-a666-8f3113829ee0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_338b7bfb-fe63-4fbf-bc4f-87b7bb364944_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_41f5d720-fbd6-4688-b136-1cbbf69fb26b_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_d526c3b4-7e11-4e2a-90e2-401c4b0c2123_verboseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:href="bsx-20230331.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementAxis_284457ce-22cc-4b79-a61a-4eaa4d3b4d8e_terseLabel_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_label_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_documentation_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis" xlink:href="bsx-20230331.xsd#bsx_StatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementAxis" xlink:to="lab_bsx_StatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ea13d32f-d864-49ad-a322-6de7044cc18a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,700,828,873 shares as of March&#160;31, 2023 and 1,696,633,993 shares as of December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ebca1c02-aaff-466d-8ba5-baa289790d2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5631e934-b3aa-4de6-845e-ea769bee9a4e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_27de6e9a-c273-4c34-bfef-5d02cf94b709_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_fc0b8853-9949-40d0-a917-ab4778a6d132_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_18362b48-2b15-434c-8d87-1fb18012c610_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_ee89d7c1-56de-4429-8131-8247c04d69d5_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_ea136e23-d7ed-4a0c-8030-c9e7e4e3d116_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8de4848b-3f3a-4f3f-a181-bc41290d0bbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsasset_fe2de132-a319-4fdd-84e5-ce27090a6b9d_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_label_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsasset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsasset" xlink:to="lab_bsx_Licensingarrangementsasset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4aa87992-b2f5-4eb1-b7f7-d211da4cbc97_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiacRhythmManagementMember_43e1323d-f1cb-4efb-9f48-d02197595736_terseLabel_en-US" xlink:label="lab_bsx_CardiacRhythmManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm Management [Member]</link:label>
    <link:label id="lab_bsx_CardiacRhythmManagementMember_label_en-US" xlink:label="lab_bsx_CardiacRhythmManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm Management [Member]</link:label>
    <link:label id="lab_bsx_CardiacRhythmManagementMember_documentation_en-US" xlink:label="lab_bsx_CardiacRhythmManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm Management</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember" xlink:href="bsx-20230331.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiacRhythmManagementMember" xlink:to="lab_bsx_CardiacRhythmManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_c66067c8-86e2-4508-bbae-dc0883ba6254_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_303e0a98-9594-4622-8efd-92b29732a192_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_cb2126b0-96a8-4e99-b6c4-2f96046c78f3_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4edfe434-d319-4f37-8bfe-8528b8485d30_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_abf66922-10de-44b8-9c8d-34e14224c50a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ac17bd9-adb4-4b9a-ada0-9d4e8fa487ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_849ff288-799a-4871-9262-418825f4c79d_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_408a1c21-5504-48dc-a4ca-ad2cac8e80a7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_167c0055-24a4-4a8f-95b5-b8370d7394f6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_66452625-c303-4cc4-9e0b-e446a87df715_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ccf9cb5d-bd84-455b-aa26-d41b9a16f01b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_fa5564d6-5905-4c13-8681-4c8369f51974_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5042c845-a404-4e9c-a989-4efb1764adbf_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_d4bfab34-12d8-430f-8ae7-8003455565f0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_4c3746b4-6c09-49d3-8259-5898e38498c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_6d1d3008-50af-4eaf-9c85-341c23100bf0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5a82cf20-8ef9-43c0-9378-15625a463ad3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_357765ec-15c0-4936-ac53-ad4768bb9819_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_b34ac624-97e8-4e70-a4d6-1dda565de988_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:href="bsx-20230331.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3c12c949-ef11-42e1-bce5-4326f07a6775_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_ce4f58ea-d6ee-46c3-9eb9-06ccb0b654f3_terseLabel_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_label_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_documentation_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity in Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:href="bsx-20230331.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:to="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3ad9a975-dffe-455b-a560-0e7515d3de3f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_8ece456a-42f7-4a66-9199-281470182978_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_78ed30ba-ccb9-4ad5-b9c6-dbff2dd9f0db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2049NotesMember_b55da08f-13b5-42ed-aa23-00ff2c1373f4_terseLabel_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_label_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_documentation_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2049NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2049NotesMember" xlink:to="lab_bsx_March2049NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2039NotesMember_ecd529b9-8b0f-46fd-89a0-4b8715302a52_terseLabel_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_label_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_documentation_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2039NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2039NotesMember" xlink:to="lab_bsx_March2039NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5205ec93-e68e-43d4-adfb-ae1148ee6425_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc1bad44-fef2-4325-ab5c-8b0d0b869cd6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028SeniorNotesMember_65757b87-9a4b-48b1-9127-3a080c9593f6_terseLabel_en-US" xlink:label="lab_bsx_March2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Senior Notes</link:label>
    <link:label id="lab_bsx_March2028SeniorNotesMember_label_en-US" xlink:label="lab_bsx_March2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Senior Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028SeniorNotesMember_documentation_en-US" xlink:label="lab_bsx_March2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028SeniorNotesMember" xlink:href="bsx-20230331.xsd#bsx_March2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028SeniorNotesMember" xlink:to="lab_bsx_March2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_711d3c2f-fc1c-4183-bafd-e8fa2db04e04_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a47ee5ab-bd99-45b2-97ed-ba3bf9bdbec5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ce7da04c-e95b-48bc-bb90-3cb5d6afa048_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_19b27a36-3d4e-49d9-9bd2-ceeda5954125_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_b6c30e36-3cfa-4d22-b663-3f5d43bf6529_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_93785b97-9dc1-4cd2-bedb-2ee8d6270f20_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_fd604dfa-674e-421e-a02a-eb877d8ba4e1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ad407da1-6496-4007-961a-c4d46140b235_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_cbbf5ba8-e9b9-41a7-90dc-1ba9ef8cc815_negatedTerseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_label_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:to="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_428b96d9-8b6d-44e3-8e70-7f45572b6052_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsMember_aeaade4b-119d-4646-b31b-186bcb1c0550_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_label_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember" xlink:href="bsx-20230331.xsd#bsx_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsMember" xlink:to="lab_bsx_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_241f22b0-8436-48dc-9ad5-1452f4e6eeab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_50f688e4-22e3-4041-a01b-5bee0250910b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_6bb78dbd-5362-455d-95cc-17a3bee24c92_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_64a02822-e094-41f0-b6b4-d602ceb5b41f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ee1b0f1b-927d-4625-bd01-b0aa9aa99c07_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_76546a86-9902-4942-8679-b3e1cac43646_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_63b52144-815f-4f73-bdfe-f3b825cdbada_totalLabel_en-US" xlink:label="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Boston Scientific common stockholders</link:label>
    <link:label id="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_label_en-US" xlink:label="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Boston Scientific common stockholders</link:label>
    <link:label id="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_documentation_en-US" xlink:label="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Boston Scientific common stockholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" xlink:href="bsx-20230331.xsd#bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" xlink:to="lab_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_ffcd8186-62d7-4f7f-9ed8-7868655d0850_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20230331.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4ebbbcee-0097-45c1-967b-8a0c915204bb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_9a74f8a8-1156-4734-aa47-390732e674b5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_fa40e523-2399-4d43-a158-aa5e985e0ea4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_54f6ece3-e5ef-45cd-a7f3-a0a360209fee_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_label_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:to="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_ca5e03b3-95f3-4468-ab91-075b477d7601_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:href="bsx-20230331.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_1e46f341-fb67-4878-961e-33542ec39a78_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_dce7c626-071c-4672-84b1-70b210135714_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_62382df5-d3bc-43e1-80f0-5bf7a7968c90_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ea0c63aa-360e-41bb-9854-0162bca13924_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_32508917-a42e-41ad-a37a-7974ef529032_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3b002c46-27d7-4374-a07f-48236e036d62_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ab7db3b6-9a97-4721-98f4-695646eab244_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_5c212062-6ee0-49fc-9fc0-85861202aee6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_bc92fd28-a135-41c8-b8da-80023df4fb25_terseLabel_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20230331.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b962dc15-1c62-424c-aec6-90dec818fb03_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_fe4662a3-19d6-4953-a509-5f08bf6a545b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves, current</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_420c31c9-4cca-499d-a8b0-57843f0a3a3e_verboseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d9946b69-f346-40f7-a1ac-51d8944feafe_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_25f2a01e-3fa7-4a09-9e67-f144e0826af0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_727f1fad-81ed-4c87-8731-15d668d22aa0_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_954e7042-cef2-43b4-bf00-b7ee31fd2eda_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_f83c2e97-0935-4b9a-8218-0628497aa3be_terseLabel_en-US" xlink:label="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from contracts with customers, disaggregated - performance measurement</link:label>
    <link:label id="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_label_en-US" xlink:label="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from contracts with customers, disaggregated - performance measurement</link:label>
    <link:label id="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_documentation_en-US" xlink:label="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from contracts with customers, disaggregated - performance measurement - measures used by CODM to make business decisions, excludes impact of foreign currency fluctuations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:href="bsx-20230331.xsd#bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:to="lab_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_3c009cc8-de69-45d8-a7e4-fa6025624c61_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_39b39e5f-5d64-48d8-b6c5-6eef78404595_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_a10f8432-bbe7-4f33-beff-6dc948d5fc55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_989091e6-f61a-492c-82f3-887914601226_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 263,289,848 shares as of March&#160;31, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b248bd3a-7abd-4dc5-9255-1551980299c8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_af548319-8ed0-4497-9ea7-235617b9d5f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6af8299e-302b-43ed-82b0-2cb2156f0618_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_78619ebf-38c6-454e-af64-903261f78ee7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_c8f6a1c0-93bc-4219-b7ba-834e29df1d08_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_b8ada7e9-f654-448d-8fce-c9308d84baf9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_76e72f84-61fc-421d-aa77-cd380f779864_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_041fb766-8207-4756-941f-1bbf11ac8428_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9682219a-953e-4430-8a1e-b95a07ba871c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_5db63441-f49d-4fd3-865f-78bd8ca502e9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_13ac305b-8111-4782-b82a-77ad1029057a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_a3359676-0265-4299-b301-3baf62b6bb46_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementassetsMember" xlink:to="lab_bsx_LicensingarrangementassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_9987906d-be88-4a10-a5af-f79f18ad0c9e_terseLabel_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_label_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:href="bsx-20230331.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:to="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_5fa37a5b-8493-48e5-9dec-3fc67cee93fb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c703b62c-8171-4de4-9a6e-11b3e3230661_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_ce19f8c2-8d93-4724-b076-e2e7034b86c0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_127046d3-b526-4774-9abd-02293d1deb7f_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_faf04a60-c488-4c9b-92fa-9ca504fb3078_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6635aa59-a273-4149-91c2-86da949a1c4f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_024ad320-f3c7-4651-a310-473a563a0749_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14295e56-5964-4870-94e5-94b8281670b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0c940d2f-0a0f-4e6a-8119-bdbc1b4e0f35_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_4a3d2cb3-afbe-4f04-83f5-cf264d527ef0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_698d31aa-06ac-4981-ab79-911a7348ed9f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_555ce655-a86e-4af0-9385-cade69a61ac8_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9d1c365a-bf32-4943-83f4-05a47791a77f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_597bb9a3-90e9-4bc9-b2a5-08424fd4d520_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_34011e40-950d-4a73-b75c-6c179a01deba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_90a0d29a-ef06-4a2b-b713-eda5f59512e2_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_f564c0c6-09a4-45b6-aedf-0901486c7b50_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_84491a79-caac-4e2f-806f-2402221df1d3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_01a0dd4e-dcf7-4f8e-83fe-34643cf69ffa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_68ab6495-1fbd-4673-8366-1e19770d7bad_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6dbeabf3-031f-487f-8380-976b65fe9e44_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_9be374ea-44a9-49ee-88b8-ccafaf06e474_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_82efba4f-48a2-406f-a376-2a0f3ee7f220_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_December2027NotesMember_be319b80-0ff0-4edf-af3b-544e61412bb4_terseLabel_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_label_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_documentation_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember" xlink:href="bsx-20230331.xsd#bsx_December2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_December2027NotesMember" xlink:to="lab_bsx_December2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_dd2134a7-48b6-4832-ae07-9baf93372348_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_020b82d4-f7a8-4d31-9bc7-1e3a396a4504_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2026NotesMember_6694a09e-74ac-419c-8a19-acc7bc00aa72_terseLabel_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_label_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_documentation_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2026NotesMember" xlink:to="lab_bsx_March2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_640bdd88-539e-489f-bd28-f0828845429e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_8fc621b1-b3f4-4da5-b0a3-34c50ab601f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9ed68ac3-46c8-4c0f-96a3-c71249a6f55c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_d1512911-49fa-40ee-af84-00154eee664a_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d88b9a3d-9e0c-4214-b220-5723fca2737e_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_a572ba50-8d6e-4479-90ce-12390c70b224_terseLabel_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen denominated factoring arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:href="bsx-20230331.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_904587e2-1292-4547-ada2-97a67a5a2664_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialChargesMember_d4c5c638-3470-4bbf-8e19-5847c0e3e2c0_terseLabel_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_label_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_documentation_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember" xlink:href="bsx-20230331.xsd#bsx_SpecialChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialChargesMember" xlink:to="lab_bsx_SpecialChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_ea0aa59e-6fab-43d4-a4d7-62dcd9d86d08_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_be146ce0-9d6b-4703-b9d8-161f5955aca7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72b9f25e-f952-406b-b976-4455f12fa467_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5e8906a0-348a-411d-bafb-cffb65b1a356_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_9c483c12-8570-4383-ad54-896cb5136640_terseLabel_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Text Block]</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:href="bsx-20230331.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:to="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7a3f148b-69c7-4119-9501-ed49fd922d2c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_2849433d-5ffd-4d18-85b6-0e87689a02fe_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_a174da1d-ad3d-4bd4-bb1a-5c05d79b4d14_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_26c396d2-6074-4cb2-b035-6101b8ba2c1c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2025NotesMember_7c6381e8-b800-418a-baa2-7b76aec81838_terseLabel_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_label_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_documentation_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember" xlink:href="bsx-20230331.xsd#bsx_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2025NotesMember" xlink:to="lab_bsx_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_4189b07f-2da2-4dff-adfc-72b7ed9af084_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d9dacf49-19d4-4fbb-9965-5d9a1de59964_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Par value)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c08157cb-183f-4cec-8eb6-cbd463a65a0e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_5ace9cf9-309e-4dc7-962b-1a42c56b7bed_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2024NotesMember_d06cb177-a1b9-4024-b85e-53e078ea43fb_terseLabel_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_label_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_documentation_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2024NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2024NotesMember" xlink:to="lab_bsx_March2024NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ca011ced-acac-48a4-82be-069a3c8921e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_496d1bf7-a569-4124-9126-b8725590178d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_24488f75-b97d-42f4-8316-06d39f7c917d_terseLabel_en-US" xlink:label="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:label id="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from Issuance of Senior Long Term Debt</link:label>
    <link:label id="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_documentation_en-US" xlink:label="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from Issuance of Senior Long Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="bsx-20230331.xsd#bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_21f4d1e1-f15c-4680-9d78-4f5724684b56_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_f27276c8-9980-462a-b62c-eb27fff15950_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_78ecf99c-325f-42f8-92f6-2c0d35cb24fc_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_88aff231-26df-4c88-a5e3-9e6d3f61c346_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_f18bf9db-2f96-4cdb-b5a5-7ba3b981d428_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring net charges (credits)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7a798b04-88dc-487b-aa12-cb1709a8a383_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_17e92c90-e611-4edd-a78b-8fbdb32f6655_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_7e1bfa20-c74e-43b9-a7a0-f592422c6d22_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_ac284415-8979-45c1-8e6f-5568f8ae57ee_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AcotecMember_16993c19-ec0b-4a3c-a3e8-9fdfef6d0c69_terseLabel_en-US" xlink:label="lab_bsx_AcotecMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acotec</link:label>
    <link:label id="lab_bsx_AcotecMember_label_en-US" xlink:label="lab_bsx_AcotecMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acotec [Member]</link:label>
    <link:label id="lab_bsx_AcotecMember_documentation_en-US" xlink:label="lab_bsx_AcotecMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acotec</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AcotecMember" xlink:to="lab_bsx_AcotecMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e912efb4-34d7-4782-8142-a6e9b335bc10_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0ea6e895-0238-4f9e-858b-0239bce7204c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f8fc769-d6ef-4cc8-8f3d-000445d7e527_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_30fe445c-6f8f-4dd0-839d-590948e06d41_terseLabel_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_label_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_documentation_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:href="bsx-20230331.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:to="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_b6c693d9-3a10-40a5-a8cb-032c2c5b1b57_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2031NotesMember_47353a12-fda1-4f5f-98a7-f3a7627165c1_terseLabel_en-US" xlink:label="lab_bsx_March2031NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2031 Notes</link:label>
    <link:label id="lab_bsx_March2031NotesMember_label_en-US" xlink:label="lab_bsx_March2031NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2031 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2031NotesMember_documentation_en-US" xlink:label="lab_bsx_March2031NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2031 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2031NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2031NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2031NotesMember" xlink:to="lab_bsx_March2031NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_69d67700-cd7a-48dc-803a-1914c0c65e5b_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for legal matters that are probable and estimable</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_9ef0de9a-f2f0-42fe-bafc-0ffe42b78d25_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_36b9d4c0-1cb6-43eb-ab95-b94de81542ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_dfb70205-6262-4be6-bdff-806df809f89b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_53f54b29-714d-4ef6-8f77-78d87f9646a0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c9880f68-e47f-427b-b5f0-cf0115868b04_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_3788782a-6599-422e-831b-183ff4a9fbf1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ac72ce6a-bdc7-42db-a1d3-5f43aa2b0792_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of March&#160;31, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_02653779-9e8b-4006-be70-acf9e065b32a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3d0fcde5-5c56-47ec-8b59-cb9ce6a3dc90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_3dd43c26-0d2b-4c24-98cf-3b26f1cb7621_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_8dcf5978-29b1-4107-b44f-ec6660ca6d75_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0ee9577-5ac6-4250-81b9-18bf0e05fe60_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dac37041-72b5-4eb0-a65a-486ff43fee86_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ElectrophysiologyEPMember_d1a16567-0843-44b8-a3a7-5569f8f35693_terseLabel_en-US" xlink:label="lab_bsx_ElectrophysiologyEPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrophysiology [Member]</link:label>
    <link:label id="lab_bsx_ElectrophysiologyEPMember_label_en-US" xlink:label="lab_bsx_ElectrophysiologyEPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrophysiology (EP) [Member]</link:label>
    <link:label id="lab_bsx_ElectrophysiologyEPMember_documentation_en-US" xlink:label="lab_bsx_ElectrophysiologyEPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Electrophysiology (EP)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember" xlink:href="bsx-20230331.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ElectrophysiologyEPMember" xlink:to="lab_bsx_ElectrophysiologyEPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_bdcb8bcc-8595-428e-b11c-8ef4c50e4bf2_terseLabel_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_label_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_documentation_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember" xlink:href="bsx-20230331.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LatinAmericaandCanadaMember" xlink:to="lab_bsx_LatinAmericaandCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_bf8ed313-dc10-451d-be0f-7365c6cc7cd4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_1e924920-a00e-4a37-9303-40532ef43be9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_94474a6e-49db-4f79-b512-024fe5ee68b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_ca1c7f4c-b77b-43c0-b5d6-b421f51ec47c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_b5efa1a3-9077-4fb6-a047-d1c048041d15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_60357d3f-b1f4-41dc-a4c2-c0c29f6ac024_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementDomain_517c0af0-38a9-4f30-833f-41b354d61b0d_terseLabel_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_label_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_documentation_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain" xlink:href="bsx-20230331.xsd#bsx_StatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementDomain" xlink:to="lab_bsx_StatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_2bcf0387-7918-48d3-80f2-85dd9e1b428c_terseLabel_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_label_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_documentation_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss" xlink:href="bsx-20230331.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Netcurrencyexchangegainloss" xlink:to="lab_bsx_Netcurrencyexchangegainloss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_8da18b41-f730-460f-af95-92116d61189c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_3c95e251-9869-44d2-8e06-55e0de5761a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b3c278fc-712e-40be-a8aa-412fa483d54e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_ea1a1240-dcff-4976-b84d-ae97117beba7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6f4d48d8-2c1b-46c6-a5e2-c8dcde3f6dbd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_d1e07492-a311-4aef-813c-4201dc51f3c9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_5d755fba-e364-4e20-b2e5-b54ffa3194aa_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_e3fc167e-acbd-41b8-a5c8-8eea6a0d9892_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_dd5a3718-8263-4ee4-8f42-8fa498d0c2cc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_72855ca4-ef39-4b18-b9f4-dac168211a9a_terseLabel_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of term loan and revolving credit facility agreement compliance with debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:href="bsx-20230331.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:to="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_dbc854ae-1083-423f-8582-70aeaadcfc5f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_28c51a0d-7311-42a6-ad89-0ee403caf59f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_f8f88b62-cb65-4fe5-81e7-7ccbc4fa3664_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_94888df9-b9fa-488e-8fd8-07653577c315_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4e5b68b8-cbca-4488-81ee-44892453fd28_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_8ed1d06d-8556-41b9-a7e5-1d185db58714_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3c15629-59be-4de8-9d0f-015a015dc626_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_17567779-6460-4680-8427-e90937d6ddbe_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_38fe7b41-01b7-4a0f-8a4a-444534b033d1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3d923716-952b-4792-ad9e-6cc6353f02ae_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1695283e-519b-47c0-8601-5f38f60f089f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8bfad328-cd9c-4bd2-a7ad-74139fd68a22_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_66241bd9-aa03-49a5-9702-4465d2c17f5b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_c3e4745a-14b2-47d9-9159-c8f19edf846c_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumLeverageRatio_b8e9dfe9-d530-4d58-8f5f-120358d6f0cc_terseLabel_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_label_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_documentation_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio permitted by revolving credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio" xlink:href="bsx-20230331.xsd#bsx_MaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumLeverageRatio" xlink:to="lab_bsx_MaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f79ad73d-be7d-4a72-a9c0-b3386f6f48b0_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8f3efa73-6fac-4145-adc7-71207c2026f6_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e38fd836-0834-4bb0-bc00-6aeeedc6a518_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_6d5f8781-ee28-40b7-a234-e5a2d470f6d2_terseLabel_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:href="bsx-20230331.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:to="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_24189de4-0ebc-4cc1-ac7f-fafaabdd48c1_terseLabel_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20230331.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_aa885864-4b20-435d-9540-f2eefb964b34_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_36aada22-801a-4bd7-8cbe-88ea4f50b51d_terseLabel_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember" xlink:href="bsx-20230331.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenueBasedPaymentsMember" xlink:to="lab_bsx_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_f73050cf-6360-4e71-bda1-1adc0b271152_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_d713520c-cf8a-4130-9ada-ed7ffd1ee861_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_99c30ad7-add0-4d77-bb46-ffddaa3c7c6e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_062321b9-b7ce-45c1-8e0a-05c87a322fe3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e756095d-6fe7-4808-8e53-17c264d1531f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_81eb3815-0397-4041-a2f2-fb5a07d04f5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_4afceac2-3bd8-40fa-b056-f3090b013bbe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_dcd25943-38b1-47e7-938f-8fedc8bad436_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_77ead129-29b6-4882-8fc5-b14c7f81b21d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8f825279-9d0a-4685-bfc6-e5efde44a5ab_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_16bebe6b-695c-41a4-8ce3-2a8734c68478_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_dbc2f8bd-bc15-481a-80f9-c356f9505545_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_dc44e388-44fb-4179-a085-f2c06dd2eb13_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_a2c40e2d-dc5e-42f4-95a1-cfd47dff5aad_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_a45fcddc-47e1-46d1-b9f7-d678f622220c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_f4993234-b383-41dd-a6e6-bcba10e6af72_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_43193c9c-df4e-4ae9-9f8f-8da0af4ad9f8_terseLabel_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_label_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_documentation_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:href="bsx-20230331.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:to="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d8043079-3c01-4b32-9d50-9bb6efb54e71_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_4424ae00-cfbd-40be-8d75-78dbc021bc6a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d72c6515-2055-4ec7-b270-9bf91761ca52_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_b0eacc67-1f0f-4e4b-a849-25e8804df1f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7b391d53-954f-4919-80bb-bc3f34dfa985_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_0446e5e4-7623-4113-bd85-dc8ae0fd0401_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a9d088c-03db-41e7-915d-63c3dd7ee4fc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_0f7131f9-248e-40c4-badc-a035ae5f07f1_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average interest rate of de-recognized receivables</link:label>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_label_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable with Imputed Interest, Effective Yield (Interest Rate)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:to="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_fa4256c7-3779-4266-8537-8438299ae0fe_terseLabel_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:href="bsx-20230331.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:to="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CurrentRequirementMember_cb235607-3b5e-4756-b050-c1cf152587b5_terseLabel_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_label_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_documentation_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember" xlink:href="bsx-20230331.xsd#bsx_CurrentRequirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CurrentRequirementMember" xlink:to="lab_bsx_CurrentRequirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5558987b-7e31-460d-9de8-f3e4b2ed1fe5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_b929d8d8-8d9a-4942-8188-2af328ba4529_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_63ec9de5-148e-480c-8e14-93371b099f29_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_83119bfc-8cc2-48ad-8bac-88287d26b308_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsliability_e448f6c6-1751-4dd2-ab01-59323a5b9c65_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_label_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsliability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsliability" xlink:to="lab_bsx_Licensingarrangementsliability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2cc738e3-842c-4953-8df2-f21b5b9d4a1b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AccruedRebatesCurrent_932d497c-266c-488c-a11d-0dc2c2a8b7ac_terseLabel_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_label_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_documentation_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent" xlink:href="bsx-20230331.xsd#bsx_AccruedRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AccruedRebatesCurrent" xlink:to="lab_bsx_AccruedRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_94f28467-b11d-43a9-bf63-2139d59369f4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_c80f59ba-4b44-47b4-a9fe-c0e125a55290_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherNet_b88b67da-2691-4455-abc7-a4a95703f01b_terseLabel_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_label_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_documentation_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet" xlink:href="bsx-20230331.xsd#bsx_OtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherNet" xlink:to="lab_bsx_OtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f67b337a-7ce4-45f4-91f0-aed88b92a8e0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_ebd55cf3-dd00-4e91-848a-54c8f7bff203_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_71549a61-9ac0-4d18-a244-d758d9045dbe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2029NotesMember_143abc8b-34a5-4378-ac43-5c70a4fee835_terseLabel_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_label_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_documentation_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2029NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2029NotesMember" xlink:to="lab_bsx_March2029NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_a6219c2c-6f7e-436f-824e-3a35fcd831fb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_d89de65f-b3b4-4e6c-a145-f474045c90f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_a02d73e0-4ce1-4ef0-9048-ebdd0159c8f4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_befac7c3-f529-42cc-ae6b-3682ad5eec73_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_44ee5160-bfb6-4364-bf3e-fc3e25be2026_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_148245d0-88c2-4728-bf16-f0979c76c378_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_58df020c-3a8b-4904-a66d-e592635f6e4a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_66f4a068-8ff9-4b63-9199-54947225899f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7da2bf62-8673-4f04-9b17-2007be5c69cb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_5280b729-c867-4e6d-9d49-4569763c08d6_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_8b81a8ff-4cf3-42f6-8d6f-b71a27a651df_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_50daa207-4739-4d38-9d3c-3ae36785ea82_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_313c9d89-8174-4018-a7f5-ba1d86a0ded9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_8a48f16c-68ad-4073-9c45-87af3aa8401e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eeb68479-fb3d-429b-8933-049525f57781_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3da7060b-0198-4e04-b743-50ad481db987_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cc390658-ff13-4658-8db6-979e04783ed6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_fb258c6c-954a-41de-b333-94b1ba67b214_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2e64555e-347e-4139-9364-2bc0988463ea_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d7fef841-c890-4f31-ba99-d2f0e76acf5b_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_00b65fee-ef2d-4b68-ba48-13ed0a408c0c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_fe6992fe-df1a-420c-aec9-1103852fb4a3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d66d69e6-de7d-42b2-a33b-6b9528ba162e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2040NotesMember_7f2c3eb7-498c-4926-91b2-95c84be53d60_terseLabel_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_label_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_documentation_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember" xlink:href="bsx-20230331.xsd#bsx_January2040NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2040NotesMember" xlink:to="lab_bsx_January2040NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_959ef539-c8b6-49e1-a1f8-e95846c19a0e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_1b631dcc-05bf-48e4-901a-b86480cdfd8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_113d51de-9cd0-4e5d-a3b2-04b23ff4b3c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cbf0577c-54a2-4b6e-9d8e-1897d7b41c79_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_1fc1f2f9-3d45-4b72-86ea-7e5bc7179f3f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_71226270-e20d-4b5d-ad20-ca9e724f113e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_ef547621-39ce-4ebd-a4fd-d78963965447_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings and debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_887687a3-1f11-4053-897a-28efc04c0491_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ca85692c-abf9-448e-86b6-0249fe828f67_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2025NotesMember_734317a9-da25-4cd7-a316-effe11a361ea_terseLabel_en-US" xlink:label="lab_bsx_March2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2025 Notes</link:label>
    <link:label id="lab_bsx_March2025NotesMember_label_en-US" xlink:label="lab_bsx_March2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2025NotesMember_documentation_en-US" xlink:label="lab_bsx_March2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2025NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2025NotesMember" xlink:to="lab_bsx_March2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_2b65c1d2-cfc7-4b8e-84d0-1fd4281cec5e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_b065f6f1-4b4f-4794-86e0-a4b3225f6c1e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_563423f8-3da7-4daf-a673-7353315c05fe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment and internal use software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_9367425b-fa80-4c3b-afaf-570586ec6c58_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_754fc44c-1da7-4458-8acc-8df0041080f7_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_e773442a-2c3f-46e5-b7ec-628fbecb1220_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_ba0b7332-de26-4be6-a063-c2e3aa782213_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract (less than)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_36df51fa-7d6e-41a0-956d-1eaf3645d19c_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2034NotesMember_43f713c0-43f1-4a06-9d65-50066d591de3_terseLabel_en-US" xlink:label="lab_bsx_March2034NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2034 Notes</link:label>
    <link:label id="lab_bsx_March2034NotesMember_label_en-US" xlink:label="lab_bsx_March2034NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2034 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2034NotesMember_documentation_en-US" xlink:label="lab_bsx_March2034NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2034 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2034NotesMember" xlink:href="bsx-20230331.xsd#bsx_March2034NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2034NotesMember" xlink:to="lab_bsx_March2034NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_a831264f-5e40-4e93-b718-0dee65d86577_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_1f5ddfec-7b42-4770-8796-4aaf060b290f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Period Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplierFinanceProgramObligationCurrent_1540ed9e-b3e8-4da3-afe5-bedd6a3c8130_terseLabel_en-US" xlink:label="lab_bsx_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program Obligation. current</link:label>
    <link:label id="lab_bsx_SupplierFinanceProgramObligationCurrent_label_en-US" xlink:label="lab_bsx_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program Obligation. current</link:label>
    <link:label id="lab_bsx_SupplierFinanceProgramObligationCurrent_documentation_en-US" xlink:label="lab_bsx_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Finance Program Obligation. current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplierFinanceProgramObligationCurrent" xlink:href="bsx-20230331.xsd#bsx_SupplierFinanceProgramObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplierFinanceProgramObligationCurrent" xlink:to="lab_bsx_SupplierFinanceProgramObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_d239513e-bdbd-4093-a8a2-ef3f7b125487_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_label_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:href="bsx-20230331.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:to="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>bsx-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9cbc6555-e4c7-43a3-bb56-c8c16faaf364,g:530e6bfc-c5ff-4de2-ac46-2fa9fa8fd4fc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20230331.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract_5812b6ae-8a8e-473c-8bb0-29f971479a75" xlink:href="bsx-20230331.xsd#bsx_EntityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_EntityAbstract_5812b6ae-8a8e-473c-8bb0-29f971479a75" xlink:to="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_70f7fb4e-e8c3-44ff-b06a-c98b05c16a15" xlink:to="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b4bd062a-4f23-42e2-be60-f4465522ce00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:to="loc_us-gaap_CommonStockMember_b4bd062a-4f23-42e2-be60-f4465522ce00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_4831b0fd-a217-4008-8b25-c2669fd30cf9" xlink:href="bsx-20230331.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:to="loc_bsx_SeniorNotedue2027Member_4831b0fd-a217-4008-8b25-c2669fd30cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_e6c0721c-573e-4d5b-812d-c3548b6b11c1" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3f06d81-c7af-453a-8147-fef95e2a7b6a" xlink:to="loc_bsx_A550MCPSSeriesAMember_e6c0721c-573e-4d5b-812d-c3548b6b11c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_77cdf1cf-8a9a-4650-b201-5760e50ba7a0" xlink:to="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_040b481f-20e4-4af6-862a-9adea5861788" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentType_040b481f-20e4-4af6-862a-9adea5861788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_cf286d54-f003-4c96-8f9e-651e6fac755a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentQuarterlyReport_cf286d54-f003-4c96-8f9e-651e6fac755a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9275f959-a6a4-4ead-a687-8410f6697854" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentPeriodEndDate_9275f959-a6a4-4ead-a687-8410f6697854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_dbc2c999-5098-4ccb-8c77-c1cabbe82edf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentTransitionReport_dbc2c999-5098-4ccb-8c77-c1cabbe82edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_cd67bf20-9b64-48cf-b24d-6adabe27603b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityFileNumber_cd67bf20-9b64-48cf-b24d-6adabe27603b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e7c83e41-4473-46cd-b497-cd8c7ebdbdb7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityRegistrantName_e7c83e41-4473-46cd-b497-cd8c7ebdbdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0752d43b-1b64-4570-859f-a74b17dd8b1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0752d43b-1b64-4570-859f-a74b17dd8b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4bfa1d5e-9606-4bb1-aab2-6009ad79cb62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityTaxIdentificationNumber_4bfa1d5e-9606-4bb1-aab2-6009ad79cb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_22954b0e-24e6-4954-a834-f21c699cc962" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressAddressLine1_22954b0e-24e6-4954-a834-f21c699cc962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_48f140b8-bb16-45ff-9654-616667db663c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressCityOrTown_48f140b8-bb16-45ff-9654-616667db663c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7afe4a31-c7d5-412f-b7e7-db0b62e5bf3c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressStateOrProvince_7afe4a31-c7d5-412f-b7e7-db0b62e5bf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e0bbc2a8-4301-4044-ab89-6785ebd0b10e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityAddressPostalZipCode_e0bbc2a8-4301-4044-ab89-6785ebd0b10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_34cc935c-9248-49f8-8acd-f934f2ccf7f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_CityAreaCode_34cc935c-9248-49f8-8acd-f934f2ccf7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b8f41319-edf0-4259-b59f-b239230d9ba9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_LocalPhoneNumber_b8f41319-edf0-4259-b59f-b239230d9ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a24d8d9e-cefd-42c1-be77-9537deff4bc4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_Security12bTitle_a24d8d9e-cefd-42c1-be77-9537deff4bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f535203e-9fbb-4c79-aaad-9f1471cd7cac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_TradingSymbol_f535203e-9fbb-4c79-aaad-9f1471cd7cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c5e0f858-2267-4a25-b9fd-2714f0bc8858" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_SecurityExchangeName_c5e0f858-2267-4a25-b9fd-2714f0bc8858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_70824263-04e4-430d-92b3-71137b54ab45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityCurrentReportingStatus_70824263-04e4-430d-92b3-71137b54ab45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_68e56036-d71b-45c8-bf97-7dd901ad1f4f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityInteractiveDataCurrent_68e56036-d71b-45c8-bf97-7dd901ad1f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_bccde279-dd03-4721-94af-bcc8fcc29042" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityFilerCategory_bccde279-dd03-4721-94af-bcc8fcc29042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_cf96b446-3f3e-4761-8499-1830b8fd0027" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntitySmallBusiness_cf96b446-3f3e-4761-8499-1830b8fd0027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9948745d-07c9-4e9d-a38c-52fcb7362ba9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityEmergingGrowthCompany_9948745d-07c9-4e9d-a38c-52fcb7362ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d2fb423b-e54c-4171-9b4c-acfed5bf679d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityShellCompany_d2fb423b-e54c-4171-9b4c-acfed5bf679d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_a1ec8cd2-3f86-4e57-adec-bb3e5e3e4fa2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingParValuePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityListingParValuePerShare_a1ec8cd2-3f86-4e57-adec-bb3e5e3e4fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_19c6b20c-6106-4bad-a44b-458ea4ebc404" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_19c6b20c-6106-4bad-a44b-458ea4ebc404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_56b2ee3a-3045-4541-b130-c6ce6d6446ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_EntityCentralIndexKey_56b2ee3a-3045-4541-b130-c6ce6d6446ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_143e83f3-deff-4533-b10b-2316cc96f266" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_CurrentFiscalYearEndDate_143e83f3-deff-4533-b10b-2316cc96f266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_8632a8fb-39c7-45fe-b854-841312ccb23b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentFiscalYearFocus_8632a8fb-39c7-45fe-b854-841312ccb23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c926c515-7307-472e-b9c9-9484a2fea131" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c926c515-7307-472e-b9c9-9484a2fea131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7e53e15b-69fd-487a-af4f-28d25bbe5f9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a28fccd3-42b4-4980-abc8-4ef8130a8c19" xlink:to="loc_dei_AmendmentFlag_7e53e15b-69fd-487a-af4f-28d25bbe5f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_842dfdb2-af2a-4737-ada0-6c52a534a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_842dfdb2-af2a-4737-ada0-6c52a534a3f2" xlink:to="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:to="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_837aeccc-e370-4e4f-975e-0fc0602fb123" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7401afc3-fc47-4902-ae9b-d46825ecb8eb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_837aeccc-e370-4e4f-975e-0fc0602fb123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f5ff4a19-fb27-406f-b57e-528cced8eb18" xlink:to="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c9db4d3-d211-4d46-99f8-36eb05a30f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c9db4d3-d211-4d46-99f8-36eb05a30f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_104a7e10-a9d6-45c3-9335-2db8dc5b4bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_104a7e10-a9d6-45c3-9335-2db8dc5b4bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9fdb98fd-33c8-4303-bc0b-71339a8a9232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_GrossProfit_9fdb98fd-33c8-4303-bc0b-71339a8a9232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f5102f3-0f48-4cc9-8176-68df5ef05acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f5102f3-0f48-4cc9-8176-68df5ef05acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f69a7ec0-c9ee-4eeb-8f87-f193a8540789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f69a7ec0-c9ee-4eeb-8f87-f193a8540789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_21f3fea9-5132-43ba-a3f0-9a1b311c7ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_RoyaltyExpense_21f3fea9-5132-43ba-a3f0-9a1b311c7ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2634f06d-9eda-4397-91d4-d0e8e7027cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2634f06d-9eda-4397-91d4-d0e8e7027cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf867b6c-37f1-44e6-9e15-19ca93279866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cf867b6c-37f1-44e6-9e15-19ca93279866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2c3ab73a-af90-4ded-a680-994f4c3e2c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_RestructuringCharges_2c3ab73a-af90-4ded-a680-994f4c3e2c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6c12618c-805a-451d-90c4-42c54e904438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_face9651-35e7-4421-9f0e-b40dfc8b1a1c" xlink:to="loc_us-gaap_OperatingExpenses_6c12618c-805a-451d-90c4-42c54e904438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e8dc02ed-e61d-4e86-b6e1-3105903a7fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_OperatingIncomeLoss_e8dc02ed-e61d-4e86-b6e1-3105903a7fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0f22cc31-1523-41f4-8ba9-83fc063abee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:to="loc_us-gaap_InterestExpense_0f22cc31-1523-41f4-8ba9-83fc063abee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e30d4af1-17ea-4e37-84b4-eed313af4dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7e9ab34f-9071-484b-a750-165b27bbc14a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e30d4af1-17ea-4e37-84b4-eed313af4dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34bbd1c7-5ad7-4bc1-b9bf-3fc3957c1ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34bbd1c7-5ad7-4bc1-b9bf-3fc3957c1ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9f9eee69-f1a0-45d2-8e4e-91b8da9cfd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9f9eee69-f1a0-45d2-8e4e-91b8da9cfd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_67120829-76b6-4ab8-bbf3-dedc747440b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_ProfitLoss_67120829-76b6-4ab8-bbf3-dedc747440b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_71c6ab5d-efd3-433b-bef8-8b57b9cabd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_DividendsPreferredStockStock_71c6ab5d-efd3-433b-bef8-8b57b9cabd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5682c868-a922-4d22-9c0b-6b9f2ad491ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5682c868-a922-4d22-9c0b-6b9f2ad491ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_c0ea578e-b331-44d7-adc1-3d90c0b916be" xlink:href="bsx-20230331.xsd#bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders_c0ea578e-b331-44d7-adc1-3d90c0b916be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6c8db84f-9861-4abb-bb69-c31bf1189e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_EarningsPerShareBasic_6c8db84f-9861-4abb-bb69-c31bf1189e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4696d586-b22a-4deb-998b-f8e349d93fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4696d586-b22a-4deb-998b-f8e349d93fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3efb7a8c-3981-4f76-b48d-bca6bcf47e00" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_456cc22a-cacb-4a0b-840e-9502a120ac56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_456cc22a-cacb-4a0b-840e-9502a120ac56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea3df3b8-0c0a-4ec7-ba8b-9c21522ca2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a4dee618-4f7c-4c71-880f-8dfbb332f815" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ea3df3b8-0c0a-4ec7-ba8b-9c21522ca2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6b45c793-74b1-4e03-844d-74aac40f4af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6b45c793-74b1-4e03-844d-74aac40f4af6" xlink:to="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:to="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e90ffa5f-33e0-4824-9acf-adc64a2fd29e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ff518265-4c1c-42ab-9473-f013fb36f107" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e90ffa5f-33e0-4824-9acf-adc64a2fd29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17146df0-fc9d-4ec5-89ac-128654b955ba" xlink:to="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3a54fdcb-22c8-4633-acc6-769e8f69c0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_ProfitLoss_3a54fdcb-22c8-4633-acc6-769e8f69c0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_75731e7f-68cc-48d2-ba90-dcdde9b5dc85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_75731e7f-68cc-48d2-ba90-dcdde9b5dc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bc6c8591-ae8e-4303-87e1-2225896aeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bc6c8591-ae8e-4303-87e1-2225896aeaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_473076e6-9dfb-4fa1-8e3e-55ed60afe4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_473076e6-9dfb-4fa1-8e3e-55ed60afe4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f234ad34-0b23-44cc-92cf-facce8744f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0280d868-51c8-4a16-b4fd-d147a7f134fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f234ad34-0b23-44cc-92cf-facce8744f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ba81b25-cd4a-43d0-87db-337a5becfb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ba81b25-cd4a-43d0-87db-337a5becfb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_ddf38dff-1be0-4e1b-922d-453f7b767039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest_ddf38dff-1be0-4e1b-922d-453f7b767039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_34743f20-a922-4a3b-9bea-7c3368eaaba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a079b9d2-5ef4-4576-8625-04056d4e84f0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_34743f20-a922-4a3b-9bea-7c3368eaaba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_891abf33-e8c1-4051-90be-89b73af50972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_891abf33-e8c1-4051-90be-89b73af50972" xlink:to="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:to="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ea68d6bb-30d0-4e86-8555-b577e2591395" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_209f766b-901e-4b93-b0be-3a8116da3bd3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ea68d6bb-30d0-4e86-8555-b577e2591395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_73220fe5-dbde-49a1-88d1-3a5362892fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f777be41-9ad9-4edf-8c83-90aa242c522e" xlink:to="loc_us-gaap_ClassOfStockDomain_73220fe5-dbde-49a1-88d1-3a5362892fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f4a41a8-8f78-43ae-8dbc-b7d2b8de736e" xlink:to="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:to="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_feea5e34-c414-4f24-b828-3936d230f5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_feea5e34-c414-4f24-b828-3936d230f5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ceae8136-3e06-46d9-ad78-e84e0b350623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ceae8136-3e06-46d9-ad78-e84e0b350623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_63e70a7f-1a85-46b8-8089-015f448cfac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_InventoryNet_63e70a7f-1a85-46b8-8089-015f448cfac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_d6ddb452-f05e-4140-87b6-6de244ca823f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_PrepaidTaxes_d6ddb452-f05e-4140-87b6-6de244ca823f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11f76cb4-9cb2-486d-b9bb-fde4eb798adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11f76cb4-9cb2-486d-b9bb-fde4eb798adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_41061ff7-44e4-4d18-93e3-c19d96daa354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_26afeee1-e2d9-4783-b5e5-92f5c20063b8" xlink:to="loc_us-gaap_AssetsCurrent_41061ff7-44e4-4d18-93e3-c19d96daa354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_01ac58e8-080b-4aa8-9473-c3e4c49d36c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_01ac58e8-080b-4aa8-9473-c3e4c49d36c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4fb60bec-d50b-484e-8105-45566d11cbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_Goodwill_4fb60bec-d50b-484e-8105-45566d11cbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f8f18c91-3294-4900-8399-7e3e19d981de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f8f18c91-3294-4900-8399-7e3e19d981de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f7dbbc90-8d21-4da7-ae86-53b1c461c966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f7dbbc90-8d21-4da7-ae86-53b1c461c966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2be35f5b-93e1-4a6f-8576-953749c5e071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2be35f5b-93e1-4a6f-8576-953749c5e071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_71b89fe5-af10-4af8-a7dc-16bd13c52f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8146b30a-3c47-40ae-8d66-b2839b6796e0" xlink:to="loc_us-gaap_Assets_71b89fe5-af10-4af8-a7dc-16bd13c52f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_afd7b70e-6459-4fc1-a937-da17ccef516b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_801f11fd-8360-4728-9e6c-451e310e2b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_DebtCurrent_801f11fd-8360-4728-9e6c-451e310e2b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e967d97a-61cc-42f3-98c9-980b64ece17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_AccountsPayableCurrent_e967d97a-61cc-42f3-98c9-980b64ece17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6cd488ff-524d-45b3-b484-2532b8dd6513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6cd488ff-524d-45b3-b484-2532b8dd6513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a6f2d32d-fd07-4fab-992b-05994a0dbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a6f2d32d-fd07-4fab-992b-05994a0dbaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7779d2b9-c6d4-4ece-b0b0-ec54cdc0225a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a13b38c-bb57-4fad-9975-230a1c7acbd6" xlink:to="loc_us-gaap_LiabilitiesCurrent_7779d2b9-c6d4-4ece-b0b0-ec54cdc0225a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_26d0c4b0-61fc-49a1-b4c2-60e2f1ece7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_26d0c4b0-61fc-49a1-b4c2-60e2f1ece7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e267ac6a-0992-412e-90bd-1218c67bf77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e267ac6a-0992-412e-90bd-1218c67bf77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f87b6895-0664-4053-9c0a-2ae8623a98a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f87b6895-0664-4053-9c0a-2ae8623a98a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d025f6f1-7506-4344-8637-c6b3eb86f2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d025f6f1-7506-4344-8637-c6b3eb86f2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3af54c9e-c7b9-4903-b983-8e08b1959752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_PreferredStockValue_3af54c9e-c7b9-4903-b983-8e08b1959752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2c3fff88-333b-414d-81b4-6144c99d6356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_CommonStockValue_2c3fff88-333b-414d-81b4-6144c99d6356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0b0972b8-ed7b-446f-b6f3-e4790bd9dd96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_TreasuryStockValue_0b0972b8-ed7b-446f-b6f3-e4790bd9dd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_89028c81-9b0f-43a6-b4b4-b9c4a918a5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_89028c81-9b0f-43a6-b4b4-b9c4a918a5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4bb0f996-d5da-4989-b7b6-47930e57b65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4bb0f996-d5da-4989-b7b6-47930e57b65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_54283459-9cf7-4ff1-a070-1e95fbd5b9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_54283459-9cf7-4ff1-a070-1e95fbd5b9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_178a432f-b760-428f-83f2-5b12a1de4ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_StockholdersEquity_178a432f-b760-428f-83f2-5b12a1de4ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a8e5dfd9-f84a-4e97-a8c7-f73feb8e2c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_MinorityInterest_a8e5dfd9-f84a-4e97-a8c7-f73feb8e2c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1cc29358-6c80-4e48-a4a5-01a49d0226dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8ef7a25c-553f-4a90-92b6-5b57233b414c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1cc29358-6c80-4e48-a4a5-01a49d0226dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_af3f51c2-3e05-4a36-be9c-eb3de10aa336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ba764a9-732a-4dad-b65d-cc90a4ba9a07" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_af3f51c2-3e05-4a36-be9c-eb3de10aa336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:href="bsx-20230331.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9a638d5a-62ca-4d7f-a02e-d424ddcd9333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9a638d5a-62ca-4d7f-a02e-d424ddcd9333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_72b79a6a-59aa-4edc-8c09-cc494629b3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_72b79a6a-59aa-4edc-8c09-cc494629b3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f84a9747-35ca-4108-bea2-8357bc5395ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f84a9747-35ca-4108-bea2-8357bc5395ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_351d6f56-778f-4ddf-9e6b-aa461a296d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_351d6f56-778f-4ddf-9e6b-aa461a296d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7a69b44b-ec99-4306-8b1b-2fcab465e180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7a69b44b-ec99-4306-8b1b-2fcab465e180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ede72590-7fdd-4094-a3c5-32784b5374d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_CommonStockSharesIssued_ede72590-7fdd-4094-a3c5-32784b5374d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_9170d17b-760b-420b-b02f-c7fcac8ad174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_9b3fc930-58b9-47f8-89eb-a8b3218aee47" xlink:to="loc_us-gaap_TreasuryStockCommonShares_9170d17b-760b-420b-b02f-c7fcac8ad174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8ad36aec-5def-4602-8254-12ad792b403d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8ad36aec-5def-4602-8254-12ad792b403d" xlink:to="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_712f9de3-b210-4f8d-8d48-93b1a7d335b9" xlink:to="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_04f28bac-4d7f-4520-a3e0-666fbf0cffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_PreferredStockMember_04f28bac-4d7f-4520-a3e0-666fbf0cffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d9882fed-2948-43ca-bd1f-bbbb922db60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_CommonStockMember_d9882fed-2948-43ca-bd1f-bbbb922db60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_30174558-ddaf-403f-8364-1666dc71941a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_30174558-ddaf-403f-8364-1666dc71941a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b6c5d671-e45d-4b20-9da9-1ca4778ee065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_RetainedEarningsMember_b6c5d671-e45d-4b20-9da9-1ca4778ee065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_94f47c89-a59e-449a-a3c6-e70299a0d947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_94f47c89-a59e-449a-a3c6-e70299a0d947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_01370484-b08a-43b9-ac1b-b705847524dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_01370484-b08a-43b9-ac1b-b705847524dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_624e1ad2-2824-4893-b20b-232a552fd544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb8d2d7a-2019-48b9-9fef-6957aadeb13e" xlink:to="loc_us-gaap_TreasuryStockCommonMember_624e1ad2-2824-4893-b20b-232a552fd544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_227f7248-9dc6-4f56-9f5e-4e17e1fe7975" xlink:to="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_99b1a185-303e-4005-8e37-2482cc4db495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_SharesIssued_99b1a185-303e-4005-8e37-2482cc4db495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b8007b74-bf43-4163-a566-08b7b5fdc965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b8007b74-bf43-4163-a566-08b7b5fdc965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a43f108-f1ee-4bcc-8840-ee743e610f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a43f108-f1ee-4bcc-8840-ee743e610f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b437db26-c59b-4ab2-8ee8-c5a2496acecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockholdersEquity_b437db26-c59b-4ab2-8ee8-c5a2496acecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_df29d49a-af5e-4fd1-9b4d-2f38fc9fbf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_df29d49a-af5e-4fd1-9b4d-2f38fc9fbf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_eff07eee-1f0a-4338-ade8-d7b7ad2965cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_eff07eee-1f0a-4338-ade8-d7b7ad2965cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_33a7f5b4-1968-49ed-82b1-ea994d90363e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_33a7f5b4-1968-49ed-82b1-ea994d90363e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9e305b6c-140c-4c5a-b127-9088e5b2b120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9e305b6c-140c-4c5a-b127-9088e5b2b120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a47c59e4-0b62-4fb4-9b5f-c18e044b6b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_CommonStockSharesIssued_a47c59e4-0b62-4fb4-9b5f-c18e044b6b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_a9378814-00fa-48d1-b319-b3ab5fdee05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_a9378814-00fa-48d1-b319-b3ab5fdee05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_72484dc6-1e03-4bb5-a2c0-2043ae4a72cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_SharesIssued_72484dc6-1e03-4bb5-a2c0-2043ae4a72cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cad97d63-7d5f-4c09-9889-e87b2fa07e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ced563d4-9925-4028-8356-8bfcaa2c74c3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cad97d63-7d5f-4c09-9889-e87b2fa07e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0647fc3-cb6d-4402-8a6b-04badc0d760a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0647fc3-cb6d-4402-8a6b-04badc0d760a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df4920b3-6c21-4d37-92c7-6f0a6daaa723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_ProfitLoss_df4920b3-6c21-4d37-92c7-6f0a6daaa723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_918f8492-2152-42cd-8090-e6fb600fdabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_DividendsPreferredStockCash_918f8492-2152-42cd-8090-e6fb600fdabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93b75b18-b517-4b14-bb61-ac254b57d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81c32506-7ff0-494a-aafe-211aa6ce88fb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93b75b18-b517-4b14-bb61-ac254b57d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cfcf4d41-0e01-4ee0-ad1b-7f8d17662b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cfcf4d41-0e01-4ee0-ad1b-7f8d17662b06" xlink:to="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:to="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_abe5be52-4b32-4a82-aa28-407d8f44d280" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f6b86730-156b-4ddc-af9d-26fb5af28b7f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_abe5be52-4b32-4a82-aa28-407d8f44d280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12ab0e92-465c-450a-b2d9-c3454ae7beb2" xlink:to="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_395ed7d8-6e16-49d5-b2af-d57ea427f058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_ProfitLoss_395ed7d8-6e16-49d5-b2af-d57ea427f058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c6394bb0-8860-4d04-8807-2f3e4a256c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c6394bb0-8860-4d04-8807-2f3e4a256c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_f8009e02-7b88-4f3e-beb9-aac0af658492" xlink:href="bsx-20230331.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_f8009e02-7b88-4f3e-beb9-aac0af658492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bcce778f-5518-4935-9dd4-6f01ee5141be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_ShareBasedCompensation_bcce778f-5518-4935-9dd4-6f01ee5141be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_a6ef1bf6-ba55-4b49-bfa3-a739c689243c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_GainLossOnInvestments_a6ef1bf6-ba55-4b49-bfa3-a739c689243c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5eee6a50-ba45-4039-b1d4-e1bbb9b07772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5eee6a50-ba45-4039-b1d4-e1bbb9b07772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_56d33c4f-61da-4693-87ca-e6c178d42c25" xlink:href="bsx-20230331.xsd#bsx_InventoryStepUpAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_bsx_InventoryStepUpAmortization_56d33c4f-61da-4693-87ca-e6c178d42c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_60435d71-9fcf-47c2-bd23-60d2ef41e968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_60435d71-9fcf-47c2-bd23-60d2ef41e968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_76385bd7-1371-442e-9efe-6cdf6624cce2" xlink:href="bsx-20230331.xsd#bsx_OtherNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_bsx_OtherNet_76385bd7-1371-442e-9efe-6cdf6624cce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9f679ef5-a908-4cb3-8da8-af4a020e4040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9f679ef5-a908-4cb3-8da8-af4a020e4040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_55bce636-80e8-48d4-9a3f-a65f526fde6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_55bce636-80e8-48d4-9a3f-a65f526fde6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9e510e3e-ee0f-4a32-9358-b26b10d92ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9e510e3e-ee0f-4a32-9358-b26b10d92ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_89cac4e4-02f5-4188-9649-c9a73e295206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_89cac4e4-02f5-4188-9649-c9a73e295206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30c533b8-3ee7-48a4-a502-eb3732e1f655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dc8de36e-2d3f-4fd6-9a7f-be96f4db6609" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30c533b8-3ee7-48a4-a502-eb3732e1f655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e75846e-6c65-4b61-9727-de48b720edad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e75846e-6c65-4b61-9727-de48b720edad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d9b6043c-8d35-409d-a30d-dafb9f1a45db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d9b6043c-8d35-409d-a30d-dafb9f1a45db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_615c29d5-53cb-4d67-a12e-56f304f60336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_615c29d5-53cb-4d67-a12e-56f304f60336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8dba98fa-da1e-4550-bdfe-eee51a36ffcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8dba98fa-da1e-4550-bdfe-eee51a36ffcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_73181be5-1d8b-4f2a-99c1-b932091bb926" xlink:href="bsx-20230331.xsd#bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies_73181be5-1d8b-4f2a-99c1-b932091bb926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ff5094-499e-4c40-bbbc-92ad6a2e5b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1b76fdde-08d8-4c55-a4e7-ee59c3c04fe4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ff5094-499e-4c40-bbbc-92ad6a2e5b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4fe53d6b-9a81-4940-89df-fd5d794295d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4fe53d6b-9a81-4940-89df-fd5d794295d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_03b0af40-691c-4885-8c1b-90fd8c78b475" xlink:href="bsx-20230331.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_bsx_PaymentsForRoyaltyRights_03b0af40-691c-4885-8c1b-90fd8c78b475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c9c763e2-57c6-4aaa-aab2-95a0d9f69e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c9c763e2-57c6-4aaa-aab2-95a0d9f69e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_b9339c3a-729b-45aa-af22-c3a84e659e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_b9339c3a-729b-45aa-af22-c3a84e659e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_138591a3-ae7e-4b87-a5c6-23b1f0c91649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_138591a3-ae7e-4b87-a5c6-23b1f0c91649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_25c7e172-7f59-45ab-88fe-a1343193cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_25c7e172-7f59-45ab-88fe-a1343193cb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e4917056-8802-4d69-9f99-1623904157ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_PaymentsOfDividends_e4917056-8802-4d69-9f99-1623904157ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_973d2607-a677-4e64-ab38-b084977f9acb" xlink:href="bsx-20230331.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_973d2607-a677-4e64-ab38-b084977f9acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_f7b2efff-fda1-442d-9190-0f8895934c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_ProceedsFromStockPlans_f7b2efff-fda1-442d-9190-0f8895934c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_631e6227-31be-49a9-ac71-857511542bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b74cf8d5-bc1f-43f4-9365-e897c48ac18c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_631e6227-31be-49a9-ac71-857511542bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc47483d-a1f2-4ae5-8141-714e83fb576e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc47483d-a1f2-4ae5-8141-714e83fb576e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d87fb9-3af7-4ff7-b566-71f2e513b771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1d87fb9-3af7-4ff7-b566-71f2e513b771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7051cae-cfc0-4f57-a697-15bead05d23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7051cae-cfc0-4f57-a697-15bead05d23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_966fd017-5262-48cf-b8d8-e68cd1f35642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_966fd017-5262-48cf-b8d8-e68cd1f35642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea607c3f-b3cf-4dd2-a9a8-d03a7ec5cce6" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b99ecbb2-d1bf-444c-94b4-8b9442528edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:to="loc_us-gaap_ShareBasedCompensation_b99ecbb2-d1bf-444c-94b4-8b9442528edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_62c89d4c-56b6-4286-b826-309421b99ac4" xlink:href="bsx-20230331.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_17d5c072-1653-4770-8511-8d45a00626a0" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_62c89d4c-56b6-4286-b826-309421b99ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20230331.xsd#ConsolidatedStatementsofCashFlowsSupplementalDisclosure"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_6ff9c092-c929-42b3-bb8b-29febd9dba9f" xlink:href="bsx-20230331.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_6ff9c092-c929-42b3-bb8b-29febd9dba9f" xlink:to="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:href="bsx-20230331.xsd#bsx_StatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:to="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_0b2cb0ee-7154-42b4-a6e9-75860db11d7d" xlink:href="bsx-20230331.xsd#bsx_StatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementAxis_4037bbd3-b1f8-4233-b08c-0d81561b07d4" xlink:to="loc_bsx_StatementDomain_0b2cb0ee-7154-42b4-a6e9-75860db11d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9686f203-45f6-4364-878c-8a16b5f452f7" xlink:to="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_652359ee-432a-4c06-8c32-f6df498881c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_652359ee-432a-4c06-8c32-f6df498881c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f866b1ab-7556-4937-a714-236bb0a55173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f866b1ab-7556-4937-a714-236bb0a55173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_da38fc41-85ca-4bb7-b45f-8fc43503b916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_da38fc41-85ca-4bb7-b45f-8fc43503b916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25254e9f-569c-4c7a-87b8-80db03ba8b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7607c046-4224-49a1-ac51-565af6aaebba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25254e9f-569c-4c7a-87b8-80db03ba8b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bsx-20230331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d8d677f-04c4-47ec-95e0-4d2f5e74517c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c54ce6cc-033f-4847-8408-f3083d839909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d8d677f-04c4-47ec-95e0-4d2f5e74517c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c54ce6cc-033f-4847-8408-f3083d839909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20230331.xsd#AcquisitionsDivestituresandStrategicInvestments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6cb5698b-e3bf-4ee3-ace4-c8f6b3e52c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_adf70413-77ac-4a86-bf75-2e2eb6e8e974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6cb5698b-e3bf-4ee3-ace4-c8f6b3e52c14" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_adf70413-77ac-4a86-bf75-2e2eb6e8e974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20230331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_44cb858e-e3f0-40f7-91e1-4dc3b93fb819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3fc2c0cb-6036-4f9d-9fbd-8fa08318ecf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_44cb858e-e3f0-40f7-91e1-4dc3b93fb819" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3fc2c0cb-6036-4f9d-9fbd-8fa08318ecf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20230331.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_43be5c61-0e9d-4847-986b-2f020fd8b209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0c403c4b-295c-4d17-b466-103566268aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_43be5c61-0e9d-4847-986b-2f020fd8b209" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_0c403c4b-295c-4d17-b466-103566268aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_54fd0bb5-a157-4636-8d04-360541a45ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0c403c4b-295c-4d17-b466-103566268aa6" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_54fd0bb5-a157-4636-8d04-360541a45ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContractualObligationsandCommitments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_58df5df0-d087-46a6-89a7-92b0d5603f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_97f3f32f-a405-414d-b689-0bb5d2f01c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_58df5df0-d087-46a6-89a7-92b0d5603f75" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_97f3f32f-a405-414d-b689-0bb5d2f01c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20230331.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_59cdb07a-1add-4500-8c10-6af0fe9f7f8b" xlink:href="bsx-20230331.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_16ca55ad-0262-4dfd-b630-4340d30d7b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_59cdb07a-1add-4500-8c10-6af0fe9f7f8b" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_16ca55ad-0262-4dfd-b630-4340d30d7b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fdba5b84-bcb3-4a6c-84ab-a720bf7c9a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_33e6c455-b542-4051-a4ac-7cb36ba4229d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fdba5b84-bcb3-4a6c-84ab-a720bf7c9a2d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_33e6c455-b542-4051-a4ac-7cb36ba4229d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3dd199ca-5d67-4a78-8e97-877108115f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ffc917a1-b7ea-4624-b20d-5f9f45ebd87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3dd199ca-5d67-4a78-8e97-877108115f92" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ffc917a1-b7ea-4624-b20d-5f9f45ebd87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20230331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_eafe9eb5-70c7-4237-9845-114c68783a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_90c3d7b9-517f-443e-8f19-cde6ba9604a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_eafe9eb5-70c7-4237-9845-114c68783a16" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_90c3d7b9-517f-443e-8f19-cde6ba9604a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20230331.xsd#WeightedAverageSharesOutstanding"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3be052e3-1b31-42c6-8902-b08a8d9b046a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3d5a493d-b04d-4048-9d01-89e0bfabbd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3be052e3-1b31-42c6-8902-b08a8d9b046a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3d5a493d-b04d-4048-9d01-89e0bfabbd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20230331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cb8f2aff-f5da-4037-9362-59b99b92ff9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_5bdc5828-4c7b-4560-9d42-6c9e1d14257c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cb8f2aff-f5da-4037-9362-59b99b92ff9f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_5bdc5828-4c7b-4560-9d42-6c9e1d14257c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20230331.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f1c639cd-75d8-4cd2-ae0c-0f114fbd752e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9013c3e7-c95c-42d6-8fe9-82e1ab83c546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f1c639cd-75d8-4cd2-ae0c-0f114fbd752e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9013c3e7-c95c-42d6-8fe9-82e1ab83c546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20230331.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_4a39f8d5-d163-4dfe-a9cc-3c059e560776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_41a58f09-747e-4c7e-9b84-56f6e44cbd98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_4a39f8d5-d163-4dfe-a9cc-3c059e560776" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_41a58f09-747e-4c7e-9b84-56f6e44cbd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20230331.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_32e1999c-5716-4a5e-940b-24504fd3b909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_228a5c3a-f363-4f8d-9853-8464ffe1a2fe" xlink:href="bsx-20230331.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_32e1999c-5716-4a5e-940b-24504fd3b909" xlink:to="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_228a5c3a-f363-4f8d-9853-8464ffe1a2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="simple" xlink:href="bsx-20230331.xsd#BasisofPresentationBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b2b470ee-0984-4207-a882-dddee7d59dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_a87874a0-7efc-474c-ba9c-2ab027b47972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2b470ee-0984-4207-a882-dddee7d59dc4" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_a87874a0-7efc-474c-ba9c-2ab027b47972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="bsx-20230331.xsd#FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_78d7d03a-03ad-4d59-bb39-4ba1e04a320e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d6e29bf6-8656-405e-8c6d-cbc56af02e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_78d7d03a-03ad-4d59-bb39-4ba1e04a320e" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d6e29bf6-8656-405e-8c6d-cbc56af02e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20230331.xsd#CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f2a9c69-b725-4118-8e7a-aa70bbdff938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_f23f16fb-b047-4477-a3cf-c3134e4c5a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f2a9c69-b725-4118-8e7a-aa70bbdff938" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_f23f16fb-b047-4477-a3cf-c3134e4c5a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="simple" xlink:href="bsx-20230331.xsd#ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20230331.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_206daee2-ba0d-4ec5-ad0c-d3c3ba80a975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_8f699d37-c2c5-4038-bcd2-d5653c93d1a2" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_206daee2-ba0d-4ec5-ad0c-d3c3ba80a975" xlink:to="loc_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock_8f699d37-c2c5-4038-bcd2-d5653c93d1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_69d5896e-2330-45bb-9ab9-8279c3d95958" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_206daee2-ba0d-4ec5-ad0c-d3c3ba80a975" xlink:to="loc_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock_69d5896e-2330-45bb-9ab9-8279c3d95958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock_d4909b57-c7f0-4b30-9cf1-bdebe492046e" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_206daee2-ba0d-4ec5-ad0c-d3c3ba80a975" xlink:to="loc_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock_d4909b57-c7f0-4b30-9cf1-bdebe492046e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_03e2c5ba-13de-4021-9d8b-057c2dc0cb05" xlink:href="bsx-20230331.xsd#bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_206daee2-ba0d-4ec5-ad0c-d3c3ba80a975" xlink:to="loc_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock_03e2c5ba-13de-4021-9d8b-057c2dc0cb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#AcquisitionsDivestituresandStrategicInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_84409ec1-3607-4ea1-ac6b-1d949d08c86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_84409ec1-3607-4ea1-ac6b-1d949d08c86c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2030936-ddff-4d5b-9b25-589005193415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember_e6e51944-929e-483a-b6ca-b6ec9ddeaa00" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:to="loc_bsx_AcotecMember_e6e51944-929e-483a-b6ca-b6ec9ddeaa00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_ca74cd98-7f4c-40df-a1a1-d7db51036bd5" xlink:href="bsx-20230331.xsd#bsx_BaylisMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9be9766b-a7eb-4b5e-b7f5-744469080979" xlink:to="loc_bsx_BaylisMedicalMember_ca74cd98-7f4c-40df-a1a1-d7db51036bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d7f0c93-3e68-44f0-a449-e0d238720062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fe9a813b-fae5-4840-b750-01ffe50ea2c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d7f0c93-3e68-44f0-a449-e0d238720062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_396d5513-cd05-432d-b9be-735b82f0667d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_0ba3c021-4e84-446f-8ace-769589f813c8" xlink:to="loc_srt_OwnershipDomain_396d5513-cd05-432d-b9be-735b82f0667d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0de3d1d7-3cd8-4165-a0c1-676cc0170ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_dba5fabf-c224-469f-af3b-4b0e5e64eef7" xlink:to="loc_us-gaap_ClassOfStockDomain_0de3d1d7-3cd8-4165-a0c1-676cc0170ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e6d068bf-414a-47a7-b465-b6a6131f9a29" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_70469e5e-4951-4058-8d6f-f9568c706a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_70469e5e-4951-4058-8d6f-f9568c706a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7efc3eea-0673-4490-a14d-f045cb6951bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7efc3eea-0673-4490-a14d-f045cb6951bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a3bdbd5d-ca28-4073-8345-f4828812812c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a3bdbd5d-ca28-4073-8345-f4828812812c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4fb7446a-bea9-40bf-b568-23e6848b0eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4fb7446a-bea9-40bf-b568-23e6848b0eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_4e0e5ac2-5834-44d8-b6ee-16393ec3544a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_4e0e5ac2-5834-44d8-b6ee-16393ec3544a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_e7775521-2297-473a-8b19-841bca821a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d08f8d82-23fa-40e6-bb4c-42b655a272d7" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_e7775521-2297-473a-8b19-841bca821a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6dd12b5c-5c9a-45c8-8ce6-74805a640190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_039bc5b7-02f4-4595-951e-b6a5aa5a6d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6dd12b5c-5c9a-45c8-8ce6-74805a640190" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_039bc5b7-02f4-4595-951e-b6a5aa5a6d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_264d50f6-ba5d-4c9f-9c40-c1eb4823015f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6dd12b5c-5c9a-45c8-8ce6-74805a640190" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_264d50f6-ba5d-4c9f-9c40-c1eb4823015f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a20989ae-ffa4-4bf3-9e33-fbc28e3646e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a20989ae-ffa4-4bf3-9e33-fbc28e3646e1" xlink:to="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_763e9931-e6df-4623-b62a-32e5d66d94ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_050b6f33-e674-4ce8-9a70-d639a04c723c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_763e9931-e6df-4623-b62a-32e5d66d94ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3d53a250-3677-4c26-9c79-f6f947f6e59d" xlink:to="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_c9f2c0c1-afa0-4cc8-a568-ca35db64b572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_c9f2c0c1-afa0-4cc8-a568-ca35db64b572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2df1a210-07b4-427b-bdf4-9b5de30d2f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2df1a210-07b4-427b-bdf4-9b5de30d2f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_e6c77896-17f2-4be1-97de-334a2db5a990" xlink:href="bsx-20230331.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_e6c77896-17f2-4be1-97de-334a2db5a990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b92d59bb-e1d4-482b-b5f1-bf7ce3808def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b92d59bb-e1d4-482b-b5f1-bf7ce3808def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_802bea24-d27b-49c6-8385-56d660424fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842b2045-c4e0-4dd3-911d-844bf70f74e3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_802bea24-d27b-49c6-8385-56d660424fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_15de5cfa-792a-43d0-a517-40d2789cc4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a20989ae-ffa4-4bf3-9e33-fbc28e3646e1" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_15de5cfa-792a-43d0-a517-40d2789cc4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_15de5cfa-792a-43d0-a517-40d2789cc4df" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5b157f23-6627-478c-ba6c-724e57c7300e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9e5606d7-b522-4cbd-a8ca-5ed40c11dd6e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5b157f23-6627-478c-ba6c-724e57c7300e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d49fad92-daa6-4b3f-8e14-ab96693e9a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_85d1bfe2-e4b1-421e-a474-1052a4447219" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d49fad92-daa6-4b3f-8e14-ab96693e9a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_da4f552f-0dd8-4954-b686-f67c5574c8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c0c6978-9db9-472e-989f-3e3bb9daf31c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_da4f552f-0dd8-4954-b686-f67c5574c8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5b3bd3ed-ead1-43e4-8b1d-d82da6040c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_da4f552f-0dd8-4954-b686-f67c5574c8ea" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5b3bd3ed-ead1-43e4-8b1d-d82da6040c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_155f625b-201a-41f9-a0d5-a0975b2c47b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_155f625b-201a-41f9-a0d5-a0975b2c47b3" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_4887f332-9ec9-4796-a086-5706f2dbec15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_b3d13030-a08f-473d-8c48-a950d97e2fde" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_4887f332-9ec9-4796-a086-5706f2dbec15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_faa71c48-9210-457c-9a20-7d2ea85c5795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_4887f332-9ec9-4796-a086-5706f2dbec15" xlink:to="loc_us-gaap_CommercialPaperMember_faa71c48-9210-457c-9a20-7d2ea85c5795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:to="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6cef02d3-0785-45a2-8e12-4fb2c3c17de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1378021b-9293-4def-be0c-5ffcbfe4dfae" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6cef02d3-0785-45a2-8e12-4fb2c3c17de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_1f7d5a10-1637-4f33-9adf-50a73633f056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_2773a337-f085-4a2d-b8fc-53b8db2abe76" xlink:to="loc_us-gaap_ShortTermDebtLineItems_1f7d5a10-1637-4f33-9adf-50a73633f056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_41e02499-d458-42f3-842d-d570164577ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_1f7d5a10-1637-4f33-9adf-50a73633f056" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_41e02499-d458-42f3-842d-d570164577ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_dab79018-4f22-4333-8aa4-7609900a2610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_155f625b-201a-41f9-a0d5-a0975b2c47b3" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_dab79018-4f22-4333-8aa4-7609900a2610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_51285cfd-6cd9-4495-a874-b77770189b51" xlink:href="bsx-20230331.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_155f625b-201a-41f9-a0d5-a0975b2c47b3" xlink:to="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_51285cfd-6cd9-4495-a874-b77770189b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_e52f0f88-34a0-4cf9-8ad0-945ecaeb5ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_155f625b-201a-41f9-a0d5-a0975b2c47b3" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_e52f0f88-34a0-4cf9-8ad0-945ecaeb5ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:href="bsx-20230331.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ce629870-18ba-4016-af8e-c403f6e5fa16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ce629870-18ba-4016-af8e-c403f6e5fa16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5e76624f-24a0-45d5-850d-a5a2bf75e798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5e76624f-24a0-45d5-850d-a5a2bf75e798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_67a0a823-159c-4a07-b90f-0f30da289eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_67a0a823-159c-4a07-b90f-0f30da289eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ab31d573-f267-42bb-8122-fcbaf152d6da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ab31d573-f267-42bb-8122-fcbaf152d6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_9856ea6a-b7c3-4415-a8b1-4942f537a79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_9856ea6a-b7c3-4415-a8b1-4942f537a79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ebd1acc2-60c4-43d1-999c-6223060daa54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ebd1acc2-60c4-43d1-999c-6223060daa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_2aa1483d-c89e-4f68-be12-c65664384daf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_2aa1483d-c89e-4f68-be12-c65664384daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_0cd68bfd-7960-4ab6-895f-487c28f1fcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_08f36ae6-aa30-4db4-a0b2-75edfe99a29e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_0cd68bfd-7960-4ab6-895f-487c28f1fcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0641db83-74fe-40a8-9de1-cd88fd60407f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:href="bsx-20230331.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0641db83-74fe-40a8-9de1-cd88fd60407f" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:to="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cb18947f-7b62-401b-b5a6-628908b4f6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_73c90a80-3901-434d-89e0-82ae41edb538" xlink:to="loc_us-gaap_VariableRateDomain_cb18947f-7b62-401b-b5a6-628908b4f6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_03c2ceb5-6cde-4797-a80d-4346d93f7f22" xlink:href="bsx-20230331.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_d81f7ec4-e43a-432b-8a95-434c904e5359" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_03c2ceb5-6cde-4797-a80d-4346d93f7f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_0c5bc943-8092-492c-aa26-f5bc9d28fdbe" xlink:href="bsx-20230331.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0641db83-74fe-40a8-9de1-cd88fd60407f" xlink:to="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_0c5bc943-8092-492c-aa26-f5bc9d28fdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_376c32be-a42b-402a-9655-3152486a20a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_0876257e-5a2c-4266-848d-a8cd1b7efde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_376c32be-a42b-402a-9655-3152486a20a2" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_0876257e-5a2c-4266-848d-a8cd1b7efde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_100cc53e-da03-47ef-b002-cd91d342f40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_376c32be-a42b-402a-9655-3152486a20a2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_100cc53e-da03-47ef-b002-cd91d342f40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_744e186c-e786-4618-942d-1cf1f3ef1e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_36a6763c-42a8-412f-ada6-49032fed108b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_744e186c-e786-4618-942d-1cf1f3ef1e4b" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_36a6763c-42a8-412f-ada6-49032fed108b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d1219271-9f3a-4c48-8947-886e10b980c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_b3afe37f-97cf-46a0-9c74-6a735e7b0a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d1219271-9f3a-4c48-8947-886e10b980c0" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_b3afe37f-97cf-46a0-9c74-6a735e7b0a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e85dc59c-7eb7-4802-ae0f-85478b74bab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_b3afe37f-97cf-46a0-9c74-6a735e7b0a48" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e85dc59c-7eb7-4802-ae0f-85478b74bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20230331.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_fc9ed9ed-8133-4296-bd95-8e3baaa048f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_23859b20-c78e-4356-bcb1-045e9208de5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_fc9ed9ed-8133-4296-bd95-8e3baaa048f2" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_23859b20-c78e-4356-bcb1-045e9208de5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#BasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_53682f72-c468-491b-bbac-81de7df5a769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_840cb760-be8d-43bc-8526-5f5d7c1af46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_53682f72-c468-491b-bbac-81de7df5a769" xlink:to="loc_us-gaap_NumberOfReportableSegments_840cb760-be8d-43bc-8526-5f5d7c1af46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#AcquisitionsandDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b4cc6dd6-34d4-4324-89da-88922a552790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b4cc6dd6-34d4-4324-89da-88922a552790" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d170710e-a87c-4084-9641-e0ca8aeed1d0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ApolloMember_0e18f355-de8c-4959-a8b1-ce48c867170e" xlink:href="bsx-20230331.xsd#bsx_ApolloMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:to="loc_bsx_ApolloMember_0e18f355-de8c-4959-a8b1-ce48c867170e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BaylisMedicalMember_d4bf583f-ec55-4141-bc4f-673618b07874" xlink:href="bsx-20230331.xsd#bsx_BaylisMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:to="loc_bsx_BaylisMedicalMember_d4bf583f-ec55-4141-bc4f-673618b07874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember_a5335df5-6e84-46e0-a116-28b9cc773abf" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_871771da-24bc-4819-a4fd-fee944341b5c" xlink:to="loc_bsx_AcotecMember_a5335df5-6e84-46e0-a116-28b9cc773abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5b1afd2c-1ba2-4b89-8ef6-f5777f5606fb" xlink:to="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5f258ab5-90ba-4d52-9748-125654025a99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:to="loc_srt_MinimumMember_5f258ab5-90ba-4d52-9748-125654025a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_60079893-69b2-4a96-911f-a0f74933c3df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:to="loc_srt_MaximumMember_60079893-69b2-4a96-911f-a0f74933c3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_4aa18974-cb25-4cfa-8c95-dcd63009dedc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a59de28e-ee15-4f43-a397-bc117c588fad" xlink:to="loc_srt_WeightedAverageMember_4aa18974-cb25-4cfa-8c95-dcd63009dedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2203084a-d854-4015-8469-171bc2c34245" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cb2bb66a-e13d-4cca-bd2f-1dc058964a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cb2bb66a-e13d-4cca-bd2f-1dc058964a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ca1ac614-0eb8-40ff-b007-41a706aa1a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ca1ac614-0eb8-40ff-b007-41a706aa1a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8c81b63e-d9a0-457c-93f8-74d37290e99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5da53b7-2897-4ca0-95fe-a81e89772746" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8c81b63e-d9a0-457c-93f8-74d37290e99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4044ec98-5a3d-4430-bd4d-627390765c55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6c95f137-0252-47ae-8c17-e289c42bfe87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6c95f137-0252-47ae-8c17-e289c42bfe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_3e79be15-e1f8-4e74-8010-7941a89620df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e0da1802-6afd-4633-aba2-b4eb396d7be6" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_3e79be15-e1f8-4e74-8010-7941a89620df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_376363d6-7840-42b4-83db-7fd2d67e9329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab6140a7-de5e-4aa0-80bf-761686a4f705" xlink:to="loc_us-gaap_SegmentDomain_376363d6-7840-42b4-83db-7fd2d67e9329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b63a39f3-2898-4f09-922b-5f3788412bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_012dffaf-b0f2-473e-ac86-6aea87dc1d92" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b63a39f3-2898-4f09-922b-5f3788412bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d94ce9c-4c6e-4d7f-a5ae-dd5c2ebd4d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f363bba-288f-407f-a798-414b7a5d10bd" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d94ce9c-4c6e-4d7f-a5ae-dd5c2ebd4d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_60136275-6268-44fa-8dbe-3eaa1b999260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f3202e43-39f3-4771-8119-bfddd0caf237" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_60136275-6268-44fa-8dbe-3eaa1b999260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6cc66ae3-f24d-42d1-8bc8-f86ac10ff347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_60136275-6268-44fa-8dbe-3eaa1b999260" xlink:to="loc_us-gaap_SubsequentEventMember_6cc66ae3-f24d-42d1-8bc8-f86ac10ff347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2a624246-9250-46c0-a0fd-64e4b1d5760c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_12c8792d-e736-450e-bb50-49f49d401281" xlink:to="loc_srt_OwnershipDomain_2a624246-9250-46c0-a0fd-64e4b1d5760c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AcotecMember_dfbd0e6e-d74b-435d-9041-1e4425aa708c" xlink:href="bsx-20230331.xsd#bsx_AcotecMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_2a624246-9250-46c0-a0fd-64e4b1d5760c" xlink:to="loc_bsx_AcotecMember_dfbd0e6e-d74b-435d-9041-1e4425aa708c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61bd3ac6-ff3c-463b-9819-a6180575c0d8" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f52fec6b-2c8a-4388-ba6e-6cc61036632b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f52fec6b-2c8a-4388-ba6e-6cc61036632b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e63e06c8-d2c6-4c08-bee3-28bf81d802ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e63e06c8-d2c6-4c08-bee3-28bf81d802ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd68a196-4c8a-4574-a1de-594929263213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fd68a196-4c8a-4574-a1de-594929263213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_01254ba3-3579-406e-9f79-efd8c6d891da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_01254ba3-3579-406e-9f79-efd8c6d891da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f9c1080-bd6d-4960-bdde-13a3d5a86e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f9c1080-bd6d-4960-bdde-13a3d5a86e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa41de7c-3b14-4529-93f7-53d93b9164db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_Goodwill_aa41de7c-3b14-4529-93f7-53d93b9164db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46ab2f52-ddf3-4575-bfed-8166c4b2a197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46ab2f52-ddf3-4575-bfed-8166c4b2a197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6eb90ee6-e0b3-4b3e-ab3e-677d5879bfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6eb90ee6-e0b3-4b3e-ab3e-677d5879bfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9b74d62-17a9-48c8-83c1-ba7270ac4d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b9b74d62-17a9-48c8-83c1-ba7270ac4d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7f0924c1-cc4f-4e5e-8037-b679cb04a1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7f0924c1-cc4f-4e5e-8037-b679cb04a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_de8c43ef-8201-4a7c-8ecb-62e8b3545ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_de8c43ef-8201-4a7c-8ecb-62e8b3545ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_571ec333-7325-4c80-adcf-2257d28cf020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_571ec333-7325-4c80-adcf-2257d28cf020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_474c60ed-bd03-4c1b-a7e6-3b3e2bc6e022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_474c60ed-bd03-4c1b-a7e6-3b3e2bc6e022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_7c1ffe3a-cb7a-472d-9e6c-53fd687ec2ed" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_bsx_DiscountRateFairValueInput_7c1ffe3a-cb7a-472d-9e6c-53fd687ec2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65cbc1b9-f381-47a5-badb-fad3165a9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65cbc1b9-f381-47a5-badb-fad3165a9582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fc8b321a-4520-45fa-9251-d20b23fb5274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fc8b321a-4520-45fa-9251-d20b23fb5274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_f79f472c-b871-46ac-ac8f-c5aca8134982" xlink:href="bsx-20230331.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_bsx_PaymentOfContingentConsideration_f79f472c-b871-46ac-ac8f-c5aca8134982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_9afaf56f-8030-4389-bd3c-37d2c2cf1caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_9afaf56f-8030-4389-bd3c-37d2c2cf1caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_858194f4-0f8f-4892-a562-c602561dad8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_Cash_858194f4-0f8f-4892-a562-c602561dad8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b0c6add1-5972-4d30-afe7-2d9f2469c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fe5eb97-2000-45ca-baae-bc1938049ec0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b0c6add1-5972-4d30-afe7-2d9f2469c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ac14ce98-2519-4a3e-b38f-11added99c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ac14ce98-2519-4a3e-b38f-11added99c0e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_22296dd6-9aea-4317-aeed-335e535f2a10" xlink:to="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b342cc71-9353-4a44-b1fe-b8575e459850" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:to="loc_srt_MinimumMember_b342cc71-9353-4a44-b1fe-b8575e459850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d9e138c2-4677-4109-9d60-3583cded856d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:to="loc_srt_MaximumMember_d9e138c2-4677-4109-9d60-3583cded856d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_0e427954-9847-43cf-87c1-eb7ba5187521" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e21e7ba-b5d2-401a-bbb8-ca4c097c0bf4" xlink:to="loc_srt_WeightedAverageMember_0e427954-9847-43cf-87c1-eb7ba5187521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_888a9f70-fa56-4073-9b5b-06b4f9c02ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0363c38a-a9f5-4d9f-b703-63623335f4f2" xlink:to="loc_us-gaap_ValuationTechniqueDomain_888a9f70-fa56-4073-9b5b-06b4f9c02ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c3323181-36fa-4f25-96ee-14678df91e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_888a9f70-fa56-4073-9b5b-06b4f9c02ab6" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_c3323181-36fa-4f25-96ee-14678df91e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd97541-458b-4afd-adb4-0b4974e5b7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_95d65818-729d-4d69-851d-e7f03a14dc2f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd97541-458b-4afd-adb4-0b4974e5b7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllBusinessAcquisitionsMember_a6083079-187d-47e2-8fab-f5eafb03eef3" xlink:href="bsx-20230331.xsd#bsx_AllBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5cd97541-458b-4afd-adb4-0b4974e5b7d7" xlink:to="loc_bsx_AllBusinessAcquisitionsMember_a6083079-187d-47e2-8fab-f5eafb03eef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_aab5ffd1-b801-4b13-bef7-40c27205631d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_1a1fce8e-6417-4090-9815-06d34a82b496" xlink:href="bsx-20230331.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_1a1fce8e-6417-4090-9815-06d34a82b496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_dbacc252-0a93-45bd-a271-716015f2750a" xlink:href="bsx-20230331.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_2e55d3bc-78e3-42e3-932e-9c0ecd907bff" xlink:to="loc_bsx_RevenueBasedPaymentsMember_dbacc252-0a93-45bd-a271-716015f2750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_45b2e89b-61d7-40d5-8a72-d144886109f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_604f488e-8de2-430f-a0b7-cd606b5517ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_45b2e89b-61d7-40d5-8a72-d144886109f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f6426809-d640-473f-9fd7-507ad21db336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_45b2e89b-61d7-40d5-8a72-d144886109f0" xlink:to="loc_us-gaap_SubsequentEventMember_f6426809-d640-473f-9fd7-507ad21db336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_16f13aa4-0b7a-485d-a93b-f5b82bfec398" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d4a81ea9-2e43-4c43-b5d9-62455dae024e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d4a81ea9-2e43-4c43-b5d9-62455dae024e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8cbca641-a3bb-4233-9ee8-915b1a4b5193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8cbca641-a3bb-4233-9ee8-915b1a4b5193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_e3ebe7c4-453f-4055-85a6-503b2107a4a7" xlink:href="bsx-20230331.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_bsx_PaymentOfContingentConsideration_e3ebe7c4-453f-4055-85a6-503b2107a4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f9329242-976d-4e94-83c8-586e1d3867a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_903f3b4c-46a8-4f54-9769-f3ebc1cbd91f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_f9329242-976d-4e94-83c8-586e1d3867a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_8d943bda-18e5-4ad8-b743-6a9da800a49e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50047745-3b52-4fc4-8c34-f72da7d97d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50047745-3b52-4fc4-8c34-f72da7d97d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_380e3c80-8d71-472d-b750-d52237d06ff2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9071b0c6-f29d-4215-8b12-ac7c8e231016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9071b0c6-f29d-4215-8b12-ac7c8e231016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_b0520a50-87fc-413f-a028-1433a54b24f7" xlink:href="bsx-20230331.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_b0520a50-87fc-413f-a028-1433a54b24f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_1604b897-aa3f-4754-b3b7-94eeb68de29f" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_e32fc93b-bcc2-4b61-9655-bdbfd3a95186" xlink:to="loc_bsx_DiscountRateFairValueInput_1604b897-aa3f-4754-b3b7-94eeb68de29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#StrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e378ea28-6d23-4b67-bf28-1ea88abe8a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e378ea28-6d23-4b67-bf28-1ea88abe8a71" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_51919f53-2263-4560-ace1-058e88b5140b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f6381495-3937-4352-b7ba-e84fc6951228" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_51919f53-2263-4560-ace1-058e88b5140b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b54e67ae-4ca5-4290-b39b-4293bc6a5e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_51919f53-2263-4560-ace1-058e88b5140b" xlink:to="loc_us-gaap_SubsequentEventMember_b54e67ae-4ca5-4290-b39b-4293bc6a5e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4924747-a454-4c3f-afcf-3e8937b97b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c48cedfd-6398-48e2-b234-bc00b3763d30" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4924747-a454-4c3f-afcf-3e8937b97b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_47b82183-d2d8-4937-84da-ebc2e3524779" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_39845a8e-e044-42f9-90c2-28447f87e7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_EquityMethodInvestments_39845a8e-e044-42f9-90c2-28447f87e7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_05e9fbc9-1808-40d0-bd76-49ae2dd73727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_05e9fbc9-1808-40d0-bd76-49ae2dd73727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_5a34fc9d-e27b-4c67-b996-ff11113fcdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_Investments_5a34fc9d-e27b-4c67-b996-ff11113fcdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_722d543e-e5a1-482a-9690-554d1e9e177a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_db7b6f83-5b90-462a-8088-66250350de2a" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_722d543e-e5a1-482a-9690-554d1e9e177a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e0d47829-7138-4342-ba12-48dab527bbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e0d47829-7138-4342-ba12-48dab527bbc7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b3edaa9d-45af-496e-af16-2b8246207324" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7606ef62-b95c-49f3-99cf-8f285971e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_7606ef62-b95c-49f3-99cf-8f285971e2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_614d2e3e-bb57-4bfd-a911-8e4ae91619eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:to="loc_us-gaap_PatentsMember_614d2e3e-bb57-4bfd-a911-8e4ae91619eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a269abaf-bf78-45ae-a46c-54f13eacdd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_93a4a3b6-3dda-452a-a996-b63f311715c0" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a269abaf-bf78-45ae-a46c-54f13eacdd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_57c938c0-4abc-4f1a-bbdd-81229bb1696b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_645818b8-07f0-4721-b34d-23bdb25c23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:to="loc_us-gaap_GoodwillMember_645818b8-07f0-4721-b34d-23bdb25c23f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d8af9a69-eb67-4a0d-8930-46b5dd3448ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d8af9a69-eb67-4a0d-8930-46b5dd3448ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_577b2e41-069b-411a-956f-c6391a0abaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_70394c25-7e84-4dc8-8ad7-623695e75e73" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_577b2e41-069b-411a-956f-c6391a0abaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a0a6380-8a9e-4b53-b8e9-888e15fdb6d3" xlink:to="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_f862414a-2e26-47dc-a3bd-aaf94117c71e" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:to="loc_bsx_MedsurgMember_f862414a-2e26-47dc-a3bd-aaf94117c71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_f2fd4373-07b8-4437-befc-9d31f2c7f6d3" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_02599a49-fc90-431a-8a25-61da339cb64e" xlink:to="loc_bsx_CardiovascularMember_f2fd4373-07b8-4437-befc-9d31f2c7f6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:href="bsx-20230331.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ef5ca2fc-910c-469f-8a68-49407b8bd0d5" xlink:to="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_76993079-993c-46f1-92c8-e71cdec0f63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_76993079-993c-46f1-92c8-e71cdec0f63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5b250bbf-4642-43f8-b82d-4a601c90ee05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5b250bbf-4642-43f8-b82d-4a601c90ee05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_e31a40c2-f753-4211-a35d-e3ae2762bba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_GoodwillGross_e31a40c2-f753-4211-a35d-e3ae2762bba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5983104-3dc3-4ee8-996c-440f6bf872b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5983104-3dc3-4ee8-996c-440f6bf872b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dcc72f85-28a6-44d8-a9b9-6a707bf2b0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dcc72f85-28a6-44d8-a9b9-6a707bf2b0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f97c0e5c-44aa-4de0-ac93-958d5757a368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_Goodwill_f97c0e5c-44aa-4de0-ac93-958d5757a368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_47358a94-0c15-446d-9cdf-4b40dfe75baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_47358a94-0c15-446d-9cdf-4b40dfe75baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_275873e9-2c96-42e2-9846-da2127252849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_275873e9-2c96-42e2-9846-da2127252849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7f503050-61ae-4664-bad9-9c3743973633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9fa443fb-a305-4471-a497-0d87eb0a27e5" xlink:to="loc_us-gaap_Goodwill_7f503050-61ae-4664-bad9-9c3743973633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bfe7f4bb-8fe9-48d3-89d9-453906a6f24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_550a6d9f-f334-4bcb-bbe0-1705bf17877c" xlink:to="loc_us-gaap_NumberOfReportableSegments_bfe7f4bb-8fe9-48d3-89d9-453906a6f24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f20fd588-211b-41d8-acd3-0f495c930674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f20fd588-211b-41d8-acd3-0f495c930674" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ef391693-560b-4e16-a5b9-6da502384a77" xlink:to="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_653a1742-bddf-4fcf-ba31-4da8fa6a3692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:to="loc_us-gaap_CashFlowHedgingMember_653a1742-bddf-4fcf-ba31-4da8fa6a3692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1f329dbe-596a-495a-9dcb-231236d0e44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_44e313e9-d74e-438d-a231-ea25f16c96ec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1f329dbe-596a-495a-9dcb-231236d0e44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3fc50ede-d2a3-47fe-9648-68a13c2d09c8" xlink:to="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_624385ac-c65c-4a1f-a415-b275be6247cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_624385ac-c65c-4a1f-a415-b275be6247cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_faf31f12-d2c6-43bc-acd7-8024e52b5e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c22a9282-e294-49d7-9a4f-bb21da101648" xlink:to="loc_us-gaap_NondesignatedMember_faf31f12-d2c6-43bc-acd7-8024e52b5e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6eb7a25f-639e-488a-a895-d33c20c7b744" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f706861c-6209-4912-8d38-0250cc423a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f706861c-6209-4912-8d38-0250cc423a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_815a8a23-d4de-47bd-952a-510e3c49dcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_ForeignExchangeContractMember_815a8a23-d4de-47bd-952a-510e3c49dcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_b51240c1-85a3-4db8-950b-8babdd5bc344" xlink:href="bsx-20230331.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_b51240c1-85a3-4db8-950b-8babdd5bc344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_8cc04df6-f5a9-488e-a74f-70e28df5c0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_InterestRateContractMember_8cc04df6-f5a9-488e-a74f-70e28df5c0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_0f1224a2-7e3f-49bc-8673-b407c3f7883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_71b70796-0f5d-4b84-9a14-2c078f461eda" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_0f1224a2-7e3f-49bc-8673-b407c3f7883a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_99e00cdd-67d8-45b3-b5ff-3923b3308102" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_92a197e2-72ef-43de-8a93-e92946580824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_92a197e2-72ef-43de-8a93-e92946580824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_13d4a74e-2605-4043-98d3-1602130f815b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_13d4a74e-2605-4043-98d3-1602130f815b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_af7f1200-bf13-48f0-8367-56747ad6a0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_af7f1200-bf13-48f0-8367-56747ad6a0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_066ca0fa-7efd-4101-8cdc-654abb97c64a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb5e1776-02b4-4794-bb25-2d14123934ea" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_066ca0fa-7efd-4101-8cdc-654abb97c64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7e4466de-7605-428d-81eb-d97d078839d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b1917f76-304f-4755-9a66-4a28615895b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:to="loc_us-gaap_CostOfSalesMember_b1917f76-304f-4755-9a66-4a28615895b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d607d9e4-33a3-418f-b23b-86a2a9e718e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:to="loc_us-gaap_InterestExpenseMember_d607d9e4-33a3-418f-b23b-86a2a9e718e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_247bc4f6-24fe-43e7-bf46-e62fe6868109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8060283c-8f38-4d13-b35b-c48a9734e252" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_247bc4f6-24fe-43e7-bf46-e62fe6868109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_86c992d8-b592-4a91-a2e0-e2a4d40fcbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c5e49d94-7393-4c5d-827e-39b45d8f2e55" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_86c992d8-b592-4a91-a2e0-e2a4d40fcbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_f366f2d9-4c29-4d66-8f74-a102a4972ee6" xlink:href="bsx-20230331.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_86c992d8-b592-4a91-a2e0-e2a4d40fcbaf" xlink:to="loc_bsx_December2027NotesMember_f366f2d9-4c29-4d66-8f74-a102a4972ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_762ddb8e-163c-4663-957f-cf170a2a5057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_94e92a44-63ee-4cd5-a4ff-0b6174c6ecc4" xlink:to="loc_us-gaap_EquityComponentDomain_762ddb8e-163c-4663-957f-cf170a2a5057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dae79b2a-508b-46d5-88e0-cec1376fe830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_762ddb8e-163c-4663-957f-cf170a2a5057" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dae79b2a-508b-46d5-88e0-cec1376fe830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5a501d22-a942-4993-b588-3a25cd70bdb0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f37a0b10-5949-4944-a7dc-916766e1cb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_LongTermDebt_f37a0b10-5949-4944-a7dc-916766e1cb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4e538087-23b6-4ffa-9a1c-b4a4200f9fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4e538087-23b6-4ffa-9a1c-b4a4200f9fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_faaae123-6c34-49d7-a529-cee5b72239bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeTermOfContract_faaae123-6c34-49d7-a529-cee5b72239bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_a7901080-465a-4bae-bfd8-7f73317aaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_a7901080-465a-4bae-bfd8-7f73317aaa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_b2c8a681-78c0-417e-b427-645035f07e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_b2c8a681-78c0-417e-b427-645035f07e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8cfcc8fb-ba8d-4e70-9cea-bdf9c7f16b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8cfcc8fb-ba8d-4e70-9cea-bdf9c7f16b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_66bb0674-a9fb-4bc9-aebf-de71c061c7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_66bb0674-a9fb-4bc9-aebf-de71c061c7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_ab6e02a9-b0d6-4e34-94ae-d4c7ac798b06" xlink:href="bsx-20230331.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_ab6e02a9-b0d6-4e34-94ae-d4c7ac798b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_a7b36140-4588-4c57-9237-21bfd421e0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_a7b36140-4588-4c57-9237-21bfd421e0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d072e343-0bd1-41a1-8d4e-afe487e3557b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d072e343-0bd1-41a1-8d4e-afe487e3557b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_50ef7ef9-38e7-43e4-9262-80bfafc55a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_50ef7ef9-38e7-43e4-9262-80bfafc55a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3b389402-6b0b-4980-acf4-2ed49f4bec4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3b389402-6b0b-4980-acf4-2ed49f4bec4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e2780699-493e-4711-b2b9-ac452e27dcda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e2780699-493e-4711-b2b9-ac452e27dcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ad2adcf4-379b-41e0-8aa7-2baefbd9716b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ad2adcf4-379b-41e0-8aa7-2baefbd9716b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_d5edd886-1161-42d2-a4cb-c0d898a4e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_d5edd886-1161-42d2-a4cb-c0d898a4e78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b3178381-e838-4e9f-aeb1-32291222d1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b3178381-e838-4e9f-aeb1-32291222d1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c07c11a2-1e15-4abb-ae36-fbdc7c282fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c07c11a2-1e15-4abb-ae36-fbdc7c282fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_6c357e13-dda4-4509-b4b2-71d9a250183d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_6c357e13-dda4-4509-b4b2-71d9a250183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_515986bb-e0ea-4e70-8dee-180a4ee28da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_515986bb-e0ea-4e70-8dee-180a4ee28da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c239f783-1f37-49c4-a2c1-ecab0389f007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_InterestExpense_c239f783-1f37-49c4-a2c1-ecab0389f007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_fcbd22b2-7273-46f4-a2b4-d014e296be7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_fcbd22b2-7273-46f4-a2b4-d014e296be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_c87e8a96-8db1-4785-b615-6e03d5b839e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_c87e8a96-8db1-4785-b615-6e03d5b839e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_4e7abb3f-097b-496d-adda-087ed9df5259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_4e7abb3f-097b-496d-adda-087ed9df5259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f49c7c8b-fdf4-4218-b6c2-28d75993f385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f49c7c8b-fdf4-4218-b6c2-28d75993f385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_862c42df-9003-42c2-89e6-e43f0ccbb5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_862c42df-9003-42c2-89e6-e43f0ccbb5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a558a962-33e9-4bab-898d-771e13cf33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a558a962-33e9-4bab-898d-771e13cf33a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_d29f3538-6fc5-45cd-8150-79969bd08bb1" xlink:href="bsx-20230331.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_d29f3538-6fc5-45cd-8150-79969bd08bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_d4d5c557-1cc6-4cd9-a996-4ad2fa18c86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_d4d5c557-1cc6-4cd9-a996-4ad2fa18c86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e6cb9cb-c271-40b3-bfca-d6bf5efaec0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e6cb9cb-c271-40b3-bfca-d6bf5efaec0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_ce244c07-9a80-422e-a0bb-6a3dbfa039f2" xlink:href="bsx-20230331.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_bsx_Netcurrencyexchangegainloss_ce244c07-9a80-422e-a0bb-6a3dbfa039f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_e98c8f91-816a-4928-917a-4c7ed4aa4813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_e98c8f91-816a-4928-917a-4c7ed4aa4813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_b5040e41-e818-4a9a-9af3-37c51236c3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_b5040e41-e818-4a9a-9af3-37c51236c3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e02a82d2-b28c-42c8-a8a2-4f65e8ea43e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e02a82d2-b28c-42c8-a8a2-4f65e8ea43e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_31b3b253-de06-49ca-b59b-8e27efd23f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_31b3b253-de06-49ca-b59b-8e27efd23f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_71fda03d-5b8c-4f4d-87f9-deeee6464661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_71fda03d-5b8c-4f4d-87f9-deeee6464661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5a77cf6a-7404-481a-8858-db71b297fa97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_90f5ec75-1262-48b4-83a5-7e9396f2d53e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5a77cf6a-7404-481a-8858-db71b297fa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f20fd588-211b-41d8-acd3-0f495c930674" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9b6e7e87-db7b-4c5e-ba9c-708b8280e053" xlink:to="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_7e230637-5647-4281-81fb-95f26a741e1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:to="loc_srt_WeightedAverageMember_7e230637-5647-4281-81fb-95f26a741e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c1bba7f9-0c83-4463-955a-715ef4742b7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:to="loc_srt_MinimumMember_c1bba7f9-0c83-4463-955a-715ef4742b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d235820-e0b2-4281-8c55-584ef75224e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29c590e0-7eea-473b-a5ff-3ca574819bea" xlink:to="loc_srt_MaximumMember_2d235820-e0b2-4281-8c55-584ef75224e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_12abbdd4-f1f9-4ce6-bba6-73977f567546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_aa52279b-35a5-42f2-8e31-3a12f0b1d43c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_12abbdd4-f1f9-4ce6-bba6-73977f567546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_90935077-8703-4b79-bbfe-4a8d19350d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_12abbdd4-f1f9-4ce6-bba6-73977f567546" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_90935077-8703-4b79-bbfe-4a8d19350d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3294ed2-633c-4f2a-b8f2-9b08ca1649cd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0ec12466-6b4b-4f8b-8cb7-54026d038371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0ec12466-6b4b-4f8b-8cb7-54026d038371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ff13f901-6969-4351-8075-5822b1c5d9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ff13f901-6969-4351-8075-5822b1c5d9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_359608c8-da40-47b6-ab4e-f4889a23d5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e10d023c-b790-4082-a901-26046b7ecebb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_359608c8-da40-47b6-ab4e-f4889a23d5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_de9fb9bd-17a9-496b-bbd0-a6443f74664b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_75001f5f-e203-4d59-8bf2-0dfac87cf325" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:to="loc_bsx_LicensingarrangementassetsMember_75001f5f-e203-4d59-8bf2-0dfac87cf325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_55ce964e-5eac-4125-ae08-4a0ae1673843" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5ee7796-54d8-476d-b419-a22b320781e0" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_55ce964e-5eac-4125-ae08-4a0ae1673843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_622e512d-4dd9-4352-8a48-30fcf4109788" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_ed2364b4-1b93-46e3-8f2b-ca77f24ddb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_ed2364b4-1b93-46e3-8f2b-ca77f24ddb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_10ea0d7c-a145-4c04-9ac5-c2eda6e44aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_10ea0d7c-a145-4c04-9ac5-c2eda6e44aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_fe90b38b-e197-47ed-b3e0-99c961cba1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_DerivativeAssets_fe90b38b-e197-47ed-b3e0-99c961cba1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_52c8f1c4-dd09-4d7e-94ca-91bff1cad42c" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_Licensingarrangementsasset_52c8f1c4-dd09-4d7e-94ca-91bff1cad42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_15a92cb4-299b-4fab-8c2a-e71bc964d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_15a92cb4-299b-4fab-8c2a-e71bc964d24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ef10d7b2-f183-4124-b9be-bb3acc7c5ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_DerivativeLiabilities_ef10d7b2-f183-4124-b9be-bb3acc7c5ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bee9b014-d283-48d0-9120-38c6d156fe32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bee9b014-d283-48d0-9120-38c6d156fe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_724e8856-8a53-4a32-92d2-1447ad2a3d6b" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_Licensingarrangementsliability_724e8856-8a53-4a32-92d2-1447ad2a3d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_20a313d7-daab-406f-b1dc-fba8d490ac9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_PaymentsForRoyalties_20a313d7-daab-406f-b1dc-fba8d490ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_77142788-bd3e-491f-8b05-f4887fe277a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_77142788-bd3e-491f-8b05-f4887fe277a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_7bf5bc2a-fce1-4bd1-8654-795c98a63fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_Cash_7bf5bc2a-fce1-4bd1-8654-795c98a63fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_b0e42dfd-40fe-4fca-be07-d55cce66c2a1" xlink:href="bsx-20230331.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_DiscountRateFairValueInput_b0e42dfd-40fe-4fca-be07-d55cce66c2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_42298032-7bfc-437d-9b43-de3e6c5f9ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_42298032-7bfc-437d-9b43-de3e6c5f9ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_c5996111-807f-4a4c-a4aa-6bfaf007f4f6" xlink:href="bsx-20230331.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_c5996111-807f-4a4c-a4aa-6bfaf007f4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_98864273-e045-4163-80b6-22be36803b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_98864273-e045-4163-80b6-22be36803b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_543f1623-e888-42bf-8e03-a0396a3dba63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a52e000-d35f-4876-9ef6-1ef651ce1e49" xlink:to="loc_us-gaap_DebtInstrumentFairValue_543f1623-e888-42bf-8e03-a0396a3dba63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_558cbe45-8e8d-41ac-9aa6-75a57265a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_558cbe45-8e8d-41ac-9aa6-75a57265a8a6" xlink:to="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f9a3cfec-fffd-45b5-b555-630ad012ca1f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member_5ed59255-fc67-4b53-a897-f4fc981f3e85" xlink:href="bsx-20230331.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_RevolvingCreditFacility2021Member_5ed59255-fc67-4b53-a897-f4fc981f3e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_8c33ad34-0796-4b13-bab4-14a75334c63f" xlink:href="bsx-20230331.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_8c33ad34-0796-4b13-bab4-14a75334c63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_932c5020-8698-45b4-b774-da9b83e21b58" xlink:href="bsx-20230331.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_932c5020-8698-45b4-b774-da9b83e21b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_0aa62300-80f9-4267-8a9b-32098d46d177" xlink:href="bsx-20230331.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_64378af1-7c2a-40ba-96da-a55f07b3f015" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_0aa62300-80f9-4267-8a9b-32098d46d177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18e7f9f1-2d2d-4581-bb0b-5d8a40e13b0e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_c439aeec-352a-4748-a2e0-dafd4c10d07f" xlink:href="bsx-20230331.xsd#bsx_March2024NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2024NotesMember_c439aeec-352a-4748-a2e0-dafd4c10d07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_19ef33c2-627c-4469-8491-61e41a6ec2d6" xlink:href="bsx-20230331.xsd#bsx_June2025NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_June2025NotesMember_19ef33c2-627c-4469-8491-61e41a6ec2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_bd249947-8421-4843-be5b-9f4e95486eb4" xlink:href="bsx-20230331.xsd#bsx_March2026NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2026NotesMember_bd249947-8421-4843-be5b-9f4e95486eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_a81459a1-9212-4593-985c-8b6b229796f9" xlink:href="bsx-20230331.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_December2027NotesMember_a81459a1-9212-4593-985c-8b6b229796f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_1e22d211-573e-4a9b-9248-bdfa056bd6db" xlink:href="bsx-20230331.xsd#bsx_March2028NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2028NotesMember_1e22d211-573e-4a9b-9248-bdfa056bd6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_1e4a511a-7e72-4c9f-993d-4de998b63459" xlink:href="bsx-20230331.xsd#bsx_March2029NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2029NotesMember_1e4a511a-7e72-4c9f-993d-4de998b63459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_7030c1e1-05d2-4e13-b03c-2fc6b428f8d3" xlink:href="bsx-20230331.xsd#bsx_June2030NotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_June2030NotesMember_7030c1e1-05d2-4e13-b03c-2fc6b428f8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_1a08b96f-5147-4f66-83e0-b58315d617be" xlink:href="bsx-20230331.xsd#bsx_November2035NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_November2035NotesMember_1a08b96f-5147-4f66-83e0-b58315d617be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_f07165c6-f437-4a51-ac3d-6a7f0a3db75b" xlink:href="bsx-20230331.xsd#bsx_March2039NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2039NotesMember_f07165c6-f437-4a51-ac3d-6a7f0a3db75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_29d236f1-2368-4ce6-9d4b-18f3fdac1614" xlink:href="bsx-20230331.xsd#bsx_January2040NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_January2040NotesMember_29d236f1-2368-4ce6-9d4b-18f3fdac1614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_92198b44-fa59-4d07-bcf5-253efc6f43d1" xlink:href="bsx-20230331.xsd#bsx_March2049NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2049NotesMember_92198b44-fa59-4d07-bcf5-253efc6f43d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ac156815-c98e-4b0a-a10b-2b4a3e2ba201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_us-gaap_SeniorNotesMember_ac156815-c98e-4b0a-a10b-2b4a3e2ba201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_f436f5d3-cf01-4dc9-b692-02cf85f8b3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_f436f5d3-cf01-4dc9-b692-02cf85f8b3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f34588ce-9259-4a32-92a2-c34ae6c6bb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_us-gaap_LineOfCreditMember_f34588ce-9259-4a32-92a2-c34ae6c6bb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2025NotesMember_e86ea74d-a7bf-4b83-9aed-9d9260d4f0c4" xlink:href="bsx-20230331.xsd#bsx_March2025NotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2025NotesMember_e86ea74d-a7bf-4b83-9aed-9d9260d4f0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028SeniorNotesMember_1917cfc3-8ac6-49a8-b112-c3393deeb2c2" xlink:href="bsx-20230331.xsd#bsx_March2028SeniorNotesMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2028SeniorNotesMember_1917cfc3-8ac6-49a8-b112-c3393deeb2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2031NotesMember_932d9bbb-e3b6-4d28-9f69-af15c324c6fd" xlink:href="bsx-20230331.xsd#bsx_March2031NotesMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2031NotesMember_932d9bbb-e3b6-4d28-9f69-af15c324c6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2034NotesMember_08863a98-a989-4962-866e-d31b1597a1ad" xlink:href="bsx-20230331.xsd#bsx_March2034NotesMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_March2034NotesMember_08863a98-a989-4962-866e-d31b1597a1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingAggregatePrincipalAmountMember_6d23833b-03a2-4204-a685-f4022d472d67" xlink:href="bsx-20230331.xsd#bsx_TheOfferingAggregatePrincipalAmountMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_TheOfferingAggregatePrincipalAmountMember_6d23833b-03a2-4204-a685-f4022d472d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_11cd4556-2c58-4ac0-8b97-3782275477dd" xlink:href="bsx-20230331.xsd#bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b6b867f6-4259-4499-b617-43f78b610df1" xlink:to="loc_bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember_11cd4556-2c58-4ac0-8b97-3782275477dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4ce7ee3b-ef4d-4d90-a0ed-f932d58e5a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_77d9a826-f9db-4da3-88dd-4b34912c07fe" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4ce7ee3b-ef4d-4d90-a0ed-f932d58e5a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_1c5c9ebc-4f06-4235-8348-94ccc05240f4" xlink:href="bsx-20230331.xsd#bsx_The2018FacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4ce7ee3b-ef4d-4d90-a0ed-f932d58e5a85" xlink:to="loc_bsx_The2018FacilityDomain_1c5c9ebc-4f06-4235-8348-94ccc05240f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e942f691-015a-4dff-9f40-d8dedf5019cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e54afd23-78c2-4e18-b107-c1cbecc4d81f" xlink:to="loc_us-gaap_CreditFacilityDomain_e942f691-015a-4dff-9f40-d8dedf5019cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2315517d-f4f8-4588-b166-9b01557450e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e942f691-015a-4dff-9f40-d8dedf5019cc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2315517d-f4f8-4588-b166-9b01557450e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:href="bsx-20230331.xsd#bsx_CovenantAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:href="bsx-20230331.xsd#bsx_CovenantDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantAxis_4739d6bc-a059-4ac7-bd64-9bb93f76e85c" xlink:to="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_09665c5b-881f-4aea-87bd-901242269a9a" xlink:href="bsx-20230331.xsd#bsx_CurrentRequirementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_CurrentRequirementMember_09665c5b-881f-4aea-87bd-901242269a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_f6712453-2323-4883-b4d5-3967e21705b0" xlink:href="bsx-20230331.xsd#bsx_ActualCovenantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_ActualCovenantMember_f6712453-2323-4883-b4d5-3967e21705b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_9078d242-557d-4d3d-b78d-07a79cb9d511" xlink:href="bsx-20230331.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_9078d242-557d-4d3d-b78d-07a79cb9d511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_75ee45fe-d8d3-4ce6-8f3a-07a0e9c6ffeb" xlink:href="bsx-20230331.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_75ee45fe-d8d3-4ce6-8f3a-07a0e9c6ffeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_a589448c-4341-41f7-9527-32144ce4fe22" xlink:href="bsx-20230331.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_a589448c-4341-41f7-9527-32144ce4fe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_bb616f1a-24f9-402c-bc10-ecb829354772" xlink:href="bsx-20230331.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_bb616f1a-24f9-402c-bc10-ecb829354772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_8da82bcb-50bf-42f3-9127-f4c1fd3457af" xlink:href="bsx-20230331.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_8da82bcb-50bf-42f3-9127-f4c1fd3457af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_cf7e2cea-9a6f-48e5-b462-3f8837711bac" xlink:href="bsx-20230331.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_69655ccc-326a-4b60-bc42-0f5af8b02062" xlink:to="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_cf7e2cea-9a6f-48e5-b462-3f8837711bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ee403d5b-6ac7-4563-aa8a-4cae55a2616d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e2f5fc29-ac61-41a6-b49d-5dc363ea2958" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ee403d5b-6ac7-4563-aa8a-4cae55a2616d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b113f6dc-2585-4a0a-9fcd-1e18cc6c4102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ee403d5b-6ac7-4563-aa8a-4cae55a2616d" xlink:to="loc_us-gaap_CommercialPaperMember_b113f6dc-2585-4a0a-9fcd-1e18cc6c4102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f002c2df-f15f-41bc-8bd1-3b97f6d1d85a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_195d6d88-15bf-4e18-8a94-fb7d4823da18" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:to="loc_bsx_LicensingarrangementassetsMember_195d6d88-15bf-4e18-8a94-fb7d4823da18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_dd03fff0-17f0-4f0e-89af-45a9eee4f170" xlink:href="bsx-20230331.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c885e8a6-0b79-44ee-a736-623bd2f3fb31" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_dd03fff0-17f0-4f0e-89af-45a9eee4f170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dcba5aea-137c-45c8-b10e-0d815e9ed19b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_f94d3f0b-9860-41ee-8efa-105fc302c5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_f94d3f0b-9860-41ee-8efa-105fc302c5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_267809e6-9979-4310-9fb7-10aab9d8fc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtCurrent_267809e6-9979-4310-9fb7-10aab9d8fc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c4f0d8d0-bcb5-4df0-8efc-5eeda49216bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LongTermDebt_c4f0d8d0-bcb5-4df0-8efc-5eeda49216bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c336a9f0-a935-4570-82f3-03d25505b121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c336a9f0-a935-4570-82f3-03d25505b121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4270736a-3265-4c32-adc3-fa990c596902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4270736a-3265-4c32-adc3-fa990c596902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c6647d7c-0062-48e0-8986-1e7593ba3d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c6647d7c-0062-48e0-8986-1e7593ba3d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f3872cac-a281-4078-9229-3d81d161f344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f3872cac-a281-4078-9229-3d81d161f344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm_68bf51d6-b207-4fa4-ab9a-1d7e3a0e456c" xlink:href="bsx-20230331.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_DebtInstrumentExtensionOptionTerm_68bf51d6-b207-4fa4-ab9a-1d7e3a0e456c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b0a06abe-1913-4314-bf24-b43098d52dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b0a06abe-1913-4314-bf24-b43098d52dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_e4b9b5e6-34c0-413b-a667-e42cc0b64a7c" xlink:href="bsx-20230331.xsd#bsx_MaximumLeverageRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_MaximumLeverageRatio_e4b9b5e6-34c0-413b-a667-e42cc0b64a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_6ea774c7-7a72-4530-8bf5-7330f482f4cd" xlink:href="bsx-20230331.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_6ea774c7-7a72-4530-8bf5-7330f482f4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_dfdbb70a-b49e-4a4f-969d-b99094a18875" xlink:href="bsx-20230331.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_dfdbb70a-b49e-4a4f-969d-b99094a18875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_c78bd823-0be1-481c-9b96-c02daa96721d" xlink:href="bsx-20230331.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_c78bd823-0be1-481c-9b96-c02daa96721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_c35facb7-1601-46c6-b350-c405186d640c" xlink:href="bsx-20230331.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_c35facb7-1601-46c6-b350-c405186d640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_e5a9a534-2a03-4971-ac49-9958b59da048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_e5a9a534-2a03-4971-ac49-9958b59da048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_cf8cb42c-8f13-44a6-98de-5378d61d0365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_cf8cb42c-8f13-44a6-98de-5378d61d0365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_89f56305-2b8e-45fb-97cd-2f9dcdb62e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_89f56305-2b8e-45fb-97cd-2f9dcdb62e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration_cb82dbd0-2d19-41c3-8948-fd2a65b7b145" xlink:href="bsx-20230331.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_QualifiedAcquisitionConsideration_cb82dbd0-2d19-41c3-8948-fd2a65b7b145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_77aa4e41-7a79-46c9-a78e-aea35edfe6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_77aa4e41-7a79-46c9-a78e-aea35edfe6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_f7356421-a786-4887-a537-edcfb2a26548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_f7356421-a786-4887-a537-edcfb2a26548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_70c722dc-7a50-445f-95a1-95948f0b49cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_PaymentsForRoyalties_70c722dc-7a50-445f-95a1-95948f0b49cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_41c764ed-0925-42f0-b20e-7912350cca86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_41c764ed-0925-42f0-b20e-7912350cca86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_e944736c-277e-4d49-afe3-37eeb8765d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_us-gaap_CommercialPaper_e944736c-277e-4d49-afe3-37eeb8765d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplierFinanceProgramObligationCurrent_e74243f8-6f1e-408b-ac07-91bc10c73c00" xlink:href="bsx-20230331.xsd#bsx_SupplierFinanceProgramObligationCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_SupplierFinanceProgramObligationCurrent_e74243f8-6f1e-408b-ac07-91bc10c73c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationPaymentExclusionFromEBITDA_d2b3ce58-4e88-4ade-ac9d-421cc467489a" xlink:href="bsx-20230331.xsd#bsx_LitigationPaymentExclusionFromEBITDA"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_LitigationPaymentExclusionFromEBITDA_d2b3ce58-4e88-4ade-ac9d-421cc467489a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_fc0fa44b-aa26-4ae6-9a6f-d8d1f03092d4" xlink:href="bsx-20230331.xsd#bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9f9321b-a77f-4ef7-86df-be77d03453b9" xlink:to="loc_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt_fc0fa44b-aa26-4ae6-9a6f-d8d1f03092d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:href="bsx-20230331.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_527ee53d-f891-4c90-bf47-5b940af8c9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d633db06-b689-4512-979a-f3d7dc6798f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_527ee53d-f891-4c90-bf47-5b940af8c9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_174b23d2-b4ca-4642-b91c-69ef73f1ca72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_376ae4e2-9703-4ce1-820c-b6577742555d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_174b23d2-b4ca-4642-b91c-69ef73f1ca72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:href="bsx-20230331.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06d0ecc9-feae-4f51-b799-ff15db7ed242" xlink:to="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82f4d914-c2e7-47ba-b036-a240e48153ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_82f4d914-c2e7-47ba-b036-a240e48153ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_532b7800-bd5f-4abb-8986-c640c0cf068e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_532b7800-bd5f-4abb-8986-c640c0cf068e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_8eeef469-5569-4971-ae74-614e2cdda21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_8eeef469-5569-4971-ae74-614e2cdda21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e99cb0c-d6bf-44b0-9bd1-31343027a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e99cb0c-d6bf-44b0-9bd1-31343027a0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_21be9653-4fb9-4dba-9d4f-36e0163e3a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_6cfc59ee-a0a5-4a3f-a2d7-e6814aaa4194" xlink:to="loc_us-gaap_Depreciation_21be9653-4fb9-4dba-9d4f-36e0163e3a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_a267424b-5275-4d99-9433-4f3d699ec5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_a267424b-5275-4d99-9433-4f3d699ec5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_e012f07e-d0dc-4fd4-ac1c-168c4c77d291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_a267424b-5275-4d99-9433-4f3d699ec5d5" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_e012f07e-d0dc-4fd4-ac1c-168c4c77d291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8f32ecad-627c-45c2-9bc8-3b4960441168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_a267424b-5275-4d99-9433-4f3d699ec5d5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8f32ecad-627c-45c2-9bc8-3b4960441168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d0649ac0-0c7b-4e1b-995d-1f523f6e3d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_a267424b-5275-4d99-9433-4f3d699ec5d5" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_d0649ac0-0c7b-4e1b-995d-1f523f6e3d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4145c997-3af8-428d-9f51-58c3594f785a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4145c997-3af8-428d-9f51-58c3594f785a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c2426591-c89d-4ffd-8aa5-c62595871c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4145c997-3af8-428d-9f51-58c3594f785a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_c2426591-c89d-4ffd-8aa5-c62595871c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5fcc9e80-5766-4c46-a412-bc399fde14db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4145c997-3af8-428d-9f51-58c3594f785a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5fcc9e80-5766-4c46-a412-bc399fde14db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_74b76f42-3481-4336-95c3-f1681fe2940d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4145c997-3af8-428d-9f51-58c3594f785a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_74b76f42-3481-4336-95c3-f1681fe2940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_843a64f8-fff9-4628-b717-fd32923cdecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4145c997-3af8-428d-9f51-58c3594f785a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_843a64f8-fff9-4628-b717-fd32923cdecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_b25e5b5f-6260-48a6-935c-3534f7cd7ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_InventoryNetAbstract_b25e5b5f-6260-48a6-935c-3534f7cd7ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_99b8b53b-c6db-41e7-9073-c92e5d780d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b25e5b5f-6260-48a6-935c-3534f7cd7ea7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_99b8b53b-c6db-41e7-9073-c92e5d780d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_295879c4-cb6f-4b83-ae2b-eb71dcc9e144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b25e5b5f-6260-48a6-935c-3534f7cd7ea7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_295879c4-cb6f-4b83-ae2b-eb71dcc9e144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9c5292aa-00b8-424f-b31b-d85c279eb6da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b25e5b5f-6260-48a6-935c-3534f7cd7ea7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9c5292aa-00b8-424f-b31b-d85c279eb6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8a375cce-1673-456d-9014-d8b2e2cc5e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b25e5b5f-6260-48a6-935c-3534f7cd7ea7" xlink:to="loc_us-gaap_InventoryNet_8a375cce-1673-456d-9014-d8b2e2cc5e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:href="bsx-20230331.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_101a1578-d390-46b0-92f0-8ac98c101f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_101a1578-d390-46b0-92f0-8ac98c101f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_4a5f0296-a3e6-401a-ae5d-8ab0daa7f248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_4a5f0296-a3e6-401a-ae5d-8ab0daa7f248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_d4993424-bb51-473e-9b3c-e472a7d91b33" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:to="loc_bsx_Licensingarrangements_d4993424-bb51-473e-9b3c-e472a7d91b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_d11484e2-a497-45ce-acb5-1c759bac2f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_d11484e2-a497-45ce-acb5-1c759bac2f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_258c64a5-8bff-4402-ae8a-3fc4f012ec1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_e14a155c-a262-4168-9135-b4d0dabad4f1" xlink:to="loc_us-gaap_OtherAssetsCurrent_258c64a5-8bff-4402-ae8a-3fc4f012ec1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_fd82c566-ed16-4eea-be40-308e62bc748c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_us-gaap_Land_fd82c566-ed16-4eea-be40-308e62bc748c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_1336d3f9-766a-4fb8-9fe2-8e230f0b984d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_1336d3f9-766a-4fb8-9fe2-8e230f0b984d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_f7bbb2bb-8968-4875-8b02-d159d3af0b29" xlink:href="bsx-20230331.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_f7bbb2bb-8968-4875-8b02-d159d3af0b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_a6529088-d2f5-413d-b526-8709c35040ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_us-gaap_ConstructionInProgressGross_a6529088-d2f5-413d-b526-8709c35040ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c1f8a29d-3d30-4f98-a51c-5c010f4024bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c1f8a29d-3d30-4f98-a51c-5c010f4024bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5277e1ab-43c2-4805-903d-878e5ee13b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5277e1ab-43c2-4805-903d-878e5ee13b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5e8b209c-59d5-4498-804a-2acb7945fb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_66535f02-bd00-410d-8c78-6b5b11ba0f68" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5e8b209c-59d5-4498-804a-2acb7945fb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_dbaf8f21-87a1-4439-a3c0-d2c59efd154a" xlink:href="bsx-20230331.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_dbaf8f21-87a1-4439-a3c0-d2c59efd154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_076d1c11-e3f5-44d2-ab57-4a4ead182ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_dbaf8f21-87a1-4439-a3c0-d2c59efd154a" xlink:to="loc_us-gaap_Depreciation_076d1c11-e3f5-44d2-ab57-4a4ead182ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_3df82e57-0fe0-4dc7-9b32-d0d1d4a07f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_3df82e57-0fe0-4dc7-9b32-d0d1d4a07f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1eea6b9a-46d1-4407-b440-c37ea1b61aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1eea6b9a-46d1-4407-b440-c37ea1b61aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b1e3bfc6-38b5-4b1c-9de9-0b86ffab9869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_us-gaap_DerivativeAssets_b1e3bfc6-38b5-4b1c-9de9-0b86ffab9869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4e82a1cb-04bc-45a5-885c-d5ba387d75bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_us-gaap_Investments_4e82a1cb-04bc-45a5-885c-d5ba387d75bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_a89f2e13-a376-41e4-aa71-e6d9fe2aa9c8" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_bsx_Licensingarrangementsasset_a89f2e13-a376-41e4-aa71-e6d9fe2aa9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IndemnificationAsset_f78003e1-2165-45a7-a6c4-7a0cfdbcd388" xlink:href="bsx-20230331.xsd#bsx_IndemnificationAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_bsx_IndemnificationAsset_f78003e1-2165-45a7-a6c4-7a0cfdbcd388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_269e6e8a-e70b-4528-a646-f58c0caddbca" xlink:href="bsx-20230331.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_bsx_OtherOtherLongtermAssets_269e6e8a-e70b-4528-a646-f58c0caddbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_10a417ce-6ea5-45d6-926c-b45a485d88d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_383d3e4d-356e-495f-8d2a-465f79d9571a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_10a417ce-6ea5-45d6-926c-b45a485d88d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_3a6ba877-44ec-418e-aaa8-dfb5d7a90905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:to="loc_us-gaap_LitigationReserveCurrent_3a6ba877-44ec-418e-aaa8-dfb5d7a90905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e9c4dbae-0fb5-4957-afb2-f8877899b98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e9c4dbae-0fb5-4957-afb2-f8877899b98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_88914394-612a-41bc-ad47-adde61b57eae" xlink:href="bsx-20230331.xsd#bsx_AccruedRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:to="loc_bsx_AccruedRebatesCurrent_88914394-612a-41bc-ad47-adde61b57eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e994d1f7-0f47-4f2e-a41e-8a6915297e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e994d1f7-0f47-4f2e-a41e-8a6915297e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c42d28a3-10cf-428a-aadf-469210580ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c42d28a3-10cf-428a-aadf-469210580ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e60325b2-54e6-4a97-913f-ac5e1b587625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bc634c8e-21b8-4cd3-b0f8-b5a3a86c9b1a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e60325b2-54e6-4a97-913f-ac5e1b587625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_e2b2aab4-3cab-4b66-b72f-c920f5fe325f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:to="loc_us-gaap_DeferredRevenueCurrent_e2b2aab4-3cab-4b66-b72f-c920f5fe325f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_62c94a16-b5fa-499e-8e5e-a7de3226ae1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_62c94a16-b5fa-499e-8e5e-a7de3226ae1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_69fd81ed-af40-41c0-93b1-cb5f5f79b790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:to="loc_us-gaap_TaxesPayableCurrent_69fd81ed-af40-41c0-93b1-cb5f5f79b790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_3b136ffc-bf03-44f2-9c93-e42a5ed905ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_3b136ffc-bf03-44f2-9c93-e42a5ed905ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_5c61b5d0-f172-40f3-aa0d-84fa60052e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_8ef99c12-2d4f-44d2-8fdf-05772c4c4614" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_5c61b5d0-f172-40f3-aa0d-84fa60052e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_93a1b090-f5fe-47f1-b7b2-ed4579c8fe09" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a1442854-18c5-4dae-b757-ec95a9e0948f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a1442854-18c5-4dae-b757-ec95a9e0948f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_2df8703c-394f-49e6-9f3e-d1cbac2350d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_2df8703c-394f-49e6-9f3e-d1cbac2350d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0dac738a-2a9b-4d15-a619-56cf004c0122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0dac738a-2a9b-4d15-a619-56cf004c0122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_720733ee-35e4-4215-a4c1-2cc876e3e568" xlink:href="bsx-20230331.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_bsx_Licensingarrangementsliability_720733ee-35e4-4215-a4c1-2cc876e3e568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0fadbc73-1a29-4bb6-8898-98c2b44ee3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0fadbc73-1a29-4bb6-8898-98c2b44ee3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_904cd778-3f53-4367-b6e8-8c6a9ed22d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_DeferredRevenue_904cd778-3f53-4367-b6e8-8c6a9ed22d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_ea142baa-23f2-4cf9-a7af-055a739a116d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_ea142baa-23f2-4cf9-a7af-055a739a116d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a454d641-257a-49b7-a349-2ff3fc3f58c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_afcfa179-46db-4bad-b304-43dcb2af0e89" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a454d641-257a-49b7-a349-2ff3fc3f58c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a73e4055-00c4-4daa-89e3-00613adc3436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_37ee2400-212d-4556-bf55-8bea4984e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a73e4055-00c4-4daa-89e3-00613adc3436" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_37ee2400-212d-4556-bf55-8bea4984e05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83af35d1-eb4c-4004-9a4e-1a123e9ccb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_37ee2400-212d-4556-bf55-8bea4984e05a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_83af35d1-eb4c-4004-9a4e-1a123e9ccb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_08c3d1d3-c0ae-4f41-b998-71283c72d1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_37ee2400-212d-4556-bf55-8bea4984e05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_08c3d1d3-c0ae-4f41-b998-71283c72d1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f907c12d-97cd-4c44-917e-4e6691aaf547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_37ee2400-212d-4556-bf55-8bea4984e05a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f907c12d-97cd-4c44-917e-4e6691aaf547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_c2c5215e-f80e-4cfc-8f8a-d189c1322295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a73e4055-00c4-4daa-89e3-00613adc3436" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_c2c5215e-f80e-4cfc-8f8a-d189c1322295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b39cee4a-cf5d-4db4-93bd-98935ea23578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b39cee4a-cf5d-4db4-93bd-98935ea23578" xlink:to="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea35b6cc-5286-4f11-aace-5bd3124272f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bea461d8-9550-4dde-9c27-29f5488c6e3f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea35b6cc-5286-4f11-aace-5bd3124272f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_eaa17436-5f13-46ed-ab66-e2c166bee175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_dbda7627-e482-4149-8d01-b417a4a826b1" xlink:to="loc_us-gaap_LitigationStatusDomain_eaa17436-5f13-46ed-ab66-e2c166bee175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ef62483b-7cef-42c2-a071-4f9bb4893d22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d5b7c131-e71e-4f2c-a78e-e885341a9ac9" xlink:to="loc_srt_LitigationCaseTypeDomain_ef62483b-7cef-42c2-a071-4f9bb4893d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a1b12861-c58b-46b4-9cb6-d5dca4b3af18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_321b71fe-d4b0-47a4-8637-cf6cb5afd97b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a1b12861-c58b-46b4-9cb6-d5dca4b3af18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f7bf5220-9668-4c30-b1f9-954016d9a878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a1b12861-c58b-46b4-9cb6-d5dca4b3af18" xlink:to="loc_us-gaap_SubsequentEventMember_f7bf5220-9668-4c30-b1f9-954016d9a878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aa97762d-4650-4d89-830c-4232bb98ab70" xlink:to="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b3be5063-3634-404d-a2ef-ea005b04b999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b3be5063-3634-404d-a2ef-ea005b04b999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_176511a9-bf63-470c-9e9a-9d2450744c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_176511a9-bf63-470c-9e9a-9d2450744c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_5d66cb4e-8391-4cdd-a60a-1a8a320cae32" xlink:href="bsx-20230331.xsd#bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior_5d66cb4e-8391-4cdd-a60a-1a8a320cae32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6a9b3ccc-f6cd-4d32-8080-864ed99cb3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fc4aa639-c21e-4535-97e9-2f9793694eb9" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6a9b3ccc-f6cd-4d32-8080-864ed99cb3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_a9f5463e-19b1-4e6c-902e-634e51414d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract_c7020620-bd90-4837-a167-dc793174f270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_a9f5463e-19b1-4e6c-902e-634e51414d6a" xlink:to="loc_us-gaap_ClassOfStockDisclosuresAbstract_c7020620-bd90-4837-a167-dc793174f270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract_c7020620-bd90-4837-a167-dc793174f270" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c448a994-2890-4625-ad08-ee3352c67076" xlink:to="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_8be2f687-5dea-4a96-bea1-2319e53b9c42" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:to="loc_bsx_A550MCPSSeriesAMember_8be2f687-5dea-4a96-bea1-2319e53b9c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_647c39f7-d2e1-41c7-8239-a08f4b6459fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ce153a12-4ea4-4f17-b1ed-ea4d291a4483" xlink:to="loc_us-gaap_CommonStockMember_647c39f7-d2e1-41c7-8239-a08f4b6459fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_db9698bf-9c9e-4fb1-bae3-a2a0e395cf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7f73b162-1b25-423d-951f-516481d48a68" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_db9698bf-9c9e-4fb1-bae3-a2a0e395cf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a9dd6974-f518-434f-92ab-a9e73382d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_db9698bf-9c9e-4fb1-bae3-a2a0e395cf7e" xlink:to="loc_us-gaap_SubsequentEventMember_a9dd6974-f518-434f-92ab-a9e73382d32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_788a2e0c-f8de-44a2-8d79-9aff2bb1fdd4" xlink:to="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2e6f984d-f2c0-41f3-8557-7c777ff4972f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:to="loc_srt_MinimumMember_2e6f984d-f2c0-41f3-8557-7c777ff4972f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a81084d0-299f-4fb8-a1f8-5a29f1fb073e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5041b0f5-8593-4e3b-8bae-147f94ba9adc" xlink:to="loc_srt_MaximumMember_a81084d0-299f-4fb8-a1f8-5a29f1fb073e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68cdef56-f175-4add-8a30-ebcf9658345f" xlink:to="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c7962a39-8133-46d6-a3e2-82e3ff9db029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c7962a39-8133-46d6-a3e2-82e3ff9db029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c9a98cdf-832f-4eed-a4fe-2e46c7a24188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c9a98cdf-832f-4eed-a4fe-2e46c7a24188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_da8b0b6c-44dc-42aa-ad8d-1d3b4ac6465d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_da8b0b6c-44dc-42aa-ad8d-1d3b4ac6465d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c113430d-3e67-467e-8380-3e87864a187e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c113430d-3e67-467e-8380-3e87864a187e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_2b194952-0792-4506-868d-7ceebdac33b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_2b194952-0792-4506-868d-7ceebdac33b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_d2a626b2-e77b-4afa-8557-55af4d4b09b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_d2a626b2-e77b-4afa-8557-55af4d4b09b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_c5cee5d3-6528-4f2e-a11c-6d39425ba0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_c5cee5d3-6528-4f2e-a11c-6d39425ba0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_5bd2fc3e-22aa-494d-89be-475a1ca2e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0c003d7b-d396-4a8c-ab36-dcf0c5095b2e" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_5bd2fc3e-22aa-494d-89be-475a1ca2e1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43c98cb0-e552-4f86-b247-665f458be49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43c98cb0-e552-4f86-b247-665f458be49f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07a1bb70-faec-4e32-b089-e334b05982b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_170a43e0-7420-41b5-b2ea-681255ae7425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_170a43e0-7420-41b5-b2ea-681255ae7425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_f3bdceee-de21-492a-9565-35d871ad1e38" xlink:href="bsx-20230331.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f08d5e79-f4c3-439e-a05f-f1d3f1f9978c" xlink:to="loc_bsx_A550MCPSSeriesAMember_f3bdceee-de21-492a-9565-35d871ad1e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b220fb72-5851-466d-b599-bfa1c27f266f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d3134460-009b-417c-9aa8-efbca8322e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d3134460-009b-417c-9aa8-efbca8322e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4ea9fcb-67f0-4555-b357-0f91163f8893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4ea9fcb-67f0-4555-b357-0f91163f8893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c80d7c94-9a82-47d9-acda-46ef60f5c043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c80d7c94-9a82-47d9-acda-46ef60f5c043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3348632-737f-41fa-ac89-c9a2381d2e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3348632-737f-41fa-ac89-c9a2381d2e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62604e58-8547-41ab-822e-a88597c8eb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62604e58-8547-41ab-822e-a88597c8eb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5257ed95-fc5d-4c44-8800-1fc31bd5b117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_28ded5a2-41aa-444a-b069-a3c2bd152912" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5257ed95-fc5d-4c44-8800-1fc31bd5b117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6ee65c70-fe08-41e4-ac24-23650884a205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5366c4ff-2eff-4366-8179-fa9ef0bf87fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6ee65c70-fe08-41e4-ac24-23650884a205" xlink:to="loc_us-gaap_NumberOfReportableSegments_5366c4ff-2eff-4366-8179-fa9ef0bf87fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6ee65c70-fe08-41e4-ac24-23650884a205" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6cb0c89d-b032-4c0c-b312-bdde8b61a3f1" xlink:to="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_2dcd3ab7-e10b-468b-9135-ac10f93ef9af" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_MedsurgMember_2dcd3ab7-e10b-468b-9135-ac10f93ef9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_d41fd7cf-325a-4e11-a4f2-03239e00ad62" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_CardiovascularMember_d41fd7cf-325a-4e11-a4f2-03239e00ad62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_12924823-56ec-4aff-a52a-09bcb7c7d404" xlink:href="bsx-20230331.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_BSXReportableSegmentsMember_12924823-56ec-4aff-a52a-09bcb7c7d404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_5e53aaa2-890d-4bb4-bb6d-773be862c971" xlink:href="bsx-20230331.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_5e53aaa2-890d-4bb4-bb6d-773be862c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_538ac22f-2abe-4d03-84f2-98f42b63edcb" xlink:href="bsx-20230331.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_538ac22f-2abe-4d03-84f2-98f42b63edcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_999af10a-a6c6-4e3f-a39d-3846ec026a6b" xlink:href="bsx-20230331.xsd#bsx_SpecialChargesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b44eacd1-08db-4681-be5b-a1056f95bd1c" xlink:to="loc_bsx_SpecialChargesMember_999af10a-a6c6-4e3f-a39d-3846ec026a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1d057151-b208-4d98-96b3-89a89132862b" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_680aa4d5-52c1-4732-92d1-3a768cd2b2e6" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_680aa4d5-52c1-4732-92d1-3a768cd2b2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_eaf1d929-21e9-45a6-8ce0-e5498fd5089e" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_2b0827f5-0f7d-4e92-9dcc-074c377130ac" xlink:href="bsx-20230331.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_2b0827f5-0f7d-4e92-9dcc-074c377130ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_db9e3a7e-a383-4e12-aeff-ebd6c8e889ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_db9e3a7e-a383-4e12-aeff-ebd6c8e889ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c0169bbb-53d4-48b3-b3dc-a335edbcf6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_OperatingIncomeLoss_c0169bbb-53d4-48b3-b3dc-a335edbcf6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_566f33d7-f2bf-4f34-a05c-16d257a48807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_566f33d7-f2bf-4f34-a05c-16d257a48807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bbc2aad-a084-448b-b671-851cb73e100c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_75eacaeb-ae4d-4fb5-aa2a-3642fa88cdad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bbc2aad-a084-448b-b671-851cb73e100c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_874a3979-dd7c-460e-a2d5-c6a5817f6162" xlink:href="bsx-20230331.xsd#bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement_874a3979-dd7c-460e-a2d5-c6a5817f6162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_d3dd48e7-ab39-4e09-9a45-f5ab7d437d5c" xlink:href="bsx-20230331.xsd#bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales_d3dd48e7-ab39-4e09-9a45-f5ab7d437d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_cf01a725-43fa-4abd-a3a9-f13727ce6d8e" xlink:href="bsx-20230331.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_cf01a725-43fa-4abd-a3a9-f13727ce6d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54528c67-4e09-4298-a8e9-511bb56cb366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_94a02ea8-c430-4012-96b7-7c2ddb5f97d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54528c67-4e09-4298-a8e9-511bb56cb366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f5fb2af2-3341-49f3-97ff-22f6faac5950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_15e8529c-4906-472b-8c09-f899ce5f01ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f5fb2af2-3341-49f3-97ff-22f6faac5950" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_15e8529c-4906-472b-8c09-f899ce5f01ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_15e8529c-4906-472b-8c09-f899ce5f01ef" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d2d643d-b764-4c87-885d-abaaa160ec03" xlink:to="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_7a3558c5-26bd-4503-8204-760204e1c861" xlink:href="bsx-20230331.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:to="loc_bsx_BSXReportableSegmentsMember_7a3558c5-26bd-4503-8204-760204e1c861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_56d80609-95f2-47eb-a8b6-b8e4b433cf13" xlink:href="bsx-20230331.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:to="loc_bsx_MedsurgMember_56d80609-95f2-47eb-a8b6-b8e4b433cf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_6610da0e-7c95-4d1b-aeac-93368be1dd98" xlink:href="bsx-20230331.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_387b4684-5e0b-4e58-99be-b8d50931e63f" xlink:to="loc_bsx_CardiovascularMember_6610da0e-7c95-4d1b-aeac-93368be1dd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_17c7c964-2b8a-4d0a-99e7-bd70e6b2505a" xlink:to="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_e8ffa499-4dc5-4b87-a1c1-0f09c8d977d0" xlink:href="bsx-20230331.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_e8ffa499-4dc5-4b87-a1c1-0f09c8d977d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_926097c2-9fc6-4a12-9446-935bf900f54d" xlink:href="bsx-20230331.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_926097c2-9fc6-4a12-9446-935bf900f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_e720a086-b06e-4f4b-8dcc-a879222f9a25" xlink:href="bsx-20230331.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_e720a086-b06e-4f4b-8dcc-a879222f9a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InterventionalCardiologyTherapiesMember_97e2170f-d6e8-4f6c-86ad-448d539fd435" xlink:href="bsx-20230331.xsd#bsx_InterventionalCardiologyTherapiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_InterventionalCardiologyTherapiesMember_97e2170f-d6e8-4f6c-86ad-448d539fd435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WatchmanMember_7d092bcb-9a99-498d-a1da-10beacd04302" xlink:href="bsx-20230331.xsd#bsx_WatchmanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_WatchmanMember_7d092bcb-9a99-498d-a1da-10beacd04302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiacRhythmManagementMember_69a8e239-a297-4f72-a50a-9fb5e55ba7c6" xlink:href="bsx-20230331.xsd#bsx_CardiacRhythmManagementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_CardiacRhythmManagementMember_69a8e239-a297-4f72-a50a-9fb5e55ba7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ElectrophysiologyEPMember_48d096ad-4f48-4ce7-bd72-2c2c31bf9761" xlink:href="bsx-20230331.xsd#bsx_ElectrophysiologyEPMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_ElectrophysiologyEPMember_48d096ad-4f48-4ce7-bd72-2c2c31bf9761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCardiologyReportingUnitMember_e49bc74d-780d-47ab-8db3-c3093cdcd55b" xlink:href="bsx-20230331.xsd#bsx_GlobalCardiologyReportingUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalCardiologyReportingUnitMember_e49bc74d-780d-47ab-8db3-c3093cdcd55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fb26417f-857b-4e14-a7f9-049771ed2a55" xlink:href="bsx-20230331.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e41af62-ed6d-4568-bf11-c9b8a24a0d87" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fb26417f-857b-4e14-a7f9-049771ed2a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fd6ba176-ed0e-4c30-a25e-2270e1704bb7" xlink:to="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_374117ac-4f82-4e26-8b25-8728bfaa7142" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_country_US_374117ac-4f82-4e26-8b25-8728bfaa7142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_f3f20dd8-2b1b-4ed9-b847-6a80f1877779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_us-gaap_NonUsMember_f3f20dd8-2b1b-4ed9-b847-6a80f1877779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_f6fe0f85-f84d-4dac-b14f-6d9bc2d81fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_us-gaap_EMEAMember_f6fe0f85-f84d-4dac-b14f-6d9bc2d81fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_b1dda1e3-c954-476c-907f-47b83508f88f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_srt_AsiaPacificMember_b1dda1e3-c954-476c-907f-47b83508f88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_dded7e3b-f816-4712-a960-5e42c1da1331" xlink:href="bsx-20230331.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_bsx_LatinAmericaandCanadaMember_dded7e3b-f816-4712-a960-5e42c1da1331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_c8641bd6-fcd3-44de-a227-971e18678506" xlink:href="bsx-20230331.xsd#bsx_EmergingMarketsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9370aa49-79d6-42c4-8965-e5bd3ac47e61" xlink:to="loc_bsx_EmergingMarketsMember_c8641bd6-fcd3-44de-a227-971e18678506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d00c6f5f-00a4-4a3d-94bf-5183831e71e1" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41519dad-3c8d-46e6-b9cf-8228f6f670a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41519dad-3c8d-46e6-b9cf-8228f6f670a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e99cfee-244b-4d37-ad72-0a34df3b1847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e99cfee-244b-4d37-ad72-0a34df3b1847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses_d8b3325e-14fd-4640-9f05-215f2a4d78c7" xlink:href="bsx-20230331.xsd#bsx_NumberOfBusinesses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_aafc96ec-dbc9-4d0d-8692-4372b88e67a2" xlink:to="loc_bsx_NumberOfBusinesses_d8b3325e-14fd-4640-9f05-215f2a4d78c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_91ce129d-e2e1-4076-ba3a-106367e5e0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_15e8529c-4906-472b-8c09-f899ce5f01ef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_91ce129d-e2e1-4076-ba3a-106367e5e0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_fbd56b79-548d-4652-85b8-f07656fe66c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_91ce129d-e2e1-4076-ba3a-106367e5e0d3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_fbd56b79-548d-4652-85b8-f07656fe66c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_f7bab60b-215d-4917-95ff-21bbb9df00a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_15e8529c-4906-472b-8c09-f899ce5f01ef" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_f7bab60b-215d-4917-95ff-21bbb9df00a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_07a0e420-5507-4db8-924b-636441af48a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_f7bab60b-215d-4917-95ff-21bbb9df00a7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_07a0e420-5507-4db8-924b-636441af48a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20230331.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_1e1ddbfb-2584-404e-b6b7-c317bfe002c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_1e1ddbfb-2584-404e-b6b7-c317bfe002c4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5fb6e67b-b001-4a04-a08d-8b72643cbd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_562e262b-f7ac-4485-b023-5a4e7bde224c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5fb6e67b-b001-4a04-a08d-8b72643cbd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aab00d75-e066-4fe0-9b72-36aad024262b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5ed574ff-f6e3-451f-ba46-8cc9ad910d8b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aab00d75-e066-4fe0-9b72-36aad024262b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_78ac358f-f6b7-420e-ab22-b95d75d12017" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_20bdea81-bda6-46a1-8a94-84bf50a9286b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_20bdea81-bda6-46a1-8a94-84bf50a9286b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c31363ee-544f-4e53-be10-a246904f48fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c31363ee-544f-4e53-be10-a246904f48fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12107e0a-d65d-4ed6-850c-8edc97b326dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12107e0a-d65d-4ed6-850c-8edc97b326dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91da8a41-0c78-4428-b10b-7d2052532f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91da8a41-0c78-4428-b10b-7d2052532f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b182e5a0-f324-4dcf-b45a-86b8dc525bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b182e5a0-f324-4dcf-b45a-86b8dc525bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_40378624-7058-4f7d-9b6b-973057857836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_40378624-7058-4f7d-9b6b-973057857836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d172199c-d55a-4301-84e1-8def14edd84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d172199c-d55a-4301-84e1-8def14edd84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4e95c508-a459-4663-9720-acfd1315ed04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4e95c508-a459-4663-9720-acfd1315ed04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3fb2de1b-0330-4fe2-9d95-5deb2a070080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3fb2de1b-0330-4fe2-9d95-5deb2a070080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7818fa27-ae7c-4667-82db-fb566f4a41d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7818fa27-ae7c-4667-82db-fb566f4a41d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_51412abd-0477-486f-b2bd-e0123049791c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_51412abd-0477-486f-b2bd-e0123049791c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_3c3b8498-f32e-4083-bfd1-f03a4794abfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_3c3b8498-f32e-4083-bfd1-f03a4794abfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_be1d6352-1d75-4655-8a52-0cebc27f303c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_be1d6352-1d75-4655-8a52-0cebc27f303c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_b70f43a6-ab1a-4fea-be97-7612804c84bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_b70f43a6-ab1a-4fea-be97-7612804c84bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c54c0d71-a2a9-4f0f-9037-8c45948cb801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c54c0d71-a2a9-4f0f-9037-8c45948cb801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_793abdf7-dce9-497c-a215-b788fc779ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_828df74e-d0b7-4786-b2d0-54799e2ed52e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_793abdf7-dce9-497c-a215-b788fc779ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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MY&3R1'F/_O7KUV,J8V-C$6+E%0Z0"A<-4F9>'X@@*N#DY$2.3$A(*-D\/-7
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M+4F"4Z#M9Y]K'@Q"E'[YY9><\3ESYA"?AN^+8&]XP#5KUD1$1!P]>I0S8F*
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86(;_!Q_6I[A(.M G     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  !K8   &*" (   #&Z.9R   +04E$051X7NW8
M,0$   B ,/N7UM\*;"<1F 4     PN8'     *#$(@0   " -(L0     -(L
M0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($
M    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@
M  !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($
M@#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(
MLP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+
M$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!
M    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+$
M  #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!
M(,TB!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+$     #2
M+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB
M!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+$     #2+$(
M    2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!
M ( TBQ      TBQ"     $BS" $    @S2($    @#2+$     #2+$(
M2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( T
MBQ      TBQ"     $BS" $    @S2($    @#2+$     #2+$(     2+,(
M 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ
M    TBQ"     $BS" $    @S2($    @#2+$     #2+$(     2+,( 0
M "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ
MTBQ"     $BS" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-
M(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"
M     $BS" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0
M  " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"
M $BS" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0   "
M-(L0     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS
M" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0
M     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $
M   @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0
M -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @
MS2($    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L
M0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($
M    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@
M  !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($
M@#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(
MLP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+
M$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!
M    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+$
M  #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!
M(,TB!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+$     #2
M+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB
M!    ( TBQ      TBQ"     $BS" $    @S2($    @#2+$     #2+$(
M    2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!
M ( TBQ      TBQ"     $BS" $    @S2($    @#2+$     #2+$(
M2+,( 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( T
MBQ      TBQ"     $BS" $    @S2($    @#2+$     #2+$(     2+,(
M 0   "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ
M    TBQ"     $BS" $    @S2($    @#2+$     #2+$(     2+,( 0
M "#-(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ
MTBQ"     $BS" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-
M(@0   " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"
M     $BS" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0
M  " -(L0     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"
M $BS" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0   "
M-(L0     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS
M" $    @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0
M     -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $
M   @S2($    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0
M -(L0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @
MS2($    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L
M0@    !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($
M    @#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@
M  !(LP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @S2($
M@#2+$     #2+$(     2+,( 0   "#-(@0   " -(L0     -(L0@    !(
MLP@!    (,TB!    ( TBQ      TBQ"     $BS" $    @[0!>9R:^^\[&
-80    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018876162000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Document - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,698,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018871707536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,389<span></span>
</td>
<td class="nump">$ 3,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">1,040<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,349<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">1,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring net charges (credits)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">552<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Preferred stock dividends</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders', window );">Net income (loss) attributable to Boston Scientific common stockholders</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss)&#160;per common share &#8212; basic</a></td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss)&#160;per common share &#8212; diluted</a></td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,435.8<span></span>
</td>
<td class="nump">1,427.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">1,446.0<span></span>
</td>
<td class="nump">1,438.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income (loss) attributable to Boston Scientific common stockholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018873259600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</a></td>
<td class="nump">$ 223<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018870789760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 570<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">2,076<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">731<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,704<span></span>
</td>
<td class="nump">5,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,478<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">13,269<span></span>
</td>
<td class="nump">12,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,060<span></span>
</td>
<td class="nump">5,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="nump">3,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,482<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">32,892<span></span>
</td>
<td class="nump">32,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,918<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">761<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,083<span></span>
</td>
<td class="nump">3,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,495<span></span>
</td>
<td class="nump">8,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">2,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of March&#160;31, 2023 and December&#160;31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,700,828,873 shares as of March&#160;31, 2023 and 1,696,633,993 shares as of December&#160;31, 2022</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 263,289,848 shares as of March&#160;31, 2023 and December&#160;31, 2022</a></td>
<td class="num">(2,251)<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">20,356<span></span>
</td>
<td class="nump">20,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(450)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">17,850<span></span>
</td>
<td class="nump">17,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">18,109<span></span>
</td>
<td class="nump">17,573<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND EQUITY</a></td>
<td class="nump">$ 32,892<span></span>
</td>
<td class="nump">$ 32,469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018873238928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract', window );"><strong>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,700,828,873<span></span>
</td>
<td class="nump">1,696,633,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018873154768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th"><div>Treasury Stock, Common</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,688,810,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 19,986<span></span>
</td>
<td class="num">$ (1,392)<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Noncontrolling Interest, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,018,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Mar. 31, 2022</a></td>
<td class="nump">16,735<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">20,043<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">$ 16,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,692,828,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">$ 17,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,696,633,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,696,633,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity at Dec. 31, 2022</a></td>
<td class="nump">$ 17,573<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">20,289<span></span>
</td>
<td class="num">(750)<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Noncontrolling Interest, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,194,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Mar. 31, 2023</a></td>
<td class="nump">18,109<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 20,356<span></span>
</td>
<td class="num">(450)<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (91)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">$ 17,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,700,828,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=128088960&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126965701&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018871647792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash provided by (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit', window );">Deferred and prepaid income taxes</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net loss (gain) on investments and notes receivable</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_InventoryStepUpAmortization', window );">Inventory step-up amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OtherNet', window );">Other, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="num">(211)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash provided by (used for) operating activities</a></td>
<td class="nump">190<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment and internal use software</a></td>
<td class="num">(111)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(1,471)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies', window );">Proceeds from (payments for) investments and acquisitions of certain technologies</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash provided by (used for) investing activities</a></td>
<td class="num">(484)<span></span>
</td>
<td class="num">(1,574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration previously established in purchase accounting</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_PaymentsForRoyaltyRights', window );">Payments for royalty rights</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Payments on short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net increase (decrease) in commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on long-term borrowings and debt extinguishment costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,184)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid on preferred stock</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Paymenttonetsharesettleemployeeequityawards', window );">Cash used to net share settle employee equity awards</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by (used for) financing activities</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="num">(363)<span></span>
</td>
<td class="num">(1,639)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">2,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">763<span></span>
</td>
<td class="nump">529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (19)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash flow impact of deferred income tax expense (benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_InventoryStepUpAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory step up amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_InventoryStepUpAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentsForRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for royalty rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentsForRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Paymenttonetsharesettleemployeeequityawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment to net share settle employee equity awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Paymenttonetsharesettleemployeeequityawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from (payments for) investments and acquisitions of certain technologies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018875207744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Supplemental Disclosure) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 570<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 763<span></span>
</td>
<td class="nump">$ 1,126<span></span>
</td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 2,168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018868116256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements include the accounts of the Company's wholly owned- subsidiaries and entities for which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2023, we acquired a majority stake investment in Acotec Scientific Holdings Limited (Acotec) and have elected to consolidate their financial statements on a one quarter lag. Accordingly, their results of operations for the period following the closing of the transaction on February 20, 2023 are omitted from the Company&#8217;s unaudited consolidated statements of operations for the quarter ended March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note B &#8211; Acquisitions, Divestitures and Strategic Investments, Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874375568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Strategic Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND STRATEGIC INVESTMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2023, we completed our acquisition of 100 percent of the outstanding equity of Apollo Endosurgery, Inc. (Apollo), a public company which offers a portfolio of devices used during endoluminal procedures to close gastrointestinal defects, manage gastrointestinal complications and aid in weight loss for patients suffering from obesity. The agreement consisted of an upfront cash payment of $10.00 per share, or approximately $615 million. The Apollo business is being integrated into our Endoscopy division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 20, 2023, we completed the acquisition of a majority stake investment in Acotec, a publicly traded Chinese manufacturer of drug-coated balloons used in the treatment of vascular and other diseases. We acquired approximately 65 percent of the outstanding shares of Acotec, for an upfront cash payment of HK$20.00 per share, or $519 million at foreign currency exchange rates at closing. The Acotec portfolio complements our existing Peripheral Interventions portfolio.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We accounted for the Acotec transaction as a business combination in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(FASB ASC Topic 805). The preliminary purchase price was comprised of the amount presented below: </span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for majority interest acquisition, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excludes approximately $140 million of cash on hand at the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded the assets acquired, liabilities assumed and the noncontrolling interest at their respective fair values as of the closing of the transaction. The preliminary purchase price allocation was comprised of the following components and the final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with FASB ASC Topic 805: </span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of noncontrolling interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the noncontrolling interest was based on the publicly traded market value of the remaining 35 percent of the outstanding shares we did not acquire as of the transaction date and is presented within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Stockholders' equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Goodwill was primarily established due to opportunities for collaboration in research and development, manufacturing and commercial strategies, and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">334</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which developed the radiofrequency (RF) NRG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and VersaCross</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which expanded our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment of $1.463 billion, net of cash acquired, subject to closing adjustments. We are integrating the Baylis Medical business into our Cardiology division.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of Baylis Medical as a business combination in accordance with FASB ASC Topic 805, Business Combinations. The final purchase price was comprised of the amount presented below: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price allocation was comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and is deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our acquisitions that closed during the first quarters of 2023 or 2022 contained contingent consideration arrangements. Changes in the fair value of our contingent consideration liability during the first quarter of 2023 associated with prior period acquisitions were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payments made during the first quarter of 2023 were primarily related to our 2021 acquisition of Farapulse, Inc. As of March&#160;31, 2023, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was approximately $359 million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to research and development (R&amp;D), regulatory and commercialization-based milestones and revenue-based payments are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of March&#160;31, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1, 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">385</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Includes publicly-held securities measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></div>As of March&#160;31, 2023, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $209 million, which represents amortizable intangible assets, in-process research and development (IPR&amp;D), goodwill and deferred tax liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874264544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,553)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,378)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(381)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,357)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,843</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,173)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,169</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in our balance of goodwill and amortizable intangible assets is related primarily to our acquisition of a majority stake investment in Acotec completed in the first quarter of 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following represents a roll-forward of our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,684</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and purchase price adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,032</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Asset Impairments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the first quarters 2023 or 2022. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140019053371648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and actively monitoring counterparty credit ratings. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, British pound sterling, Swiss franc, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815, Derivatives and Hedging (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our unaudited consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our unaudited consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time. The cash flows related to the derivative instruments designated as cash flow hedges are reported as operating activities in our consolidated statements of cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of March&#160;31, 2023 and December&#160;31, 2022, we designated as a net investment hedge our &#8364;900 million in aggregate principal amount of 0.625% euro-denominated senior notes issued in November 2019 and due in 2027 (2027 Notes). For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Cumulative Translation Adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ther Comprehensive Income (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the remaining time to maturity is within 36&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature between one and three years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.114%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">319</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">319</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">674</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">308</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,313</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $170 million invested in money market funds and time deposits as of March&#160;31, 2023 and $673 million as of December&#160;31, 2022, we held $400 million in interest-bearing and non-interest-bearing bank accounts as of March&#160;31, 2023 and $256 million as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We maintain a financial asset and associated liability for our licensing arrangements measured at fair value in our accompanying unaudited consolidated balance sheets in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We elected the fair value option to measure the financial asset and associated liability as it provides for consistency and comparability of these financial instruments with others. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of March&#160;31, 2023 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$113 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$120 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $8.467 billion as of March&#160;31, 2023 and $8.203 billion as of December&#160;31, 2022. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018879188752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $9.005 billion as of March&#160;31, 2023 and $8.935 billion as of December&#160;31, 2022, with current obligations of $510 million as of March&#160;31, 2023 and $20 million as of December&#160;31, 2022. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.875%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,495</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,915</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective May 2023, the interest rate payable will decrease by 0.25 percent and begin accruing at a rate of 6.50 percent following recent upgrades to our credit ratings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks scheduled to mature on May 10, 2026, with one-year extension options, subject to certain conditions. On March 1, 2023, we entered into an amendment of the 2021 Revolving Credit Facility credit agreement, which provided for an extension of the scheduled maturity date to May 10, 2027 and replaced the London Interbank Offered Rate (LIBOR) with the Secured Overnight Financing Rate (SOFR) as the Eurocurrency Rate for Dollars, including applicable credit spread adjustments and relevant SOFR benchmark provisions, among other things described under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the 2021 Revolving Credit Facility as of March&#160;31, 2023 or December&#160;31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility, as amended.</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.52 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of 3.75 times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for any qualified acquisitions due to our funding of these acquisitions using cash on hand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement, as amended on March 1, 2023, provides for an exclusion from the calculation of consolidated EBITDA, as defined by the credit agreement, through maturity, of certain charges and expenses. The credit agreement amendment reset the starting date for purposes of calculating such permitted exclusions in each case from March 31, 2021 to December 31, 2022. Permitted exclusions include any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses associated with our current or future restructuring plans. As of March&#160;31, 2023, we had $457 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $1.000 billion plus all accrued legal liabilities as of December&#160;31, 2022 for a total of $1.443 billion. As of March&#160;31, 2023, we had $1.424 billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the 2021 Revolving Credit Facility. We had no commercial paper outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In April 2023, we issued commercial paper to partially fund our acquisition of Apollo. As of the date of this Quarterly Report on Form 10-Q, we had approximately $400 million of commercial paper outstanding, which directly reduces our borrowing capacity under the 2021 Revolving Credit Facility. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $9.067 billion as of March&#160;31, 2023 and $8.986 billion as of December&#160;31, 2022. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, American Medical Systems Europe B.V. (AMS Europe), an indirect, wholly owned subsidiary of Boston Scientific, completed a registered public offering (the Offering) of &#8364;3.000 billion in aggregate principal amount of euro-dominated senior notes comprised of &#8364;1.000 billion of 0.750% Senior Notes due 2025, &#8364;750 million of 1.375% Senior Notes due 2028, &#8364;750 million of 1.625% Senior Notes due 2031 and &#8364;500 million of 1.875% Senior Notes due 2034 (collectively, the Eurobonds). Boston Scientific has fully and unconditionally guaranteed all of AMS Europe's obligations under the Eurobonds, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and no other subsidiary of Boston Scientific will guarantee these obligations. AMS Europe is a &#8220;finance subsidiary&#8221; as defined in Rule 13-01(a)(4)(vi) of Regulation S-X. The financial condition, results of operations and cash flows of AMS Europe are consolidated in the financial statements of Boston Scientific. The Offering resulted in cash proceeds of $3.270 billion, net of investor discounts and issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $3.275&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. We recorded associated debt extinguishment charges of $194 million during the first quarter of 2022 presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $143 million as of March&#160;31, 2023 and $135 million as of December&#160;31, 2022, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of March&#160;31, 2023 and December&#160;31, 2022 we had not recognized a related liability for any outstanding letters of credit within our accompanying unaudited consolidated balance sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a supplier financing program offered primarily in the U.S. where our suppliers can opt to receive early payment at a nominal discount, while allowing us to lengthen our payment terms and optimize working capital. Our standard payment term in the U.S. is 90 days. All outstanding payables related to the supplier finance program are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited consolidated balance sheets and were $128 million as of March&#160;31, 2023 and $129 million as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018879218208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 326), we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach, applying country or region-specific factors, to determine the reserve to record at accounts receivable commencement for certain customers. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. In addition, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,050</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:1pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">711</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $82 million for the first quarter of 2023 and $76 million for the first quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,160</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">787</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">761</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,995</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,035</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018867918864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.851%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our reported tax rates for the first quarter of 2023, as compared to the same period in 2022, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include debt extinguishment charges recorded in the first quarter of 2022, as well as certain discrete tax items primarily related to provision-to-return adjustments recorded in the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $501 million of gross unrecognized tax benefits, of which a net $415 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2022, we had $492 million of gross unrecognized tax benefits, of which a net $410 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $77 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018879044448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, product liability, securities and commercial claims have been asserted against us and similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity. For additional information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our accompanying unaudited consolidated statements of operations. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $416 million as of March&#160;31, 2023 and $443 million as of December&#160;31, 2022 and includes certain estimated costs of settlement, damages and defense primarily related to product liability cases or claims related to our transvaginal surgical mesh products. A portion of this accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $135 million as of March&#160;31, 2023 and $149 million as of December&#160;31, 2022. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We did not record any litigation-related net charges during the first quarter of 2023 or 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against four then-asserted patents, which resulted in the court staying the case until 2020. All IPRs concluded and confirmed the validity of certain claims of each challenged patent. In </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2023, the District Court issued summary judgment rulings dismissing certain claims and defenses. Trial on the remaining two asserted patents is scheduled for May 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2017, The Board of Regents, University of Texas System and TissueGen. Inc. (collectively, UT), served a lawsuit against us in the Western District of Texas. The complaint against the Company alleges patent infringement of two U.S. patents owned by UT, relating to &#8220;Drug Releasing Biodegradable Fiber Implant&#8221; and &#8220;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#8221; and affects the manufacture, use and sale of our Synergy&#8482; Stent System. UT primarily seeks a reasonable royalty. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the UT&#8217;s Petition for Certiorari. UT proceeded with its case against us in Delaware. In January 2023, a jury trial was held on the issue of whether the one UT patent still asserted in the case was valid and whether it was infringed by the Company. On January 31, 2023, a jury concluded that UT&#8217;s patent was valid and willfully infringed by the Company, and awarded UT $42 million in damages. Following the trial, UT has filed a motion seeking prejudgment interest and enhanced damages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has filed a motion seeking judgment as a matter of law in its favor or alternatively a new trial.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Multiple product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us, predominantly in the United States, Canada, the United Kingdom, Scotland, Ireland, and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. We have entered into individual and master settlement agreements in principle or are in the final stages of entering agreements with certain plaintiffs' counsel, to resolve the majority of these cases and claims. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. In addition, in April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records related to mesh settlements. The Company has notified our insurer and retained counsel to respond to the demand. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for remaining claims asserted against us associated with our transvaginal surgical mesh products and the costs of defense thereof. We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest these cases and claims. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#8217;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. Subsequently, on March 30, 2022, the Federal Prosecutor&#8217;s office issued a non-binding recommendation that is contrary to the Attorney General&#8217;s recommendation. The full Commission is considering both of these recommendations but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#8217;s decision.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam. The Company has received related subpoenas for documents from the Office of the U.S. Attorney for the District of Massachusetts and the Securities and Exchange Commission. The Company is cooperating with government agencies while investigating these allegations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2023, the Company received a subpoena from the U.S. Department of Justice (DOJ) that seeks documents and information relating to its ambulatory electrocardiography monitoring (AECG) business. The Company is cooperating with the DOJ in responding to this subpoena.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020, Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all others similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. The plaintiffs filed an Amended Complaint in June 2021 that seeks unspecified compensatory damages in favor of the alleged class as well as unspecified equitable relief. The Company filed a Motion to Dismiss in July 2021, which, in December 2022, the Court granted in part and denied in part. The Company intends to vigorously defend itself against the surviving allegations. On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#8217;s decision to retire the LOTUS System and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company cooperated fully with the requests, and on January 3, 2022, the SEC informed us that it was concluding its investigation and that it did not intend to recommend an enforcement action. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above. The Company received letters on behalf of the Union Excavators Local 731 Pension Fund, Diane Nachbaur, and Frank Tripson, three stockholders of the Company, on July 26, 2021, July 29, 2021, and February 13, 2023, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items. On February 7, 2023, Diane Nachbaur filed a shareholder derivative complaint in the United States District Court for the District of Massachusetts against the Company, Michael F. Mahoney, Nelda J. Connors, Charles J. Dockendorff, Yoshiaki Fujimori, Donna A. James, Edward J. Ludwig, David Roux, John E. Sununu, Ellen M. Zane, Joseph M. Fitzgerald, Daniel J. Brennan, Shawn McCarthy, Ian Meredith, Kevin Ballinger, and Susan Vissers Lisa.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874375568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of March&#160;31, 2023, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared, and we paid, a cash dividend of $1.375 per MCPS share to holders of our MCPS as of February 15, 2023, representing a dividend period from December 2022 through February 2023. On April 24, 2023 the Committee declared a cash dividend of $1.375 per MCPS share to holders of our MCPS as of May 15, 2023, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">representing a dividend period from March through May 2023. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheet as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874264544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Weighted Average Number Of Shares Outstanding [Text Block]</a></td>
<td class="text"><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,446.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,438.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of diluted weighted average shares outstanding because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the first quarter of 2023 and 2022, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented within our accompanying unaudited consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to Boston Scientific common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We issued approximately four million shares of our common stock in the first quarter of 2023 and 2022 following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first quarter of 2023 or 2022. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of March&#160;31, 2023, we had the full amount remaining available under the authorization.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874290480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aggregate our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. In accordance with FASB ASC Topic 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we identified our reportable segments based on the nature of our products, production processes, type of customer, selling and distribution methods and regulatory environment, as well as the economic characteristics of each of our operating segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and evaluate our reportable segments based on their respective net sales, operating income, excluding intersegment profits, and operating income as a percentage of net sales, all excluding the impact of foreign currency. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations and are included in the reconciliation below. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for net sales by reportable segment presented in accordance with U.S. GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018867918864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes within our accompanying unaudited consolidated statements of operations. Our business structure is organized into five operating segments. The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">395</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">853</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,873</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note K- Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information on our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $521 million as of March&#160;31, 2023 and $509 million as of December&#160;31, 2022. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiology business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our Cardiology business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $42 million in the first quarter that was included in the above contract liability balance as of December&#160;31, 2022. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. </span></div>Variable Consideration<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on variable consideration, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018879044448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss) Note [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018867918864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_NewAccountingPronouncementsPolicyTextBlock', window );">New Accounting Pronouncements, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first quarter of 2023, we implemented the following standards on a prospective basis, none of which had a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2022-01</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2022-02</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments- Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2022-04</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities&#8212; Supplier Finance Programs (Subtopic 405-50) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enhances the transparency of supplier finance programs by requiring that a buyer in a supplier finance program disclose sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASC Update No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. We do not expect the adoption to have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NewAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>New Accounting Pronouncements, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NewAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874139984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note B &#8211; Acquisitions, Divestitures and Strategic Investments, Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018879218208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874294000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Commitments and Contingencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text">FASB ASC Topic 450, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span>within our accompanying unaudited consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018871720912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock', window );">ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</a></td>
<td class="text">ASC Update No. 2022-01<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. </span>Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock', window );">ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2022-02</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments- Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as </span></div>amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock', window );">ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50)</a></td>
<td class="text">ASC Update No. 2022-04<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Update No. 2022-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities&#8212; Supplier Finance Programs (Subtopic 405-50) </span>enhances the transparency of supplier finance programs by requiring that a buyer in a supplier finance program disclose sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock', window );">ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASC Update No. 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. We do not expect the adoption to have a material impact on our financial position or results of operations.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018871738544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Strategic Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text">Changes in the fair value of our contingent consideration liability during the first quarter of 2023 associated with prior period acquisitions were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investment [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1, 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">385</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Includes publicly-held securities measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for majority interest acquisition, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excludes approximately $140 million of cash on hand at the closing of the transaction.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text">The preliminary purchase price allocation was comprised of the following components and the final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with FASB ASC Topic 805: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of noncontrolling interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">334</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text">The final purchase price allocation was comprised of the following components:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874164176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,553)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,378)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(381)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,357)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,843</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,173)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,169</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following represents a roll-forward of our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,684</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and purchase price adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,032</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018873165808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock', window );">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.114%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</a></td>
<td class="text">The following are the balances of our derivative and nonderivative assets and liabilities:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">319</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#8364;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">319</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">674</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,182</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">308</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,313</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of March&#160;31, 2023 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of March 31, 2023</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$113 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$120 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018873274368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text">The debt maturity schedule for our long-term debt obligations is presented below: <div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.875%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,495</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,915</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective May 2023, the interest rate payable will decrease by 0.25 percent and begin accruing at a rate of 6.50 percent following recent upgrades to our credit ratings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div>(4)&#160;&#160;&#160;&#160;Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock', window );">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility, as amended.</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.52 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt [Table Text Block]</a></td>
<td class="text">We had no commercial paper outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In April 2023, we issued commercial paper to partially fund our acquisition of Apollo. As of the date of this Quarterly Report on Form 10-Q, we had approximately $400 million of commercial paper outstanding, which directly reduces our borrowing capacity under the 2021 Revolving Credit Facility.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of term loan and revolving credit facility agreement compliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018873163536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade accounts receivable, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Disclosure [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,050</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">711</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,160</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">787</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">761</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,995</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,035</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874129760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems', window );"><strong>Schedule of Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock', window );">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.851%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874164176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,446.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,438.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of diluted weighted average shares outstanding because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874050432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874133344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">395</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Interventional Cardiology Therapies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Watchman</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiology</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">853</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,873</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note K- Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information on our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">440</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1)Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018875038240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>R<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018879299808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>reportablesegments</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018872943824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 04, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 20, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 20, 2023 </div>
<div>KRW (&#8361;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
<td class="nump">$ 1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=bsx_AcotecMember', window );">Acotec</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_ApolloMember', window );">Apollo | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="nump">$ 615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember', window );">Baylis Medical | Weighted Average [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="nump">&#8361; 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec | Weighted Average [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec | Weighted Average [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember', window );">Acotec | Weighted Average [Member] | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=bsx_AcotecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=bsx_AcotecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_ApolloMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_ApolloMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_AcotecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018868578640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Beginning Balance</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AllBusinessAcquisitionsMember', window );">All Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>contingent consideration liability, probability of payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationLiabilityProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_AllBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_AllBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018875346512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Strategic Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative investments(1, 2)</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018872770448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 15,185<span></span>
</td>
<td class="nump">$ 14,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(9,357)<span></span>
</td>
<td class="num">(9,173)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="nump">12,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">$ 13,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="nump">$ 4,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">4,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="nump">8,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">9,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, Gross</a></td>
<td class="nump">23,169<span></span>
</td>
<td class="nump">22,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">12,707<span></span>
</td>
<td class="nump">12,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(7,553)<span></span>
</td>
<td class="num">(7,378)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(381)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (1,422)<span></span>
</td>
<td class="num">$ (1,400)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_IntangibleAssetsandGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_IntangibleAssetsandGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018861521968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>derivative_instrument </div>
<div>units</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>derivative_instrument </div>
<div>units</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>derivative_instrument</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="nump">$ 229,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269,000,000<span></span>
</td>
<td class="nump">$ 206,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">7,657,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,321,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">1,040,000,000<span></span>
</td>
<td class="nump">955,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">53,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">65,000,000<span></span>
</td>
<td class="nump">279,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="nump">319,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="nump">1,009,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">133,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">57,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">63,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="num">(19,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">8,467,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 979,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="nump">960,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember', window );">Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="num">$ (18,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember', window );">Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">170,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">319,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">604,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,009,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">170,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">172,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">319,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">319,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,009,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,009,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">213,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">299,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">972,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">$ 971,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">952,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ForwardCurrencyContractsTimetoMaturity', window );">Forward Currency Contracts, Time to Maturity | units</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">$ 168,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">132,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(29,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Netcurrencyexchangegainloss', window );">Net currency exchange gain (loss)</a></td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">3,623,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,235,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</a></td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</a></td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative, Term of Contract (less than)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeRemainingMaturity1', window );">Derivative, Remaining Maturity</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 189,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="num">$ (3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of Interest Rate Derivatives Held | derivative_instrument</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 2,673,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(69,000,000)<span></span>
</td>
<td class="num">(30,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(54,000,000)<span></span>
</td>
<td class="num">(23,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet', window );">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(19,000,000)<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ForwardCurrencyContractsTimetoMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forward Currency Contracts, Time to Maturity in Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ForwardCurrencyContractsTimetoMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Netcurrencyexchangegainloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Netcurrencyexchangegainloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeRemainingMaturity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeRemainingMaturity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018860887440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="3"></th>
</tr>
<tr>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>Rate</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,005,000,000.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,935,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,915,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ExclusionFromEbitdaForRestructuringCharges', window );">Exclusion from EBITDA for Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">457,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_LitigationAndDebtExclusionFromEbitda', window );">Litigation and Debt Exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,443,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Legal payments remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,424,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_QualifiedAcquisitionConsideration', window );">Qualified Acquisition Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 194,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from Issuance of Senior Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3,271,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_SupplierFinanceProgramObligationCurrent', window );">Supplier Finance Program Obligation. current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_LitigationPaymentExclusionFromEBITDA', window );">Litigation payment exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from Issuance of Senior Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,270,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember', window );">Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember', window );">Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_CurrentRequirementMember', window );">Current Requirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_ActualCovenantMember', window );">Actual, Covenant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember', window );">Requirement, as of December 31, 2021 and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember', window );">Requirement, four succeeding quarters following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fifth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, sixth quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, seventh quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember', window );">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain', window );">the 2018 Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 2,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember', window );">March 2024 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember', window );">June 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember', window );">March 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">979,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember', window );">March 2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember', window );">March 2029 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember', window );">June 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember', window );">November 2035 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember', window );">March 2039 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember', window );">January 2040 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember', window );">March 2049 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,067,000,000.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,986,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Finance Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2025NotesMember', window );">March 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,088,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,067,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028SeniorNotesMember', window );">March 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">816,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2031NotesMember', window );">March 2031 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">816,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2034NotesMember', window );">March 2034 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingAggregatePrincipalAmountMember', window );">the Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember', window );">the Offering - early redemption of combined aggregate principal SN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member', window );">2021 Revolving Credit Facility | Line of Credit | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_DebtInstrumentExtensionOptionTerm', window );">Debt Instrument, Extension Option, Term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember', window );">Euro Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember', window );">Yen Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 194,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember', window );">Renminbi Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash proceeds from Issuance of Senior Long Term Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DebtInstrumentExtensionOptionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Option, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DebtInstrumentExtensionOptionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExclusionFromEbitdaForRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exclusion from EBITDA for Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExclusionFromEbitdaForRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Legal payments remaining to be excluded from calculation of consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationAndDebtExclusionFromEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationAndDebtExclusionFromEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationPaymentExclusionFromEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation payment exclusion from EBITDA</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationPaymentExclusionFromEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio permitted by revolving credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_QualifiedAcquisitionConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Qualified Acquisition Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_QualifiedAcquisitionConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplierFinanceProgramObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplier Finance Program Obligation. current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplierFinanceProgramObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_CurrentRequirementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_CurrentRequirementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_ActualCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_ActualCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2031NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2031NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2034NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2034NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingAggregatePrincipalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingAggregatePrincipalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018876219536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 570<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted Cash Equivalents in Other long-term assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">763<span></span>
</td>
<td class="nump">529<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">$ 2,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Trade accounts receivable, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">2,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Allowance for doubtful accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charges to expenses</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Utilization of allowances</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">1,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangements', window );">Licensing arrangements</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other Assets, Miscellaneous, Current</a></td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">1,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_EquipmentFurnitureAndFixturesGross', window );">Equipment, furniture and fixtures</a></td>
<td class="nump">3,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Capital in progress</a></td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">5,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">3,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract', window );"><strong>Supplemental Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_IndemnificationAsset', window );">Indemnification asset</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OtherOtherLongtermAssets', window );">Other, Other Long-term Assets</a></td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets, Noncurrent</a></td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves, current</a></td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_AccruedRebatesCurrent', window );">Accrued Rebates, Current</a></td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">1,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued Royalties, Current</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes Payable, Current</a></td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other Sundry Liabilities, Current</a></td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="nump">608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AccruedRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AccruedRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EquipmentFurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equipment, furniture and fixtures Gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EquipmentFurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_IndemnificationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indemnification asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_IndemnificationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherOtherLongtermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherOtherLongtermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018875345104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate from continuing operations</a></td>
<td class="nump">29.40%<span></span>
</td>
<td class="nump">29.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">$ 501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874875616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for legal matters that are probable and estimable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior', window );">Brazil CADE - # of individuals for alleged anti-competitive behavior | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Brazil CADE - # of individuals for alleged anti-competitive behavior</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018870823536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 24, 2023</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Liquidation Preference, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred Stock, Dividends Per Share, Declared</a></td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874632640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">1,435,800<span></span>
</td>
<td class="nump">1,427,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">10,200<span></span>
</td>
<td class="nump">10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">1,446,000<span></span>
</td>
<td class="nump">1,438,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">4,000,000,000<span></span>
</td>
<td class="nump">4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018872189616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="num">$ (203)<span></span>
</td>
<td class="num">$ (198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">552<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(310)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales', window );">Impact of Foreign Currency Fluctuations on Net Sales</a></td>
<td class="nump">88<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,389<span></span>
</td>
<td class="nump">3,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">$ 1,252<span></span>
</td>
<td class="nump">$ 1,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">31.90%<span></span>
</td>
<td class="nump">31.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,280<span></span>
</td>
<td class="nump">$ 1,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">$ 2,049<span></span>
</td>
<td class="nump">$ 1,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">26.40%<span></span>
</td>
<td class="nump">25.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,110<span></span>
</td>
<td class="nump">$ 1,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement', window );">Revenues from contracts with customers, disaggregated - performance measurement</a></td>
<td class="nump">3,301<span></span>
</td>
<td class="nump">3,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember', window );">Total allocated to reportable segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember', window );">Corporate expenses and currency exchange [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember', window );">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">$ (110)<span></span>
</td>
<td class="num">$ (117)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impact of Foreign Currency Fluctuations on Net Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeAllocatedToReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income Allocated to Reportable Segments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeAllocatedToReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeUnallocatedToSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income Unallocated to Segment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeUnallocatedToSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues from contracts with customers, disaggregated - performance measurement - measures used by CODM to make business decisions, excludes impact of foreign currency fluctuations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Segmentoperatingincomeaspercentageofnetsales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment operating income as percentage of net sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Segmentoperatingincomeaspercentageofnetsales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018866401056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 3,389<span></span>
</td>
<td class="nump">$ 3,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,389<span></span>
</td>
<td class="nump">3,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bsx_NumberOfBusinesses', window );">Number Of Businesses | business</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">$ 521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember', window );">Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Endoscopy [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Urology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Neuromodulation [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember', window );">Interventional Cardiology Therapies | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_WatchmanMember', window );">Watchman | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember', window );">Cardiac Rhythm Management [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember', window );">Electrophysiology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember', window );">Cardiology [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Peripheral Interventions [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | APAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | Latin America and Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">1,154<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,154<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 956<span></span>
</td>
<td class="nump">$ 853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NumberOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Businesses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NumberOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_WatchmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_WatchmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140018874674688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">$ (35)<span></span>
</td>
<td class="num">$ (27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>bsx-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bsx-20230331.xsd" xlink:type="simple"/>
    <context id="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibc1ec8ea8b374d0f9b1e9578a88e69eb_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i988810e1696c4da3b18cc0a7b19cf868_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i112e69f95e3e4061b901b02e1a6de8a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i084ee228a45f4b7bb61fef97408d319a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idadc520412e74e82b77efd62c7563138_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d208a9bfbca47429c91e10ed844e600_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83010d83b2be4843a9ea73d6857ee43b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifcda9e1071cc41d1b93c4164824d0842_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica6363b1347143b687c646c7bb59890c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie4beb43815f44c8b975c46b4b7dcd066_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i96e1149027c4441c86624768b5319f84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52087d690e344eaf99a1374ee56c5df4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i79e80c25d9ef462985f4e0f891a5b5cd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e47b7f759564f6592973c4f4e05220f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe43718923134537b554888041f98acb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib78ee2c8696148b78cf12753cd58c0d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bbe8629ec3a41feb7b1b3879baf9550_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2fec5a384762417b96db579ad6bd03ad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3892319bf8004a208cbf25a606b4a2ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5b064580a3054b7d8d6931e0234eef25_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8922db963039472f89f06b87d8657844_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd4b8ebe7cc34378889bcc457b5e983e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18021923822a43228b64f5223b7421f5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ife464a07c09f41ecacbbec13eb93f31d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d52170be4f743378a4992e23d45569a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i519498f0b57b477a94d127c9d99d8c5c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib8039f48a66e437e86506c950f222249_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i550af412f2a94281896257850ac5c3cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10379de39e614c0bb89ed6c005f3c30d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if0f36ed1cf1547ba8293d1a829a2537e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7482b0cc18cc4cb5b95be5e301a03847_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia6a51d9fab43472e9dba2c8acb6cbee6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieec344c42ac640aaa2b967fe3886e028_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i657a9b55825b423f8043e4c0876ac4e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id2475a56a63d43499ecd47cd83f768cf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic86f00778306481a9e2dc5461c401ba6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2e1f4c4ff1e4eb6af4ba1ad9104b9e9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia31ddba351344e03b261775eff8755cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iff97cdf22f9541feb9bbf358623cd961_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bf26ed1cd4b4ca5b515533656d047c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide43a5e742264d82bcb232842cf9058d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i479f625a10cb442d893bd1055659f74b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i50b5bcfa88dc4695b6f53f461176ea44_I20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ApolloMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-04</instant>
        </period>
    </context>
    <context id="ibc8125bb5d9343a4aa4a0b3bea2a48af_D20230404-20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ApolloMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-04</startDate>
            <endDate>2023-04-04</endDate>
        </period>
    </context>
    <context id="i3bb00ce3cc2f43ed83cc43d46d7f4ece_I20230220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-20</instant>
        </period>
    </context>
    <context id="i0f1076c0e73c48b8b0c16cb99f3fffa9_D20230220-20230220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-20</startDate>
            <endDate>2023-02-20</endDate>
        </period>
    </context>
    <context id="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0ca73a484cd94f89b00ba120bfc589b5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i098c221da06c4b958585f779d2867c19_I20230220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">bsx:AcotecMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-20</instant>
        </period>
    </context>
    <context id="id93085ad25bc42338a5eab7de3e2cc41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99682e6da7ba40fab6c56eea230eec3f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6514d87e72ac4153a2523faf7d9b4ca6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i21630f12b7d5477cbc3cbb55360587fb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3c05ab454f604b7e938efdb8a3a9bedf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3aeee52d764f4a80911bef9fddad1874_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie4d69f63508e4a52a7d288bbf2fa5e41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86dca2ec31934d279f4e60c2ac7559cc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if3e100c180dc4202883a3c603581fbc8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AcotecMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie0216d912a174028acfdb839676e95d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3b304742c4c54945b75a66597634648a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i586764f8498244c29e88444e4724fcbf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1ad160e4bd8e4bcaae224e370af0b112_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BaylisMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1330d5e86f34de7b8796fe68b26f65f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AllBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic81d6dae3feb405fb58015de09433300_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e856d6687ec4e31a4d71bf973d3f28a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i50cbf9066de44563ae1182748610f8cc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86458492bffb48499c122917fa84b6b6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie0700cfd128447b2b2157afb226d4c49_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icfd41fe9b8c14589a6244f96d5d3a3a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if0bcfb39920f4c2784fb6593b98b240a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i94c92289dc0046e1b8af6587d9138ebb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied91f3fdd793487f8fafa2ef73d957a5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i75960dbfc53b4af29aeaf34569b6fa73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7064ffd3368f4eb3a7afa617f099937f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia4a460c2d84a40f2ab75d16a46ca5cf6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9902b3acea745368d2e51c9c3ed82a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib44c957fd74e4baeb93c089d85303850_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice6eb7f283e54256a9c5b643698ee72a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i72c98bbaa94e4fb39183b5fc22e895a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c826c5e16734ec89717f304d8a0b98b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie7783d7ba4b7469eb8012fe17848bea5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f826c50348c4250a015338b19792179_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i713c9dc3fe0f4edbb6508415483a74d7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a25af27795f4ad8995a221fef790ba3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i933e991579d346d98f5c6e3aef002501_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i437328dd08c04fb38d5a0b1b7015575b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ide57541620ac4f40b0aae359edea5b51_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ife05e78966de43f7831ac0435f16576a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idf9290bf261f4bbc88ca0dbf2972f8f8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i163d6247ba884128b6b3970a5d92963d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4daa711fa7aa43a598a5f35231e982df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b1a0b34b25746219cf0093a08066c29_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i916d03913e7d49e3a4641da09851e47e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i65e34a5fda334589af3a7f69f399f02e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icb8afe4953c841d8aa1dc82c3cacc365_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i260db5b023b64acb974aa51c8180c68b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaab5e7cbf2c543baa4c3f372a5dae6d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id43b656f9a51461296e0ba67c8f28cbc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9aa626542bcf4ab68ce0b85324fa5af0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88522e1e6ca14c4791fddea4df68cca6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i98a5103b5ac749c482317cc548c95557_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4353264371b04e91b16a346daea2114e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i604d52d7511a4332aafdb01088748afd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i783e008233514aabb69842649a72e8e1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9b13667e719d448990cfdf861dda79e9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5662554837084169851758271c9ea643_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfe2b43cff154363a0fbd139022c61e4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i988b6f2675a842b0bf177b07312667ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i533dcba4722d4149a322054e6c21ee4e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic842743075f046118858ebcc610ace3b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9a67240557664530a64b7331a50a1002_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1c9733ef28a84cab80420249d9e34d87_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3156378bfa9448c8b52d41d89ee9ce34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia66d194331bf40009415048dd898504b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0625121c73b44dba2d3eade5207ea87_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i07d1fca83b854131a110d8eddc52fb99_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i945f22e98cb74c1c921b309349665d17_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1ac0fa25ca3e402287e10a15580bdd69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dbe63612beb45b3af51e535c5506a1e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ce906fb637148c7bbedc7b9646ab929_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic29f210b79834812843eecfdcd89818f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i38524f4cd7624584aff36aaaa318766a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i898b0c24ec0d4089ac323f8880881ab3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i173913dc9a954a229c38034702d71dc5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3dc55f108fce475dbd810515e835da38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i51a5c614a81345d596f132ed31bd8119_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iafdb1c08d9594ebc81c23f84214e5a94_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64284d2d674f41c599406b01b23425de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b970c3c44be41b196e66ac05259c26d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bd7be06f3824d1989da8148901d8857_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied2485d2d4fc42b2b4036a2cad3a8e72_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9892c74d12a64698ac3adb3291ee7fff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifae34dead96b45bcaba914062e411b97_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i64d6aed0afb24247bf0a0818471c3a5f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i238dacb96f504855af458d65d8c5cce3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i227be4a1b97846078107b1f776038d7a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if03bea69ff7e4976a0b0e30e39be825e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i568fb51f289d40f6ba75256d02005ddf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i62061beaf669413399ee8f50383a8892_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd06220f00384ae1a2d2a575490aaa1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2338d944a80349399e24d2d75f5c59bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id2e5cf0d439f46b3b717276488fa7f9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15c4a58684af4de9a487717ee618db7c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e6c809593e643f1a097ae6dde04b29b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib14a9ce7ffb8424bafe5c3db543bd32a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i088272e4bb994960b019011fb46c0bcd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i329ce681993e4c38be14123408b7f068_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2dc024eaf21d42bc86c27732930f65b6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i312f5201ec3c474d9b5a19c25fa7259b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c3009e88a024e31b2102e6f4b8d5acb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i756598df01014441b201792edc1fde81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a479cf5286f46b28b355c4f1a206db6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0554d11e01874a65b0a89d983fc7a7a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d7028932f6e425aab12bf8635b89b38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc2b17f7d56a4b5aa6d7e274b8e3927b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i791d7b45dd054f389d7c0019d2f8803c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i67c3d756333b4be29340b18df8cd60c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2031NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i466b11229a244bf095c3c6d222c59179_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i67d72460629d49a5bfd6e1d207d392c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2034NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf8331296051435fb2a207702eabbbd7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i90ed1700e1b14f63b822bf214bf1ce6e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7750de1d7104c23afc566121d84f163_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4fae5b08170b41889f5b3dedb667c496_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i960943048d6b4bd9ba267c6e877a0a08_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f0b0dd532a74f04a579435e6746d19e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fc300f5c54f4bb08de690a8b948588e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieb6225368867454f86259df1ee8ed4f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a33141a69104417b94015557d906a3c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9e31ad2072de41b69ce29a3a8a2beccb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i77928e50ff7a48e385018d59595b61eb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i88b7c20939ab4f34a1fa7424a5d6d03f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib94a53ec039740fa8792e11ae883a02c_I20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="i31562662eb6547fe95ffff0dfca2001c_D20210510-20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-10</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="ie74fb9edc1e54a079f786a420c2ee7ef_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib16e6c7d489f4c34bf5a29a3c06aa219_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if1c5d438e1c44a81b2540ede941cd82f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id82f0c35a27940c9ae9176b5aeb5e9d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7d9caf21868444e99250f18158da8bab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iac1e88fabb7b45c9855c38e764079bc7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8202332b83334006af73c7c6ce87639e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie8e5721798f64931ab7f86adf91517af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1db4cf9dde84158b7c54dd06393c41d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c5612e005724c8d8c4db7a76f3396e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6fd64d7c247c409fa4207f722c6c224c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id5c8a81e01b64601bd86cd95599e9025_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i33b1a47c2971475a887f95d6f09d61f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingAggregatePrincipalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i093f5b3abdd745f1a8241d0453842764_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i561fec84ddc04b59a8105f1d9d8ac489_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i703997e880b841bf912c19d2455d4f77_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0e8b97cc2e8d4eb88ae1bdfe5cc6884c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib453388f5f184e4a82c28c4a8350b8bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1d7c0732e164ffa8188acb478deb5c8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ice1cde59638b4723b05549750c61c718_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99eaf8749fec4bd4bef896df3b9fd8c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i40a0ea6834ac41f1b607a21df3a62801_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia218bd3302d5488a916178d33c82b82b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i801c5c1c6a2442c086808723bb7fc47b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib6c9ebfb99fa4dfeb3304751f22498b5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i924e9479e6bf4f81906b0781426a7ba1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i524c7cd3f2f6432d98a7ae708c5f5aca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4d88790c2af246f9a293243672a14f79_D20230131-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2023-01-31</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i5c8184b4c8c243b8af7637900054690c_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="ib7f86060f0074e3fa81c9253f3234640_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i95ef2210d01348d08fdd30f6ff1570b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i21deea3483f54e3b81ef33228bfe3f5f_D20230424-20230424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-24</startDate>
            <endDate>2023-04-24</endDate>
        </period>
    </context>
    <context id="i729502d0e5784f61982c93b93148e4fb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib25a90bd0f1c4959a574e6b17d6a6895_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieb4decd76ac944aba2576f8d09ebafe2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia920d3162ecd41e8890b68584ba18ffd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i84eb384121c84b858baf58516ec1fe4a_I20201214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="ia353d52644074339b237aca193b8b1e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i892e1507c0f84e27b277daf33bcc248a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iabd1740aa87b4096a3a080290bcc5749_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i720152cb93a648a2bb7df641008979ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1209edcbb30e47fa9c4fb81d208f7e6d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic1262f85d5444afeb2e8bf8a337371ed_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1ae924fcb6454d58b1beb6db9683dbdd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3179b68ff7d44c6494abf26a8009b478_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib2beece93d3c417d868a8435ec76e880_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3c68fb8458984a4f8ea9ffdd46d5ea2c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i49e2cf8c97fd4c64965a5f6aa819f9e4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id347fa0ecf034855bd36b1bc5861689f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1dc12ab5d66c4eb2b1365bc49a5014fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie71b6743f2b6457e8bf78a9b44e1408a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b43f39a384c40b3a17cb49b4126801d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20046af1ade34a1bb48b675de0ca23e5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib9d8827599584437aad144dac6477fee_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3cc3815af2cc4d4a9f6872e38a324d73_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9ddbe086cb5145cd83bb64b7179f7739_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id4b5346710804266aa4d620df4bb34fc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3e204df240ac4042a4b13bf6f20f5c4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i096721fee95e47b791ea57339f0c6c6e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0f00f6a7bb3544d58920179cebba0281_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie96d08ce6f50458ab49816d256c5879f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0790d1be80ae447488c9e5a9fc97437c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78a866861cad402094fd324c25ba0ee9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3cdc59667be948b992bcf7274af8504f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iff459ba706d649ddbd4ec72d239941dd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie3e41fa3eab7468c8b4e91101c3d9016_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib57c51fa109d491fbf453b46c2cf46ca_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idefdec8766de4485b6cdc952038f1024_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f524aabbb214853af93224fac9bf26a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7c333bda857d4e739b41fed616fa6e68_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i18982ae6885f4b8198ee1ce626bc22fd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib01b2243c2754130a4e2ed20fe142983_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i73e952a467484badaea6d0b16ca1fa44_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife24678eb6c34b28945046363ea2e300_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:InterventionalCardiologyTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic784b1fc58dc49f699ae6044fe608256_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib93ae74b5a9e41fdbaa62e517659928e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i08294063f673491c88ed513f79e9696f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i943d4120b79b4e69b07762eaf7b26e21_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6096985306aa4386b7ea6027c25d855c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3410600120b47b5bfe3ab5c48f59e1c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:WatchmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if02e957943204cfb9fb85d6b73a32689_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie616f026675d4c09a0ac3e6282f05cf8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i38f221dbc7b741d79383b223f9e27c7b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i26380f708b9e4841930b61b187def315_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iee563d35506f470b9f10eb39f4283205_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib8d8f220044d42889463ea08e1cf165b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:CardiacRhythmManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0e0c54cf535041beb749a2a1df797e45_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5556344fb56743dbae6d822773174a4a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i28b59b162ea849ca9be28f0f9fa67f2d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i078220c195b64332b042b94c0d76ab95_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd1c2ac83d1f46a6be7dd082708aa903_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3c352b4948b8481485df395a9cc353c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:ElectrophysiologyEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i10971b0415014c579cc2dbb8f66240e4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7961173213db4f5d91d6d2e7211fd02c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2f0050baa10746afa4706c455030ba41_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i829d668e2b3c49fc845a7c3a6cdd828c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3889e23d356499d9f44ad951bed2120_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb44bd7e5a5c407ebc133a722c9a1308_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCardiologyReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i03e6d0e45f264ed697fcf267f645c2fc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie4503a934cd0405d9071461ef9d0b03c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iad755ea2c6d3473d8e3a08e615f25c1b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3068a1c629b847b3b49438fc4cb80ef1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8b5eca007cb54f15afd6e2c739116757_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id9688a45fc2049beb9a82a633381002e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5422ebead84c4ded81dca3fef4d9458f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i844a962b3a3d4374b6d7ab653485bcbd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie73f4b2c0cdd4b4d86b93f555d5f2835_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i95a6956ee87544c1ad636a7500e3ef26_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2cb98bc5824349e0a016e837ad7726b5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic937499f758443ae828dea9b24a41dba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i510c5d8a3423489a9deb5ae4f8f2de17_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3fc93a4a42604befa962d6c0f4e94d6e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica31a05afc6142cdb6e3553ebec68348_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i89df95595aa24a1c9855a94a80a41df0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f896077c40e4dbabd217e2aa1f4c9a5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7bba908d72404714bf08fea400279688_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f4f8c9dec7f4aec8d00394ff1f2c185_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieffcfd57b85847f5b9ac168b84a7fb47_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d805dfd29434cc483bf10e47f598abd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i975a78bf3f974f3d82fb89c8f671b311_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4dc7a3a9179c4bee8cc766a1114c8a59_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6264f6b9421a4ec4a9454dbc24c596cc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="krw">
        <measure>iso4217:KRW</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="derivative_instrument">
        <measure>bsx:derivative_instrument</measure>
    </unit>
    <unit id="units">
        <measure>bsx:units</measure>
    </unit>
    <unit id="reportablesegments">
        <measure>bsx:reportablesegments</measure>
    </unit>
    <unit id="business">
        <measure>bsx:business</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl8zLTEtMS0xLTE5MDkwMA_90f54358-ecb9-47be-a7fb-9fd571c35636">0000885725</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl80LTEtMS0xLTE5MDkwMA_d6452de4-11a3-4e5f-b321-c2aadd21610f">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl81LTEtMS0xLTE5MDkwMA_426111ba-9d3e-41c0-80da-5bc968ad9bef">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl82LTEtMS0xLTE5MDkwMA_6d302b1a-d2a5-4c8e-bb12-d7a5028dcbb7">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80L2ZyYWc6OTNlYzcwMDliNmQwNDAwODhjOTgzM2FjNmRiMDgxOTAvdGFibGU6MTJlODAyMmMxZjNkNDhiMWIyOGNlZTI1ZGJiMjIwZWIvdGFibGVyYW5nZToxMmU4MDIyYzFmM2Q0OGIxYjI4Y2VlMjVkYmIyMjBlYl83LTEtMS0xLTE5MDkwMA_ca0614e2-7c36-45b5-aefd-e9cfa38aa208">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA1_58c3106e-5487-4e22-8fa6-9abf532771e2">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6YWU4YzExYjgzZTE0NDhkYzkwYTc3MWIyZGRhZDUyODkvdGFibGVyYW5nZTphZThjMTFiODNlMTQ0OGRjOTBhNzcxYjJkZGFkNTI4OV8wLTAtMS0xLTE5MDkwMA_4297bc37-a7e4-4e9d-bdd7-c89f42e81d1c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8xMjA_09ca490d-fa99-4803-a981-d69ba4bd0fa4">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6OTY0NTE0MDU4NTdmNDNhZTg4ZjllODBlNmM1ZGNiZmUvdGFibGVyYW5nZTo5NjQ1MTQwNTg1N2Y0M2FlODhmOWU4MGU2YzVkY2JmZV8wLTAtMS0xLTE5MDkwMA_275e632f-f555-4933-bbda-186ed5fdffa8">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEw_26439fe7-7691-4d96-851e-54fbed352bdd">1-11083</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEx_74fdedff-be60-42c3-abf8-7fd833e6c578">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6Njc4NjUxZjhjZDQ5NDllMmI5OTUwMWNmMGQ4MzRhM2YvdGFibGVyYW5nZTo2Nzg2NTFmOGNkNDk0OWUyYjk5NTAxY2YwZDgzNGEzZl8wLTAtMS0xLTE5MDkwMA_9ca6deeb-dd06-4f8b-a512-c0f64e9ebe64">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6Njc4NjUxZjhjZDQ5NDllMmI5OTUwMWNmMGQ4MzRhM2YvdGFibGVyYW5nZTo2Nzg2NTFmOGNkNDk0OWUyYjk5NTAxY2YwZDgzNGEzZl8wLTItMS0xLTE5MDkwMA_c2a647e4-6d44-4f0c-b96f-5cfceedbaad0">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA2_89575c21-083c-4136-8eb7-2054a3a922c8">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA3_ebadd50e-b810-47b3-90d4-5c9d76e52473">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEy_15e62344-8782-4677-b1c1-67cdb6a9f026">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDAx_0d4c3d30-8ef1-4b41-8585-c5fd623d7dc5">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA4_aad7cf8a-4ce3-4f6d-b0bc-7a7c54b807b7">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDEz_2123a617-8e29-4b6f-9152-a415530fe99d">683-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8xLTAtMS0xLTE5MDkwMA_a5e35047-fee6-4649-b90a-311ed4513247">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8xLTItMS0xLTE5MDkwMA_e62245ad-ae3e-4be0-a7b3-cdb5f8f2685a">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i241df491a83746aa8a2e623cf050b41d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8xLTQtMS0xLTE5MDkwMA_eb95bbcd-4aa0-4af1-8721-c0a1e3c36dc6">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8yLTAtMS0xLTE5MDkwMA_e42e08ce-2f85-488f-98a1-f58523a67a76">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8yLTItMS0xLTE5MDkwMA_8c6119c8-b373-4642-94bc-fbb174d859a2">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ieeba3c95978f445c97ae5cf61e71169e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8yLTQtMS0xLTE5MDkwMA_e04aef53-b5a0-4abe-8551-cd406a7151f2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8zLTAtMS0xLTE5MDkwMA_bccf9afb-ba54-4e5f-af4b-263367f72544">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8zLTItMS0xLTE5MDkwMA_baa76ba9-ac8a-4103-bcad-3db3454571b4">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDExMzUwM2I4ODI1NGE0ZjgxNWU3MmQ1Y2FhZGE1OWIvdGFibGVyYW5nZTpkMTEzNTAzYjg4MjU0YTRmODE1ZTcyZDVjYWFkYTU5Yl8zLTQtMS0xLTE5MDkwMA_8fdc917e-62f0-4872-a152-1fa74203a3d6">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDA0_39eea763-84eb-4181-9d9a-0f74baaa7d6a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDAy_edc10973-5ca0-4c26-994a-8fd966cbe15b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDM0ZTk2OGUxZmU2NGU1MThkOTgzYmIyZWMzMmFmMTQvdGFibGVyYW5nZTpkMzRlOTY4ZTFmZTY0ZTUxOGQ5ODNiYjJlYzMyYWYxNF8wLTAtMS0xLTE5MDkwMA_f65a95ba-38e9-49b8-a148-3b346d232233">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDM0ZTk2OGUxZmU2NGU1MThkOTgzYmIyZWMzMmFmMTQvdGFibGVyYW5nZTpkMzRlOTY4ZTFmZTY0ZTUxOGQ5ODNiYjJlYzMyYWYxNF8xLTMtMS0xLTE5MDkwMA_5e4e4c3b-0fc2-40f0-9394-d042a7fd301f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGFibGU6ZDM0ZTk2OGUxZmU2NGU1MThkOTgzYmIyZWMzMmFmMTQvdGFibGVyYW5nZTpkMzRlOTY4ZTFmZTY0ZTUxOGQ5ODNiYjJlYzMyYWYxNF8yLTMtMS0xLTE5MDkwMA_ab5e586f-d15c-427b-9e28-328f904626ad">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8yMDAz_4fdd04be-96a1-4c6e-a312-301409e9b774">false</dei:EntityShellCompany>
    <dei:EntityListingParValuePerShare
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8xOTYy_1213641e-c4cc-49bf-8ee8-92e1f304eb3f"
      unitRef="usdPerShare">0.01</dei:EntityListingParValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ibc1ec8ea8b374d0f9b1e9578a88e69eb_I20230428"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xL2ZyYWc6NDkyYjYyN2YzNDFiNDFlNTgwMWFhMWY5NWFmYmU2YTQvdGV4dHJlZ2lvbjo0OTJiNjI3ZjM0MWI0MWU1ODAxYWExZjk1YWZiZTZhNF8xOTk5_c31e140b-b819-4539-a99e-e71b71fea8ba"
      unitRef="shares">1437698101</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMy0xLTEtMS0xOTA5MDA_a1b7245a-68c0-4aa6-9702-5d9c69514baa"
      unitRef="usd">3389000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMy0zLTEtMS0xOTA5MDA_48df2a06-27d8-42ac-b8b8-8f2e135c377f"
      unitRef="usd">3026000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNC0xLTEtMS0xOTA5MDA_fe07021c-af01-4747-ab07-b0d2741a4301"
      unitRef="usd">1040000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNC0zLTEtMS0xOTA5MDA_250919c6-14aa-42be-bf15-555f53ab0adc"
      unitRef="usd">955000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNS0xLTEtMS0xOTA5MDA_b7416a25-c404-4dc5-93be-3bfd7dc9922a"
      unitRef="usd">2349000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfNS0zLTEtMS0xOTA5MDA_411af54a-4429-426c-ba0d-02dcf472df2a"
      unitRef="usd">2071000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOC0xLTEtMS0xOTA5MDA_43cd86ee-ae56-4be7-ae9f-aef7d70780df"
      unitRef="usd">1215000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOC0zLTEtMS0xOTA5MDA_c52d1d5c-fb33-42c5-8b81-efc67e873c2e"
      unitRef="usd">1060000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOS0xLTEtMS0xOTA5MDA_51769dd9-29b5-4b29-b0a6-a6ad7fa31753"
      unitRef="usd">337000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfOS0zLTEtMS0xOTA5MDA_e54ac776-ae80-4d25-a5d2-16b12eaafe71"
      unitRef="usd">319000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:RoyaltyExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTAtMS0xLTEtMTkwOTAw_193b4c43-c4d6-468e-9d01-d9d912df9caa"
      unitRef="usd">11000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTAtMy0xLTEtMTkwOTAw_f25a4c59-0047-4757-a14c-69489f9c6c5c"
      unitRef="usd">12000000</us-gaap:RoyaltyExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTEtMS0xLTEtMTkwOTAw_329bc664-19b3-4471-bafc-f5376467f6aa"
      unitRef="usd">203000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTEtMy0xLTEtMTkwOTAw_a194df8f-8ce3-4ed7-b7c9-50bc9cc178a7"
      unitRef="usd">198000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTQtMS0xLTEtMTkwOTAw_42bbf697-c5b2-4444-84a9-d11b8ea3e76b"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTQtMy0xLTEtMTkwOTAw_7657d510-02cb-4202-a40b-8d4bd709e834"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCharges
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTUtMS0xLTEtMTkwOTAw_83573916-dbd1-425b-9c9b-08099677ea2d"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTUtMy0xLTEtMTkwOTAw_7acb73fb-df4e-4924-82d6-839a73910a6a"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTgtMS0xLTEtMTkwOTAw_43bc5d7b-8796-424b-abbb-c99179c0ce12"
      unitRef="usd">1797000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTgtMy0xLTEtMTkwOTAw_27776946-6545-4a4e-b29e-1f685d367c1a"
      unitRef="usd">1605000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTktMS0xLTEtMTkwOTAw_dcb620b8-6fe7-4fb4-9c22-22952ecafd68"
      unitRef="usd">552000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMTktMy0xLTEtMTkwOTAw_15aea8b8-667c-4ed6-b937-9177c8d0f78c"
      unitRef="usd">466000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjItMS0xLTEtMTkwOTAw_9a76d258-db44-4f31-881a-69088d07036c"
      unitRef="usd">65000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjItMy0xLTEtMTkwOTAw_354c7682-951b-440f-ba55-4bb482a0f1f7"
      unitRef="usd">279000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjMtMS0xLTEtMTkwOTAw_f16d8eac-cc2e-4272-8105-424a2f5a01ca"
      unitRef="usd">-43000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjMtMy0xLTEtMTkwOTAw_c3704d91-b57a-45db-9dc4-2406ff7f84e7"
      unitRef="usd">-31000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjQtMS0xLTEtMTkwOTAw_644f3d8f-fd6b-4ef8-bcf6-2d364451c8ed"
      unitRef="usd">444000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjQtMy0xLTEtMTkwOTAw_cde1a182-d2ee-4615-85d6-56fdf6f6baf2"
      unitRef="usd">156000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjUtMS0xLTEtMTkwOTAw_e23d01e1-2d1a-42d2-9baf-bd3050c3f733"
      unitRef="usd">131000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjUtMy0xLTEtMTkwOTAw_f11fe47b-5ba8-4ae1-acb5-b1abc3853ecb"
      unitRef="usd">45000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjYtMS0xLTEtMTkwOTAw_f1787460-5268-4352-a0ae-c09b45ec0105"
      unitRef="usd">314000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjYtMy0xLTEtMTkwOTAw_ceaf1812-609a-4f4d-888c-fe47738c5cfd"
      unitRef="usd">110000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjctMS0xLTEtMTkwOTAw_b326dba5-8ab4-479c-8c35-7c45bc4cda42"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjctMy0xLTEtMTkwOTAw_9987c680-3f21-4ce5-b81f-5a10f6ea3f00"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjktMS0xLTEtMjEzODcz_bff3f0d2-165b-4609-a3ae-d4bbe7935c56"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjktMy0xLTEtMjEzODcz_80aa467e-7263-4042-98c8-d6200a5cdb35"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <bsx:NetIncomeLossAttributableToBostonScientificCommonStockholders
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjgtMS0xLTEtMTkwOTAw_355f9ad3-bacb-4020-bc07-99f0a443cddd"
      unitRef="usd">300000000</bsx:NetIncomeLossAttributableToBostonScientificCommonStockholders>
    <bsx:NetIncomeLossAttributableToBostonScientificCommonStockholders
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMjgtMy0xLTEtMTkwOTAw_65f7d587-1c0b-4f7e-b5ce-f5ddda048057"
      unitRef="usd">97000000</bsx:NetIncomeLossAttributableToBostonScientificCommonStockholders>
    <us-gaap:EarningsPerShareBasic
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzAtMS0xLTEtMTkwOTAw_09869312-1242-40bc-8e66-8a8d25d710e5"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzAtMy0xLTEtMTkwOTAw_e7c102ea-e010-47cc-a206-d566046fbd8c"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzEtMS0xLTEtMTkwOTAw_d2c7a8e2-3674-4a94-b67f-03fb55a87973"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzEtMy0xLTEtMTkwOTAw_17c13657-aede-4ee3-a23f-3514486f07f7"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzQtMS0xLTEtMTkwOTAw_e341ed4a-e7cf-4720-95ad-bff58593a76d"
      unitRef="shares">1435800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzQtMy0xLTEtMTkwOTAw_2057ff1d-9b03-401d-9381-4d0efa14bde3"
      unitRef="shares">1427800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzUtMS0xLTEtMTkwOTAw_c5fb5842-a199-4545-8dc7-3e4ea347b41d"
      unitRef="shares">1446000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xOS9mcmFnOjI1MzFmMjkzYzNiOTRlYzdhMzg4OWI3YzA3ZTZlYzY3L3RhYmxlOmMzMTJmOWY3YjY1YjQxMjdiMjg0ODIyZGI5MGM4ZTc5L3RhYmxlcmFuZ2U6YzMxMmY5ZjdiNjViNDEyN2IyODQ4MjJkYjkwYzhlNzlfMzUtMy0xLTEtMTkwOTAw_1a3f809e-585e-46da-a693-0bcb0cd626bc"
      unitRef="shares">1438400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMi0xLTEtMS0xOTA5MDA_f1787460-5268-4352-a0ae-c09b45ec0105"
      unitRef="usd">314000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMi0zLTEtMS0xOTA5MDA_ceaf1812-609a-4f4d-888c-fe47738c5cfd"
      unitRef="usd">110000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNC0xLTEtMS0xOTA5MDA_dd7b95ba-1fee-4a98-8eff-fc69cfb34c06"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNC0zLTEtMS0xOTA5MDA_1ff23a7f-12bb-4e49-8921-e98a11494dae"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNS0xLTEtMS0xOTA5MDA_362014a3-c54b-4b53-babd-01728298a5b4"
      unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNS0zLTEtMS0xOTA5MDA_d9e3b17b-1c97-4209-b215-f6f97e7e0427"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNy0xLTEtMS0xOTA5MDA_7aa92dfd-4bed-4a79-ad49-8fbb098f3852"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfNy0zLTEtMS0xOTA5MDA_acf35cc8-67c2-43a1-9003-ebd9ba16662a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOC0xLTEtMS0xOTA5MDA_ac12faec-3dfe-4e21-b8b1-a6847086f91c"
      unitRef="usd">-91000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOC0zLTEtMS0xOTA5MDA_f39f491e-2b8e-4006-bb24-b3b40cd9c71e"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOS0xLTEtMS0xOTA5MDA_12243445-414e-401e-8781-49b0daea3e3d"
      unitRef="usd">223000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfOS0zLTEtMS0xOTA5MDA_13a0db0e-09e8-4dba-9112-8ca11e3b59a3"
      unitRef="usd">69000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTAtMS0xLTEtMjA0Mjc2_aa26840f-145f-45d1-a14e-e6419efb51cf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTAtMy0xLTEtMjA0Mjg0_5cd1d855-9999-4abd-b26e-5e0e8520ef33"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTEtMS0xLTEtMjA0Mjc2_3bb0a7e4-9d76-47d9-866d-b27117be2971"
      unitRef="usd">223000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yMi9mcmFnOmJiZDQ4MGIzMDNmZDQ4M2U5ZWQwMGE2YzRhNWVmMTE2L3RhYmxlOjcyZWI5YTBmMTUzNTQ4Y2I5ZDdlMjJiMzFkMmNhOTQ2L3RhYmxlcmFuZ2U6NzJlYjlhMGYxNTM1NDhjYjlkN2UyMmIzMWQyY2E5NDZfMTEtMy0xLTEtMjA0Mjg0_39045199-d018-4893-b496-4659f06e9acb"
      unitRef="usd">69000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNC0xLTEtMS0xOTA5MDA_a3f851be-acd1-4cc9-8d1d-aee7ae265019"
      unitRef="usd">570000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNC0zLTEtMS0xOTA5MDA_9e25bd26-f147-4006-93bf-772a1d72d370"
      unitRef="usd">928000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNS0xLTEtMS0xOTA5MDA_172a1097-7156-4551-be0c-0294cb17d671"
      unitRef="usd">2076000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNS0zLTEtMS0xOTA5MDA_187ce7cd-9d5c-4cea-8c06-f90d1a8c7019"
      unitRef="usd">1970000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNi0xLTEtMS0xOTA5MDA_e83d32de-efb3-4610-a692-1c3dcc5bb2e2"
      unitRef="usd">2050000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNi0zLTEtMS0xOTA5MDA_205fa99f-f4dd-4987-bbdd-40fc8d2746f6"
      unitRef="usd">1867000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNy0xLTEtMS0xOTA5MDA_80d8249d-5785-4c8f-b652-26a48e8f384d"
      unitRef="usd">296000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNy0zLTEtMS0xOTA5MDA_4d963b7f-8774-4e96-b6c9-8e8737f6ac8f"
      unitRef="usd">264000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfOS0xLTEtMS0xOTA5MDA_656cb860-6275-4542-8fd5-490b79fc86cf"
      unitRef="usd">711000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfOS0zLTEtMS0xOTA5MDA_5a200384-2e0d-445c-8007-0a7f1ed058be"
      unitRef="usd">731000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTAtMS0xLTEtMTkwOTAw_cad188ee-1be7-4870-bb97-f5521c324866"
      unitRef="usd">5704000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTAtMy0xLTEtMTkwOTAw_97c70ce9-d36d-4bba-a665-02f13bfc5a3a"
      unitRef="usd">5760000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTEtMS0xLTEtMTkwOTAw_70459911-14a1-4569-9f25-36803ae14adc"
      unitRef="usd">2478000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTEtMy0xLTEtMTkwOTAw_49149d3d-f5b6-4761-a100-4ef9885d44f1"
      unitRef="usd">2446000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTItMS0xLTEtMTkwOTAw_2b32bcc5-8f5b-4240-a9ec-8009e259f4fa"
      unitRef="usd">13269000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTItMy0xLTEtMTkwOTAw_35bc769e-f733-48cb-8f0e-8d07bc2ae168"
      unitRef="usd">12920000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTMtMS0xLTEtMTkwOTAw_93da46b3-01ae-4580-a92e-126d31874737"
      unitRef="usd">6060000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTMtMy0xLTEtMTkwOTAw_9c78c2f3-a622-4b3a-b245-0dd192c68aa1"
      unitRef="usd">5902000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTQtMS0xLTEtMTkwOTAw_e0cb44b0-bd73-486b-af6f-5e7bd923e22b"
      unitRef="usd">3900000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTQtMy0xLTEtMTkwOTAw_617685c5-18f0-4877-99a1-1976f031d3c6"
      unitRef="usd">3942000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTUtMS0xLTEtMTkwOTAw_4c573ded-30cb-46b1-91ee-d6daeda42cbf"
      unitRef="usd">1482000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTUtMy0xLTEtMTkwOTAw_7b05d348-e3c8-44c9-8f64-be5ff3d369d9"
      unitRef="usd">1500000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTYtMS0xLTEtMTkwOTAw_7ce19842-93e1-49e9-b1f0-51d43a28ad09"
      unitRef="usd">32892000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMTYtMy0xLTEtMTkwOTAw_eef1f5de-d33f-497a-be5f-4020fabd1145"
      unitRef="usd">32469000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjAtMS0xLTEtMTkwOTAw_6dbe0254-45d2-4909-ab77-a3be641affb6"
      unitRef="usd">510000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjAtMy0xLTEtMTkwOTAw_f4d9e20f-80f5-442c-a0a2-8d51ecf3f9e0"
      unitRef="usd">20000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjEtMS0xLTEtMTkwOTAw_294b5328-c280-40f2-91a1-b0e215282e58"
      unitRef="usd">868000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjEtMy0xLTEtMTkwOTAw_974be403-a615-4a59-a387-d2520ebd10e3"
      unitRef="usd">862000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjItMS0xLTEtMTkwOTAw_fcceb9c9-e876-4658-9cad-f5bc8c52cf94"
      unitRef="usd">1918000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjItMy0xLTEtMTkwOTAw_e34dd29b-a130-466a-9d83-dd90e39ef525"
      unitRef="usd">2160000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjMtMS0xLTEtMTkwOTAw_e286facd-8f41-4cf6-ad2c-831dfffdaa98"
      unitRef="usd">787000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjMtMy0xLTEtMTkwOTAw_88eb6f54-3046-4fe3-84b4-1010eb8508ac"
      unitRef="usd">761000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjQtMS0xLTEtMTkwOTAw_c9b4058e-b736-4189-ae60-1e347879845d"
      unitRef="usd">4083000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjQtMy0xLTEtMTkwOTAw_2cf34e8e-236d-42da-93ce-144287ee7906"
      unitRef="usd">3803000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjUtMS0xLTEtMTkwOTAw_a446cb3d-79e4-44f7-add8-6adf648891ca"
      unitRef="usd">8495000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjUtMy0xLTEtMTkwOTAw_4e5074ad-65b2-48c1-928b-09ca691ea003"
      unitRef="usd">8915000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjYtMS0xLTEtMTkwOTAw_1baa34c0-8ea7-476e-b4bc-ede9e940883e"
      unitRef="usd">210000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjYtMy0xLTEtMTkwOTAw_32b92c68-2e2b-4d41-9b2f-d97ff8c75b3f"
      unitRef="usd">144000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjctMS0xLTEtMTkwOTAw_4336c5be-7cd6-4086-acb2-059dd314ba2a"
      unitRef="usd">1995000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjctMy0xLTEtMTkwOTAw_fc2989ce-d1b2-4491-a24f-20bff54d83f0"
      unitRef="usd">2035000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjktMS0xLTEtMTkwOTAw_8e1eae3a-8e7e-4333-9ca4-e0b1ab6add46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMjktMy0xLTEtMTkwOTAw_b8d454d7-a743-4a34-b61d-b09a2a571ffe"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfMjE_04069b73-0ba7-4f1e-9341-cb6b43539ee2"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfMjE_acaeeb5e-9b25-49eb-925d-7ec6d0363bd6"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNDc_930cdab0-d6d5-4357-9c40-ab02fedaae60"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNDc_dd91a30d-c7eb-4f75-9650-021687e74649"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNjY_15a7b00a-b5f3-479d-958f-e5e447b432cb"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMC0xLTEtMTkwOTAwL3RleHRyZWdpb246NDA1ZTJiMWRiMzRjNDE3NmIwZmQ1YWFlNjM2NGYyY2VfNjY_38f33198-585e-4f0f-8d98-621bc3d10100"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMS0xLTEtMTkwOTAw_d09820ae-9edc-48b9-947a-b8338c242739"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzItMy0xLTEtMTkwOTAw_cebd71db-7f1c-47b9-aa63-d5d8343e8296"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfMTg_426048c0-9485-4a48-9e5b-ebdd8de1bb9c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfMTg_e3f37f63-a634-4a87-aac1-0ebc5339db2f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfNDQ_1981ac40-f733-4895-ad07-adb5838b9b7a"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfNDQ_f99949aa-f6f3-40bb-9f92-d0e9b6e4e84c"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfNTQ5NzU1ODE0MDQ0_3d4ce748-11fe-4985-bd35-82719f8317eb"
      unitRef="shares">1700828873</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246OWNjOWI5ZjE0YWYzNDE0MzkzOGYxMzBlNWVkMjBhMzZfMTAy_934d7d64-7451-4092-ae28-aa7c2ed65fe6"
      unitRef="shares">1696633993</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMS0xLTEtMTkwOTAw_5782d451-dbb1-4d5f-a190-afb3f515aab5"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzMtMy0xLTEtMTkwOTAw_1aea7773-49b8-4151-8a5b-0f0d245885b1"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246YzVmZTI0YTJkOTA5NDMzOTgyNDczZDhjNDM0Njg4NjhfMzA_97a6d4de-340c-483c-adb3-ba5666fd5a73"
      unitRef="shares">263289848</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMC0xLTEtMTkwOTAwL3RleHRyZWdpb246YzVmZTI0YTJkOTA5NDMzOTgyNDczZDhjNDM0Njg4NjhfMzA_d668475a-218b-436f-a581-e75c12e231a5"
      unitRef="shares">263289848</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMS0xLTEtMTkwOTAw_3036e4d2-e7ef-41e7-98f9-31f824540892"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzQtMy0xLTEtMTkwOTAw_5fb89591-d2a8-46f4-8663-760d63b61160"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzUtMS0xLTEtMTkwOTAw_76aa1949-1c9b-476f-a9c8-49ac452b5fbb"
      unitRef="usd">20356000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzUtMy0xLTEtMTkwOTAw_f996aa4b-57a7-41a4-a8c9-5df63b62212e"
      unitRef="usd">20289000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzYtMS0xLTEtMTkwOTAw_9b4bf53d-9356-49db-9c4a-c7bc3d723627"
      unitRef="usd">-450000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzYtMy0xLTEtMTkwOTAw_0cc41653-6c97-404d-a644-4ff714dafd9f"
      unitRef="usd">-750000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzctMS0xLTEtMTkwOTAw_3f657852-bb5d-497f-bed9-55a95d131f97"
      unitRef="usd">178000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzctMy0xLTEtMTkwOTAw_cfd2ea7f-0108-45c0-b3d3-932e919dfe44"
      unitRef="usd">269000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzgtMS0xLTEtMTkwOTAw_db0dbb8c-a468-4737-8145-0ffaf538ab58"
      unitRef="usd">17850000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzgtMy0xLTEtMTkwOTAw_ca67fe7e-2d39-4fdc-a84f-589bc445b1a8"
      unitRef="usd">17573000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMS0xLTEtMTkyMjg5_e1aea8b5-82ae-4404-9d0f-21ac17512a3e"
      unitRef="usd">259000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMy0xLTEtMTkyMjk3_8ad91a68-4ccd-4ba0-bd16-b2b3b90133d8"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNDAtMS0xLTEtMTkzMDQ3_c9f87448-98b6-4754-ac72-d69cd4d659a0"
      unitRef="usd">18109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfNDAtMy0xLTEtMTkzMDM3_6f46721f-38c7-46dc-8de9-a33214fb2995"
      unitRef="usd">17573000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMS0xLTEtMTkwOTAw_a6e7c76c-08fe-4bb6-a5d8-e6d1de87052f"
      unitRef="usd">32892000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yNS9mcmFnOjViNDNiMzg0MDhmZjRiZTc4ZTlmYzM5MTYzNzY0NTE1L3RhYmxlOmZmYmJmNmI5MzY0MjQ3ODBiNTdiNzlhMGI0ZWNiNGQzL3RhYmxlcmFuZ2U6ZmZiYmY2YjkzNjQyNDc4MGI1N2I3OWEwYjRlY2I0ZDNfMzktMy0xLTEtMTkwOTAw_51d4e01e-607d-4d60-bcd3-2332d550f91d"
      unitRef="usd">32469000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i084ee228a45f4b7bb61fef97408d319a_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMy0xLTEtMS0xOTA5MDA_a4d03878-30a5-473c-abe1-130aff4589bd"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="idadc520412e74e82b77efd62c7563138_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMy0zLTEtMS0xOTA5MDA_29f00b4a-b1bd-4e16-96ec-f0d5cecc7358"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3d208a9bfbca47429c91e10ed844e600_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNC0xLTEtMS0xOTA5MDA_c3ebf336-b1a1-4bac-8901-adad8dcb80bb"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i83010d83b2be4843a9ea73d6857ee43b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNC0zLTEtMS0xOTA5MDA_ee77214d-0092-4f88-80cf-bccac9ad6b3e"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssued
      contextRef="ifcda9e1071cc41d1b93c4164824d0842_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNS0xLTEtMS0xOTA5MDA_14f47a0e-d256-4730-b8a1-3ef18868c88e"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ica6363b1347143b687c646c7bb59890c_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNS0zLTEtMS0xOTA5MDA_1eff8d89-defb-43e7-9546-ef32b3e70170"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="ie4beb43815f44c8b975c46b4b7dcd066_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNy0xLTEtMS0xOTA5MDA_2f992e0f-8175-4a04-a588-7ab2b34c7dc6"
      unitRef="shares">1696633993</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i96e1149027c4441c86624768b5319f84_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNy0zLTEtMS0xOTA5MDA_b62ff99a-95ee-482c-9039-cd8230c98067"
      unitRef="shares">1688810052</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOC0xLTEtMS0xOTA5MDA_3fb25a5d-c873-4119-96be-f92d7fd0facb"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOC0zLTEtMS0xOTA5MDA_7a5cc832-2549-4c7e-930f-e33564ad7c84"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOS0xLTEtMS0xOTA5MDA_2ca25875-e90e-40c9-8fac-2f7b6d5cbc24"
      unitRef="shares">4194880</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfOS0zLTEtMS0xOTA5MDA_47347554-7ddc-431d-a358-a698fc3d49d3"
      unitRef="shares">4018935</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesIssued
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTAtMS0xLTEtMTkwOTAw_1683620d-cbcb-4f4e-b843-33e47a79d538"
      unitRef="shares">1700828873</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTAtMy0xLTEtMTkwOTAw_3c305ea6-36e8-4d89-a285-ec87ff041dde"
      unitRef="shares">1692828987</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i084ee228a45f4b7bb61fef97408d319a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTMtMS0xLTEtMTkwOTAw_b7676f56-2983-4643-90d0-5af61a8e9b42"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idadc520412e74e82b77efd62c7563138_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTMtMy0xLTEtMTkwOTAw_9d3f84da-0e59-47b0-bf15-2348028ee381"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i3d208a9bfbca47429c91e10ed844e600_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTQtMS0xLTEtMTkwOTAw_0467c718-b1b7-45e3-ae24-201a297fa754"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i83010d83b2be4843a9ea73d6857ee43b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTQtMy0xLTEtMTkwOTAw_8049b0e1-df6d-4f60-997f-c87d267a6d4d"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcda9e1071cc41d1b93c4164824d0842_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTUtMS0xLTEtMTkwOTAw_ab13c31e-dbad-48af-88d0-656cdd3a34f3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica6363b1347143b687c646c7bb59890c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTUtMy0xLTEtMTkwOTAw_f7721c9c-35f1-4eb4-a3eb-ba35925ecf63"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4beb43815f44c8b975c46b4b7dcd066_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTctMS0xLTEtMTkwOTAw_dc7eb818-a280-465b-af7c-37f0fb3aca28"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i96e1149027c4441c86624768b5319f84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTctMy0xLTEtMTkwOTAw_24ccb4d5-dac7-4f2e-a4de-bbd9cd846f89"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTgtMS0xLTEtMTkwOTAw_8907d047-afd8-4607-87ed-d6667d1ec7f4"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTgtMy0xLTEtMTkwOTAw_5d525fb7-ebcf-433b-a276-f00f002dcfc5"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="id08f694f1b574a5f9f01e9b905835606_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTktMS0xLTEtMTkwOTAw_888cdc71-b6cb-4407-b6ba-09cb86c199a1"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i5bd1da0ee9324dbdb9407de82485dcc7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMTktMy0xLTEtMTkwOTAw_51c4f8fa-bc62-45c9-af6c-3a7ce82ffcf7"
      unitRef="usd">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79e80c25d9ef462985f4e0f891a5b5cd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjAtMS0xLTEtMTkwOTAw_14aed425-78fa-4831-a101-f83ee1238337"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e47b7f759564f6592973c4f4e05220f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjAtMy0xLTEtMTkwOTAw_08fadb1c-0053-4c32-9d32-515460ebf625"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe43718923134537b554888041f98acb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjItMS0xLTEtMTkwOTAw_d2b52b92-185e-4883-a5b9-4ad678940539"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib78ee2c8696148b78cf12753cd58c0d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjItMy0xLTEtMTkwOTAw_21a663f5-b4cb-425f-99d4-008387762cf6"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7bbe8629ec3a41feb7b1b3879baf9550_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjMtMS0xLTEtMTkwOTAw_d893d329-043b-4d63-a538-074e8758e9f9"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2fec5a384762417b96db579ad6bd03ad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjMtMy0xLTEtMTkwOTAw_78b62f45-934e-4dba-9ed0-cb9a2d13e0e5"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3892319bf8004a208cbf25a606b4a2ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjQtMS0xLTEtMTkwOTAw_0ab35f81-9410-45a6-9826-d9210f7f4ca3"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b064580a3054b7d8d6931e0234eef25_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjQtMy0xLTEtMTkwOTAw_c97490d4-9fd5-4dfd-a517-ee19d0c6418b"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8922db963039472f89f06b87d8657844_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjYtMS0xLTEtMTkwOTAw_79ea34a8-aa8b-463b-b862-4dbf98a9b0dc"
      unitRef="usd">20289000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd4b8ebe7cc34378889bcc457b5e983e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjYtMy0xLTEtMTkwOTAw_c80930c6-0fdb-48b4-b04c-941d3338faa1"
      unitRef="usd">19986000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i18021923822a43228b64f5223b7421f5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjktMS0xLTEtMTkwOTAw_d9fcb140-273c-4bb0-b6c4-5b7f288c8168"
      unitRef="usd">68000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ife464a07c09f41ecacbbec13eb93f31d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMjktMy0xLTEtMTkwOTAw_e1cff3b0-d7a0-4dc0-95f2-2c12ae978af3"
      unitRef="usd">57000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d52170be4f743378a4992e23d45569a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzAtMS0xLTEtMTkwOTAw_d8abd47e-6581-4b24-b459-d498a9f3a63a"
      unitRef="usd">20356000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i519498f0b57b477a94d127c9d99d8c5c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzAtMy0xLTEtMTkwOTAw_64a22d50-28b1-413c-85ed-eba75d469962"
      unitRef="usd">20043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8039f48a66e437e86506c950f222249_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzItMS0xLTEtMTkwOTAw_f2e4759b-0e4b-4d3a-be1e-ba32358c63fb"
      unitRef="usd">-750000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i550af412f2a94281896257850ac5c3cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzItMy0xLTEtMTkwOTAw_a9d5a03e-ae7f-4f14-99de-b2e307b812d6"
      unitRef="usd">-1392000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i10379de39e614c0bb89ed6c005f3c30d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzMtMS0xLTEtMTkwOTAw_fe5a86eb-22fa-4181-a251-8fe425fd41b8"
      unitRef="usd">314000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if0f36ed1cf1547ba8293d1a829a2537e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzMtMy0xLTEtMTkwOTAw_50a8b326-0603-4c5a-afd8-9e8d2e0a3856"
      unitRef="usd">110000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i10379de39e614c0bb89ed6c005f3c30d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzQtMS0xLTEtMTkwOTAw_70a821bf-2c1f-41f4-b882-8f591f83966f"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="if0f36ed1cf1547ba8293d1a829a2537e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzQtMy0xLTEtMTkwOTAw_987d9a46-b143-4ff1-bc2b-be33ed816a45"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7482b0cc18cc4cb5b95be5e301a03847_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzUtMS0xLTEtMTkwOTAw_0724e536-4b40-4bd5-8707-50f274ecd3f7"
      unitRef="usd">-450000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6a51d9fab43472e9dba2c8acb6cbee6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzUtMy0xLTEtMTkwOTAw_66e7782d-082a-47cc-a48f-96dc7467d04d"
      unitRef="usd">-1296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieec344c42ac640aaa2b967fe3886e028_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzctMS0xLTEtMTkwOTAw_1df53416-4532-484f-ad3d-d5bdf6205516"
      unitRef="usd">269000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i657a9b55825b423f8043e4c0876ac4e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzctMy0xLTEtMTkwOTAw_69a14372-664c-459d-ac6d-f7aacad1a8e0"
      unitRef="usd">263000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id2475a56a63d43499ecd47cd83f768cf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzgtMS0xLTEtMTkwOTAw_4ef4cc38-6f8b-46b6-b070-591903b06817"
      unitRef="usd">-91000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic86f00778306481a9e2dc5461c401ba6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzgtMy0xLTEtMTkwOTAw_9c5525c2-3554-49de-b146-c8ff63218cab"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2e1f4c4ff1e4eb6af4ba1ad9104b9e9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzktMS0xLTEtMTkwOTAw_ff00ee60-909d-4973-83ef-6e20d59c2572"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia31ddba351344e03b261775eff8755cf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfMzktMy0xLTEtMTkwOTAw_66e1ecb9-9b24-42e4-bc08-6f667b69bc87"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquity
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDAtMS0xLTEtMTkwOTAw_987ad8f4-99c6-4e66-b2dc-61c927c3e7be"
      unitRef="usd">17850000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDAtMy0xLTEtMTkwOTAw_e3ccf39f-bba8-4afa-a691-2fbb799e7900"
      unitRef="usd">16735000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff97cdf22f9541feb9bbf358623cd961_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDMtMS0xLTEtMjE2NDM5_2ead4d0c-f9b3-4af6-9de5-ee2b04229959"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bf26ed1cd4b4ca5b515533656d047c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDMtMy0xLTEtMjE3NzQ4_f2ba58f5-255d-4b93-b5cf-8282533e6b22"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDQtMS0xLTEtMjE2NDM5_84ed8a1b-6ae8-4074-b1cf-a6dc92ac948f"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDQtMy0xLTEtMjE3NzQ4_ab30bd27-2c6a-4fd6-8244-9d341b27af88"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDUtMS0xLTEtMjE3NzM2_c4bcde9d-ded2-4a65-a1c8-e9c6c1826dbc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDUtMy0xLTEtMjE3NzQ4_d9615e9b-03ad-4139-ad24-a8b7cb16c7f7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="iff10f7bf1ef94359a44ca3caf35f7b73_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDYtMS0xLTEtMjE3NzE0_d15fc27c-9311-4240-90d0-1fe2588f9947"
      unitRef="usd">259000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i0d975e1d863943fb89f1801378d7e584_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDYtMy0xLTEtMjE3NzQ4_64f94272-6f1b-4af7-88da-6945a47d9bbf"
      unitRef="usd">0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide43a5e742264d82bcb232842cf9058d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDYtMS0xLTEtMjE2NDUx_4e7ebc31-2f39-49c4-a7de-4cf4878fca8d"
      unitRef="usd">259000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i479f625a10cb442d893bd1055659f74b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDctMy0xLTEtMjE3NzQ4_6a263480-f65a-4bdf-a1ca-8f03a96841a9"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDgtMS0xLTEtMjE2NDE3_879dfe7b-5c16-4928-a87f-8b821913466f"
      unitRef="usd">18109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8yOC9mcmFnOjQ4ZTk4MDg3MmUwZDQxN2I5ZWYyMDY2NWRmMjhlOTViL3RhYmxlOmZkNzViMGUxZWI1MzQ2MzdhYjY0M2E5ODgwYTgyMmE0L3RhYmxlcmFuZ2U6ZmQ3NWIwZTFlYjUzNDYzN2FiNjQzYTk4ODBhODIyYTRfNDgtMy0xLTEtMjE2NDI3_db05423b-2c9e-480d-b34b-779fb03d8cc1"
      unitRef="usd">16735000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMi0xLTEtMS0xOTA5MDA_6f4697be-3697-4b1f-9122-4ef7c1665d67"
      unitRef="usd">314000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMi0zLTEtMS0xOTA5MDA_213ccc73-6489-4209-bef6-9e4061bd4525"
      unitRef="usd">110000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNS0xLTEtMS0xOTA5MDA_fd21f7a5-4619-4734-acf4-de4bb1c598bf"
      unitRef="usd">285000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNS0zLTEtMS0xOTA5MDA_e5d8f7a9-dea5-46f5-b949-d2de2df40349"
      unitRef="usd">274000000</us-gaap:DepreciationDepletionAndAmortization>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNi0xLTEtMS0xOTA5MDA_adbbb724-8913-4721-97d5-c5be55f15fdb"
      unitRef="usd">19000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNi0zLTEtMS0xOTA5MDA_1bf4ddf4-eb49-4831-91b2-1dfbfe185372"
      unitRef="usd">-75000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNy0xLTEtMS0xOTA5MDA_a8fef64b-7760-4a5c-ab1f-cb46023a0359"
      unitRef="usd">55000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNy0zLTEtMS0xOTA5MDA_3c98db47-c092-4d12-b890-09b881713352"
      unitRef="usd">52000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnInvestments
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfOS0xLTEtMS0xOTA5MDA_54b81fe9-e947-4abd-ae49-c70c8e5d8e3a"
      unitRef="usd">-31000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfOS0zLTEtMS0xOTA5MDA_61c738e9-6355-496a-82c5-f72d84b5806f"
      unitRef="usd">-20000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTAtMS0xLTEtMTkwOTAw_e4c31059-c723-42c9-8711-07eafbd76969"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTAtMy0xLTEtMTkwOTAw_dd70530d-a13e-465c-9db3-2902c4fe2254"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:InventoryStepUpAmortization
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTEtMS0xLTEtMTkwOTAw_f3c8ae38-3cec-4546-bc61-0f873b36cfde"
      unitRef="usd">0</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTEtMy0xLTEtMTkwOTAw_6781d158-3a25-4d00-af1c-c9e66a889a45"
      unitRef="usd">17000000</bsx:InventoryStepUpAmortization>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTMtMS0xLTEtMTkwOTAw_343f7953-ea1d-4281-b589-a6923fb40299"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTMtMy0xLTEtMTkwOTAw_4b77eaa5-1c6f-4873-8eab-4501b37848cd"
      unitRef="usd">-194000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <bsx:OtherNet
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTQtMS0xLTEtMTkwOTAw_e18e3ad1-30f6-467f-9027-2ea23ee5f96e"
      unitRef="usd">-2000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTQtMy0xLTEtMTkwOTAw_9402e80f-54c4-4073-9f24-46c935997caf"
      unitRef="usd">19000000</bsx:OtherNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTYtMS0xLTEtMTkwOTAw_a69c15e9-341e-42e6-87ac-8750ea10b7d4"
      unitRef="usd">86000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTYtMy0xLTEtMTkwOTAw_00891407-84c7-4154-a804-cd018895b8e6"
      unitRef="usd">66000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTctMS0xLTEtMTkwOTAw_13492677-0c01-4c2b-b2f6-bfc387d62530"
      unitRef="usd">185000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTctMy0xLTEtMTkwOTAw_33e7277e-6d4d-4b8b-9e18-12fb129babdb"
      unitRef="usd">108000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTgtMS0xLTEtMTkwOTAw_8df93ea8-9550-4fe2-8a34-ea7fc769b59e"
      unitRef="usd">41000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTgtMy0xLTEtMTkwOTAw_8956ade8-e8b0-4eb7-a0a6-6e762fdb38b0"
      unitRef="usd">140000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTktMS0xLTEtMTkwOTAw_73f02d37-126c-4855-8390-0fe2239cd71f"
      unitRef="usd">-211000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMTktMy0xLTEtMTkwOTAw_60b13a67-3e89-4bb6-adee-6795ed2f3e0d"
      unitRef="usd">-368000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjEtMS0xLTEtMTkwOTAw_618ef1bb-6dfa-4e41-a1b8-993b1c87dec1"
      unitRef="usd">190000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjEtMy0xLTEtMTkwOTAw_7252984e-a678-4f9b-b743-e443cf77cf4c"
      unitRef="usd">-58000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjQtMS0xLTEtMTkwOTAw_c2d9142c-3538-431e-abd0-58786bc8d04a"
      unitRef="usd">111000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjQtMy0xLTEtMTkwOTAw_233dba4c-01d3-4171-acae-1bb6cbc4707c"
      unitRef="usd">121000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjUtMS0xLTEtMTkwOTAw_01add138-ad43-4ce0-bee2-43bbfe5ba0a2"
      unitRef="usd">3000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjUtMy0xLTEtMTkwOTAw_97766767-58c8-4287-a28d-5b25cebef20c"
      unitRef="usd">8000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjYtMS0xLTEtMTkwOTAw_11b5846e-36d1-4332-837a-fd26a78492e9"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjYtMy0xLTEtMTkwOTAw_221def01-a481-4ad2-b3d0-384fedcb7cae"
      unitRef="usd">1471000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjctMS0xLTEtMTkwOTAw_0e8cb054-ff2b-40a5-93a8-d69961a23012"
      unitRef="usd">10000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjctMy0xLTEtMTkwOTAw_8f443b47-9148-4dfe-b3cd-b17c1213e618"
      unitRef="usd">10000000</bsx:ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjktMS0xLTEtMTkwOTAw_347c92af-a711-424f-a7be-f61cf158374b"
      unitRef="usd">-9000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMjktMy0xLTEtMTkwOTAw_dc2747f0-e23e-4975-8325-629ea872bfe8"
      unitRef="usd">-19000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzEtMS0xLTEtMTkwOTAw_1ea5e0fb-3513-49e7-af67-35d684f8d9c5"
      unitRef="usd">-484000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzEtMy0xLTEtMTkwOTAw_7a6ec952-c594-481e-89a9-fba92d4a897f"
      unitRef="usd">-1574000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzQtMS0xLTEtMTkwOTAw_c465b6d6-2aa4-4b68-b983-af01a6eda53c"
      unitRef="usd">34000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzQtMy0xLTEtMTkwOTAw_107bc4d2-6647-4875-9316-1477637fdbbb"
      unitRef="usd">20000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzUtMS0xLTEtMTkwOTAw_d691ba4c-1d66-4cd9-9529-33e936bb72b8"
      unitRef="usd">34000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzUtMy0xLTEtMTkwOTAw_787269c9-75f9-4370-b525-9d94696202e1"
      unitRef="usd">39000000</bsx:PaymentsForRoyaltyRights>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzYtMS0xLTEtMTkwOTAw_fbc3adcc-0c3f-48ca-9e9e-07767ddf7d97"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzYtMy0xLTEtMTkwOTAw_462f6b96-6dfb-402e-93a1-521c1e7dc634"
      unitRef="usd">250000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzgtMS0xLTEtMTkwOTAw_e02b3452-742a-4675-a13b-0a86ef960736"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfMzgtMy0xLTEtMTkwOTAw_422c4e15-318f-4e6e-9639-28814c707dc9"
      unitRef="usd">223000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDEtMS0xLTEtMTkwOTAw_afb74c6d-43df-4010-b0b5-4bc37ad47309"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDEtMy0xLTEtMTkwOTAw_623bd7bb-7b0d-4463-abc4-afacd8e383bb"
      unitRef="usd">3184000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDItMS0xLTEtMTkwOTAw_7b6efbbf-ca25-4883-b331-7a47e49e6a2d"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDItMy0xLTEtMTkwOTAw_4ac2f287-1612-4ef3-b9be-23cebab00e44"
      unitRef="usd">3271000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDMtMS0xLTEtMTkwOTAw_ae2aefcc-a53b-4b73-a6e2-7748174357b7"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDMtMy0xLTEtMTkwOTAw_d09fad32-5302-4135-911d-bd90bede03a5"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDYtMS0xLTEtMTkwOTAw_521bdb71-1329-4dca-bc48-94bd56d44cea"
      unitRef="usd">50000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDYtMy0xLTEtMTkwOTAw_cc28e152-2769-42c8-979f-10271c051c90"
      unitRef="usd">46000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDctMS0xLTEtMTkwOTAw_202e6c16-d8b1-4c6d-a3ec-a95177d159e4"
      unitRef="usd">63000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDctMy0xLTEtMTkwOTAw_72dcdbc1-bddc-4623-b635-18fc648ad709"
      unitRef="usd">52000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDgtMS0xLTEtMTkwOTAw_bcbdd978-b986-405f-84a6-847bfb95587a"
      unitRef="usd">-69000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNDgtMy0xLTEtMTkwOTAw_622cc74b-0846-47c7-aeb9-038093d28873"
      unitRef="usd">-6000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTAtMS0xLTEtMTkwOTAw_0b891057-ea26-4090-a971-89e7bea48c1a"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTAtMy0xLTEtMTkwOTAw_71f0fdf5-a892-4da5-a05d-b565eeb04fe2"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTItMS0xLTEtMTkwOTAw_18486ba1-68d3-4018-b041-c51bad99600a"
      unitRef="usd">-363000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTItMy0xLTEtMTkwOTAw_ad727bcc-9776-4b23-aeb5-375435dbdce5"
      unitRef="usd">-1639000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTMtMS0xLTEtMTkwOTAw_96ba7a76-33a2-4320-9410-aea4f1fe8357"
      unitRef="usd">1126000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTMtMy0xLTEtMTkwOTAw_62decddd-2eba-4bfd-965d-63836fc4a24c"
      unitRef="usd">2168000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTQtMS0xLTEtMTkwOTAw_52104f42-616c-4b8d-9215-213dc8cbe0f3"
      unitRef="usd">763000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjhjZWExMmRmNDk3MDQ2NzE5NTRhYWM3MTY0NjNiNGY2L3RhYmxlcmFuZ2U6OGNlYTEyZGY0OTcwNDY3MTk1NGFhYzcxNjQ2M2I0ZjZfNTQtMy0xLTEtMTkwOTAw_fcad2cad-71a8-41d4-ad62-971fe2cf13cf"
      unitRef="usd">529000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ShareBasedCompensation
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfMy0xLTEtMS0xOTA5MDA_d1c2b6f4-9acd-4ed9-afe8-5c99d2c223b8"
      unitRef="usd">55000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfMy0zLTEtMS0xOTA5MDA_fb38efbf-d976-4cd9-bc5c-707b3e1b7e04"
      unitRef="usd">52000000</us-gaap:ShareBasedCompensation>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfNS0xLTEtMS0xOTA5MDA_50197c63-05a9-499b-a0f7-84f96abde0ac"
      unitRef="usd">-9000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOjViNDM5NTVjNWQxZjRiYTNiMmU4NzY0YzgwNTI0NWI0L3RhYmxlcmFuZ2U6NWI0Mzk1NWM1ZDFmNGJhM2IyZTg3NjRjODA1MjQ1YjRfNS0zLTEtMS0xOTA5MDA_4e68f25e-2c6f-4674-bb6d-00596ebe3a10"
      unitRef="usd">-19000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMi0xLTEtMS0xOTA5MDA_a3f851be-acd1-4cc9-8d1d-aee7ae265019"
      unitRef="usd">570000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMi0zLTEtMS0xOTA5MDA_ac8e8d21-7119-40f3-83f8-f13e75be871b"
      unitRef="usd">325000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMy0xLTEtMS0xOTA5MDA_44990b9d-e93b-4893-a830-2fe7aa90379c"
      unitRef="usd">135000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfMy0zLTEtMS0xOTA5MDA_c6af4bc8-bb90-447f-bb97-d012ef28ea12"
      unitRef="usd">146000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNC0xLTEtMS0xOTA5MDA_5cd487b8-c1a8-4032-963b-2d527ef397eb"
      unitRef="usd">57000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNC0zLTEtMS0xOTA5MDA_f518e1ef-4872-43b5-b3fa-6be7203ba32d"
      unitRef="usd">59000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNS0xLTEtMS0xOTA5MDA_7d65ee37-9843-4739-a9f9-b0f7ee4c8ac6"
      unitRef="usd">763000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNS0xLTEtMS0xOTA5MDA_f8bce413-3461-4074-bede-8075b5083fb2"
      unitRef="usd">763000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zMS9mcmFnOmY0NjQzOTliNDU3ODRlMmM5OTRjMmNmNDkzYzM1YjQ5L3RhYmxlOmNkMWZmNDI5ODMyOTQ5NmU4YzVlNjA3MmQ3ZDgyYjU1L3RhYmxlcmFuZ2U6Y2QxZmY0Mjk4MzI5NDk2ZThjNWU2MDcyZDdkODJiNTVfNS0zLTEtMS0xOTA5MDA_ae8ab1aa-d5c9-4bbc-b277-f461037f00d9"
      unitRef="usd">529000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zNy9mcmFnOjA5Mjg0ODFiYjc0YTRmYjZiNzZiNjZhYmYzNDUyNjJlL3RleHRyZWdpb246MDkyODQ4MWJiNzRhNGZiNmI3NmI2NmFiZjM0NTI2MmVfMTkzMw_c874fd3e-ee77-4337-b0dc-edf978f1d1ed">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE A &#x2013; BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements include the accounts of the Company's wholly owned- subsidiaries and entities for which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated in consolidation. In the first quarter of 2023, we acquired a majority stake investment in Acotec Scientific Holdings Limited (Acotec) and have elected to consolidate their financial statements on a one quarter lag. Accordingly, their results of operations for the period following the closing of the transaction on February 20, 2023 are omitted from the Company&#x2019;s unaudited consolidated statements of operations for the quarter ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Note B &#x2013; Acquisitions, Divestitures and Strategic Investments, Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8zNy9mcmFnOjA5Mjg0ODFiYjc0YTRmYjZiNzZiNjZhYmYzNDUyNjJlL3RleHRyZWdpb246MDkyODQ4MWJiNzRhNGZiNmI3NmI2NmFiZjM0NTI2MmVfMTk0Mw_aa7bc990-8882-4e73-8cac-555383e66ebb">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Note B &#x2013; Acquisitions, Divestitures and Strategic Investments, Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NTU_9b38e7be-dd5d-4130-9ffd-d461d499f9a2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE B &#x2013; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2023 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 4, 2023, we completed our acquisition of 100 percent of the outstanding equity of Apollo Endosurgery, Inc. (Apollo), a public company which offers a portfolio of devices used during endoluminal procedures to close gastrointestinal defects, manage gastrointestinal complications and aid in weight loss for patients suffering from obesity. The agreement consisted of an upfront cash payment of $10.00 per share, or approximately $615 million. The Apollo business is being integrated into our Endoscopy division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 20, 2023, we completed the acquisition of a majority stake investment in Acotec, a publicly traded Chinese manufacturer of drug-coated balloons used in the treatment of vascular and other diseases. We acquired approximately 65 percent of the outstanding shares of Acotec, for an upfront cash payment of HK$20.00 per share, or $519 million at foreign currency exchange rates at closing. The Acotec portfolio complements our existing Peripheral Interventions portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We accounted for the Acotec transaction as a business combination in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(FASB ASC Topic 805). The preliminary purchase price was comprised of the amount presented below: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for majority interest acquisition, net of cash acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Excludes approximately $140 million of cash on hand at the closing of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We recorded the assets acquired, liabilities assumed and the noncontrolling interest at their respective fair values as of the closing of the transaction. The preliminary purchase price allocation was comprised of the following components and the final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with FASB ASC Topic 805: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the noncontrolling interest was based on the publicly traded market value of the remaining 35 percent of the outstanding shares we did not acquire as of the transaction date and is presented within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Stockholders' equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets. Goodwill was primarily established due to opportunities for collaboration in research and development, manufacturing and commercial strategies, and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;334&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2022, we completed our acquisition of Baylis Medical Company Inc. (Baylis Medical), a privately-held company which developed the radiofrequency (RF) NRG&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and VersaCross&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access, which expanded our electrophysiology and structural heart product portfolios. The transaction consisted of an upfront cash payment of $1.463 billion, net of cash acquired, subject to closing adjustments. We are integrating the Baylis Medical business into our Cardiology division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisition of Baylis Medical as a business combination in accordance with FASB ASC Topic 805, Business Combinations. The final purchase price was comprised of the amount presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and is deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of our acquisitions that closed during the first quarters of 2023 or 2022 contained contingent consideration arrangements. Changes in the fair value of our contingent consideration liability during the first quarter of 2023 associated with prior period acquisitions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The payments made during the first quarter of 2023 were primarily related to our 2021 acquisition of Farapulse, Inc. As of March&#160;31, 2023, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was approximately $359 million. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$80 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected contingent payment amounts related to research and development (R&amp;amp;D), regulatory and commercialization-based milestones and revenue-based payments are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1, 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Includes publicly-held securities measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. &lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2023, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $209 million, which represents amortizable intangible assets, in-process research and development (IPR&amp;amp;D), goodwill and deferred tax liabilities.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i50b5bcfa88dc4695b6f53f461176ea44_I20230404"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjM3Ng_36c09289-d177-4615-b369-0ec7ecaa8af7"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i50b5bcfa88dc4695b6f53f461176ea44_I20230404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjM4Ng_ce3d1764-bdda-4ceb-9c2f-4d96f010f0d2"
      unitRef="usdPerShare">10.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="ibc8125bb5d9343a4aa4a0b3bea2a48af_D20230404-20230404"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQyNQ_ab8077a9-44e1-44af-a9dc-85b1385e3b30"
      unitRef="usd">615000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i3bb00ce3cc2f43ed83cc43d46d7f4ece_I20230220"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQ4MQ_cb21fe9b-4a24-4a85-8d24-6238aa83e474"
      unitRef="number">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i0f1076c0e73c48b8b0c16cb99f3fffa9_D20230220-20230220"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQ1Ng_e03f8889-0af5-46f6-82a0-30f6480ebf35"
      unitRef="krw">20.00</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i0f1076c0e73c48b8b0c16cb99f3fffa9_D20230220-20230220"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY0NjQ0Mw_c6111197-eb07-4b61-81bb-20ff99974588"
      unitRef="usd">519000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfNTQ5NzU1ODQ0NDcy_b8bb75fd-a772-4965-84c2-0cd124558a34">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for majority interest acquisition, net of cash acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Excludes approximately $140 million of cash on hand at the closing of the transaction.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY5NWQxZTU4MjIyODQ0NWE5M2NlNTc5MTM0MmI4MTliL3RhYmxlcmFuZ2U6Zjk1ZDFlNTgyMjI4NDQ1YTkzY2U1NzkxMzQyYjgxOWJfMS0xLTEtMS0yMTY4Mzk_b9cbdbec-763c-46de-950c-35630022514d"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY5NWQxZTU4MjIyODQ0NWE5M2NlNTc5MTM0MmI4MTliL3RhYmxlcmFuZ2U6Zjk1ZDFlNTgyMjI4NDQ1YTkzY2U1NzkxMzQyYjgxOWJfMi0xLTEtMS0yMTY4NTA_4517ef1f-286e-4302-826d-b5066e786291"
      unitRef="usd">375000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Cash
      contextRef="i3bb00ce3cc2f43ed83cc43d46d7f4ece_I20230220"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY1NTEzNw_8cb416d1-4f19-45bb-8600-adf65d60bcb5"
      unitRef="usd">140000000</us-gaap:Cash>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfNTQ5NzU1ODQ0NDcz_c3998293-4797-46aa-83ca-6fc839d8318f">The preliminary purchase price allocation was comprised of the following components and the final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with FASB ASC Topic 805: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfMS0xLTEtMS0yMTY4NTg_c6f4f813-45fd-415e-8ac6-a187c255bf63"
      unitRef="usd">336000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfMi0xLTEtMS0yMTY4NTg_45113075-7e78-4411-8ad9-017c995ffd61"
      unitRef="usd">334000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNC0xLTEtMS0yMTY4NjY_d270d58f-0b8e-4913-b7e0-f07ec01a1b82"
      unitRef="usd">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNS0xLTEtMS0yMTY4NzQ_6721414c-5480-4064-b5ac-ed73b302bb56"
      unitRef="usd">23000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNi0xLTEtMS0yMTY4NzQ_f6cc8005-cbe4-448b-aa48-023dff8a4193"
      unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNy0xLTEtMS0yMTkyNjU_45e90ab8-eab6-4bed-896d-d1b8736ca098"
      unitRef="usd">259000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjE4ZmQxMzE5NDdiNzQ4NThiZTkzZTY1YzM2ZDQwYTZkL3RhYmxlcmFuZ2U6MThmZDEzMTk0N2I3NDg1OGJlOTNlNjVjMzZkNDBhNmRfNy0xLTEtMS0yMTY4NzQ_6c754631-c091-4f23-b3e8-e18bce1778e8"
      unitRef="usd">375000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i098c221da06c4b958585f779d2867c19_I20230220"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA5OTUxMTY1ODM4Mg_56fe5516-065d-4f63-af91-1f7eb3409ef6"
      unitRef="number">0.35</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i62a39fcae9b649dc9bada7f03f73beee_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfNTQ5NzU1ODQ0NDc0_f7a01f64-33c8-4019-ab2e-3fba8c36d804">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;334&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id93085ad25bc42338a5eab7de3e2cc41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfMy0xLTEtMS0yMTc0MzE_4d656921-95a1-48ac-a2c6-1c10ac94c1c7"
      unitRef="usd">308000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i99682e6da7ba40fab6c56eea230eec3f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfMy0zLTEtMS0yMTc0MzE_7d75b654-76a3-4d09-90ca-995a5d1c571a">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i6514d87e72ac4153a2523faf7d9b4ca6_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfMy01LTEtMS0yMTc0MzE_375f5709-9e20-426c-a6ac-93b7e3276927"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i21630f12b7d5477cbc3cbb55360587fb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNC0xLTEtMS0yMTc0MzE_5c14d478-db16-4bba-8b06-b0d3a4e91b00"
      unitRef="usd">15000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3c05ab454f604b7e938efdb8a3a9bedf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNC0zLTEtMS0yMTc0MzE_6460a2ba-d824-4946-bcb7-43e28c507faa">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i3aeee52d764f4a80911bef9fddad1874_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNC01LTEtMS0yMTc0MzE_70ad9df0-f894-4e31-ad94-cff738b21e0e"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie4d69f63508e4a52a7d288bbf2fa5e41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNS0xLTEtMS0yMTc0MzE_90c93878-5e79-4eef-a42f-768f93c169f0"
      unitRef="usd">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i86dca2ec31934d279f4e60c2ac7559cc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNS0zLTEtMS0yMTc0MzE_4a9735b1-32ab-4c4d-8efe-9421aeb47caa">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="if3e100c180dc4202883a3c603581fbc8_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfNS01LTEtMS0yMTc0MzE_94c8a923-7df0-42b9-ae47-34f63a166e58"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0ca73a484cd94f89b00ba120bfc589b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmFjYmY4MmQ0OTQzMzQwNmJhMWY0NWQ0YTU1NGMyYzBkL3RhYmxlcmFuZ2U6YWNiZjgyZDQ5NDMzNDA2YmExZjQ1ZDRhNTU0YzJjMGRfOC0xLTEtMS0yMTc0MzE_45113075-7e78-4411-8ad9-017c995ffd61"
      unitRef="usd">334000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTY2NA_3d63c648-cff8-4120-807e-6f3db1ae54e7"
      unitRef="usd">1463000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NDg_ca764d8e-57f2-48e5-961f-ce3ef9151e96">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjNkZjI2NGMwODk2ZTQ3MGY4OGUxODNjNGY5OTQ2NWQzL3RhYmxlcmFuZ2U6M2RmMjY0YzA4OTZlNDcwZjg4ZTE4M2M0Zjk5NDY1ZDNfMS0xLTEtMS0xOTA5MDA_3d63c648-cff8-4120-807e-6f3db1ae54e7"
      unitRef="usd">1463000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjNkZjI2NGMwODk2ZTQ3MGY4OGUxODNjNGY5OTQ2NWQzL3RhYmxlcmFuZ2U6M2RmMjY0YzA4OTZlNDcwZjg4ZTE4M2M0Zjk5NDY1ZDNfNC0xLTEtMS0xOTA5MDA_7d497ad6-7494-4b3e-ac67-d6f3ba9b92b1"
      unitRef="usd">1463000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NDk_c654895f-0aa3-4f2b-bde7-6f41a6544093">The final purchase price allocation was comprised of the following components:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfMS0xLTEtMS0xOTA5MDA_ff964a07-df69-4753-b74e-530a4d292684"
      unitRef="usd">988000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfMi0xLTEtMS0xOTA5MDA_2c69ed59-537b-4500-b8e1-29a59e0f0caa"
      unitRef="usd">657000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfNC0xLTEtMS0xOTA5MDA_048fb420-83ce-46af-9c8b-2b39c14ce9a6"
      unitRef="usd">112000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfNi0xLTEtMS0xOTA5MDA_7cb12e17-e2a4-4bf6-98c6-246956b353af"
      unitRef="usd">287000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfNy0xLTEtMS0xOTA5MDA_8909cabc-9026-4b7b-b0e4-3f35bc1c04e9"
      unitRef="usd">7000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmYyMTJkZTk2YmM2MTQ4YmNhZDk2MjcwZDYyNjhkYzY1L3RhYmxlcmFuZ2U6ZjIxMmRlOTZiYzYxNDhiY2FkOTYyNzBkNjI2OGRjNjVfOC0xLTEtMS0xOTA5MDA_52a42427-0615-4ad3-a41b-7de09f63d097"
      unitRef="usd">1463000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i8082d523142c463b948e3b8c9eabb365_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NDA_7806b9be-b9c1-4435-b33c-0be629d48aec">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3b304742c4c54945b75a66597634648a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfMy0xLTEtMS0xOTA5MDA_4a6982b8-aa0f-4ac6-8fb1-436013030a1a"
      unitRef="usd">622000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i586764f8498244c29e88444e4724fcbf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfMy0zLTEtMS0xOTA5MDA_46fcf1f1-3be8-4a98-aba5-356184e5c90b">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i1ad160e4bd8e4bcaae224e370af0b112_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfMy01LTEtMS0xOTA5MDA_f5805eeb-f715-49bf-9d44-cfc36115aa30"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ie0216d912a174028acfdb839676e95d6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjQ2NGM2Y2Y3NzZkMzQ0MmI5NzZiNTRhMTg5OWFkMWZkL3RhYmxlcmFuZ2U6NDY0YzZjZjc3NmQzNDQyYjk3NmI1NGExODk5YWQxZmRfOC0xLTEtMS0xOTA5MDA_8cec826f-f2b2-405f-9e50-a89bf76ef12a"
      unitRef="usd">657000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2MjU_afeef178-55df-49b9-85e7-54be47165f17">Changes in the fair value of our contingent consideration liability during the first quarter of 2023 associated with prior period acquisitions were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfMS0xLTEtMS0xOTA5MDA_14a5528d-aeec-4686-95f6-e017c3791d4d"
      unitRef="usd">149000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfNC0xLTEtMS0xOTA5MDA_6b22568d-a926-4221-9cfb-85393af9df2e"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfNS0xLTEtMS0xOTA5MDA_2a93ece4-fef1-4032-8953-3fe220b7c69c"
      unitRef="usd">68000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOmY2YWMwOTM0Yzc3ODQxYzk4ZmIyYjUxYjAxMTQ5NWIzL3RhYmxlcmFuZ2U6ZjZhYzA5MzRjNzc4NDFjOThmYjJiNTFiMDExNDk1YjNfNi0xLTEtMS0xOTA5MDA_bb7660e0-f281-427a-9e09-bfa9def2c666"
      unitRef="usd">93000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ia1330d5e86f34de7b8796fe68b26f65f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfODUyMw_12dbd7a3-77a3-4a9b-878a-9041a8faad92"
      unitRef="usd">359000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2MjA_dcfad165-65e2-4834-8f6b-e885548644e8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$80 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic81d6dae3feb405fb58015de09433300_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS0xLTEtMS0xOTA5MDA_9c4a6c14-67c3-448e-9880-e5f6d92ef8f8"
      unitRef="usd">13000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i4e856d6687ec4e31a4d71bf973d3f28a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS00LTEtMS0xOTA5MDA_70d16b5c-636e-455a-a1a9-c1ca2c0dab2e"
      unitRef="number">0.01</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i50cbf9066de44563ae1182748610f8cc_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS02LTEtMS0xOTA5MDA_6772970d-c89c-46f6-b806-91a17fb7ad80"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i86458492bffb48499c122917fa84b6b6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMS03LTEtMS0xOTA5MDA_17e9416d-483a-45b6-8273-34479ce46ce0"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i4e856d6687ec4e31a4d71bf973d3f28a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMi00LTEtMS0xOTA5MDA_d218cc18-7da0-479d-8543-de58a99690c8"
      unitRef="number">0.10</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i50cbf9066de44563ae1182748610f8cc_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMi02LTEtMS0xOTA5MDA_40cb952e-631d-4f1d-a985-d9c67ecdeb5a"
      unitRef="number">0.25</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i86458492bffb48499c122917fa84b6b6_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfMi03LTEtMS0xOTA5MDA_b70ac1fc-5095-4f5d-a928-caae8e06a247"
      unitRef="number">0.22</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie0700cfd128447b2b2157afb226d4c49_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC0xLTEtMS0xOTA5MDA_bde221a4-0704-4b79-87ed-43526e908617"
      unitRef="usd">80000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="icfd41fe9b8c14589a6244f96d5d3a3a7_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC00LTEtMS0xOTA5MDA_4c6a51c5-4218-4f06-9160-59c9dd39ad1e"
      unitRef="rate">0.06</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="if0bcfb39920f4c2784fb6593b98b240a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC02LTEtMS0xOTA5MDA_3785f66b-e9a7-4447-a9ed-f12425abc172"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i94c92289dc0046e1b8af6587d9138ebb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNC03LTEtMS0xOTA5MDA_c8e79f0f-6f99-4cee-bd6c-03d69de5e691"
      unitRef="rate">0.07</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="ie0700cfd128447b2b2157afb226d4c49_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNS00LTEtMS0xOTA5MDA_07afc07d-965e-41d8-a16d-ad4ea9c95eb0"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i94c92289dc0046e1b8af6587d9138ebb_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjdmNzIzODg3YjdkYzRjMjliNzhjMGU4MjkyZjYwODFiL3RhYmxlcmFuZ2U6N2Y3MjM4ODdiN2RjNGMyOWI3OGMwZTgyOTJmNjA4MWJfNS03LTEtMS0xOTA5MDA_d9d86145-3973-4598-9556-d132e32dfe2b"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA2NTI_2f1e6715-6590-4ab2-8263-1e134aab7813">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1, 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Includes publicly-held securities measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMi0xLTEtMS0xOTA5MDA_4be4e5cf-9d66-4858-93fb-6d0907c1d35a"
      unitRef="usd">166000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMi0zLTEtMS0xOTA5MDA_3805e258-3485-4f45-b9c8-7f28a532ab61"
      unitRef="usd">188000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMy0xLTEtMS0xOTA5MDA_1b9a524a-1c5c-4889-8d0c-c0c9a8277d88"
      unitRef="usd">219000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfMy0zLTEtMS0xOTA5MDA_cb5fb182-56b0-4c8e-8fb2-014b1f6c5a03"
      unitRef="usd">219000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:Investments
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfNi0xLTEtMS0xOTA5MDA_39c6b3f7-88fa-4af8-9f13-866f0249aaa5"
      unitRef="usd">385000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RhYmxlOjAzMmFlNzA2NThjZTRjY2ZiN2NmODhmM2Y5OWQ1ZWQ4L3RhYmxlcmFuZ2U6MDMyYWU3MDY1OGNlNGNjZmI3Y2Y4OGYzZjk5ZDVlZDhfNi0zLTEtMS0xOTA5MDA_3b550d31-c4d3-40fa-9797-b2261d0ea367"
      unitRef="usd">407000000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80My9mcmFnOmQxNzZjYTM3NTU5NDQwYmJiNjIzZWViZWJmODFlNTJlL3RleHRyZWdpb246ZDE3NmNhMzc1NTk0NDBiYmI2MjNlZWJlYmY4MWU1MmVfMTA0NzU_7032fbf3-606d-457d-b0f5-edd0c03d2969"
      unitRef="usd">209000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RleHRyZWdpb246MWEyYjc5NzE2MDVkNDU3Njg4NWU1ZmFiOWIzZjk4M2FfNTQ5NA_048fa059-ad85-4b7e-962f-4a1954514261">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE C &#x2013; GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,422)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,843&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,169&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,820&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The increase in our balance of goodwill and amortizable intangible assets is related primarily to our acquisition of a majority stake investment in Acotec completed in the first quarter of 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following represents a roll-forward of our goodwill balance by global reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,684&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,032&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not record any goodwill impairment charges in the first quarters 2023 or 2022. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RleHRyZWdpb246MWEyYjc5NzE2MDVkNDU3Njg4NWU1ZmFiOWIzZjk4M2FfNTQ3Nw_09bf01cc-1ae0-4406-9de6-da64f1e06e9f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,422)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,843&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,169&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,820&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ied91f3fdd793487f8fafa2ef73d957a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi0xLTEtMS0xOTA5MDA_fc09b878-07a0-48c8-80c3-0070f3cd0302"
      unitRef="usd">12707000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ied91f3fdd793487f8fafa2ef73d957a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi0zLTEtMS0xOTA5MDA_f1182640-ec7a-45c5-86b6-2e4f3df334ed"
      unitRef="usd">7553000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i75960dbfc53b4af29aeaf34569b6fa73_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi01LTEtMS0xOTA5MDA_9b08941a-8123-4594-b6df-2980f9654e82"
      unitRef="usd">12397000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i75960dbfc53b4af29aeaf34569b6fa73_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMi03LTEtMS0xOTA5MDA_2e39216c-5b2e-4fc8-8114-0946b8e37a77"
      unitRef="usd">7378000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7064ffd3368f4eb3a7afa617f099937f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy0xLTEtMS0xOTA5MDA_d4487ead-23ef-4b73-b38f-e3836dfc8a77"
      unitRef="usd">473000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7064ffd3368f4eb3a7afa617f099937f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy0zLTEtMS0xOTA5MDA_3ec21d3d-e667-4999-8596-3c7ad62e6e7b"
      unitRef="usd">381000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia4a460c2d84a40f2ab75d16a46ca5cf6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy01LTEtMS0xOTA5MDA_8bcbc3e7-48c9-474e-8bb7-81f07080e3a4"
      unitRef="usd">486000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia4a460c2d84a40f2ab75d16a46ca5cf6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMy03LTEtMS0xOTA5MDA_a2540abb-27aa-43e1-8251-a994a6fe7102"
      unitRef="usd">394000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id9902b3acea745368d2e51c9c3ed82a7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC0xLTEtMS0xOTA5MDA_7d6cb7eb-cd65-4a61-8562-9288d0449747"
      unitRef="usd">2005000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id9902b3acea745368d2e51c9c3ed82a7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC0zLTEtMS0xOTA5MDA_1019c8c3-8e19-46ff-bc9f-969196735f2a"
      unitRef="usd">1422000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib44c957fd74e4baeb93c089d85303850_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC01LTEtMS0xOTA5MDA_ab0fd33e-37b2-42db-ae9a-fe62e45c9a39"
      unitRef="usd">1960000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib44c957fd74e4baeb93c089d85303850_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNC03LTEtMS0xOTA5MDA_80f0d3aa-4536-4480-aac4-76acb3a6e7e1"
      unitRef="usd">1400000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS0xLTEtMS0xOTA5MDA_168003b5-78e6-466e-8baf-49d3a24603be"
      unitRef="usd">15185000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS0zLTEtMS0xOTA5MDA_ca758393-4d9d-478d-98f2-ba037350547a"
      unitRef="usd">9357000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS01LTEtMS0xOTA5MDA_59e18d80-7e45-4fda-a5b6-22e8e70fffb9"
      unitRef="usd">14843000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNS03LTEtMS0xOTA5MDA_b6078225-af34-4871-875b-4db25a0411f6"
      unitRef="usd">9173000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:GoodwillGross
      contextRef="ice6eb7f283e54256a9c5b643698ee72a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy0xLTEtMS0xOTA5MDA_49879ad5-d08c-4657-901e-03dac805223a"
      unitRef="usd">23169000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ice6eb7f283e54256a9c5b643698ee72a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy0zLTEtMS0xOTA5MDA_b8286c25-1507-4470-b2b4-4ca4246e4930"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="i72c98bbaa94e4fb39183b5fc22e895a5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy01LTEtMS0xOTA5MDA_c2d8f235-c885-4a15-8e58-a2992c3ea6a1"
      unitRef="usd">22820000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i72c98bbaa94e4fb39183b5fc22e895a5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfNy03LTEtMS0xOTA5MDA_f02361b2-cd04-4968-9276-8e672443db17"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9c826c5e16734ec89717f304d8a0b98b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfOS0xLTEtMS0xOTA5MDA_25df7151-a549-4925-a400-0c9b001291b6"
      unitRef="usd">112000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie7783d7ba4b7469eb8012fe17848bea5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfOS01LTEtMS0xOTA5MDA_de52a677-3893-47ce-a9d2-d00dad6b32dc"
      unitRef="usd">112000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6f826c50348c4250a015338b19792179_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTAtMS0xLTEtMTkwOTAw_9137673b-9870-4c57-acb4-15d848738578"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i713c9dc3fe0f4edbb6508415483a74d7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTAtNS0xLTEtMTkwOTAw_44a51614-a7fe-4041-9278-a14f0353c925"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTEtMS0xLTEtMTkwOTAw_b777554e-a5a1-427b-8da5-d79f446014bc"
      unitRef="usd">232000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjZhODA1NzBiNTQyNTQwNDA5ZTI2ZmM0Y2ZlMmM3YzdiL3RhYmxlcmFuZ2U6NmE4MDU3MGI1NDI1NDA0MDllMjZmYzRjZmUyYzdjN2JfMTEtNS0xLTEtMTkwOTAw_32164d70-6b76-4621-a2a8-30bfc9ffd827"
      unitRef="usd">232000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RleHRyZWdpb246MWEyYjc5NzE2MDVkNDU3Njg4NWU1ZmFiOWIzZjk4M2FfNTQ3MQ_6ec562e4-2d6e-4b8c-95dd-454dd2b3d6d4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following represents a roll-forward of our goodwill balance by global reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,684&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,032&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i7a25af27795f4ad8995a221fef790ba3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfMS0xLTEtMS0xOTA5MDA_4fb7ace5-242d-481f-9b2c-e0933e6802d1"
      unitRef="usd">4237000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i933e991579d346d98f5c6e3aef002501_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfMS0zLTEtMS0xOTA5MDA_d7abc2fd-ddf0-4459-aa61-d0634b192b95"
      unitRef="usd">8684000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfMS03LTEtMS0xOTA5MDA_e282f9f3-190c-43ee-acb3-d97628d8039c"
      unitRef="usd">12920000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC0xLTEtMS0xOTA5MDA_b69679c6-8e5f-416e-8228-7d05577d97e9"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC0zLTEtMS0xOTA5MDA_21ead877-6d7d-4419-a063-57abc8106f25"
      unitRef="usd">336000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC0zLTEtMS0xOTA5MDA_536050c6-d176-4a2e-8e65-4cadc2a3a0eb"
      unitRef="usd">336000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNC03LTEtMS0xOTA5MDA_a2664bcf-3249-41d4-9891-9d136c1995dd"
      unitRef="usd">336000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNS0xLTEtMS0xOTA5MDA_19a742ed-d44b-470f-bd42-b6062878ec0a"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNS0zLTEtMS0xOTA5MDA_977c9d12-641d-4bf8-bfa1-5452c7ba68c2"
      unitRef="usd">13000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNS03LTEtMS0xOTA5MDA_bf17473b-1c96-4712-a105-ccb58e26eb87"
      unitRef="usd">13000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i437328dd08c04fb38d5a0b1b7015575b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNi0xLTEtMS0xOTA5MDA_d36a2f93-76c4-426f-9798-5c85e80f8ba0"
      unitRef="usd">4237000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ide57541620ac4f40b0aae359edea5b51_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNi0zLTEtMS0xOTA5MDA_d4aa68b4-6836-44e6-bb75-c6e88733c968"
      unitRef="usd">9032000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF80OS9mcmFnOjFhMmI3OTcxNjA1ZDQ1NzY4ODVlNWZhYjliM2Y5ODNhL3RhYmxlOjVlMzcxYThhMGI2MTRmYWE5ZjYzOWRkNWZjNzNiMTE4L3RhYmxlcmFuZ2U6NWUzNzFhOGEwYjYxNGZhYTlmNjM5ZGQ1ZmM3M2IxMThfNi03LTEtMS0xOTA5MDA_7785e0cf-76eb-42da-b49b-83de58f8efc4"
      unitRef="usd">13269000000</us-gaap:Goodwill>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNTU_6bd84cd7-bc33-4b17-bd04-4091814acadf">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE D &#x2013; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and actively monitoring counterparty credit ratings. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in euro, British pound sterling, Swiss franc, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815, Derivatives and Hedging (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax (OCI) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our unaudited consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our unaudited consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time. The cash flows related to the derivative instruments designated as cash flow hedges are reported as operating activities in our consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of March&#160;31, 2023 and December&#160;31, 2022, we designated as a net investment hedge our &#x20ac;900 million in aggregate principal amount of 0.625% euro-denominated senior notes issued in November 2019 and due in 2027 (2027 Notes). For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains and losses within the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Cumulative Translation Adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of O&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ther Comprehensive Income (OCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We reclassify these gains and losses to current period earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also use forward currency contracts that are not part of designated hedging relationships as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest Rate Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interest rate risk relates primarily to U.S. dollar and euro-denominated borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as cash flow hedges outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; until the underlying hedged transaction occurs. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the remaining time to maturity is within 36&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature between one and three years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note M &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;674&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,313&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $170 million invested in money market funds and time deposits as of March&#160;31, 2023 and $673 million as of December&#160;31, 2022, we held $400 million in interest-bearing and non-interest-bearing bank accounts as of March&#160;31, 2023 and $256 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#x2122; Drug. We maintain a financial asset and associated liability for our licensing arrangements measured at fair value in our accompanying unaudited consolidated balance sheets in accordance with FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We elected the fair value option to measure the financial asset and associated liability as it provides for consistency and comparability of these financial instruments with others. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of March&#160;31, 2023 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$113 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$120 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our strategic investments and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of the fair values of our intangible assets including goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our outstanding debt obligations was $8.467 billion as of March&#160;31, 2023 and $8.203 billion as of December&#160;31, 2022. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ife05e78966de43f7831ac0435f16576a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMzQyOQ_fcb0fa53-b33c-47a1-8db9-271deea5dd26"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ife05e78966de43f7831ac0435f16576a_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMzQ2NQ_7199218e-0561-49ea-9936-76cefbb9da2e"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DerivativeTermOfContract
      contextRef="idf9290bf261f4bbc88ca0dbf2972f8f8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNDQyMg_a87b23d9-f68a-4717-bae0-b73d595e5d37">P1Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i163d6247ba884128b6b3970a5d92963d_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNTE3Mw_addfe1f4-e070-431b-850c-56bbd3b63965"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i4daa711fa7aa43a598a5f35231e982df_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNTE3Mw_fbc44c2b-6335-48b3-ac27-a6790ff99cee"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNjQ_f567a446-9a79-44d0-8784-d47111f43c19">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9b1a0b34b25746219cf0093a08066c29_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMi00LTEtMS0xOTA5MDA_f8d484e6-143d-4c15-8eb9-a29c44bf875c"
      unitRef="usd">2673000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i916d03913e7d49e3a4641da09851e47e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMi02LTEtMS0xOTA5MDA_8ab6989a-8ed0-42e7-ae58-acd5eedc0d2f"
      unitRef="usd">2725000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i65e34a5fda334589af3a7f69f399f02e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMy00LTEtMS0xOTA5MDA_b542d239-4de0-43b2-8029-3767743a24e7"
      unitRef="usd">365000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icb8afe4953c841d8aa1dc82c3cacc365_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfMy02LTEtMS0xOTA5MDA_e7967d34-b1b4-4048-a8cd-fe4bba5fcac2"
      unitRef="usd">365000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i260db5b023b64acb974aa51c8180c68b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNC00LTEtMS0xOTA5MDA_2bcaba32-7ff9-4806-9267-8138b8ed8adc"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaab5e7cbf2c543baa4c3f372a5dae6d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNC02LTEtMS0xOTA5MDA_b78a5622-9a2a-4538-acd0-291a638bc171"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id43b656f9a51461296e0ba67c8f28cbc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNS00LTEtMS0xOTA5MDA_17551758-6cad-41d2-b4ee-292074e09913"
      unitRef="usd">3623000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9aa626542bcf4ab68ce0b85324fa5af0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNS02LTEtMS0xOTA5MDA_adfee72e-1dbd-4274-a719-29e7bae90f95"
      unitRef="usd">4235000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNy00LTEtMS0xOTA5MDA_dec75e76-dc7e-4cfb-9f1e-9759a9808237"
      unitRef="usd">7657000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmYxNjE3Mjg5YTRkYjQyNDViMDQ3YmU5MDExNzAwYWZlL3RhYmxlcmFuZ2U6ZjE2MTcyODlhNGRiNDI0NWIwNDdiZTkwMTE3MDBhZmVfNy02LTEtMS0xOTA5MDA_4a940370-9d07-4d1e-9960-09917f908607"
      unitRef="usd">8321000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ife05e78966de43f7831ac0435f16576a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNjI4Ng_fcb0fa53-b33c-47a1-8db9-271deea5dd26"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <bsx:ForwardCurrencyContractsTimetoMaturity
      contextRef="i88522e1e6ca14c4791fddea4df68cca6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNjQyNQ_ad92e96b-d898-4102-9e5c-3b9b461e0014"
      unitRef="units">36</bsx:ForwardCurrencyContractsTimetoMaturity>
    <us-gaap:DerivativeRemainingMaturity1
      contextRef="idf9290bf261f4bbc88ca0dbf2972f8f8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfNjUyNQ_11fe4527-c346-4ad8-92b0-ec4a843d1ace">P1Y</us-gaap:DerivativeRemainingMaturity1>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNjg_f5f6e97b-3579-43ef-ac53-b6edd41102b8">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0xLTEtMS0xOTA5MDA_83bf1d9f-d852-4fd3-ba28-f74049dbf776"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0yLTEtMS0xOTA5MDA_f55f663f-3306-4132-9b29-6743d1263239"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0zLTEtMS0xOTA5MDA_c6af3df1-9319-4088-a5a7-a192ed33ea53"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS02LTEtMS0xOTA5MDA_57a1cb01-1118-428e-a3b8-293216b78f2a"
      unitRef="usd">1040000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS04LTEtMS0xOTA5MDA_61dc5c2b-e2c1-4fc7-9819-c35cfc2b3e11"
      unitRef="usd">-69000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS05LTEtMS0xOTA5MDA_07212487-9850-4cf4-80ba-a4378db623d7"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i98a5103b5ac749c482317cc548c95557_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNS0xMC0xLTEtMTkwOTAw_147615d7-b636-44e2-80a3-80b1c24fb0f1"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0xLTEtMS0xOTA5MDA_e7302308-daaf-443a-aec2-e2b12a33c58f"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0yLTEtMS0xOTA5MDA_e0a08402-d28b-4b0e-9435-31ad84b6bfd3"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0zLTEtMS0xOTA5MDA_bedf6048-3904-4ab1-8564-61001ca45d95"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi02LTEtMS0xOTA5MDA_435718f0-acbc-4dc7-924d-fa738da41b1f"
      unitRef="usd">65000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi04LTEtMS0xOTA5MDA_e208bff1-7740-4d63-b18b-31d41d3e71cb"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi05LTEtMS0xOTA5MDA_dde6b2d8-d2fc-4099-8ca5-fc3a8c530e3b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="ia88f6dde0b964ca99c8a50cfdb240705_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfNi0xMC0xLTEtMTkwOTAw_572c687c-581b-4e38-b49e-a28495ea0636"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0xLTEtMS0xOTA5MDA_532cb633-dd50-47b9-a4b7-5991e5d2c739"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0yLTEtMS0xOTA5MDA_4d6d7ea9-ed5a-438a-aae5-2e93eba06ece"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0zLTEtMS0xOTA5MDA_a7680845-8242-4ba9-a0c8-0b7c493173bf"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC02LTEtMS0xOTA5MDA_a1456219-077d-4036-b254-e9328652f2c9"
      unitRef="usd">43000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC04LTEtMS0xOTA5MDA_cfb15e2f-f5af-4ac6-9efe-21b3fc302568"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC05LTEtMS0xOTA5MDA_c55201a7-d0de-47f7-a135-d7bee0a018af"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i4353264371b04e91b16a346daea2114e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfOC0xMC0xLTEtMTkwOTAw_22d9633a-e335-4546-9184-eabe03045b1d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMS0xLTEtMTkwOTAw_6048a163-50f7-4855-a363-1a5f6cb4f1e3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMi0xLTEtMTkwOTAw_25a0bcce-56c6-4692-b097-59c8486f00bf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMy0xLTEtMTkwOTAw_1eff7cab-2003-4f69-ab29-fb872e5da0ee"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtNi0xLTEtMTkwOTAw_435718f0-acbc-4dc7-924d-fa738da41b1f"
      unitRef="usd">65000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtOC0xLTEtMTkwOTAw_51bbaf8b-3b71-415a-b713-75283f88d1ad"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtOS0xLTEtMTkwOTAw_62588d5d-a2c4-4e3c-af03-65ea7106fa02"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6a4f7040a32d48d9918df357d163dc8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNmNGIwNWVhOWRkNTQ1NjNiMjI0N2I4Mjg4MWYzNjU1L3RhYmxlcmFuZ2U6Y2Y0YjA1ZWE5ZGQ1NDU2M2IyMjQ3YjgyODgxZjM2NTVfMTAtMTAtMS0xLTE5MDkwMA_7a290d73-e06c-4721-bd5f-a9103b3ebd50"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0xLTEtMS0xOTA5MDA_e3f0cb63-cfff-477c-9285-673b3cd4c67a"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0yLTEtMS0xOTA5MDA_a7cb5715-94cf-4fd7-b38a-18b4301f9be0"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0zLTEtMS0xOTA5MDA_dd9c2ca6-c1dc-4117-9505-77a34c51f610"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS02LTEtMS0xOTA5MDA_7c7f4ad1-3f51-4351-ba7e-3b6a052b4bdc"
      unitRef="usd">955000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS04LTEtMS0xOTA5MDA_00f516b3-253a-49b8-bf9e-60969397ac7e"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS05LTEtMS0xOTA5MDA_4a2e87a2-34d3-4a85-9d63-bebc2052c06b"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic76db327c0df40a49ea18f992520c9c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNS0xMC0xLTEtMTkwOTAw_dda97b59-2f85-4fca-be3c-ed07b7ffae19"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0xLTEtMS0xOTA5MDA_c4bb1d01-76da-4e1f-908e-5ac7c6da1e12"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0yLTEtMS0xOTA5MDA_8661090d-966f-46d9-a726-115d7aa5084e"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0zLTEtMS0xOTA5MDA_8bfbfbfc-98c8-4c4e-8ade-53d2dfb7f805"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi02LTEtMS0xOTA5MDA_fc71126f-21b7-4079-b775-140217ccb6ff"
      unitRef="usd">279000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi04LTEtMS0xOTA5MDA_42a67fd2-a8b9-4791-adfd-bc841264a806"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi05LTEtMS0xOTA5MDA_d5ec38e4-676e-4862-8ca0-99d280d96bdc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i604d52d7511a4332aafdb01088748afd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfNi0xMC0xLTEtMTkwOTAw_65e93823-eb67-4fdb-a9e4-e96143ab5677"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0xLTEtMS0xOTA5MDA_6ec960ce-9f0c-45e3-8ca7-5a1217d97fd8"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0yLTEtMS0xOTA5MDA_eea9085a-5194-4955-81e1-03833f184da5"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0zLTEtMS0xOTA5MDA_1ce41d2c-58ec-4ce8-978b-30cc47bc3282"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC02LTEtMS0xOTA5MDA_d187d415-ec34-4eeb-a1ea-fd2bc0cc9194"
      unitRef="usd">31000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC04LTEtMS0xOTA5MDA_11a86315-33ae-47bd-9fbd-46492cc215cb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC05LTEtMS0xOTA5MDA_3b9778fa-80c4-4b77-801f-33446fb766ba"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i783e008233514aabb69842649a72e8e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfOC0xMC0xLTEtMTkwOTAw_9317c160-b1de-4ca3-af8b-9474c29619b1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMS0xLTEtMTkwOTAw_195649ae-ae9b-4c93-8c1d-9c753163ef5f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMi0xLTEtMTkwOTAw_b1b1ef5b-aab1-4e69-9b32-f149e999ea09"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMy0xLTEtMTkwOTAw_2f26b51a-c5c0-4c8e-8dbe-cfd8b0608749"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtNi0xLTEtMTkwOTAw_fc71126f-21b7-4079-b775-140217ccb6ff"
      unitRef="usd">279000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtOC0xLTEtMTkwOTAw_53167074-ede9-46e9-9cd7-4b4e08c15423"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtOS0xLTEtMTkwOTAw_270e2b6d-fd63-4f95-a732-e6803d84b249"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3cd3757556ec4d6e989b91ddd025b82d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjI3MTEzODRlZmRmMTRmNzY4ODUxYmEyMjVlNjJmY2ZmL3RhYmxlcmFuZ2U6MjcxMTM4NGVmZGYxNGY3Njg4NTFiYTIyNWU2MmZjZmZfMTAtMTAtMS0xLTE5MDkwMA_ede68a8e-7765-4cd4-aa5e-cf3631372bf3"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i9b13667e719d448990cfdf861dda79e9_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_29689ede-1f5b-442a-b35e-06700a51d862"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i9b13667e719d448990cfdf861dda79e9_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_b46dbc61-95c8-4f44-8649-c52eb480d31f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i5662554837084169851758271c9ea643_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_c9850542-259a-4068-a8df-f7f87e3cc40f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i5662554837084169851758271c9ea643_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfODA2NA_fd29fda2-bd91-4f33-a4e7-e6dff3153536"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNjA_bdf3f4e1-45d1-4a9d-bff2-f197256052cc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="icfe2b43cff154363a0fbd139022c61e4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjEzYzI5Y2RjNzdiODQzZDFiM2UwZWI3MmZmOGVkODZiL3RhYmxlcmFuZ2U6MTNjMjljZGM3N2I4NDNkMWIzZTBlYjcyZmY4ZWQ4NmJfMi02LTEtMS0xOTA5MDA_b6594121-6312-49a4-8693-d3f08b81cba2"
      unitRef="usd">189000000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet
      contextRef="i988b6f2675a842b0bf177b07312667ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjEzYzI5Y2RjNzdiODQzZDFiM2UwZWI3MmZmOGVkODZiL3RhYmxlcmFuZ2U6MTNjMjljZGM3N2I4NDNkMWIzZTBlYjcyZmY4ZWQ4NmJfMy02LTEtMS0xOTA5MDA_7ae20cd4-068f-43dc-a89a-deb971c5cdc3"
      unitRef="usd">9000000</bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i533dcba4722d4149a322054e6c21ee4e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjEzYzI5Y2RjNzdiODQzZDFiM2UwZWI3MmZmOGVkODZiL3RhYmxlcmFuZ2U6MTNjMjljZGM3N2I4NDNkMWIzZTBlYjcyZmY4ZWQ4NmJfNC02LTEtMS0xOTA5MDA_3a024e7e-7d13-4e57-8f45-03113d2ad764"
      unitRef="usd">-3000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxOTg_dbd00209-786e-4a37-938c-f9182a510ec0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="ic842743075f046118858ebcc610ace3b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMi00LTEtMS0xOTA5MDA_4e4ad668-55ba-4ddc-9ca0-94b1393939dd"
      unitRef="usd">-8000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMi02LTEtMS0xOTA5MDA_9fa3fddd-6eca-461d-a7df-5ddf07fe212f"
      unitRef="usd">-29000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ic842743075f046118858ebcc610ace3b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMy00LTEtMS0xOTA5MDA_9a353da9-fdc4-452a-9017-3f85ca7fe954"
      unitRef="usd">-6000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfMy02LTEtMS0xOTA5MDA_bfe3f286-aa5d-42b9-86eb-98436bd83252"
      unitRef="usd">21000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <bsx:Netcurrencyexchangegainloss
      contextRef="ic842743075f046118858ebcc610ace3b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfNC00LTEtMS0xOTA5MDA_0442aa93-0fa1-4371-8bcd-376e6a79ea37"
      unitRef="usd">-14000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="ia1fbd3a5c02348ae9988bcc0fb63d2e5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjdkZDNkM2I3Y2U4ODQ2ZDc5NDUwZDE3NTRhNmQ3Y2VhL3RhYmxlcmFuZ2U6N2RkM2QzYjdjZTg4NDZkNzk0NTBkMTc1NGE2ZDdjZWFfNC02LTEtMS0xOTA5MDA_2917b02a-60bb-4509-87a7-062591ef7b46"
      unitRef="usd">-9000000</bsx:Netcurrencyexchangegainloss>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxOTA_1eb0cf5c-4dd8-4d49-8acb-4bc5cfdc4bf3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNzU_4c246301-612a-4068-89bd-0c1c4dd6ae10">The following are the balances of our derivative and nonderivative assets and liabilities:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the &#x20ac;900 million debt principal associated with our 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i9a67240557664530a64b7331a50a1002_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNC00LTEtMS0xOTA5MDA_c8288b8a-847b-4d1f-9940-39b7b9bb0bed"
      unitRef="usd">168000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i1c9733ef28a84cab80420249d9e34d87_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNC02LTEtMS0xOTA5MDA_2775a26a-fd36-4c7d-8171-61a15e6cfdcf"
      unitRef="usd">196000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i3156378bfa9448c8b52d41d89ee9ce34_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNS00LTEtMS0xOTA5MDA_ef46caea-8b42-4553-a443-4a4f987e623a"
      unitRef="usd">132000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ia66d194331bf40009415048dd898504b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNS02LTEtMS0xOTA5MDA_98291def-fa46-40b9-99a3-496038472acd"
      unitRef="usd">149000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ia0625121c73b44dba2d3eade5207ea87_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNi00LTEtMS0xOTA5MDA_90ddbbe3-6957-4d30-b1c5-bc4b7de06351"
      unitRef="usd">299000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i07d1fca83b854131a110d8eddc52fb99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfNi02LTEtMS0xOTA5MDA_3086c4b0-cb1d-47c5-8bd7-cf3ba4be1467"
      unitRef="usd">345000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i945f22e98cb74c1c921b309349665d17_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfOC00LTEtMS0xOTA5MDA_0239ebce-fe30-43ae-803d-5aaf63936df3"
      unitRef="usd">19000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i1ac0fa25ca3e402287e10a15580bdd69_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfOC02LTEtMS0xOTA5MDA_fb30e9d2-5410-48cc-90f4-3c551ce828a1"
      unitRef="usd">36000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTAtNC0xLTEtMTkwOTAw_7737a891-3fc4-4c44-b52b-6def7eec03c0"
      unitRef="usd">319000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTAtNi0xLTEtMTkwOTAw_923857f4-4999-476c-9234-be19d1ccefe8"
      unitRef="usd">381000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i6dbe63612beb45b3af51e535c5506a1e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTUtNC0xLTEtMTkwOTAw_9396b3c8-928f-4e13-aa51-484a435f826b"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i2ce906fb637148c7bbedc7b9646ab929_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTUtNi0xLTEtMTkwOTAw_7ba3ebc2-9b7e-4a38-a13b-841f48738d93"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ic29f210b79834812843eecfdcd89818f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTYtNC0xLTEtMTkwOTAw_1c4a1e0b-b70f-4a9f-b87a-dbe0a68eb113"
      unitRef="usd">971000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i38524f4cd7624584aff36aaaa318766a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTYtNi0xLTEtMTkwOTAw_0f5c1a0e-c039-48d3-8dd2-bcbd224d2b41"
      unitRef="usd">952000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ia0625121c73b44dba2d3eade5207ea87_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTgtNC0xLTEtMTkwOTAw_f663ec30-1955-46e1-96c8-189c5e707461"
      unitRef="usd">972000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i07d1fca83b854131a110d8eddc52fb99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMTgtNi0xLTEtMTkwOTAw_7489c034-92c0-40f7-a1e7-24dc7444e269"
      unitRef="usd">953000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i898b0c24ec0d4089ac323f8880881ab3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjAtNC0xLTEtMTkwOTAw_40d065fd-f851-4f06-a8d4-95afc12ef296"
      unitRef="usd">37000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i173913dc9a954a229c38034702d71dc5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjAtNi0xLTEtMTkwOTAw_82b491b3-6b15-4329-aa49-79ab5b3f4397"
      unitRef="usd">52000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjEtNC0xLTEtMTkwOTAw_2ad0cac3-2699-4337-844b-a3a4b7f8235c"
      unitRef="usd">1009000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjhiZTBlYmQzZDliNzQ0ZTNiZjAzMGE0MjIyZmE0MjBmL3RhYmxlcmFuZ2U6OGJlMGViZDNkOWI3NDRlM2JmMDMwYTQyMjJmYTQyMGZfMjEtNi0xLTEtMTkwOTAw_711aa731-ab1b-4a67-be16-626f339408b6"
      unitRef="usd">1005000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebt
      contextRef="ife05e78966de43f7831ac0435f16576a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfOTkxMg_fcb0fa53-b33c-47a1-8db9-271deea5dd26"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTQxNzE_b6444e9d-9607-46cd-866c-b17f55a5eef8">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;674&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,313&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of March&#160;31, 2023 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$113 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$120 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xLTEtMS0xOTA5MDA_314ab883-a11c-441f-b505-7914c7b0a8ae"
      unitRef="usd">170000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0zLTEtMS0xOTA5MDA_ca53fefd-1bed-4108-b04a-a23477fa1e49"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC01LTEtMS0xOTA5MDA_80c00944-86bc-4827-8338-14933428a311"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC03LTEtMS0xOTA5MDA_e50c1239-a71b-4a85-a595-b0de65e6eae7"
      unitRef="usd">170000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC05LTEtMS0xOTA5MDA_2e395b67-8d8e-4117-a5c9-3550c7d0c171"
      unitRef="usd">673000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xMS0xLTEtMTkwOTAw_fab77f84-dfc7-4c10-863f-9c79d260338e"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xMy0xLTEtMTkwOTAw_84dca408-4427-4eaa-813c-adcf96fdd0b2"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNC0xNS0xLTEtMTkwOTAw_f0dd1175-cf26-4d03-9826-57492726e05f"
      unitRef="usd">673000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xLTEtMS0xOTA5MDA_e542af8c-4b0c-400b-a1ad-fb85c3b15427"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0zLTEtMS0xOTA5MDA_9723d3db-9b2c-47ea-a70a-6d4e27fa932f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS01LTEtMS0xOTA5MDA_62722c64-b46b-4ee1-a821-298784cf7f84"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS03LTEtMS0xOTA5MDA_386a4f6b-354b-4446-80ac-7b6748fdb70a"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS05LTEtMS0xOTA5MDA_f693ea15-f840-4a9b-9d6c-a3db994e4fa9"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xMS0xLTEtMTkwOTAw_6a3e4e42-bd53-4fb7-b644-f52d478a8b6c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xMy0xLTEtMTkwOTAw_eb81e857-d71a-4636-9e61-109630ae41db"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNS0xNS0xLTEtMTkwOTAw_e1a35aab-c742-408b-98b4-a929009dab3a"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xLTEtMS0xOTA5MDA_9ecbab1e-a6be-4c7e-a0af-ff3781d1a41f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0zLTEtMS0xOTA5MDA_f34b37b1-3c55-429e-827e-d751181da376"
      unitRef="usd">319000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi01LTEtMS0xOTA5MDA_ff8c41ee-08bd-4a9f-85e6-ea61fb2fd09e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi03LTEtMS0xOTA5MDA_c211a95b-8673-40f5-9aa3-92106dc613b6"
      unitRef="usd">319000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi05LTEtMS0xOTA5MDA_862efa8e-f15d-47ac-9be1-97827272962e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xMS0xLTEtMTkwOTAw_bfe50c05-4a66-429a-845e-0028b778e7ea"
      unitRef="usd">381000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xMy0xLTEtMTkwOTAw_a3c06e9b-0ec1-4dd3-818d-6612d1377d7a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNi0xNS0xLTEtMTkwOTAw_8f58f001-a124-46b0-aec4-7ec22fc87fb2"
      unitRef="usd">381000000</us-gaap:DerivativeAssets>
    <bsx:Licensingarrangementsasset
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xLTEtMS0xOTA5MDA_360a4805-2731-4c18-acc5-7d1ae78d7b5c"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0zLTEtMS0xOTA5MDA_a8b47554-9977-4d00-b576-3d406d88e418"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy01LTEtMS0xOTA5MDA_2f19bb55-7b5e-4d8b-a2f8-0052532af7cf"
      unitRef="usd">113000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy03LTEtMS0xOTA5MDA_c72f9b63-9886-4083-90ca-c6eb58b74e86"
      unitRef="usd">113000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy05LTEtMS0xOTA5MDA_9ffbf972-b545-4937-923a-4c33b1bd14df"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xMS0xLTEtMTkwOTAw_39ed1404-c65a-4c99-9bb2-f7b31d9175b5"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xMy0xLTEtMTkwOTAw_80632c42-ee09-45e3-ae5d-1bffe6f1f755"
      unitRef="usd">127000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfNy0xNS0xLTEtMTkwOTAw_350f1422-0715-480c-8723-4d2daa9783a4"
      unitRef="usd">127000000</bsx:Licensingarrangementsasset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xLTEtMS0xOTA5MDA_6bed7698-73de-410f-9fb8-0023ce3ffc56"
      unitRef="usd">172000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0zLTEtMS0xOTA5MDA_d7ee5a5d-d387-4c27-bfe1-4ef3e29958f2"
      unitRef="usd">319000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC01LTEtMS0xOTA5MDA_41383734-b543-4edb-b42b-5f1685b04db3"
      unitRef="usd">113000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC03LTEtMS0xOTA5MDA_c97fde6a-b2f0-40ff-a9b9-be0b3d2a3fa7"
      unitRef="usd">604000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC05LTEtMS0xOTA5MDA_2e782927-511f-4b8c-b701-5ead155068de"
      unitRef="usd">674000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xMS0xLTEtMTkwOTAw_cbefff54-6d5d-44ee-83a0-bad05b67288f"
      unitRef="usd">381000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xMy0xLTEtMTkwOTAw_3788a87c-1efe-42c3-8356-48425cf91874"
      unitRef="usd">127000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfOC0xNS0xLTEtMTkwOTAw_e1e752d0-eeff-45ec-982d-68703227db31"
      unitRef="usd">1182000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMS0xLTEtMTkwOTAw_fd181395-ebac-4589-a844-b62e1d68ac72"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMy0xLTEtMTkwOTAw_28a3cd05-50bc-47df-92a0-7376d17b8186"
      unitRef="usd">1009000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtNS0xLTEtMTkwOTAw_42133548-0107-4009-9c3c-701013db2147"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtNy0xLTEtMTkwOTAw_a8b02708-fcdd-4a65-904a-17d705732edb"
      unitRef="usd">1009000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtOS0xLTEtMTkwOTAw_539daa5f-b78f-4985-b483-3b3cf3dacafa"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMTEtMS0xLTE5MDkwMA_f8a67ab3-891b-423f-b766-cf891e5cae96"
      unitRef="usd">1005000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMTMtMS0xLTE5MDkwMA_a0dbccad-de5e-4cec-9959-6534c60f581e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTAtMTUtMS0xLTE5MDkwMA_c3ff4c70-b0bb-48a8-a15c-dd86aed8fa2a"
      unitRef="usd">1005000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMS0xLTEtMTkwOTAw_7e32d864-25ac-4a36-8f25-637edbb8d3cb"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMy0xLTEtMTkwOTAw_6cd3c0fd-e93d-4ffd-8149-68ba860704af"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtNS0xLTEtMTkwOTAw_2bc47a1c-bfb1-4859-a09f-e8de423a63a5"
      unitRef="usd">93000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtNy0xLTEtMTkwOTAw_04e3cad7-2b2f-44b0-aaa4-627e4a92a2b5"
      unitRef="usd">93000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtOS0xLTEtMTkwOTAw_24feb00e-e404-41dd-863e-cf8d43185d25"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMTEtMS0xLTE5MDkwMA_58176d24-4c50-413c-bd12-7eccd74d85e9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMTMtMS0xLTE5MDkwMA_637bb6a8-190d-462e-a258-b3f303dd21b6"
      unitRef="usd">149000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTEtMTUtMS0xLTE5MDkwMA_117cc8ea-6481-477e-9907-eb4e186df299"
      unitRef="usd">149000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:Licensingarrangementsliability
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMS0xLTEtMTkwOTAw_a8b2ec5c-4eb2-4a59-9b78-4e16094e9abf"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMy0xLTEtMTkwOTAw_cf2e81b0-5e87-43fd-a252-cb4259785ad9"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItNS0xLTEtMTkwOTAw_85c64eba-02a0-48b1-9350-afd01fc54759"
      unitRef="usd">120000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItNy0xLTEtMTkwOTAw_710ff144-4aed-4d13-ac17-12b50d2b8a26"
      unitRef="usd">120000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItOS0xLTEtMTkwOTAw_23666e66-dcc5-439f-8930-ae53c1b06f65"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMTEtMS0xLTE5MDkwMA_af55ee11-f3d9-4c93-a482-0608c3d22095"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMTMtMS0xLTE5MDkwMA_42ec3dde-8a34-4ca7-86ca-cb8029c3b811"
      unitRef="usd">159000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTItMTUtMS0xLTE5MDkwMA_87bf7d2b-630b-405f-857f-71b99d697372"
      unitRef="usd">159000000</bsx:Licensingarrangementsliability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMS0xLTEtMTkwOTAw_2fc7ec00-f23a-4146-9ceb-ed251170b891"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3dc55f108fce475dbd810515e835da38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMy0xLTEtMTkwOTAw_569b1e1e-9563-4c60-93fa-1daeed5ec520"
      unitRef="usd">1009000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtNS0xLTEtMTkwOTAw_2c5f3656-6277-4df4-b62a-78219280d46b"
      unitRef="usd">213000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i51a5c614a81345d596f132ed31bd8119_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtNy0xLTEtMTkwOTAw_10ad80b8-6d74-4c5e-9ce9-9401f312ba9c"
      unitRef="usd">1222000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtOS0xLTEtMTkwOTAw_0e0880d4-94fb-438c-a8b0-0d2bc6005f22"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i64284d2d674f41c599406b01b23425de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMTEtMS0xLTE5MDkwMA_b341ee8c-918f-4328-80e5-ae24a078c97b"
      unitRef="usd">1005000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMTMtMS0xLTE5MDkwMA_47ac1156-2f33-47bc-b1f7-63707bd4318b"
      unitRef="usd">308000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1bd7be06f3824d1989da8148901d8857_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmY2NzcxNmU0MWVlZjQ1NjlhMjJiMDE0NDNhODQ3MzlkL3RhYmxlcmFuZ2U6ZjY3NzE2ZTQxZWVmNDU2OWEyMmIwMTQ0M2E4NDczOWRfMTMtMTUtMS0xLTE5MDkwMA_92878604-aaa1-4134-b70a-1e85a9ef7e96"
      unitRef="usd">1313000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ibba79a1a66ec493ea4f7bd9c95df17a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTE2MTM_314ab883-a11c-441f-b505-7914c7b0a8ae"
      unitRef="usd">170000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="iafdb1c08d9594ebc81c23f84214e5a94_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTE2Nzg_2e395b67-8d8e-4117-a5c9-3550c7d0c171"
      unitRef="usd">673000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:Cash
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTE2OTk_b7bd2586-5555-4e8c-9ee3-96ad5c5577a7"
      unitRef="usd">400000000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTA5OTUxMTY0MzAwNQ_86fed00e-ed7d-4d78-8e72-094d4b7e4c56"
      unitRef="usd">256000000</us-gaap:Cash>
    <bsx:Licensingarrangementsasset
      contextRef="ied2485d2d4fc42b2b4036a2cad3a8e72_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfMS0xLTEtMS0xOTA5MDA_1e6f99a9-4604-4e69-985b-4bea16b6190f"
      unitRef="usd">113000000</bsx:Licensingarrangementsasset>
    <bsx:DiscountRateFairValueInput
      contextRef="i9892c74d12a64698ac3adb3291ee7fff_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfMS00LTEtMS0xOTA5MDA_d80cde16-f716-4c28-8537-f71859272eb4"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ifae34dead96b45bcaba914062e411b97_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfMS03LTEtMS0xOTA5MDA_43deb376-eae2-48a6-b3b8-eeb840acc200"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsliability
      contextRef="ied2485d2d4fc42b2b4036a2cad3a8e72_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC0xLTEtMS0xOTA5MDA_6a289c10-1fc0-49c4-b40e-97fcfde06973"
      unitRef="usd">120000000</bsx:Licensingarrangementsliability>
    <bsx:DiscountRateFairValueInput
      contextRef="i64d6aed0afb24247bf0a0818471c3a5f_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC00LTEtMS0xOTA5MDA_9fe30e75-e527-48e9-94a2-2b6e43f956a4"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i238dacb96f504855af458d65d8c5cce3_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC02LTEtMS0xOTA5MDA_a5724c60-1827-4a6a-993c-d6bee00ef7b6"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i227be4a1b97846078107b1f776038d7a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjRhN2Q4NmZiYTMxZDQxZDE5YmE3NzhiZThmYzQyZjg2L3RhYmxlcmFuZ2U6NGE3ZDg2ZmJhMzFkNDFkMTliYTc3OGJlOGZjNDJmODZfNC03LTEtMS0xOTA5MDA_94ae2689-e4db-4469-96b8-d2ae63b46ed2"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsasset
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfMS0xLTEtMS0xOTA5MDA_9dffbdfe-9af2-4f6f-a04a-1c8e2f30e189"
      unitRef="usd">127000000</bsx:Licensingarrangementsasset>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="if03bea69ff7e4976a0b0e30e39be825e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfMi0xLTEtMS0xOTA5MDA_2db7ee43-d9a7-4aa7-a398-9ad1c443c57f"
      unitRef="usd">18000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="if03bea69ff7e4976a0b0e30e39be825e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfMy0xLTEtMS0xOTA5MDA_6b0617ae-b455-4348-ba58-dd0e855ffd80"
      unitRef="usd">4000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsasset
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOjM1NDdkNTA4ZjgxNzRhNThhMmYxOWM4YjNiODllZDg1L3RhYmxlcmFuZ2U6MzU0N2Q1MDhmODE3NGE1OGEyZjE5YzhiM2I4OWVkODVfNC0xLTEtMS0xOTA5MDA_4c8f4018-1dfa-4839-9fc9-21092abbf8ee"
      unitRef="usd">113000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsliability
      contextRef="i1b970c3c44be41b196e66ac05259c26d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfMS0xLTEtMS0xOTA5MDA_c5f00acf-00d1-45bc-8fb0-fabfcd2f2d37"
      unitRef="usd">159000000</bsx:Licensingarrangementsliability>
    <us-gaap:PaymentsForRoyalties
      contextRef="i568fb51f289d40f6ba75256d02005ddf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfMi0xLTEtMS0xOTA5MDA_264c1ad0-d5b2-4e57-9f37-306a2d80a634"
      unitRef="usd">43000000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i568fb51f289d40f6ba75256d02005ddf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfMy0xLTEtMS0xOTA5MDA_49c9c889-d7e8-40f0-b226-c33042aaaefd"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsliability
      contextRef="i91b5ea7f66c54577bf9e3acc1c6e56a9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RhYmxlOmNkNGQzYTllMDkwNzQyNGRiMTljMTVjYzhlODFlNDNiL3RhYmxlcmFuZ2U6Y2Q0ZDNhOWUwOTA3NDI0ZGIxOWMxNWNjOGU4MWU0M2JfNC0xLTEtMS0xOTA5MDA_37a326d5-7905-426f-b82e-469198ccfa77"
      unitRef="usd">120000000</bsx:Licensingarrangementsliability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTM4MDg_c04d5b1b-9662-4eef-92e9-218b9326ca90"
      unitRef="usd">8467000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF81NS9mcmFnOmY4YzdhNWQ3M2I2NTRhOGU4Y2M1OTY0MWZhZWU1NjQ5L3RleHRyZWdpb246ZjhjN2E1ZDczYjY1NGE4ZThjYzU5NjQxZmFlZTU2NDlfMTM4MjQ_fc5b76f2-d26b-4e1f-ad35-63243e83b79c"
      unitRef="usd">8203000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkzNw_e9e80d0c-d7e1-4d7f-9621-79c90067180f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE E &#x2013; CONTRACTUAL OBLIGATIONS AND COMMITMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Borrowings and Credit Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had total debt outstanding of $9.005 billion as of March&#160;31, 2023 and $8.935 billion as of December&#160;31, 2022, with current obligations of $510 million as of March&#160;31, 2023 and $20 million as of December&#160;31, 2022. The debt maturity schedule for our long-term debt obligations is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.875%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,495&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,915&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective May 2023, the interest rate payable will decrease by 0.25 percent and begin accruing at a rate of 6.50 percent following recent upgrades to our credit ratings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 10, 2021, we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks scheduled to mature on May 10, 2026, with one-year extension options, subject to certain conditions. On March 1, 2023, we entered into an amendment of the 2021 Revolving Credit Facility credit agreement, which provided for an extension of the scheduled maturity date to May 10, 2027 and replaced the London Interbank Offered Rate (LIBOR) with the Secured Overnight Financing Rate (SOFR) as the Eurocurrency Rate for Dollars, including applicable credit spread adjustments and relevant SOFR benchmark provisions, among other things described under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the 2021 Revolving Credit Facility as of March&#160;31, 2023 or December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.52 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Revolving Credit Facility includes the financial covenant requirement for all of our credit arrangements that we maintain the maximum permitted leverage ratio of 3.75 times through the remaining term. The agreement provides for higher leverage ratios, at our election, for the period following a qualified acquisition for which consideration exceeds $1.000 billion. In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times. The maximum permitted ratio steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively. Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility. We have not elected to increase the maximum permitted leverage ratio for any qualified acquisitions due to our funding of these acquisitions using cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenant requirement, as amended on March 1, 2023, provides for an exclusion from the calculation of consolidated EBITDA, as defined by the credit agreement, through maturity, of certain charges and expenses. The credit agreement amendment reset the starting date for purposes of calculating such permitted exclusions in each case from March 31, 2021 to December 31, 2022. Permitted exclusions include any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses associated with our current or future restructuring plans. As of March&#160;31, 2023, we had $457 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreement, are excluded from the calculation of consolidated EBITDA, as defined by the agreement, provided that the sum of any excluded net cash litigation payments do not exceed $1.000 billion plus all accrued legal liabilities as of December&#160;31, 2022 for a total of $1.443 billion. As of March&#160;31, 2023, we had $1.424 billion of the litigation exclusion remaining.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any inability to maintain compliance with this covenant could require us to seek to renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable&lt;/span&gt;&lt;span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper program is backed by the 2021 Revolving Credit Facility. We had no commercial paper outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In April 2023, we issued commercial paper to partially fund our acquisition of Apollo. As of the date of this Quarterly Report on Form 10-Q, we had approximately $400 million of commercial paper outstanding, which directly reduces our borrowing capacity under the 2021 Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had senior notes outstanding of $9.067 billion as of March&#160;31, 2023 and $8.986 billion as of December&#160;31, 2022. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, American Medical Systems Europe B.V. (AMS Europe), an indirect, wholly owned subsidiary of Boston Scientific, completed a registered public offering (the Offering) of &#x20ac;3.000 billion in aggregate principal amount of euro-dominated senior notes comprised of &#x20ac;1.000 billion of 0.750% Senior Notes due 2025, &#x20ac;750 million of 1.375% Senior Notes due 2028, &#x20ac;750 million of 1.625% Senior Notes due 2031 and &#x20ac;500 million of 1.875% Senior Notes due 2034 (collectively, the Eurobonds). Boston Scientific has fully and unconditionally guaranteed all of AMS Europe's obligations under the Eurobonds, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and no other subsidiary of Boston Scientific will guarantee these obligations. AMS Europe is a &#x201c;finance subsidiary&#x201d; as defined in Rule 13-01(a)(4)(vi) of Regulation S-X. The financial condition, results of operations and cash flows of AMS Europe are consolidated in the financial statements of Boston Scientific. The Offering resulted in cash proceeds of $3.270 billion, net of investor discounts and issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used the net proceeds from the Offering to fund the tender offer and early redemption of combined aggregate principal amount of $3.275&#160;billion of certain of our outstanding senior notes, as well as to pay accrued interest, tender premiums, fees and expenses. We recorded associated debt extinguishment charges of $194 million during the first quarter of 2022 presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had outstanding letters of credit of $143 million as of March&#160;31, 2023 and $135 million as of December&#160;31, 2022, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of March&#160;31, 2023 and December&#160;31, 2022 we had not recognized a related liability for any outstanding letters of credit within our accompanying unaudited consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a supplier financing program offered primarily in the U.S. where our suppliers can opt to receive early payment at a nominal discount, while allowing us to lengthen our payment terms and optimize working capital. Our standard payment term in the U.S. is 90 days. All outstanding payables related to the supplier finance program are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our unaudited consolidated balance sheets and were $128 million as of March&#160;31, 2023 and $129 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzk_a8c45f24-5a6b-4e3f-9eb2-b74a5aa47735"
      unitRef="usd">9005000000.000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfOTU_4808aa9c-5c3f-4751-946b-de11c39b5524"
      unitRef="usd">8935000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTM2_d0c99085-efdc-45f5-9a55-66bc523b35dc"
      unitRef="usd">510000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTUy_1d248772-ca78-401c-91fb-3a804d2ea6a0"
      unitRef="usd">20000000</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkyMg_29b25e48-0ff6-4c01-b0b7-cb8c015e30df">The debt maturity schedule for our long-term debt obligations is presented below: &lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.875%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,495&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,915&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Coupon rates are semi-annual, except for the euro-denominated senior notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Effective May 2023, the interest rate payable will decrease by 0.25 percent and begin accruing at a rate of 6.50 percent following recent upgrades to our credit ratings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;These notes are euro-denominated and presented in U.S. dollars based on the exchange rate in effect as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;(4)&#160;&#160;&#160;&#160;Amounts repaid, or partially repaid as the case may be, in connection with the March 2022 tender offer and early redemption of certain of our outstanding senior notes are described below.</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i62061beaf669413399ee8f50383a8892_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNC02LTEtMS0xOTA5MDA_26f9d7bd-2efd-47b1-a28f-4a989b452f87"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idd06220f00384ae1a2d2a575490aaa1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNC04LTEtMS0xOTA5MDA_0aaa1230-a59f-4132-b2fb-4b069b2a1895"
      unitRef="usd">504000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62061beaf669413399ee8f50383a8892_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNC0xMC0xLTEtMTkwOTAw_3ab279a8-d20e-4dce-ade3-c5b30d75c1d2"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNS02LTEtMS0xOTA5MDA_6b5a789b-9fb9-4b2a-a45c-f5c4de189446"
      unitRef="usd">1088000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id2e5cf0d439f46b3b717276488fa7f9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNS04LTEtMS0xOTA5MDA_dc2b67c4-01ff-4530-9e74-395847e46292"
      unitRef="usd">1067000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNS0xMC0xLTEtMTkwOTAw_be91e41e-e93f-46ff-a36f-70ec62a6b27c"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i15c4a58684af4de9a487717ee618db7c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNy02LTEtMS0xOTA5MDA_22a0032a-08b5-4910-a751-595f6e8a3c15"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2e6c809593e643f1a097ae6dde04b29b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNy04LTEtMS0xOTA5MDA_cd98618e-2731-48d2-b26f-12c824c7acbe"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i15c4a58684af4de9a487717ee618db7c_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfNy0xMC0xLTEtMTkwOTAw_a65e3151-e09d-4418-b56f-e92fbf22a54d"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib14a9ce7ffb8424bafe5c3db543bd32a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOC02LTEtMS0xOTA5MDA_ae0eda16-0f97-4c0e-a4ff-23c81ba9e909"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i088272e4bb994960b019011fb46c0bcd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOC04LTEtMS0xOTA5MDA_34b1d457-7374-445e-acad-889a2f43c9cb"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib14a9ce7ffb8424bafe5c3db543bd32a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOC0xMC0xLTEtMTkwOTAw_da0b9780-2585-4609-a862-887b00c121b2"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ife05e78966de43f7831ac0435f16576a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOS02LTEtMS0xOTA5MDA_0a60bb9f-8815-4d0e-b755-735865b6747d"
      unitRef="usd">979000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i329ce681993e4c38be14123408b7f068_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOS04LTEtMS0xOTA5MDA_f64ec8e1-5594-4a6d-8081-4bbf68e69765"
      unitRef="usd">960000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ife05e78966de43f7831ac0435f16576a_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfOS0xMC0xLTEtMTkwOTAw_016ed6dd-b6c3-43e8-b689-29f1a27c9afa"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTAtNi0xLTEtMTkwOTAw_771b011a-dc10-4758-bc59-f8156922e231"
      unitRef="usd">816000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i312f5201ec3c474d9b5a19c25fa7259b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTAtOC0xLTEtMTkwOTAw_8513c8d1-be57-490a-9eeb-130428513686"
      unitRef="usd">800000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTAtMTAtMS0xLTE5MDkwMA_955f3563-03e0-4835-b944-f0eda2b99c9f"
      unitRef="number">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0c3009e88a024e31b2102e6f4b8d5acb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTEtNi0xLTEtMTkwOTAw_152b53cd-251e-4cdf-ba13-bbc5af62a06f"
      unitRef="usd">344000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i756598df01014441b201792edc1fde81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTEtOC0xLTEtMTkwOTAw_a9958174-a26f-47eb-a0f2-71a2acc44b80"
      unitRef="usd">344000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0c3009e88a024e31b2102e6f4b8d5acb_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTEtMTAtMS0xLTE5MDkwMA_1940fc08-95ff-400e-aae0-0d8880f1adf0"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6a479cf5286f46b28b355c4f1a206db6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTItNi0xLTEtMTkwOTAw_625a0556-6852-4b2b-8a87-cf0676d7cdcb"
      unitRef="usd">272000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0554d11e01874a65b0a89d983fc7a7a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTItOC0xLTEtMTkwOTAw_224f4245-a982-4315-8f56-7a4d22aaa7f2"
      unitRef="usd">272000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a479cf5286f46b28b355c4f1a206db6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTItMTAtMS0xLTE5MDkwMA_a5001517-62f7-42fc-b097-15cedb8e1ae0"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9d7028932f6e425aab12bf8635b89b38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTMtNi0xLTEtMTkwOTAw_8fdecbd7-ace0-4877-b2af-9915d93b17bc"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icc2b17f7d56a4b5aa6d7e274b8e3927b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTMtOC0xLTEtMTkwOTAw_90a746ab-fdb4-43fe-9c0f-2fdfba3ab8a4"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d7028932f6e425aab12bf8635b89b38_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTMtMTAtMS0xLTE5MDkwMA_43083b20-809b-49c1-9b96-d747695d5b26"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTQtNi0xLTEtMTkwOTAw_700e83a7-aa55-4dfc-a8ac-e9659ff226e8"
      unitRef="usd">816000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i67c3d756333b4be29340b18df8cd60c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTQtOC0xLTEtMTkwOTAw_1a5ef0a2-5a63-44a8-b2b9-4fdc86e39866"
      unitRef="usd">800000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTQtMTAtMS0xLTE5MDkwMA_d8541632-1e3d-427e-811e-3cef5c11cce2"
      unitRef="number">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i466b11229a244bf095c3c6d222c59179_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTUtNi0xLTEtMTkwOTAw_2df4ef09-e50f-49f0-bc26-884d566bf574"
      unitRef="usd">544000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i67d72460629d49a5bfd6e1d207d392c8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTUtOC0xLTEtMTkwOTAw_85635932-d066-49ba-b67e-4e5d8218835e"
      unitRef="usd">534000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i466b11229a244bf095c3c6d222c59179_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTUtMTAtMS0xLTE5MDkwMA_5a0736b6-166a-4176-a9de-66db7fbe1d7a"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icf8331296051435fb2a207702eabbbd7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTYtNi0xLTEtMTkwOTAw_ba290da7-0a97-4f28-838f-a1bb1feedbda"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i90ed1700e1b14f63b822bf214bf1ce6e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTYtOC0xLTEtMTkwOTAw_0891c2c3-9248-4d84-b9a7-c4584b069b91"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icf8331296051435fb2a207702eabbbd7_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTYtMTAtMS0xLTE5MDkwMA_dba312da-3f26-48eb-af97-28e36d9ef332"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie7750de1d7104c23afc566121d84f163_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTctNi0xLTEtMTkwOTAw_679c672d-ce6d-4c7f-ae26-1da41b57e19e"
      unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4fae5b08170b41889f5b3dedb667c496_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTctOC0xLTEtMTkwOTAw_c5dab5b7-e435-4faa-96ec-cfa166edcd8e"
      unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie7750de1d7104c23afc566121d84f163_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTctMTAtMS0xLTE5MDkwMA_c7a2ff21-0876-48e9-a5b9-067ad02f170b"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i960943048d6b4bd9ba267c6e877a0a08_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTgtNi0xLTEtMTkwOTAw_fe6d0483-4d24-46c9-9e52-7289ceb0bd18"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9f0b0dd532a74f04a579435e6746d19e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTgtOC0xLTEtMTkwOTAw_19b645fe-6921-4997-abad-976a320d7405"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i960943048d6b4bd9ba267c6e877a0a08_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTgtMTAtMS0xLTE5MDkwMA_93bc0cc3-b21a-4e51-8606-1b10df6410cb"
      unitRef="number">0.07375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0fc300f5c54f4bb08de690a8b948588e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTktNi0xLTEtMTkwOTAw_35461b61-4db8-450d-b865-dccf46a589ea"
      unitRef="usd">650000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ieb6225368867454f86259df1ee8ed4f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTktOC0xLTEtMTkwOTAw_eb58db8e-3c5c-40bd-81fa-083e5c5e8f01"
      unitRef="usd">650000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0fc300f5c54f4bb08de690a8b948588e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMTktMTAtMS0xLTE5MDkwMA_484b62be-4d75-4947-8a0a-f17a34c6532c"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i6a33141a69104417b94015557d906a3c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjAtNi0xLTEtMTkwOTAw_f57c79fc-4d8e-4d72-b196-c425baada9e7"
      unitRef="usd">-73000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i9e31ad2072de41b69ce29a3a8a2beccb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjAtOC0xLTEtMTkwOTAw_819d9dac-1bac-4a93-8b9c-f90b7f9cc7b6"
      unitRef="usd">-76000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i77928e50ff7a48e385018d59595b61eb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjItNi0xLTEtMTkwOTAw_afc593f5-6075-4a21-b168-74d54c5a7655"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i88b7c20939ab4f34a1fa7424a5d6d03f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjItOC0xLTEtMTkwOTAw_9cc4a6bb-7dab-4d86-914e-cd44e156f4e7"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjMtNi0xLTEtMTkwOTAw_c751bac8-a3ed-4661-9032-1569d2e77ba4"
      unitRef="usd">8495000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmJlOWJjZmNmODJkNTQzYTY4ZDFhYjJhNTI4MjA1NTkwL3RhYmxlcmFuZ2U6YmU5YmNmY2Y4MmQ1NDNhNjhkMWFiMmE1MjgyMDU1OTBfMjMtOC0xLTEtMTkwOTAw_aa6daa83-0145-46d2-8d5f-c61f438a64eb"
      unitRef="usd">8915000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib94a53ec039740fa8792e11ae883a02c_I20210510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTQ0Nw_d60c0371-153e-474f-8745-55e75783ca4c"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bsx:DebtInstrumentExtensionOptionTerm
      contextRef="i31562662eb6547fe95ffff0dfca2001c_D20210510-20210510"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkzOA_928531c0-465e-4671-917e-492986221b62">P1Y</bsx:DebtInstrumentExtensionOptionTerm>
    <us-gaap:LongTermDebt
      contextRef="ie74fb9edc1e54a079f786a420c2ee7ef_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTg5MA_395350f7-532a-42b4-a559-5e424e469487"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib16e6c7d489f4c34bf5a29a3c06aa219_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTg5MA_c86d4532-dfe5-4edd-9958-c9f8304e0746"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkyNQ_c993f6fe-2d74-473d-a1f5-5de2541f6083">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we were in compliance with the financial covenant required by the 2021 Revolving Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.52 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;</bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock>
    <bsx:MaximumLeverageRatio
      contextRef="if1c5d438e1c44a81b2540ede941cd82f_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmU1YTIzYzk5MTc0OTRiZGVhMTNmYzUzN2RhYzgzZGY3L3RhYmxlcmFuZ2U6ZTVhMjNjOTkxNzQ5NGJkZWExM2ZjNTM3ZGFjODNkZjdfMi0yLTEtMS0xOTA5MDA_b197b32f-0768-49bf-9a08-000626fd5571"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="id82f0c35a27940c9ae9176b5aeb5e9d3_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOmU1YTIzYzk5MTc0OTRiZGVhMTNmYzUzN2RhYzgzZGY3L3RhYmxlcmFuZ2U6ZTVhMjNjOTkxNzQ5NGJkZWExM2ZjNTM3ZGFjODNkZjdfMi00LTEtMS0xOTA5MDA_81b8234e-b024-4fcf-a7ea-64f01a92b701"
      unitRef="number">2.52</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i7d9caf21868444e99250f18158da8bab_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjQyNw_d3d289bd-cdd1-43e2-893b-c9d01a9b997a"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:QualifiedAcquisitionConsideration
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjYwNw_2c3c7893-cd75-4e78-8d52-afb56d3e509b"
      unitRef="usd">1000000000</bsx:QualifiedAcquisitionConsideration>
    <bsx:MaximumLeverageRatio
      contextRef="iac1e88fabb7b45c9855c38e764079bc7_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjc5OQ_ec275608-810f-4cf5-9952-0fc3aa56c9f1"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i8202332b83334006af73c7c6ce87639e_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjg5OA_6cbf27ed-a2fc-4383-ba65-4d682ac0ea09"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ie8e5721798f64931ab7f86adf91517af_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjkwMg_8dcaccc3-e65b-4ed7-8618-063e04de8e44"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ic1db4cf9dde84158b7c54dd06393c41d_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjkwOQ_936f25ef-dda6-420b-93c7-3d09d0c58bba"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i2c5612e005724c8d8c4db7a76f3396e6_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMjk2Nw_e0c9f03e-601d-40a4-914f-51965383bd5d"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:ExclusionFromEbitdaForRestructuringCharges
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzQxNg_445b8cbe-6c03-4f65-b157-1112dad7ad2e"
      unitRef="usd">500000000</bsx:ExclusionFromEbitdaForRestructuringCharges>
    <bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzU1MA_fd516dff-8461-4016-9e6f-185b72eb33ad"
      unitRef="usd">457000000</bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <bsx:LitigationPaymentExclusionFromEBITDA
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzg4MA_f85bfaba-0d67-4a8d-a2e9-e168bcf3ea2e"
      unitRef="usd">1000000000</bsx:LitigationPaymentExclusionFromEBITDA>
    <bsx:LitigationAndDebtExclusionFromEbitda
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTQ5NzU1ODE1MjcxOQ_59195504-ee34-44f0-a836-d20a68bc70d6"
      unitRef="usd">1443000000</bsx:LitigationAndDebtExclusionFromEbitda>
    <bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMzkxOA_979d4840-881c-4542-964a-b3b65423c46f"
      unitRef="usd">1424000000</bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i6fd64d7c247c409fa4207f722c6c224c_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkwMw_9725760b-bb5e-4b85-abce-1258aa17a21b">We had no commercial paper outstanding as of March&#160;31, 2023 or December&#160;31, 2022. In April 2023, we issued commercial paper to partially fund our acquisition of Apollo. As of the date of this Quarterly Report on Form 10-Q, we had approximately $400 million of commercial paper outstanding, which directly reduces our borrowing capacity under the 2021 Revolving Credit Facility.</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ie74fb9edc1e54a079f786a420c2ee7ef_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDc4MQ_395350f7-532a-42b4-a559-5e424e469487"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib16e6c7d489f4c34bf5a29a3c06aa219_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDc4MQ_c86d4532-dfe5-4edd-9958-c9f8304e0746"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:CommercialPaper
      contextRef="id5c8a81e01b64601bd86cd95599e9025_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTQ5NzU1ODE1MjQxOA_38371083-969a-44f4-847b-6fab663c72ca"
      unitRef="usd">400000000</us-gaap:CommercialPaper>
    <us-gaap:LongTermDebt
      contextRef="i6a33141a69104417b94015557d906a3c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDg4MQ_921286bb-1d6f-4eef-8010-bc0a42dacbe2"
      unitRef="usd">9067000000.000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9e31ad2072de41b69ce29a3a8a2beccb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNDg5Nw_e4545d30-1246-4aa7-a406-1e6011f672a8"
      unitRef="usd">8986000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i33b1a47c2971475a887f95d6f09d61f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTQyOA_c47bb229-d9c3-4b0a-ade9-5fccd0ba9489"
      unitRef="eur">3000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTUwNQ_1aa3d264-ee69-4f0b-a992-c0891080e843"
      unitRef="eur">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2338d944a80349399e24d2d75f5c59bc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTUxMQ_9196adce-2f7d-4b87-b879-d9350c1d83d5"
      unitRef="rate">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTUzNw_85ee19d7-e481-412d-b897-a97fe2967af3"
      unitRef="eur">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2dc024eaf21d42bc86c27732930f65b6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTU0Mw_2d8c2ddb-42e6-4fee-8f29-450dcce9ffb3"
      unitRef="rate">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTU2OQ_209d00ca-7ad1-4091-8a6e-37e605bbc6bb"
      unitRef="eur">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i791d7b45dd054f389d7c0019d2f8803c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTU3NQ_1cf14a9f-efc4-48a9-9be4-6ea2bf09b7d7"
      unitRef="rate">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i466b11229a244bf095c3c6d222c59179_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTYwNA_81b90762-1f55-442b-bda3-fef8c798b5ce"
      unitRef="eur">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i466b11229a244bf095c3c6d222c59179_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNTYxMA_f1e0a402-119d-4e90-9059-29098479fe7c"
      unitRef="rate">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <bsx:CashProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i093f5b3abdd745f1a8241d0453842764_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNjEzMw_33c35350-2ffe-4413-b938-c9ebef25f143"
      unitRef="usd">3270000000</bsx:CashProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i561fec84ddc04b59a8105f1d9d8ac489_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNjMxNQ_b920b9c9-e0c2-494e-8b65-2ef09db1ed9b"
      unitRef="usd">3275000000</us-gaap:LongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNjQ4OA_36ae2218-04b3-4bd5-8988-2084676d7043"
      unitRef="usd">-194000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzkwNw_13c68774-e493-42c1-ba09-2e6f70228d96">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i703997e880b841bf912c19d2455d4f77_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi0xLTEtMS0xOTA5MDA_3fac6dc4-520d-4000-b58b-b8393c573a9e"
      unitRef="usd">188000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i0e8b97cc2e8d4eb88ae1bdfe5cc6884c_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi0zLTEtMS0xOTA5MDA_b9931753-ed29-4c20-b317-1a5167e7fa6f"
      unitRef="number">0.055</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ib453388f5f184e4a82c28c4a8350b8bc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi01LTEtMS0xOTA5MDA_6c5a836d-ec6a-41ae-8609-0a0ac03d3f6a"
      unitRef="usd">161000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ib1d7c0732e164ffa8188acb478deb5c8_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMi03LTEtMS0xOTA5MDA_b49a8446-8528-4553-bd2d-97843136048c"
      unitRef="number">0.024</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ice1cde59638b4723b05549750c61c718_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy0xLTEtMS0xOTA5MDA_245fca9c-9731-4674-9c7a-b373ef8aeafa"
      unitRef="usd">188000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i99eaf8749fec4bd4bef896df3b9fd8c3_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy0zLTEtMS0xOTA5MDA_f70fe0f5-c644-4bdb-b98e-0ce277117929"
      unitRef="number">0.005</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i40a0ea6834ac41f1b607a21df3a62801_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy01LTEtMS0xOTA5MDA_f7251323-216a-4316-bb57-05f12b81d151"
      unitRef="usd">194000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ia218bd3302d5488a916178d33c82b82b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfMy03LTEtMS0xOTA5MDA_352e37fe-7f1f-43a3-b09a-a3aa9731920b"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i801c5c1c6a2442c086808723bb7fc47b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC0xLTEtMS0xOTA5MDA_d3c0930e-6488-40d9-a117-ab723a87edb4"
      unitRef="usd">14000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ib6c9ebfb99fa4dfeb3304751f22498b5_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC0zLTEtMS0xOTA5MDA_5101dc3b-54f5-4fb2-bbc6-870a71e8b6c2"
      unitRef="number">0.030</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i924e9479e6bf4f81906b0781426a7ba1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC01LTEtMS0xOTA5MDA_e274d07a-bbb6-48c7-9c3e-0ce414c2cff1"
      unitRef="usd">13000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i524c7cd3f2f6432d98a7ae708c5f5aca_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RhYmxlOjU1MWFkN2NiMTU5ZDRhNDA4YjkwMDI0NmIwNGM2ZTY2L3RhYmxlcmFuZ2U6NTUxYWQ3Y2IxNTlkNGE0MDhiOTAwMjQ2YjA0YzZlNjZfNC03LTEtMS0xOTA5MDA_3e2757bc-6ce9-4acc-8451-30e19841535c"
      unitRef="number">0.031</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzM5NQ_1113ee2f-13a1-4d99-a3db-3a87fd893d08"
      unitRef="usd">143000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfNzQxMQ_a12e48d9-0188-4aab-8aa4-ce724bdeb83b"
      unitRef="usd">135000000</us-gaap:LettersOfCreditOutstandingAmount>
    <bsx:SupplierFinanceProgramObligationCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTA5OTUxMTYzOTkwMA_a8ee6a44-bdf9-4d44-8346-be52b993cf13"
      unitRef="usd">128000000</bsx:SupplierFinanceProgramObligationCurrent>
    <bsx:SupplierFinanceProgramObligationCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF82MS9mcmFnOmI3OWYwMTVhZGNjNDRjZTU5YjNkZjFkMmZjYmQ2OWYwL3RleHRyZWdpb246Yjc5ZjAxNWFkY2M0NGNlNTliM2RmMWQyZmNiZDY5ZjBfMTA5OTUxMTYzOTg4NQ_6ab30a5f-83b7-4fc9-a727-6622d8178c03"
      unitRef="usd">129000000</bsx:SupplierFinanceProgramObligationCurrent>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc2NA_fa62b81a-c949-4e9b-b8a7-92fc5a83f6b7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE F &#x2013; SUPPLEMENTAL BALANCE SHEET INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 326), we record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach, applying country or region-specific factors, to determine the reserve to record at accounts receivable commencement for certain customers. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. In addition, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,050&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;731&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,446&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $82 million for the first quarter of 2023 and $76 million for the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indemnification asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;761&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,995&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc1MA_8c5ff44a-7457-4912-8dd4-7c56fb75b110">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMi0xLTEtMS0xOTA5MDA_27e9d991-4f56-4747-9feb-5ae4c812733c"
      unitRef="usd">2194000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMi0zLTEtMS0xOTA5MDA_29c40b35-6200-4845-97fa-1228942dd75e"
      unitRef="usd">2079000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMy0xLTEtMS0xOTA5MDA_23b77a4d-dae7-40e1-96d0-200c9df09624"
      unitRef="usd">118000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfMy0zLTEtMS0xOTA5MDA_a623d9af-2c84-47b6-95e7-820e1a8c4748"
      unitRef="usd">109000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfNC0xLTEtMS0xOTA5MDA_1078254b-ca18-4238-9307-388348334641"
      unitRef="usd">2076000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjBlZmE0MGZjZWNlNjQ0Mzg5MDVhNmI4NmU0NzU0NzA1L3RhYmxlcmFuZ2U6MGVmYTQwZmNlY2U2NDQzODkwNWE2Yjg2ZTQ3NTQ3MDVfNC0zLTEtMS0xOTA5MDA_4819fbf0-d460-4177-9265-c18a27ae1f20"
      unitRef="usd">1970000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMi0xLTEtMS0xOTA5MDA_e8b687d7-83f5-4106-b478-8713db3d2d2f"
      unitRef="usd">109000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMi0zLTEtMS0xOTA5MDA_085f60d7-a3e1-4f06-96f0-ad8eb97fc6b8"
      unitRef="usd">108000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMy0xLTEtMS0xOTA5MDA_18e49edf-fa6b-40fa-9cf2-17277d712ae4"
      unitRef="usd">16000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfMy0zLTEtMS0xOTA5MDA_70edde59-a11a-4030-bb7b-96a45bcea62e"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNC0xLTEtMS0xOTA5MDA_0ef383f7-91d2-4889-ba1d-7da0032b6a9a"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNC0zLTEtMS0xOTA5MDA_f2399c7e-0999-4b6f-9531-af9ffc19b825"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNS0xLTEtMS0xOTA5MDA_a5ccb4e8-d057-40a6-9f1a-76a77c744feb"
      unitRef="usd">118000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmMxNDdkZjg0NTYxODQ0NzhiZmM1N2MzMTI3MzNkMDM4L3RhYmxlcmFuZ2U6YzE0N2RmODQ1NjE4NDQ3OGJmYzU3YzMxMjczM2QwMzhfNS0zLTEtMS0xOTA5MDA_6be7bb7d-e632-4276-a0d4-1afbfe078ae0"
      unitRef="usd">113000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc2MQ_897916e3-89b5-4b4d-a3ea-c55b4d24d920">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,050&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMi0xLTEtMS0xOTA5MDA_89cecba6-bdbb-470d-9a54-7a49e41b0b75"
      unitRef="usd">1223000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMi0zLTEtMS0xOTA5MDA_97c8bdae-1014-40fb-a8a1-794b185640ea"
      unitRef="usd">1171000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMy0xLTEtMS0xOTA5MDA_0d594695-3cdf-4b06-83aa-c8286b55a659"
      unitRef="usd">176000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfMy0zLTEtMS0xOTA5MDA_b78aa2df-3813-4da1-ad02-790984910897"
      unitRef="usd">147000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNC0xLTEtMS0xOTA5MDA_962b65d8-a36e-4fcd-8cf7-ea3fd61b2bc7"
      unitRef="usd">651000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNC0zLTEtMS0xOTA5MDA_835fdd39-c44b-4214-94dd-fb914e9f618a"
      unitRef="usd">548000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNS0xLTEtMS0xOTA5MDA_b6a39518-d805-4171-aa66-630099f7012f"
      unitRef="usd">2050000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmI2ZTE2YzQ5Mzc2OTRiNzdhMDU2NDU1NjMzMjQxNDRlL3RhYmxlcmFuZ2U6YjZlMTZjNDkzNzY5NGI3N2EwNTY0NTU2MzMyNDE0NGVfNS0zLTEtMS0xOTA5MDA_d75cc5a0-da69-4d88-a563-4e15decb6e9d"
      unitRef="usd">1867000000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjczNg_6c04bf30-1f18-418c-abb4-f1129967231d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;731&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMi0xLTEtMS0xOTA5MDA_77534565-27c2-485b-ae85-e8417cd0c59d"
      unitRef="usd">135000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMi0zLTEtMS0xOTA5MDA_1aa96047-9242-4ed6-8146-3e5e58db69e4"
      unitRef="usd">149000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMy0xLTEtMS0xOTA5MDA_c35d173a-c7eb-42b4-af91-61ceb770617c"
      unitRef="usd">187000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfMy0zLTEtMS0xOTA5MDA_ec666ab9-07ba-4254-9b31-5fc9f50514f3"
      unitRef="usd">232000000</us-gaap:DerivativeAssetsCurrent>
    <bsx:Licensingarrangements
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNC0xLTEtMS0xOTA5MDA_6f80d074-26b0-4b38-a4e2-df24cec98f31"
      unitRef="usd">56000000</bsx:Licensingarrangements>
    <bsx:Licensingarrangements
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNC0zLTEtMS0xOTA5MDA_09231015-c827-4552-a4bf-0b008b800384"
      unitRef="usd">60000000</bsx:Licensingarrangements>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNS0xLTEtMS0xOTA5MDA_0c407898-e0ca-40a9-993f-46b0357db80f"
      unitRef="usd">333000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNS0zLTEtMS0xOTA5MDA_5cff76a2-401f-47ff-ade4-b17d57a24c35"
      unitRef="usd">290000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNi0xLTEtMS0xOTA5MDA_dea787a1-eb3e-46b6-beac-5ac40700e597"
      unitRef="usd">711000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjc4OWUyYTZhYzFlNTRjOTI4NmJlZWUzZmJmZDM3ZWExL3RhYmxlcmFuZ2U6Nzg5ZTJhNmFjMWU1NGM5Mjg2YmVlZTNmYmZkMzdlYTFfNi0zLTEtMS0xOTA5MDA_266d7eda-bd40-4e36-89ba-899533dc3a4f"
      unitRef="usd">731000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjcyNA_e976c90a-b6a8-4f25-8986-b2065399e060">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,446&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMi0xLTEtMS0xOTA5MDA_0ddd3a94-84e1-449b-abe9-8dad90e84415"
      unitRef="usd">141000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMi0zLTEtMS0xOTA5MDA_d37ff7d1-13c2-4d26-963d-39c20c940985"
      unitRef="usd">137000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMy0xLTEtMS0xOTA5MDA_8dae29f1-8c2e-4c13-883f-ff877427506a"
      unitRef="usd">1763000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfMy0zLTEtMS0xOTA5MDA_6019fe7a-c04f-4636-89a7-404ca64b99d8"
      unitRef="usd">1695000000</us-gaap:BuildingsAndImprovementsGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNC0xLTEtMS0xOTA5MDA_ac129a15-d792-402e-bc82-6c230631e981"
      unitRef="usd">3367000000</bsx:EquipmentFurnitureAndFixturesGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNC0zLTEtMS0xOTA5MDA_bded6c73-9977-4782-9c9b-15d66c138404"
      unitRef="usd">3297000000</bsx:EquipmentFurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNS0xLTEtMS0xOTA5MDA_5f83147e-f270-4e0a-9388-7474a4d208f4"
      unitRef="usd">567000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNS0zLTEtMS0xOTA5MDA_b8792792-8986-411d-890e-4ba2b52a3078"
      unitRef="usd">598000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNi0xLTEtMS0xOTA5MDA_3ad7082b-8503-4bff-b104-6c40aaebea69"
      unitRef="usd">5837000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNi0zLTEtMS0xOTA5MDA_9ddfe742-1a9f-4354-88a8-543aa4f3350f"
      unitRef="usd">5728000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNy0xLTEtMS0xOTA5MDA_62fe37a4-a026-4d80-8559-d97c05f0e79e"
      unitRef="usd">3359000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfNy0zLTEtMS0xOTA5MDA_551fb855-278d-42fb-95e1-7a32078c7188"
      unitRef="usd">3282000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfOC0xLTEtMS0xOTA5MDA_e91be736-b417-462c-b12a-23f949b0e60b"
      unitRef="usd">2478000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmZiNzk3ZjIzZjNjMTQ3YzVhNGM2ZDFkNDZkYzdjYzFjL3RhYmxlcmFuZ2U6ZmI3OTdmMjNmM2MxNDdjNWE0YzZkMWQ0NmRjN2NjMWNfOC0zLTEtMS0xOTA5MDA_0d913c3f-bc39-414f-a58e-eba3c027857d"
      unitRef="usd">2446000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMTA5OTUxMTYzMDU5Mg_e8cfcbba-dddd-4420-9754-1fcd3f08a152"
      unitRef="usd">82000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjAwMw_ec27ee1c-e211-4a30-a3ec-5a7f68efe0f2"
      unitRef="usd">76000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc0NQ_0348905a-ce66-488b-a7c3-e9089ac3a10e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indemnification asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMi0xLTEtMS0xOTA5MDA_10b323fc-8269-4d9f-ba45-36507f3f507f"
      unitRef="usd">57000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMi0zLTEtMS0xOTA5MDA_342a5155-2a65-43a5-a340-1edb2b133f6e"
      unitRef="usd">48000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMy0xLTEtMS0xOTA5MDA_1268d436-9999-493f-bf8b-160c896d604b"
      unitRef="usd">399000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfMy0zLTEtMS0xOTA5MDA_debfe007-1b37-4a94-9a48-4d63f65c4d66"
      unitRef="usd">386000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssets
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNC0xLTEtMS0xOTA5MDA_9dd71232-6273-4b6d-aa54-be5a7a03a878"
      unitRef="usd">133000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNC0zLTEtMS0xOTA5MDA_8f9efbaa-96d6-4137-bf75-1fc965ab3a44"
      unitRef="usd">149000000</us-gaap:DerivativeAssets>
    <us-gaap:Investments
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNS0xLTEtMS0xOTA5MDA_d5091d85-eca3-42ae-b6ec-3279160e78fa"
      unitRef="usd">385000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNS0zLTEtMS0xOTA5MDA_4e8238ce-467a-4349-b9ca-08fd60ca7973"
      unitRef="usd">407000000</us-gaap:Investments>
    <bsx:Licensingarrangementsasset
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNi0xLTEtMS0xOTA5MDA_0cafe917-0fa7-4b89-9162-fc469e5d94d7"
      unitRef="usd">57000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNi0zLTEtMS0xOTA5MDA_e7f120fd-34ee-474c-856c-1e457404f0e9"
      unitRef="usd">67000000</bsx:Licensingarrangementsasset>
    <bsx:IndemnificationAsset
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNy0xLTEtMS0xOTA5MDA_95558f1f-a0c6-42e2-bd50-4201b6c45074"
      unitRef="usd">170000000</bsx:IndemnificationAsset>
    <bsx:IndemnificationAsset
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfNy0zLTEtMS0xOTA5MDA_eae72371-9339-473d-a266-6d827be9ebe8"
      unitRef="usd">172000000</bsx:IndemnificationAsset>
    <bsx:OtherOtherLongtermAssets
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOC0xLTEtMS0xOTA5MDA_f8ecdda4-1857-463a-8df2-434940649555"
      unitRef="usd">280000000</bsx:OtherOtherLongtermAssets>
    <bsx:OtherOtherLongtermAssets
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOC0zLTEtMS0xOTA5MDA_0890a05b-6805-42d0-808e-e848cd0af03d"
      unitRef="usd">271000000</bsx:OtherOtherLongtermAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOS0xLTEtMS0xOTA5MDA_6f790e6c-5715-4baf-bc1e-70ef7a08eb2e"
      unitRef="usd">1482000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ4N2MyMzMxMjZjZjQwMjdiYjdkNjM0NmVhYzBmM2MxL3RhYmxlcmFuZ2U6ZDg3YzIzMzEyNmNmNDAyN2JiN2Q2MzQ2ZWFjMGYzYzFfOS0zLTEtMS0xOTA5MDA_80921a0a-30be-4750-84ee-63e37f7194ab"
      unitRef="usd">1500000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc3MA_337d2a2c-cc06-4fbb-9645-7bbbef796f91">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMi0xLTEtMS0xOTA5MDA_23ec3014-baf4-4441-aff1-f10d663ad2e7"
      unitRef="usd">207000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMi0zLTEtMS0xOTA5MDA_660997f1-1f08-4b22-b1d3-9f1dcc88bf3a"
      unitRef="usd">231000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMy0xLTEtMS0xOTA5MDA_0e285e38-aeb1-482a-b04a-54ef07fd9cf3"
      unitRef="usd">661000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfMy0zLTEtMS0xOTA5MDA_7c9f7615-e870-454d-b871-59215931fd9c"
      unitRef="usd">830000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNC0xLTEtMS0xOTA5MDA_adf38cda-19e6-4a65-90e9-9523c220be6e"
      unitRef="usd">347000000</bsx:AccruedRebatesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNC0zLTEtMS0xOTA5MDA_d269e1c5-2f11-4bc3-9a9b-0f472174eee9"
      unitRef="usd">352000000</bsx:AccruedRebatesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNS0xLTEtMS0xOTA5MDA_e43ca630-97c8-4fd5-ae20-3e56686dce02"
      unitRef="usd">83000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNS0zLTEtMS0xOTA5MDA_a6ba9bfe-2db9-4b2b-b6de-05a7dd28d853"
      unitRef="usd">74000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNi0xLTEtMS0xOTA5MDA_2bcb9cec-4749-48d1-9abb-6e8c67bd8507"
      unitRef="usd">620000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNi0zLTEtMS0xOTA5MDA_cfaf165d-42ad-45df-a26c-d448c20fa2ae"
      unitRef="usd">674000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNy0xLTEtMS0xOTA5MDA_f69cd9c2-f456-4c75-bff4-d31143c2c1d1"
      unitRef="usd">1918000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ2ZGUxYTIyMDhhYzQxZGZhNjdjZDU4MjNlMzA3MTYzL3RhYmxlcmFuZ2U6ZDZkZTFhMjIwOGFjNDFkZmE2N2NkNTgyM2UzMDcxNjNfNy0zLTEtMS0xOTA5MDA_7978a241-6b7f-404b-99b6-204d05908969"
      unitRef="usd">2160000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc3MQ_8346e1dc-fc9e-4324-80f7-4e1399ad238a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;761&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMi0xLTEtMS0xOTA5MDA_75c269fb-5c94-445b-99b8-81d3249109f5"
      unitRef="usd">231000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMi0zLTEtMS0xOTA5MDA_c2e19fb9-b9e0-4a88-9298-10a9d7a5ab64"
      unitRef="usd">220000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMy0xLTEtMS0xOTA5MDA_0f927afc-b99b-4bf0-aea3-badd445f057b"
      unitRef="usd">57000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfMy0zLTEtMS0xOTA5MDA_74125b7b-ae1d-48d4-843b-f010c6d9cc21"
      unitRef="usd">79000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNC0xLTEtMS0xOTA5MDA_ce9a422b-2a25-4c4b-b1b6-0830969eefcd"
      unitRef="usd">281000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNC0zLTEtMS0xOTA5MDA_a7a70a26-bea6-44ba-a301-fb617a0fba11"
      unitRef="usd">232000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNi0xLTEtMS0xOTA5MDA_4e21adfc-1830-45a6-921d-da13f04db274"
      unitRef="usd">217000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNi0zLTEtMS0xOTA5MDA_1d92d3a8-f49f-4eb8-ae1b-aa8dfaceb2c7"
      unitRef="usd">230000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNy0xLTEtMS0xOTA5MDA_454fbf8e-5ed7-40ba-b992-277dd54f80f9"
      unitRef="usd">787000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOmQ5NTM4MTM5M2EwZjRkZDI4MTNiMDZmZTlkZmY0MTA5L3RhYmxlcmFuZ2U6ZDk1MzgxMzkzYTBmNGRkMjgxM2IwNmZlOWRmZjQxMDlfNy0zLTEtMS0xOTA5MDA_c56a248a-7dfd-44d2-9b91-80225ace812a"
      unitRef="usd">761000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RleHRyZWdpb246ODkyZmNiZDg3YjIwNDc0YTllOTY5MWMyMGQwNDdmNWJfMjc1OA_dd67451c-13c3-45ad-a4a5-725c16600779">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,995&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMi0xLTEtMS0xOTA5MDA_f21df74a-022f-4167-80cc-358fe9941791"
      unitRef="usd">608000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMi0zLTEtMS0xOTA5MDA_961ee9f4-0cf6-4c28-8256-3501e558637b"
      unitRef="usd">597000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMy0xLTEtMS0xOTA5MDA_50eff50b-68e8-49da-91f1-cc0cc68b387e"
      unitRef="usd">209000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfMy0zLTEtMS0xOTA5MDA_e9b9201b-9e36-4b3d-9858-120782840105"
      unitRef="usd">212000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNC0xLTEtMS0xOTA5MDA_84d6bda5-0422-41c9-9cd5-54ad5e4fadfe"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNC0zLTEtMS0xOTA5MDA_cb196a5f-9c5c-458e-bfa8-e9e05e193326"
      unitRef="usd">75000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <bsx:Licensingarrangementsliability
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNS0xLTEtMS0xOTA5MDA_9fd22c8f-472d-44e8-8311-8eb669996dd4"
      unitRef="usd">63000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNS0zLTEtMS0xOTA5MDA_e45ce938-44d0-411e-873a-6e9b1d0dc941"
      unitRef="usd">80000000</bsx:Licensingarrangementsliability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNi0xLTEtMS0xOTA5MDA_27eb5e28-eca4-473b-b1fc-343dfc1d7da8"
      unitRef="usd">360000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNi0zLTEtMS0xOTA5MDA_0ac9d45a-22c0-432c-88c5-65425682c0a8"
      unitRef="usd">347000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNy0xLTEtMS0xOTA5MDA_af229ef5-68f2-48d5-98e4-54949fe470ab"
      unitRef="usd">290000000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfNy0zLTEtMS0xOTA5MDA_2c0d3ac9-55ad-4465-b994-f024b1ee5805"
      unitRef="usd">289000000</us-gaap:DeferredRevenue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOC0xLTEtMS0xOTA5MDA_0ff111a0-6bc0-4706-a191-6c3f267f2937"
      unitRef="usd">457000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOC0zLTEtMS0xOTA5MDA_edcb33e2-e109-4eb5-8540-8c59d7caa977"
      unitRef="usd">434000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOS0xLTEtMS0xOTA5MDA_21d0ed2b-c357-48a7-ad7c-115acdedf594"
      unitRef="usd">1995000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF83Ni9mcmFnOjg5MmZjYmQ4N2IyMDQ3NGE5ZTk2OTFjMjBkMDQ3ZjViL3RhYmxlOjlhYzc4ZGI5Mzg0ZDRlZjQ5MWYwNmRkZDkwZmQ1ZDgyL3RhYmxlcmFuZ2U6OWFjNzhkYjkzODRkNGVmNDkxZjA2ZGRkOTBmZDVkODJfOS0zLTEtMS0xOTA5MDA_379c39b2-6aa9-4bf8-b446-3b0b3d4010e1"
      unitRef="usd">2035000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfMTMwMg_13b5b851-a1d9-4a47-a101-035d37fc2ff8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE G &#x2013; INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate from continuing operations is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in our reported tax rates for the first quarter of 2023, as compared to the same period in 2022, relate primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These include debt extinguishment charges recorded in the first quarter of 2022, as well as certain discrete tax items primarily related to provision-to-return adjustments recorded in the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we had $501 million of gross unrecognized tax benefits, of which a net $415 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2022, we had $492 million of gross unrecognized tax benefits, of which a net $410 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $77 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfMTMwNA_fbcbdf74-222a-4d4f-8ce2-47743f916bb1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RhYmxlOjIyZTA2YTEzYWY1MjRiOTg5OGNhNTBhM2EwZDFhNDE5L3RhYmxlcmFuZ2U6MjJlMDZhMTNhZjUyNGI5ODk4Y2E1MGEzYTBkMWE0MTlfMi0xLTEtMS0xOTA5MDA_aa8ec6d3-6480-4163-a6c3-d4a9b1c6f27e"
      unitRef="number">0.294</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RhYmxlOjIyZTA2YTEzYWY1MjRiOTg5OGNhNTBhM2EwZDFhNDE5L3RhYmxlcmFuZ2U6MjJlMDZhMTNhZjUyNGI5ODk4Y2E1MGEzYTBkMWE0MTlfMi0zLTEtMS0xOTA5MDA_936205d0-1bc3-4d9f-acc3-939f1d7681a2"
      unitRef="number">0.291</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfNjYw_846111b3-cd71-47c4-930e-262289314e98"
      unitRef="usd">501000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfNzE0_92041702-4dd6-4456-a562-886309ec93e3"
      unitRef="usd">415000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfNzg3_874767a3-a982-47c8-9778-9a3b3ff2824d"
      unitRef="usd">492000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfODQx_97089ec6-aa51-4789-ae78-36d1fafd45cc"
      unitRef="usd">410000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF84NS9mcmFnOmNkZTdlZDYzMjgwYTRlZjg4ZTMyYWFmYzhjY2M3MDU3L3RleHRyZWdpb246Y2RlN2VkNjMyODBhNGVmODhlMzJhYWZjOGNjYzcwNTdfMTI4Nw_96451dd2-4c42-4b11-becb-d1ad425691b0"
      unitRef="usd">77000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMTMxMjY_c54d0fc9-bed3-42fb-b1d5-e885fac37384">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;NOTE H &#x2013; COMMITMENTS AND CONTINGENCIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, product liability, securities and commercial claims have been asserted against us and similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity. For additional information, refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item 8 of our most recent Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our accompanying unaudited consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accrual for legal matters that are probable and estimable was $416 million as of March&#160;31, 2023 and $443 million as of December&#160;31, 2022 and includes certain estimated costs of settlement, damages and defense primarily related to product liability cases or claims related to our transvaginal surgical mesh products. A portion of this accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $135 million as of March&#160;31, 2023 and $149 million as of December&#160;31, 2022. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Supplemental Balance Sheet Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. We did not record any litigation-related net charges during the first quarter of 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, Cook) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#x2019;s Instinct&#x2122; Endoscopic Hemoclip. The Company seeks lost profits, a reasonable royalty and a permanent injunction. The case was transferred to the District Court for the Southern District of Indiana. Cook filed Inter Partes Review (IPR) requests with the U.S. Patent and Trademark Office (USPTO) against four then-asserted patents, which resulted in the court staying the case until 2020. All IPRs concluded and confirmed the validity of certain claims of each challenged patent. In &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2023, the District Court issued summary judgment rulings dismissing certain claims and defenses. Trial on the remaining two asserted patents is scheduled for May 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2017, The Board of Regents, University of Texas System and TissueGen. Inc. (collectively, UT), served a lawsuit against us in the Western District of Texas. The complaint against the Company alleges patent infringement of two U.S. patents owned by UT, relating to &#x201c;Drug Releasing Biodegradable Fiber Implant&#x201d; and &#x201c;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#x201d; and affects the manufacture, use and sale of our Synergy&#x2122; Stent System. UT primarily seeks a reasonable royalty. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the UT&#x2019;s Petition for Certiorari. UT proceeded with its case against us in Delaware. In January 2023, a jury trial was held on the issue of whether the one UT patent still asserted in the case was valid and whether it was infringed by the Company. On January 31, 2023, a jury concluded that UT&#x2019;s patent was valid and willfully infringed by the Company, and awarded UT $42 million in damages. Following the trial, UT has filed a motion seeking prejudgment interest and enhanced damages.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has filed a motion seeking judgment as a matter of law in its favor or alternatively a new trial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Multiple product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us, predominantly in the United States, Canada, the United Kingdom, Scotland, Ireland, and Australia. Plaintiffs generally seek monetary damages based on allegations of personal injury associated with the use of our transvaginal surgical mesh products, including design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. We have entered into individual and master settlement agreements in principle or are in the final stages of entering agreements with certain plaintiffs' counsel, to resolve the majority of these cases and claims. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. In addition, in April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records related to mesh settlements. The Company has notified our insurer and retained counsel to respond to the demand. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a product liability accrual for remaining claims asserted against us associated with our transvaginal surgical mesh products and the costs of defense thereof. We continue to engage in discussions with plaintiffs&#x2019; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest these cases and claims. The final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Governmental Investigations and Qui Tam Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#x201c;technical note,&#x201d; announced that it was launching a formal administrative proceeding against Boston Scientific&#x2019;s Brazilian subsidiary, Boston Scientific do Brasil Ltda. (BSB), as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. Under applicable guidance, BSB could be fined a percentage of BSB&#x2019;s 2016 gross revenues. In August 2021, the investigating commissioner issued a preliminary recommendation of liability against all of the involved companies, and also recommended that CADE impose fines and penalties. However, on October 25, 2021, the CADE Attorney General's office recommended dismissal of the charges and allegations against BSB and the individual BSB employees who were still individual defendants. Subsequently, on March 30, 2022, the Federal Prosecutor&#x2019;s office issued a non-binding recommendation that is contrary to the Attorney General&#x2019;s recommendation. The full Commission is considering both of these recommendations but has not yet issued its decision. We continue to deny the allegations, intend to defend ourselves vigorously and will appeal any decision of liability by the full Commission to the Brazilian courts. During such an appeal, the decision would have no force and effect, and the Court would consider the case without being bound by CADE&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam. The Company has received related subpoenas for documents from the Office of the U.S. Attorney for the District of Massachusetts and the Securities and Exchange Commission. The Company is cooperating with government agencies while investigating these allegations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 5, 2023, the Company received a subpoena from the U.S. Department of Justice (DOJ) that seeks documents and information relating to its ambulatory electrocardiography monitoring (AECG) business. The Company is cooperating with the DOJ in responding to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 4, 2020, Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#x2122; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all others similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. The plaintiffs filed an Amended Complaint in June 2021 that seeks unspecified compensatory damages in favor of the alleged class as well as unspecified equitable relief. The Company filed a Motion to Dismiss in July 2021, which, in December 2022, the Court granted in part and denied in part. The Company intends to vigorously defend itself against the surviving allegations. On December 15, 2020, the Securities and Exchange Commission&#x2019;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#x2019;s decision to retire the LOTUS System and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company cooperated fully with the requests, and on January 3, 2022, the SEC informed us that it was concluding its investigation and that it did not intend to recommend an enforcement action. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#x2019;s Board of Directors conduct an investigation into actions by the Company&#x2019;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above. The Company received letters on behalf of the Union Excavators Local 731 Pension Fund, Diane Nachbaur, and Frank Tripson, three stockholders of the Company, on July 26, 2021, July 29, 2021, and February 13, 2023, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items. On February 7, 2023, Diane Nachbaur filed a shareholder derivative complaint in the United States District Court for the District of Massachusetts against the Company, Michael F. Mahoney, Nelda J. Connors, Charles J. Dockendorff, Yoshiaki Fujimori, Donna A. James, Edward J. Ludwig, David Roux, John E. Sununu, Ellen M. Zane, Joseph M. Fitzgerald, Daniel J. Brennan, Shawn McCarthy, Ian Meredith, Kevin Ballinger, and Susan Vissers Lisa.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMTMxMzE_bd7685b7-fc00-4899-a752-1e59e2cf6e7b">FASB ASC Topic 450, &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;within our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;within our accompanying unaudited consolidated statements of operations.</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjU0NQ_cc5befef-75e9-4f71-93e4-2359ebec1d62"
      unitRef="usd">416000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjU2MQ_c854ff8b-dc5c-41b9-a0e6-9cfd53ce246f"
      unitRef="usd">443000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjkzNw_44990b9d-e93b-4893-a830-2fe7aa90379c"
      unitRef="usd">135000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfMjk1Mw_4eb20e28-0e6a-4293-8f8c-27dcd4f4c4b6"
      unitRef="usd">149000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i4d88790c2af246f9a293243672a14f79_D20230131-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfNTQ5NzU1ODQzMzAy_331cca7c-db1c-4cd2-a6d4-920df5439cf7"
      unitRef="usd">42000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <bsx:BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85MS9mcmFnOjkzNjQ0N2MyNDVlNjRmMGQ4NmY4MjQ1M2FlZmRlOTIzL3RleHRyZWdpb246OTM2NDQ3YzI0NWU2NGYwZDg2ZjgyNDUzYWVmZGU5MjNfNTQ5NzU1ODI4MTc4_e9b55f5f-cff0-4be1-bafc-ebb88733d9b4"
      unitRef="units">29</bsx:BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfMTcxNA_a9cf6137-758e-4c1e-95ac-99be98de2f82">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE I &#x2013; STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of March&#160;31, 2023, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2023, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared, and we paid, a cash dividend of $1.375 per MCPS share to holders of our MCPS as of February 15, 2023, representing a dividend period from December 2022 through February 2023. On April 24, 2023 the Committee declared a cash dividend of $1.375 per MCPS share to holders of our MCPS as of May 15, 2023, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;representing a dividend period from March through May 2023. We have presented cumulative, unpaid dividends within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheet as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note J &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNTI_b6b0481e-cdfd-450c-8c5f-a76653cc2b0b"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5c8184b4c8c243b8af7637900054690c_I20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNDY4_3d8e9522-4762-48e8-ad28-b4558169c4ce"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="ib7f86060f0074e3fa81c9253f3234640_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNDgx_1ea9d662-1c2b-4222-b816-95c9d5c69f67"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i5c8184b4c8c243b8af7637900054690c_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNTky_13a78b1c-cb45-4f57-aff6-5c08553fce8b"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="ib7f86060f0074e3fa81c9253f3234640_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfNjYz_a91a8aec-2d13-460e-9e51-0ba8bc9f087c"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="i95ef2210d01348d08fdd30f6ff1570b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfODA0_36fc31c9-a711-4167-91b9-7ff2e39476e4"
      unitRef="usd">1006000000.000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="ibfdb9354133b4f21abeeec2fddbd3c5f_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfMTAyMA_3491d997-fc6e-407a-ba18-e203de08b64b"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="i21deea3483f54e3b81ef33228bfe3f5f_D20230424-20230424"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF85Ny9mcmFnOjZmZWRlZmVhNjMwZDQ3N2JiZGJmOTM4ODNhMTU2NDZmL3RleHRyZWdpb246NmZlZGVmZWE2MzBkNDc3YmJkYmY5Mzg4M2ExNTY0NmZfMTIxMQ_77d9b023-e08c-4c81-a9a7-2fb8583a8bbc"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareDeclared>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzIwOTg_ef27ad79-520f-4072-8962-5074e6b1f0fa">&lt;div style="margin-top:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE J &#x2013; WEIGHTED AVERAGE SHARES OUTSTANDING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,446.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,438.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of diluted weighted average shares outstanding because their effect in the periods presented below would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&#160;per common share - diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the first quarter of 2023 and 2022, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was reduced by cumulative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preferred stock dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as presented within our accompanying unaudited consolidated statements of operations, for purposes of calculating &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income attributable to Boston Scientific common stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We issued approximately four million shares of our common stock in the first quarter of 2023 and 2022 following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first quarter of 2023 or 2022. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of March&#160;31, 2023, we had the full amount remaining available under the authorization.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzIxMDA_35eaa3e2-7a5f-49f1-8c01-00c3a19ff64f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,446.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,438.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzItMS0xLTEtMTkwOTAw_e341ed4a-e7cf-4720-95ad-bff58593a76d"
      unitRef="shares">1435800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzItMy0xLTEtMTkwOTAw_2057ff1d-9b03-401d-9381-4d0efa14bde3"
      unitRef="shares">1427800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzMtMS0xLTEtMTkwOTAw_5240b6fe-fe7a-44d5-8578-ae958fe9f8e5"
      unitRef="shares">10200000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzMtMy0xLTEtMTkwOTAw_6c42ea76-3b55-4335-be03-29005fa94179"
      unitRef="shares">10600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzQtMS0xLTEtMTkwOTAw_c5fb5842-a199-4545-8dc7-3e4ea347b41d"
      unitRef="shares">1446000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTplYWQzMGNjMzlkZWM0ZDQ3YmYwMzMyNjE4ZWEzNWYwMy90YWJsZXJhbmdlOmVhZDMwY2MzOWRlYzRkNDdiZjAzMzI2MThlYTM1ZjAzXzQtMy0xLTEtMTkwOTAw_1a3f809e-585e-46da-a693-0bcb0cd626bc"
      unitRef="shares">1438400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzIxMDc_1523d865-93d7-4743-94a1-67a1c2e73f68">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of diluted weighted average shares outstanding because their effect in the periods presented below would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i729502d0e5784f61982c93b93148e4fb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzItMS0xLTEtMTkwOTAw_c342ff22-f63a-4e89-9bc7-02f28f9dbbb3"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib25a90bd0f1c4959a574e6b17d6a6895_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzItMy0xLTEtMTkwOTAw_aeb0d7d2-424d-40fb-a950-8d666fa68d9b"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieb4decd76ac944aba2576f8d09ebafe2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzMtMS0xLTEtMTkwOTAw_a583c5db-b4fd-4a42-96d5-b2a039d851c6"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia920d3162ecd41e8890b68584ba18ffd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90YWJsZTowNzZkZmYwNWQ3MDk0ZmY4YWRkYjUwZmZlYjQwOWI0Ni90YWJsZXJhbmdlOjA3NmRmZjA1ZDcwOTRmZjhhZGRiNTBmZmViNDA5YjQ2XzMtMy0xLTEtMTkwOTAw_b5114e94-b5e0-49e4-b364-5a26ea30392f"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzU0OTc1NTgxNjM0MA_5dd041c8-9fe6-4014-8336-3d7dd64ff663"
      unitRef="shares">4000000000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzU0OTc1NTgxNjM0MA_f0cabbfc-9212-40f0-a9ad-6b0e2d719ebe"
      unitRef="shares">4000000000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i84eb384121c84b858baf58516ec1fe4a_I20201214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDAvZnJhZzo3YzQyZTU4OGEwZjI0MjA4YTg5ZjcxY2Y1YjVkZDQwOS90ZXh0cmVnaW9uOjdjNDJlNTg4YTBmMjQyMDhhODlmNzFjZjViNWRkNDA5XzE5OTY_86ff54bb-b0c0-4a07-92ca-04ac832801ff"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90ZXh0cmVnaW9uOmQyNWNhYjA1NzBlMjRjZmFiODNmY2M2ZmY0ODAyNzdmXzE4ODU_e52df917-370e-4165-a5dc-43e45e682473">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE K &#x2013; SEGMENT REPORTING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We aggregate our core businesses into two reportable segments: MedSurg and Cardiovascular, each of which generates revenues from the sale of medical devices. In accordance with FASB ASC Topic 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we identified our reportable segments based on the nature of our products, production processes, type of customer, selling and distribution methods and regulatory environment, as well as the economic characteristics of each of our operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure and evaluate our reportable segments based on their respective net sales, operating income, excluding intersegment profits, and operating income as a percentage of net sales, all excluding the impact of foreign currency. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations and are included in the reconciliation below. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for net sales by reportable segment presented in accordance with U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,066&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income margin of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90ZXh0cmVnaW9uOmQyNWNhYjA1NzBlMjRjZmFiODNmY2M2ZmY0ODAyNzdmXzI5Mg_8500daf6-f47f-496d-baa3-bfea303dc951"
      unitRef="reportablesegments">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90ZXh0cmVnaW9uOmQyNWNhYjA1NzBlMjRjZmFiODNmY2M2ZmY0ODAyNzdmXzE4ODQ_f5a3aa51-67fe-46b6-943f-d485610935e4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,066&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income margin of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzUtMS0xLTEtMTkwOTAw_262f9622-7805-42ec-935f-f838906e6cc1"
      unitRef="usd">1252000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzUtMy0xLTEtMTkwOTAw_29d62156-ceff-4f41-99ef-c04e6009cb82"
      unitRef="usd">1164000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzktMS0xLTEtMTkwOTAw_7a37b9d7-dcad-427d-a7e5-07a5f5afd221"
      unitRef="usd">2049000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzktMy0xLTEtMTkwOTAw_980c1bff-2912-4d59-a5da-c0ab407566b5"
      unitRef="usd">1902000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="i892e1507c0f84e27b277daf33bcc248a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEwLTEtMS0xLTE5MDkwMA_3872cbde-5311-4197-b4e1-95354a480179"
      unitRef="usd">3301000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement
      contextRef="iabd1740aa87b4096a3a080290bcc5749_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEwLTMtMS0xLTE5MDkwMA_f2e18d07-e719-4e19-bb3b-363e4863ff05"
      unitRef="usd">3066000000</bsx:RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement>
    <bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEzLTEtMS0xLTE5MDkwMA_d634245d-c0fc-4620-a9ff-7d0a962e5af1"
      unitRef="usd">88000000</bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales>
    <bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzEzLTMtMS0xLTE5MDkwMA_013dc147-dfed-4afe-af9e-1a0d554aedc3"
      unitRef="usd">-40000000</bsx:ImpactOfForeignCurrencyFluctuationsOnNetSales>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzE0LTEtMS0xLTE5MDkwMA_099de6e2-446d-4802-b419-eeede2414cef"
      unitRef="usd">3389000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpjZDYzNDBkNmRlZGE0MTk2YTgzNTgzOTFhODlhZjM0NC90YWJsZXJhbmdlOmNkNjM0MGQ2ZGVkYTQxOTZhODM1ODM5MWE4OWFmMzQ0XzE0LTMtMS0xLTE5MDkwMA_d91165a1-de3e-4070-9479-17897ecab1c3"
      unitRef="usd">3026000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzItMS0xLTEtMTkwOTAw_3a7aa5d3-b87f-4730-8165-7594a1152e59"
      unitRef="usd">400000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzItMy0xLTEtMTkwOTAw_0ff98262-85b2-4d68-bde9-69271028a8d4"
      unitRef="usd">371000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzMtMS0xLTEtMTkwOTAw_ebd3be58-b535-4001-8d0f-9eaec0c5213e"
      unitRef="usd">541000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzMtMy0xLTEtMTkwOTAw_4f03b04e-e5bf-47a9-a2f4-4a2c710ae122"
      unitRef="usd">477000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i720152cb93a648a2bb7df641008979ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzQtMS0xLTEtMTkwOTAw_114b8cae-2ac4-446f-8205-e3916a4f7522"
      unitRef="usd">940000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1209edcbb30e47fa9c4fb81d208f7e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzQtMy0xLTEtMTkwOTAw_22bee932-e2bb-4985-916d-64a23fd74750"
      unitRef="usd">847000000</us-gaap:OperatingIncomeLoss>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ic1262f85d5444afeb2e8bf8a337371ed_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzctMS0xLTEtMTkwOTAw_8098dede-2bec-40ff-aff4-d699bbe31ee0"
      unitRef="usd">75000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i1ae924fcb6454d58b1beb6db9683dbdd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzctMy0xLTEtMTkwOTAw_c831ceb9-afca-4b78-ba06-3b8116622b95"
      unitRef="usd">66000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i3179b68ff7d44c6494abf26a8009b478_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzgtMS0xLTEtMTkwOTAw_6657c27c-2918-40c0-8fea-73af7f320c21"
      unitRef="usd">110000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ib2beece93d3c417d868a8435ec76e880_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzgtMy0xLTEtMTkwOTAw_08605f6a-f820-424e-bad3-3bfcabfa86cf"
      unitRef="usd">117000000</bsx:OperatingIncomeUnallocatedToSegment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzktMS0xLTEtMTkwOTAw_4572f071-d59f-40ba-ad87-20f7defcfe4d"
      unitRef="usd">203000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzktMy0xLTEtMTkwOTAw_71fd532d-7bd4-4bd9-9e51-83de81f460d4"
      unitRef="usd">198000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEwLTEtMS0xLTE5MDkwMA_6b9467a5-6afc-47cd-9db7-d7263b5ff7c9"
      unitRef="usd">552000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEwLTMtMS0xLTE5MDkwMA_4d9442f8-0f49-47e3-bd3d-c00d25ff8de3"
      unitRef="usd">466000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzExLTEtMS0xLTE5MDkwMA_84da4c2d-316d-495b-b5aa-2d427a3b2de7"
      unitRef="usd">-108000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzExLTMtMS0xLTE5MDkwMA_1d8c50dc-1344-4cf7-be26-b591c24d30e8"
      unitRef="usd">-310000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEyLTEtMS0xLTE5MDkwMA_00e568ec-9f65-4f39-b14f-eceb4a2b72eb"
      unitRef="usd">444000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTozMzYxMDY4MGRlZmM0NGE1YjlmNTRlMzRiYzNhMmJhNS90YWJsZXJhbmdlOjMzNjEwNjgwZGVmYzQ0YTViOWY1NGUzNGJjM2EyYmE1XzEyLTMtMS0xLTE5MDkwMA_a5511e4e-bff0-4d2d-8109-ae15396ced22"
      unitRef="usd">156000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzItMS0xLTEtMTkwOTAw_b7e9ec11-0aa9-4cfe-b49f-020e0a6f77f2"
      unitRef="number">0.319</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzItMy0xLTEtMTkwOTAw_4ef737dc-8bca-43a7-985c-ae946eb569b0"
      unitRef="number">0.318</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzMtMS0xLTEtMTkwOTAw_37a7afc2-47cd-4365-82bc-05a775d64ef2"
      unitRef="number">0.264</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMDYvZnJhZzpkMjVjYWIwNTcwZTI0Y2ZhYjgzZmNjNmZmNDgwMjc3Zi90YWJsZTpiYzQ4NWU4MTMxYTM0NjYzYmE0ZjAzMDRlMWVmNTJlMi90YWJsZXJhbmdlOmJjNDg1ZTgxMzFhMzQ2NjNiYTRmMDMwNGUxZWY1MmUyXzMtMy0xLTEtMTkwOTAw_2ee172d5-9eb9-4f8b-b7da-caaf0c34c1cf"
      unitRef="number">0.251</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzI2NDE_203bf293-c1a5-4be6-9bcd-37e189d7373e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE L &#x2013; REVENUE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes within our accompanying unaudited consolidated statements of operations. Our business structure is organized into five operating segments. The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;850&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;395&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interventional Cardiology Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Watchman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;853&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Note K- Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for information on our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;440&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $521 million as of March&#160;31, 2023 and $509 million as of December&#160;31, 2022. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#x2122; Patient Management System within our Cardiology business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our Cardiology business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $42 million in the first quarter that was included in the above contract liability balance as of December&#160;31, 2022. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. &lt;/span&gt;&lt;/div&gt;Variable Consideration&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information on variable consideration, refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.&lt;/span&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <bsx:NumberOfBusinesses
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzIyMw_9df7a0a7-6b95-4032-a56b-c1aa0929e682"
      unitRef="business">5</bsx:NumberOfBusinesses>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzI2NDQ_950b726f-2ae1-4b89-a46c-4b6db286dbe3">The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;850&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;395&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interventional Cardiology Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Watchman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;853&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Note K- Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for information on our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;440&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c68fb8458984a4f8ea9ffdd46d5ea2c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtMS0xLTEtMTkwOTAw_70703c9a-64b1-4ebf-842f-76fb373d5082"
      unitRef="usd">351000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49e2cf8c97fd4c64965a5f6aa819f9e4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtMy0xLTEtMTkwOTAw_fc3fafd6-dca1-41f0-91d1-aee770207b49"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id347fa0ecf034855bd36b1bc5861689f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtNS0xLTEtMTkwOTAw_08959919-d622-49cc-81c8-6e1b1f23bfc7"
      unitRef="usd">577000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dc12ab5d66c4eb2b1365bc49a5014fe_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtNy0xLTEtMTkwOTAw_0fdef2ce-42a7-4bb8-8ccd-e8c9fd6794c6"
      unitRef="usd">312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie71b6743f2b6457e8bf78a9b44e1408a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtOS0xLTEtMTkwOTAw_4d76dcc3-6842-4712-a465-cba936f338b5"
      unitRef="usd">220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b43f39a384c40b3a17cb49b4126801d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzMtMTEtMS0xLTE5MDkwMA_1780efe6-db49-4f9c-8e1e-590b298b7dbd"
      unitRef="usd">531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20046af1ade34a1bb48b675de0ca23e5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtMS0xLTEtMTkwOTAw_962835af-684a-4f8d-a632-1b3047c286ca"
      unitRef="usd">326000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9d8827599584437aad144dac6477fee_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtMy0xLTEtMTkwOTAw_1a3acf4d-4bfd-44d3-89e3-489baffa9fe9"
      unitRef="usd">143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cc3815af2cc4d4a9f6872e38a324d73_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtNS0xLTEtMTkwOTAw_135ed890-32e8-438f-8c08-7b9d397eebab"
      unitRef="usd">469000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ddbe086cb5145cd83bb64b7179f7739_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtNy0xLTEtMTkwOTAw_b12a2993-b54a-4292-9a48-5ae12007fd47"
      unitRef="usd">286000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4b5346710804266aa4d620df4bb34fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtOS0xLTEtMTkwOTAw_e35c5432-3169-4b52-8f43-baac96d27913"
      unitRef="usd">127000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e204df240ac4042a4b13bf6f20f5c4b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzQtMTEtMS0xLTE5MDkwMA_7144e824-2874-48c2-b176-dce437cda8a7"
      unitRef="usd">413000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i096721fee95e47b791ea57339f0c6c6e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtMS0xLTEtMTkwOTAw_5a64879d-37a7-44d7-86d7-fed9b788dea8"
      unitRef="usd">172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f00f6a7bb3544d58920179cebba0281_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtMy0xLTEtMTkwOTAw_ccd2e363-a9be-487b-9102-1700eac0cd01"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie96d08ce6f50458ab49816d256c5879f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtNS0xLTEtMTkwOTAw_686f1ea2-2936-4482-99e0-cc92cabb9bf1"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0790d1be80ae447488c9e5a9fc97437c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtNy0xLTEtMTkwOTAw_6225a460-74dd-465f-900e-296e4ab10c15"
      unitRef="usd">161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78a866861cad402094fd324c25ba0ee9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtOS0xLTEtMTkwOTAw_f54f22a3-7dc8-4386-9e53-0590a49c7137"
      unitRef="usd">49000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cdc59667be948b992bcf7274af8504f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzUtMTEtMS0xLTE5MDkwMA_44b9de20-2064-4c63-8370-6aa0958a8e69"
      unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff459ba706d649ddbd4ec72d239941dd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtMS0xLTEtMTkwOTAw_04df89cc-aa21-441c-b6d7-8d6b660e0e74"
      unitRef="usd">850000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3e41fa3eab7468c8b4e91101c3d9016_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtMy0xLTEtMTkwOTAw_475b482f-abfb-4307-bf0e-d5aa194437cc"
      unitRef="usd">430000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d6e1f37ca7943058227b53c9ef9838c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtNS0xLTEtMTkwOTAw_fbcabe9d-889b-42b3-943b-afc5926db36d"
      unitRef="usd">1280000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib57c51fa109d491fbf453b46c2cf46ca_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtNy0xLTEtMTkwOTAw_2421d7cb-a7a1-43a4-b965-def13597b5f1"
      unitRef="usd">758000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idefdec8766de4485b6cdc952038f1024_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtOS0xLTEtMTkwOTAw_3ee0fc5d-0420-424a-aa48-30d322363026"
      unitRef="usd">395000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia353d52644074339b237aca193b8b1e9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzYtMTEtMS0xLTE5MDkwMA_919ddaa1-8271-486a-a99a-bf6cacb2c97e"
      unitRef="usd">1153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f524aabbb214853af93224fac9bf26a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctMS0xLTEtMTkwOTAw_e2907425-4570-4743-8fd5-677bee711599"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c333bda857d4e739b41fed616fa6e68_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctMy0xLTEtMTkwOTAw_aeb244bf-7504-4b50-b6d3-b5bbb2d5881b"
      unitRef="usd">408000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18982ae6885f4b8198ee1ce626bc22fd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctNS0xLTEtMTkwOTAw_47204d98-07b2-4c0b-9feb-e23671760fac"
      unitRef="usd">591000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib01b2243c2754130a4e2ed20fe142983_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctNy0xLTEtMTkwOTAw_6254ef07-63e5-43ea-88f1-5dad155d01c1"
      unitRef="usd">186000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73e952a467484badaea6d0b16ca1fa44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctOS0xLTEtMTkwOTAw_9e71d1bc-4d96-4bd0-96ca-1588fc04c004"
      unitRef="usd">358000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife24678eb6c34b28945046363ea2e300_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzctMTEtMS0xLTE5MDkwMA_212aa759-24c0-4ded-9f6d-1243709cff1f"
      unitRef="usd">544000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic784b1fc58dc49f699ae6044fe608256_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtMS0xLTEtMTkwOTAw_6c193b86-9694-462e-bdb0-7823eddf22ac"
      unitRef="usd">265000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib93ae74b5a9e41fdbaa62e517659928e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtMy0xLTEtMTkwOTAw_ccf304ac-e2cc-4a84-9f0a-a0714abf8af1"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08294063f673491c88ed513f79e9696f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtNS0xLTEtMTkwOTAw_f19c53c7-f939-4689-9efa-839c98b03134"
      unitRef="usd">291000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i943d4120b79b4e69b07762eaf7b26e21_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtNy0xLTEtMTkwOTAw_3db3e5c6-a577-40ca-b860-c74728c8256d"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6096985306aa4386b7ea6027c25d855c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtOS0xLTEtMTkwOTAw_95476f91-8d7b-4a6c-915e-f230aa6e6981"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3410600120b47b5bfe3ab5c48f59e1c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzgtMTEtMS0xLTE5MDkwMA_d6f80e5b-5334-42b7-b4a9-283b18002e51"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if02e957943204cfb9fb85d6b73a32689_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktMS0xLTEtMTkwOTAw_6f8dc5ff-6b9c-4f73-9ff9-65c1cef2702b"
      unitRef="usd">345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie616f026675d4c09a0ac3e6282f05cf8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktMy0xLTEtMTkwOTAw_4a5702f9-727e-4b96-bf25-7444d82202c9"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38f221dbc7b741d79383b223f9e27c7b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktNS0xLTEtMTkwOTAw_0782a681-8ef1-4320-908f-540766918f11"
      unitRef="usd">548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26380f708b9e4841930b61b187def315_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktNy0xLTEtMTkwOTAw_d4d4c80c-9b29-4ede-90f5-6d1033b452fe"
      unitRef="usd">325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee563d35506f470b9f10eb39f4283205_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktOS0xLTEtMTkwOTAw_31fdfcd1-7cb9-4102-af16-38352e824e4c"
      unitRef="usd">195000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8d8f220044d42889463ea08e1cf165b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzktMTEtMS0xLTE5MDkwMA_36489aa7-82ce-4f55-a23d-dc9b2d5b605a"
      unitRef="usd">519000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e0c54cf535041beb749a2a1df797e45_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTEtMS0xLTE5MDkwMA_64eb456b-78db-4bb0-95dd-13fe7a3b1811"
      unitRef="usd">85000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5556344fb56743dbae6d822773174a4a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTMtMS0xLTE5MDkwMA_9a3ae9ab-509c-4440-a0ae-f0cb1b493ebb"
      unitRef="usd">91000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28b59b162ea849ca9be28f0f9fa67f2d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTUtMS0xLTE5MDkwMA_45682eed-2280-4ff5-8196-01171cf4bb5c"
      unitRef="usd">177000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i078220c195b64332b042b94c0d76ab95_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTctMS0xLTE5MDkwMA_258f6949-17f1-47e9-ab58-fdd6622f4ef7"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd1c2ac83d1f46a6be7dd082708aa903_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTktMS0xLTE5MDkwMA_23e3fffc-c727-49f4-bad9-50c31ca79bd3"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c352b4948b8481485df395a9cc353c5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEwLTExLTEtMS0xOTA5MDA_6bfc674b-ff57-47d2-bbb7-d7e686f0e08d"
      unitRef="usd">118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10971b0415014c579cc2dbb8f66240e4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTEtMS0xLTE5MDkwMA_ef1904a5-8e54-4d6e-918b-c8a218a21811"
      unitRef="usd">879000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7961173213db4f5d91d6d2e7211fd02c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTMtMS0xLTE5MDkwMA_65a1c5f7-2fab-4a1a-9080-5b6f89759063"
      unitRef="usd">727000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f0050baa10746afa4706c455030ba41_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTUtMS0xLTE5MDkwMA_ed877d49-5a7e-4f99-b951-f49d5743bda9"
      unitRef="usd">1606000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i829d668e2b3c49fc845a7c3a6cdd828c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTctMS0xLTE5MDkwMA_03c9f31c-b8f6-405e-8638-7e446d11acb2"
      unitRef="usd">764000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3889e23d356499d9f44ad951bed2120_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTktMS0xLTE5MDkwMA_775a5c5c-c8f5-4d7c-a611-d655f968d7ea"
      unitRef="usd">644000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb44bd7e5a5c407ebc133a722c9a1308_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzExLTExLTEtMS0xOTA5MDA_b39446b3-9070-4e33-80c2-897c6affc3a6"
      unitRef="usd">1407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03e6d0e45f264ed697fcf267f645c2fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTEtMS0xLTE5MDkwMA_77bb0971-0390-4e1c-a55c-af7d930feba6"
      unitRef="usd">275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4503a934cd0405d9071461ef9d0b03c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTMtMS0xLTE5MDkwMA_33a33d3b-d30e-4859-b254-bd8999979901"
      unitRef="usd">229000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad755ea2c6d3473d8e3a08e615f25c1b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTUtMS0xLTE5MDkwMA_e62a8c52-fabf-4541-b6b1-8ded971cf702"
      unitRef="usd">503000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3068a1c629b847b3b49438fc4cb80ef1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTctMS0xLTE5MDkwMA_0d134990-ea39-41da-8078-9ecabb7415b2"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b5eca007cb54f15afd6e2c739116757_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTktMS0xLTE5MDkwMA_7cbbad33-c673-46d9-9155-093383f647ec"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9688a45fc2049beb9a82a633381002e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEyLTExLTEtMS0xOTA5MDA_64e4ada0-9fe5-49a0-b290-e81c3d4b9c12"
      unitRef="usd">465000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5422ebead84c4ded81dca3fef4d9458f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTEtMS0xLTE5MDkwMA_bec07abb-611c-4b04-a1cc-fa31b25ed6f2"
      unitRef="usd">1154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i844a962b3a3d4374b6d7ab653485bcbd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTMtMS0xLTE5MDkwMA_32f30353-c740-4656-972f-3957de8af0ed"
      unitRef="usd">956000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2296ba5f80e4fdf9f8c978bf59dde1c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTUtMS0xLTE5MDkwMA_05d42b5a-039f-4373-810e-a3e5e7b52ba6"
      unitRef="usd">2110000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie73f4b2c0cdd4b4d86b93f555d5f2835_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTctMS0xLTE5MDkwMA_1b6afaa8-f7f3-4e72-a7a3-993a96a03be6"
      unitRef="usd">1019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95a6956ee87544c1ad636a7500e3ef26_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTktMS0xLTE5MDkwMA_c3083d01-e30c-44c4-9e10-21f0e6a8cdf8"
      unitRef="usd">853000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c584ccce9524b2cbc19a156462ccc1e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzEzLTExLTEtMS0xOTA5MDA_8efce28e-1622-42d7-b26b-c3d6869d5421"
      unitRef="usd">1873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cb98bc5824349e0a016e837ad7726b5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTEtMS0xLTE5MDkwMA_a889054f-3079-43b8-bb0f-aa13e4d43658"
      unitRef="usd">2003000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic937499f758443ae828dea9b24a41dba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTMtMS0xLTE5MDkwMA_c04612d4-fdb2-41c0-a814-5490631a0b44"
      unitRef="usd">1386000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTUtMS0xLTE5MDkwMA_5ecff000-f056-441b-a287-b2ffb9c100e3"
      unitRef="usd">3389000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i510c5d8a3423489a9deb5ae4f8f2de17_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTctMS0xLTE5MDkwMA_e8e7724f-53f3-4305-af29-af52415e0c3b"
      unitRef="usd">1778000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fc93a4a42604befa962d6c0f4e94d6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTktMS0xLTE5MDkwMA_a1eb89da-9c3b-4ec0-b7f1-c518ed859b8f"
      unitRef="usd">1248000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTo0MDA4MjM2MzVkNWI0NjVjOGFkYTRmYmI1NzE1NGY4Ny90YWJsZXJhbmdlOjQwMDgyMzYzNWQ1YjQ2NWM4YWRhNGZiYjU3MTU0Zjg3XzE1LTExLTEtMS0xOTA5MDA_1d7ce86b-d601-4d55-b6ec-4ca8bcd3e2dc"
      unitRef="usd">3026000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica31a05afc6142cdb6e3553ebec68348_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzItMS0xLTEtMTkwOTAw_f5086eb8-82e4-4537-9e31-fa24e9d3b4bc"
      unitRef="usd">2003000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89df95595aa24a1c9855a94a80a41df0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzItMy0xLTEtMTkwOTAw_18e639e0-fae8-4362-a36d-587c307b2771"
      unitRef="usd">1778000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f896077c40e4dbabd217e2aa1f4c9a5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzMtMS0xLTEtMTkwOTAw_f5dadb22-2a7c-4974-83d8-8e3dfd94c332"
      unitRef="usd">712000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bba908d72404714bf08fea400279688_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzMtMy0xLTEtMTkwOTAw_c0f60d61-0828-4568-9d54-0f1653b4c805"
      unitRef="usd">624000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f4f8c9dec7f4aec8d00394ff1f2c185_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzQtMS0xLTEtMTkwOTAw_e8cc8615-3b45-4f90-aadb-f40ff01e6d72"
      unitRef="usd">548000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieffcfd57b85847f5b9ac168b84a7fb47_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzQtMy0xLTEtMTkwOTAw_b7515618-538c-4d53-b9b6-2c44e31d322c"
      unitRef="usd">517000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d805dfd29434cc483bf10e47f598abd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzUtMS0xLTEtMTkwOTAw_fcd4fae3-5328-4805-8039-5ce35065de00"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i975a78bf3f974f3d82fb89c8f671b311_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzUtMy0xLTEtMTkwOTAw_1a7acd05-f042-4710-b399-99003ebf7099"
      unitRef="usd">107000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEwLTEtMS0xLTE5MDkwMA_5ecff000-f056-441b-a287-b2ffb9c100e3"
      unitRef="usd">3389000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEwLTMtMS0xLTE5MDkwMA_5a126123-72cc-4556-9277-0fcc5d65a77f"
      unitRef="usd">3026000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4dc7a3a9179c4bee8cc766a1114c8a59_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEyLTEtMS0xLTE5MDkwMA_abdb2a59-3ef0-41b7-b5e7-efbdf077a414"
      unitRef="usd">529000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6264f6b9421a4ec4a9454dbc24c596cc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90YWJsZTozZmIzNzliMzhiNTE0YjhiYTk1YTAzOTdiNGFhYjhmMS90YWJsZXJhbmdlOjNmYjM3OWIzOGI1MTRiOGJhOTVhMDM5N2I0YWFiOGYxXzEyLTMtMS0xLTE5MDkwMA_47be3d05-8228-4c3f-bd2a-6490103ecd0d"
      unitRef="usd">440000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzE0NDE_a17daa72-be0b-468e-b636-502cfc8e6e83"
      unitRef="usd">521000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzE0NTc_5562dd5f-b974-46fe-961f-27348e374eb0"
      unitRef="usd">509000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTIvZnJhZzo2NDhmMWFiYjEyNTU0ZGU4OGNjMDY3NWRlMWQyNzI1NS90ZXh0cmVnaW9uOjY0OGYxYWJiMTI1NTRkZTg4Y2MwNjc1ZGUxZDI3MjU1XzIwMTI_83627fe3-3194-4275-b47a-54db7f0ba14c"
      unitRef="usd">42000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90ZXh0cmVnaW9uOjdjZjQ3MWVkYmI3YTRlNDhiMWVjMmZkZWExMDQ4Y2Q5XzMzMg_34de7b2c-334e-4fd4-9038-791a71479d88">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE M &#x2013; CHANGES IN OTHER COMPREHENSIVE INCOME&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;178&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further detail on our net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our cash flow hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90ZXh0cmVnaW9uOjdjZjQ3MWVkYmI3YTRlNDhiMWVjMmZkZWExMDQ4Y2Q5XzMzNg_f9415a6a-afe3-46f2-858d-b38b89081524">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;178&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;R</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtMS0xLTEtMTkwOTAw_7a5a19b3-d1e2-4b11-8c0c-f0c414079575"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtMy0xLTEtMTkwOTAw_5e3a29e0-50e4-4fa3-8dd2-1b7679381d25"
      unitRef="usd">269000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtNy0xLTEtMTkwOTAw_539ea107-1271-4b6b-bbf6-789e017b2a00"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i112e69f95e3e4061b901b02e1a6de8a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzEtOS0xLTEtMTkwOTAw_971886e8-eaef-453f-8fd5-471cca5038ef"
      unitRef="usd">269000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItMS0xLTEtMTkwOTAw_549f4525-92d5-42f5-b5cf-187c35f26973"
      unitRef="usd">-40000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItMy0xLTEtMTkwOTAw_bcbc45ad-3569-4af9-a5ee-079d499190af"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItNy0xLTEtMTkwOTAw_b5dc3fa1-f4e2-462b-a3f4-144f442c8661"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzItOS0xLTEtMTkwOTAw_ee038d57-295f-491c-a3a3-a31e255f2285"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtMS0xLTEtMTkwOTAw_e391fa68-e344-4578-964f-a35c332f6d35"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtMy0xLTEtMTkwOTAw_44770456-0eb8-47ec-9abe-ef9997da1249"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtNy0xLTEtMTkwOTAw_f3dc82f3-f4de-4f1e-a876-41fee761f1c6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzMtOS0xLTEtMTkwOTAw_1eefcff9-d1b7-48c3-af12-3317771ec153"
      unitRef="usd">56000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtMS0xLTEtMTkwOTAw_8d4521ea-e00d-46f2-8046-c26c9bf3f9bc"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtMy0xLTEtMTkwOTAw_7afec61c-e7b1-4182-ba11-60e5b86f2e55"
      unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtNy0xLTEtMTkwOTAw_c414d577-c05f-4b27-ab91-d06a978de754"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzQtOS0xLTEtMTkwOTAw_83f9e1b3-dd06-470d-8b5e-5f3a16884818"
      unitRef="usd">-91000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtMS0xLTEtMTkwOTAw_8dbd4908-44d2-4685-9eef-91d8431122bb"
      unitRef="usd">-43000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtMy0xLTEtMTkwOTAw_b219a86a-5f0a-4ca8-bef6-9c5bccacc474"
      unitRef="usd">225000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtNy0xLTEtMTkwOTAw_e28d1736-bde4-41d0-8a8f-5e30001619f9"
      unitRef="usd">4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i988810e1696c4da3b18cc0a7b19cf868_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTpmMDk3OTcyZGQyMTE0NzUyYmNmN2NhNjlkYzFjMTMzZi90YWJsZXJhbmdlOmYwOTc5NzJkZDIxMTQ3NTJiY2Y3Y2E2OWRjMWMxMzNmXzUtOS0xLTEtMTkwOTAw_9351c2bd-fe5a-4488-b2c8-5e875306dfa8"
      unitRef="usd">178000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtMS0xLTEtMTkwOTAw_9d5193b5-5d53-4070-b01a-7f6db835e111"
      unitRef="usd">93000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtMy0xLTEtMTkwOTAw_a8aa3f30-213c-4bd6-8a43-b4fe229b54e1"
      unitRef="usd">206000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtNy0xLTEtMTkwOTAw_7977f47d-7774-4d84-a1f5-3f0b8f7abe99"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifbdc62a26ba54204a2e8338c42fb00ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzEtOS0xLTEtMTkwOTAw_158998e1-b2f6-4a19-934f-d06a94daf38e"
      unitRef="usd">263000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItMS0xLTEtMTkwOTAw_0c84435f-0426-43bb-b6ce-a5b1230f4b61"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItMy0xLTEtMTkwOTAw_e075e1f1-f867-4d2e-9264-e23b7d6056fd"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItNy0xLTEtMTkwOTAw_18128200-9486-4fce-8625-059a01267070"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzItOS0xLTEtMTkwOTAw_e9ef5748-5e10-40e3-9719-f299c2dc2ae0"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtMS0xLTEtMTkwOTAw_85f0a9a0-8256-4f71-bfe4-0cd057fc850c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtMy0xLTEtMTkwOTAw_fa4f94eb-ce5c-493e-a559-d4e670f7fcda"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtNy0xLTEtMTkwOTAw_c390a30f-ac45-4771-96df-c592aad7b4df"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzMtOS0xLTEtMTkwOTAw_70a4c2f9-ce8b-479d-931a-ed085ad96962"
      unitRef="usd">14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtMS0xLTEtMTkwOTAw_b9abe2dc-09c7-4fd0-a69b-f158d92a5e7d"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtMy0xLTEtMTkwOTAw_7fc604c5-1cf4-436c-be8f-c8a50c369793"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtNy0xLTEtMTkwOTAw_87c5ff5c-689b-4a0f-887d-3e3f7b271d09"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2887ce8cd383457f9ee11384c498b860_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzQtOS0xLTEtMTkwOTAw_e579f13c-3e08-4b40-bb45-b473f3029d5f"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtMS0xLTEtMTkwOTAw_05b85ad6-1d9a-4c7b-90b4-1ef0413a7188"
      unitRef="usd">29000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtMy0xLTEtMTkwOTAw_1322f267-e20a-4a95-b00b-5459267372b2"
      unitRef="usd">229000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtNy0xLTEtMTkwOTAw_7b5319e8-d358-48b4-b73a-5a6f4ee6da02"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i52087d690e344eaf99a1374ee56c5df4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMTgvZnJhZzo3Y2Y0NzFlZGJiN2E0ZTQ4YjFlYzJmZGVhMTA0OGNkOS90YWJsZTplN2FhOWE1Zjc1YjI0OTEwOGNlNDQwZDAyM2ViZGVlMS90YWJsZXJhbmdlOmU3YWE5YTVmNzViMjQ5MTA4Y2U0NDBkMDIzZWJkZWUxXzUtOS0xLTEtMTkwOTAw_a4598470-b4f0-4d06-9afe-d174d9c7f081"
      unitRef="usd">222000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <bsx:NewAccountingPronouncementsPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0Mjc_c348c7c0-eabc-4dde-a1b6-89b459ece7ab">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE N &#x2013; NEW ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first quarter of 2023, we implemented the following standards on a prospective basis, none of which had a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-01&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-02&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments- Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-04&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities&#x2014; Supplier Finance Programs (Subtopic 405-50) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;enhances the transparency of supplier finance programs by requiring that a buyer in a supplier finance program disclose sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards to be Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASC Update No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</bsx:NewAccountingPronouncementsPolicyTextBlock>
    <bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0OTc1NTgzMjY4NA_a9aa5957-45de-40c6-a978-f562a7a05eb5">ASC Update No. 2022-01&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. &lt;/span&gt;Update No. 2022-01 expands the current single-layer method to allow multiple hedged layers of a single closed portfolio under the method, among other updates to these methods.</bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock>
    <bsx:ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0OTc1NTgzMjY4Mw_aa96cb22-a2b3-430f-bc14-e6beb2734314">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-02&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments- Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;makes amendments related to troubled debt restructurings for entities that have adopted Update No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as &lt;/span&gt;&lt;/div&gt;amendments related to vintage disclosures for entities with investments in financing receivables that have adopted Update No. 2016-13.</bsx:ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock>
    <bsx:ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0OTc1NTgzMjY4Mg_9820ac5a-bf61-4e67-bc20-98e4b4420b94">ASC Update No. 2022-04&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Update No. 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities&#x2014; Supplier Finance Programs (Subtopic 405-50) &lt;/span&gt;enhances the transparency of supplier finance programs by requiring that a buyer in a supplier finance program disclose sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude.</bsx:ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock>
    <bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock
      contextRef="i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQzZmFkYjk5ODc0NDQyMjE5MjljMGRiMGRlZGJhZjU4L3NlYzo0M2ZhZGI5OTg3NDQ0MjIxOTI5YzBkYjBkZWRiYWY1OF8xMjQvZnJhZzo0M2ZjYjAwMTRlYjk0NTUwYjczODk5Yjc2OWIwM2NhNi90ZXh0cmVnaW9uOjQzZmNiMDAxNGViOTQ1NTBiNzM4OTliNzY5YjAzY2E2XzU0MDg_a4068733-d62f-4efe-8f1c-daca7250aa60">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASC Update No. 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Update No. 2022-03 clarifies the guidance in Topic 820 related to measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, as well as introduces new disclosure requirements for these types of equity securities. Update No. 2022-03 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. We do not expect the adoption to have a material impact on our financial position or results of operations.&lt;/span&gt;</bsx:ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>70
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MH"?")/M+'O-G7;=#O'6B1%0$0PFB(,[_LZ>B(C8"!E9% "T"Z*L N^H7G"+
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MJ3W'N!85$G2/5RQ&??.CT2GXP!:[SJLCAY8CV1AZ!C2+F2.'C:3 [L/;]0G
MS?7YQ?7-]=WUEPDX_W8%OOQY?WWWCQ5N8)QUVTX$K&;FB<"H]<%&?RU3R^N<
ME0+D=*;Z><>1<E.M/T"M;R1?UM]PIEQ*7M27"TK4;-4&JGW&N=S>Z,]"N\^
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M8:+>[^N)XBNS9<ZYP@W8##,\(H'0!GA_P;G:3O0NW!ZZXG]02P,$%     @
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MEQ$3F1+JH?ZTU+&:(T"!1:!?TK$$HUECIK&A^ .@J .$XT2B)H7 0$NAC6X
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MA4GYZPQ!I"P-P/.)014;+FB!^N=OIW\"4$L#!!0    ( .: I%;ZRK)9' 4
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MNP'HJLNK)E:M?&<U5Q;[-#]<8F/,M-N Z[G"NZ@G[H"FU1[]!U!+ P04
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M8<IZQEIZ;Y746G)6*!JS5&MB;A0#(K 2:@.5Y?"K0V J#@PT.@D;"ATJ"*.
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M,FFDA'Q[K%DF()1PD:77V7LAZVTF-=4:8$<3W2@&R^1BHU-M#M!909VD>%?
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MD@Z-QJ0._1ZI!H*R;4HT&?.X(8^CP.QP,-RE07VC*/VFK W.)CS$BMO/JM(
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M#VD:#<#]>0P"F!^T0/%&S+?_"U!+ P04    " #F@*16%]V:*> 1  #C,@
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MSWHP0<WY?G<T&JY3TV[-8O!@5'/A==O@?JM&9SFA",?9DRNB?.[?Q' (Q75
MBG65)B$L(9+15"OE#_H/(Y5+72JN2JB%!8>RNW '=LUS'R+D":07UO7.]3M
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M\'RAH0#_A1:H?]?RX?\ 4$L#!!0    ( .: I%8R#[-*JP@  -$4   9
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M"WD:?># K9HCU7/P:*SS" O92(MI*'TP'5T!NI>!:/:Z18NIF#[65A""!&Q
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M<)3U0A%OOC2F]B^M9J;!A/8?EW@4D987X/>YP3FS^\(.MF\Q3_\'4$L#!!0
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M(,]3E9Z+SJ@+E9I43"W"OA_WQ_N)4,#6JJW#[SU^UB/"]BYJOQ SC'$GDB?
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;*U6;6_;-A#^*P>OZSK
MLV4[;K(V,>"\%,VZ-%F<KAB&?: ERB(JD2I)V?%^_9XC925%W0 %]J&-2=T]
M]]PK[WAC["=72.GIOBJU.^D5WM>OAD.7%K(2;F!JJ?$E-[82'D>[&KK:2I$%
MI:H<CI/DY; 22O=FQ^'NQLZ.3>-+I>6-)==4E;#;4UF:S4EOU-M=W*I5X?EB
M.#NNQ4HNI/]0WUB<AAU*IBJIG3*:K,Q/>O/1J],#E@\"?RJY<8]^$WNR-.83
M'RZSDU["A&0I4\\( G_6\DR6)0.!QN<6L]>99,7'OW?H;X+O\&4IG#PSY4>5
M^>*D=]2C3.:B*?VMV;R5K3]3QDM-Z<+_M(FRD\,>I8WSIFJ5P:!2.OX5]VT<
M'BD<)=]0&+<*X\ [&@HLSX47LV-K-F19&FC\([@:M$%.:4[*PEM\5=#SLX4W
MZ:?"E)FT[B>Z^-PHOST>>B#S]V':HIQ&E/$W4"9T9;0O'%WH3&9?Z@_!J*,U
MWM$Z'3\)>"7L@":C/HV3\>0)O$GGYB3@3;[#37IOO*2_YTOG+8KCGWUN1]2#
M_:C<,*]<+5)YTD-'.&G7LC=[_L/H9?+Z"<X''>>#I]!GB[OKLW=OKW\_O[A=
M@/,?'R[O_MK'\6F4]]=W%W1)SW\X&H]&KVD?*-V@$Z2U,J,0)_HH25C\:WQA
MK/H7]]Z0<JZ1-$U0A67)#>4*"#DR.=6=O@OZ2I/1DHRER@ '@5$0%#K@Y.J>
M?"&I-ALDHX\6<FJE!?<H3A%*ZK15L+(4W+=4"^M5JFJ<]*I/I@Y-#1,&8)8L
M=Y]C8"M-W@>%M&PRB%*FUBJ3#!5$^I0:O8;E,%7:J[5AU.X(3V05#7AI*]R4
M"B63!9)?461G=%,MP0*Q:*,"(\XKWP1<H;=M$/IH;P2U\>$N;VP@O^9"A"LB
M3JKEEDQC8RS;FAW0M:8KL:7Q8>B)!$ 21JJZE!YQ%PA%#E9L#21&23]Y.>Y/
MD^11EJ:#:?(C0#3\,'9+9R$.7BU+^54%O+@ZNUG\W*=%3-V<!!C#<Y5*SF'(
M7[,L51HBL#\Z;//9"!1JN!AH#.B.8X6GIK8FE3)SE%M3!3@V^. #2@/U5T/L
M7F'TRG)+SWX]G':U)W(D!J63-6F(<(.Y8S=6^9AQEYI&^Y@>!*E"[7)YA7-G
M0][C97,2L9V'^&#FI$4W=/HA!X%5(4* Q6IEY0IDGO1W@->0EI'F@,Z;8(H=
MS)5UGCXWJ.-8*=$*?YJC4CWR :+>RP#$QD^-L,R7SI7%(V:LHQ<LW@DB075C
M72.TYZRT_8K)EN'58Z:AX5P#M](.O*VNK\&Y%=,2:<KZ(5 ;;CK%!TJ%*QX:
M*?HY03HXLR%$(;ULK*W7G0OAHPC'-W)IX?R61M-=A*T,8U/')GDP %AELE@;
MYS*5H;>@,D:TK&E6Q0,8 X7FF*,X2QH?1&SZ(DZ=8_^3*]R(W^=%K*T=^]#(
M@3@F;2%XND4$,$R;JHDCKX^JY@1TB"X,#PS7>9K:!K*["M[=,TV1\E3 =(EM
M(;BT&!;E;THN6AR6HA1<L''M$WNJ?T"W7-8<AO!*_O;P@.Q[22$6;+?&<J6!
MKT2)&0:#V.%\F(@>2R(^@^DE;NEH%]K*H#-0A9"CN=8-%&]E;:S',T*\?&&@
M_?*.L()"-RZB8?CK.(AXB&G6;1\!+EY4PUJA"627/PQ=L-'A3>!NX!>,?1GL
M>ZJ'CS:J2MI5V!O9!XR5N%QUM]UJ.H\;V8-XW&L1V)7"["EE#M5D<#CM1:*[
M@S=UV,^6QF/;"S\+K-?2L@"^YP89: ]LH%O89_\!4$L#!!0    ( .: I%:.
MBRJJ*08  ,@.   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;)U7;4_<
M.!#^*];>J4<EV'<H1P%I*=N6DPJ(I>V'ZCYXDPFQ<.+4=G;A?OT]X[R0;1=4
M5:!-XGAFGGE[)CY>&WOO4B(O'C*=NY->ZGUQ-!BX**5,NKXI*,>;Q-A,>CS:
MNX$K+,DX"&5Z,!X.#P:95'GO]#BL7=O38U-ZK7*ZML*562;MXQEILS[IC7K-
MPHVZ2STO#$Z/"WE'"_*?BVN+IT&K)589Y4Z97%A*3GJST='9E/>'#5\4K5WG
M7K G2V/N^>$B/ND-&1!IBCQKD+BLZ!UIS8H XWNML]>:9,'N?:/]?? =OBRE
MHW=&?U6Q3T]ZAST14R)+[6_,^B/5_NRSOLAH%W[%NMJ[_W=/1*7S)JN%@2!3
M>765#W4<.@*'PV<$QK7 .."N# 64Y]++TV-KUL+R;FCCF^!JD 8XE7-2%M[B
MK8*</_T:8%,L9BNRR()8I-*2$U>E=U[FL<KOC@<>AGC[(*J5GE5*Q\\HG8A/
M)O>I$_,\IGA3?@" +<IQ@_)L_*+"3]+VQ62T*\;#\>0%?9/6ZTG0-WE&WUS:
M')XY<4VV\EA\FRV=MRB2?[?Y6ZF;;E?'C7/D"AG120^=X<BNJ'?ZZH_1P?#M
M"V"G+=CI2]I_3M%EF2V!^RK9DBSQ[98>O#C3)KK?ZLG+MBZO;N?B'_'JC\/Q
M:/16?)U??/AX.S\7LR_SF]F'N5A\G-W,%^+J\^WB=G9Y?G'Y0=RFEF@CX0+I
MBM*0KQV5HVJU1@.ZUR%[_#,6K4^R]LE5GIB.)P'$^"TWG8K$:'<ZV>\?\G7\
M!M=+$!8E"9I;F$1$)LO0XVB7Z%[0]U*MI*;<.S$:]L?\<_!+)O=$K'3)FV!F
M>M ?!K.'_2F\))$8#0[C?8ZBTBJO(+XF% \]1+IDSQ-K,N&Q-Y(Z*K4,S -\
MC=KU+X!84B1+1ZQ&V<9'Q)'5%F25B9T(99:SHB7S*JBOU+%(H14+!+++O=H+
M1L%Y1[^7HT4(IBG8ATV$.Z/78H*_3^^N%V)G#*$I__/R#=707)V,;?)%:5T)
MB,(;K,/'K-#F$0B#R!ZS;,PIQ>1Q50@++:%CK7R*6).-%.)36!4A=#Z5OLK"
M'::21V-@I8I6$^1$(I"8.?>H&11&29P2-KQ1-IAP0<H2\@8 =:S[P<..7QM"
MRL&3I291%J8R&ID<9EV=> Y1']()XS+BTG@2%VU_A1"G1L<0^$O,4;?^,>"0
M<:S8<:F1^6KTXJF/(@XS*%2_RH&$Q(XV#GD#VA99(+2G6FZA-=6WUP0FKYBD
MTT!5.2)/S[=4-Y,QV@ 7DJBE1V*6OH:'*#X ?U8!HXL)F<(\8WB.53 ^CP2Z
MTC[6,AGYU,3!Z;K!-FMJMWZ4:VGC"G2HR*U-J)*P5+=3U2]+VFR4?FCSYJE#
M+T&M<JW"#=0JV:MRSLL-YMOM+X1$O61-U4(:N?R13)YD4# -/_Q <94P'+A3
M.4\RWE#5;F&L#ST6JI=5!+<?."NMU995G'CR_7U=_XFRSHOOI;2^JHU "1Q=
MIH7=KCQ>!H>:4/Q<^ZC2Y[U82[>9@-U@!IKP:69^A5>I&>1<_E7=[\RO%Z_[
M8A9%QG*-ZL?=;KNP34MQ&3%W/N(3*POJD.YKRUV*=S6Z6*U43#DJ"["ZE,LT
M!,YD I$1TY3,'SD"92Y+M&W@KMP9K>)0*6@63UG5.J =()5U^7*G@PL+X^K@
M-,Y!60>R]-ZJ9>D#SR":9P8 <[&(%'=:@N'8C6I-)R+T#=,33YNBL.9!@45(
M,\$ ><WXG=3\1(CUS'FY'CI3L2JTFIVQ[X=F79'S=:G"(ER*?!OK,E<<GA".
M*)4<CQ)CRFX9#^V6,!2"E[&*16X\5W_S#BGY;=< @SWKBZM<G%-$@2-'T_#U
M.=P-RLX,*(<%SI5%(QC$.\1XQ<&N;730X,V=E9F0)4C JO^::'6V0%=9<';_
M'/6'PZ%8UOG9@A[%';QZ&N$,>Q?L@2^ N'*LU%K(S)0Y1X4/9VQ2KJ32U;0*
MP0TSLH94#9AMGZN#SNDB(WL7SE \!J&\.FBTJ^TQ;5:=3IZV5V<\( 9A.:$I
M@>BP_V:_)VQU;JH>O"G"665I/$X^X3;%49,L;\#[Q&"\U ]LH#V\GOX/4$L#
M!!0    ( .: I%:%5,!B=08  !00   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;,U86W/J.!+^*UW,SA14,6",0TA.DBIRF3.IW5PJ)#L/4_L@;&%K
MCRTQDAR2_?7[M0R$)"1S=FL?]@7+4G?KZT]]L3A:&OO-%5)Z>JI*[8Y;A?>+
MPW[?I86LA.N9A=18F1M;"8]7F_?=PDJ1!:6J[,=1-.I70NG6R5&8N[4G1Z;V
MI=+RUI*KJTK8YU-9FN5Q:]!:3]RIO/ \T3\Y6HA<3J5_6-Q:O/4W5C)52>V4
MT63E_+@U&1R>)BP?!/ZNY-)MC8D]F1GSC5\NL^-6Q(!D*5//%@0>C_),EB4;
M HP_5C9;FRU9<7N\MOY+\!V^S(239Z;\366^.&Z-6Y3)N:A+?V>6O\J5/WML
M+S6E"[^T;&23N$5I[;RI5LI 4"G=/,73BH<MA7'T@4*\4H@#[F:C@/)<>'%R
M9,V2+$O#&@^"JT$;X)3F0YEZBU4%/7\RE3DH]G0G%\9ZI?.COH=97NRG*Q.G
MC8GX Q-#NC+:%XXN=":SU_I]P-E@BM>83N-/#5X)VZ/AH$MQ% \_L3?<^#@,
M]H;?ZR/]/IDY;Q$1_]CE;F,MV6V-L^30+40JCUM( R?MHVR=_/3#8!1]^01K
MLL&:?&9]!]9SY=+2N-I*^OU>/GDZ+4WZ;2?PSTU?W]Q?T%_IIQ_&\6#PA:87
M7Z\NKN_I[N+VYN[^\OHK_29)Y+F5N?"23&TI-=AT5CL8<DXZ4MH;\DN#;&1T
M8E9*<@U@=TA7,IO6-B>A,SH3-E/F4;BT+H7MDA1I069.RT)AD$LM+39Q,/0H
M=8W!W)J*? %[ D8A6<E,I:)$ACVJ5+H>77(* U$F="J1);Z@7R;34YI,S^C>
M+%1*\3CJTGL"N[24I#),JKF26?!LAP,AN;&J PPM/#,.("R^L":K4^^ZZQ$7
M% S3P$N7_/,BR#8)*^$PZD[)FS,9F4*PJ5D=M"KI"Y.YL "J08\W]IFD?E36
M:$;2)>$ N2SYR5AD:K2IX&!:" Y::6%0I8YW7!/+*%&IP2KONO:IQV=:21&B
MAW>4CZ*LU\?[9R0H%G$+&0HG:70(/ARX^[*1TBG\Q?D^I66=-3/ MS+'%,T5
MT\9[O]5B]P1A,H4H&@"[L;6)  $O9ID'52'M/(NA&:'<:O!MK=3I<_"S$99-
M*+W;#%J[_$TE9I3F4,<BF/G92AP).)!/:'P<]8Q]+8:BH9T(YP_Z+8GLGSCR
MQI0OA&_2IE!ROH4@DZD*3:P2WZ2E]MG-^54'.Z*S9>"*D%0S\&OTSRL=HT6)
M$*IQM,Q196JVOP8&<4PAMO\51-= NY0;DRT5QPVS#<8LGX;0N6*7!4+5!PZ5
M#8?#T90'IM,_:@!D8_T,1XW@XN#?,,&'LA*F=FJ1F-YUNAP;WB(7:KL.]%<S
MGZM_>45KB<WSX,WG6D'IHK;@26AZT.Q^^^*AP[4G5(OS4"V0_"&QPO+5^5V'
MW2XE>]U,IL9Q<DQ*Y&*=%UP@UM$#VIS<</Z?Q%*7=9])(-4@Q\8R#%:2&%\V
MRFT4<W@RDQS$:XM>/,%/+FK0X!CB4H>CTL^\;:T%LH!M<-"84F6!(@=O9!-[
M9A-O')C,TEL8G$"6*TFJ2M6P,.-/LA[(FB-2$%77!H7A;YL&<=?49DZVE[RD
MV?,.WRET0NV;K=Z6Z8?>M$=?)Y-;,/X6 X S,F^\*-T+5[QG@_A]RG(/PI)8
M+$J<.2]QIR/P4_WO*%2.4V]N2E"$ (3)"IG%2Z'8R87?JERNTZ/[PDKYZDN(
MKD':-)#&'S+\$V^:Y%]HT(WWXO <C)(W#9/B;I0<8.D@BM'<P,W6"7Q0R8;=
M833 ;S0:T>6'E9+F)2?HRLOQF-I)U $*:(\/PC.*1]\1JB]^)%'$>ON#MS[L
M)0-*]O=7^+^W(!\D$8V3?20W&H!)PRFMLO&0SM95>E.=NZL@9\.%S/)0BKAA
MH:*L:O?';>,U&1R-WPFRO;_7H?9HU*&OVS7W_[;:=O_+2OM J)X[BR>U!P,$
M#G[W.S39T8ZH'4=#%C@8=^CF+:^KR-I#!B2(UYO0K#:-C!&U!Q$4VT/>Y<_#
M$6&8))Q,>Z-=F8@;!7HI7RG>(<%5-%?ZHX-^G[C#0>^ ?N3'&(^W:3OJ)9B-
M]WH#^G'7;:"_=5/#=V(>[J/X"N'X;BYMF]G-E7?2W/1>Q)O[\E4 [JB4<ZA&
MO?V]%MGF#MJ\>+,(][Z9\?@H#<,"UW9I60#K<X-ZOWKA#39_!)S\&U!+ P04
M    " #F@*16>$FV2\@'  !:$0  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6R]6&UOX[@1_BL#W^)N%W!L2Y;?=I, 3N*VN=MD@[S<%BWZ@99HFUB)
M])%4'/?7]QE*EIU--M=^*1#(>B&'SSPS\PR9XXVQW]Q*2D]/1:[=26OE_?IC
MM^O2E2R$ZYBUU/BR,+80'H]VV75K*T46)A5Y-^[UAMU"*-TZ/0[O;NSIL2E]
MKK2\L>3*HA!V>R9SLSEI1:W=BUNU7'E^T3T]7HNEO)/^87UC\=1MK&2JD-HI
MH\G*Q4EK&GT\2WA\&/"[DAMW<$_LR=R8;_QPF9VT>@Q(YC+U;$'@YU&>RSQG
M0X#Q1VVSU2S)$P_O=];_$GR'+W/AY+G)OZK,KTY:XQ9E<B'*W-^:S=]D[<^
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M]G@ OB\,6*L?>('FWRFG_P%02P,$%     @ YH"D5EY&$FL:!   ;@H  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C$N>&ULU59;;RHW$/XKHSW5$4A1]@;D
M<@ )"&DB-21*:/I0]<'LSK)NO#;']D+.O^]X=[,A$J&JJC[TQ=C&\\WEFYF=
MX4[I%Y,C6G@MA#0C+[=V<^G[)LFQ8.94;5#2/YG2!;-TU&O?;#2RM!(JA!\%
MP< O&)?>>%C=/>CQ4)56<(D/&DQ9%$S_F*)0NY$7>F\7CWR=6W?ACX<;ML8G
MM+]N'C2=_!8EY05*PY4$C=G(FX27TYY[7SUXYK@S>WMPGJR4>G&'VW3D!<X@
M%)A8A\#H9XLS%,(!D1G?&TRO5>D$]_=OZ->5[^3+BAF<*?$;3VT^\LX]2#%C
MI;"/:G>#C3]]AY<H8:H5=O7;L\B#I#16%8TP65!P6?^RUR8.>P+GP2<"42,0
M57;7BBHKKYAEXZ%6.]#N-:&Y3>5J)4W&<>E(>;*:_N4D9\>SG,DU&N 2[FV.
M&F:J('9S%_8MPJU,5(%#WY(J)^ G#>RTAHT^@8WA3DF;&YC+%-./\CZ9V-H9
MO=DYC8X"WC%]"G%X E$0Q4?PXM;ON,*+/\'[W%GH_**,Z9[ @DI"9;!DKR?P
M@)JK%.IHP>^3E;&:$NJ/0Y&I%?<.*W9%=FDV+,&11ZH-ZBUZXZ]?PD'P[8A;
MO=:MWC'T\1&'8*$LF;[$5PM3H9*7@\8?AU_<+^=P!U^_G$=A^ UF-Y/%S_,G
MN%W _?)F_@BS^[N'Q_G-?/%T^SRG:SK/89DC9$I0^7.Y!LM6@O)MH]66IPA$
M ]5V(I@Q/.,)<Z5J@+J'"WU-4O+!)][X)&J29$V29:]P"1W*XH(+X3"Z0%5+
M-2EA5FJ-,OD!2\VD$94*F*1_4G%1=[&F(KIAE@"NB.HM<[T"KKED,N%,4"2)
M\/+P\XR"E,(4)>TL94K5L PPF38.W%HL#"R5): I$P2)P(PS^PH3+%;TI,GL
M"'Z"3MBE-1I<T!HVN[\-!*R0&O2A4'9Z01?" #K]+G1BM]19T04G"*Q0I7/J
M79!\R;0JJ%\F95%2N.A"'=$?$60_IB5PFT&W<?282&URI^=$>T[4F75!?G^,
M#M5\DK=%[T+C'E-$HGYU</OP[/S_3[NC^<(Y& 4#YUD\J%,@_E?$#RA8<1^(
M^NCLOZ$]I(7@P]X_('U CXE,$NL=)]S50G11T7VQ%Q2Z?\2,M%A5=[2KMAW=
M8+IV+6;BOO3<<JS9N&9<PS,3)<(=,E-JK FEN$%6ZLKD%"WC9+^DUJ.KIL+E
M%NM,@9QPL8J5TO0U<_2_)5GREF1V+\G87I(Y QQDPDP.&?7 0V@NM9(VM=+W
M3,S:3.1[F7AZZ$/A[\T !>IU->D8XH)XKL>!]K8=IB;U#/'^O)[$B :*HP&!
M&8D&IV=]#W0]W=0'JS;51+%2EN:3:IO30(C:/:#_,T7$- >GH!TQQW\!4$L#
M!!0    ( .: I%;>-KZ'<P8  , /   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;*U7:V_;-A3]*Q<>T*V XU<>#=(D0.*D:X;&#>*T_3#L RU1%E>)
M5$DJKO_]SB4E/SH[&X8!02Q1O)?GOLZ]/%\8^]7E4GKZ7A;:771R[ZNS?M\E
MN2R%ZYE*:GS)C"V%QZN=]UUEI4B#4%GT1X/!2;\42G<NS\/:@[T\-[4OE)8/
MEEQ=EL(NKV5A%A>=8:==>%3SW/-"__*\$G,YE?Y3]6#QUE]I254IM5-&DY79
M1>=J>'9]Q/O#AL]*+MS&,[$E,V.^\LM=>M$9,"!9R,2S!H&?9SF61<&* .-;
MH[.S.I(%-Y];[>^"[;!E)IP<F^*+2GU^T3GM4"HS41?^T2S>R\:>8]:7F,*%
M_[2(>]\<=2BIG3=E(PP$I=+Q5WQO_+ A<#K8(S!J!$8!=SPHH+P17ER>6[,@
MR[NAC1^"J4$:X)3FH$R]Q5<%.7\Y@=^NDL34VBL]IP=K-)X3";][=][W.((W
M]I-&W754-]JC[I#NC?:YHUN=RG1;O@]H*WRC%M_UZ$6%]\+VZ'#8I=%@=/B"
MOL.5O8=!W^$>?1NV3KW0J;"IHT]5*KPDO-(X%WHN2>EMKRB=J*J0]/O5S'F+
M5/ICEV_BT4>[C^;R.G.52.1%!_7CI'V6G<M7/PU/!F]?,.QH9=C12]I?#F27
M'DRADN4NT/^@]N/3+4WHU4^GH^'P+4UNO]#5>/SQT^3I;O(K/3Q^G.!Y?'M_
M.WF:TH.TRJ0J$46Q[)(&(K%&5&TA(F'A9>=JF=)L23Z7].YJ>DW&DL$+:*.)
M#CGI@_P,FJ7KT:-,H*!8MM)N%4:_K.+9E!K2QH,TOM4*YXC45($#&$I!@K+:
MUUB7628#*Q#'O\=QQOG>,!QE?_C<I04DGD51<ZXPX!\L@EPJO;2HTN:[\?B@
M1-%H<F2R-1;^JVWP4%D)O60;:RWJ5'E8E1CM$#(^.*5,:8$$A"(8Z^-Q/;JI
M+<OP29FRSM.W6EB<SZ=PM03 JD3:L@#4A)VF  ^SW-IO3(YLC*L:<T%S"CFC
M#0R!LD6NDIQRD6(;>!!!!A(H1AFT5JP15L:I:)^%_QW(,9B-+F(%KP/XU73<
MEMS$]!CKZ& PW+/<I1L<^"P8F LE^EZF<S;@ER>#>-/I\/CU&;T3"-AG!$>N
MOA\@Z:V'P<K0![&$8^ZESTW:VW6X_(X8< [!1TEM+3Q&#EH*>5 $V3+(<I %
M>Y!*6!8H(<=Q<&[8%2/<"%)2&(<OU0I%#5*TX8BHK4NB-$ :,[X.J%R3?Z[=
MM,]AHSW+77JW"L:=!EO5(5\.:&PE<HL^&.=P2N.]P]$)O/=D33TK@/5&SCPJ
MC*42'_(K^ORSTAX]FFZ48ZM0/ ZI\)4C NUI+  KBY"N;$"K,&6%=ELA1@GB
MPO"*K<V%1VX]-U4*D2V3AB<'P\,])@52&KU]P:Y[*1@K[^;(;.]$CNY42PB+
M0^T4!?_NMN^Y\4>ZX8\MLQ;*Y^@BR%D?A=%1FB)!P"TX##D-#_T[!^Q)@:,]
MRUWZH,1,%0%*XR6:UE55*.19-%IRBYA;4<)ETWKF@]>.!L<'QX/7,"/G+;$<
MT.\T^A9*(EFR%UVK*&L45:TB$'FDW,A+L$O0K.;J44PQ^P1;+TKLR#*5* X7
MR SX0]F'#,0[^S8N*!W'T3#7S3!KMGP<U*UJ5%#M(A_N8E#>%RHR,.&FAI\=
M:<$=HANG1N714M9L6X4VUZ4DS H(O#5EL\@ZV\^L=-T"2C'7RM<IVLQZ\,#N
MF:2[#8Z^T_1;#=KE2';7;;'I=3O#S>6Q9K_-E&\9<C389L@?RN(6(8.%4PGB
MB]F+A/@3O8#QC3'/\<"#<-!4@-4".ZBDX?*_HP'M":LRU63/O$83XV C!59P
M-DNI#&!6G8Q1/@>43*6:9 3G(C@\K*$E&]#L!JJ8>HAEKF8JIH9CY#L5;A4[
MJMJ:M.;,Y^EE7=WM*!$3ARL]4C1&#AE(?UMK&%1VN$:YC:&"M60X >B74J!W
MS"3ZEF9/B(S[^ U8HISA87C<;3HZYM "$P*V "KRK,V[2#AP,3J&DUMJ>_1%
MM@,1NESP7;XQ$\&1D7W^E]X^,4TW>WGZ:_+9; Y9 7U;76'<P&<>$R/JF"TO
M0_W/P]2N ;R_<:LJI9V'NZ.C8%*\8*U65]?3JW@K6V^/=UO<8A!:1X7,(#KH
MO3GND(WWQ?@"^@UWM)GQN/&%QQQ7;&EY [YG!D32O/ !JTO[Y5]02P,$%
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MTP'LU\[%PR01'/\]K/\!4$L#!!0    ( .: I%:U"C_@J@0  $4-   9
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MW[RNE/"*M0:>K>U:9$'1/RELOB5[&Q%N9N^7DJ$$@RW(9A7)7G 9M8)+W>C
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M@D="TP \GRHTH/D%+5!^H#S_#U!+ P04    " #F@*16NBWA[S $  #\"0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;.U:>V_;.!+_*H2WN^<
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MTKN"3P-T?>X/_ &O(6"M46"L/>!4+&OW94_!EDYMT'9J@^V=6GW+H=_F:,.
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M6=&/A\8[T'FIM=L:/D'_AV9_ 5!+ P04    " #F@*16"T@W8N #   @"0
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MV$+M!&A_K91]FC@#N^?;\G]02P,$%     @ YH"D5K(FN[AW!   7 D  !D
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M.K:$ZO;&^1YAV2/P#Q!".%?25@;.9('%:_TQL3E0XD^4EOQ3P'.A1Q"R(?"
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M-I439?6D#/"09I\7'^?D_U!+ P04    " #F@*1638^8.X\&  #-,P  &0
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M$Z"_YYRKYXEIK_UMFOP!4$L#!!0    ( .: I%9%Z@/4AP8   TK   9
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MK=IH>FJ%EIIFK0/57KK?=CZ7H^YZQQ-E2\I]YK7.I59#%<9.39:^WKZZ2O@
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M)Q@ L,0/*I=@Y0163L+D.AF@$+^ 7P>X/X(A7]?ZM\T"D6TJ[,[+W1^@V(%
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M)E":1&D*I6F*9EYIVJ0 GCT%,)?@#^G7:%,D<>Y\B%=Q<C]X/>Q;.W*LAM[
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MG&9I?2 URC.QP_?UXR5<MJ^3@.3$T0<&*DG528DZ'HXZVX'AD3\+%_'S9@^
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M:8$HC1\UIM>$M([[XP?TCV[OM)<E-S!3\F^18C;VWGLLA17?2+Q5NS^AWL_
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M;MLL4HZ@JT4EV?C$HNNQ>^:.SH"^)K*&.[9UK!^L;@O"(WL20AJB!RR@AY;
M DB%+#K;E%>3=Y6^8K.')^);?<L]EU]K5%\76]. DP+.[F; 9R*KN! 7*Z"\
M"/EJD4:4R:K5!V6,SC[8;]: _29#:0WIZV)KFN <37!TF-!#7W&<M3N@#-#9
M 9UL7L5VYN?H[(^IKIA-"X[EKJVLW2XG(MX[WOL]-,<\0DM,6I_5ZA"=3=!:
M!E=L^8NDHPO]P?FSQ=<5M6G#L<:UU46NLHQ _Z)5MN;PG,E' O+W^;>JQ%#'
MZNR'UNI7*YNOBZWIVK&0MEV=A8:MM8[6RN9I9?-UL35].=;DMKHHOYS43G.:
M!T$L&^TI;?2NM#%7#Z2S"5I+<%ULI0GFR=OR!-BVV*;@LF[(4E&^.*_/UELA
MM\4&@'GL7NZC+##;DI2C&#82:O7'4F56;DV4!X+NBG?O:RH$38IF!#@$EG>0
MUS>4BM>#/$"]033[ 5!+ P04    " #F@*16T#CY_BD$  "Y$P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T."YX;6S-F%MOVS84Q[_*@=8-+>!:5U^:V09L
M*\,"+*L1K^M#L0=&.K:X2*)+4G&Z3S]24N2;HCF&,#0/L2B=\]<YO\.+R-&6
M\0<1(4IX2N)4C(U(RLV5:8H@PH2(+MM@JIZL&$^(5$V^-L6&(PESIR0V'<OJ
MFPFAJ3$9Y?<6?#)BF8QIB@L.(DL2PK_-,&;;L6$;SS?NZ#J2^H8Y&6W(&I<H
M/VT67+7,2B6D"::"LA0XKL;&U+[R;4\[Y!9_4MR*O6O0J=PS]J ;-^'8L'1$
M&&,@M011/X\XQSC62BJ.KZ6H4;U3.^Y?/ZO_DB>ODKDG N<L_DQ#&8V-H0$A
MKD@6RSNV_17+A'I:+V"QR/_#MK2U# @R(5E2.JL($IH6O^2I!+'GH'3J'9S2
MP3EV\%YP<$L']UP'KW3(49M%*CD'GT@R&7&V!:ZME9J^R&'FWBI]FNJZ+R57
M3ZGRDY//.1@,8?J(7!4:EA'A*.!C)H4D:4C3-;SU41(:BW?P'CXM?7C[YAV(
MPHRF\$?$,J$L10?>Z/8MC6-543$RI8I/O\4,REAF12S."[&X<,M2&0FX3D,,
M#_U-E5>5G/.<W,QI%+PEO NNW0''<MR:>.;GNSLU[GZSNX]!%VPO=[<:LG&K
M4KFYGON"WC25-*1QI@<*+#'(.)54U>#Z*8@S!0Q6G"4P9\DFDR0?5&P%UX2G
MJH8"%LB+VL*7WY0PW$A,Q%]U12JB\.JCT//0E=B0 ,>&FF@$\D<T)C_]8/>M
MG^L(MRGFMR1V0-^KZ'M-ZJ<#Y?<LN5=,%>/3(=.!&1$TJ*-;O*6?OT5/RH\3
MVW-[0TOUD,=]<'5VSN#$SF^,^D(FO8I)[R(FONZEZG;-7#(-_U:3FEHX9!V<
MWFG2:NP<HZFSZI^ :0S]0C#]"DR_S<Y2\JHCTJ_I!IY*]IA)G9T[]$ZH-,9]
M(95!16702*5,_4:(#,-.2:+\?:\7[Q 6Y)ON&S#EG*1KU-<=("NIV*EE?H54
M9ASK. U.\E>YEW]'J,XW]1OSN9#6L*(U;*8E6?  =[C)>! I.+#@;,U)TH%I
M)B/&Z3^Z?R4LJQ]*C>*OG<7;%/,+L<'!\-TC?P#K0P7KPW]WK:8^]'&C5\0Z
M4(W"KP75IIC?DM@!4-O:?1A:W\7G1AE&2P5H5<UO2^VP!'O?YG9CKVZI!)V&
M::*,8'\V=$^GS+.L_.9L+J7E[&@YC;1ZW9[U(]S.%TNUIB#7H*;PY1;UREO?
M\QKU7MWSVE3SVU([9+G;:MC?QU[#;G6ST:J:WY;:80EV^PV[></Q?PS^TTV&
MX]6,_K/,_.9\7LO+W#O32)"O\[,A 8'.I3@!J.Y6YT_3_-3EZ/[,OIH7IT@[
MF>)02^WOUS05$.-*25K=@=HR\.*<J&A(MLE/3NZ9E"S)+R,D(7)MH)ZO&)//
M#?V"ZK1N\B]02P,$%     @ YH"D5O)7QSQO!@  )R(  !D   !X;"]W;W)K
M<VAE971S+W-H965T-#DN>&ULS5KM;MLV%'T5PBN&%&ABD9*_LL1 XJQ;@:4+
MXF4;,.P'(]$V44IT2=I)ASW\2$JV+(EBZTTK\B>QY,O+<[^/*5T\<?%!K@A1
MX#EEF;SLK91:G_?[,EZ1%,LSOB:9_F;!18J5OA3+OEP+@A.[*&5]% 3#?HII
MUIM>V'MW8GK!-XK1C-P)(#=IBL6G:\+XTV4/]G8W[NERI<R-_O1BC9=D3M3#
M^D[HJ_Y>2T)3DDG*,R#(XK)W!<]GX< LL!*_4O(D#SX#8\HCYQ_,Q;ODLA<8
M1(216!D56/_;DAEAS&C2.#X62GO[/<W"P\\[[6^M\=J81RS)C+/?:*)6E[UQ
M#R1D@3=,W?.G'TEAD 48<R;M7_!4R 8]$&^DXFFQ6"-(:9;_Q\^%(PX61+!E
M 2H6H-H"A%H6A,6"T!J:([-FW6"%IQ>"/P%AI+4V\\'ZQJ[6UM#,A'&NA/Z6
MZG5J.B=+'10%[LF:"T6S)3BY(0I3)E^#5X!FX)8RIOTM+_I*;V<6]>-"]76N
M&K6H#L$MS]1*@N^SA"35]7T-<X\5[;!>(Z_"6RS.0 C? !2@$#S,;\#)J]<Z
MEPQR_,B(S&UQ09U]N6:TT^Q!'.Z]&UJ]X1=[]X^K1ZF$3MX_70[-M45N;::B
MS^4:Q^2RITM6$K$EO>FWW\!A\)W+Y(Z450R/]H9'/NW3]YOTD0C %P?A ;OX
M@+^_+&C7^1Y#NX?I1]LINNAO#VWTHOB7-@[V-@Z\P;TG,<]BRBBV#4G;^O.:
M"&S#?"?X@BIP\A.7NI 6@J=@OK-><3#3!<493; BR6=28M!E2G2DK.*NX=Y=
M0V]*7*6F!/[*G46>]1R2Q&5PKF5T$/13%(2UN#N$X&2\%ZH '.T!CKP R^C1
M+.8I 2?,1,^%<=1(S,&@GII-F6@X=",<[Q&._0C52A=5X;LW("/*!6[<V/@4
M!N,:.H=0" ,WO,D>WL0+[]VAV_*\>22::9"=0Q5^)LY"GS1]%44UQ$T9.&CQ
M)PS*Z1?X(:<ZWY6I74T*],C/P&PC!,GB3^ MV\1J8]-5 IVR[S6GFF/F-J#8
MYA#=N.YRA\QIU.)R>#"_H;_3:EBR%19L;!F&XTD=F$,J0&V^124RY$5V2Y+Y
M1NB1=TO,,'!V-[^*8]M;5]JJ!I?#'OJG_=<9"+!3DM"5MJK+2IH _3RA=%#1
M/*X8X['U@O;*?<D=YAZ: )L\(0J">I(WA<(1;,GQD@) [\C4(=^2;$-D'E$=
M?ALWJ4F\6A7TG0CY!B14XN52D*4U[11HL^U/L"PF("58;@0QYCFM&S1F'42-
M:>.2@L.HQ;YR9D/_T-X16%Z?C5@:&V+]G?ZQ9U(]\_:A?!<8'< +SD+8Z$0M
M<BV3'9:C'?IGN[]+CAP>'C<2R"$%!V$+LG*D0_],GV&14+[%,MXP+/S-TJOI
MZ,KO2%O5[I(KP,E+:)9>QG*TRSK25OWU6Y(5Y"<KG31+U&0A@PC6<MTA%(U&
M[E1')55!?JKR%9IE@>"P2%$0U=N,0PI. M1B7TEXD)_P=-0LBUUJ31 -ZX2X
M16[0,M10R6.0=^C[FV6QMN)A".O-TB$%QZ.69HE*NH#\=.%Z_KLKS[U=TZ_R
MV!;0E;:J TJ^@5["F0/J]-"A*VU5EY44!ODIS-?H.D/'SZR@T50=4D';D0 J
MJ0WR4YM?N,(,X,-1X#IS\Y:(=X>CX]V1MJH_2D*%QB^A1#KE8EUIJ[JLY&+(
M?W!SQ,D7:A[#3*)&]V\*C:,6^A"6]"?TTY\9%SJM=6QV)V 2X"S1)5P<V)#G
M>(4S/6!]J>[?X^@C]HZT53U2$JH0OH!4#[VL[FB7=:2MZK*2HX5^CM;@T ]9
MI746/G+Z 37/[T:#6NJ[A-IZ?'CP&,G/R'[@/'FBC-F$Y_84F&HRF2VIZ?%8
M2LW8:+K&5%@"JNM +(F>:3C^N*&2FNSH)W1+I*)*S[%309@UV/#0DT+Z-8@%
M2:C2R[3CE3"GGT([ZM1N6KWUF?7?/X#;FWN#B-F9F:=GS*7*2Y9I1$M[TZ_)
M&85NGY']'\=?8<EGP^@E%'"G#+@K;567E0PX])^X_9<";IZ1G39_NKBEZM.K
M?_#(7?/'I7T30>H<WV0J?Z*]O[M_V^'*/N.OW;^&Y[/\G8523?X*Q:TN!II)
MP,A"JPS.1AJ8R-]*R"\47]L'^X]<:1)K/ZX(3H@P OK[!>=J=V$VV+\;,OT'
M4$L#!!0    ( .: I%:9_UC1"!$  %C)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;+U=;6_;1AK\*X2O.+1 47/YSIQCP-'F< 7J7I TUP.*^T!+
MM"1$$GTDG9=#?_Q1LN1=[CY>BN0LO[2Q\W"XSTB[F1U1.U=?BO)3M<KSVOFZ
MW>RJUQ>KNGYX=7E9S5?Y-JM^*A[R7?,W]T6YS>KFQW)Y63V4>;8X7+3=7'JN
M&UUNL_7NXOKJ\+MWY?55\5AOUKO\7>E4C]MM5GY[DV^*+Z\OV,7I%^_7RU6]
M_\7E]=5#MLP_Y/7'AW=E\]/E,\IBO<UWU;K8.65^__KBAKWB+';W5QQ*_K7.
MOU32GYU]+W=%\6G_P\^+UQ?N?DCY)I_7>XRL^=_G?)9O-GNH9B#_/:)>/-]T
M?Z'\YQ/ZWP_=-]W<954^*S:_KQ?UZO5%<N$L\OOL<5._+[[\(S]V%.[QYL6F
M.OS7^?)4&Z47SORQJHOM\>)F!-OU[NG_V=<C$](%/GOA N]X@:=<X'DO7. ?
M+_#/O2 X7A <F'EJY< #S^KL^JHLOCCEOKI!V__A0.;AZJ;]]6[_PG^HR^9O
MU\UU]?7[_'.^>\R=[WE>9^M-]8/SG;/>.;?KS:9Y6:JKR[JYR;[T<GX$?/,$
MZ+T Z#NWQ:Y>5<[;W2)?M*^_; ;W/$+O-,(WGA'P-BM_<GSVH^.YGN]\_,"=
M[[_[P;E[K)JZBAK@['P\[X1'P' S#,_G73"M=OWG%\0_X/HOX:ZK;+DL\V5V
MF!?%O7-ZB?[XI2EU?J[S;?4?ZG5YP@UHW/T"\JIZR.;YZXMFA:CR\G-^<?W7
MO[#(_1O%(1*,@\!:? ;/? 8F].<W^'U9;)U9\]8LFZ6FF63URID=IE=>_NB\
M_3K?/"[6NZ5S4U7-NRI?.+]E7RF2GVX6'VZV7U0_7_M^DEY=?I;)(XI<+VH7
M<>.P!Y(2/I,2&DGYM?D7I<HV.3F_PW-:?"J*S"T:!S&PQ>BYQ<C<XN/V+B^=
M?]X[;XY+15XY?YK6C3>1UE.H=&V\9=]9 0)KL1,_LQ,;5YF7)L(OZ^QNO5G7
MWYP_;NZJ0PFYUL3(M08)QD%@+5:39U83XWNNDU6*RD2;;J''E/>=\;9]&2)N
MZ(KIW6H\?6X\-;^=5MENF>^%P]@W5HI\8R'!. BLQ2]SA4QSQ[VU?GS6">_S
M>;'<K?^GJJ^C>G.U52[PE+>;>2Q]B4.AM9F3!"XS,O=QMZZ;?\\_U%E-_WMG
MOK[O>PZ*QE%H;>X\P9UG28P>@5&D(M$X"JU-JA#XS*AWT8KT>#=Y0C>[?E^=
MTGH5B^-$$6SFD0]E1DAU9M;J1EEZO+:K3[V*ZM.&^&9"?3.S_/YY5^?E[C"G
MLHWSQVV^EZKT- ))Z",Y2#2.0FN3*/0]BVRM34@9/X.B<11:FU2Q+6!&?0Q?
MFV)]-OI)I,Y9HLH+M#EK0]DS(>V96=N;UZ;DK#Z)*J)/D-AO]RF4/#,*V>NW
MS4N\W+^VMUGY*:\K\_($E>M0-(Y":YN60K![KJ7ER4.J[QD4C:/0VJ0*+>^9
MM3QX>3K>K>7X>*K3110%@:M,6O.XA_(B=+IGE*SFQ>EX;4>7>A'1I0WA[ GA
M[)F%\]O=HJCFQ<,WXYID!ND]?:!&. JM3:#0UUY@:TT"">8CJ4@TCD)KDRK$
MO&<6\^@U27?6PSA69RM1Y#-UMMK0YY[0YUZ' 6]<DPBO7>^2*-*[M"&8/2&8
M/;-@UM<DYT^GTW(R@_:>3E #'876)E3H;"^QM48A7?(9%(VCT-JD"E'OF44]
M>HU*]4__0O4S"ZJ(>>KLM2'2?2'2?;.K;ERC?-TIU[NDBK0NS:,8VJ50S;Y9
M-9-KU/D>E!F]]X,%4'\<A=9F5NANWY8_[D/]<2@:1Z&U294>@)G4'_<)?UQ]
M4F%&%JG;'_.XA_(BU+L_PAWW"7=<[Y(JTKJT(:=](:=]LYS^6!:;8FG>XIDA
M>D\>J"N.0FO3)U2W;\L5]Z&N.!2-H]#:I J1[T_JBONZWQU$JB%#%3%?G:LV
MM+HOM+H_PA/W=;>;Z)(HTKNT(9Y](9Y]LWA65Z1S-GAFR-Z3"6J,H]#:CV,*
MS1W8,L8#J#$.1>,HM#:I0N('DQKC@>YY^YJ:((H\]3,O;A[W4%Z$0 ]&&..!
M[GD37>I%1)<V%',@%'-@5LS$"G7^]LZ,W7M60?UR%%J;5^G1<5M^>0#URZ%H
M'(76)E4(_&!2OSS0K7 6J$\%445>K$YB&\H]$,H]&.&7![H53G1)%.E=VI#2
M@9#2@5E*_YH_-J][L7C</,TIX\H$=<FA:!R%UJ91*._ EDL>0%UR*!I'H;5)
M%4(_F-0E#W0#W/,#=<X216ZJSED;BCT4BCT<X9*'N@&N=TD5:5V:1S&T2R&A
M0[.$?FEE.F>[9X;N.ZF@:!R%UJ95*/#0ED4>0BUR*!I'H;5)%8(_G-0B#ZF'
MP]4OA5!%D?IIO'G<0WD1@CT<89&'U*/A6I=$D=ZE#04=2E_>[/KVYHLKU?G;
M/O,]>L\NJ(>.0FOS*Y1X:,M##Z$>.A2-H]#:I KA'T[JH8>Z/1YI<YFPT#71
M84/'AT+'AR,<]% WQ_4>"0-=Z]&&K Z%K [-LOJP)C4O_G%1FF7E8OWD5_VV
MRLOL8?U"]U +'8K&46CM;[8+01[9LM CJ(4.1>,HM#:I0O]'DUKH$?%L>:H^
M/405!<KFB9O'/907(>"C$19Z1#Q;KG=)%.E=VE#4D5#4D5E1G[%(G;,1--^E
M]_R"FNDHM#;#0IM'MLST"&JF0]$X"JU-JM@*1).:Z1'ADR>JS4P6J9^(F<<]
ME!?I\)<19GI$^.1ZEU21UJ4-31T)31V9-?5YB];Y>T+S[7I/-*CACD)K4RV$
M>F3+<(^@ACL4C:/0VJ2*G4$TJ>$>Z5YZX";JO*:>75>_@VL>]]"SF82^CT<8
M[C%Q@(O6)5&D=VD>Q= NA>".S8+[]ZR>K[;9CFP2:JA#T3@*K4V;T..Q+4,]
MAAKJ4#2.0FN3*N1_/*FA'A./DVO;(JI(.T+//.ZAO C1'H\PU&/B<7*]RS,>
M3.?F40SM4JCHV*RB3RO1.3L\,U3O203US5%H;1J%Z(YM^>8QU#>'HG$46IM4
MZ:#&27WS6/?$O4@]YI(J4D]:XN9Q#^5%"/)XA',>ZZXXT251I'=I0R''0B''
M9H4LK4SG;^/,F+UG$]0Y1Z&US^<4RCJQY9PG4.<<BL91:&U2A9!/)G7.$^*Y
M<G7N4C7JU#6/>B@K0J<G(WSSA'BJ7.N1J-%ZM"&;$R&;$[-L/CA.V=QYO_I6
MK[;.;;;+EODVW]7&]<D,VGLJ04UR%%J;4*&W$ULF>0(UR:%H'(76)E7(^V12
MDSPA#E]13W&;445,_6#>/.ZAO B]GHPPR1/B\!6]2Z)([]*&@$Z$@$[, KI[
MC3IGVV>^2>_I!;7&46AM@J5#SVU9XPG4&H>B<11:FU0A_)-)K?&$<+T#37 0
M1:HJX>9Q#^0E%0(^'6&-IX3KK75)%6E=FD<QM$NAJ%.SHCYKS3I_0VB^6]]Y
M!D7C*+0VTT*EI[;<]!3JID/1. JM3:K8%J23NNDI=<*Y^GD]4<12;5K;4/>I
M4/?I"#<])8QRO4OB\72]2QMR.Q5R.S7+[;?[3+>R>%A]J];=9[F8P7I/(ZB?
MCD)K$RGT>6K+3T^A?CH4C:/0VJ2*[4 ZJ9^>$F>7:P=94D5,_33>/.ZAO @5
MGX[PTU/BY'*]2Z)([]*&K$ZEG**.T\U?7)O.V02:P7M/*VP\D9U\(CF@R):U
M?D(&\8J%XS XA5DIP,B=U%\_W4Z>J(FZ2Z**0O6HN(Z!#Z;&DZ@98;*?+NYH
ME'@Z76_42F20*V4&N1UGGYL6KAYY,N;;])]J4/,=!J?0+ 40N;;\]Q,RC%FH
M P^#4YB5(H_<24WXT^WD::L]>T0515K>BGG@@ZF1@HS<$3[\Z>*.1O4BHE$K
MV4*N%"[DGF'%=V\).V#Z3R6HVPZ#4VB4DHA<6X;["1G&+-1RA\$IS$K91^ZD
MKOOI=NW3!%PM%XHJ"USUY*:.P0^E1\X@[0@A-2]41+(HU2Q51C1K*354C@T]
MPX/OOT?L@.T]Q=!YHE84NYPH:B]2%)PI"@X5M9,J*L>*3IPK2D2&)K%Z@"]5
M%4?JEWL[ACZ8'$G8CXH6)5)#J5;U*JI5*TI;#A?M2!>E%ZX>>T1PZ"@X==1.
M[*B<.VHO>!2</ J.'K63/2J'CTZ</DH$B\;J@9@SJBK2CB?H&/I@<B35/RJ
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M,18N0Q_)7,MZX'=14,@2?$;/.O6R@<?IP+)N/,W?N<.I_70HBL;&&9=M/&,
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M$J>W:XP"3*6!^'U)"']YD ,4Y[#S_P!02P,$%     @ YH"D5D3+E-MN P
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MQ<)7-G>=E)?8ME8?-:^.;SL<W]1X\P]02P,$%     @ YH"D5J&7ZI3) 0
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MGU!+ 0(4 Q0    ( .: I%8'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ YH"D5LM'N[+O    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ YH"D5IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #F@*16_2V\_RD'  !@*P  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ YH"D5CYN@$**!0  F!8  !@              ("!;0\  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .: I%9!1]^5?P,  /8*   8
M              " @2T5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " #F@*166VW/08\&   2'   &               @('B&   >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ YH"D5GA9G[+G @
M@ D  !@              ("!IQ\  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( .: I%:W&A-I2 H  /)L   8              " @<0B
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #F@*16KKV@
M3 X(  "X(@  &               @(%"+0  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ YH"D5M# ES?A @  & D  !@
M ("!AC4  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( .:
MI%:KOQ'8IP8    0   8              " @9TX  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " #F@*16#?&X>K\-   *)P  &0
M        @(%Z/P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( .: I%;ZRK)9' 4  '8+   9              " @7!-  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ YH"D5H !(.IR%P  '5,
M !D              ("!PU(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " #F@*16%]V:*> 1  #C,@  &0              @(%L:@
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( .: I%8R#[-*
MJP@  -$4   9              " @8-\  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ YH"D5C4&+:(T!   VPD  !D
M ("!984  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #F
M@*16-TRKW;49  !,1@  &0              @('0B0  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( .: I%96%#[,104  +P+   9
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M970R,2YX;6Q02P$"% ,4    " #F@*16WC:^AW,&  # #P  &0
M    @(&4P@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M .: I%:>^,]E,0,  "\'   9              " @3[)  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ YH"D5C]MK\VY @  0 8  !D
M             ("!ILP  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " #F@*16V0__@[D#  !)"   &0              @(&6SP  >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( .: I%:U"C_@J@0
M $4-   9              " @8;3  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ YH"D5J.5:#1U"   K!P  !D              ("!
M9]@  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #F@*16
MNBWA[S $  #\"0  &0              @($3X0  >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( .: I%8D6-<&F@L  %DI   9
M      " @7KE  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ YH"D5L^S25'?!P  -!4  !D              ("!2_$  'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #F@*16,:Z#)I\%   )$0
M&0              @(%A^0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( .: I%;[9%G$5P(  $\%   9              " @3?_  !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ YH"D5@M(-V+@
M P  ( D  !D              ("!Q0$! 'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    " #F@*16T!KGGDT$  #*"0  &0
M@('<!0$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( .:
MI%:R)KNX=P0  %P)   9              " @6 * 0!X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ YH"D5G4I2 2  P  80D  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( .: I%9%Z@/4AP8   TK   9
M  " @<0K 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
MYH"D5ND<E8A!'   JE\! !D              ("!@C(! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    " #F@*165:*N^_$7  #R70$ &0
M            @('Z3@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( .: I%8X!>=*&0P  )!=   9              " @2)G 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ YH"D5I)2AYLA P
M(PH  !D              ("!<G,! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    " #F@*16Z7A1>%,#  "N"P  &0              @('*
M=@$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( .: I%9G
MU.(>B00  "P:   9              " @51Z 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ YH"D5M X^?XI!   N1,  !D
M     ("!%'\! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M  "L%@  #0              @ '>H $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( .: I%:7BKL<P    !,"   +              "  7>D 0!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( .: I%:M2;L82 0  "TB   /              "
M 6"E 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #F@*16H9?JE,D!  "@
M'@  &@              @ '5J0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " #F@*16*+1H$\,!  ")'@  $P              @ '6
LJP$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     .P [ !00  #*K0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>316</ContextCount>
  <ElementCount>357</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>109</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure</Role>
      <ShortName>Consolidated Statements of Cash Flows (Supplemental Disclosure)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Acquisitions, Divestitures and Strategic Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments</Role>
      <ShortName>Acquisitions, Divestitures and Strategic Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Hedging Activities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</Role>
      <ShortName>Hedging Activities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Contractual Obligations and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</Role>
      <ShortName>Contractual Obligations and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Weighted Average Shares Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</Role>
      <ShortName>Weighted Average Shares Outstanding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Changes in Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</Role>
      <ShortName>Changes in Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies</Role>
      <ShortName>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</Role>
      <ShortName>Commitments and Contingencies Commitments and Contingencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Acquisitions, Divestitures and Strategic Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables</Role>
      <ShortName>Acquisitions, Divestitures and Strategic Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Contractual Obligations and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</Role>
      <ShortName>Contractual Obligations and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Weighted Average Shares Outstanding (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</Role>
      <ShortName>Weighted Average Shares Outstanding (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReporting</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Revenue</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Changes in Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</Role>
      <ShortName>Changes in Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Acquisitions and Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails</Role>
      <ShortName>Acquisitions and Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContingentConsiderationDetails</Role>
      <ShortName>Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StrategicInvestmentsDetails</Role>
      <ShortName>Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Contractual Obligations and Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails</Role>
      <ShortName>Contractual Obligations and Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockholdersEquity</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Weighted Average Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails</Role>
      <ShortName>Weighted Average Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReportingTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RevenueTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="bsx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Changes in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Changes in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bsx-20230331.htm">bsx-20230331.htm</File>
    <File>bsx-20230331.xsd</File>
    <File>bsx-20230331_cal.xml</File>
    <File>bsx-20230331_def.xml</File>
    <File>bsx-20230331_lab.xml</File>
    <File>bsx-20230331_pre.xml</File>
    <File>ex102-2023grantxnqagreemen.htm</File>
    <File>ex103-2023grantxrsuagreeme.htm</File>
    <File>ex104-2023grantxtsrawardag.htm</File>
    <File>ex105-2023grantxonsgawarda.htm</File>
    <File>exhibit22-subsidiaryissuer.htm</File>
    <File>exhibit311-ceo302q12023.htm</File>
    <File>exhibit312-cfo302q12023.htm</File>
    <File>exhibit321-ceo906q12023.htm</File>
    <File>exhibit322-cfo906q12023.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="926">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>75
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 27,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 926,
    "http://xbrl.sec.gov/dei/2022": 36
   },
   "contextCount": 316,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 628,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 46,
   "keyStandard": 311,
   "memberCustom": 58,
   "memberStandard": 47,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Document",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Acquisitions, Divestitures and Strategic Investments",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments",
     "shortName": "Acquisitions, Divestitures and Strategic Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Goodwill and Other Intangible Assets",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Hedging Activities and Fair Value Measurements",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
     "shortName": "Hedging Activities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i2887ce8cd383457f9ee11384c498b860_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Contractual Obligations and Commitments",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitments",
     "shortName": "Contractual Obligations and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i2887ce8cd383457f9ee11384c498b860_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Supplemental Balance Sheet Information",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.bostonscientific.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.bostonscientific.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Weighted Average Shares Outstanding",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding",
     "shortName": "Weighted Average Shares Outstanding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Segment Reporting",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.bostonscientific.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Operations (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Revenue",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.bostonscientific.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Changes in Other Comprehensive Income",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome",
     "shortName": "Changes in Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - New Accounting Pronouncements",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Basis of Presentation Basis of Presentation (Policies)",
     "menuCat": "Policies",
     "order": "23",
     "role": "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies",
     "shortName": "Basis of Presentation Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "menuCat": "Policies",
     "order": "24",
     "role": "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies",
     "shortName": "Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies",
     "shortName": "Commitments and Contingencies Commitments and Contingencies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - New Accounting Pronouncements (Policies)",
     "menuCat": "Policies",
     "order": "26",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Acquisitions, Divestitures and Strategic Investments (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
     "shortName": "Acquisitions, Divestitures and Strategic Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables",
     "shortName": "Goodwill and Other Intangible Assets Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables",
     "shortName": "Hedging Activities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Contractual Obligations and Commitments (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables",
     "shortName": "Contractual Obligations and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Weighted Average Shares Outstanding (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables",
     "shortName": "Weighted Average Shares Outstanding (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Segment Reporting (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.bostonscientific.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Revenue (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.bostonscientific.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Changes in Other Comprehensive Income (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables",
     "shortName": "Changes in Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Basis of Presentation (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.bostonscientific.com/role/BasisofPresentationDetails",
     "shortName": "Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Acquisitions and Divestitures (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
     "shortName": "Acquisitions and Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i098c221da06c4b958585f779d2867c19_I20230220",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i112e69f95e3e4061b901b02e1a6de8a0_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Contingent Consideration (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
     "shortName": "Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "ia1330d5e86f34de7b8796fe68b26f65f_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Strategic Investments (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
     "shortName": "Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Goodwill and Other Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Hedging Activities and Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
     "shortName": "Hedging Activities and Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Contractual Obligations and Commitments (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
     "shortName": "Contractual Obligations and Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails",
     "shortName": "Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Stockholders' Equity (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.bostonscientific.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i5c8184b4c8c243b8af7637900054690c_I20200527",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Weighted Average Shares Outstanding (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails",
     "shortName": "Weighted Average Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Segment Reporting (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.bostonscientific.com/role/SegmentReportingDetails",
     "shortName": "Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Revenue (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.bostonscientific.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "0",
      "lang": "en-US",
      "name": "bsx:NumberOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Changes in Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
     "shortName": "Changes in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "idadc520412e74e82b77efd62c7563138_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "idadc520412e74e82b77efd62c7563138_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i988810e1696c4da3b18cc0a7b19cf868_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
     "shortName": "Consolidated Statements of Cash Flows (Supplemental Disclosure)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.bostonscientific.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20230331.htm",
      "contextRef": "i671dec7af405423f8246f88bd9ce4b5a_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 109,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method",
        "label": "ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-01, Derivatives and Hedging (Topic 815): FV Hedging -Portfolio Layer Method"
       }
      }
     },
     "localname": "ASCUpdateNo202201DerivativesAndHedgingTopic815FVHedgingPortfolioLayerMethodPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)",
        "label": "ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-02, Financial Instruments, Credit Losses (Topic 326:Troubled Debt Restructurings and Vintage Disclosures)"
       }
      }
     },
     "localname": "ASCUpdateNo202202FinancialInstrumentsCreditLossesTopic326TroubledDebtRestructuringsAndVintageDisclosuresPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.",
        "label": "ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions."
       }
      }
     },
     "localname": "ASCUpdateNo202203FairValueMeasurementTopic820FairValueMeasurementOfEquitySecuritiesSubjectToContractualSaleRestrictionsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50)",
        "label": "ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50)"
       }
      }
     },
     "localname": "ASCUpdateNo202204LiabilitiesSupplierFinanceProgramsSubtopic40550PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AccruedRebatesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates, Current",
        "label": "Accrued Rebates, Current",
        "terseLabel": "Accrued Rebates, Current"
       }
      }
     },
     "localname": "AccruedRebatesCurrent",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_AcotecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acotec",
        "label": "Acotec [Member]",
        "terseLabel": "Acotec"
       }
      }
     },
     "localname": "AcotecMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ActualCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actual Covenant.",
        "label": "Actual, Covenant [Member]",
        "terseLabel": "Actual, Covenant [Member]"
       }
      }
     },
     "localname": "ActualCovenantMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AllBusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Business Acquisitions",
        "label": "All Business Acquisitions [Member]",
        "terseLabel": "All Business Acquisitions"
       }
      }
     },
     "localname": "AllBusinessAcquisitionsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ApolloMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Apollo",
        "label": "Apollo [Member]",
        "terseLabel": "Apollo"
       }
      }
     },
     "localname": "ApolloMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BSXReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BSX Reportable Segments [Member]",
        "label": "BSX Reportable Segments [Member]",
        "terseLabel": "BSX Reportable Segments [Member]"
       }
      }
     },
     "localname": "BSXReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BaylisMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Baylis Medical",
        "label": "Baylis Medical [Member]",
        "terseLabel": "Baylis Medical"
       }
      }
     },
     "localname": "BaylisMedicalMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brazil CADE - # of individuals for alleged anti-competitive behavior",
        "label": "Brazil CADE - # of individuals for alleged anti-competitive behavior",
        "terseLabel": "Brazil CADE - # of individuals for alleged anti-competitive behavior"
       }
      }
     },
     "localname": "BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CardiacRhythmManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiac Rhythm Management",
        "label": "Cardiac Rhythm Management [Member]",
        "terseLabel": "Cardiac Rhythm Management [Member]"
       }
      }
     },
     "localname": "CardiacRhythmManagementMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular [Member]",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular [Member]"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "verboseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash flow impact of deferred income tax expense (benefit)",
        "label": "Cash flow impact of deferred income tax expense (benefit)",
        "terseLabel": "Deferred and prepaid income taxes"
       }
      }
     },
     "localname": "CashFlowImpactOfDeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CashProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash proceeds from Issuance of Senior Long Term Debt",
        "label": "Cash proceeds from Issuance of Senior Long Term Debt",
        "terseLabel": "Proceeds from Issuance of Senior Long-Term Debt"
       }
      }
     },
     "localname": "CashProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "label": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "terseLabel": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "label": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "terseLabel": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bsx_ContingentConsiderationLiabilityProbabilityOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration liability, probability of payment",
        "label": "contingent consideration liability, probability of payment",
        "terseLabel": "contingent consideration liability, probability of payment"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityProbabilityOfPayment",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_CorporateExpensesincludinghedgingactivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Expenses including hedging activities [Member]",
        "label": "Corporate Expenses including hedging activities [Member]",
        "verboseLabel": "Corporate expenses and currency exchange [Member]"
       }
      }
     },
     "localname": "CorporateExpensesincludinghedgingactivitiesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CovenantAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Axis]",
        "terseLabel": "Covenant [Axis]"
       }
      }
     },
     "localname": "CovenantAxis",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CovenantDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Domain]",
        "terseLabel": "Covenant [Domain]"
       }
      }
     },
     "localname": "CovenantDomain",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CurrentRequirementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Requirement.",
        "label": "Current Requirement [Member]",
        "terseLabel": "Current Requirement [Member]"
       }
      }
     },
     "localname": "CurrentRequirementMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DebtInstrumentExtensionOptionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Option, Term",
        "label": "Debt Instrument, Extension Option, Term",
        "terseLabel": "Debt Instrument, Extension Option, Term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionOptionTerm",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_December2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2027 Notes [Member]",
        "label": "December 2027 Notes [Member]",
        "terseLabel": "December 2027 Notes [Member]"
       }
      }
     },
     "localname": "December2027NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "label": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "label": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DiscountRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, Fair Value Input",
        "label": "Discount Rate, Fair Value Input",
        "terseLabel": "Discount Rate, Fair Value Input"
       }
      }
     },
     "localname": "DiscountRateFairValueInput",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ElectrophysiologyEPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Electrophysiology (EP)",
        "label": "Electrophysiology (EP) [Member]",
        "terseLabel": "Electrophysiology [Member]"
       }
      }
     },
     "localname": "ElectrophysiologyEPMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity [Abstract]",
        "label": "Entity [Abstract]",
        "terseLabel": "Entity [Abstract]"
       }
      }
     },
     "localname": "EntityAbstract",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bsx_EquipmentFurnitureAndFixturesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment, furniture and fixtures Gross.",
        "label": "Equipment, furniture and fixtures Gross",
        "terseLabel": "Equipment, furniture and fixtures"
       }
      }
     },
     "localname": "EquipmentFurnitureAndFixturesGross",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_EuroDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Factoring Arrangements [Member]",
        "label": "Euro Denominated Factoring Arrangements [Member]",
        "terseLabel": "Euro Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "EuroDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ExclusionFromEbitdaForRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion from EBITDA for Restructuring Charges",
        "label": "Exclusion from EBITDA for Restructuring Charges",
        "terseLabel": "Exclusion from EBITDA for Restructuring Charges"
       }
      }
     },
     "localname": "ExclusionFromEbitdaForRestructuringCharges",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ForeigncurrencydenominatedindebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "foreign currency denominated in debt [Member]",
        "label": "foreign currency denominated in debt [Member]",
        "terseLabel": "foreign currency denominated in debt [Member]"
       }
      }
     },
     "localname": "ForeigncurrencydenominatedindebtMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForwardCurrencyContractsTimetoMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Contracts, Time to Maturity in Months",
        "label": "Forward Currency Contracts, Time to Maturity",
        "terseLabel": "Forward Currency Contracts, Time to Maturity"
       }
      }
     },
     "localname": "ForwardCurrencyContractsTimetoMaturity",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_GlobalCardiologyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Cardiology Reporting Unit [Member]",
        "label": "Global Cardiology Reporting Unit [Member]",
        "terseLabel": "Cardiology [Member]"
       }
      }
     },
     "localname": "GlobalCardiologyReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalEndoscopyEndoReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "label": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "terseLabel": "Endoscopy [Member]"
       }
      }
     },
     "localname": "GlobalEndoscopyEndoReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalNeuromodulationNmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "label": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "terseLabel": "Neuromodulation [Member]"
       }
      }
     },
     "localname": "GlobalNeuromodulationNmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalPeripheralInterventionsPiReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "label": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "terseLabel": "Peripheral Interventions [Member]"
       }
      }
     },
     "localname": "GlobalPeripheralInterventionsPiReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalUrologyandPelvicHealthReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "label": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "terseLabel": "Urology [Member]"
       }
      }
     },
     "localname": "GlobalUrologyandPelvicHealthReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ImpactOfForeignCurrencyFluctuationsOnNetSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact of Foreign Currency Fluctuations on Net Sales",
        "label": "Impact of Foreign Currency Fluctuations on Net Sales",
        "terseLabel": "Impact of Foreign Currency Fluctuations on Net Sales"
       }
      }
     },
     "localname": "ImpactOfForeignCurrencyFluctuationsOnNetSales",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_IndemnificationAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification asset",
        "label": "Indemnification asset",
        "terseLabel": "Indemnification asset"
       }
      }
     },
     "localname": "IndemnificationAsset",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_IntangibleAssetsandGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets and Goodwill [Table]",
        "label": "Intangible Assets and Goodwill [Line Items]",
        "terseLabel": "Intangible Assets and Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsandGoodwillLineItems",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_InterventionalCardiologyTherapiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Cardiology Therapies",
        "label": "Interventional Cardiology Therapies [Member]",
        "terseLabel": "Interventional Cardiology Therapies"
       }
      }
     },
     "localname": "InterventionalCardiologyTherapiesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_InventoryStepUpAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory step up amortization",
        "label": "Inventory step up amortization",
        "terseLabel": "Inventory step-up amortization"
       }
      }
     },
     "localname": "InventoryStepUpAmortization",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_January2040NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2040 Notes [Member]",
        "label": "January 2040 Notes [Member]",
        "terseLabel": "January 2040 Notes [Member]"
       }
      }
     },
     "localname": "January2040NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes [Member]"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2030NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2030 Notes",
        "label": "June 2030 Notes [Member]",
        "terseLabel": "June 2030 Notes [Member]"
       }
      }
     },
     "localname": "June2030NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LatinAmericaandCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America and Canada [Member]",
        "label": "Latin America and Canada [Member]",
        "terseLabel": "Latin America and Canada [Member]"
       }
      }
     },
     "localname": "LatinAmericaandCanadaMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "label": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Legal payments remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingarrangementassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement assets [Member]",
        "label": "Licensing arrangement assets [Member]",
        "terseLabel": "Licensing arrangement assets [Member]"
       }
      }
     },
     "localname": "LicensingarrangementassetsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingarrangementliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement liabilities [Member]",
        "label": "Licensing arrangement liabilities [Member]",
        "terseLabel": "Licensing arrangement liabilities [Member]"
       }
      }
     },
     "localname": "LicensingarrangementliabilitiesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Licensingarrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements",
        "label": "Licensing arrangements",
        "terseLabel": "Licensing arrangements"
       }
      }
     },
     "localname": "Licensingarrangements",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsasset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, asset",
        "label": "Licensing arrangements, asset",
        "terseLabel": "Licensing arrangements, asset"
       }
      }
     },
     "localname": "Licensingarrangementsasset",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsliability": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, liability",
        "label": "Licensing arrangements, liability",
        "terseLabel": "Licensing arrangements, liability"
       }
      }
     },
     "localname": "Licensingarrangementsliability",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationAndDebtExclusionFromEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion of litigation payments and any debt Issued to fund tax deficiency payments",
        "label": "Litigation and Debt Exclusion from EBITDA",
        "terseLabel": "Litigation and Debt Exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationAndDebtExclusionFromEbitda",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationPaymentExclusionFromEBITDA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation payment exclusion from EBITDA",
        "label": "Litigation payment exclusion from EBITDA",
        "terseLabel": "Litigation payment exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationPaymentExclusionFromEBITDA",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_March2024NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2024 Notes [Member]",
        "label": "March 2024 Notes [Member]",
        "terseLabel": "March 2024 Notes [Member]"
       }
      }
     },
     "localname": "March2024NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2025 Notes",
        "label": "March 2025 Notes [Member]",
        "terseLabel": "March 2025 Notes"
       }
      }
     },
     "localname": "March2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2026NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2026 Notes [Member]",
        "label": "March 2026 Notes [Member]",
        "terseLabel": "March 2026 Notes [Member]"
       }
      }
     },
     "localname": "March2026NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Notes [Member]",
        "label": "March 2028 Notes [Member]",
        "verboseLabel": "March 2028 Notes [Member]"
       }
      }
     },
     "localname": "March2028NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Senior Notes",
        "label": "March 2028 Senior Notes [Member]",
        "terseLabel": "March 2028 Senior Notes"
       }
      }
     },
     "localname": "March2028SeniorNotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2029NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2029 Notes [Member]",
        "label": "March 2029 Notes [Member]",
        "terseLabel": "March 2029 Notes [Member]"
       }
      }
     },
     "localname": "March2029NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2031NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2031 Notes",
        "label": "March 2031 Notes [Member]",
        "terseLabel": "March 2031 Notes"
       }
      }
     },
     "localname": "March2031NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2034NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2034 Notes",
        "label": "March 2034 Notes [Member]",
        "terseLabel": "March 2034 Notes"
       }
      }
     },
     "localname": "March2034NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2039NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2039 Notes [Member]",
        "label": "March 2039 Notes [Member]",
        "terseLabel": "March 2039 Notes [Member]"
       }
      }
     },
     "localname": "March2039NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2049NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2049 Notes [Member]",
        "label": "March 2049 Notes [Member]",
        "terseLabel": "March 2049 Notes [Member]"
       }
      }
     },
     "localname": "March2049NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum leverage ratio permitted by revolving credit facility agreement.",
        "label": "Maximum Leverage Ratio",
        "terseLabel": "Maximum Leverage Ratio"
       }
      }
     },
     "localname": "MaximumLeverageRatio",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_MedsurgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg [Member]",
        "label": "MedSurg [Member]",
        "terseLabel": "MedSurg [Member]"
       }
      }
     },
     "localname": "MedsurgMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income (loss) attributable to Boston Scientific common stockholders",
        "label": "Net income (loss) attributable to Boston Scientific common stockholders",
        "totalLabel": "Net income (loss) attributable to Boston Scientific common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToBostonScientificCommonStockholders",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Netcurrencyexchangegainloss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net currency exchange gain (loss)",
        "label": "Net currency exchange gain (loss)",
        "terseLabel": "Net currency exchange gain (loss)"
       }
      }
     },
     "localname": "Netcurrencyexchangegainloss",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NewAccountingPronouncementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Accounting Pronouncements, Policy",
        "label": "New Accounting Pronouncements, Policy [Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_Noncashimpactoftransferredroyaltyrights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash impact of transferred royalty rights",
        "label": "Non-cash impact of transferred royalty rights",
        "terseLabel": "Non-cash impact of transferred royalty rights"
       }
      }
     },
     "localname": "Noncashimpactoftransferredroyaltyrights",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_November2035NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2035 Notes [Member]",
        "label": "November 2035 Notes [Member]",
        "terseLabel": "November 2035 Notes [Member]"
       }
      }
     },
     "localname": "November2035NotesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NumberOfBusinesses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Businesses",
        "label": "Number Of Businesses",
        "terseLabel": "Number Of Businesses"
       }
      }
     },
     "localname": "NumberOfBusinesses",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_OperatingIncomeAllocatedToReportableSegments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Allocated to Reportable Segments",
        "label": "Operating Income Allocated to Reportable Segments",
        "terseLabel": "Operating Income Allocated to Reportable Segments"
       }
      }
     },
     "localname": "OperatingIncomeAllocatedToReportableSegments",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeUnallocatedToSegment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Unallocated to Segment",
        "label": "Operating Income Unallocated to Segment",
        "negatedTerseLabel": "Operating Income Unallocated to Segment"
       }
      }
     },
     "localname": "OperatingIncomeUnallocatedToSegment",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets [Abstract]",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, net",
        "label": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNet",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherOtherLongtermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, Other Long-term Assets",
        "label": "Other, Other Long-term Assets",
        "terseLabel": "Other, Other Long-term Assets"
       }
      }
     },
     "localname": "OtherOtherLongtermAssets",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of contingent consideration",
        "label": "Payment of contingent consideration",
        "negatedLabel": "Payment of contingent consideration",
        "terseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentsForRoyaltyRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for royalty rights",
        "label": "Payments for royalty rights",
        "negatedTerseLabel": "Payments for royalty rights"
       }
      }
     },
     "localname": "PaymentsForRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Paymenttonetsharesettleemployeeequityawards": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to net share settle employee equity awards",
        "label": "Payment to net share settle employee equity awards",
        "negatedTerseLabel": "Cash used to net share settle employee equity awards"
       }
      }
     },
     "localname": "Paymenttonetsharesettleemployeeequityawards",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from (payments for) investments and acquisitions of certain technologies",
        "label": "Proceeds from (payments for) investments and acquisitions of certain technologies",
        "negatedTerseLabel": "Proceeds from (payments for) investments and acquisitions of certain technologies"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_QualifiedAcquisitionConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified Acquisition Consideration",
        "label": "Qualified Acquisition Consideration",
        "terseLabel": "Qualified Acquisition Consideration"
       }
      }
     },
     "localname": "QualifiedAcquisitionConsideration",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RDRegulatoryandCommercializationbasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "label": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "terseLabel": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]"
       }
      }
     },
     "localname": "RDRegulatoryandCommercializationbasedMilestoneMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RenminbiDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renminbi Denominated Factoring Arrangements",
        "label": "Renminbi Denominated Factoring Arrangements [Member]",
        "terseLabel": "Renminbi Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "RenminbiDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of December 31, 2021 and through remaining term of facility",
        "label": "Requirement, as of December 31, 2021 and through remaining term of facility [Member]",
        "terseLabel": "Requirement, as of December 31, 2021 and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility",
        "label": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility [Member]",
        "terseLabel": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, four succeeding quarters following qualified acquisition",
        "label": "Requirement, four succeeding quarters following qualified acquisition [Member]",
        "terseLabel": "Requirement, four succeeding quarters following qualified acquisition"
       }
      }
     },
     "localname": "RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, seventh quarter following qualified acquisition",
        "label": "Requirement, seventh quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, seventh quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSeventhQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, sixth quarter following qualified acquisition",
        "label": "Requirement, sixth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, sixth quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSixthQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, fifth quarter following qualified acquisition [Member]",
        "label": "Requirement, fifth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fifth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfifthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.",
        "label": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "revenue-based payments [Member]",
        "label": "revenue-based payments [Member]",
        "terseLabel": "revenue-based payments [Member]"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from contracts with customers, disaggregated - performance measurement - measures used by CODM to make business decisions, excludes impact of foreign currency fluctuations",
        "label": "Revenues from contracts with customers, disaggregated - performance measurement",
        "terseLabel": "Revenues from contracts with customers, disaggregated - performance measurement"
       }
      }
     },
     "localname": "RevenuesFromContractsWithCustomersDisaggregatedPerformanceMeasurement",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevolvingCreditFacility2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility 2021",
        "label": "Revolving Credit Facility 2021 [Member]",
        "terseLabel": "2021 Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacility2021Member",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "label": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Line Items]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Line Items]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationLineItems",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Table]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Table]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationTable",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_Segmentoperatingincomeaspercentageofnetsales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment operating income as percentage of net sales",
        "label": "Segment operating income as percentage of net sales",
        "terseLabel": "Segment operating income as percentage of net sales"
       }
      }
     },
     "localname": "Segmentoperatingincomeaspercentageofnetsales",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits",
        "label": "Special Charges [Member]",
        "terseLabel": "Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits"
       }
      }
     },
     "localname": "SpecialChargesMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "statement [Axis]",
        "label": "statement [Axis]",
        "terseLabel": "statement [Axis]"
       }
      }
     },
     "localname": "StatementAxis",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for statement [Axis]",
        "label": "statement [Domain]",
        "terseLabel": "statement [Domain]"
       }
      }
     },
     "localname": "StatementDomain",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of term loan and revolving credit facility agreement compliance with debt covenants.",
        "label": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]",
        "terseLabel": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalBalanceSheetInformationTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information (Textuals) [Abstract]",
        "verboseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SupplierFinanceProgramObligationCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Finance Program Obligation. current",
        "label": "Supplier Finance Program Obligation. current",
        "terseLabel": "Supplier Finance Program Obligation. current"
       }
      }
     },
     "localname": "SupplierFinanceProgramObligationCurrent",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_The2018FacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the 2018 Facility",
        "label": "the 2018 Facility [Domain]",
        "terseLabel": "the 2018 Facility [Member]"
       }
      }
     },
     "localname": "The2018FacilityDomain",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheOfferingAggregatePrincipalAmountMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the Offering - aggregate principal amount",
        "label": "the Offering - aggregate principal amount [Member]",
        "terseLabel": "the Offering"
       }
      }
     },
     "localname": "TheOfferingAggregatePrincipalAmountMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the Offering - early redemption of combined aggregate principal SN",
        "label": "the Offering - early redemption of combined aggregate principal SN [Member]",
        "terseLabel": "the Offering - early redemption of combined aggregate principal SN"
       }
      }
     },
     "localname": "TheOfferingEarlyRedemptionOfCombinedAggregatePrincipalSNMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalAllocatedToReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total allocated to reportable segments [Member]",
        "label": "Total allocated to reportable segments [Member]",
        "terseLabel": "Total allocated to reportable segments [Member]"
       }
      }
     },
     "localname": "TotalAllocatedToReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_WatchmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Watchman",
        "label": "Watchman [Member]",
        "terseLabel": "Watchman"
       }
      }
     },
     "localname": "WatchmanMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_YenDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yen denominated factoring arrangements.",
        "label": "Yen Denominated Factoring Arrangements [Member]",
        "terseLabel": "Yen Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "YenDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20230331",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "verboseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r471",
      "r586",
      "r604",
      "r627",
      "r628",
      "r651",
      "r664",
      "r672",
      "r738",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r471",
      "r586",
      "r604",
      "r627",
      "r628",
      "r651",
      "r664",
      "r672",
      "r738",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r337",
      "r587",
      "r652",
      "r670",
      "r733",
      "r734",
      "r740",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r337",
      "r587",
      "r652",
      "r670",
      "r733",
      "r734",
      "r740",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r464",
      "r471",
      "r473",
      "r474",
      "r475",
      "r562",
      "r586",
      "r604",
      "r627",
      "r628",
      "r651",
      "r664",
      "r672",
      "r728",
      "r738",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r464",
      "r471",
      "r473",
      "r474",
      "r475",
      "r562",
      "r586",
      "r604",
      "r627",
      "r628",
      "r651",
      "r664",
      "r672",
      "r728",
      "r738",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r293",
      "r472",
      "r681",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r338",
      "r339",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r653",
      "r671",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r613",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r653",
      "r671",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r293",
      "r472",
      "r681",
      "r682",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "verboseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r627",
      "r628",
      "r752",
      "r754",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r343",
      "r597",
      "r642"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Trade accounts receivable, net",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r17",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r236",
      "r343",
      "r344",
      "r632"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r6",
      "r193",
      "r205"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r21",
      "r635"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued Royalties, Current"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r94",
      "r226"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r35",
      "r39",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r245",
      "r248",
      "r250",
      "r251",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r237",
      "r598",
      "r609",
      "r610"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r259",
      "r260",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r36",
      "r39",
      "r148",
      "r554",
      "r605",
      "r606",
      "r691",
      "r692",
      "r693",
      "r705",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r33",
      "r39",
      "r148",
      "r260",
      "r261",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r476",
      "r477",
      "r478",
      "r705",
      "r706",
      "r707",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r238",
      "r345",
      "r351"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Less: allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r66",
      "r82",
      "r89"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r190",
      "r204",
      "r230",
      "r272",
      "r321",
      "r327",
      "r333",
      "r349",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r503",
      "r507",
      "r532",
      "r669",
      "r736",
      "r737",
      "r750"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r222",
      "r241",
      "r272",
      "r349",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r503",
      "r507",
      "r532",
      "r669",
      "r736",
      "r737",
      "r750"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r161",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r498",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r127",
      "r128",
      "r498",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedTerseLabel": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r501",
      "r698"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration net expense (benefit)",
        "verboseLabel": "Contingent consideration net expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r136",
      "r137",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Business Combination, Contingent Consideration, Liability Ending Balance",
        "periodStartLabel": "Business Combination, Contingent Consideration, Liability Beginning Balance",
        "terseLabel": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r136",
      "r138"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r136",
      "r138"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r141",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "ACQUISITIONS AND STRATEGIC INVESTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r129",
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Finance Lease Obligation"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r611",
      "r612",
      "r669",
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r68",
      "r224",
      "r630"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r61",
      "r68",
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r61",
      "r181"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease)\u00a0in cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r272",
      "r296",
      "r297",
      "r298",
      "r300",
      "r307",
      "r308",
      "r349",
      "r393",
      "r395",
      "r396",
      "r397",
      "r400",
      "r401",
      "r431",
      "r432",
      "r435",
      "r439",
      "r446",
      "r532",
      "r629",
      "r680",
      "r701",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r2",
      "r191",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r26",
      "r198",
      "r211"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r96",
      "r385",
      "r386",
      "r617",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r705",
      "r706",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,700,828,873 shares as of March\u00a031, 2023 and 1,696,633,993 shares as of December\u00a031, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r42",
      "r256",
      "r258",
      "r265",
      "r593",
      "r601"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r144",
      "r151",
      "r256",
      "r258",
      "r264",
      "r592",
      "r600"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r52",
      "r263",
      "r591",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss) Note [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Capital in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r448",
      "r449",
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r46",
      "r587"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r197",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r232"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r269",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r418",
      "r425",
      "r426",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "CONTRACTUAL OBLIGATIONS AND COMMITMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r192",
      "r194",
      "r203",
      "r275",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r551",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r416",
      "r531",
      "r647",
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r23",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r24",
      "r275",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r551",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r24",
      "r109",
      "r112",
      "r113",
      "r114",
      "r182",
      "r183",
      "r185",
      "r202",
      "r275",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r551",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r184",
      "r414",
      "r429",
      "r647",
      "r648"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r687"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r66",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r66",
      "r316"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r243",
      "r244",
      "r531",
      "r639"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r31",
      "r163",
      "r187",
      "r242",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r31",
      "r163",
      "r187",
      "r242",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r162",
      "r164",
      "r169",
      "r171",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r159",
      "r162",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r159",
      "r162",
      "r169",
      "r171",
      "r174",
      "r175",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Assets, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Liabilities, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r243",
      "r244",
      "r531",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeRemainingMaturity1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Remaining Maturity",
        "terseLabel": "Derivative, Remaining Maturity"
       }
      }
     },
     "localname": "DerivativeRemainingMaturity1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r153",
      "r155",
      "r156",
      "r159",
      "r160",
      "r167",
      "r169",
      "r172",
      "r173",
      "r175",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative, Term of Contract (less than)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r459",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r115",
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "terseLabel": "Dividends, Preferred Stock, Cash"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r115",
      "r201"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r266",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r294",
      "r296",
      "r298",
      "r299",
      "r300",
      "r304",
      "r520",
      "r521",
      "r594",
      "r602",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r266",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r296",
      "r298",
      "r299",
      "r300",
      "r304",
      "r520",
      "r521",
      "r594",
      "r602",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Weighted Average Number Of Shares Outstanding [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of foreign exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r108",
      "r217",
      "r259",
      "r260",
      "r261",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r292",
      "r306",
      "r350",
      "r447",
      "r476",
      "r477",
      "r478",
      "r489",
      "r490",
      "r519",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r554",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r77",
      "r322",
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r231",
      "r529",
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Measurement alternative investments(1, 2)"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r522",
      "r523",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r416",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r523",
      "r559",
      "r560",
      "r561",
      "r647",
      "r648",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r525",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r416",
      "r465",
      "r470",
      "r523",
      "r559",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r416",
      "r465",
      "r470",
      "r523",
      "r560",
      "r647",
      "r648",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r416",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r523",
      "r561",
      "r647",
      "r648",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r416",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r559",
      "r560",
      "r561",
      "r647",
      "r648",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r526",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r427",
      "r444",
      "r517",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r643",
      "r712",
      "r713",
      "r714",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r228",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r372",
      "r374",
      "r375",
      "r377",
      "r588",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r88",
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r83",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r533",
      "r535",
      "r537",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r639",
      "r659",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r162",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "terseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r49",
      "r76",
      "r679"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Net loss (gain) on investments and notes receivable"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r66",
      "r102",
      "r103"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r227",
      "r360",
      "r590",
      "r645",
      "r669",
      "r717",
      "r724"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill Ending Balance",
        "periodStartLabel": "Goodwill Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r362",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r361",
      "r368",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, Gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r361",
      "r368",
      "r645"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r124",
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Translation and Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r45",
      "r272",
      "r321",
      "r326",
      "r332",
      "r335",
      "r349",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r532",
      "r641",
      "r736"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r159",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]",
        "verboseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r44",
      "r189",
      "r199",
      "r214",
      "r321",
      "r326",
      "r332",
      "r335",
      "r595",
      "r641"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss)\u00a0before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r378",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r273",
      "r484",
      "r487",
      "r488",
      "r491",
      "r493",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r274",
      "r291",
      "r292",
      "r319",
      "r482",
      "r492",
      "r494",
      "r603"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).",
        "label": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option",
        "terseLabel": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r373",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "verboseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r85",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r81",
      "r86"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r184",
      "r200",
      "r262",
      "r315",
      "r550"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "verboseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r639",
      "r659",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r79",
      "r636"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r239",
      "r631",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r79",
      "r638"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r79",
      "r637"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investment [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r685"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r196",
      "r209",
      "r669",
      "r703",
      "r715",
      "r747"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r223",
      "r272",
      "r349",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r504",
      "r507",
      "r508",
      "r532",
      "r669",
      "r736",
      "r750",
      "r751"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r18",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r18",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r26",
      "r730"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves, current"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r26",
      "r730"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Estimated Litigation Liability, Noncurrent"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation Settlement, Amount Awarded to Other Party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r5",
      "r194",
      "r206",
      "r415",
      "r430",
      "r647",
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Capital Lease Obligations",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r24",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r97",
      "r98",
      "r387",
      "r388",
      "r389",
      "r731",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r387",
      "r681"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "verboseLabel": "Accrual for legal matters that are probable and estimable"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r30",
      "r195",
      "r208",
      "r272",
      "r349",
      "r393",
      "r395",
      "r396",
      "r397",
      "r400",
      "r401",
      "r532"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Noncontrolling Interest, Period Increase (Decrease)"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money Market Funds, at Carrying Value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash provided by (used for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r61",
      "r64",
      "r67"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r146",
      "r150",
      "r254",
      "r257",
      "r291",
      "r292",
      "r693"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss) attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r142",
      "r447",
      "r705",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r154",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of Interest Rate Derivatives Held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r321",
      "r326",
      "r332",
      "r335",
      "r641"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "verboseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r240",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "totalLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other Assets, Miscellaneous, Current"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other Assets, Noncurrent",
        "verboseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r34",
      "r37",
      "r534",
      "r536",
      "r541"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r39",
      "r43",
      "r260",
      "r542",
      "r544",
      "r548",
      "r691"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r144",
      "r145",
      "r147"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r246",
      "r248"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "verboseLabel": "Net change in derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r246",
      "r248"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r246",
      "r248",
      "r509",
      "r510",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r248",
      "r252"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r248",
      "r252",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": {
     "auth_ref": [
      "r247",
      "r248",
      "r252",
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax": {
     "auth_ref": [
      "r247",
      "r248",
      "r252",
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax": {
     "auth_ref": [
      "r247",
      "r248",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r247",
      "r248",
      "r511",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax": {
     "auth_ref": [
      "r247",
      "r248",
      "r511",
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r37",
      "r40",
      "r41",
      "r253",
      "r540"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r108",
      "r255",
      "r258",
      "r263",
      "r542",
      "r547",
      "r548",
      "r591",
      "r599",
      "r691",
      "r692"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Total other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Period Change [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r35",
      "r37"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r35",
      "r37"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Net change in defined benefit pensions and other items",
        "negatedTotalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r37",
      "r40",
      "r119",
      "r253"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "totalLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other long-term liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r99"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other Sundry Liabilities, Current"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration previously established in purchase accounting"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r694",
      "r695"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Payments for Royalties",
        "terseLabel": "Payments for Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid on preferred stock"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for acquisitions of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment and internal use software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareCashPaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Preferred Stock, Dividends, Per Share, Cash Paid"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "terseLabel": "Preferred Stock, Dividends Per Share, Declared"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r7",
      "r109",
      "r110",
      "r701",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r270",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r7",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r7",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of March\u00a031, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r634",
      "r644",
      "r716"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "verboseLabel": "Net proceeds from issuance of preferred stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs",
        "verboseLabel": "Proceeds from Issuance of Senior Long-Term Debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r696",
      "r697",
      "r699"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net increase (decrease) in commercial paper"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "negatedTerseLabel": "Proceeds from Royalties Received",
        "terseLabel": "Proceeds from Royalties Received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r221",
      "r254",
      "r257",
      "r267",
      "r272",
      "r283",
      "r291",
      "r292",
      "r321",
      "r326",
      "r332",
      "r335",
      "r349",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r502",
      "r505",
      "r506",
      "r521",
      "r532",
      "r595",
      "r641",
      "r665",
      "r666",
      "r693",
      "r736"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "bsx_NetIncomeLossAttributableToBostonScientificCommonStockholders",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r93",
      "r225"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r95",
      "r210",
      "r596",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment, net [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": {
     "auth_ref": [
      "r183",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.",
        "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)",
        "verboseLabel": "Average interest rate of de-recognized receivables"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r39",
      "r43",
      "r260",
      "r542",
      "r546",
      "r548",
      "r691"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r39",
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r72",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Payments on long-term borrowings and debt extinguishment costs"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "negatedTerseLabel": "Payments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r68",
      "r69",
      "r224"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted Cash and Cash Equivalents in Other current assets",
        "verboseLabel": "Restricted cash and restricted cash equivalents included in Other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r614",
      "r615",
      "r616",
      "r686",
      "r700"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents included in Other long-term assets",
        "verboseLabel": "Restricted Cash Equivalents in Other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r66",
      "r382",
      "r383",
      "r729"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Restructuring net charges (credits)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r115",
      "r207",
      "r608",
      "r610",
      "r669"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r217",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r292",
      "r350",
      "r476",
      "r477",
      "r478",
      "r489",
      "r490",
      "r519",
      "r605",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r312",
      "r313",
      "r325",
      "r330",
      "r331",
      "r337",
      "r338",
      "r341",
      "r458",
      "r459",
      "r587"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "verboseLabel": "Trade accounts receivable, net [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r39",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Other Comprehensive Income [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "verboseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r24",
      "r109",
      "r112",
      "r113",
      "r114",
      "r182",
      "r183",
      "r185",
      "r202",
      "r647",
      "r649",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r162",
      "r169",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r645",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r14",
      "r15",
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Disclosure [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r168",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r233",
      "r234",
      "r235",
      "r307",
      "r431",
      "r432",
      "r433",
      "r435",
      "r439",
      "r444",
      "r446",
      "r651",
      "r680",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r309",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r381",
      "r384",
      "r645",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r321",
      "r324",
      "r329",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (Shares Issued)",
        "periodStartLabel": "Shares, Issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r219",
      "r309",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r379",
      "r381",
      "r384",
      "r645",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Statement, Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r272",
      "r296",
      "r297",
      "r298",
      "r300",
      "r307",
      "r308",
      "r349",
      "r393",
      "r395",
      "r396",
      "r397",
      "r400",
      "r401",
      "r431",
      "r432",
      "r435",
      "r439",
      "r446",
      "r532",
      "r629",
      "r680",
      "r701",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDivestituresandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r28",
      "r108",
      "r217",
      "r259",
      "r260",
      "r261",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r292",
      "r306",
      "r350",
      "r447",
      "r476",
      "r477",
      "r478",
      "r489",
      "r490",
      "r519",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r554",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r306",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of shares issued.",
        "label": "Stock Issued During Period, Shares, Period Increase (Decrease)",
        "terseLabel": "Stock-based compensation (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r108",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r75",
      "r669",
      "r703",
      "r715",
      "r747"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total stockholders\u2019 equity",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r142",
      "r143",
      "r149",
      "r217",
      "r218",
      "r260",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r350",
      "r447",
      "r476",
      "r477",
      "r478",
      "r489",
      "r490",
      "r519",
      "r542",
      "r543",
      "r548",
      "r554",
      "r606",
      "r607",
      "r703",
      "r715",
      "r747"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodStartLabel": "Total stockholders' equity",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r271",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r447",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r108",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stock issuance (Par value)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r549",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r549",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r549",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes Payable, Current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandDivestituresDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "verboseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r346",
      "r347",
      "r427",
      "r444",
      "r517",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r712",
      "r713",
      "r714",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock, Common"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury Stock, Common, Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r27",
      "r116",
      "r117"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 263,289,848 shares as of March\u00a031, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r108",
      "r115",
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r479",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r276",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charges to expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Utilization of allowances"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow [Member]"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r295",
      "r300"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r294",
      "r300"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r674": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r675": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r676": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r677": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r678": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>76
<FILENAME>0000885725-23-000026-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-23-000026-xbrl.zip
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M(VZ_<_J@GDB#\U\[.5-O_"L?WV"[,^BD\^9/1UM4_K'4L4YF2@X+" -*%Z_
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ME-,6V>38:2F!O611J@0SS@L+,19M?"WEE(.5<\-.-_J]^N*#?K?+P<,:=\&
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MQ:13C,9H*XQWI0&5&VY!VC\%^L<GPU'_B 9;U!UOIUO)4U/RM742!B,8*%9
M=!2TIY*C1XTA4FZ2%US 9$9\GT8B,BH["P70BR!EI!)*SIBE=["P.-. TMWQ
M> 39AF*U$9X C4+'D;>/L:C"L6 3(L!9Q]\XS? [R=VLH,/;G%!QA">#AJQ<
M*'6SCL0\W1D34EIXO*;!9/H>KVB20B3I14[ =_9>HTY6:.-EB>D6=]*:82C]
MM'^9"[#>C$T37F6CM 25P.H8P)../@7"&+5M4B6DOP3B(SSK=E@HN9/FL^H1
M"0[7<Y *I0.V(YAJ,*:#=9:"R0T8-IJF_&XF0HY:U-V]$B0# 4QT!JTUP5D-
M%GP#:A4U=B2OB7 QWM:XUT/P"B"I0-X#U(KN"DJ*31I06>!F5MV$Q"RM((B9
M(]R8$$DI(.T$%A&E;,".9G<"6S=/B6?%ZJ'46F1#WA8.JLE%[X(M9'U4MEA3
M9A^0?QT =;M7'&]*=)"\S#8CZ4(1A"G1>"%-)A% L]C$[ OG3^R>C <ZQQ:@
M\Y^3S_)TOSR^TAFF_@EW0GZ,PX,GW?[;25F'Q]RU'5;9WHA_&_+;#<8M/SK[
MD#Y<(;.ULD7[=5%N?W"&O5S+5-,@=;#;>3<^/U8+MM[ITG#4[S5%S8&\L=E:
M[RBQOY$(V<E8@M-9%]4$+GS7D?0C+FF=??71R5%#,&H$L^P@K,T$8*Q&DM(K
M!]Y*47Q*"XS^* SP]!HPF&GTSPI&?=VH 8**I43@7T*22@7I"GJ(-C9@F&<6
M,-HT.]I,:D_""9%*ELH#N*BBDL9AB4K9# D:4/FFB5BE-]0[H7&8^QS/Z@LW
M)MHHN99N"=$GR58NH%4 )=ALLD:-#:C0>3?P,I=,\/T**>XF^F*)U,EHP&\T
M^OXUKT7$5*(.08D"23D/)5H3= P^*A"+N*=AG+*YUC5 "DKYD),08$E&C\4:
M[W*0VE-L0#;O+"!Q-JUK0_DA0Z_HDK,+&KPKOF!!1<7I')@H-F#EX13F(F9%
M>,X$*W)=)*HC8%$!"8L&8T.T!9V>_8)[C1/>Y.KP.6&AE*RU]04H,K=FS;/2
M%1%"T*X!DRX_)+SGS.":X[ 1$&IZ:?90EQDJC,YD:?G+A"85.Z<:=AM"FIPF
MY1"$8@5*A X,ZU-69&0*J58I44V(6>]<RF,$9L+&E>R (&+=%C )YL7>L)R\
M$7.J5[<OLLEI62)+T17E-1E0QF)()EK0-GBJ"V5G7\O6>IG*CXCM:;^?WW:Z
M34EB<RH%'R-B8.6J Q_2ZVA*4HI\,!><?J:5:[8E-3F="LDKFPQ)ZS10\L$Q
M_],"LD=11Z?F6*?6>L\'_43#X18-"0?I8+F75SA2[_:/ZR,T1-6H;AZ1:PV*
MZ, &BEY(54@Z#S[27*O:- 4XP>UYRE@#A89:5]0(%-)H[:,,+BCI&C _]L,"
MG),Q$*E3R$D7$AQ&YQBM$1ZD <\1-60WQQHX)^,@J P6Y5PP!3#[P!2%!5:H
MN" B-F 0ZWTMYLLLT^WS6PP_C$&O4QZ>#/8;(I*@-84@C0M9@\W!%Y,L::0B
M!-O()FWD\761/,9![O3?X#"==''0$,E MB2+=@E= "V,5\I%PQ:02O#:-VGY
M\S2U9OIK0#@8"[6N>?&"8[1<0O$I.!^+"3F3G#-!WK2N35^>H)U6/F?ADZ@Q
MM\^&0S@9'?-)XTP#(KD9\6*38X:9N.-!6B4P00$1!2)I$RC3>->CN1#)+7JQ
MR4F&N;HAY\,XRUL7#J$ELMIH4Z0USC9@*/%9O[<_HL'1"L71I]D&*Y3&5_$;
MN(W^B&8XCGJ?;D4G7^XQ<%F0>O7%UN7EUTZX8G>FF+L7966!&)/W">L\M0I.
M%5]\@YS;/RGO=WK[*S3L[/?PP[JRCS98R1?'*$\JL66%Q?:&&ZO[_PU'@Y/Z
MS%N=X>M/FW[2'Q WO'J:#FHF"G]\R\9@'IVKM#I;!2ZBY]!>^6BC#DZ@R8PS
M/C;[]N);,%IYCZ'EX<6Y'T1_D[ :/L5.[UE_.'QT=M'NQU7)/JM;=I&_=7%B
M PQ;?O_&KSKO7_D+4U?-]I5G?K?A@XSHI"SH$.L^8,$SP]>UM L%KW*9_<!Y
M =3IC;I$6;?B@:B, ZMD2$6(H%%X86U2#1B*GEGP?--YUE32 :8[B> )IC=+
MFX4.4I/+$$@C6*@;*01O)(&CA?E;('BV;; UI(%]=D:MQ\N?BD97;"@ZA"(4
M+6SPK8!G@T9KO3<T'-4+KX>@F="N63'$J2XL(0A&)PZ8LD>4.7F5=,*4:D7!
MA2%>P'CVK;&JJQM,9,V(%C#%X #1R.2E%\DV(3UJ >.?@G&-S"\@G$X& ^JE
M,Q9*_Z@S[K).+U-LBDE&C(9<BD4E SHB0M)%.X4F(]G<@)4$"RPW&\L37'#!
M +;&EL#&&*Q4P9*(:%WR1?D4&U"D9R9"K$G.+<R*F0N(5ED#*J8"&*U/# UO
MM(*"!DL#%G8LH'%#5H-%I11)L@DE)'!!EIP)(1=&22,V59M9#S@;Q'\R<S;U
ME^&5<S3C(]\])U/G8*30T6!R$!)XMCTN,0GS*1ACW!Q-1C<>?]=^B+5>ZA_1
M^_R89_UT17<\[@]'FV4;N]],PK@U^GGCHZ+3GZQ'[XMEPRYBL) PA,0*6$N0
MU5H[3C1I-XN9U;=F1#RS9 O6&*$#[H35TV.^_@:JLTQ?\4 SS;:@G8P"*,@H
M+=;T?2144@(M%&]^%.\&,-_H88[I:Y]%*$Z 0*TR^!R"]+EHXW)-7DM^H7TW
MXEHN(5[K C; KRQXY@17T#B;HU8NB5Q8[2 02E]"4$:)%)(<*YRZ5#BU4+BY
MX7)W/JY3U]<W-3D')R#7;:&-E A:*T0.Z5B]O'?@^?>%OLT/O6R.+;C=N&XJ
MBN>\)M8"I;61@!BC#1XXT OH%'E:.+HY4KQ9XYPS%==-1?MTRMH99XRE5%??
M!Q]BD#EGH4ST:N'V%G'=@F=.4N%"E-I:1TZ&#.!#J','Q5O6.72!0H,&4MYC
M;/4_)_Q<C_M'Q_T>O5^_?7G:<DHG1W5K&\H[ ^P-SX6_G ]/SGW,/$;OQEIE
M:I$F5ZLUV;I"Q!FOG*R[GEO0#3*KS9#R5'0Y%5(1="I%&M!6HR@Q2QVXC60E
MP>RG?#0G$KJ+HR(WD\+F?;1%66>0XZPH8I'.1>&T5-4O-6"U^2Q'.,U1J!L?
M6K@1]!JM<XH(3JD,$@)J]IX&R"8EB: !*]@6$<+=L[F)+:T#+9PI JR4C"I/
M,3%)$)A(QP:1_JE4C+D68L?5Y[GY_O%XIZ0:W=>KYC@E!B7S38TF\4W!(X7J
MVU-B%FIUW22B05'& E:S$]8$M$Z!,,99"T8+#EBC8^R@$2B%4+/O8QLT%'C#
M5/ 1=K&7:/N Z"OX?CZ@8^SD"SP/EWMYC/C'XU'P4:.*9<L4&*=4E.?0)F'T
M OC^$'(@#=DWH%CV K@- N[DU@YI::RNY7$Q /CDHZG13?:!*# _;,! T@*X
MUP?N):-(#32Q:&V6 1B)L0 C*8 T GQFK'K^)2Y,[ *ILV%345AEI)+)Z0B0
M(ZJL"3,9)1RA;\"V>3>)U%FQ)\)E61)Z';T!R3&&E")[RCD956((=]N>S(HN
M!3!%*0H^10>):;:248N@(5AKLFR +C7$X$Z TTYER&56S$DMM%Y0F82:@#7
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MTRAF53J/!Y0[HR>8ZCJLSTJ1;-&;?O=-I[?_Z4F36KG[K-.CS7+5 U2^L7-
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M]P+L,^( 5B]\[GE>\>>3(-4C-WC^X[;UX8\O]"$&$V/*;4 4_*/(MG=*MI-
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MP\L^;.!/1Y_>U%FK_87$]\/&<?V\U:ZSP\M7\3JOOG[ZN-\Y_'B(6J_E>>M
MG=B3U[W6<1TU+E^?-(Z_7AY>-CNM]GZ\ECMJ7'ZAK8]U<GBY33ZU/\7G#LE;
MLG]T>'+>;9TT+AOM_YRT/AZ2P^-#='C\_KQQ[#J-XR^PM5N_2/?0>-.@G]J6
M77\F?M?9)_R!'UXVSALGA^Q3?'_S^)].<W?OHHGK%ZW=][1Q_)_4WN^'ET?=
MYF4W-"[@^=OVWJAQ &,[MEEC=_NS1D9@RC3@TD) M>9 "8@!BT/,%4/4:+VQ
M13:)5/_ZZ]>)<\N>X(*,5UL0,0L)G8FOG%Q9,F^M*6]A*87UTCHB"64B*.\1
M(I):JJ21'!:\A:]Y"V?>*CMO74[R%I4N8 TYP,))0+&VP,2A!3)@CPBS1(B0
M> MB7GK>6@,U6T[?QIUTLM,?CM*&\.F@[\[L:)BL$7>K#8D7:_S,U:+2E+IT
M*9CZOQ7>]/MNN-US!W[PK6/]\" .0F;.93%G<V=:\04/H\!#%N@0QXH**H V
M4  #'184:1H'<6,+;4(*'\J<LUEAI8IOXBMO]24\>SPO72+=A><,V44@.R5V
M,(,*17L,H&B@1;%C/# !,< 8"XQ$]&IG-[848Z4'[!I(G0HZ[MX,^L-A$CJA
M,[J7PKEJ\]P;!NM'ETN7/\68O"N&).N=I9'GP;3>,5'4<(T9L!120)UE0)'(
MH,0$)YQ5"F.]L84W"5V6AVN1?;6G=']EZ#^-4LK07PWTIYU$".G :)1,%*NH
MF[@%1D,'('8V4(&3"RE!'PI4;>B75E8MM*]];V-N/:]1VD%=:ZU\5<.I]Z7F
MST]];^B'+^\5Q#/OVEN^:ZS!O+O#CA7C<U9EGH('OAN?_+)9^^)[<3)VB]3D
MVIUT>IWA:#"N17(].;/#^M$LMJMA>3,>E.V>V_YE2/;&(Y(5W;(476N&\YH2
MZR3W'FC/.*#&B_A(A?@C"">@D-"%Y+S&J/R^L.R\+H])EK']Z-B>LM8LPPXY
M9D$PA$1KS3(0!Q,!'RP77@IBL2\VIGCY-Z;60$/=$?90 0VU[X>^. J2M)/S
MWWRW?YHJO3Y,.,T;%U9I<EU!T.=X+"*M[OX<B2M._1DZ9?_WK#/PKMXK\CT/
MAVE#,9/J(J0ZP_O-D.#*.06P,BP*)JR @9H#S;4301,D&-G8(D24/DIJI>[M
M]4;T"L(A,Z(?"=%3,LDSJJT0$<)>0D =9D SAP'B!F&O=? "142C\L=KKX%(
MJK:C:;]_H;NCBVM-E'U)CR>)QCW_PZ[,G#A_-'A[N^##@A?;7[]'7OS^&2EB
MXG)&@*6. \JE!\K%T7#**81=4#8=8T$/WN;+3J'R@G3Y*B>#]$$@O9@ :<!,
M4\L4@) *0 430"-J 5=4J@A1;IF-(,6E!^D:")=J>W>V3_KQ9BZ+C( /4B_/
MPOQ;NGJYV?VM4.^-=.]+QW1].OTV&F:B7(@H]Z;5#,'*6,XI0,H00*E P.A@
M06!$<,I%X$G-Q!6L]"9>=MJ41\YDU"X7M9/R1B-%79 !2.LC:KT3P BK (/&
M*FN1D%I$>:-DZ5%;.7U3OANNRCMSQY9%D5?;E9BR(L3;3CNL<14;=IP?Y^NN
M]?R//=?:'\;W?.B,;L\0]^R=&$O7ZJ_.AO%^TM[+B>GTBC'Y.58[-X=J>S"(
MBL"GG9SASE%Z6.]%S7#6&[7"+1]YV]&FT^V,+E"6#PO)A_?3HI]B8P)7 EAF
M<!3]E ))M0(.(2.])EYP4PGO2'9AED?S9_27%/V3QH/@3#B&((#8&D#CZ )-
MH0'24>,$5#Y.B$J@?PV46+5]H_M^.!J<V='9(!UB2?++'NG!E_@%?]B!=YW1
M\'[RZUDX7581^_9S-';& Y'9<B&V_#"ME21A@BC$@3,.1;9D!BBK#( 2*L6%
M\!J[Y" MO:<E^T?+HY4R5)<!U2EAHZT1)!C@ O6 *AS-&NPXD$3IA&&HN=[8
MHJ5':N5T3?ENN"KOS!U;%B5>P;22ORF4.H>+X]8<$FN^H"]=>_\XRG\5P37,
MY_>6M]1_F>'!),8R)PR00O&HRJD!VA@#K%)(* NM1S@=X!/JP:=-%H)*A=R;
MSQ7[2Q?S&?NKQ?ZDS,=""*XH!YQ1!JB.6M]@Y0$*7#)'N+ H!6!O<KBL@_E/
M@?TUD%253LG3Z=G^B:_]T>T/'^;%?*X\NSJ-52^&YFT<F$RF"Y'IUVDAY:SA
M&!H)>/ "T& H4!9C@+%BV%L=')<;6XP]>#=H(314R//Y7.&].AF5X7U_>$]J
M)<2TUZE8"8^R* 6*<F 4$2!:2<)*!X.0=F.+\F55+LE**6>DS!DIJRM_1T=^
M\$/Z7L52_IFS4C[U.Y]9A&\]%?WUP]$SS1;PQU-:6==]GX\BWT."'=>G+2RE
M!7>82> ,I='"(@A(B33@"LJHP 0D/$HP/NVKFO(ZY#C;*B)TZ8921N@#$3II
M)!%&K> 2 \60 93" (QF*869H1)K&% 0&UM83*<Y*A%$UT"T5#L8MM#.FRD*
M]IG%O#ZR7!G&!L='4^ZCU/W-?J__JQLID^1]2+(Q+6,"XDYZ;8&UV .*!082
M09;VWC4.3$-D4W#==)Z ^3DRA\"6&+E+D#$9N8^"W$EY8XF U"D$#!,:4.8,
M4,Y2@"GD(8@@J1<IBV.9D;L&ZJ:" 8;UFWO@XPT!XT-_X*]=A"-]_K"Z(,^X
MUML*/#?7^V:O!_V3\4'*L]A_5QMK_=[P53%XX_>UT]#MG8\&.@Y!IZ<'%_61
M/QE&'DYW.>@710JN3<U,P@N1\(PCUYS20)P,(#@>;4P?)# V<( =B2\Q9*5W
M43[1!Y].6!18%7(4/6.R6($3*9-%:<AB2K$YCS22&#CLHZW%$0.2.0X8#R[P
MP(T.*;J9/7C7_FG)8@U$7;5=5O4?*FY)>7.J:PH_O7"+''ME\KX:#T'FT85X
M=,;9;8^)@\C'<7 H6K[88: B=P+C"&30DB (B3PZP_0MVY'0[+DJFW3*<'TP
M7*>2=B,4/!4&,*,EH#H"5UO#@$':6"(9\=9$&^G!ISJRMZKBWBHQDQ.:?K2$
M4QO5/ATWNV>>4MR\&_0C.>9H[H4)\G#6'IR0@G((&.:1( G#0$/M@87*4.9M
M'!:6//G33J1K*)3GF'H9S]SE\[8K8)2EZZ_,*/=GE"E/D]<!280!ARI:2($Z
M(*6T(.DP0:1E-KA4S&@ZO55FE&>B!.]R<95&$<Z>)^\&/OC!P*>YT;=?:Z[S
MK>-\SSVH(F]%>;P4L5N_$OGN]7#\&*>#-$S%CTSM"U&[G1:+AF#NC&9 :D,!
M%<H":0D#PE)F++5.T[2),*T5%P[[*(=4RV=Z2Q'DE2&^.HA/JC>EXG!Q"0$)
M& %J/0-&H@"81C!PKTF L+H07P/M5&HOVFRZF/*BU?1H-.B8LY$V75\;]6N]
M7W;]XYO'V_X/B@.K(*\^I7**@_0S@&/[QOBT^[?%9-Q,214ZY]Z!2S_H9PY>
MB(-O)% YWKN,_7#YV800:;8HBLX,H-&.!IIH#QPUQ@M%F&4\6:P2(_QWZ5/J
MYX-^Y?%S99 _&<@O)D NH=:4"P\$Y@102#%0TDK@.(90,^L,8=4!^1H(JU+G
MUIAS>W)*6+WJ#T>18PYLQ_=&G="QL2].3OJ]L??JJ-^-$GQ*9:W0EBU=%_[W
MBAI?EC6H/+NW9GA^U_HSGJD_)^I.,4\/;DS3O.8LM.;,2'%,& M*.P+B[(["
M$F((C(4"*!6@II18Y]S&%H&5WIJID@<Q,VUFVN6K_<RTC\ZTDVY4SH)P3 J
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M*$@4L$YB JV2D(L"P5)NRF0]L.G3\65#\!I(GFIOC?\BV/.^^!SA1% &KFA
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M7-[?AL@!C\M:P9J[,Y(M*RFTDR'E<;$<4,\Y,-A9P)%56%CBA?')6-B4,Z+
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M3&PJA6^$#\K@'SL),PF]2Y-?H,Y>(=]#D&]*IJ$&=B0-@!YC!A1W1C'2G&"
M/\,CB4&Q/&4:KA,ZZ=NI LE>BJ1'V.$$-106 RA,F!L*$\^4XS1:C*TI))U4
MDKY*DC[IP86A]-XC&JP!CA,]TB+W2  U%M'!G'.WMDG7B5!+).DOR@%Y<QC:
M@MA-@$-NY#6/&Z.R;*/Z7X_W^DN"^M/?>P[4UTHI@@,16CCN#;-$.8>-M$2[
MJ(0J4'\&?^T#4;\"]CF ?4JGVIP2S".G2!#A -@5 #LE.:*$>:><#3BRM4TY
MQ<8U%)%G("?W<_FL2FA@!;45U%Z!VIQB);W0.##.@XE:&\(D#R$7+O>1EZIT
M!;5+!K77.71TQE/X#TEB%.+$<V2\H$A+4)6IBX2YF/(X)JV$%=3.Z'KG2^!Z
M9_!*OMVWS;#,OO=9G[(8Z'_V#!P(__K&WYO_"S^&=SHQG<-&:SC/XW-XW._V
M&O%\@*V;_VL[_QPMXWM?9F%K7]^U]FE:^U]26;BB0DD[A7+"+[VC $!M^KY1
M*%'M5K&R3?ICD/-CFO"0\$%1,6DCVSJ!:0#UZL2<IZMDL0T_?#^DBQ4S! .^
M<>.X#)Z&T]+(?MKN-A(>O.F$INDU_@[_.FOXWM%P0QD[L126-_CR%&/A4?N]
MFT^Y+G^+'G*"9QIS>74PQG\>C<3]U!P&9#O!_$0F]D+GC6F>F?/NVC^OKBI8
M4M=&\/K+W_B.,3[:.Y;+&_;I=J?(+W\#JR!TTE'P3&9IGB4[ZB3R\8\&9]%X
MJ[62G'-*B:;:86^Q#]Z:F*L?<FUS+^%#,AZ\2[RE""\QD^)^,Q9,K/S'AX 9
MU^/;W:][N_7LZ[N=]_6]G0\[[[)WNU\^[7[9VMN!C[?JV]G7;V^_[FSO;'W9
M>?_U1DE>FO=YMUO_NOOGSO;6WGMX]#WXIP8O]C7;_9"]V_KZ[^S#G[O?OV:_
M?:MO?=O>@6-^7_Y7^NWKMT^?_BS>8^O/;*?^8?=+K9B>>SS['1O5U/.*S?$2
M>8LM%MZ]:4Z[X<WPEW\-BWXU6L4;%"?]:[#Q#> Z(=0UUE/<L/SZ$KPV< E@
M \OFX,Z#KS>*KZX1M?([J38DY3=^C3?(C=_==EFU(71^KZO>_AU3C_.L<J:K
MWF$[OI..Z8E#IRCC#K R=)Y&+9V0INEZZ1[@?LAJ<-Q1-WO?2LG--=-Q1QDC
MZU?4@)4VKH\(8''!-XT>W,S-$C[4:&5PGR;LE=V)V(UY1F$>#6G)5TRR\S[Z
M4-Q+[7F18TT?)H5WA6$OF7S>,AJW$>FO_=/39J&$@4*VTRI]PW#,O=;IS$/V
M*''QSW'UEU*-]$X]OQ"JHE@-LJ9;Z/1CE;_"K_1[>$B,WC/;X&<;@+EM\,M@
M9I_MU9XS%?5KJL+X-BVK=V.KZH48TO^"8VMY?>^OX_KWS[\.CN&Z>_5&[>0;
MKU_LX_V+PS/0EW']^PZ^;DA/G]4N?I+Z]QHYV/YP4H=WJ-&=\X/TS,=?CG>W
MMTCM^#/<[TL<&=&_8GB/K;RVO?7#$T>MB!QIXSSBP6MD8E H=UI[ZBAE5JUM
MYOD298H]D6>P I[E>;7GS'ZM@&<1P'-Q'7BB92I$&Y'7*=#? ?!8ESLDL;0L
M$"L#YHLHQ/9TH?XOH [^,G8CF@TAZNT6*N+P&B>GIBPBTNO Y0:]B#KM<]/L
MG6?%++^8DK.S#<T\65KW#T2[EIR5BFC#G*0I*6>D'<?F8S =Y6Q44#H'E-:_
M3G*X'!,MG6 (YT8CKK5%!D>)%(]:&.L#-FYM\R'Y4E7"P/**[/T#FBJ1?2J1
MG6 _/ @5:1X0=2(B+B1'U@J/,,ZU"#8P0_#:)ED2F;T];N75^O]RJ5;&_Y>S
MF^]9^?\>R\.P531*N)?+[T5X#K[ IRW7:#9*$W"OG9E!#-=9HW?4:-T6 V9-
ML^ALWCT*H==],XNSX46YIF9R R[*V_>B1FXQ3KWE$L Y7>OOAFEJ=Y4JNK>O
MZ_K*>&$FTKE??ZGUB6=*1=MJ74]\V.J],YW..8S:7Z;9#R]#CSBI_ZQ]/X#O
MX%[;M?/=O<]Y'72(_8N_FO7C+58[^<P.M@_/]X^_D>MZQ#X%O0/N63O^R6L7
M.SE<GQ[L'8$^\HW6MMWYP;;_N;O]1P-TE%AK3*K^AD65$QN0<3ZUGG$:*4\\
M,B%($ZA(IH&US5Q.-KV[7R+QTJ1]W6$>J&"M@K5'2_NJ8&W!L#9A'C%.!>4I
M09(0C3B.#"E .A0)"S*W04EBUS89?;!;^JE@[:GC.V]+QWA,B?PR9Z6$1E%H
M#;X!7?!1$O/N2Z!W03/M9*[?Z<!S9J;;#6/<N4RS6/$2?TO+'"?2:"NP71S8
M3@D!XEQK;+5'03.+N-(,&<4PHA$XI-&82>W6-@E[@3% E>PNF!Y5LONHLCM!
ME)PPD5NGD+4:(\YE3+])Y#&A(5(5#*$@NU-Z)R]M&,W"#7++PH56B/<TVZU#
MU N=DX<SGY7UP3\[\QF#S>26+ZEHA9AS(&;]W91@&>>YDE8A5Q0.P8PB+8#W
M4)]3&2+3,MAD,5NBRGM5R,PJD)U*7!<@KI-APCE1@80(>HE,57%MCBR+!@D;
M)$R1-8QZ$-?)0)FJ4.8C"MN2%<H<A/Q<*\,S8UKFDEGX%UO8[6$CLR2 7Y77
M?'U;P90P9]BR\Q"81%IQAKAD&AD=-;(XRA"X4\:):EF\NF41E76!$X88%P0(
M?0JE#3X@A65N<ZQ8M/2FHJM/41IPMAWU0:4!'X3R2YZ&>>LKWOJ6U48_Y_B\
ME.V^*O&Z@K@^&0,0E+'$&.1SIQ&WUB%+I4018!XS&3'V^@DKO#X;C,\EPX^3
MX;'XRJ2BNDQUF>HRU66JRU27>?++/!TIJ$I?/WH:T/0Q5S>7ODX/6S#R.XLQ
M,[XV/*FJEUW5RW[*7+9B$==W]]Y_S?9VL[U_O\^N%)O^L%/?JK_;V?ISO.ST
M;86F;\?/&<5!CL2AU+CJ_1-X,;> RF]7%>_=SJ%I-2Z*5?%N!([P!RC<GSJA
MFRI1IC]WXX<A6GX=@>5VH^N:[6Z_$_;@F=XVV^[G,VO@]?.!!GX,FNWQ(=[=
M_M#8/W9X?^_+R?[Q0:-^ ?\='X#VO'\!FOEY_?B/)FC3S?#O+^<'W_VIA1&L
M;?\\W]W^S&O?06.^^')4_PCGG.PP^(_63SXT#HYKN+ZW0VLG?\7:WL^+VMD/
M!Q,9/0LH!%";.6,2P60Z%'S44D7B2?!K6>@Z<YH6?:<?;D3RYQ>#;"O[GW\H
M2LB_LK=;7W>*&NN?OKS_FNJ4%]7CGZ8\^7-L97M %HQ+M31-*T5.SL,<$BR^
M;7=[[5;VU37@DT8$>7W7[IP.0#<[,G^'S(;0RDX[X=1TRIBT=+^.+_*O4Z9V
M\3<0D'3WTTX#[G+:A!<\#*W0,<WF>?H^G/;*<Q.Y^=8JGJ^0RBX T\;7C>SC
MUM:GWPN7<'')=%BCU85U5UAM"E[TH=TYR0A&GXO#MI+!HAE*FPK!Z5V^A,-^
MLWCP\M.OZ/];+XZ%JYUGOJ!8P^"Z#)ZLJ -5W&A4M;8X//&GDHUUDC\ZO;4]
MST:/F?J?%M5+FZ$7;J!DWX]@S/K=X3LWTJ5@5'OKQ0U3\%QW/5L["^MK&0!;
M^MGN=^"?=/NU=,B[<D;7LI, B^KV64HG-6 Z87TVNL5HI4^Z?=MM^(;I- (\
MT$XY].W31BN= F\.2P_(2GK>]6(PC$\KN5P8OZ6UT^@64]INP13"\:TT1DUX
MCQ2]DKX8.^'W8K$U8(>&-VX%%[I=TSDO!BJ:1B>MGA$NCRVJ8:#C1K9[&M++
MP%7AR'X3'B&=6XQ5427]I%U420^75=++*69D/4L;109KLYC>X<U!TN#RON$*
M#CN<Z>'%>T>F5]!E&XK2LT4 PO".Y\%TTIW2TVS#Y4YLZ%R]&U#N0@3@B.;Y
M>@93-Y?875UC*:8RP/+N'K7[39^>".ACL6[@2L?]5FG1+J0BW>BAMQD/+MV!
M0\LW4VF$TN5/8*6E.4Z)+5NM5A\N^:58N; .1A+X?QL5HDX?\R&Z] 87Z0]@
M=DRD_U\W.SMJ)UQLG[6"1U<$M9BT)..]]$=:D6='#7<T?C[(#QQ6T*H.7"8]
MX>6C-%+)A=#MP0IM#OX:O,FP9$9YBZ)VDQE@ZZ5 AF8#=!,SP&HWSJY&$!(;
M'5@B_^F;#EP\O5N2B/7L++WP "T-R-9QN]/HG:>Q^9D0]N]00D6Z[I:#%>G&
MT>S?[682IF[V)]P_W?VW\IAR1RB>+S1+*84E/#8-Z8D 7Z;O;H",\".,GK5I
M#J]);GGV$!62")0XE$9E" =E\!'\V6RVS])HIP\3B2S L9S:L>$LY"383C\!
M(,5C\-2&5RL63J=],CZA!761_^K>M-"N;MA3GG#X?C>BX\W*_\I+Z]#V46ZO
MY;H=MHVXK",#^^_G<I! [";Q[',Q/TE0^F5QF;1QM\OE/JQ)4URGW8=G]=V-
M<GBWDAR6BZ?<U[O]D^&*2!>#M3=NE@$N 0NT6"[M5"R_O/+T)[]NO<G>A4[/
M%#+9[)\,=OA.^^SR'9.>>WDOX_WP&H4YJ5ML@<7ET@[=3WL:L()/  ]I7SZ$
M4P=[=!+?-!BFZ1*9&E^OI0H^P,3AM0;C<VV)/:X*^!40$T83GO;]WVF(/X&L
MN//RYRO6ZS#H=<9(Z[3&2"E%$0^2(>6,0WF>,\6"$,':V_2Z<6\>?A(SZ:6@
MWYB-,EWSNUP%6;D,;B8ES_E6M\+7=]C8_C;-?MK*0OD2;3<BV,F"6$A>L=4-
M&-HLW.1*>:QBGSAM)^M7HR3P[<-6H]RK.J T#"TB"8#2#:9K-'M';0 1N-7)
M4"TJV?KEQ1I#?C!E+[ZD&.F,3@$<@&"#FZ>_+K?E6\CETL[C]-$9&]O?  [1
M8+0N0JF=#19O.>^_SSA^-PS9T(WP*.$-,XCH]&')ZK#LLK<CZ\Q68HBELP#T
MW^U&8H6-'HQ/N:%]!1[5"X>P8^R,"",<5USDWZ.+ &T")G6IXR3++HQ"@$$+
MW4=^_]O?-CW-<DU ,70[HZ$K^J^ \@'[>/?_92D@J7?^K"-66 CZG2*OT =@
M.,WK3.*?5ZC$Y-\/(;.S6;8Y>R++]ML^Z!2AVX4%;I,6!E*R=/9J7!ORFI//
MOX##'._OU5A][UL.YYWMGP!/.=ZY./C^5^/@^Q\GP'F:];U)7G.P_1XX3/VH
M=N%('7A+??MM8Q\X3>VXWH3SFL")@/-\(R6OV:)P_1\ZM020-B#O<X\X81CI
M&#WR7!#/M8[:T#+4K]'J![_5@S&R6.66!!&T@L-\-#$(0W5.&5>".+TZ!NXQ
M"'WW^=O.UYUDUOX*$+KSU_NO>SM[W[Z\_UKV2-W[LK7W_N/.NVRGGKXJG3\O
M5__;G9$1W6FM:4^U0(Y,&I<VF:$V!(<EPV&R+OK"D W\S%SN;QL9<+MBVT[Z
MV*5RU1WOEW;::6>%[?F*">?2&CUN:?;C5^^6U&UL_SR$/UK7#!I#HRA<#48W
M*9_MF2GD=!;XH<3J]2L6#]?NIJ*M(5'(DT7=J_0%I&L.>H/!^Q<SEG(G_8NU
M:-SF@R\L2>,4ZJ4. HAU*]LZ[32:&5^_M"]>2D*YL$8#D43OQA#PTMAQ/0H<
MV]RZ:)3RC@N=6Q%SEH*'B13!<#[([N&8CT>!TYMV[+%)N32I[,:_V@E0=@8V
MV?*H3O*KEA(.S_&K]P:>#_EV,>?I-J/0<$1?WTX/S_7M5VTOQ:+#O0Y_,.&P
MIDHC3Y*76I"4X"LTPL"T@C-&F2C7-@F>K&"9S+:%$V-@CVOW>X MI5,G%+PW
M?;-UFJRZJ?ENXEB'H7.^#JJ'V\A^*[_Y?3TSV6G?-@NV5]K12X-\.X*^E>Q_
MR7@7 <G:Z7H^_-U()O;"\^?[A1(8X.+-?C*K%WCO@B_P.MFQDQZ7'9INK]-.
MIOKD;X.#/*AR+ND]I8=N\H!"#@K/UM#79QJ%^; 4J0PN6^Y>IW!(@:7=?GK<
MPE60MJ^V#;!8SY-2'S)SV D%Y&8#IU\H<FY!YONG<'3Z/&7FGIKSD\%X_M=M
MZ1:P_HNF6 L1N)WZAQE$KKC?)V#DER6#\.N6'0ZRXP(#J1$<6>\-XBY8I!V-
MB'LM(N@A$?M4_2?U.)@J/5DW#>MZ(AKF%!;NKT;:VIOGMT__M6FW3A&:6YM[
MS3@SW,#_L64V&&HX2.] *X)I1]/F?S+M9HJ.]+473L=60ZG5#D%WIS5 W?#!
M-#I%72DR&_X^<VK.,R^AS^?USS^,55C*U#:(!P(_3$1&>X>25L54'IAE>&T3
M4'ER 0T\&27$#&#6#N8N:W0S&Q(:)5 [[ S\C0/"6("Q:Y^>C^(97BS9*WC.
MA+/P&M<I7<E7N,Y,_M7+K0MD%NAZLKF^.TH3$-+.TH\P5; 3%2Y<W^D?(M<>
MVHZ;[;2Q7(:O) =G,+TA_O]MNLDWU"FVGG9INVET@^FF0)/OXW[@*[@Q'T-C
MUF(,&.8 LS@+7L%OG"4U7D8>7!AL&)3BBJ$]$T3PVN<?SE(2@[:(&\KAA\J1
M\O";H$P!/V.!2PX0,04A;B%HQ<Y3*-3#I5SHXC<SDG__W\V;TL_.V;6EA2/!
M$IAED,QQ997%C@AGM8XLQFCT8%."I86FK3'\.'M2Q5S2FB+ 7 )F42E@_=C$
M'%A_%$A1@Q'#47"%@XTL3]KP#,QE'J[RP&51<95G6S3)\>U E2!$2Q0L!E71
M"H(4L1:F*D:MM>2Y2KVJIW1-&W*55' (!ANVY]:@MK,[S\(O=V1:H(5U"AL?
M'#((_1DPFS*4Z5()+/?M0;0.L)GP:Q!&";M.X_0H1<1FQ7PGIU^AOXW.O</Q
M\9BTYX[S7F&*D+XY1:C*]GGAV3X@> ,_4FF%+Z#U;E_25=]3[@CE1$CJ\\"C
M8$H)*[SCSC--E#3/YVV:TX7\J=\!" 2EH;"PI+C2=FEZ>E;'\9PY3$ND]Y&\
MC/L9A >/!9X/-I-QUTH1ZCO2F]TED9B6AS'*=RJ"7 <9&5\3J38=W\W>MN&?
M[+</6U_?_C[]B'=MG\)QRQO\MO7UW>_97ONTX3*%\_7EB6PH1G!(KK(Q=M5]
M[&>\]8F*D<U@U"X'[?>2)9QV!H'5H.6?#L7IM!"G,U-,*_S1+>VNES&G8TY#
M&YKMLS?S+/K;(A6H83HZ UJ;X-H[;8TW,@+IELR&$&8)P'1'P?>;H$!/T:^[
M;\_'_GJM<0OU5 WGXAO9A>>J;[OS'Z!06)E'CXQ,Q4JU $V9.XJP\[!3Y+DR
MC,\=D+ R'7$5WY!D\1UQ"=O BLYZV2DER89# \(2YC]R%=JTW@=ARS[C8P'I
M$YVE[].H]XE&?2&-G)ZQ@<#=VTTQ/9\&YJ_$'D;FX&'^S[C%>#UKA<)*5E;=
M'1IG'V6K%!OY# \_18-,DX+8QA082MD8I5;R&[F6NO[2&OK-./,OKZ/?C"\^
MAS'O7B3G-F/>0-RZ>^V!D6[(?$*W'GJ[L2CY-W(?K+9=;E#>;S^O?__\ZV#O
M&X=[G!=$YCL\&ZW#<2ZO[=5P[62'U_::C>OE_0Z.?Y*#XGJ'\#X['.Y']O=^
M7NS3;Z1^\?-7[>+S^?[QX:_=[W_$VF79UO/:'A"HBY\_K';6V^"0%,PA4+<#
MTCEVB.6"84QI3KA?VV1R95K\+<4V^-C%5I<929^JH.I2HNF#BZ9B9R0S'/05
MKWE4VF)L#:'81I?#7_FLQ;"G>$2^C')B=GR9#IRTDZVBL] 03S^VV_X,F.A6
MR_\)7S>:12@N' /JK0?TK?!V'KQM7,7;^M[6#YX3&2*)B"H1$&>8(D6%1S;'
M0@2I!-5D.MX^D\'E,>NI+C7>WUB&]?%-F_F&NI/<T]O(/;F+W3]RM[-;+<KO
M?Q6Y -T'!+O=+V1E>FGIRN][A]\7CGU_43_[H9SE1*3^]C%U@\ZM14I@C(R/
M(O<"6V?SU.1P2JC T.\[5(V+VC0IFK9W1XV'9_34/H.C8I2Q6YBFBXUY9$58
MSYJ7&W+Z,NW(PYI+&0S*>)F22^-$[S)199A#4]0)2JG0Q75&911NGH/LR6S<
MDQ0E^*L$92HQ*9R1E?F[,']?_'!,:T5UZLVB4RB_,0CPT2 1G6(:L)*H>-V'
MBKV./AH>*'.<\EQ'RXW3VF !<R;I=7/Y';X6,W)=3G>[7)9X&:O>,5S+<1";
MGVIW#7UPP_-&2[> DD&ECJ&DP/GC,I)X;"KR=!G@.:I2$E*QKY3K6=CU!G5G
MIOGY)OQ,R35T/4]V8?[1J>[P.Z>F\DW,X9NH_ AW^1&6RN;_',K.4 =^/-OO
MDEEL*MOW<UMKADMNU=6-TKQR_)X?P'FUB_=PO&_4+S[S^MY1XV#OY\4!J!/[
M%_ DZ3I[!S^OFU=J>T<G0'XN4HVE.MV!YSPDNQ__:.[NU9OUX[^.:Q<'/X$,
M'=5/ODR8L^M[AS^<B# /!+A/\O]SD@>4^M$A0Y1T-,]M%&QMD[$'-V)_*G/V
M2G<QG5'@MD[:\# 7!8D!S<6T#AOIUVL]S^=IGSQE$)Z[??+R@L\]3<53-;&=
MT?25!Q=][/= UZ\0[CX(-V% /DP&9 *T/T<R2(4X)P00SFN$B02E((_1BV1
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MKU/ZC F%,;,YDBH - N1'"\F(JX!L"D7\%T :,[7R6HW[YA73I_9*53A[>O
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MTBPH9[E37)KH-#!4BD1IKEV<WW"J0?%A07'*)Q6BH%8JA9C.1T64C\B:0%'
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ML/@I6X<U?:ZD:@-M?HOMF)K]XJ?=[Z>@0,2:0N,4&MLY1:X4 >('B+8$$JV
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MUB'873]C=1(([M'A=M6JE]S6I6$1U6 1LCP[U4%:GA3FV#(:N X&1$9(3*A
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M--HX0T((F JGZ7*3<^_0<:"6]O>6]GL'VZ7&?D7:$R.R?A>1C<:!M#<Y$$_
M_/9*,")93"*MHK2O>7?U>;=FW"4R;G."<1UQ!)C3(;#3".)1&F0<HR@1;J(Q
M)EIL:L:M&?=^Q?!K[ET.]YY/<"]-5#I!+/+"8Q"[.B(=7$0^!>VPQ%KQE>?>
M.D9_@X5^6\O4EPY]]0G[%8.HQJ2"41^QK[GTZ164NNKZLAA\?]+1G^U[A15'
M,42#.*PN6/T!6-WQB+4G@E.VL47J'/P5S<%? G,^5"WAFC_OP)^3KCFJ<*1.
M!I1RN7*>C$!6@84?I<8L:.YHMA'J6GFUU*QK>S^8X7[I,Q=[.]_.]K:_@+24
MVH+!KI048+H'CJP5V71GDA&FJ$MLQ>KBE8&^7_K6M>+HU"G\&+UZ[%DYS:*9
MSH<<MO5OU_UEZ^IIU;'[AB-#.>;WFLFK_#M\4O51LQW 4G^-B"[5[$<_KDOO
M<5R7_/P@IXQO!1V:0:?:,M,_W[<+VVH5I_#03N@5@ N][ H)1;-= %84Y5(7
MUG7^B:_*#^ ;J&^_%S]]!83XN6@!1A3V!+9;OU=T+\ "'I"ZG9/B86=</O!U
MLP^D]G/08'O_S?LG7(*BWRFB[;9AIV=2#4E=$A78,_JR,V+^*P>8X4M%M;\Z
M[=Y1\[17@*08W;U9O'!6HJO(2F\[W:(SR/_O]_JVG9<A>[W/;#=<E->XS*\!
M,9UUYK+.ANWELSC350DJCLN7,K,5\/R2W6HVFYO-@+(6Z)6;C695"QALI4AU
M71G5IR#;!2+UREW7@VV:+Z/\U8SPP(L_[(B*)6@-DRUA3P^S+3.Y@5_]H%5M
MZPK<0DXQ@WM&&QX>L5D<'#5[L.&!^VVK^,>V!O&&QQ[!<UV,[<MKY:[/WP8^
MB+U>R3-P?X6C@"-M^#"+,.M]IQMLV\?BK-D_*MYN?_BMV/[PICCHG#9]H8G8
M+-Y7DJYB49A#.X"0:P*S54+Q57$&<VB&HMWI9];K?&T#5>%KYR57]D9L&4N(
M+I\T&G@>PG# 0W%Z=;@EET\/^@+F7SC*LW5!^3CH=J8*)^5-U/;-4]C?5Z'>
MS@3["NO]D6W#EH!-D&RS.V0,V^]WFVY0J6* ;M67>J,]U3OM#/,XFZ5L@ U_
ML>%6"NV*-P?;3XEPEX"R:G+@:24FJ)/SNR2,(TQ*%14Q@7-M#/8I)"U)"%:9
M:$J7!!NY)-BD2P)/>B0F'0QO =FW.[[YIH+C/TH,;L3^?CJPW[?'..&@\X?-
MW[@UM0"OIX>B%?_SU_GAIW#J*)>'QT?'#;I+#G?\C\_'GTGCW2X_/#@Z_OSC
MHX#O?X?QMPX//M+&3BOM[VS3QO87:J0V,41$<FX/Y]0BQT1$6"J,K2!!2[J0
M,ZI>^359><=E<%X29$3NMY X1UIR@[R@T7&- R-IH9474E(AN&8*:TZDT8(H
MH:DBWD0K.;O%#5FO_&.MO(>EP8)31(6QB&.ID=4AH:225I%YSW&]\L]RY5.@
M)@5+D0N& ,\SABR/"D494F)$,,'DQE:C,^5+OL,'%_Z^,S!>:V_$K=Z(D659
MV9/7F7=#*C<&)_ U7_V=>;'9'MAJ'<8,P.$[.-U4V8::MK#.FJ%_- HXC=U8
MN?-?X\M;K.MU6H/^];=,1@B6;482/!<EB9R@U]C/H^ZE9?PU(M>-]ANR.53U
MVK;.['EOXY<K4P([#4V0<'+VUTXRI0>;9&6RAVS"E4O^>@#6>[>RAO]M5V8L
MQ5$W"X=_-3E+-CACM.*@7U)BJ/$X. SVI[-)Z"]J8^N@M%K!X'J3Y4H['RRT
MTY&@Z\-$]PLR3?!0)1IDI$H)4%DEQ5Q0:DU,,8&N9'U*WM)*!L(],6QG00-?
M=E0E9GU@W$BBO=0<E&B 5"4CD1<2=<B[$X7.%0$J*IMXELPL:0#XI#7@M(_<
M"3M3;:ZDINM]?WUYN/E]N]?O#LJSRZ/H;/_(]D_LN1O+NXXA8W!&O7YG=X@T
MV?75;!^<Q=8_<0_&=M0K5^4 QOA;J^._O3"1N7?PY_?&,>C)(;'$(XA+$>"'
M-0&YE/+!!Z.HD+FCN]\H(B@6IWG?=0?Q6F"\NA,?&QJW>YG!]FS7'U5.*D9>
M%7DSO;H(UXV""./NRC1T98T=_VU>[K$QK]6K?!,\Z9]F9]!KG5^Y4KI\1T<C
ML^]T9B2C*-%CAONUR%NX@#U<N$=3)2ZINBJZQ)SK?"6T43'U,$+TO5_T2_8N
M3DK^+D!9'@OFN@BK\_I:=_)4(CSLX\K;>*$U=&'Y<CY!RY[VXNO1+[^&9N^T
M9<]?-]OE:,N;?CVQW:\@8(>JQ@P?;_F^ZO)0[AJS*23)HG=XBGCXXJ%4WBRE
M\D2B0W6-ZDU.Q+67\2:YXS7!^)WNO&FP1&UJ3M=DL%1L<J779;!D4THVUV.'
MA]4G5&FBR@#)[+SOE3BG?A?8JE)! 2;@1:V<2C"5TG?#;&\Z:]/MG$VFZ*W(
M\9HI++VF\<6T*-JY#%#65*JH]'O'#V.^[>)CVPY",XL34.7!9FR&,J+UH0__
M5!H#*"'#"I?PA9J$%0FW2V=)ILT?H(L=@"Z6M??BIZR__WQ%_1E7XK.H'ZGO
M5RBY_NAU([5V+D.E_QFF05W:/4O:4DOZZEV+G@R5J1P#SVF8)2<5(\JNYEK-
MEBMOKTUNNE/QH"6>]+PKB9\4/N:J.U-3=GF4[?1*6#[M=G)^6"]/)CP$?9=&
MTYGG&U8.%OZ_11/3YY__$YWKF'/B"\35?(K4<>93(H(SR2Q.+A!F,*5>DLB_
MO)\50I\^SS%LW_9FB, SCW <='Z[XA_<&72!H T8"Z&5-_"9'.;8_?'Y!SR7
M_G7<^!&:^SLPUIVWS3WZ\>SPTWNV=W)XLO_N[V_[.X?-J<,<!XWC/(?#=WNL
M0=_SQD[CV]ZG]S\.#WYK?3[VYX<PGL-/?_+&R7_3WHPFXDX*PPDE2#)"$3<V
M1]P-0X$EK)TFWMFR1\*R3C@O@L++*X&X0'6X=<"I):LO#U!C;SWDZ*R&>C4%
M%Z'@=6G@#T*]!?N7/O69RN7+7J.UDXE*):SFU&&7B%(.*X#NG-X6;I.]5Z-R
M'WL1:'5]\[]^Q]TB?9]/^X]'$L#GTP)8V4AQ/D")I4Z(L^"1U<:B$)U1Q L?
M/-O8NK?XG8TNCR-A5ZEDZJ*XMMPJP\^O)-1Z^@+6BWA+$;+/M-S/G"1<I*:(
M8 #"SG)%:> $3")&*18\2D])C#Q>+V6O*24R6K^_ $ON:.?6DG8Q2=N8T6B+
M64QY5!&I0!CB42BD$Q<(,T)8H#8HR5>FELB,<@63:9;WR"Q[@(ROT6;_X 'A
M!ZVXG\J*'9?J9J_1Z5_&2+9[PR#)6&[893QN/[UMMFW;-VWKC]@M\Z;;/FZW
MP^7'PR3049COQ:>%P;B^!!<PIM@@I65$W#*%#-,>)4,TM8+@Z/%:I(4U+G*^
M<E[6Y1G5"X='=?[T\DAZ/N%Z]:SBJ!3!>%Y8)Z4>/-F=CR65C;V@S-NZ> 4\
MN=T;2@L0O)W> #!\L>RDJ^E$64@./\GN+U/%/1\U60F$X2:NK,Y%LY6$VC3R
M;MDO-U]C^@&RE<RFE-=?7JW!ZDU"UFFL<S]UAEXZVL@@@.)J?'-V5@(U<V0E
M+"E2O_9Y(D^<:F/6E&P'1]T8BTJ_+W;;^>A[F0A=,/)J#KH\Q+;/90W6)1EG
M!5()%__J6B8AS-Z^V0"8QQ,QSXQ?'.7H@S/X X+&R\T;&]DEQ4^M,@?R!I/D
MJ5V<:\DOLZE>.A)>99NMSG&J<YP>PP7L-:>*,ZQ$PEP2HK70T7DO";8^,G=+
MP9 ;?,$CE^]^>R(!:N9IR5M=9L_$*1R^'69G+GW//M./?'_G3WJXXT5CY^/9
MX<XNR\]HG/P)U_X^FG0*-^A?<-^?/SX?A^/#@Z^\L7/XK?'C&VX<_/9M[\!G
MMQD\"ZY]>IOSG_"D4YA';H.4&@GA+.(A>&2\Q<AP1YC)_X6PL:7O[Q1^\,2G
M&@YK.'P@.+0DN<"L\(!U7-MH<B**]S@YR0*-XNY5]FLX?%(XG(J1F619"B$@
M&3W H20!6142$B$DK%*DA.:&-]/I*.N"A\_ J%K#A-6;[*:9<98Z"_,1#:27
MG7^Y&G;!A/@[N&2*JVTJGT\#BT<2<N?3.K^Q3+!@#4K!<\0%M<A@HA!+6G@+
M4LX(OK$E[R'CEIAM63/QDI.HEZ#,UJS[2*P[?5PI19:HEKG=3$"<.H.TC X9
MS9ET03,J*.BG]VX\\^ ,_ STT)5.ZYX=><EZZ(7B&;\/:Y:/::9/[;5_R&?,
M:9$-\XD8;/?0&>3LI-&ZK*WK9_9FN*OK9QD$6A5I.ILR3ZL2YU-*P*@C/AVQ
M:>;2S*.U#%U AC;>3*N_.%=4MX8AG"Q!G"F"0 $*B"D99:Z';IF:V?/TKCZ>
M)3#,>CC%:^BLH?-)W>HU="X5.J?,#VJ(<IA:)+%SB L,YH>R"F%)A2$Q*<?E
MK,.:SP8Y5]1L>9B#,D]T,N+:Q,8IQ"G/2KS-[9;^+MLM[46;O><G5;'JB:G<
M?9X/>V HC[\<_MCH_X#M[,^KGR_[4,_V%Q(=]DGXG)R@X0<'S+$>T,=YX;,'
M,_?:G3S4\Q2'=F;4I>S&_PV:Y;&95FO\%'59;;G3OJ9\<[\S+*E<-:P;M>.#
M;7[96JQLD!B;.?!1MJ;K5^6AF]8U6\U^\[*EG;.MLHE>[RC&_F;Q*9_F[L?N
M2>X-F*^/=2OKI,FBTC>/<]#+!XS*AW1A2Y]UNM_*LT&^VW3Y<-#Y5-5HBE^M
M6&'H:]"CG/E.L^=;$_&X"6A]BGU6_#1-UI_+ 0,T]9IYL8;+$@'!3JH#854I
MR[-8G'4&K9 W5\S+F:N#V_.\X\HP9(+=!#?VKJ[SL!MD-Y[F5I+P[+(O9-F5
M$4ASFOO?CO7*F/8OY1H"O5?PR+&: L,.J;X;0[,/.R=7Q,Y-%(>M)'T>;NR>
MVF[_O*QV/FAW(RQIYH;2735J@E&M5-G6[ZP]_;B)6\LFK!>WE@TD/2@!^8%Y
MPIE1>F77R%S7<]!OYKN*-#IS69QT0FR5_'E2[95[<$_Y\M#)Y.QURG<.2K*?
M#LHVGK8_ZD!9_&_0R4MX"AMN6/J]UX1M9:]C_+)Y9OFZ$]O]!E]X->,1S=Q<
M,BL_Q3S/&SZH&E<^ IC/&U8O>55T2A":;HE2MT 9:X&BZA8HJS&6)VB!,K.5
MR:VM229:F20=,5><1![@9\):> 9J$04;+%)!R(J>9.XXN/&?DHQ#;,OH,VJH
MVQ_'FO,2,(??*D&S@JRJ%6OKO#R?7#:T@&7M=EQ>VU+-@,\NWU)!5191-FL@
M^:O#9NSYS@JK +TS^C]:)8"9R7SOVQ>' L>/^P^1[<(J>,GJ?^/'QR_<PXU
M:"0)'3;&T\8%A#WQ8!%(&PF>:ONC<8S6$%#!&8\QZ$2$%TDFX/B4G)DT%PZR
M"MMIM3IG61QG^3:F.??FDNQ#T5F>IK^4G:^G>X,M:F#/W1OIUDG?_KY'[QRB
M!;O+67RF-X52#]+?XFXM/F[I;X'QPS3C6/Y@B=PT:S58,M^ KCGNJ]?GN.^-
MZ3^SLSL>Y3S^C;2XI5/1BA[6_VWH,OF072:]!_%7R$TQQVAGF$;9X8W8Y@R
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M\@P(<$KEP^BA\V'4U0/K?+,\K_Y[N=(DZQ>4D%^+]Q6C#%?W<M.<Q/Y1)\!
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ML:?&GH?&'@DZ.P\T2,43)UX8P[%TF#@*VKP(<6G84]MC2_%=9SRZVB75.J5
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M&K&7@-C+:FM2J^ /".?3*CC!-FCL-))!E:72,7M5##(<D\0(==;XK()32FM
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M*/XLRG0$\D>QY4$Y[Y>J*:BXV\VLI30'L#653O)I  \6#YH>=-AS\^,QM7C
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M9%3R*42<QS3-'T-\-]?>W?CL.3!2[?J[5]??54/R[K9CMQRN]X1<%Y(':6/
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M;_E,>V?T/]*RTIC^?\LG5ES*'[]7<&6+@U;7@5'5/P7 \2/]SG?;;=#N /]
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M!2=)8LW6"K"L0+T%DNT-X^,1\94DNW69%"V-]E*'+JW[,36<V[OIC-C]B#)
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M&6Y2##(Y/7:+H!?+49EKL&?"4F4X]L9&L,&D$S8Z$4VX9*ILS5%+YB@\S5&
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M#81HRX_\9?.#5FG>XP9-<(<V:'[=WNDH-6.L%$[>OI0JHY6>S3.?LTJ077U
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M"8KSX ^,D1/:(:?S.!VAF#6Y$;'6EP1F[XU3\KL+<LR]C+JF2Q0#<]'O":'
MW(D\.&IGE/<TZL"CT]I&XG+_*.^EUI>TQCM'!#8-"!_/_+Q?FH/#]^WC(6#
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M"+9AT]/!../T!LFFCS+I*^)DUSG+-Q6J.E/Y'C/''ESMGD"57U(2]>*5>VL
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M^+N6'!P;?=!_UR^&\/FV7Y_:KM_&KB_(7P\SPX71%N0IR0FG5A*A+"-ARE+
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MOY&M7D.P%:W5PY:F/9Q,4Z!A:A>M%9NWW[*+/\FLM>W5)72]@3 YQ_4;ZO_
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M\ QG?J?WR<_[C*&J;='-;=&"FGVJ8\$3$9-(:4MX3A.215(2E;$LR>-8)K$
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M>Q-%]R:6JD, JZNLRPH!U,JZ5&6=@P*QLC9-) ,]#4%%4VN)U(:3/$QUG$I
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M<TDT_(=PSB@1:<Q):)6.+,UD&+.U-PM\]XH<!B<Z&+9,8-N#8AC\9R0'0S-
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M(\\$@7V?$:MX(DRL!=?I$E,L:F]_!55T&?SZM8HN2T7GD(!);<BHU23B!N!
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M;958?:4T?(P[YW'F-H/^^>R)PV\/)YXKQ^A!:V!,T(#OM8I@NP<P*AB34=Z
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MHI ;D:V]B>G\%EIUOT$Y@-VR*&"!)[/O]"LOYW\=OW/>:JM6((.>&:Z2;!R
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MS_FEY1!AL6%A@Z'L!CY 6[K+XT' B-J]'^AO'9<2X?T3^+#?^>%QN'NQ/DZ
M#^=4GJ$?9EZV30/9Q$=,N:BW?;)7$"^GU9PXE03CX"8,L[? __('&FJ  9*K
M^K@^;0I1"]#+!4=+=L8Z+C5<U8;UE*5/.N5WWDPW[Z%<P7MGH;P0N@GP9Q#E
M/2P&EOK! U,@N#O^U88%:*L;J$T3S&^P,PEN3L+=;LZN!+R?B+S!C1-GSIG.
MD79;Z&29G KZ$2-0DBYT /*U Y\&F5NS$?IAL,V63N=FKX?[VYY+4\1UAW7K
M!B$E__/"[:,+?KC-V&W\#WQTXEK8OX-Y+SXY(/2J3TDNM[_GF/(=YRFQBE+"
M,R&(3&-&0A,+PY1-3)K/@GT9\BS/>2+2../P'9%FD4V%S4(;ICQ6LZ<D[S?W
MWP:;^^^"@_X9+"F/Z7HPGX/L976A-_+[!UX=8!2R*$U%#.^6<&9R&:HPD3JD
MTH1QDNF'D_9;&KJ5L60>:#B^T. *R$5-\6&N*L*['FC9!1P!VURG7Q1E'O6O
M0/YZX!S<,:*$Q?+;$1XZ5 _0L!7U"L"LN2Q\>+0%6V9_X& 1H' ,%#M8/ZCR
MJQT0 C<%_ 0$^=5H7,A\T,^=<^R"\&#ANO[8P+$SG;?Q,>?&W14>68;!_$@D
M0A]W[J$W@AT?UO4W&!H?)!_?&Y^'D649N%YL[EF]?B"["**F,RK\G^&;+NZ&
M,+!S,3WA#@ "0NB.NM7594#97>F<.9\Z/9Y"[Q:X6/G\Q/M\;YA;# E7V>9S
M\SR&=U7W[C*>..J-"MR)7/B^BO27KNS$G9+%U6J0U="GCV,7BE3^,^:N51GP
M?Y0S\N=3JIJ?MU(\''I0WAVX $O@_PB.9HDH<&VP8$9>!R_P#*1SQ5>\M5#(
M@9EDYOMQK>+:[H-3ZLZ[RJ.91="ZU.AB<E0QQT'U%$N^>%?[_2YUC9 $U\C'
M%.B\XA1LS$_#_%G.\P*.NWY*!FBH</NY>MXR+JE9O \$YV#EGR)I[&,?6WU7
M6_[%IG^!S>$[.1C@PGZ5G='S2!)[?+QZ\H4V/W]7*LYA [,DC8T@W*8A$9'A
MA$4 5W.C0ITP3&!-KL]]EM<5X3@A>8HTYUHL[B,6K %BD<7<VBPGVG5RAY4@
MDIJ$@'KJ.%(&_400"S[?8'E&+!872)19!:[$;E(55\'"7Z-DG]#C0=>U57.S
MF[4/1(\/#::^C'L![':]XH<\=J&H8C0X=A@9K&MK'*P%6.!26L;)"8A32WN)
M/W8&1NJ+P(X<'5"5+XTW_P]\Q6<H3"5UX/>"/S[OO_^SPHTN4\=-B(MKN(SJ
MMBI3,UJ3+.NISP!)MG^ E.+^!)>L%KK8]?'/,N$)CV>&3QM:@E5[BBUJ;[QH
M[V#-,+L4_F][LG*U5;J158+GG'_G7 B:"TV,B'*,K41$9A$ES)I42D&1LW;M
M3;B D7:%-ZM:0)8C(&$#!,3DC&+G7]BK).$,!"2SF2(LU4ISRQ7/$Q 0/M]3
M[$;;UD:PM\+Q_??C^/[^Z.S,;S2P.[TM<RCW6P8\]YW):<636F-[[2&*B\[H
MMG;'\V64!MRTJ=/<A:$([3/.KJV"Q]W?K>'+#?Y_F^2RH8CBGEM,T-7,:7B)
MA.![XUQ,-WD^7E:XLC28]G7O^TUE1^28 ?K#U2EU.AC?.I.P6'*2Y^UPVP@@
MS516PM6'EYEW6..T/BT%9<"Q2NGPW99\_ 6?,7-0[W&3/W"LCOL ")8'?O!3
MQ1=QY7R]/.5;]Q#*=OKGXS.^F4-[ERU]X0]1KIX98I(#IBZ\8%G:Z4VM^3_
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M6<PXS1-KB#6I))SKF&1QFA%I1)Q9(VQF8LQBWYCOD79+4[O84CPHX)IYY)T
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M$^8S=<J5E6T:OL>R"^&^WOAFVO@)S!Q=9'YW?[6/;NJ<G>LIHDN:*-PD!OP
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MP1-JG0A2>C"%J"-,"N>YL0(3GJXZ*-<"WEP K]84.X68J(^(4ZL0=TXC[7U
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MEH=J)/A<)$644Q*4![11N>(QLQPY(P6@>R),&- U.;2MA&ZAIX6>ID /;$X
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MF+!"DD6P %BT2.M$D @V$"$")IYD\O_@34Q;\5\L\5<L&D$MEXIK[FRPT<J
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M ^'_:$;\2"GG<B@0868R^H.=: 5P19M4, RGZ#+Z4]4>EGG"P@QBC)DUC/N
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MTTBL#%%;7.X'2FB['QYF/VSY+T)(&H( HRZ?L.<R160D28@JQG4$YAL=AOV
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M/@CQR:G?6[+A#Z=!UD'A8K%^&E9\-*Q])!K LI>]=+*?L76K,!K%L_ZVF=9
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MVJF,I'_!-_W_;^_+F]M6KCV_"LJY\YX\1='<M-G)K9(EV='$MAQ)SLW,/Z]
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M=WU[VSVRFULSI=#NL"7?6FPN*(4U"6=NL5)8OPG;)ZW3MZ+F'1V]A"!8=/)
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M0%2DS6H<AN^9THU] 1S%WPU/QARY G0+ MIS;N%(_'07%CK?[M3FY0B(IB^
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M3U6FF)$L!"PF#=*,,L1*R6'%)E<'7MR4XBN$KZ<J!G5:$.N0,IN'\D@HH:E
M <'Q\JB@BP5*)\-HE20LY=?B/V122!4MEJ-[L."!C@5FL=,7BM*RD<O+2S%:
MY/.3,\ ?63"6I00S\QN;M#@G%W2K8]2/#,[+O%?8K0MY7-N]_*6<T:@Z(5K&
MBQ/XF$ /MVX\QF0T+,'C-$(5A8SU+BFB?AGAP\.C9ONH]^SAP\/F8>^X1J,N
M_NZ@._^=M=N!@\[&HK+;\N2*$=(5#9&-FG1<I#9786X?3 =S"ZZTU7:"&=)%
M9&[3X-JTA;M#]'.X/!=@^VAG57M\E17/S:+8U9U;)6!O.?ZORB1DMQX:U9PD
MF:[BWMLA@OSM92WW?\W/^EI?LM?V;9.EBFWCS[6(0RS+*EM"&;73[6X$R 3,
M?>+>% Q6Y/KC( H(?""0!:950;!GVZ26LPU;-<,QGF_]YKJINJQ6"V\W.NV#
M:B/@.>^)\\BMF+GJG6>\MY4D6;^CZ1XT3^IW,IO8B54"@DM#]-,JD.5P+X7#
MM0Y;];M'EL,1AZOAR=25P]5/PZZ%UOZT[*&-GO:U2 4YJPE?A>%(*7*_-"5M
M$9.HV(AMX0/=HT>R@05IN^OBP=N[O2>/UB.?9WOKRDB7KG>NMVPWZ:/;W@Q]
MO)#M;;>:C[6P=_O^U4_IL 4"]DF;9/RSB":/\3=O---VKUY(,#<?_\L=3]Z=
MZ@3,U[N;@+D<>K:F9S-MFFUB\TIMD0ZFVDH:/7VG4'DJDYSI<E*^]W1_'IEH
M[2[ 4V+X'K/$P)[: O KRJJ?3E&7VYPRTY2 IT7C _FU+ <H=GZK6<,CCW&I
MG\1*$6.SB.3/7X(0^0.!VL=4&1./90<(N%&N?^=&'D&]5G70XPHF[)0A >_'
MPHW@ST$>.FKS)DG\+X&5,*Y'-2HFA"FRO6T37VI=M>"#IO0Z*@FO)\NNPRG9
M%<;W2T67/:$53LAE0#Y""H;M*SK,S+D:5&:(,1F&$(?#P.L)IQ!,!+Z(S^#>
MZ(<E4:_[\#5P=N<^H(8/D8+U1I@^*A SZA 9=]]B!AM'UCTI[X9M;&S1?^LJ
MTQ_%&1>=^A7!.,P6+NZNQE.N6URM8I$V:;9N4>'-8X<@\4.V9D$D?C<"+D'J
M-=;B3O($F"$7>8L[-\QYE&(\^ .;X6"GPG<@*0;,^NLE7$]][G9 S0IIMOBO
MC8I8W%O7&>0)'8\!8?NB++O3<9QDP7\8Z%=>WZU>_TXYO4JG(\JGLVG+H>SU
M,MJ)KM#BJ=Y.J]KMNM'^2D) N)*?(N&Z<KH$!P'J?C0,\$]L$8=&0IK&7D!]
M5G1':>P.@YV]BK;?+\N=A;H>\ '< _@S!0G.J@W5;D@FZ.R]%Y$ LV>'W3>W
M,4&1#"/X3:FU$O)'-TBPP7<NC.9W:M>\TJZ%@6QW16 H.&+BR_YX,&@R9-WE
MMW9']T->VL*^JEG>=3U5FR\Q&,GOG?_ZTW&GW7[GG!J7JN&<!^3FXJ[6N+ ;
MW6SRLK#D-\I<8$,7]&L=!!&Z\A (I^C<BI2 /9K0C>=<PJ><5=&FYMC86?.2
M<?^#U/D['V[X ,>'/0FI@RRV;FRW]O_..EBA&OH"A@U+C:$6$IZ;)$BS-*E=
MQ8J9ZY#/DEQ!-YW)6[9W!F(WR';9XWQE-B#N-(PNF>]C-_&1[LX#8$%9G,"%
MFQ 6D]^0?LJ2E[I!72WO56 G*>TH_&Z8N&-G#]D4<:7RCG\-W>@UZS%SOG6H
MVWG&$'3HBA/ #L5='%+W2?E2V266.U R@S :PV';V"A5*BM[Z:CSK'R5\%4'
M+UB_QZ]!N"JZ9G,:VZ8RA!-B>PYX.L6+3*H#\?HF7DX'% I4);2=UJBK63EG
M[S?*3^<PQR,E1L?80E%J8*=1E ,9S++&OVVW/K9PA[[F29J[4<;V09"JRU;6
M'LKW4>D1Z,JFON;H[6"%%D;Y<'KSWCF].7-NXPE0>Z_3:M2+3K%C8H9FTGF0
M3N(4COP,J>"J#\=11@7>",G&@YIMUR9WX[=.:R4]E5H]*N5E >WN*VW&U(4[
MO=5TX2)9039QK==!$17'@R*8!(JCOU%21NE6KSUZ2O'W)K9N:4R]LPJ#1N+N
ML<13!"YUE&4WXF#J5Q5^BTZK?5(A[I4C'=TD:=X'E48W H['DU!D'$9%U1#$
M[K@O$GZ5ZGRSW;)V+CE6HTQ>JB[+RYR]!E0BO:PV^L/JT)'UZS6H=[\.;D5B
M1& &8&9&/TX2WE"T&9X.J3F+T/+J5X-LGIPTCP^Z&"=_ L9FK_/\+?K:O6;G
MJ/ND89?!8:X,,?FXR:Z,,[H]^?^9SL%0EZ#' +#E8> 2\-]%"=328K23+>UA
M6 ?HQNE#.:@ZE#+GV 6DJ%^"?+BK.[>3R(>_%@5K40;96LL2IQ6@^NAG"Q <
M2ZWBGNV\+%Q-K0MH]PX/9C \G_.N_G21MH5<LC2\C(8[1R?;0L0[(+&W$ 'G
MM-+^?V&P-YWFL<6%L+@L<_>LW;; (=O JU\2QD/M/,GH;*_V)CN^4%G#_I($
M[.7)PPU5MOU;^V0JT(2E%S*B-!T]PJ%@C/ !M@MSR?(@'5&%!8:>NLW.T8'3
M-T8I%W"D(L))1'&&11M%$].)^Z#&H#P?F&(BQD$^YB0;RM,%G2I4Z6KP7![)
M;%W<"]'/G"#%7 A/<-EYJ5T?_K[J5.<RFU]UW/)H]-2Q,"5/XGU?1/$XB&C7
M^W'DZPH7STV2!UD2&BBZ1<I(&\LHHK/9D.B'4C.\F7@H?L4CB'FAE,I 9IQG
M&*4D*C*IBT*8W>:12J:O;=+KI^#?>> '&7<9/',G^$L,S5(FVF:S6>J7 D I
MPA<Z11C3SQ/LNPE;9J0 \592AJ+-"C:R#YU$#-V$VT;G";/-N-BVYX_>O\#J
MY5YK?O4RSC;P__)J>3UMNW?PRM8\;V(N-:UYWGRZRZW[P[DV/1K;:!HLSH@'
MGB@& ZZ3<3)8+ZD=U#]:]A<VZH51SE#*K4@QMN<C[$-\_SSY'L4^;%-7U=[A
MT5J2* Z>UJKTUS= I<FNG)ZR/=Z Y5WF;$9'G39]5],5;**'3?1X4>W.+AZC
MC3PIU+2C;5@Z)\V>;<.RMD93+YRTVI:T;'RKID8LUG08 !0,4H*>08P$22&2
MDF-P 79/!6)EZHZ%PJJ$<16L!)8?&;5U*J !O_4R,P"$9;K!)).5V3*V1*78
M6(<-$T.W?^;X 4B\!$-!/$]X@M<P:Y=3S3B!WA#@%WLSIV)2ZD6ZU&I!B6"G
M%#)2\P8*\A*1\6N#3(Q38[4&N@*5S:0@AN%Z[\,/\@1+&I$4V*6[R@RZS^B
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M?*^X'[07H43J@&=UN&=/&HQ5#]ER0J.<L%/>#5M.:,L)-RJ%%"+KZRI!8$@
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M; <OKN?FU/6D=*>!2_S2"RWY\ +R=5(TD;'712HKHUR*>0K?1 /5B,&X,GZ
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M!8%X)Y96HI!M%;KHU/2X(E]Y5W7Z;8,U1)U\SGAOBN0](7PJ.K3JX=:0(4,
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M)MPM$YN AL*;M2"+L6@<IBK5$ZQLZ7&*C5O(,^YIAVG."><X@-:3Q0U.C/"
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M[$JR[&'>NXU]'DD>, ]W$V,00EF;DON/,&!4T^2GB"0>B]':;(N(.6LM7D<
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MT;\A+@M@56V> +OA;<'T,,FJAE4<# GM4.C$ZCN/D9<9/3HX?)\#<Z5ZK4[
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MKZ<W81G3(MJ&%=]-A]['"LV8_W)]P]M[)#5OE#5Y*Y(H$K*7M::,INYH#$5
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M A:-H).X#D @EQ$2=\B4BB8VGRRT!LIQZT@+^7>04CD#].LX#*>W-\*9%L^
M1A),KG4(.)S,.JKT:O:8<YP@LT)';KW_B9)[^B/48 ,B:UX_M /,XU:GKGE;
M$<EL&\"V0CF5DP&.3(**40,MF1'U-4U!!2M2\YSPM9M-8[OO=_PZ^Z=)+X7L
M;382;*9W6B56&Q8Z#^AL%"60Y6I:-PS>#-EW\':T96?%"[%WW+15])<994N2
MD*+)H$A4X(*)P%0,.;%L#6L=ZN@BMK^]_-Z/1Z4_K0',7B[*"Q8EF#1K^B_)
ML"(= 4->89WN0_M):S/FYNG/_B9T1T%VT2VM_Z6?<9@GM[MKU#F>/<]=<82.
MEJ3)5*(# ASS#-#4:3"LY!!;!V/N@?/L26\EZJYZH3U4^^IEM#IR!U%S2Q8$
M&38Q&@XA":VBMMDV'Z+T5&N1F^I%<^%W< FPE.<JA"W5H 1?+4I5R$SPL\ R
M<HN\H/6V_>WV$RGOV8?J/<3XV.4]=Y9P:894O1T-9ZW::OJCY:+XC!*BJ(-%
MBJ-]+-<%RLB#S5+JV+ISXKV GDA>^%9$K].9O07>0;;,$J:KK-4-0'64'KX2
MT"-GB.]/W*@KJ1],)4IT660;B#'N0;E(KE_! L9K&T+&R)O?P1Q0%39-%S^0
M)FPC[ XTX+9]^]O,FNHQ582+(9&+8\GWUX)!D,C &#)Q"TNEY/8S5^_B.+RU
MV("B>QLA[B#?#I)E%\+M<T#9.R<*9A!>U5JH%"!F7LALC=$+D6/[*,D=$,?
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MTK",N)[O]84<TC]??)SBYS\^W[+\M,E2)E7 \#HIR'@)SJ8 :!*W+BN1A-[
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M)P[12\$\K_6I2QO:RHN2-FB.5K\>B; .,E(V%UA/^E(T\PJ4KY5K2;%:\)S
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MX +C<;1C&\EWT2JB037JS;&<@RI:BP(LUZL9KQ4MQAG:8FW2VJKDFH_X;KJ
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MO8OF<0S0_5BZA_(]1'P8\E/DKE;F@8V&#"#&:U%X,&"$\\Q%54SS:I)#D?Z
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M>6LQKN!R[XCY;_WA:+R0VO3NZQ#'D]/^YQO[Y.7%[?#2Y8_T(DLFY,Q!>RM
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M@CK,@)]]:';<IUKVRANM48F:=Y"=1J:5SPRD$@SI'2K"IF"Q=8^:/?/E@>E
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M4N]CSM0U/*LN[AT0]13<O8OF0%'=-NJZW7^RC:SWQ (41H$@_PI!URQRQZ+
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M:C^TTY*P%:!'B\ID^CVMY0;L&?RP,I$T:K[X$<PWX@.ZE=^Q [K]E-@9J_T
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MP\]BS\P_[ 2ZQ[L&Q3M4>&P8H8:-I@T*Y$'P;=BG7]H?9!<"7&V#NYZ-,'K
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M#C.9ZSTJ$DH*IV/@,&*-;0][/'T1:+W 3C% *[!6;3_)L=;N"M E, J"6L,
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M%6[0ZS=&WAJ:4$F89\<;-B/35OV#]$SK&_VHYE,YDS?J[4**[=D%EWF.69K
MG,6%\=$(S3(LU>9?CK."XC@IB NW' XQ-C(Q$II%OY'1C3N. &A'%I?!TC,[
M[",2\#3GO/:!".#( (-^\:<5?/F)=UP9RM.Q]7*DG&4"D132(I(09?H#)THR
M6*2,2B:YXIG3MWUZJ+%]XVU)_^6?<1(7_P9D+;&'K_4XN+XNI'\4]]'Q[=!
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MA*B,(>(T@2BE&)*HH# AN<SR-$%IBMURP(\-,S:392-E4Y^^K*J5"2VIS-?
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M/O!SZFP^Y[/7>0:9F_.SCU6UDN+=:F'R4.6BG(NFD=)G^4?]IVI2Q$+;6:R
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M-D_]8A2X7JFGY23+$)<,$>.?)1SB6-F:"#R"V'PL4VD\-B6==KY<!QS;9^Z
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M&X]<XQ\;*Q-&RC^^S&</9B4\57N1$Z*)RFS)+X1X"C&7";3%FV$:T31GW,;
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M<<*($GZ9M<>&&1N9K#-+:Z*VV)$Z@VPS?83#JV?6: M5BXS<)B0ZY.8>?>S
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MG,3SKLQP4],S/W6?%<^TY0#3X^YD#3=- SEE/2XB+R\N#+ -7E_' 0;S$L,
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M:78!=KJ!M7)@H]VF$(H]A+%3$%3/\B.T8!/NQGWO,8T]T^2 ,^A-JZ'A#L3
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M,[,CU.2YL>9[3$G?^SFU>:CK= &V6I6>=5VO"[#1S/S-ZG917K)5+V""26#
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M96;;P<M<V7/%D?GB1TD$!56YPBJ1"&5>]OS18<:V9$LIH1GI"921\?:G"$[
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MNVGA@UG8/0RGD=]C2\,'DA,['%Z/\#>-UQLGFU%L+IK=>EW>%\9'G']E*]N
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M34?CR4>"O*<\UTZ181^US1F3]A&3;=V]:[ZJ?CGAA$E6*@HT+A! B$A M%!
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M8K/9AA8G6'+%N,X!S%-M#ZV:]5Q.(* EYKC0BBJ$7-CIQ//'1D.UBDFEX_;
MG1O1G$*PFU$BX-(S=?A!XDP.9PP_P@(K)?[RL/C^;^;.F@#,7W;S_M3S!IG@
M9XS9S.1SEX7Y&=N]R5_-_']>5B<2/BS5/Y_57+R\7SRQZ7Q"N<I+I!A B%&
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MOE<KR]NY76O6O=QGL\4?M@K&ZGHNOZB56GY7JR^+V>S#8OD'6\H)S" GF41
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MHQ%6&"T,SY@ETCPU&+Y86AA$1\NF!3XJ,/G9=A>ZTY7@W:>_4(1"S"#($6$
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M!!^<HBT?G(0.O+#P >)PR>%U]P5MPHRKLWQ6[00/VPJS<:334M%,4 @43E.
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MN'V^C?34,&K^P*;+ZO3 [?S;\WKU47U7LWP3G"N49BG+ 85E:=PSCLT*"I5
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MN%4U^;8YNQCBH9Y$UF5I$0.OGEEG"*A\7/$8D WD2(="Y^D%GT.DTX<]>?.
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M71B8[F*>*>TJ:/I=?57B>5DU"/ID1O?]XHE-YY,\S065A *2E@@@:,MCE+H
MG*628 :EDE[-$L\)'-LT;^N;[!1.ZB0D)3?9ND_?GM?; P8W;#DWR\B5C5+7
M08:KA+\DIYX5TNKV[,"Y^0PQAZ-G6CF!WE5BM4U^K_6-F<+B"$VLC)5SXH9-
M4'$T_B ?Q?6^,+KZP*;+_Y?-GM4O+[\JMGJN"P9]6*I_/JNYJ#L^$X:(3K$
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M(&68.1"](N\X<3>0ZUV5F72QCC:,4\L=,3IH(GW7?KY[>9JBD49*^NPHHD.
M<K?Z,),?>L+&@4)MP(B\'7\;)YBFQ:<; E9M#<HO(\.B]D%A,)S+6S0A @E0
M&D@'98*+/B3[7'_V0P#R'#T#C8+H"3/5)'^LO_^UFFWY#99WY_.KY7(^#E?+
M4O_]=?;$D:NTY=%J2[SCG$@TE<25:C<=7.8^2<>@-L+V)G*@L1(]P:Y?'0T\
M\/T9YEYW;S"_W+[!W.CA<CZ;H X7HTC!*V.!!"'*150JC^#0"13)4638,1U>
M>DAZ-!$#S:6H#+;3ZJ*!8_07/Y_BGEG<])%Z[1?C.-+1IF!+O&XU*[X 6O&
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MR$*@\\ET0I.:JHRI:KXD9R]-OEB2LX]86R[)\=HF'3#HH(FNNIQ9I529R62
M*\>$V^D&Z=^E)&<OM>Y6DK.'A!MP@F_%\J8DTS_F[BWFJEK)&!- HBGUR2$C
M*1,;K4!)><]+_T3.>SMX'A+3R'7XX8:EKK@;P,TF_6OD&\$YS:!("@GWDBL9
M99L8[B4E-+>.9Z@>,SVBHI$CZ#CU/HR8CI-U VC9%D+F9(*A0+14*)",CIMW
MPI#DF8D1LF*Z^FB7PPK_^L]75K0KAPFX 8BL&NC?N?1,ZB"H)Z*;+DH[8>CR
M6M<*%[1Q&FK7A=ZGH!%#<J ^'TXM.%RX3=R1K^A?5<7<S:[FVF< 8 1XL:D&
MS6E0:!/1^JF(A&@1:A\X6PD9%BK'Z'8K3(X1<Q-H*34CY1$/_O;+/Z_&W_RD
MO#I[M7SCY_/K\?3L;WYR!2/DR2L0DD3)).XG+DFPW!+AA$Y<T*Q\;?]V)\):
M0--1$'CHO5371@NG58QERL7BM]D2RFS/#S,_77R&",@?GN6_P7(MPE$$#Y8)
M30103:1&^?F$YSM8"30(1?5N8\/W,5*[$C=L6%4?:OUHI0F;]G[Z#>F>S:^1
MB9$68*@WF:"WJ)#Z@#XCM8Y0IK*4-F8?:_=OW%Q_6*^Y/FP.EFT3R/@TATL_
M3EW'VU'2*06I.,E485S(9*DQ")KH!%S*Z"T7M1L8;ZX_[/UX?60<+-L&CJ@U
M[3>MQ-<U@O=D-&(L&QV#)"X&3J35J30^#B0GD!",LS[5#L)W(&O8Z^[>4%1-
M$PV ZS[QDE'-<B[C>@"=M\0L<0($B<PEIY/W0M4N7-L?,+T-$^G!CSE8N@W4
MC7V:ETD#R^M2>+Q$L!>G_W)=>CRBS$=EP1)J:>DMY.WJ"704(*-T2>A8.ZWS
M'#TM.,!5(O=J0F_"I?G+;)9^'T\F(YF#I@$B2:I0CLXYL8RB6Z:4UHFQ&')M
MPW*S=@M.;A5H'"3,!HZ8A[-5$<FW Y]O><HV,QL=(X([M(V.HD\FG",&!!3S
M:%FJG<39A:X6_. JX*FNA";LR]OUPK>3'6Z9&V630H@..4B<X6'K37E(IHD2
M@46I6735)]4^34T+CG 5&%42> -6:<-U+U70:Q>-!Q JJU <L]*#6&=B2U&L
M4\)(%Q504[MY[U9"6G"$JP#F>#$W86C64\$-"]:5VWJ?&46ZLR7>I$B8#HF)
MJ'@VM5M0[#&!O;<)4-5OIO829 .AT,VLZW&7C=YL<U_\\^7UW7RWX(V6'H],
MT36C]AC]:Y5(1,/H9?#.[]9';0^ [$I;(Z57=>[!>U%($Y9F@[.'F0CGF0C"
M1A*",N6E;R+.&44X[D46C8\AU79IGJ9FV-O-?O3_-,B.4443L'H+X?;.S%*6
M&<L)G7N-QM=P2QSH6*9J@V 4>."U@_&-Y9L!SE$Z?>07'R;>)K!Q<]OZR5^7
MV]4;/L!IDYSQ!'WWTN4P"^(P.L1?:- 2(K#ZSLY62H8]N7I"3 6AMP*>^16N
M^TA*(QV3M#9GHK@L;T>#*#,8).%*E#+(I!7KH6!B.S'#)@'[@U %T3>!HBY,
MW,((1H8\"9Y(3K033QGNP@.ARCGI:0K>I\H8>H*483.!/2&HAMB;P,\6'HPQ
M+O'@2-1)EO:K4%X$40)1R9@BJEW5;B1V(&IZ2_SUA)HCA=U"/#^;GGV%^45Q
MV[J2QLMQ^>C2).=CF(S/5G.H1UPG&B6RH5F.J\<9049.-#IQF2&3)E0/N':B
MK!F/J,?@J[Z*FK!4CS+H&](L:73@&G>?]H2BQ262<2A/H!-AG-FH3<C&U#9;
M+Y#4C._4']AJ*J65NXU-%NXR[[E4NEFG"-5:EA?VHHR"]827NQHNO+.^E]X]
M6ZEIQJ?J#UF55-&$Z2I#7L==\\%%-UIENAQ/SV :QZ6FDG*5=6;$J%*'+:0D
M5@N#_D 0$"SZD_4?83Q-3C-N5W_ JJ6,!LS5,Q*RD(WG*A*E1":RM$'&.$03
MA5XK%R)()FOGH(Z\0>GM4O8DJ*JDB@9 ]>EFW8ZEU=NDTD)&1@<D&@Q5I*."
M!&<%L4!M8$YA %2[T= 6,H9^D%I'PX]+HX\2=P.(V9AAOJ*?1Y%SMI8(9+Z\
M$TC$LB QU)#(EDM:5!]\^I"&H2]M>\'*48)N "A?2S?=J_GU!@<TE-94P1)(
M!CF0.J/-S8* -"50<"FYVE!Y3,7031!Z <N1PFZGX_6KE+IF9W[RR8\QTEQG
M-#8VP\@ZRFVTC+A <VD<4?HRXSX(+J+0F/7*UQX+\C)50[=*[055E971@%'Z
M#$L_GD+ZQ<^G& DL7L5X=7$U*1A^"WD<Q\N1#,B)<YHDE= Q=-:14-Z]X;81
M%!3^4=5^)/8R54.W1.T%7I65T0"\-CC8J0.\DMR*4M?E8GGPE#$8Q;"#$@9.
MY9!40"M=__)W'Q*'C>;ZLFL]JJF)'-1CN8V8L5X*CDZ *?4VW&9B1>8H+\8]
M2R!]K-\^]B$5PQ;H]H2F(X7=P$7?K^/I;(YTW[8V]Q94RLF1;$OO?G"&>!L-
MR49D"!9X-+7MTD,:=H**_<&@<I2@&SC?'HOEH-$0+$;NA+)$1UN:ADI+O/2*
M4.:E2X@,7?W8JT/Y3J!T/Q@H!U!J S;OI43QR&>1%8N\],Q1I3D_1C;@(H$@
M$C#JO1 ]UI%OI6G8X_/4U>3'J^6'G9GPJ5/(.2S'T4_N<W/<W(3['WR:V0G/
M,'/D_ 3D>X3+IM)G)#VU_KWE[RJ[@L@18TBB;,FZFVR)=1#P] V",^L!I'E!
MR(>O7O?6!I?X..]>#J4N\_<)YE_.<=F1\UK8I#S1/)9]:#*&+1Q(DERF%),3
MHG9I\6Z4#7.W<R*T/'_G4T59#7B"][GJ6%B\NEJ>HWO[+T@CPX-!CCQ1SA>_
M-D5B(W5X!$@G-4=Y0NW',\]3-,P541.0.THYC4+M_6)QA9R4J,D9:8A09=,P
M:M$9\!R#;65"5,+5;VKZ-#7#7"PU!+$#E-)$MFSC/N-)\RP42SHK38RQ&&"E
ME,MS-925EYIY[G2RM0M.=R!KF%NG@2!76TT-F+8-EAY;::]=D#(0B,Z5R=Z:
MV, "X3GZ(+4"9FOW#GN&G&$NH(9'VE%J:1%A:R,-"0Q7CA*34R*2.DF\B(H(
M;JP,I<%(ZF'BXS92AKEA:@59!ZBC 53=*S=9\]2Q,W+,T,1,($:7KFL<?PF4
M9Q(-[H]H/?Y;;<?_26*&29<-A*PZ*JF&K1-DS&Z;I2QF^7&BL-;8T5U7Z2V7
M=A";]0>3/G?YX)/0'B)1"=#ITA1]?:XD8=PGXWB05-2_SMF!L,JC23DWV7!I
MB4M1$UF\3)=+:VQ@!E@&XTSMNK-&1Y-6PL(+LTGWD7<#9^(M]2N)E)J2V;1[
M>%(&HAG&LTL@2."EE5>VB=A4>!.!>9.$4*'VB[)G"6H$2P=H^BG0'"WV!C#T
M@(?U]+L<;.+)>%0Q0[>@^ 8NX^[23AGO$P0F:F>YMA+2"&:.5_2LMM0;@,[]
MA-RO<!%@/J(R<QM\7-TG2%5&S0N@1&N=0Z8QYU2___AC.H8%3@7U/IO\/$#6
M#>!E(Q)=,Y"<M3Q#(MS),I Q>A(2RR3@_SG.4]"TQQ3G'DCI[25/?:0<)^4&
M8/+$$X U,X)B[*B4)2EYQ#P5I<Y1H[>'H$_1,"=9;<@\2]"P;WOJPZ>>]!N
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MLM))B"@ST2QY(K43Q)KH">C(C$V21ZYV\"*?66+8MT4G]!AKB;F1HWQ1#A#
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M/>B" )H[:]#/MJ$TW67(=[9 HJ2BM ;)GO5W5[@WN<.$*GTBZ&D7LU]=-O%
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MD56(5P<,VG),4DJP<MMIU3$(.1400MLL7"I,/,/8LO$8'+9:_A2WFIV@I(-
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MS]6:9@TN6 &9*^+/<.;+O_A,K">I>O!,K*?(O3\ [0QN,4H8QSQD4Z=L6UG
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MS2E86*4OW]_A-SS;KM$HA5>8!1A9IQ87$2 Z6J@^,I<"-\JGUKV AE$V[<3
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MT\8.W0+L-*5TL"VW\''>7:4)\Z %,L8@2UIGRED#'HL!3E\T3\A1M2X+;,K
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ML.ID27>(EMW2BB8Z8POMO$(3YI7W$ TG3TX6Z^@[EDOK3G^'*9G6<SY=PX]
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M6PH[BN-WO.@FUOQORV^[C4O>]ET#<Y%V)]"\CE8LQH"K_56B=I+K3)*)C^4
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M1+^RGE>E[BMX-*+2!:NC+2]3MUV1H?++T"=3"@ZI?6A!RS0'(., \'D4T@\
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M$H=*TZ[0>(>]AY1I^_R-.V?O.'EW AM:B_?TD9D5K[(L+()WAA8!IR7FL)#
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M?E[4BXD9ZN"#E@I$8!25>%M'\BD/WFL7M<^!J=95.*=1//$0DC'"QV=4X=&
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M<72 +,?6U=$0_(JK^3)_W(35YAE@>-D'+G]:UND$].\___$5%VN<Z9*21\=
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MDQ!01$ ROKFZI[SY[)P!9$T;/8R'K4:*Z E;'\(_?R6W;C4/9W=72]*T<X<
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M8S_GLSU/,RN8E1(1I$:2G*B<J,1!I.2L08GZ;B/-X04&5V_I*VYLA*3&PNW
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M-G<5]*W\MXC]K8P;RVP&;@@D$\JF-\3RZ$GV2NLL0;*GDU..C_J#\,[H_T_
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M.1CC4A[H#6)?EKKME;_&0W=+Z*@=M=K:,6/S#^4W#_/TW__Q?U!+ P04
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MO5X&0ZS170'M_H]6*RZT;$,LF]8,?F) [_-"P.^I#MNBLO>J J@JDRN[S^6
MG(0P"ECB8EQB0^U[(A)9PTK6L-':T\.-G/)2*EI*TM$]9(#^*E1NK! :TSAD
M_/U%#1D[L.62N$=,F?=(10'1:22[$[J'W @[<.F8VOE1^A\SFX!,1)^+I%-Q
M5DUIXQD<_R%Z,+ZBIDN1/*$".<*+ZM?8FH[2S6YE#I ',;%&%&.16(4Q@Y:
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M.!R<!!]/0(P'&X(9<?C1H$4$1.2!O>YP__3D]#T<T(.SPX&[_G!@;@CQ42A
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MV<H.2MI!"FQS_8$M!.4*C7D'3:TYJKK4=Q@:X6BWRDT>D7Q8E+.XF/MS[.&
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M7WHV3=S8Q.V0: LTD9PJ2(JE6$.MRRF?3TG"F80)R N#@<VY:Q,'1]>@1C\
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M4^G^<+7[CZX7->G1_UW#>$=T7*^&DB^!IT*WBCK_BC;.)3786-M+JUK8J"H
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M=_<N&UN[1P5,[3 ;<_.UK,>O[$$$)M.ICE$#PYQ\.RMX "_F=O"K@2HD14F
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M>T=M>?V7>N7DWJ^G)[\$O\&/1ZB9'JN9.%I6)[/]:!1VJD3Z@D5P1M4NJ5G
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M,!^AWR 8 OE?M@?;FM%-&XSW"/NUO4G>6&*%]I&W[GT.1'H]NT3$R1'H2U#
M$^L6J3VQ:?ZTDMK<M&7O-H)P.SA%(R6IZ@54<:E1_!,CR9K3=,F0ZYNPM7HR
M6F%FGWH&NV(NL"?-&*.4*;UHG%B&$,GRD:\R+)[J88(^+B1AQ^:\65NR9_Y0
M_1?9E;W4Z$]>-!/S[3+VL).[G8GUZ%PJYRBS>5MG2+E5XBQ^)\3X0/1\4'YL
MP&H,=A]@LTO6,/RM:,<20BN5PJ5A!<>^UEW2&UL(6\&%OI@!A2@N,2\)]8XM
M^BEDC.%P#(XGV\'O\$%MU8U9C:Y5/ #I3+&^51CH<(M^.M=QK]2QPW9'6G=H
MCHC%38(:B^4\.IXZG/OD0'AR(#PY$%9JA59L@1H.!"\T3_5\/U(MXU-%[3I7
MU#Y;J8K:[[:CM\4'.?S_CO9/OP@=Y$M@0(<JNAP7V&EY2V8XHO_>W#\ P6(T
MH5[_XCW/!.3H'YPR*:">%CZ#2RS: *%>=K#4YTA[\?Y&IC?WLVQA=% &(Z<<
MZTP H*D5D4VMM"AU9_*EM-@TBVX2C%WMU'O].8G@V0U\.U,LX=WIPT-31K9!
MLB> (:X0++%NDW&\4JK&HH?GF"J>V?Q\O_%XM]C.E:W$>533Q^TV#;U-@8?:
MO3C&VJT$C%2NL#*#N)CH4GMEPH1R;8$/I?T[98H/P42HN<Z"\],_2_F80>O&
M LUN-KIL:.,EY22O85%DB)@SFL=UI*55W2SA(5*K/. $1JQG($'*0O6Z"S8>
MVP?]I (+H=8+^83N2^#("3];[BH#J02#!Q":AJEQ\VYTB]3 N^4>(<E5$M<X
MI.M)+@4%E!7;Q7BRT#!V3Q@=:D&6<+>;K2%5CRH9CPIE26C)AVQ> TE%N;UV
M05Q_6$S:+Q&OA[?"*UJ\D^V](DGC2\&;G)3RZQ<MV]TSJ,O;9B*[;N$;4YE*
M6\X*"+/41BEDI'DO6+Z7$^^W2O:@!$R5J(?MC+5%MGYJ*1BT]%!'FNJGV#L.
MQE3]8?WRUT.?[L52;3097(*+;=8G2K6"0\K4&%*_0D*U+I>#Z=SDKWKVLI>+
M^"-L0915/V_A1?=4C+&QN\FP0MV??RRM>^L7T9GK44EBBKT/#W?U]A:NWH7/
M'OTEA$E%!XI1,%K%WE2;!H=.RB>^](:T]6D/?66??2E=@KRQI7R\2+@##W>A
MGB\EP24HUDA[R+]^XW53D@1';4%56K*R5RJM%[7)<BP/4GQ9#>_=4J=7!&1_
MF>J!'0BR/$JFZ-&E9E4((HFX"OE]UJE@5#R%78&S6Q5!BHG$4?+WO^T]?_8&
M-(Z/A'=2\-!U\!_8UXFBVOEA$N=8(T>*NZ+I$$?-Z==(9B:G^QQ.]!R[R<-A
M.H.'/X.'QTFDPP#,J&E>N@>#SJ!B-)*:;\9R:SV%._=>O"E#NIR'#(IWC/7:
M")&4E.CABA"4LK0#"N\V(BPPQ="+?-29>JKQFY_>P,VH6!2U'N+DR6!1HG/
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M2M\'BY].U^*(NRZ*!7/)4&">_KF]O3W,U?CP*KVAO\=7\<$H3NCW49;>YNI
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M8[^<,;DE]]^\;P&+OIS!_AA3&DT93#$P,RVS)/X='Z<[A<V-I+4\&'IL(]U
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MC&W-K1%LGAY?9/28+KT66P?J=_1%)7B5>\]4PP%UFW1O5&&&%X1KKDE'EK4
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M:]P&T.C@3%"+RA>X*1.C.CDVZ ZO+H%88E\>@$($'\ C1,\%+"-)X6 UJ[C
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M!>L5,$UGQ$]E"\R,A@TD!QD:(KDQF+0=KPC'$W\H<5/1?S&;)7HZW'KIZ<-
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M&V6*+K7.X,>Z\F$V\R+?HD?HFTUXHB ["3A 4Z)LBC$IM"PR>C:V&:)%[K,
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MI%>9Z4]X]G.XEFRBO"6.)!2/[!94D!0N#!^^93\.[JJK3Q(!@"*EI!R/'*-
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M)^]BGYE130;:14F#ZJCIJ9M(0*UTJ!X?3) >UD!9E/9HN5D[U5?TY%0B'ZO
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M..9K49B?H3#X)SV^X#"QVX))DQUBG+UJ299%=_;PU@]>SL09-PHPA2RV76(
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M(=#NA!.ZKP+D,<PHTB4E/P2%OJ:0&1/K@.F4@KB6LJQVH,):E1B]0R\/5PZ
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MD^A31>&E%M-HI"86HU%C8<EGY!XW/;/@MSQA2PECK7GW*S@U?)?^C#%^;;D
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MUW^E9XME'97@?CX&P-8] /;Z,0!V?><NC^37*S7$<)T]N7)'&GT3T5:$+%O
MRJ)?,*."2F%L5/\NN;BJ:X4 +*:6 LRV.ZP?6]64:TXVT^=H<)?;%4B7\)R-
M;%DOFN3VERA3)-:JQMA&6DQ1D4!>0(@T0(O5DQE\Z%5B9EF'KG![-DT28 YS
MQ*K[UT\VL9_\LE1 -R63&6) *5V"RTCNU(0PU]1GAT.Y?:>7ZB%4$_6O[".A
MCI@VACH33)!V5:X[/-LZNV5I6(SKOF+BGB2D'E#2X,"]+# ,O!")=G10#Q==
MWB0W.22D$M0OPYM#[!-DY"8:['UFKG[[AH!F6LS($^=%D__YC]<[;_ X_LUM
M8.'OIV_B:.?UBYU0=ST_<>JJKT7VK<-[$R.0;N _WYHN1-:RC2Q0&&R)@9NH
MX 6[3YX\M8<EPZ28%/:K0=5*_4K83@K'3.M:W*:>XXIJ>MW6F<F>GTA+(4<C
M^/D*\$9GD[:I8*PN05I0$7E #\NX!![N=I!X@/B.6.W5 G0D_^BD4636^'%Y
MGC0Y2_W)+)M(N]>-]&VDHL5JC@BX1+3CI0.D#$/I"+Q#DP_7<1J:F&UCK<2N
MT?Z=.<=/[&WLZ33.CY"7@VO-*Q<DZX[DMS63,<GY?7!V\@&QID 1MT?,#YR9
M48_J9+L[H-9A_HAPP1YV9L-98RID=5C'<-P;PTT$$<*WRE]/-\.[M0Q."G:!
M.G0OY;DF!" YN[9^5G9<%F%3K8HL<WMKOF3R5-@Q#G>C0G=V+=]);$LJA'-7
M#D[MG%H#M<*M*U\*=S/3JJH%%XLX%6;P"BJS@<4*8<'ZH'_:VLVFUTO!!W*"
M_UULC7%Z&[O/ND7POBH3-#,3J" O-N(X%1P>*N!@^GO]*O#IBM1S5I0$TDI:
M:"X1-P.37KZ-"_$O#5>H5EZ@?-GF&&E@I+T!M#(MY@S \E^G-CK\:VA*3C4M
M*0IF6XWB"RQ604%!.P2$ZHOK6?0$(FJ#W42"C4]X9)XTHYCYM?B.R:QHDRN6
MH7BN&[K'EB!6'9*+65,B.?6F1WGG(Z1@^SQ"L>HXUI!H'!HZLH38.(+-U)!K
MX7H[04)D.C<<E&L3?$D6QM0S$Y:7.AVSB7W:WTI\.Z:-H'#GQD3[L"6AGPY#
M< R=$"KJ,)D:Z>#T.TDP=+0V-X?EHL,E=G&#OCQ>NJM^VH DWVBY\:37>5S9
M(11B/A#.V.;^&+TO5&?ICOI]X\Q-L%(HAQTU;U@O:WO6H.X()FM#L9OU2,Q[
M<%=AX'4J[60Y$#OKJ9!:D9ENHF/#HLPI]00](R*\^*9XE@\\)I@V_ O!S0E,
M"C: ;<^F%IBE(5U^KV'-/2OI0"8'ME5OG0_F8@C4)O<Q[^1E.$O2O!G_W?-R
M.%98'>82O6,%8$8](DE*P64?+EQ40AJ^CGN\ -=M LZ/EE]CHP4XF1GGLJ"Q
M)IHZL:^@.VUJH!O'+I]PVK,&4IV1,U6D1LUUKC*2MO 1-^GR]Z+='=Z\!HNF
M++Z,94'(PTAT%W8C6>P6+,3I0XT?KIB@79H4*P!G3[3)&KHU1;4!UIQ\AL,"
MRHC;'2]L_BFH<R@).M/Q:FT;,R]:)?W2)BB95"9)3^J1^#&I1IS*I=%J-H5=
MW3WQ6\9CF1]'O<QV]F<!MC,C255Y#'>M>;AK]\ECN&OE!I&R#7?1W.M^9M#A
MJ'VWJIU2O7H,FPWLT*2MG&I?P#[]GMXV4KE)(D&EB!#NQ&3"5CNHXNO+M&@P
M+]IB.+9=<YC@-L9:4^)2E)?8^T:!U!VK-&MC7Y.0=BFVE?1FS+4!ZI4\XQX9
MV &7!-U.(*BW(U1#*(]25=0/JS;=JTUN'5F7;*TZ_9JGKT;U:B6E-S6TI:FP
M L([YD2 MWTM,6%/VXZ#>1.4WN,?<%$:>4"\E9;(_-Y4U+7%@G2$%TOW)A3V
M99TFU^1BWL-V[)*![-^M*5 W%_CKI.VFB+QE."\%B'#]6<^X7:A]PE-**>,\
MS:B<W]:N]]$YP[+N%?/4U>/9C!7\XQU6A)YMO3*]W_GIRC0\M=Y_+O)(,[]Q
M_,?MLVU_ 3CF@<EHW[,)SRWL@.&"W$]P,5'-(YZ1%2-05*;-C'K0LS:,X4CT
M^Y;W(A'N?'#4!46[R4V;J7("(E5TGIU^L.>UNWQWGQ('-\STW"4:JQJPS<1@
ML[ZT%Q8TV847GK]Z<P\/XX>?4=$V#N).+8SU:(+VQO[DH,@7/_!*H^:X;6R8
MC(LL*ZXH$-AJ^!!N662:(,71"4VA!2CL^D;'D>E.)T]@>H(D^,71*9!3,R?.
M\J$ 6QJ$UZ&'X"OB]XS4&#4RHU-<U^D5<>1*K,G]S];WWK1(>9@C 2WYM\Z;
MI1+P6_.(_W?P87"\5KSLH2;2_S;X[\%OOYZ=WW*['Y6?KY"HG%8,ET,EJDF"
M+,>DP:.U8!I7MG%L.@!"Y X,$(1L#TG46'IJL]A](?'4=I[,+1K+=O.K6(DZ
MEOI?JPWEHAJY!U#3(V B8;%)3#]*Z*6+*-=L  RU]P.9Z;'!&GBK\@N<RF_J
M3W5!I0GM;>W'"P+-$607@16,TGEJYB\Y#?BKB<YUB=A*V*?-X1)QD,="'?DO
MO@=W_>C@[>#XI'O1'X8+_A[R@.\6I8!!5H@SV(ZV'M@8>6.H*%:ZVBY!%8,;
M>:2'*H?+Z<>*\8B/BVW0:7>B#:S+D%9))MOY/0U-I #*\8F,[0<OV.P#K6FH
M\:WD +<X;E_ C^\#=W@_.!K\<=OZQ7O$ [C3@U6P39S_P*2+PM%^4.2EA-GL
MMW*,WJM,+:I4(7Q&QG4_EZ@P1V\+&'4-&B300JDXK]T?@4/7IGO\J+U^^EK@
M'=@W"(?(!7[48QZ#-?1GE''E@,E8<3!Z"/H^4LY%H;TM14<Q%U=3A@FF=CAT
M#?C#A<U4"5HS#-'G"%6?)8F6!D'\?9CCGT&:$C.36QT;;-V&:2PD;I9P:08%
MA5K%LC(EF\":!%K5#&JTO=DY!FY.,7Z,^*Q]Q&?G,>*S<H/\& 9Y4LD%CXY7
M<]'E5KC(AF,.'OLQF6NWA_5Z8.KHGBM_W,/,PA'']C]@Z+JJ#//UV[)_, BG
M^ZI6Z^5-E.0NSY7XO&L>"K8&AG9*72]6NQ8?$5/O-S_=72]^^O._:H8;-@=>
MPD7<@MW($,K^)_./-XC<#NK"3VE.:Z*'WH1N[N<P 6R1@[YBV6K:=?[:S6W[
M"<^OADG5B7FS?+U-7_U8)]WOGKW:?OUD^==/MG>6?O>5AOV1ILS3AIVIP*#Y
MKQ^>_M#:/'-IMF%#P(*C=!Y#6/(3ZK:WZ@=U,>__7OKU_;0[_QSMA&$%'+1S
M ,4\))JPW]_V2SPT\QDE%\F'-[\> P34_NLA"<E0TY\Q,RZM)=C0Y&HV3"<-
MYQQXE?&<8^S$0U-Q9IH)VU.2.(G@LLC1'V7T:E148YNU:L&Q$Q =?;TI/0
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M6#+B^I9K+9Z<]I<O3S.',S$_L%)F@O'%C%XT2>UU$+[RD7]E+GBFAREZMY"
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MQ<B.C>W4EJV:MM+O7T\7P=?3RR%'?PTV14GE(P2D]Z.<X2_<6CK6])4:&/%
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MJQ)&\F+DSUHE:SWX)TL&GW!@=U($*IE@_RQB4:Q*>GDH>5*0C=B3 R=?V]7
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M1P0DG<;7:P_C901RI@90[T5>IS&1,^<J4*I"#-" MQ:F35S(<* .V&TB1XD
M\+,YW'FTP>*2_H)"DNY<KOU4?4JF=4,A]G$!;U@W3J7<2OU^_D#]>(D*I&C
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M)OO\(86.QU$(6?)X.,J>YQ^Q?6)Q:5,L.6NE9Z"FB8+WSMYM<B<;?V8>C'X
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M9RL!J3Y7";;C_C6_@#<K:,HF0<Q/'#2W<_3/173)58E@-AVB4M%'. \3/B7
MRQ+L-S5SLQK_49HD/%'7J*2U#W6TMW$VGCB*Z"]E4N;JC"H7"#AV_P!KE]-
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MHDYU=T0VDREQ!:\,U)P/7 ;HE^ <*^H&T>ZY;AZN@.QENHW)#W3W,RY^M9;
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MLDG^4B[YJR^>?'4LN=NW>%X8^PL'FD])]G@1NFX\F9U%X3P_4>A[B1J19</
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MC?7UPBM8PLM^^.[5^OK:&V*>(OO@B\&;Y3" ]8>ZNM0Z"Z[R.E!9',PUY\)
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M@R]"@]^F=KWQP%#Y%+XI1XJ5Z*;\6?E9E< ''8+?,R*?-KFOAX ^IL7:*,6
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M3-55CF0%"G?#&FB&BML\$].V)EDR:K*ZGM8LZAP=/55@?L87-[Z'!'7[6$V
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MB,H,(\NPL"T@$NL-^=4MQ<H.EDE^=E!^T629,860=.5O\<?LB+8' ,\+%U,
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MNK##YWU3@J\'6HN52W2_!\%M.N_2)+-V#KEK!NQ%/7"6M4VG@=UDMZ2R69Q
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MLLGX4B[CJR^4?'T8N=NE>%8$^PO'F,](]GC!N6XHF?U$X2P74>@[B!I!9</
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M+S#1M7N%=[JGC6+$E>*I[]RHA)'D2:;N5WE$X=X:Z\:P:E&#GU!+ P04
M" #F@*16J335,1<)  "A40  &P   &5X:&EB:70S,3$M8V5O,S R<3$R,#(S
M+FAT;>U<;6_;.!+^?K^"ZV#[ MBRY;<V3AJ@35)L@&V[F_6A=Y\.M$39O%"B
MEJ3L^'[]S9!R[-A*8K=)(Z,*4-<6AYSAD'SFA:2.?SG[<CK\]Q_G9&)B0?[X
MYX??+TY)K=%L?NV<-IMGPS/RV_#3[Z3KM7PR5#31W'"94-%LGG^ND=K$F'30
M;,YF,V_6\:0:-X>736RJVQ12:N:%)JR='.,3^&0T//G'\2^-!CF301:SQ)!
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M]4G@>R"R$-H$Z%G!@#K %D=O)P7D0-!#,!1BB6HYH.@UU@"<H<T4U9$B$T
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M=^T/5T9O)Z.W=82Q8?NVCTVV-H%@-J<\1,M&M4SLYC+58!4QTXSFCJIP87K
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MYY/ ]T"F#-H$Z)G#@"+ ED!O)P'D0-!#,)1RAFH9H)@%U@"<S*5\BDB12B
M*%. -XZ=<?($U Q)*-783'%.\X$P5E-@1/&AEQND+,[!E9D*LR1MCE@Y8CTM
M8C761ZP?')%ZMY;O6Y.A399:00=$A1 (P2-<TEU"-7?@ 6 @,*4!BYQP@YD*
M889(CF01.%_H@.%O)DP@E4FA'KIE&@;"T21:!9S!8T/> 6@P#BCDD>'B.AC2
M>,#)1_!X+E/)31:E[=-2K?F.OW?U:TWF?_F? A,ML8<P9$+0-YI#-H\T*-!F
MW,);W$+@ACU>!#V@P*#S=A)J"X%L*[GL$AR^C&97  <VMQHU7BE?NR$BT_?3
M=?$:*.>7]/SGPO[-:T[A73 3Y]R  ("8+G!]&-.+&%,'-#7K5\'@ML\!FC-.
M/EQ6*8!G"A[D2!CGEP(5CUT[F/:?>;3S7K'FDCJLS^+E&507,X\9"P5XMR"+
M&Q2W*VG2OA%,4"VP \)']<Y/C[&EU&"D[>RC<6&Y\V*5X02SA=952B@.6"HI
M.M_0+2?$+&*'&C[^GT];P+<^1T+PCZ$^9UOO#V\EE]R,_ !FI+]E9F0'-E"K
M=VWTYD9O(Z.W=H2Q9/O6CTW6-H%@-D>"H66C1L5N<YD:L(J8:49S1S6;FAXP
MAH+VA11V@OF:56S1$#LKY0R0MZ&W2.<RU2[@N\XZE*0Z 0-H7'XI"&#@G0 N
M9SW@,==4@AV$$IZ@@462-+;>UH$A%HD+MW)KEUN[W-JM *!@!ZQ=;D4>4./%
MB,K4Q1<(L3P,>6#%",#1K,B?OS7K1$K^Y^IDNC,74!&B'.-3]GV5VKMYKQ/+
MT1MJCOL1X<.;D*0_W>EP%I!['4Q/42"#'/%SQ,\1?Q$L6([XNX_XYQY2EZ$9
MSZ-DNPVN9 'Y-X@3,/6E@B#5"+US>:9;[47*6'B"AU"A%0.J(7_Y<W#DW1)Q
M"'8#O/8%NDS, -#<'9S!,S5Q>B/+>R_)D)J;1!SZ^\[.<.8"(=?[+$B9$"FN
MN,Q.T2S0%[]#(;E5N9M+OE>]W7O5S7RO^IGVJMTY8#8%X^+,)T47>1X<9^XI
M@MP&B9ZE_040BJ9,6*7-35;%/8#&HDA8R_E*I[^OJ':>-1,@DZO^#L 3?&R#
M/CS\C[L;4Y3G?Z4"1':XGL:!.YKS/M]\SKWJW*O>B<WGW*M^A!H_2DDP+X[W
M,O#0#9[AP8L:\,]DIXZRK> QIU>8XO!Y:9?D<!EU=\Y[>I9Q(Z3/=FW]X:<5
MSBQE4-'P&U]VA57(,O! K/%")I@CEV$QIDA,&D54@RI<-[)88>5YS]S/W16<
M_SZO>SM\_Q_.3NS"[O)6!WP[84?B"0DU..5%0'7N(@BP"^[6369 BCZK(>*1
MDB..J8V8#K++0SH+.GB42#7A4#H>*A]IT%OF"<S)=V9YRLL@7W%7@I_W@O,+
M7U5NEP^J!X^ZJMPJ5]>\_OM"S=Y75B_7&D\O;*-:;C;J3RYLK=QLW<UT@XO5
MSV-F'$0M3BT_JUXKXPO(L1Q_;[MI?E65_48GI%%TKWI97VDODQU\5;TLV/Q'
M7$7*1'P5:[]UT^S-7N/@R+C/Y5>(K(JBGO7FUX\P0_-%NUWW![/.[YA&\[7Z
M*FLU5]E6K^4=-, 7USQ(\= 9^9<(./FJN1&,9Y<FSX:"A^333>S[Q>_?;1#X
M+KRQ+U'^E84=?P5HQ)?>X3<;/3=LU5D5V@<MI_;N*AN\#NS6IW\]H7M1XLG?
M4$L#!!0    ( .: I%;VJFE,"P8  !,K   ;    97AH:6)I=#,R,2UC96\Y
M,#9Q,3(P,C,N:'1M[5I;4]LX%'[?7Z&&*:4SQ)?8(==F)@0S9 9(2\RV?=I1
M;#G6UK&\DD+(_OH]DIT"@;0IA1;8,$PF]I'._?)9<?O5P:#G?W[OH5A.$O3^
M?/^XWT.ELFE^='JF>> ?H"/_Y!BYAF4CG^-44$E9BA/3]$Y+J!1+F35-<S:;
M&3/'8'QL^F>F8N6:"6."&*$,2YVVN@.?!(>=/]JORF5TP(+IA*02!9Q@24(T
M%30=HX\A$5]0N5RLZK%LSNDXEJAB51STD?$O] +G=$EE0CH+/FTSOVZ;6DA[
MQ,)YIQW2"T3#=R7J-,*H'@:X7K-=%]LA=HC3B!H6&57<6JUF_66#DB8LS_<(
M.4_(N]*$IN68*/E-MV+4JIELS6@HXZ9M6:]+>FFG';%4@CP.^_.O.9M;S"2Y
ME&6<T'':U":5\JT+<L 2QIM;EOYK*4HYPA.:S)MO?#HA IV2&3IC$YR^V140
MAK(@G$;Y0D'_): 3J*<O9[G*->"3T)0L3+ KUNN6UB(D >-8Q;$Y34/"U:I2
MQ_MTU-_O^\BI&/9-6^ZVXN^ID#2:/[H=[AUVE#K;6_:>U=KH^3!Y4>KTO#._
M?]CO=?W^X!0-#E'OJ.\=(N^3USOW^W]Z< NHWAFTB+/A>??41_X V75T;@R-
MGO'T[1MZ/6V9[50MU!VB[L'@O>\=W#!GL:9A[2D/^$?>,["K>[;?/?6&Y<&G
M8^\SZO9\I7K%LBH_KOL=;>PIEE0_10%+4Q*H#H9F5,9(Q@1]F&(NH9G-T1G)
M&)<(B(>,3_(*M*WR!\0BM,^$!,(PH# U:$0#&#(\*]HAVE&,MK?JE8K5ZK%)
MAM.YOK);;U'$N):3@=8L1 0Z9XA., _B7()C[^9C"@L4T02(7U4;DF#*87""
M#W :(N\RB'$Z)B!Z,J%"*,GPKU:&, Q13#@!5:\KDYNTT&57K]6]6T \0%0O
MIB0"QB!(T@N"!A&81KBR6"TM;-&<1W,$%&4[$;LHFW(QQ1!$R:[*62FL_%&X
M#DIF5UF%0Y:I67U]SXV5JG *B4/,1S@EHCRX3,@<=0.I*"HOE?)8HA$6P K,
MCJE 7U(V X^-R?96M7Z/;KEVY@80=<)AE\2CA"P6C!@'5Y8A@1.<"=)<?&F%
M5&0)GC=IJM-0;VI-,!\#,A@Q*=FDJ5#!A?)G@)-"B):7DPO T'"->MU1F$&"
MGC)<""[@A*'AA"G#V[0]PW;ME53+6$W[%E?'L/964^_+M5XSW$9C+;:F]D/N
M"_"V@.Q\5W)*2P%)2 1%GT&'80D-T5:D_UH9#D- B\U*=HF VKJ=%LL1R8/Q
MZ_N5=0<$*%SS"ZR6+'L\DS7')I4@*EC#"3OVV]P/US]_VB<%E>>"GGNBJ+Y9
MS*YHFL @"Z!M)VIJ?)TDG/PSI9RH1QZA&NI2H][!A9=A5MG5G7!Q%2V/H:\C
MJ&C,=L-QH?<V6FI W0C+>I5:-,.5$?IV_"!1OQ$]2\6NM$Z6/*86S[3L*C]5
M=C_GT%5E^<#^_NTU2U/ AI,<00(RE9@J2$9S1+<H:$P5-,TX$:IV=Q49)PF"
M;2 8)U#9(H-B%CFVBVB*TT#=!X:A/G/1T!%639.\]!D 42U3?!?7&K<KVM18
MY@4^'?@*3Q8 -\AC(F+EZ90!Z 2$3:![AH"K';>E8;K^IM&]0LB ;3,FR"XL
MY\5&>GT?0-Z1BGA0>!=N :#F) )DG0:* BL4(^"M3K0T2%_NOE=-UT'L%O6N
MW@P2QIB'"1$ZVDK F*20 ,DU792M">R<XK%2!(EI$!=ZK/6$_KO <<UP]NKW
M <>NX5:K#PYC7=O8:U0>G&W5,JI5Y_'1\4OJK@\+$_^7+MF,\'MX=%. A6_V
MYS=/9);3;>]A'M1>DLNVM]Q:2^A/=$)AE),$'1KH!,<L)?--FOWR/E]H_\Q<
M\IW4>833DA>>4)MBVX"J52Y9\?/)IN(V%;>IN&?@DDV!/?E3\:?FNZ?D,L7N
M2?GK!,^1F[_.L#EI>/P2_O'#^"?R&MLZOPPLO4&9L?P5TB8G"59@Z]8[E5=I
MI?/)NMJ"1Q#^J5R]Y:[#[!4:WOC,7Q?5+ZYV_@-02P,$%     @ YH"D5K)2
MK204!@  H2H  !L   !E>&AI8FET,S(R+6-F;SDP-G$Q,C R,RYH=&WM6NMS
M&C<0_]Z_8HLGB3-C[@&'S2O,8(S'=!SC&-(DGSKBI ,UQ^DJ"6/ZUW>E._S&
M]3AV:KLPGAN.E?:]JY]D-7_=ZW>&WXZ[,-'3&(X_[Q[V.E HNNZ7<L=U]X9[
M<##\> B!X_DPE"117'.1D-AUNT<%*$RT3NNN.Y_/G7G9$7+L#D]<PRIP8R$4
M<ZBFA5;3_()/1FCKE^:OQ2+LB7 V98F&4#*B&869XLD8OE"FOD.QF(_JB'0A
M^7BBH>25RO!%R._\E&1TS77,6DL^33=[;[I62',DZ*+5I/P4./U0X%%880&K
M1;3LTR!BM6JE,AKMD HA84@)J_WAHY(N#L_F*+V(V8?"E"?%"3/RZT')V:FD
MNC'G5$_JON>]*=BAK68D$HWR),[/OF9L;C#3[$P72<S'2=V:5,BF+LFAB(6L
M;WCVTS"48D2F/%[4WPWYE"DX8G,X$5.2O-M2&(:B8I)'V4#%_V:H$ZIG7^>9
MRCO()^8)6YK@E[PW#:L%9:&0Q,2Q/DLHDV94H=7]>M#;[0VA7')*5VVYW8H_
M9TKS:/'D=@2WV%%HO=WPM[W&6L_'R8M"J],]&?;V>YWVL-<_@OX^= YZW7W8
M[QVUCSJ]]B'^A-3N";:(D\'G]M$0AGWPJ_#9&3@=Y_G;-^AVK&5^N>)!>P#M
MO?[QL+MWQ9SEF)JW;3PP/.B^ +O:)[OMH^Z@V/]ZV/T&[<[0J%[RO ?4\"UM
M[#F65"^!4"0)"TT'@SG7$] 3!I]F1&IL9@LX8:F0&I"X+^0TJT#?*WX"$<&N
M4!H)@Y#CJL$C'N(B(].\'<*F8?1VHUHJ>8V.F*8D6=@WO_$>(B&MG!2U%A08
M=DX*'XD,)YF$LK^5+5-$0<1C))ZK-F#A3.+"B3X@"87N63@AR9BAZ.F4*V4D
MXY\927$QA F3#%6]K$QFTE*7+3O6]FZ%\4!1G0EG$>SSA"0A)S'T(S2-26.Q
M&9K;8CF/%H 48SM36Y#.I)H1#*(6%^5L%#;^R%V');-EK")4I&:MOCSGRDA3
M.+G$ 9$CDC!5[)_%; 'M4!N*R4NC/-$P(@I9H=D3KN![(N;HL3%[NU&I/J!;
MWCMS0XPZDSA+DU',E@-&0J(KBYC ,4D5JR^_-"A7:4P6=9[8-+23&E,BQX@,
M1D)K,:T;5'!J_!F2.!=BY67D'##4 J=:+1O,H%%/39>"<SCA6#CA:GJ3MNWX
M@;^2ZCFK:7=Q+3O>]FKJ0[E6=YR@5KL76]?Z(?,%>EMA=GXHE O7 A*S"(L^
MQ0XC8DYA([*?1DHH1;18+Z5G@-3&S;2X'I$L&#^_7WFW0(#<-3_!:BW2IS/9
M<JQSC:+">SAATW^?^>'R\X=]DE-E)NBE)XKIF_G:%<UB7,A";-NQ637.5Q+)
M_IIQR<R61YF&>JU1;Y+<R[A6^95-NGR+KB]#YTM0WIC]6CG WEMKF 7J2ECN
M5ZEY,UP9H;OCAXEZ1_0\$[O"?;+D*;5XH657^J&R^S&'KBK+1_;W?UZS/$%L
M.,T0)")33;B!9#Q#=,N")MQ TU0R96IWRY!)' -.0\&(V)"08C&K#-M%YT@.
M&5)[YF*A(XZ:Q5GI"P2B5J;Z5USKW*QHUV*95[@[&!H\F0/<,(N)FAA/)P)!
M)R)LAMV3(JXN!PT+T^TWB^X-0D9LFPK%MG"XS"?RR_,0\HY,Q,/<N_@3 FK)
M(D3626@H.,(P0M[F1,N"].O=]Z+IED'<H-[6FU'"F$@:,V6C;02,68()$%_2
MQ=@:X\P9&1M%0,W"2:[' W;HSQY35YURS7\(I@YPXLZCH]^@Y)2JC\^VXCF>
MO_WTH/HU->7'19?_2Y>L5_X'>'1=@+EO=A=7#W*NI]OVX^SO7I/+WFX$.PUE
MG[!'$LYB^,V!7405B 376?;3VWRN_0MSR=V9\P1'+*\\G]:UMH94JUS2/<,]
MF^:G#'[GN/,[QKTYI^9.@]FHK_B'S+H<U^6X+L<7X))U@3W[<_;GYKOGY#+#
M[EGYZR-90)!=D%@?0CQ]":\\WK]VGS$5V87.NF0Q,5CFQ@W'BY#86'@74\@(
M73?3JZ?<=D:\XF3YRC.[O&FOD;;^ 5!+ 0(4 Q0    ( .: I%9-?=-'HY4"
M %1%'P 0              "  0    !B<W@M,C R,S S,S$N:'1M4$L! A0#
M%     @ YH"D5EE*>@.A$P  +M0  !               ( !T94" &)S>"TR
M,#(S,#,S,2YX<V102P$"% ,4    " #F@*16&3R]T38D   .9 $ %
M        @ &@J0( 8G-X+3(P,C,P,S,Q7V-A;"YX;6Q02P$"% ,4    " #F
M@*16[*S[E!"8  "F9@8 %               @ $(S@( 8G-X+3(P,C,P,S,Q
M7V1E9BYX;6Q02P$"% ,4    " #F@*16@-9V?L A 0"G6 P %
M    @ %*9@, 8G-X+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4    " #F@*16
MN86F%26Y  "[$ @ %               @ $\B 0 8G-X+3(P,C,P,S,Q7W!R
M92YX;6Q02P$"% ,4    " #F@*16+Y82#*B6  #4LP, '@
M@ &3004 97@Q,#(M,C R,V=R86YT>&YQ86=R965M96XN:'1M4$L! A0#%
M  @ YH"D5J+&'!;QF   (;0# !X              ( !=]@% &5X,3 S+3(P
M,C-G<F%N='AR<W5A9W)E96UE+FAT;5!+ 0(4 Q0    ( .: I%;BM]D1BS@
M "]H 0 >              "  :1Q!@!E>#$P-"TR,#(S9W)A;G1X='-R87=A
M<F1A9RYH=&U02P$"% ,4    " #F@*16PR*. %TX  "B9@$ '@
M    @ %KJ@8 97@Q,#4M,C R,V=R86YT>&]N<V=A=V%R9&$N:'1M4$L! A0#
M%     @ YH"D5MX1<?7+ @  _0H  !X              ( !!.,& &5X:&EB
M:70R,BUS=6)S:61I87)Y:7-S=65R+FAT;5!+ 0(4 Q0    ( .: I%:I--4Q
M%PD  *%1   ;              "  0OF!@!E>&AI8FET,S$Q+6-E;S,P,G$Q
M,C R,RYH=&U02P$"% ,4    " #F@*163-LE*"$)  "#40  &P
M    @ %;[P8 97AH:6)I=#,Q,BUC9F\S,#)Q,3(P,C,N:'1M4$L! A0#%
M  @ YH"D5O:J:4P+!@  $RL  !L              ( !M?@& &5X:&EB:70S
M,C$M8V5O.3 V<3$R,#(S+FAT;5!+ 0(4 Q0    ( .: I%:R4JTD% 8  *$J
M   ;              "  ?G^!@!E>&AI8FET,S(R+6-F;SDP-G$Q,C R,RYH
8=&U02P4&      \ #P D!   1@4'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
